PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hader, SL; Smith, DK; Moore, JS; Holmberg, SD				Hader, SL; Smith, DK; Moore, JS; Holmberg, SD			HIV infection in women in the United States - Status at the millennium	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IMMUNODEFICIENCY-VIRUS-INFECTION; GENITAL-TRACT INFECTIONS; SEX-DIFFERENCES; HIGH-RISK; CLINICAL-MANIFESTATIONS; DEPRESSIVE SYMPTOMS; DISEASE PROGRESSION; VIRAL LOAD; DRUG-USE; CARE	Context During the past decade, knowledge of human immunodeficiency virus (HIV) infection in women has expanded considerably but may not be easily accessible for use in understanding and prioritizing the clinical needs of HIV-infected women. Objectives To perform a comprehensive review of epidemiologic, clinical, psychosocial, and behavioral information about HIV in women, and to recommend an agenda for future activities. Data Sources A computerized search, using MEDLINE and AIDSline, of published literature was conducted; journal articles from January 1981 through July 2000 and scientific conference presentations from January 1999 through July 2000 were retrieved and reviewed for content; article reference lists were used to identify additional articles and presentations of interest. Study Selection Data from surveillance and prospective cohort studies with at least 20 HIV-infected women and appropriate comparison groups were preferentially included. Data Extraction Included studies of historical importance and subsequent refined analyses of topics covered therein; these and studies with more current data were given preference. Four studies involving fewer than 20 women were included; 2 studies were of men only. Data Synthesis Women account for an increasing percentage of all acquired immunodeficiency syndrome (AIDS) cases, from 6.7% (1819/27140 cases) in 1986 to 18% (119810/724656 cases) in 1999. By the end of 1998, of all newly reported AIDS cases among women, proportionally more were in the South (41%), among black women (61%), and from heterosexual transmission (38%). Of note, increasingly more women have no identified or reported risk, about half or more of whom are estimated to be infected heterosexually. It is estimated that a total of at least 54% of women newly reported with AIDS in 1998 acquired HIV through heterosexual sex, including women in the no identified or reported risk category estimated to have been infected heterosexually, meeting the surveillance heterosexual risk definition. Natural history, progression, survival, and HIV-associated illnesses-except for those of the reproductive tract-thus far appear to be similar in HIV-infected women and men. Although antiretroviral therapy has proven to be highly effective in improving HIV-related morbidity and mortality rates, women may be less likely than men to use these therapies. Drug use, high-risk sex behaviors, depression, and unmet social needs interfere with women's use of available HIV prevention and treatment resources. Conclusions Continued research on HIV pathogenesis and treatment is needed; however, emphasis should also be placed on using existing knowledge to improve the clinical care of women by enhancing use of available services and including greater use of antiretroviral therapy options, treating depression and drug use, facilitating educational efforts, and providing social support for HIV-infected women.	Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hader, SL (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, E-45,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	sth5@cdc.gov						ALTICE FL, 1994, 10 INT C AIDS AUG 7; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], [No title captured], DOI DOI 10.1023/A:1022359307814; AVIS NE, 1997, 1997 NAT C WOM HIV A; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Boxwell D, 1999, 39 INT C ANT AG CHEM; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; BURACK JH, 1993, JAMA-J AM MED ASSOC, V270, P2568, DOI 10.1001/jama.270.21.2568; CDC, 1999, MMWR-MORBID MORTAL W, V48, P1; *CDCP, 1999, HIV AIDS SURV REP, V11; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P861; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P846; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P845; *CDCP, 1996, HIV AIDS SURV REP, V8; *CDCP, 2001, MORT L285 SLID SER T; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P409; CHIASSON M, 1998, 2 AIDS MAL C APR 6 8; Chiasson MA, 1997, OBSTET GYNECOL, V89, P690, DOI 10.1016/S0029-7844(97)00069-0; Cohen M, 2000, AM J PUBLIC HEALTH, V90, P560, DOI 10.2105/AJPH.90.4.560; CONLEY LJ, 1999, 6 C RETR OPP INF JAN; Cu-Uvin S, 1999, CLIN INFECT DIS, V29, P1145, DOI 10.1086/313434; Cunningham WE, 1999, MED CARE, V37, P1270, DOI 10.1097/00005650-199912000-00010; CURRIER JS, 1997, 1997 NAT C WOM HIV A; DENKE M, 1997, HARRISONS PRINCIPLES, P451; Distabile P, 1999, J URBAN HEALTH, V76, P435, DOI 10.1007/BF02351501; Dong KL, 1999, J ACQ IMMUN DEF SYND, V21, P107; DUERR A, IN PRESS AM J OBSTET; ElBassel N, 1997, AM J PUBLIC HEALTH, V87, P66, DOI 10.2105/AJPH.87.1.66; Ellerbrock TV, 1996, OBSTET GYNECOL, V87, P1030, DOI 10.1016/0029-7844(96)00047-6; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; FIORE T, IN PRESS AIDS CARE; FREEMAN TJ, 1999, 1999 NAT HIV PREV C; GERVASONI C, 1999, 6 C RETR OPP INF JAN; GREENBERG AE, 1992, AIDS, V6, P849, DOI 10.1097/00002030-199208000-00014; Greenblatt RM, 2000, J INFECT DIS, V181, P82, DOI 10.1086/315207; Greenblatt RM, 1999, SEX TRANSM DIS, V26, P143, DOI 10.1097/00007435-199903000-00004; GUINAN ME, 1987, JAMA-J AM MED ASSOC, V257, P2039; HANKINS CA, 1992, J ACQ IMMUN DEF SYND, V5, P957; Harlow SD, 2000, J ACQ IMMUN DEF SYND, V24, P68; Holmes R, 1997, SOUTHERN MED J, V90, P697, DOI 10.1097/00007611-199707000-00009; Irwin KL, 2000, OBSTET GYNECOL, V95, P525, DOI 10.1016/S0029-7844(99)00621-3; Junghans C, 1999, LANCET, V353, P589, DOI 10.1016/S0140-6736(05)75645-2; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Klevens RM, 1999, AM J EPIDEMIOL, V149, P75, DOI 10.1093/oxfordjournals.aje.a009730; KLOSINSKI LE, 1998, 12 WORLD AIDS C JUN; LEE D, 1999, 6 C RETR OPP INF JAN; LEE LM, 1998, 12 WORLD AIDS C JUN; LEPRI AC, 1994, BRIT MED J, V309, P1537, DOI 10.1136/bmj.309.6968.1537; Lichtenstein B, 1997, ADDICT RES, V5, P279, DOI 10.3109/16066359709004343; LICHTENSTEIN K, 2000, 7 C RETR OPP INF JAN; LINDEGREN ML, 1994, PEDIATR INFECT DIS J, V13, P525, DOI 10.1097/00006454-199406000-00012; Maini MK, 1996, GENITOURIN MED, V72, P27; MARKSON L, 1999, 6 C RETR OPP INF JAN; Marx R, 1997, J ACQ IMMUN DEF SYND, V14, P44, DOI 10.1097/00042560-199701010-00008; Massad LS, 1999, J ACQ IMMUN DEF SYND, V21, P33, DOI 10.1097/00126334-199905010-00005; MASSAD S, 2000, 7 C RETR OPP INF JAN; MELNICK SL, 1994, JAMA-J AM MED ASSOC, V272, P1915, DOI 10.1001/jama.272.24.1915; MINKOFF H, 2000, 7 C RETR OPP INF JAN; Mofenson LM, 1999, AIDS, V13, pS205; Moore J, 1999, AIDS, V13, P2459, DOI 10.1097/00002030-199912030-00018; MOORE J, IN PRESS AIDS BEHAV; MOORE J, 2000, 13 INT AIDS C JUL 9; Neal JJ, 1997, J ACQ IMMUN DEF SYND, V14, P465, DOI 10.1097/00042560-199704150-00011; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; OHMIT SE, 1998, 12 WORLD AIDS C JUN; Palacio H, 1999, J ACQ IMMUN DEF SYND, V21, P293, DOI 10.1097/00126334-199908010-00006; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Prins M, 1999, AIDS, V13, P2361, DOI 10.1097/00002030-199912030-00007; Rabkin JG, 1997, AIDS, V11, P507, DOI 10.1097/00002030-199704000-00015; Rompalo AM, 1999, J ACQ IMMUN DEF SYND, V20, P448, DOI 10.1097/00042560-199904150-00006; ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; Solomon L, 1998, J ACQ IMMUN DEF SYND, V17, P253, DOI 10.1097/00042560-199803010-00011; SPENCE MR, 1991, ANN INTERN MED, V115, P827, DOI 10.7326/0003-4819-115-10-827; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; SUTINEN J, 1999, 6 C RETR OPP INF JAN; TURNER BJ, 1994, J ACQ IMMUN DEF SYND, V7, P1250; VLAHOV D, 1994, AIDS, V8, P819, DOI 10.1097/00002030-199406000-00015; Weisser M, 1998, J ACQ IMMUN DEF SYND, V17, P404, DOI 10.1097/00042560-199804150-00004; WEISSMAN MM, 1992, PSYCHIAT DISORDERS A, P53; Wilson TE, 1999, AIDS, V13, P591, DOI 10.1097/00002030-199904010-00008; Zhou XJ, 1999, ANTIMICROB AGENTS CH, V43, P121, DOI 10.1128/AAC.43.1.121; Zierler S, 1999, J Am Med Womens Assoc (1972), V54, P79; 2001, GEND HIV VIR LOAD WO	88	190	192	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1186	1192		10.1001/jama.285.9.1186	http://dx.doi.org/10.1001/jama.285.9.1186			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231749				2022-12-28	WOS:000167194700023
J	Schwetz, BA				Schwetz, BA			New first-line therapy for advanced breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1146	1146		10.1001/jama.285.9.1146	http://dx.doi.org/10.1001/jama.285.9.1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231734				2022-12-28	WOS:000167194700006
J	Staszewski, S; Keiser, P; Montaner, J; Raffi, F; Gathe, J; Brotas, V; Hicks, C; Hammer, SM; Cooper, D; Johnson, M; Tortell, S; Cutrell, A; Thorborn, D; Isaacs, R; Hetherington, S; Steel, H; Spreen, W				Staszewski, S; Keiser, P; Montaner, J; Raffi, F; Gathe, J; Brotas, V; Hicks, C; Hammer, SM; Cooper, D; Johnson, M; Tortell, S; Cutrell, A; Thorborn, D; Isaacs, R; Hetherington, S; Steel, H; Spreen, W		CNAAB3005 Int Study Team	Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults - A randomized equivalence trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	39th Interdisciplinary Conference on Antimicrobial Agents and Chemotherapy (ICAAC)	SEP 26-29, 1999	SAN FRANCISCO, CALIFORNIA				PROTEASE INHIBITOR THERAPY; IMMUNODEFICIENCY-VIRUS INFECTION; LONG-TERM RESPONSE; COMBINATION THERAPY; VIROLOGICAL FAILURE; PLUS INDINAVIR; RESISTANCE; 1592U89; SUPPRESSION; SUSCEPTIBILITY	Context Abacavir, a nucleoside analogue, has demonstrated suppression of human immunodeficiency virus (HIV) replication alone and in combination therapy. However, the role of abacavir in a triple nucleoside combination regimen has not been evaluated against a standard protease inhibitor-containing regimen for initial antiretroviral treatment. Objective To evaluate antiretroviral equivalence and safety of an abacavir-lamivudine-zidovudine regimen compared with an indinavir-lamivudine-zidovudine regimen. Design and Setting A multicenter, phase 3, randomized, double-blind trial with an enrollment period from August 1997 to June 1998, with follow-up through 48 weeks at 73 clinical research units in the United States, Canada, Australia, and Europe. Patients Five hundred sixty-two antiretroviral-naive, HIV-infected adults with a plasma HIV RNA level of at least 10000 copies/mL and a CD4 cell count of at least 100 x 10(6)/L. Interventions Patients were stratified by baseline HIV RNA level and randomly assigned to receive a combination tablet containing 150 mg of lamivudine and 300 mg of zidovudine twice daily plus either 300 mg of abacavir twice daily and indinavir placebo or 800 mg of indinavir every 8 hours daily plus abacavir placebo. After 16 weeks, patients with confirmed HIV RNA levels greater than 400 copies/mL were eligible to continue receiving randomized treatment or receive open-label therapy. Main Outcome Measure Virologic suppression, defined as HIV RNA concentration of 400 copies/mL or less at week 48. Results The proportion of patients who met the end point of having an HIV RNA level of 400 copies/mL or less at week 48 was equivalent in the abacavir group (51% [133/262]) and in the indinavir group (51% [136/265]) with a treatment difference of -0.6% (95% confidence interval [CI], -9% to 8%). In patients with baseline HIV RNA levels greater than 100 000 copies/mL, the proportion of patients achieving less than 50 copies/mL was greater in the indinavir group than in the abacavir group with 45% (45/100) vs 31% (30/96) and a treatment difference of -14% (95% CI, -27% to 0%). The 2 treatments were comparable with respect to their effects on CD4 cell count. There was no difference between groups in the frequency of treatment-limiting adverse events or laboratory abnormalities. One death in the abacavir group was attributed to hypersensitivity reaction, which occurred following rechallenge with abacavir, approximately 3 weeks after initiating study treatment. Conclusions In this study of antiretroviral-naive HIV-infected adults, the triple nucleoside regimen of abacavir-lamivudine-zidovudine was equivalent to the regimen of indinavir-lamivudine-zidovudine in achieving a plasma HIV RNA level of less than 400 copies/mL at 48 weeks.	Univ Frankfurt Klinikum, Zentrum Inneren Med, D-60596 Frankfurt, Germany; Univ Texas, SW Med Ctr, Dallas, TX USA; Dept Vet Affairs, Dallas, TX USA; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; CHRU Nantes, Nantes, France; Houston Clin Res Network, Div Montrose Clin, Houston, TX USA; Hosp Santo Antonio dos Capuchos, Serv Med 3, Lisbon, Portugal; Duke Univ, Durham, NC USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; St Vincents Hosp, Sydney, NSW 2010, Australia; Royal Free Hosp, London NW3 2QG, England; Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA; Merck & Co Inc, W Point, PA USA; Glaxo Wellcome Res & Dev Ltd, Greenford, Middx, England	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; St. Paul's Hospital; University of Saskatchewan; Nantes Universite; CHU de Nantes; Duke University; Harvard University; Beth Israel Deaconess Medical Center; St Vincents Hospital Sydney; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; GlaxoSmithKline; Merck & Company; GlaxoSmithKline	Staszewski, S (corresponding author), Univ Frankfurt Klinikum, Zentrum Inneren Med, Haus 68,Theodor Stern Kai 7, D-60596 Frankfurt, Germany.							[Anonymous], 1992, MMWR MORB MORTAL WKL, V41, P1; BORENSTEIN M, 1994, CONTROL CLIN TRIALS, V15, P411, DOI 10.1016/0197-2456(94)90036-1; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Casado JL, 1998, AIDS, V12, pF131, DOI 10.1097/00002030-199811000-00005; Daluge SM, 1997, ANTIMICROB AGENTS CH, V41, P1082, DOI 10.1128/AAC.41.5.1082; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; *DIV AIDS, 1996, DIV AIDS TABL GRAD S; *EUDR WEB SIT, 2001, POINTS CONS SWITCH S; Faletto MB, 1997, ANTIMICROB AGENTS CH, V41, P1099, DOI 10.1128/AAC.41.5.1099; FISCHL M, 1999, 6 C RETR OPP INF JAN; Goodgame JC, 2000, ANTIVIR THER, V5, P215; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Harrigan PR, 2000, J INFECT DIS, V181, P912, DOI 10.1086/315317; Harrington M, 2000, LANCET, V355, P2147, DOI 10.1016/S0140-6736(00)02388-6; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; HETHERINGTON SV, 2000, 7 C RETR OPP INF JAN; Kempf DJ, 1998, AIDS, V12, pF9, DOI 10.1097/00002030-199805000-00001; LANIER R, 1998, ANTIVIR THER S, V3, P36; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Maguire M, 2000, AIDS, V14, P1195, DOI 10.1097/00002030-200006160-00017; Mehta S, 1997, AIDS, V11, P1665, DOI 10.1097/00002030-199714000-00002; Miller V, 2000, AIDS, V14, P163, DOI 10.1097/00002030-200001280-00012; Moyle GJ, 2000, CURR OPIN INFECT DIS, V13, P19, DOI 10.1097/00001432-200002000-00004; MURPHY RL, 1999, 39 INT C ANT AG CHEM; POZNIAK A, 2001, BRIT HIV ASS BHIVA G; Raboud JM, 1999, J INFECT DIS, V180, P1347, DOI 10.1086/314998; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Saag MS, 1998, AIDS, V12, pF203, DOI 10.1097/00002030-199816000-00002; Squires KE, 2000, AIDS, V14, P1591, DOI 10.1097/00002030-200007280-00015; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Staszewski S, 1998, AIDS, V12, pF197, DOI 10.1097/00002030-199816000-00001; STONE VE, 1998, 12 WORLD AIDS C JUN; Tisdale M, 1997, ANTIMICROB AGENTS CH, V41, P1094, DOI 10.1128/AAC.41.5.1094; *US DEP HHS, 2001, GUID US ANT VIR AG H	40	221	224	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1155	1163		10.1001/jama.285.9.1155	http://dx.doi.org/10.1001/jama.285.9.1155			9	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231744	Bronze			2022-12-28	WOS:000167194700018
J	McKie, AT; Barrow, D; Latunde-Dada, GO; Rolfs, A; Sager, G; Mudaly, E; Mudaly, M; Richardson, C; Barlow, D; Bomford, A; Peters, TJ; Raja, KB; Shirali, S; Hediger, MA; Farzaneh, F; Simpson, RJ				McKie, AT; Barrow, D; Latunde-Dada, GO; Rolfs, A; Sager, G; Mudaly, E; Mudaly, M; Richardson, C; Barlow, D; Bomford, A; Peters, TJ; Raja, KB; Shirali, S; Hediger, MA; Farzaneh, F; Simpson, RJ			An iron-regulated ferric reductase associated with the absorption of dietary iron	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CYTOCHROME B(561); ELECTRON-TRANSFER; TRANSPORTER; MOUSE; MICE; GENE; PURIFICATION; MEMBRANES; PROTEIN	The ability of intestinal mucosa to absorb dietary ferric iron is attributed to the presence of a brush-border membrane reductase activity that displays adaptive responses to iron status. We have isolated a complementary DNA, Dcytb (for duodenal cytochrome b), which encoded a putative plasma membrane di-heme protein in mouse duodenal mucosa. Dcytb shared between 45 and 50% similarity to the cytochrome b561 family of plasma membrane reductases, was highly expressed in the brush-border membrane of duodenal enterocytes, and induced ferric reductase activity when expressed in Xenopus oocytes and cultured cells. Duodenal expression Levels of Dcytb messenger RNA and protein were regulated by changes in physiological modulators of iron absorption. Thus, Dcytb provides an important element in the iron absorption pathway.	Univ London Kings Coll, Rayne Inst, Guys Kings & St Thomas Sch Med, Dept Mol Med, London SE5 9NU, England; Univ London Kings Coll, Guys Kings & St Thomas Sch Med, Dept Diabet Endocrinol & Internal Med, London SE5 9PJ, England; Univ London Kings Coll, Guys Kings & St Thomas Sch Med, Dept Clin Biochem, London SE5 9PJ, England; Univ London Kings Coll, Guys Kings & St Thomas Sch Med, Inst Liver Studies, London SE5 9PJ, England; Univ London Kings Coll, Dept Pharm, London SE1 8WA, England; Harvard Univ, Brigham & Womens Hosp, Sch Med, Membrane Biol Program, Boston, MA 02115 USA	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School	McKie, AT (corresponding author), Univ London Kings Coll, Rayne Inst, Guys Kings & St Thomas Sch Med, Dept Mol Med, Denmark Hill Campus,123 Coldharbour Lane, London SE5 9NU, England.		Simpson, Robert J/A-8776-2013; Bomford, Adrian/A-7462-2011; Farzaneh, Farzin/B-4902-2009	Simpson, Robert J/0000-0002-2196-5368; Farzaneh, Farzin/0000-0002-9275-2415; Barlow, David/0000-0002-0094-5122; Hediger, Matthias/0000-0003-1946-027X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DeLeo FR, 1999, J LAB CLIN MED, V134, P275, DOI 10.1016/S0022-2143(99)90208-1; ESCRIOU V, 1994, J BIOL CHEM, V269, P14007; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; FONTECAVE M, 1994, BIOMETALS, V7, P3; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; GRUENHEID S, 1995, GENOMICS, V25, P514, DOI 10.1016/0888-7543(95)80053-O; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HUGGENVIK JI, 1989, BLOOD, V74, P482; Kobayashi K, 1998, J BIOL CHEM, V273, P16038, DOI 10.1074/jbc.273.26.16038; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Okuyama E, 1998, BBA-PROTEIN STRUCT M, V1383, P269, DOI 10.1016/S0167-4838(97)00216-1; ORIORDAN DK, 1995, EUR J CLIN INVEST, V25, P722, DOI 10.1111/j.1365-2362.1995.tb01950.x; POUTNEY DJ, 1999, BIOMETALS, V12, P53; RAJA KB, 1992, BIOCHIM BIOPHYS ACTA, V1135, P141, DOI 10.1016/0167-4889(92)90129-Y; RIEDEL HD, 1995, BIOCHEM J, V309, P745, DOI 10.1042/bj3090745; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMAN DG, 1993, MOL CELL BIOL, V13, P4342, DOI 10.1128/MCB.13.7.4342; SIMPSON RJ, 1984, BIOCHIM BIOPHYS ACTA, V772, P220, DOI 10.1016/0005-2736(84)90047-6; SIMPSON RJ, 1991, BRIT J HAEMATOL, V78, P565, DOI 10.1111/j.1365-2141.1991.tb04490.x; Simpson RJ, 1996, J NUTR, V126, P1858; SIMPSON RJ, 1999, CLIN SCI, V96, pP16; Trinder D, 2000, GUT, V46, P270, DOI 10.1136/gut.46.2.270	24	765	801	8	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1755	1759		10.1126/science.1057206	http://dx.doi.org/10.1126/science.1057206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230685				2022-12-28	WOS:000167320600050
J	Furth, SL; Hwang, W; Yang, C; Neu, AM; Fivush, BA; Powe, NR				Furth, SL; Hwang, W; Yang, C; Neu, AM; Fivush, BA; Powe, NR			Relation between pediatric experience and treatment recommendations for children and adolescents with kidney failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STAGE RENAL-DISEASE; AMBULATORY PERITONEAL-DIALYSIS; RESOURCE UTILIZATION; MEDICAL SPECIALTIES; HEMODIALYSIS; CARE; MORTALITY; JUDGMENTS; THERAPY; SYSTEMS	Context Children and adolescent patients with renal failure are frequently cared for by adult subspecialists, While peritoneal dialysis is used in less than 17% of adults with kidney failure, it is the preferred dialysis treatment for children. National data show that 45% of children receiving dialysis are treated with peritoneal dialysis and pediatric nephrologists report its use in 65% of patients receiving dialysis. Whether differences in peritoneal dialysis use among children are due to the pediatric experience of the clinician has not been examined. Objective To assess whether the pediatric experience of nephrologists directly affects treatment recommendations for children with kidney failure. Design Cross-sectional survey using 10 case vignettes per survey based on random combinations of 8 patient characteristics (age, sex, race, distance from facility, cause of renal failure, family structure, education, and compliance). Setting and Participants National random sample of office-, hospital-, and academic medical center-based adult and pediatric nephrologists, stratified by geographic region and conducted June to November 1999. Of 519 eligible physicians, 316 (61%) responded, including 191 adult and 125 pediatric nephrologists. Main Outcome Measure Treatment recommendations for peritoneal dialysis vs hemodialysis, compared based on nephrologists' pediatric experience. Results After controlling for patient characteristics, pediatric nephrologists were 60% more likely than adult nephrologists to recommend peritoneal dialysis for identical patients (odds ratio, 1.61; 95% confidence interval, 1.35-1.92). This was true regardless of dialysis training, years in practice, practice setting, geography, or patient characteristics. Conclusions Our data indicate that pediatric specialization of clinicians influences treatment recommendations for children and adolescents with end-stage renal disease. Referring children to adult subspecialists may lead to differences in treatment choices and processes of care.	Johns Hopkins Med Inst, Dept Pediat, Div Pediat Nephrol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Furth, SL (corresponding author), 600 N Wolfe St,Pk 327, Baltimore, MD 21287 USA.	sfurth@jhmi.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002586, K24DK002643] Funding Source: NIH RePORTER; NIDDK NIH HHS [K08 DK02586-01A1, K24 DK02643] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alloatti S, 2000, J NEPHROL, V13, P331; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; BREM AS, 1988, PEDIATR NEPHROL, V2, P460, DOI 10.1007/BF00853442; BROWNBRIDGE G, 1991, PEDIATR NEPHROL, V5, P612, DOI 10.1007/BF00856653; CHURCHILL DN, 1993, KIDNEY INT, V43, pS16; Coyte PC, 1996, AM J KIDNEY DIS, V27, P557, DOI 10.1016/S0272-6386(96)90167-5; Evans ED, 1995, PEDIATR CLIN N AM, V42, P1579; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; FINE RN, 1987, PEDIATR CLIN N AM, V34, P789; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; FOX MP, 1993, AM J KIDNEY DIS, V22, P32, DOI 10.1016/0272-6386(93)70179-3; Franks P, 2000, J GEN INTERN MED, V15, P163, DOI 10.1046/j.1525-1497.2000.04079.x; Furth SL, 1997, ARCH PEDIAT ADOL MED, V151, P545, DOI 10.1001/archpedi.1997.02170430011002; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; GUTMAN RA, 1981, NEW ENGL J MED, V304, P309, DOI 10.1056/NEJM198102053040601; KAISER BA, 1994, PEDIATR NEPHROL, V8, P733, DOI 10.1007/BF00869106; KRAVITZ RL, 1995, ANNU REV PUBL HEALTH, V16, P431; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; MCFALL SL, 1994, MED CARE, V32, P106, DOI 10.1097/00005650-199402000-00002; Meyer GS, 2000, J GEN INTERN MED, V15, P188, DOI 10.1046/j.1525-1497.2000.06039.x; Murphy SW, 2000, KIDNEY INT, V57, P1720, DOI 10.1046/j.1523-1755.2000.00017.x; NISSENSON AR, 1986, AM J KIDNEY DIS, V7, P229, DOI 10.1016/S0272-6386(86)80009-9; NISSENSON AR, 1993, KIDNEY INT, V43, pS120; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; PERRIN JM, 1989, NEW ENGL J MED, V320, P1183, DOI 10.1056/NEJM198905043201805; STABLEIN DM, 2001, N AM PED REN TRANSPL; Stapleton FB, 1997, J AM SOC NEPHROL, V8, pS5; US Renal Data System, 1999, USRDS 1999 ANN DAT R; WENNBERG J, 1982, SCI AM, V246, P120, DOI 10.1038/scientificamerican0482-120; YAGER J, 1986, GEN HOSP PSYCHIAT, V8, P152, DOI 10.1016/0163-8343(86)90073-3	30	27	27	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2001	285	8					1027	1033		10.1001/jama.285.8.1027	http://dx.doi.org/10.1001/jama.285.8.1027			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	403ME	11209173				2022-12-28	WOS:000167046400024
J	Fitchet, A; Neal, R; Bannister, P				Fitchet, A; Neal, R; Bannister, P			Lesson of the week - Splenic trauma complicating cardiopulmonary resuscitation	BRITISH MEDICAL JOURNAL			English	Review									Manchester Royal Infirm, Manchester Heart Ctr, Manchester M13 9WL, Lancs, England; Blackburn Royal Infirm, Blackburn BB2 3LR, Lancs, England; Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester	Fitchet, A (corresponding author), Manchester Royal Infirm, Manchester Heart Ctr, Oxford Rd, Manchester M13 9WL, Lancs, England.							ADLER SN, 1983, ARCH INTERN MED, V143, P813, DOI 10.1001/archinte.143.4.813; BERNARD SA, 1993, AUST NZ J SURG, V63, P312, DOI 10.1111/j.1445-2197.1993.tb00390.x; KOUWENHOVEN WB, 1984, JAMA-J AM MED ASSOC, V251, P3133, DOI 10.1001/jama.251.23.3133; KRISCHER JP, 1987, CHEST, V92, P287, DOI 10.1378/chest.92.2.287; MENZIES D, 1991, BRIT J UROL, V67, P440, DOI 10.1111/j.1464-410X.1991.tb15179.x; NAGEL EL, 1981, CRIT CARE MED, V9, P424, DOI 10.1097/00003246-198105000-00037; Nolan J, 1998, BRIT MED J, V316, P1844; Stallard N, 1997, RESUSCITATION, V35, P171, DOI 10.1016/S0300-9572(97)00054-3; VITELLO JM, 1991, J TRAUMA, V31, P426, DOI 10.1097/00005373-199103000-00023	9	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	2001	322	7284					480	481		10.1136/bmj.322.7284.480	http://dx.doi.org/10.1136/bmj.322.7284.480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406YD	11222427	Green Published			2022-12-28	WOS:000167243000024
J	Lourens, LJ; Wehausen, R; Brumsack, HJ				Lourens, LJ; Wehausen, R; Brumsack, HJ			Geological constraints on tidal dissipation and dynamical ellipticity of the Earth over the past three million years	NATURE			English	Article							TIME-SCALE; PRECESSION; INSOLATION; CALIBRATION; GLACIATION; TIMESCALE; OBLIQUITY; CONSTANT; DUST; MYR	The evolution of the Solar System has been shown to be chaotic(1), which limits our ability to retrace the orbital and precessional motion of the Earth over more than 35-50 Myr (ref. 2). Moreover, the precession, obliquity and insolation parameters(3,4) can also be influenced by secular variations in the tidal dissipation and dynamical ellipticity of the Earth induced by glacial cyclicity(3,5-10) and mantle convection(11). Here we determine the average values of these dissipative effects over the past three million years. We have computed the optimal fit between an exceptional palaeoclimate record from the eastern Mediterranean Sea and a model of the astronomical and insolation history(3) by testing a number of values for the tidal dissipation and dynamical ellipticity parameters. We find that the combined effects of dynamical ellipticity and tidal dissipation were, on average, significantly lower over the past three million years, compared to their present-day values (determined from artificial satellite data and lunar ranging(3,4,12)). This secular variation associated with the Plio-Pleistocene ice load history has caused an average acceleration in the Earth's rotation over the past 3 Myr, which needs to be considered in the construction of astronomical timescales and in research into the stationarity of phase relations in the ocean-climate system through time.	Univ Utrecht, Fac Earth Sci, NL-3584 CD Utrecht, Netherlands; Univ Oldenburg, Inst Chem Biol Marine Environm ICBM, D-26111 Oldenburg, Germany	Utrecht University; Carl von Ossietzky Universitat Oldenburg	Lourens, LJ (corresponding author), Univ Utrecht, Fac Earth Sci, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.		Brumsack, Hans-Jürgen/O-7942-2016	Brumsack, Hans-Jürgen/0000-0002-5549-5018				BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; DEHANT V, 1990, J GEOPHYS RES-ATMOS, V95, P7573, DOI 10.1029/JD095iD06p07573; Forte AM, 1997, NATURE, V390, P676, DOI 10.1038/37769; GANOR E, 1982, ATMOS ENVIRON, V16, P581, DOI 10.1016/0004-6981(82)90167-6; GANOR E, 1991, ATMOS ENVIRON A-GEN, V25, P2665, DOI 10.1016/0960-1686(91)90196-E; GORDEYEV VV, 1978, DOKLADY EARTH SCI SE, V238, P150; HILGEN FJ, 1991, EARTH PLANET SC LETT, V104, P226, DOI 10.1016/0012-821X(91)90206-W; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; KROON D, 1998, P ODP SCI RES, V160, P181; LAMBECK K, 1980, EARTHS VARIABLE GEOP; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; Laskar J, 1999, PHILOS T R SOC A, V357, P1735, DOI 10.1098/rsta.1999.0399; LAWRENCE RL, 1987, SCIENCE, V236, P1547; Lourens LJ, 1996, PALEOCEANOGRAPHY, V11, P391, DOI 10.1029/96PA01125; MARTIN JM, 1979, MAR CHEM, V7, P173, DOI 10.1016/0304-4203(79)90039-2; MITROVICA JX, 1995, GEOPHYS J INT, V121, P21, DOI 10.1111/j.1365-246X.1995.tb03508.x; Mitrovica JX, 1997, GEOPHYS J INT, V128, P270, DOI 10.1111/j.1365-246X.1997.tb01554.x; Mitrovica JX, 1997, J GEOPHYS RES-SOL EA, V102, P2751, DOI 10.1029/96JB03175; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; PELTIER WR, 1994, GEOPHYS RES LETT, V21, P2299, DOI 10.1029/94GL02058; Raymo ME, 1989, PALEOCEANOGRAPHY, V4, P413, DOI 10.1029/PA004i004p00413; ROSSIGNOLSTRICK M, 1983, NATURE, V304, P46, DOI 10.1038/304046a0; Sakamoto T., 1998, CONTINUOUS SEDIMENTA, V1, P37; STEPHENSON FR, 1995, PHILOS T R SOC A, V351, P165, DOI 10.1098/rsta.1995.0028; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; VENKATARATHNAM K, 1971, MAR GEOL, V11, P261, DOI 10.1016/0025-3227(71)90028-4; Wehausen R, 2000, PALAEOGEOGR PALAEOCL, V158, P325, DOI 10.1016/S0031-0182(00)00057-2	30	141	145	1	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1029	1033		10.1038/35059062	http://dx.doi.org/10.1038/35059062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234009				2022-12-28	WOS:000167148800042
J	White, SR; Sottos, NR; Geubelle, PH; Moore, JS; Kessler, MR; Sriram, SR; Brown, EN; Viswanathan, S				White, SR; Sottos, NR; Geubelle, PH; Moore, JS; Kessler, MR; Sriram, SR; Brown, EN; Viswanathan, S			Autonomic healing of polymer composites	NATURE			English	Article							POLY(METHYL METHACRYLATE); CRACK; MECHANISMS; INTERFACES; FRACTURE; REPAIR; GLASS	Structural polymers are susceptible to damage in the form of cracks, which form deep within the structure where detection is difficult and repair is almost impossible. Cracking leads to mechanical degradation(1-3) of fibre-reinforced polymer composites; in microelectronic polymeric components it can also lead to electrical failure(4). Microcracking induced by thermal and mechanical fatigue is also a long-standing problem in polymer adhesives(5). Regardless of the application, once cracks have formed within polymeric materials, the integrity of the structure is significantly compromised. Experiments exploring the concept of self-repair have been previously reported(6-8), but the only successful crack-healing methods that have been reported so far require some form of manual intervention(10-18). Here we report a structural polymeric material with the ability to autonomically heal cracks. The material incorporates a microencapsulated healing agent that is released upon crack intrusion. Polymerization of the healing agent is then triggered by contact with an embedded catalyst, bonding the crack faces. Our fracture experiments yield as much as 75% recovery in toughness, and we expect that our approach will be applicable to other brittle materials systems (including ceramics and glasses).	Univ Illinois, Dept Aeronaut & Astronaut Engn, Urbana, IL 61801 USA; Univ Illinois, Dept Theoret & Appl Mech, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	White, SR (corresponding author), Univ Illinois, Dept Aeronaut & Astronaut Engn, Urbana, IL 61801 USA.		Kessler, Michael/C-3153-2008; White, Scott/G-9667-2013	Kessler, Michael/0000-0001-8436-3447; White, Scott/0000-0002-0831-9097; Brown, Eric/0000-0002-6812-7820				Dry C, 1996, COMPOS STRUCT, V35, P263, DOI 10.1016/0263-8223(96)00033-5; DRY CM, 1993, SPIE P, V1916, P438; Gamstedt EK, 1999, J MATER SCI, V34, P2535, DOI 10.1023/A:1004684228765; GRUBBS RH, 1989, SCIENCE, V243, P907, DOI 10.1126/science.2645643; INAGAKI M, 1985, J AM CERAM SOC, V68, P704, DOI 10.1111/j.1151-2916.1985.tb10129.x; JUD K, 1979, POLYM BULL, V1, P697; JUD K, 1981, J MATER SCI, V16, P204, DOI 10.1007/BF00552073; Kausch H. H., 1982, Plastics and Rubber Processing and Applications, V2, P265; Lee LH, 1991, ADHESIVE BONDING, P239; LIN CB, 1990, POLYM ENG SCI, V30, P1399, DOI 10.1002/pen.760302109; MOSTOVOY S, 1967, J MATER, V2, P661; PECHT MG, 1995, PLASTIC ENCAPSULATED, P235; Raghavan J, 1999, J APPL POLYM SCI, V71, P775, DOI 10.1002/(SICI)1097-4628(19990131)71:5<775::AID-APP11>3.3.CO;2-9; Sanford MS, 1998, ORGANOMETALLICS, V17, P5384, DOI 10.1021/om980683f; Schwab P, 1996, J AM CHEM SOC, V118, P100, DOI 10.1021/ja952676d; STAVRINIDIS B, 1983, PHYS CHEM GLASSES, V24, P19; TALREJA R, 1989, J STRAIN ANAL ENG, V24, P215, DOI 10.1243/03093247V244215; TALREJA R, 1994, DAMAGE MECH COMPOSIT, P139; WANG PP, 1994, J POLYM SCI POL PHYS, V32, P1217, DOI 10.1002/polb.1994.090320709; WIEDERHO.SM, 1970, J AM CERAM SOC, V53, P486, DOI 10.1111/j.1151-2916.1970.tb15996.x; Wool R. P., 1995, POLYM INTERFACES STR, P445; WOOL RP, 1981, J APPL PHYS, V52, P5953, DOI 10.1063/1.328526	23	3029	3327	76	1966	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					794	797		10.1038/35057232	http://dx.doi.org/10.1038/35057232			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236987				2022-12-28	WOS:000166938800033
J	Montgomery, SL				Montgomery, SL			Gained in the translation - Scientific knowledge is enriched as it moves between languages.	NATURE			English	Editorial Material																			0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					667	667		10.1038/35055634	http://dx.doi.org/10.1038/35055634			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217839				2022-12-28	WOS:000166816400022
J	Stark, H; Dube, P; Luehrmann, R; Kastner, B				Stark, H; Dube, P; Luehrmann, R; Kastner, B			Arrangement of RNA and proteins in the spliceosomal U1 small nuclear ribonucleoprotein particle	NATURE			English	Article							ELECTRON-MICROSCOPY; SNRNP; RESOLUTION; COMPLEXES; IDENTIFICATION; ORGANIZATION; PRINCIPLE; JUNCTIONS; DOMAIN; 70K	In eukaryotic cells, freshly synthesized messenger RNA (pre-mRNA) contains stretches of non-coding RNA that must be excised before the RNA can be translated into protein. Their removal is catalysed by the spliceosome, a large complex formed when a number of small nuclear ribonucleoprotein particles (snRNPs) bind sequentially to the pre-mRNA. The first snRNP to bind is called U1; other snRNPs (U2, U4/U6 and U5) follow(1). Here we describe the three-dimensional structure of human U1 snRNP, determined by single-particle electron cryomicroscopy at 10 Angstrom resolution. The reconstruction reveals a doughnut-shaped central element that accommodates the seven Sm proteins common to all snRNPs, supporting a proposed model of circular Sm protein arrangement(2). By taking earlier biochemical results into account, we were able to assign the remaining density of the map to the other known components of U1 snRNP, deriving a structural model that describes the three-dimensional arrangement of proteins and RNA in U1 snRNP.	Inst Mol Biol & Tumorforsch, D-35037 Marburg, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Stark, H (corresponding author), Inst Mol Biol & Tumorforsch, Emil Mannkopfstr 2, D-35037 Marburg, Germany.	Holger.Stark@mpibpc.mpg.de		Holger, Stark/0000-0002-6161-1118				ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; DUCKETT DR, 1995, CELL, V83, P1027, DOI 10.1016/0092-8674(95)90218-X; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Hartmuth K, 1999, J MOL BIOL, V285, P133, DOI 10.1006/jmbi.1998.2300; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HOET RM, 1993, NUCLEIC ACIDS RES, V21, P5130, DOI 10.1093/nar/21.22.5130; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; KASTNER B, 1990, P NATL ACAD SCI USA, V87, P1710, DOI 10.1073/pnas.87.5.1710; KASTNER B, 1992, J CELL BIOL, V116, P839, DOI 10.1083/jcb.116.4.839; KROL A, 1990, NUCLEIC ACIDS RES, V18, P3803, DOI 10.1093/nar/18.13.3803; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; LIN WL, 1984, J MOL BIOL, V180, P947, DOI 10.1016/0022-2836(84)90265-1; Moore M., 1993, RNA WORLD, P303; NAGAI K, 1994, RNA PROTEIN INTERACT, P150; NELISSEN RLH, 1994, EMBO J, V13, P4113, DOI 10.1002/j.1460-2075.1994.tb06729.x; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; TAZI J, 1993, NATURE, V363, P283, DOI 10.1038/363283a0; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; VANHEEL M, 1986, OPTIK, V73, P119; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; vanVenrooij WJ, 1995, CURR OPIN IMMUNOL, V7, P819, DOI 10.1016/0952-7915(95)80054-9; Walter F, 1998, RNA, V4, P719, DOI 10.1017/S135583829898030X; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8	29	194	201	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2001	409	6819					539	542		10.1038/35054102	http://dx.doi.org/10.1038/35054102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206553				2022-12-28	WOS:000166570500054
J	Chan, HB; Aksyuk, VA; Kleiman, RN; Bishop, DJ; Capasso, F				Chan, HB; Aksyuk, VA; Kleiman, RN; Bishop, DJ; Capasso, F			Quantum mechanical actuation of microelectromechanical systems by the Casimir force	SCIENCE			English	Article							PRECISION-MEASUREMENT; MU-M; PLATE; RANGE; LENS	The Casimir force is the attraction between uncharged metallic surfaces as a result of quantum mechanical vacuum fluctuations of the electromagnetic field. We demonstrate the Casimir effect in microelectromechanical systems using a micromachined torsional device. Attraction between a polysilicon plate and a spherical metallic surface results in a torque that rotates the plate about two thin torsional rods. The dependence of the rotation angle on the separation between the surfaces is in agreement with calculations of the Casimir force. Our results show that quantum electrodynamical effects play a significant role in such microelectromechanical systems when the separation between components is in the nanometer range.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Capasso, F (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.	fc@lucent.com		Aksyuk, Vladimir/0000-0002-9653-4722				Bezerra VB, 1997, MOD PHYS LETT A, V12, P2613, DOI 10.1142/S0217732397002740; BLOCKI J, 1977, ANN PHYS-NEW YORK, V105, P427, DOI 10.1016/0003-4916(77)90249-4; Bordag M, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.045003; Casimir H. B. G., 1948, P KON NED AKAD WET, V51, P793; Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532; DERJAGUIN BV, 1956, Q REV CHEM SOC, V10, P295, DOI 10.1039/qr9561000295; ELIZALDE E, 1991, AM J PHYS, V59, P711, DOI 10.1119/1.16749; Klimchitskaya GL, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.062107; Lambrecht A, 2000, EUR PHYS J D, V8, P309, DOI 10.1007/s100530050041; Lamoreaux SK, 1999, PHYS REV A, V59, pR3149, DOI 10.1103/PhysRevA.59.R3149; Lamoreaux SK, 1997, PHYS REV LETT, V78, P5, DOI 10.1103/PhysRevLett.78.5; Lamoreaux SK, 1999, PHYS REV LETT, V83, P3340, DOI 10.1103/PhysRevLett.83.3340; LIFSHITZ EM, 1956, SOV PHYS JETP-USSR, V2, P73; MARADUDIN AA, 1980, PHYS REV B, V22, P1677, DOI 10.1103/PhysRevB.22.1677; MILONNI PW, 1992, CONTEMP PHYS, V33, P313, DOI 10.1080/00107519208223981; Mohideen U, 1998, PHYS REV LETT, V81, P4549, DOI 10.1103/PhysRevLett.81.4549; PALIK ED, 1950, HDB OPTICAL CONSTANT; Roy A, 1999, PHYS REV LETT, V82, P4380, DOI 10.1103/PhysRevLett.82.4380; Schaden M, 2000, PHYS REV LETT, V84, P459, DOI 10.1103/PhysRevLett.84.459; SCHWINGER J, 1978, ANN PHYS-NEW YORK, V115, P1, DOI 10.1016/0003-4916(78)90172-0; Serry FM, 1995, J MICROELECTROMECH S, V4, P193, DOI 10.1109/84.475546; SPARNAAY MJ, 1958, PHYSICA, V24, P751, DOI 10.1016/S0031-8914(58)80090-7; Spruch L, 1996, SCIENCE, V272, P1452, DOI 10.1126/science.272.5267.1452; TRIMMER WS, 1997, MICROMECHANICS MEMS	24	741	752	6	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1941	1944		10.1126/science.1057984	http://dx.doi.org/10.1126/science.1057984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239149				2022-12-28	WOS:000167401600039
J	Raoult, D; La Scola, B; Lecocq, P; Lepidi, H; Fournier, PE				Raoult, D; La Scola, B; Lecocq, P; Lepidi, H; Fournier, PE			Culture and immunological detection of Tropheryma whippelii from the duodenum of a patient with Whipple disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYMERASE CHAIN-REACTION; DIAGNOSIS; AMPLIFICATION; PCR; ENDOCARDITIS; BACTERIUM; BACILLUS; DNA	Context Culture of Tropheryma whippelii has been established only once, in human fibroblast cell lines from a heart valve inoculum. Molecular-based diagnostic techniques, although highly sensitive, may be less specific. New diagnostic tools involving isolation of bacteria from contaminated intestinal biopsies and immunohistological detection need to be developed. Objective To describe a novel method for detection and culture of T whippelii strains. Design, Setting, and Subjects Laboratory analysis of duodenal biopsy specimens from a patient with typical relapsing Whipple disease with intestinal involvement, performed Marseille, France, in March 2000, Biopsy specimens were decontaminated with antimicrobial agents and inoculated onto cell cultures. Mouse anti-T whippelii polyclonal antibodies were used to detect T whippelii in fixed specimens taken from the patient before and after relapse, compared with specimens from 10 controls. The genotype of the isolate was determined by amplification and sequencing of 2 DNA fragments (ITS and 23S rRNA). Main Outcome Measure Isolation and genotyping of a new strain(s) of T whippelii from the case patient's biopsy specimens. Results A strain was grown from the case patient's intestinal specimen that has a genotype different from the first strain isolated, During 2 episodes of Whipple disease, T whippelii bacteria were detected by immunochemistry in the patient's duodenal biopsy specimens, but not in controls. Conclusions A second strain of T whippelii has been isolated and a protocol for isolation from the intestine has been proven to be efficient. Immunodetection of T whippelii in intestinal biopsy specimens may provide a useful tool for the diagnosis and follow-up of patients with Whipple disease. Both techniques need further evaluation and confirmation.	Univ Mediterranee, Fac Med, CNRS, Unite Rickettsies, F-13385 Marseille 05, France; Hop Denain, Serv Med B, Denain, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Raoult, D (corresponding author), Univ Mediterranee, Fac Med, CNRS, Unite Rickettsies, 27 Blvd Jean Moulin,UPRESA 6020, F-13385 Marseille 05, France.		LA SCOLA, Bernard/P-6477-2016; Fournier, Pierre-Edouard/AAC-6155-2021; RAOULT, Didier/A-8434-2008	LA SCOLA, Bernard/0000-0001-8006-7704; Fournier, Pierre-Edouard/0000-0001-8463-8885; RAOULT, Didier/0000-0002-0633-5974				CHO C, 1984, GASTROENTEROLOGY, V87, P941; DOBBINS WO, 1995, NEW ENGL J MED, V332, P390, DOI 10.1056/NEJM199502093320611; Ehrbar HU, 1999, LANCET, V353, P2214, DOI 10.1016/S0140-6736(99)01776-6; ENZINGER FM, 1963, VIRCHOWS ARCH A, V336, P238, DOI 10.1007/BF00957912; FELDMAN M, 1988, AM J MED SCI, V63, P539; FLEMING JL, 1988, MAYO CLIN PROC, V63, P539, DOI 10.1016/S0025-6196(12)64884-8; Goldenberger D, 1997, J CLIN MICROBIOL, V35, P2733, DOI 10.1128/JCM.35.11.2733-2739.1997; Gubler JGH, 1999, ANN INTERN MED, V131, P112, DOI 10.7326/0003-4819-131-2-199907200-00007; HENDRIX JP, 1950, ARCH INTERN MED, V85, P91, DOI 10.1001/archinte.1950.00230070113006; Hinrikson HP, 1999, J CLIN MICROBIOL, V37, P152, DOI 10.1128/JCM.37.1.152-156.1999; Hinrikson HP, 1999, INT J SYST BACTERIOL, V49, P1701, DOI 10.1099/00207713-49-4-1701; Hinrikson HP, 2000, J CLIN MICROBIOL, V38, P595, DOI 10.1128/JCM.38.2.595-599.2000; Hinrikson HP, 2000, INT J SYST EVOL MICR, V50, P1007, DOI 10.1099/00207713-50-3-1007; La Scola B, 1998, J CLIN MICROBIOL, V36, P2847, DOI 10.1128/JCM.36.10.2847-2852.1998; LASCOLA B, IN PRESS INT J SYST; Maiwald M, 2000, J BACTERIOL, V182, P3292, DOI 10.1128/JB.182.11.3292-3297.2000; Maiwald M, 1998, APPL ENVIRON MICROB, V64, P760; Pron B, 1999, EUR J CLIN MICROBIOL, V18, P62, DOI 10.1007/s100960050228; Ramzan NN, 1997, ANN INTERN MED, V126, P520, DOI 10.7326/0003-4819-126-7-199704010-00004; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; RICKMAN LS, 1995, NEW ENGL J MED, V332, P363, DOI 10.1056/NEJM199502093320604; Schoedon G, 1997, J INFECT DIS, V176, P672, DOI 10.1086/514089; Street S, 1999, LANCET, V354, P1178, DOI 10.1016/S0140-6736(99)03065-2; VITALDURAND D, 1997, MEDICINE, V76, P170; vonHerbay A, 1997, GASTROENTEROLOGY, V113, P434, DOI 10.1053/gast.1997.v113.pm9247461; vonHerbay A, 1996, GASTROENTEROLOGY, V110, P1735, DOI 10.1053/gast.1996.v110.pm8964398; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Whipple GH, 1907, B JOHNS HOPKINS HOSP, V18, P382; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z; YARDLEY JH, 1961, B JOHNS HOPKINS HOSP, V109, P80	31	56	58	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2001	285	8					1039	1043		10.1001/jama.285.8.1039	http://dx.doi.org/10.1001/jama.285.8.1039			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403ME	11209175	Bronze			2022-12-28	WOS:000167046400026
J	Rothschild, LJ; Mancinelli, RL				Rothschild, LJ; Mancinelli, RL			Life in extreme environments	NATURE			English	Review							LITORALIS DNA-POLYMERASE; COLI PLASMID PUC19; DESICCATION TOLERANCE; RADIATION-RESISTANCE; MICROBIAL DIVERSITY; UVC RADIATION; VACUUM UV; BACTERIA; MICROORGANISMS; TEMPERATURE	Each recent report of liquid water existing elsewhere in the Solar System has reverberated through the international press and excited the imagination of humankind. Why? Because in the past few decades we have come to realize that where there is liquid water on Earth, virtually no matter what the physical conditions, there is life. What we previously thought of as insurmountable physical and chemical barriers to life, we now see as yet another niche harbouring 'extremophiles'. This realization, coupled with new data on the survival of microbes in the space environment and modelling of the potential for transfer of life between celestial bodies, suggests that life could be more common than previously thought. Here we examine critically what it means to be an extremophile, and the implications of this for evolution, biotechnology and especially the search for life in the Universe.	NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Rothschild, LJ (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	Lrothschild@mail.arc.nasa.gov; rmancinelli@mail.arc.nasa.gov	Mancinelli, Rocco/L-8971-2016					Abe F, 1999, TRENDS MICROBIOL, V7, P447, DOI 10.1016/S0966-842X(99)01608-X; Aghajari N, 1998, STRUCTURE, V6, P1503, DOI 10.1016/S0969-2126(98)00149-X; Aguilar A, 1998, EXTREMOPHILES, V2, P367, DOI 10.1007/s007920050080; Arrhenius S., 1903, UMSCHAU, V7, P481; Ball Philip., 1999, H2O BIOGRAPHY WATER; BARTLETT DH, 1999, ENIGMATIC MICROORGAN, P503; Battista Jr, 1998, CONT CANC RES, P287; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BEARDALL J, 1984, PHYCOLOGIA, V23, P397, DOI 10.2216/i0031-8884-23-3-397.1; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BELL CM, 1989, SEDIMENTOLOGY, V36, P651, DOI 10.1111/j.1365-3091.1989.tb02091.x; Ben-Amotz Ami, 1999, P401; BENAMOTZ A, 1990, TRENDS BIOTECHNOL, V8, P121, DOI 10.1016/0167-7799(90)90152-N; BIDIGARE RR, 1993, J PHYCOL, V29, P427, DOI 10.1111/j.1529-8817.1993.tb00143.x; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; Blochl E, 1997, EXTREMOPHILES, V1, P14; Brock T.D., 1978, THERMOPHILIC MICROOR; BROCK TD, 1969, J BACTERIOL, V98, P289, DOI 10.1128/JB.98.1.289-297.1969; CARIELLO NF, 1991, NUCLEIC ACIDS RES, V19, P4193, DOI 10.1093/nar/19.15.4193; CASTANIER S, 1992, GEOBIOS-LYON, V25, P811, DOI 10.1016/S0016-6995(92)80063-J; Cheng CHC, 1999, NATURE, V401, P443, DOI 10.1038/46721; CHOU FI, 1990, J BACTERIOL, V172, P2029, DOI 10.1128/jb.172.4.2029-2035.1990; Chyba CF, 2000, NATURE, V403, P381, DOI 10.1038/35000281; CLARKE A, IN PRESS EVOLUTION P; Cody GD, 2000, SCIENCE, V289, P1337, DOI 10.1126/science.289.5483.1337; Cogoli A., 1989, ESA, P49; COOPER WJ, 1992, ENCY EARTH SYSTEM SC, V2, P527; Cowan DA, 1998, TRENDS BIOTECHNOL, V16, P241, DOI 10.1016/S0167-7799(98)01181-0; Cox C. S., 1995, BIOAEROSOLS HDB; COX CS, 1993, ORIGINS LIFE EVOL B, V23, P29, DOI 10.1007/BF01581988; COX CS, 1991, ROLES MAILLARD REACT; Cox CS., 1987, AEROBIOLOGICAL PATHW; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; CROWE JH, 1971, AM NAT, V105, P563, DOI 10.1086/282745; Cummings SP, 1999, EXTREMOPHILES, V3, P81, DOI 10.1007/s007920050102; DOEMEL WN, 1971, J GEN MICROBIOL, V67, P17, DOI 10.1099/00221287-67-1-17; DOSE K, 1995, ADV SPACE RES, V16, P119, DOI 10.1016/0273-1177(95)00280-R; DOSE K, 1995, ORIGINS LIFE EVOL B, V25, P277, DOI 10.1007/BF01581591; Dundas I, 1998, EXTREMOPHILES, V2, P375, DOI 10.1007/s007920050081; Edwards KJ, 2000, SCIENCE, V287, P1796, DOI 10.1126/science.287.5459.1796; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Ferreira AC, 1999, EXTREMOPHILES, V3, P235, DOI 10.1007/s007920050121; Franks F., 1985, BIOPHYSICS BIOCH LOW; Friedmann E.I, 1994, VIABLE MICROORGANISM; FRIEDMANN EI, 1982, SCIENCE, V215, P1045, DOI 10.1126/science.215.4536.1045; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; GLASHEEN JS, 1988, J EXP BIOL, V135, P363; Horikoshi K, 1998, CURR OPIN MICROBIOL, V1, P291, DOI 10.1016/S1369-5274(98)80032-5; Horikoshi K., 1998, EXTREMOPHILES MICROB; HORNECK G, 1994, ADV SPACE RES, V14, P315, DOI 10.1016/0273-1177(94)90484-7; HORNECK G, IN PRESS EVOLUTION P; Hough DW, 1999, CURR OPIN CHEM BIOL, V3, P39, DOI 10.1016/S1367-5931(99)80008-8; Isken S, 1998, EXTREMOPHILES, V2, P229, DOI 10.1007/s007920050065; ISRAELI E, 1994, ATMOSPHERIC MICROBIA, P166; Ito S, 1998, EXTREMOPHILES, V2, P185, DOI 10.1007/s007920050059; Jaenicke R, 1996, FASEB J, V10, P84, DOI 10.1096/fasebj.10.1.8566552; JAVOR B, 1989, HYPERSALINE ENV; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; JUNGE K, IN PRESS ANN GLACIOL; Kamekura M, 1998, EXTREMOPHILES, V2, P289, DOI 10.1007/s007920050071; Kato C, 1998, APPL ENVIRON MICROB, V64, P1510; KENNISH MJ, 1994, PRACTCAL HDB MARINE, P236; KOHSHIMA S, 1984, NATURE, V310, P225, DOI 10.1038/310225a0; Krulwich TA, 1998, EXTREMOPHILES, V2, P217, DOI 10.1007/s007920050063; Larsen H., 1967, ADVANCES MICROBIAL P, V1, P97; LERUDULIER D, 1983, APPL ENVIRON MICROB, V46, P152, DOI 10.1128/AEM.46.1.152-159.1983; Lighthart B., 1994, ATMOSPHERIC MICROBIA; MACELROY RD, 1974, BIOSYSTEMS, V6, P74, DOI 10.1016/0303-2647(74)90026-4; Madigan MT, 1997, SCI AM, V276, P82, DOI 10.1038/scientificamerican0497-82; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MANCINELLI RL, 1978, APPL ENVIRON MICROB, V35, P1095, DOI 10.1128/AEM.35.6.1095-1101.1978; Mancinelli RL, 2000, PLANET SPACE SCI, V48, P1093, DOI 10.1016/S0032-0633(00)00083-0; MARCHANT J, 2000, NEW SCI, V2247, P4; Marguet E, 1998, EXTREMOPHILES, V2, P115, DOI 10.1007/s007920050050; MATTILA P, 1991, NUCLEIC ACIDS RES, V19, P4967, DOI 10.1093/nar/19.18.4967; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; MORITA RY, 1975, BACTERIOL REV, V39, P144, DOI 10.1128/MMBR.39.2.144-167.1975; Nakasone K, 1998, EXTREMOPHILES, V2, P149, DOI 10.1007/s007920050054; Newcomb TG, 1998, CONT CANC RES, P65; Nichols D, 1999, CURR OPIN BIOTECH, V10, P240, DOI 10.1016/S0958-1669(99)80042-1; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nies DH, 2000, EXTREMOPHILES, V4, P77, DOI 10.1007/s007920050140; NORTON CF, 1988, J GEN MICROBIOL, V134, P1365; Oren A, 1999, ENIGMATIC MICROORGAN, P339; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PEAK MJ, 1995, J BACTERIOL, V177, P6316, DOI 10.1128/jb.177.21.6316-6318.1995; Pick Uri, 1999, P467; PLEDGER RJ, 1994, FEMS MICROBIOL ECOL, V14, P233, DOI 10.1111/j.1574-6941.1994.tb00109.x; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Pourzand C, 1999, PHOTOCHEM PHOTOBIOL, V70, P380, DOI 10.1111/j.1751-1097.1999.tb08239.x; REYSENBACH AL, IN PRESS MICROBIOLOG; Richter H, 1865, SCHMIDTS JB GES MED, V126, P243; Rothschild L.J., 1999, P551; ROTHSCHILD LJ, 1994, J PHYCOL, V30, P431, DOI 10.1111/j.0022-3646.1994.00431.x; ROTHSCHILD LJ, 1990, ICARUS, V88, P246, DOI 10.1016/0019-1035(90)90188-F; ROTHSCHILD LJ, EVOLUTION PLANET EAR; RUNDEL P W, 1991, Aliso, V13, P1; Russell NJ, 2000, EXTREMOPHILES, V4, P83, DOI 10.1007/s007920050141; SCHLEPER C, 1995, NATURE, V375, P741, DOI 10.1038/375741b0; SCHLEPER C, 1995, J BACTERIOL, V177, P7050, DOI 10.1128/jb.177.24.7050-7059.1995; Schuliger J. W., 1993, Molecular Marine Biology and Biotechnology, V2, P76; SECKBACH J, 1970, NATURE, V227, P744, DOI 10.1038/227744a0; SECKBACH J, 1999, ENIGMATIC MICROORGAN, P427; SECKBACH J, 2000, JOURNEY DIVERSE MICR; Seki K, 1998, NATURE, V395, P853, DOI 10.1038/27576; Sellek GA, 1999, ENZYME MICROB TECH, V25, P471, DOI 10.1016/S0141-0229(99)00075-7; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Stone R, 1999, SCIENCE, V286, P36; Storey KB, 1996, ANNU REV ECOL SYST, V27, P365, DOI 10.1146/annurev.ecolsys.27.1.365; Thomson W., 1894, POPULAR LECT ADDRESS, P132; Tyrrel R.M., 1991, OXIDATIVE STRESS OXI, P57; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; VANTHIELEN N, 1999, ENIGMATIC MICROORGAN, P245; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; Vishnivetskaya T, 2000, EXTREMOPHILES, V4, P165, DOI 10.1007/s007920070031; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; WEHNER J, 1995, J PHOTOCH PHOTOBIO B, V28, P77, DOI 10.1016/1011-1344(94)07089-7; WEHNER J, 1995, J PHOTOCH PHOTOBIO B, V30, P171, DOI 10.1016/1011-1344(95)07158-X; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Willem S, 1999, EXTREMOPHILES, V3, P221, DOI 10.1007/s007920050119; Winn C.D., 1995, MICROBIOLOGY DEEP SE, P255; WRIGHT JC, 1989, J EXP BIOL, V142, P267; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zeikus JG, 1998, EXTREMOPHILES, V2, P179, DOI 10.1007/s007920050058	126	1175	1261	11	798	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1092	1101		10.1038/35059215	http://dx.doi.org/10.1038/35059215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234023	Green Published			2022-12-28	WOS:000167148800057
J	Yamaguchi, S; Kobayashi, M; Mitsui, S; Ishida, Y; van der Horst, GTJ; Suzuki, M; Shibatall, S; Okamura, H				Yamaguchi, S; Kobayashi, M; Mitsui, S; Ishida, Y; van der Horst, GTJ; Suzuki, M; Shibatall, S; Okamura, H			Gene expression - View of a mouse clock gene ticking	NATURE			English	Article									Kobe Univ, Sch Med, Dept Anat & Brain Sci, Kobe, Hyogo 6500017, Japan; Tohoku Inst Technol, Dept Elect, Sendai, Miyagi 9828577, Japan; Erasmus Univ, Dept Cell Biol & Genet, MGC, NL-3000 DR Rotterdam, Netherlands; Kumamoto Univ, Sch Med, Ctr Anim Resources & Dev, Inst Mol Embryol & Genet, Kumamoto 8620976, Japan; Waseda Univ, Sch Human Sci, Dept Pharmacol & Brain Sci, Tokorozawa, Saitama 3591192, Japan	Kobe University; Tohoku Institute Technology; Erasmus University Rotterdam; Kumamoto University; Waseda University	Yamaguchi, S (corresponding author), Kobe Univ, Sch Med, Dept Anat & Brain Sci, Kobe, Hyogo 6500017, Japan.		van der Horst, Gijsbertus TJ/E-3661-2015	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Okamura, Hitoshi/0000-0002-3013-4881				Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; RUSAK B, 1977, J COMP PHYSIOL, V118, P145, DOI 10.1007/BF00611819; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3	4	83	87	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					684	684		10.1038/35055628	http://dx.doi.org/10.1038/35055628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217850				2022-12-28	WOS:000166816400033
J	Gale, EAM				Gale, EAM			Two cheers for inhaled insulin	LANCET			English	Editorial Material									Univ Bristol, Southmead Hosp, Diabet Med Div Med, Bristol 10HA 5NB, Avon, England	Southmead Hospital; University of Bristol	Gale, EAM (corresponding author), Univ Bristol, Southmead Hosp, Diabet Med Div Med, Bristol 10HA 5NB, Avon, England.							CEFALU WT, IN PRESS ANN INTERN; CORSTJENS M, 2000, HARVARD BUSINESS MAR, P20; Heinemann L, 2000, DIABETES CARE, V23, P1343, DOI 10.2337/diacare.23.9.1343; HEUBNER W, 1924, KLIN WOCHENSCHR, V3, P2342; JENSEN HF, 1938, INSULIN ITS CHEM PHY; Patton JS, 1996, ADV DRUG DELIVER REV, V19, P3, DOI 10.1016/0169-409X(95)00113-L; Skyler JS, 1998, DIABETES, V47, pA61; Yudkin JS, 2000, LANCET, V355, P919, DOI 10.1016/S0140-6736(99)09225-9	8	19	19	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					324	325		10.1016/S0140-6736(00)03631-X	http://dx.doi.org/10.1016/S0140-6736(00)03631-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210986				2022-12-28	WOS:000166897900002
J	Lekuona, I; Laraudogoitia, E; Salcedo, A; Sadaba, M				Lekuona, I; Laraudogoitia, E; Salcedo, A; Sadaba, M			Congestive heart failure in a hypertensive patient (don't forget the stethoscope)	LANCET			English	Editorial Material									S CArdiol Hosp Galdakao, Serv Vasco Salud Osakidetza, Vizcaya, Spain	Galdakao Hospital	Lekuona, I (corresponding author), S CArdiol Hosp Galdakao, Serv Vasco Salud Osakidetza, B Labeaga S-N DP 48960, Vizcaya, Spain.							CROTTY KL, 1993, J UROLOGY, V150, P1355, DOI 10.1016/S0022-5347(17)35778-6; TAKAHA M, 1980, J UROLOGY, V124, P315, DOI 10.1016/S0022-5347(17)55424-5; Thome SD, 1998, MAYO CLIN PROC, V73, P1109, DOI 10.4065/73.11.1109; VANWAY CW, 1995, VASCULAR SURG, V2, P1439; VARELA ME, 1928, REV MED LAT AM, V14, P3244	5	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					358	358		10.1016/S0140-6736(00)03644-8	http://dx.doi.org/10.1016/S0140-6736(00)03644-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210999				2022-12-28	WOS:000166897900015
J	Mathias, CJ; Deguchi, K; Schatz, I				Mathias, CJ; Deguchi, K; Schatz, I			Observations on recurrent syncope and presyncope in 641 patients	LANCET			English	Article							CHRONIC AUTONOMIC FAILURE; POSTURAL HYPOTENSION; VASOVAGAL SYNCOPE; ISOPROTERENOL; VASODEPRESSOR; POPULATION	Background Syncope is a common disorder that is potentially disabling and affects both young and old. Once neurological, cardiological, and metabolic causes have been excluded, there remains a group in which diagnosis is unclear; some may have an autonomic basis. We therefore did a retrospective study on consecutive patients referred to our tertiary referral autonomic centres between 1992 and 1998 with recurrent syncope and presyncope, in whom nonautonomic causes, before referral, had been sought and excluded. The object was to find out whether autonomic investigation helped diagnosis. Methods Data from case notes and from the autonomic database on 641 patients were analysed. Syncopal patients with a known or provisional diagnosis of autonomic failure were excluded from analysis. The role of screening tests in establishing or excluding an autonomic cause was assessed. Response to additional autonomic tests (such as head-up tilt with or without venepuncture, and food challenge and exercise) was documented. Some patients underwent further testing if non-autonomic neurological, psychiatric, and other disorders were considered. Findings Screening autonomic function tests indicated orthostatic hypotension and confirmed chronic autonomic failure in 31 (4.8%) patients. Neurally mediated syncope was diagnosed in 279 (43.5%) on the basis of clinical features and autonomic testing. Most had vasovagal syncope (227 [35%]); other causes included carotid sinus hypersensitivity (37 [5.8%]), and a group of 15 (2.3%) were associated with rarer causes such as micturition and swallowing. Miscellaneous cardiovascular causes (systemic hypotension, arrhythmias), or drugs, contributed to syncope in 53 (8.3%). Non-autonomic neurological causes included vestibular dysfunction (32 [5%]) and epilepsy (11 [1.7%]). In 56 (8.7%) a psychiatric cause was thought to be contributory. In 179 (27.9%), syncope was of unknown cause. and (227 autonomic testing. Mos [35%]); other causes. Interpretation in recurrent syncope and presyncope, when cardiac, neurological, and metabolic causes have been excluded, autonomic investigation can aid management by making, confirming, or excluding various factors or diagnoses.	St Marys Hosp, Imperial Coll Sch Med, Neurovasc Med Unit, Div Neurosci & Psychol Med,Pickering Unit, London W2 1NY, England; UCL, Inst Neurol, Univ Dept Clin Neurol, Auton Unit, London, England; Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Univ Hawaii, Dept Med, Honolulu, HI 96822 USA	Imperial College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Hawaii System	Mathias, CJ (corresponding author), St Marys Hosp, Imperial Coll Sch Med, Neurovasc Med Unit, Div Neurosci & Psychol Med,Pickering Unit, Praed St, London W2 1NY, England.	c.mathias@ic.ac.uk						BENDITT DG, 1992, ANNU REV MED, V43, P283, DOI 10.1146/annurev.me.43.020192.001435; CALKINS H, 1993, AM J MED, V95, P473, DOI 10.1016/0002-9343(93)90329-N; CRITCHLEY EMR, 1983, BRIT MED J, V286, P500, DOI 10.1136/bmj.286.6364.500; Deguchi K, 1999, J NEUROL NEUROSUR PS, V67, P220, DOI 10.1136/jnnp.67.2.220; DERMKSIAN G, 1958, JAMA-J AM MED ASSOC, V168, P1200, DOI 10.1001/jama.1958.03000090030007; Dey AB, 1997, QJM-MON J ASSOC PHYS, V90, P1; ELBADAWI KM, 1994, CLIN AUTON RES, V4, P41; GARDNER WN, 1989, BRIT J HOSP MED, V41, P73; Grubb BP, 1997, PACE, V20, P2019; Hainsworth R., 1999, AUTONOMIC FAILURE TX, P428; KAPOOR WN, 1982, JAMA-J AM MED ASSOC, V247, P2687, DOI 10.1001/jama.247.19.2687; Kapoor WN, 1998, SYNCOPE: MECHANISMS AND MANAGEMENT, P1; KAPOOR WN, 1990, MEDICINE, V69, P160, DOI 10.1097/00005792-199005000-00004; KAPOOR WN, 1992, ANN INTERN MED, V116, P358, DOI 10.7326/0003-4819-116-5-358; Kaufmann H, 1997, J CLIN NEUROPHYSIOL, V14, P183, DOI 10.1097/00004691-199705000-00003; KENNY RA, 1996, SYNCOPE OLDER PATIEN, P107; Lempert T, 1996, J ROY SOC MED, V89, P372, DOI 10.1177/014107689608900705; LIPSITZ LA, 1985, Q J MED, V55, P45; MATHIAS CJ, 1991, J NEUROL NEUROSUR PS, V54, P726, DOI 10.1136/jnnp.54.8.726; Mathias CJ, 1998, LANCET, V352, P33, DOI 10.1016/S0140-6736(05)79513-1; Mathias CJ, 2000, CLIN AUTON RES, V10, P43, DOI 10.1007/BF02291389; Mathias CJ, 1999, J NEUROL, V246, P893, DOI 10.1007/s004150050479; Mathias CJ, 1999, AUTONOMIC FAILURE TX, V4, P169; MCINTOSH SJ, 1993, AM J MED, V95, P203, DOI 10.1016/0002-9343(93)90261-M; NOBLE RJ, 1977, JAMA-J AM MED ASSOC, V237, P1372, DOI 10.1001/jama.237.13.1372; PEMBERTON J, 1989, BRIT MED J, V298, P660, DOI 10.1136/bmj.298.6674.660; PETCH MC, 1994, BRIT MED J, V308, P1251, DOI 10.1136/bmj.308.6939.1251; PETERSEN MEV, 1995, QJM-MON J ASSOC PHYS, V88, P209; SAVAGE DD, 1985, STROKE, V16, P626, DOI 10.1161/01.STR.16.4.626; SCHATZ IJ, 1996, CLIN AUTON RES, V6, P125; SMITH GDP, 1995, QJM-MON J ASSOC PHYS, V88, P251; Zaidi A, 1998, BRIT MED J, V317, P869, DOI 10.1136/bmj.317.7162.869	32	126	136	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					348	353		10.1016/S0140-6736(00)03642-4	http://dx.doi.org/10.1016/S0140-6736(00)03642-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210997				2022-12-28	WOS:000166897900013
J	Rizzo, T				Rizzo, T			Habituation technique in study of development of fetal behaviour	LANCET			English	Editorial Material							DIABETIC MOTHERS; HUMAN-FETUS; EMERGENCE; STATES; WOMEN				Rizzo, T (corresponding author), 851 Washington St, Elmhurst, IL 60126 USA.							Doherty NN, 2000, EARLY HUM DEV, V59, P85, DOI 10.1016/S0378-3782(00)00089-X; MCCALL RB, 1993, CHILD DEV, V64, P57, DOI 10.1111/j.1467-8624.1993.tb02895.x; MULDER EJH, 1987, EARLY HUM DEV, V15, P231, DOI 10.1016/0378-3782(87)90082-X; NIJHUIS JG, 1982, EARLY HUM DEV, V6, P177, DOI 10.1016/0378-3782(82)90106-2; Rizzo TA, 1997, CHILD DEV, V68, P26, DOI 10.2307/1131922; ROBERTSON SS, 1986, DEV PSYCHOBIOL, V19, P223, DOI 10.1002/dev.420190308; van Heteren CF, 2000, LANCET, V356, P1169, DOI 10.1016/S0140-6736(00)02766-5; VISSER GHA, 1985, EARLY HUM DEV, V12, P167, DOI 10.1016/0378-3782(85)90179-3; VISSER GHA, 1992, DEV PHARMACOL THERAP, V18, P175, DOI 10.1159/000480620	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					328	329		10.1016/S0140-6736(05)71499-9	http://dx.doi.org/10.1016/S0140-6736(05)71499-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210991				2022-12-28	WOS:000166897900007
J	Wang, GJ; Volkow, ND; Logan, J; Pappas, NR; Wong, CT; Zhu, W; Netusil, N; Fowler, JS				Wang, GJ; Volkow, ND; Logan, J; Pappas, NR; Wong, CT; Zhu, W; Netusil, N; Fowler, JS			Brain dopamine and obesity	LANCET			English	Article							RECEPTOR-BINDING CHARACTERISTICS; STRIATAL DOPAMINE; NUCLEUS-ACCUMBENS; C-11 RACLOPRIDE; COCAINE ABUSERS; IN-VIVO; REWARD; FOOD; ASSOCIATION; GENE	Background The cerebral mechanisms underlying the behaviours that lead to pathological overeating and obesity are poorly understood. Dopamine, a neurotransmitter that modulates rewarding properties of food, is likely to be involved. To test the hypothesis that obese individuals have abnormalities in brain dopamine activity we measured the availability of dopamine D-2 receptors in brain. Methods Brain dopamine D-2 receptor availability was measured with positron emission tomography (PET) and [C-11]raclopride (a radioligand for the dopamine D-2 receptor). Bmax/Kd (ratio of the distribution volumes in striatum to that in cerebellum minus 1) was used as a measure of dopamine D-2 receptor availability. Brain glucose metabolism was also assessed with 2-deoxy-2[F-18]fluoro-D-glucose (FDG). Findings Striatal dopamine D-2 receptor availability was significantly lower in the ten obese individuals (2.47 [SD 0.36]) than in controls (2.99 [0.41]; p less than or equal to0.0075). In the obese individuals body mass index (BMI) correlated negatively with the measures of D-2 receptors (r=0.84; p less than or equal to0.002); the individuals with the lowest D-2 values had the largest BMI. By contrast, neither whole brain nor striatal metabolism differed between obese individuals and controls, indicating that striatal reductions in D-2 receptors were not due to a systematic reduction in radiotracer delivery. Interpretation The availability of dopamine D-2 receptor was decreased in obese individuals in proportion to their BMI. Dopamine modulates motivation and reward circuits and hence dopamine deficiency in obese individuals may perpetuate pathological eating as a means to compensate for decreased activation of these circuits. Strategies aimed at improving dopamine function may be beneficial in the treatment of obese individuals.	Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, GJ (corresponding author), Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA.				NIDA NIH HHS [DA 06891-02] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006891] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Balcioglu A, 1998, INT J OBESITY, V22, P325, DOI 10.1038/sj.ijo.0800589; Baptista T, 1999, ACTA PSYCHIAT SCAND, V100, P3, DOI 10.1111/j.1600-0447.1999.tb10908.x; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bina KG, 2000, NEUROENDOCRINOLOGY, V71, P68, DOI 10.1159/000054522; Blum K, 1996, AM SCI, V84, P132; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Comings DE, 1996, MOL PSYCHIATR, V1, P325; FARDE L, 1986, SCIENCE, V231, P258, DOI 10.1126/science.2867601; FOLTIN RW, 1990, PHARMACOL BIOCHEM BE, V36, P869, DOI 10.1016/0091-3057(90)90092-V; HATTORI S, 1994, BRAIN RES BULL, V35, P41, DOI 10.1016/0361-9230(94)90214-3; HIETALA J, 1994, PSYCHOPHARMACOLOGY, V116, P285, DOI 10.1007/BF02245330; HOEBEL BG, 1985, AM J CLIN NUTR, V42, P1133, DOI 10.1093/ajcn/42.5.1133; LOGAN J, 1994, J CEREBR BLOOD F MET, V14, P995, DOI 10.1038/jcbfm.1994.132; MACRAE PG, 1987, PSYCHOPHARMACOLOGY, V92, P236; Martel P, 1996, PHARMACOL BIOCHEM BE, V53, P221, DOI 10.1016/0091-3057(95)00187-5; MAZZIOTTA J C, 1986, P493; NOBLE EP, 1994, INT J EAT DISORDER, V15, P205, DOI 10.1002/1098-108X(199404)15:3&lt;205::AID-EAT2260150303&gt;3.0.CO;2-P; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; TOWELL A, 1988, PHARMACOL BIOCHEM BE, V30, P641, DOI 10.1016/0091-3057(88)90077-9; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; Wang GJ, 1997, EUR ADDICT RES, V3, P49, DOI 10.1159/000259147; Wang GJ, 1997, NEUROPSYCHOPHARMACOL, V16, P174, DOI 10.1016/S0893-133X(96)00184-4; Wang GJ, 1999, J NUCL MED, V40, P1285; WANG GJ, 1994, J NUCL MED, V35, P1457; YANOVSKI SZ, 1993, AM J PSYCHIAT, V150, P1472	29	1336	1365	3	126	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					354	357		10.1016/S0140-6736(00)03643-6	http://dx.doi.org/10.1016/S0140-6736(00)03643-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210998	Green Submitted			2022-12-28	WOS:000166897900014
J	Stewart, EA				Stewart, EA			Uterine fibroids	LANCET			English	Review							MEDROXYPROGESTERONE ACETATE; LAPAROSCOPIC MYOMECTOMY; ABDOMINAL HYSTERECTOMY; INTERFERON-ALPHA; HORMONE ANALOGS; DOUBLE-BLIND; LEIOMYOMATA; WOMEN; GROWTH; EMBOLIZATION	Uterine leiomyomas (fibroids or myomas), benign tumours of the human uterus, are the single most common indication for hysterectomy, They are clinically apparent in up to 25% of women and cause significant morbidity, including prolonged or heavy menstrual bleeding, pelvic pressure or pain, and, in rare cases, reproductive dysfunction. Thus, both the economic cost and the effect on quality of life are substantial. Surgery has been the mainstay of fibroid treatment, and various minimally invasive procedures have been developed in addition to hysterectomy and abdominal myomectomy, Formation of new leiomyomas after these conservative therapies remains a substantial problem, Although medications that manipulate concentrations of steroid hormones are effective, side-effects limit long-term use, A better approach may be manipulation of the steroid-hormone environment with specific hormone antagonists, There has been little evidence-based evaluation of therapy, New research into the basic biology of these neoplasms may add new treatment options for the future as the role of growth factors and genetic mutations in these tumours are better understood.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Uterine Fibroids,Dept Obstet Gynecol & Reprod, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Stewart, EA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Uterine Fibroids,Dept Obstet Gynecol & Reprod, 75 Francis St, Boston, MA 02115 USA.	eastewart@partners.org		Stewart, Elizabeth/0000-0003-1110-2400	NICHD NIH HHS [HD-115301] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acien P, 1996, FERTIL STERIL, V65, P41, DOI 10.1016/S0015-0282(16)58025-X; Anania CA, 1997, MOL HUM REPROD, V3, P685, DOI 10.1093/molehr/3.8.685; Arcangeli S, 1997, OBSTET GYNECOL, V89, P857, DOI 10.1016/S0029-7844(97)81430-5; Benassayag C, 1999, AM J PHYSIOL-ENDOC M, V276, pE1112, DOI 10.1152/ajpendo.1999.276.6.E1112; BROSENS IA, 1999, PATHOGENESIS MED MAN; BUTTRAM VC, 1981, FERTIL STERIL, V36, P433; CARLSON KJ, 1994, OBSTET GYNECOL, V83, P556, DOI 10.1097/00006250-199404000-00012; CARR BR, 1993, J CLIN ENDOCR METAB, V76, P1217, DOI 10.1210/jc.76.5.1217; Chegini N, 1999, J CLIN ENDOCR METAB, V84, P4138, DOI 10.1210/jc.84.11.4138; Chiaffarino F, 1999, BRIT J OBSTET GYNAEC, V106, P857, DOI 10.1111/j.1471-0528.1999.tb08409.x; Chiaffarino F, 1999, OBSTET GYNECOL, V94, P395, DOI 10.1016/S0029-7844(99)00305-1; COUTINHO EM, 1989, FERTIL STERIL, V51, P939; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; de Aloysio D, 1998, MATURITAS, V29, P261, DOI 10.1016/S0378-5122(98)00014-0; DERMAN SG, 1991, OBSTET GYNECOL, V77, P591; Dou QC, 1996, J CLIN ENDOCR METAB, V81, P3222, DOI 10.1210/jc.81.9.3222; Dubuisson JB, 1997, CURR OPIN OBSTET GYN, V9, P233; FEDELE L, 1995, HUM REPROD, V10, P1795, DOI 10.1093/oxfordjournals.humrep.a136176; Felberbaum RE, 1998, HUM REPROD, V13, P1660, DOI 10.1093/humrep/13.6.1660; FILICORI M, 1983, AM J OBSTET GYNECOL, V147, P726, DOI 10.1016/0002-9378(83)90463-5; FRIEDMAN AJ, 1994, HUM REPROD, V9, P1618, DOI 10.1093/oxfordjournals.humrep.a138762; FRIEDMAN AJ, 1988, FERTIL STERIL, V49, P404; GARCIA CR, 1984, FERTIL STERIL, V42, P16; GARNET JD, 1964, OBSTET GYNECOL, V23, P898; Goldfarb HA, 1995, OBSTET GYN CLIN N AM, V22, P807; Goodwin SC, 1998, CURR OPIN OBSTET GYN, V10, P315, DOI 10.1097/00001703-199808000-00006; Gross K, 2000, OBSTET GYNECOL S, P95, DOI [10.1016/S0029-7844(00)00715-8, DOI 10.1016/S0029-7844(00)00715-8]; Hillis SD, 1996, OBSTET GYNECOL, V87, P539, DOI 10.1016/0029-7844(95)00478-5; Hockstein S, 2000, J REPROD MED, V45, P139; Iverson RE, 1996, OBSTET GYNECOL, V88, P415, DOI 10.1016/0029-7844(96)00218-9; KETTEL LM, 1993, FERTIL STERIL, V60, P642; Kjerulff KH, 1996, J REPROD MED, V41, P483; Kjerulff KH, 2000, OBSTET GYNECOL, V95, P319, DOI 10.1016/S0029-7844(99)00544-X; Law P, 1999, LANCET, V354, P2049, DOI 10.1016/S0140-6736(99)04958-2; Lee BS, 1998, AM J REPROD IMMUNOL, V40, P19; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; LINDER D, 1965, SCIENCE, V150, P67, DOI 10.1126/science.150.3692.67; MALONE LJ, 1969, OBSTET GYNECOL, V34, P200; MANGRULKAR RS, 1995, BIOL REPROD, V53, P636, DOI 10.1095/biolreprod53.3.636; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; Marshall LM, 1998, FERTIL STERIL, V70, P432, DOI 10.1016/S0015-0282(98)00208-8; MASHAL RD, 1994, GENE CHROMOSOME CANC, V11, P1, DOI 10.1002/gcc.2870110102; Minakuchi K, 1999, LANCET, V353, P2127, DOI 10.1016/S0140-6736(99)01648-7; MURPHY AA, 1993, J CLIN ENDOCR METAB, V76, P513, DOI 10.1210/jc.76.2.513; Nezhat C, 1996, INT J FERTIL MENOP S, V41, P280; Niu HR, 1998, OBSTET GYNECOL, V91, P735, DOI 10.1016/S0029-7844(98)00014-3; Palomba S, 1998, FERTIL STERIL, V70, P111, DOI 10.1016/S0015-0282(98)00128-9; Parazzini F, 1996, J REPROD MED, V41, P316; PARAZZINI F, 1988, OBSTET GYNECOL, V72, P853, DOI 10.1097/00006250-198812000-00008; PARKER WH, 1994, OBSTET GYNECOL, V83, P414; Pedeutour F, 1998, GENE CHROMOSOME CANC, V23, P361, DOI 10.1002/(SICI)1098-2264(199812)23:4<361::AID-GCC12>3.0.CO;2-4; Pelage JP, 2000, RADIOLOGY, V215, P428, DOI 10.1148/radiology.215.2.r00ma11428; Ravina JH, 2000, FERTIL STERIL, V73, P1241, DOI 10.1016/S0015-0282(00)00497-0; RAVINA JH, 1995, LANCET, V346, P671, DOI 10.1016/S0140-6736(95)92282-2; REED WB, 1973, ACTA DERM-VENEREOL, V53, P409; RICE JP, 1989, AM J OBSTET GYNECOL, V160, P1212, DOI 10.1016/0002-9378(89)90194-4; ROSS RK, 1986, BRIT MED J, V293, P359, DOI 10.1136/bmj.293.6543.359; ROSS RK, 1986, BRIT MED J, V293, P1027, DOI 10.1136/bmj.293.6553.1027-b; Sampson JA, 1912, SURG GYNECOL OBSTET, V14, P215; Schwartz LB, 1998, FERTIL STERIL, V70, P580, DOI 10.1016/S0015-0282(98)00193-9; SCHWARTZ LB, 1993, AM J OBSTET GYNECOL, V168, P180, DOI 10.1016/S0002-9378(12)90910-2; SHAW RW, 1991, CURR OPIN OBSTET GYN, V3, P859; STEWART EA, 1994, J CLIN ENDOCR METAB, V79, P900, DOI 10.1210/jc.79.3.900; Stewart EA, 1998, OBSTET GYNECOL, V92, P624, DOI 10.1016/S0029-7844(98)00243-9; Stewart EA, 1996, HUM REPROD UPDATE, V2, P295, DOI 10.1093/humupd/2.4.295; STOVALL TG, 1995, OBSTET GYNECOL, V86, P65, DOI 10.1016/0029-7844(95)00102-W; TRELOAR SA, 1992, AM J OBSTET GYNECOL, V167, P82, DOI 10.1016/S0002-9378(11)91632-9; Ubaldi F, 1995, HUM REPROD UPDATE, V1, P81, DOI 10.1093/humupd/1.1.81; Vashisht A, 1999, LANCET, V354, P307, DOI 10.1016/S0140-6736(99)02987-6; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; Walker CL, 2000, J SOC GYNECOL INVEST, V7, P249, DOI 10.1016/S1071-5576(00)00056-3	72	780	816	7	92	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2001	357	9252					293	298		10.1016/S0140-6736(00)03622-9	http://dx.doi.org/10.1016/S0140-6736(00)03622-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214143				2022-12-28	WOS:000166693400035
J	Crisp, D				Crisp, D			Planetary science - The nightside of Venus	SCIENCE			English	Editorial Material							AIRGLOW; EMISSION; OXYGEN		NASA, New Millennium Program, Jet Prop Lab, Pasadena, CA 91109 USA	National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Crisp, D (corresponding author), NASA, New Millennium Program, Jet Prop Lab, Pasadena, CA 91109 USA.		Crisp, David/F-6642-2017	Crisp, David/0000-0002-4573-9998				CONNES P, 1979, ASTROPHYS J, V233, pL29, DOI 10.1086/183070; Crisp D, 1996, J GEOPHYS RES-PLANET, V101, P4577, DOI 10.1029/95JE03136; KRASNOPOLSKY VA, 1976, KOSM ISSLED, V14, P789; Makhlouf UB, 1997, ADV SPACE RES-SERIES, V19, P583, DOI 10.1016/S0273-1177(97)00177-4; Phillips J. L., 1988, Sky and Telescope, V75, P250; Slanger TG, 2001, SCIENCE, V291, P463, DOI 10.1126/science.291.5503.463; TRAUGER JT, 1983, ICARUS, V55, P272, DOI 10.1016/0019-1035(83)90082-9; Wang DY, 2000, J ATMOS SCI, V57, P1906, DOI 10.1175/1520-0469(2000)057<1906:SPWIFW>2.0.CO;2; Ward WE, 1997, GEOPHYS RES LETT, V24, P1127, DOI 10.1029/97GL01022	9	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2001	291	5503					444	445		10.1126/science.1057630	http://dx.doi.org/10.1126/science.1057630			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11228142				2022-12-28	WOS:000166487500028
J	Agani, F				Agani, F			Mental health challenges in postwar Kosova	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Clin Ctr, Prishtina, Kosova, Yugoslavia		Agani, F (corresponding author), Univ Clin Ctr, Prishtina, Kosova, Yugoslavia.							Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; JONES L, 1993, BRIT MED J, V307, P112, DOI 10.1136/bmj.307.6896.112; *US INT DEV AG, 2000, KOS CRIS FACT SHEET	3	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1217	1217		10.1001/jama.285.9.1217	http://dx.doi.org/10.1001/jama.285.9.1217			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231759	hybrid			2022-12-28	WOS:000167194700032
J	Casellas, R; Shih, TAY; Kleinewietfeld, M; Rakonjac, J; Nemazee, D; Rajewsky, K; Nussenzweig, MC				Casellas, R; Shih, TAY; Kleinewietfeld, M; Rakonjac, J; Nemazee, D; Rajewsky, K; Nussenzweig, MC			Contribution of receptor editing to the antibody repertoire	SCIENCE			English	Article							B-CELL DEVELOPMENT; MOUSE BONE-MARROW; GENE-EXPRESSION; MICE; REARRANGEMENTS; MODEL; LYMPHOCYTES; MATURATION; TOLERANCE; DELETION	Receptor editing, clonal deletion, and anergy are the mechanisms by which B cells maintain tolerance to self antigens. To determine the extent to which receptor editing shapes the normal antibody repertoire, we generated an immunoglobulin kappa polymorphism that facilitates the detection of;editing of immunoglobulin light chains in vivo. We found that B cells are targeted for editing during a 2-hour delay in development at the pre-BII cell stage, and that about 25% of all antibody molecules are produced by gene replacement. These results suggest that receptor editing represents a major force in shaping the antibody repertoire.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Cologne; Scripps Research Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.		Kleinewietfeld, Markus/AAI-4497-2021; Nussenzweig, Michel/AAE-7292-2019; Rakonjac, Jasna V/E-6836-2011	Rakonjac, Jasna V/0000-0002-6756-4682; Kleinewietfeld, Markus/0000-0002-2832-3149; Rajewsky, Klaus/0000-0002-6633-6370	NIAID NIH HHS [R01 AI033608] Funding Source: Medline; PHS HHS [33890] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033608] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Arakawa H, 1996, INT IMMUNOL, V8, P91, DOI 10.1093/intimm/8.1.91; Braun U, 2000, P NATL ACAD SCI USA, V97, P7429, DOI 10.1073/pnas.050578497; BURNET M, 1959, CLONAL SELECTION THE; Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARLTEY SB, 1993, CELL, V72, P325; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Kouskoff V, 2000, P NATL ACAD SCI USA, V97, P7435, DOI 10.1073/pnas.130182597; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; OPSTELTEN D, 1983, J IMMUNOL, V131, P2635; Pelanda R, 1996, IMMUNITY, V5, P229, DOI 10.1016/S1074-7613(00)80318-0; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; ROCHA B, 1990, EUR J IMMUNOL, V20, P1697, DOI 10.1002/eji.1830200812; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	29	248	266	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1541	1544		10.1126/science.1056600	http://dx.doi.org/10.1126/science.1056600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222858				2022-12-28	WOS:000167153400043
J	Lang, P; Stolpa, JC; Freiberg, BA; Crawford, F; Kappler, J; Kupfer, A; Cambier, JC				Lang, P; Stolpa, JC; Freiberg, BA; Crawford, F; Kappler, J; Kupfer, A; Cambier, JC			TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers	SCIENCE			English	Article							B-CELL ACTIVATION; ANTIGEN RECEPTOR; T-CELL; TYROSINE PHOSPHORYLATION; CROSS-LINKING; LYMPHOCYTES-B; MOLECULES; EXPRESSION; PROTEIN; PROLIFERATION	Previous findings suggest that during cognate T cell-B cell interactions, major histocompatability complex (MHC) class II molecules transduce signals, leading to Src-family kinase activation, Ca2+ mobilization, and proliferation. Here, we show that antigen stimulation of resting B cells induces MHC class It molecules to associate with Immunoglobulin (Ig)-alpha /Ig-beta (CD79a/CD79b) heterodimers, which function as signal transducers upon MHC class II aggregation by the T cell receptor (TCR). The B cell receptor (BCR) and MHC class II/Ig-alpha /Ig-beta are distinct complexes, yet class It-associated Ig-alpha/beta appears to be derived from BCR. Hence, Ig-alpha/beta are used in a sequential fashion for transduction of antigen and cognate T cell help signals.	Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; National Jewish Health	Cambier, JC (corresponding author), Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.			Cambier, John/0000-0002-7803-242X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI020519] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 20519, AI 22295] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDRE P, 1994, J EXP MED, V179, P763, DOI 10.1084/jem.179.2.763; Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; CAMBIER JC, 1991, J IMMUNOL, V146, P2075; CAMBIER JC, 1989, J EXP MED, V170, P877, DOI 10.1084/jem.170.3.877; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CAMBIER JC, UNPUB; CHERONIS JC, 1994, J MED CHEM, V37, P348, DOI 10.1021/jm00029a006; Chirmule N, 2000, J IMMUNOL, V164, P248, DOI 10.4049/jimmunol.164.1.248; Drake JR, 1997, J EXP MED, V186, P1299, DOI 10.1084/jem.186.8.1299; GOLD MR, 1991, P NATL ACAD SCI USA, V88, P3436, DOI 10.1073/pnas.88.8.3436; JACKSON MR, 1992, P NATL ACAD SCI USA, V89, P12117, DOI 10.1073/pnas.89.24.12117; KANNER SB, 1995, TISSUE ANTIGENS, V46, P145, DOI 10.1111/j.1399-0039.1995.tb03113.x; KIM KJ, 1979, J IMMUNOL, V122, P549; Lane P, 1996, CURR OPIN IMMUNOL, V8, P331, DOI 10.1016/S0952-7915(96)80121-X; LANE PJL, 1990, J IMMUNOL, V144, P3684; MOONEY NA, 1990, J IMMUNOL, V145, P2070; MORIO T, 1994, EUR J IMMUNOL, V24, P651, DOI 10.1002/eji.1830240325; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.iy.11.040193.001555; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Schrader CE, 1997, J IMMUNOL, V158, P153; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; WADE WF, 1989, P NATL ACAD SCI USA, V86, P6297, DOI 10.1073/pnas.86.16.6297	27	91	91	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1537	1540		10.1126/science.291.5508.1537	http://dx.doi.org/10.1126/science.291.5508.1537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222857				2022-12-28	WOS:000167153400042
J	Jay, V; Vajsar, J				Jay, V; Vajsar, J			The dystrophy of Duchenne	LANCET			English	Article							MUSCULAR-DYSTROPHY		Univ Toronto, Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Jay, V (corresponding author), Univ Toronto, Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada.							BROWN RHJ, 1988, TRENDS NEUROL SCI, V11, P450; GUTMANN DH, 1989, ANN NEUROL, V26, P189, DOI 10.1002/ana.410260202; JAY V, 1993, PEDIATR PATHOL, V13, P635; POORE GV, 1983, SELECTIONS CLIN WORK; WORTON R, 1995, SCIENCE, V270, P755, DOI 10.1126/science.270.5237.755	5	13	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					550	552		10.1016/S0140-6736(00)04052-6	http://dx.doi.org/10.1016/S0140-6736(00)04052-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229686				2022-12-28	WOS:000167011700029
J	Bogert, C; Dufka, C				Bogert, C; Dufka, C			Sexual violence in Sierra Leone	LANCET			English	Editorial Material									Human Rights Watch, New York, NY 10118 USA		Bogert, C (corresponding author), Human Rights Watch, 350 5th Ave, New York, NY 10118 USA.								0	1	1	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					304	304		10.1016/S0140-6736(00)03627-8	http://dx.doi.org/10.1016/S0140-6736(00)03627-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214148				2022-12-28	WOS:000166693400040
J	Tattersfield, AE; Lofdahl, CG; Postma, DS; Eivindson, A; Schreurs, AGM; Rasidakis, A; Ekstrom, T				Tattersfield, AE; Lofdahl, CG; Postma, DS; Eivindson, A; Schreurs, AGM; Rasidakis, A; Ekstrom, T			Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial	LANCET			English	Article							QUALITY-OF-LIFE; INHALED FORMOTEROL; MICROVASCULAR LEAKAGE; AGONIST FORMOTEROL; SALMETEROL; SALBUTAMOL; BUDESONIDE; DURATION; ONSET	Background Asthma guidelines recommend that long-acting inhaled beta -agonists should be used as maintenance therapy for patients with asthma inadequately controlled on an inhaled corticosteroid. We studied the safety and efficacy of the long acting beta -agonist formoterol compared with terbutaline, each taken as needed, in patients with moderate to severe asthma. Methods Patients were taking an inhaled corticosteroid (mean dose 870 mug daily) and had a forced expiratory volume in 1 a (FEV1) of at least 50% predicted (mean 74%). Those requiring an inhaled beta -agonist three to eight times a day during the study run-in period (362 of 621 who started) were randomly assigned formoterol 4.5 mug or terbutaline 0.5 mg as needed by Turbuhaler in daily doses up to 54 mug and 6 mg, respectively, for 12 weeks in a double-blind, parallel-group study. Analyses were by intention to treat. Findings The 362 randomised patients (157 men, 205 women) had a mean age of 47 years. Patients taking formoterol had a longer time to their first severe asthma exacerbation (relative-risk ratio 0.55 [95% CI 0.34-0 8.9]), took fewer inhalations of study drug, and had larger increases in FEV1 (5%) and morning and evening peak expiratory flow (mean difference in increase 11 L/min and 8 L/min) than those taking terbutaline. No safety issues were identified. Interpretation When taken as needed, formoterol 4.5 mug provided better asthma control than terbutaline 0.5 mg in patients requiring moderate doses of relief medication despite inhaled corticosteroid treatment. Safety studies should be extended to a wider population of patients with asthma.	City Hosp, Div Resp Med, Resp Med Unit, Nottingham NG5 1PB, England; Univ Lund Hosp, Dept Resp Med, Lund, Sweden; Univ Groningen Hosp, Dept Pulmonol, Groningen, Netherlands; Havblik Med Ctr, Dept Med, Arendal, Norway; Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; Sotiria Hosp, Dept Resp Med, Athens, Greece; Astra Zeneca Res & Dev, Lund, Sweden	University of Nottingham; Lund University; Skane University Hospital; University of Groningen; Onze Lieve Vrouwe Gasthuis Hospital; AstraZeneca	Tattersfield, AE (corresponding author), City Hosp, Div Resp Med, Resp Med Unit, Nottingham NG5 1PB, England.	anne.tattersfield@nottingham.ac.uk						ADVENIER C, 1992, BRIT J PHARMACOL, V105, P792, DOI 10.1111/j.1476-5381.1992.tb09059.x; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; ARVIDSSON P, 1991, EUR RESPIR J, V4, P1168; ARVIDSSON P, 1989, EUR RESPIR J, V2, P325; BALUK P, 1994, AM J PHYSIOL, V266, pL461, DOI 10.1152/ajplung.1994.266.4.L461; BREMNER P, 1993, EUR RESPIR J, V6, P204; ERJEFALT I, 1991, AM REV RESPIR DIS, V144, P788, DOI 10.1164/ajrccm/144.4.788; Greiff L, 1998, THORAX, V53, P1010, DOI 10.1136/thx.53.12.1010; Guhan AR, 2000, THORAX, V55, P650, DOI 10.1136/thorax.55.8.650; Juniper EF, 1999, EUR RESPIR J, V14, P1038, DOI 10.1183/09031936.99.14510389; JUNIPER EF, 1995, AM J RESP CRIT CARE, V151, P66, DOI 10.1164/ajrccm.151.1.7812574; KALLSTROM BL, 1994, BRIT J PHARMACOL, V113, P687; LINSEN VMJ, 1996, EUR RESPIR J, V9, P1684; MAESEN FPV, 1995, BRIT J CLIN PRACT, V49, P294; MIDGREN B, 1992, CHEST, V101, P1019, DOI 10.1378/chest.101.4.1019; *NIH, 1995, PUBL NHLBI; Palmqvist M, 1997, EUR RESPIR J, V10, P2484, DOI 10.1183/09031936.97.10112489; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Politiek MJ, 1999, EUR RESPIR J, V13, P988, DOI 10.1034/j.1399-3003.1999.13e10.x; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Ringdal N, 1998, RESP MED, V92, P1017, DOI 10.1016/S0954-6111(98)90348-1; Totterman KJ, 1998, EUR RESPIR J, V12, P573, DOI 10.1183/09031936.98.12030573; vanderMolen T, 1997, THORAX, V52, P535, DOI 10.1136/thx.52.6.535; Wallin A, 1999, AM J RESP CRIT CARE, V159, P79, DOI 10.1164/ajrccm.159.1.9801007; WALLIN A, 1990, THORAX, V45, P259, DOI 10.1136/thx.45.4.259; WHELAN CJ, 1993, BRIT J PHARMACOL, V110, P613, DOI 10.1111/j.1476-5381.1993.tb13855.x; Wilding P, 1997, BRIT MED J, V314, P1441, DOI 10.1136/bmj.314.7092.1441	27	135	140	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2001	357	9252					257	261		10.1016/S0140-6736(00)03611-4	http://dx.doi.org/10.1016/S0140-6736(00)03611-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214127				2022-12-28	WOS:000166693400009
J	Kornak, U; Kasper, D; Bosl, MR; Kaiser, E; Schweizer, M; Schulz, A; Friedrich, W; Delling, G; Jentsch, TJ				Kornak, U; Kasper, D; Bosl, MR; Kaiser, E; Schweizer, M; Schulz, A; Friedrich, W; Delling, G; Jentsch, TJ			Loss of the CIC-7 chloride channel leads to osteopetrosis in mice and man	CELL			English	Article							MEDIATED EXTRACELLULAR ACIDIFICATION; OSTEOCLASTIC BONE-RESORPTION; RENAL TUBULAR-ACIDOSIS; RUFFLED BORDER; RESORBING OSTEOCLASTS; MEMBRANE-PROTEIN; PROTON PUMP; GENE; MUTATIONS; CELLS	Chloride channels play important roles in the plasma membrane and in intracellular organelles. Mice deficient for the ubiquitously expressed CIC-7 Cl- channel show severe osteopetrosis and retinal degeneration. Although osteoclasts are present in normal numbers, they fail to resorb bone because they cannot acidify the extracellular resorption lacuna. CIC-7 resides in late endosomal and lysosomal compartments. In osteoclasts, it is highly expressed in the ruffled membrane, formed by the fusion of H+-ATPase-containing vesicles, that secretes protons into the lacuna. We also identified CLCN7 mutations in a patient with human Infantile malignant osteopetrosis. We conclude that CIC-7 provides the chloride conductance required for an efficient proton pumping by the H+-ATPase of the osteoclast ruffled membrane.	Univ Hamburg, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; Univ Hamburg, Inst Pathol, Abt Osteopathol, D-20246 Hamburg, Germany; Univ Ulm, Univ Kinderklin, D-89075 Ulm, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Martinistr 52, D-20246 Hamburg, Germany.			Jentsch, Thomas/0000-0002-3509-2553				ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Brandt S, 1995, FEBS LETT, V377, P15, DOI 10.1016/0014-5793(95)01298-2; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; Christenson RH, 1997, CLIN BIOCHEM, V30, P573, DOI 10.1016/S0009-9120(97)00113-6; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; GERRITSEN EJA, 1994, PEDIATRICS, V93, P247; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; KEITH CG, 1968, ARCH OPHTHALMOL-CHIC, V79, P234; KOMAK U, 2000, HUM MOL GENET, V9, P2059; Kornak U, 1999, BBA-GENE STRUCT EXPR, V1447, P100, DOI 10.1016/S0167-4781(99)00128-1; Lazner F, 1999, HUM MOL GENET, V8, P1839, DOI 10.1093/hmg/8.10.1839; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Nesbitt SA, 1997, SCIENCE, V276, P266, DOI 10.1126/science.276.5310.266; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Palokangas H, 1997, J CELL SCI, V110, P1767; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Ponting CP, 1997, J MOL MED-JMM, V75, P160; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Schlesinger PH, 1997, J BIOL CHEM, V272, P18636, DOI 10.1074/jbc.272.30.18636; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Vaananen HK, 2000, J CELL SCI, V113, P377	40	735	771	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					205	215		10.1016/S0092-8674(01)00206-9	http://dx.doi.org/10.1016/S0092-8674(01)00206-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207362	hybrid			2022-12-28	WOS:000166879700005
J	Iyer, VR; Horak, CE; Scafe, CS; Botstein, D; Snyder, M; Brown, PO				Iyer, VR; Horak, CE; Scafe, CS; Botstein, D; Snyder, M; Brown, PO			Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; GENE-EXPRESSION; DNA-REPLICATION; S-PHASE; IN-VIVO; COMPLEX; KINASE; REGULATOR; MEIOSIS	Proteins interact with genomic DNA to bring the genome to life; and these interactions also define many functional features of the genome. SBF and MBF are sequence-specific transcription factors that activate gene expression during the G1/S transition of the cell cycle in yeast(1,2). SBF is a heterodimer of Swi4 and Swi6, and MBF is a heterodimer of Mbp1 and Swi6 (refs 1, 3). The related Swi4 and Mbp1 proteins are the DNA-binding components of the respective factors, and Swi6 may have a regulatory function(4,5). A small number of SBF and MBF target genes have been identified(3,6-10). Here we define the genomic binding sites of the SBF and MBF transcription factors in vivo, by using DNA microarrays. In addition to the previously characterized targets, we have identified about 200 new putative targets. Our results support the hypothesis that SBF activated genes are predominantly involved in budding, and in membrane and cell-wall biosynthesis, whereas DNA replication and repair are the dominant functions among MBF activated genes(6,11). The functional specialization of these factors may provide a mechanism for independent regulation of distinct molecular processes that normally occur in synchrony during the mitotic cell cycle.	Stanford Univ, Med Ctr, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Yale University	Brown, PO (corresponding author), Stanford Univ, Med Ctr, Dept Biochem, Stanford, CA 94305 USA.			Snyder, Michael/0000-0003-0784-7987				ANDREWS BJ, 1989, NATURE, V342, P830, DOI 10.1038/342830a0; Ayte J, 1997, MOL CELL BIOL, V17, P6246, DOI 10.1128/MCB.17.11.6246; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BREEDEN L, 1994, GENETICS, V138, P1015; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DIRICK L, 1992, NATURE, V357, P508, DOI 10.1038/357508a0; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Harrington LA, 1996, NUCLEIC ACIDS RES, V24, P558, DOI 10.1093/nar/24.4.558; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; JOHNSTON LH, 1986, EXP CELL RES, V165, P541, DOI 10.1016/0014-4827(86)90606-3; KOCH C, 1994, CURR OPIN CELL BIOL, V6, P451, DOI 10.1016/0955-0674(94)90039-6; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Leem SH, 1998, NUCLEIC ACIDS RES, V26, P3154, DOI 10.1093/nar/26.13.3154; LOWNDES NF, 1991, NATURE, V350, P247, DOI 10.1038/350247a0; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; MCINTOSH EM, 1993, CURR GENET, V24, P185, DOI 10.1007/BF00351790; MEASDAY V, 1994, SCIENCE, V266, P1391, DOI 10.1126/science.7973731; OGAS J, 1991, CELL, V66, P1015, DOI 10.1016/0092-8674(91)90445-5; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; PRIMIG M, 1992, NATURE, V358, P593, DOI 10.1038/358593a0; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; ZHU Y, 1994, GENE DEV, V8, P885, DOI 10.1101/gad.8.8.885	27	813	849	2	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					533	538		10.1038/35054095	http://dx.doi.org/10.1038/35054095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206552				2022-12-28	WOS:000166570500053
J	Kwan, P; Brodie, MJ				Kwan, P; Brodie, MJ			Neuropsychological effects of epilepsy and antiepileptic drugs	LANCET			English	Review							TEMPORAL-LOBE EPILEPSY; QUALITY-OF-LIFE; NEWLY-DIAGNOSED EPILEPSY; COGNITIVE FUNCTION; ELDERLY PATIENTS; ANTICONVULSANT MONOTHERAPY; PSYCHOMOTOR IMPAIRMENT; DIFFERING DOSAGES; SODIUM VALPROATE; DOUBLE-BLIND	Epilepsy and its treatment can have deleterious cognitive and behavioural consequences. Affected individuals have a higher prevalence of neuropsychological dysfunction than the general population because of complex interactions among several multifaceted and overlapping influences-for example, underlying neuropathologies, Ictal and interictal neuronal discharges, a plethora of antlepileptic drugs, and numerous psychosocial issues. Research into the clinical relevance of these factors has been dogged by a range of methodological pitfalls Including lack of standardisation of neuropsychological tests, small numbers and multiple testing, and statistical failure to appreciate differential effects of interactive elements In Individual patients. Although antiepileptic drugs can impair neuropsychological functioning, their positive effect on seizure control might improve cognition and behaviour. Each person should be assessed individually with respect to factors unique to his or her seizure disorder and its treatment.	Univ Glasgow, Western Infirm, Dept Med & Therapeut, Epilepsy Unit, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	Brodie, MJ (corresponding author), Univ Glasgow, Western Infirm, Dept Med & Therapeut, Epilepsy Unit, Glasgow G11 6NT, Lanark, Scotland.	Martin.J.Brodie@clinmed.gla.ac.uk		Kwan, Patrick/0000-0001-7310-276X				AARTS JHP, 1984, BRAIN, V107, P293, DOI 10.1093/brain/107.1.293; AIKIA M, 1992, EPILEPSY RES, V11, P199, DOI 10.1016/0920-1211(92)90099-F; Aldenkamp AP, 2000, EPILEPSIA, V41, P1167, DOI 10.1111/j.1528-1157.2000.tb00322.x; ALDENKAMP AP, 1995, SEIZURE, V4, P95, DOI 10.1016/S1059-1311(95)80088-3; Baker GA, 2000, EPILEPSIA, V41, P98, DOI 10.1111/j.1528-1157.2000.tb01512.x; BENSCH J, 1977, DEV MED CHILD NEUROL, V19, P335; BERENT S, 1987, EPILEPSIA, V28, P61, DOI 10.1111/j.1528-1157.1987.tb03624.x; Brodie MJ, 1999, EPILEPSY RES, V37, P81, DOI 10.1016/S0920-1211(99)00039-X; Brodie MJ, 1997, EPILEPSY RES, V26, P423, DOI 10.1016/S0920-1211(96)01007-8; BRODIE MJ, 1987, EUR J CLIN PHARMACOL, V31, P655, DOI 10.1007/BF00541291; CAMFIELD CS, 1979, J PEDIATR-US, V95, P361, DOI 10.1016/S0022-3476(79)80507-7; CAVENESS WF, 1980, EPILEPSIA, V21, P509, DOI 10.1111/j.1528-1157.1980.tb04302.x; Cochrane HC, 1998, EPILEPSIA, V39, P1088, DOI 10.1111/j.1528-1157.1998.tb01295.x; CRAIG I, 1994, EPILEPSIA, V35, P381, DOI 10.1111/j.1528-1157.1994.tb02448.x; Cramer JA, 2000, EPILEPSIA, V41, P868, DOI 10.1111/j.1528-1157.2000.tb00255.x; CURRAN HV, 1993, EUR J CLIN PHARMACOL, V44, P529, DOI 10.1007/BF02440853; Deckers CLP, 1997, EPILEPSIA, V38, P570, DOI 10.1111/j.1528-1157.1997.tb01142.x; DELGADOESCUETA AV, 1981, NEW ENGL J MED, V305, P711, DOI 10.1056/NEJM198109173051231; Dichter MA, 1996, NEW ENGL J MED, V334, P1583, DOI 10.1056/NEJM199606133342407; Dimond KR, 1996, PROG NEURO-PSYCHOPH, V20, P407, DOI 10.1016/0278-5846(96)00005-X; Dodrill CB, 1997, NEUROLOGY, V48, P1025, DOI 10.1212/WNL.48.4.1025; DODRILL CB, 1995, EPILEPSIA, V36, P164, DOI 10.1111/j.1528-1157.1995.tb00976.x; DODRILL CB, 1992, PSYCHIAT CLIN N AM, V15, P383; DODRILL CB, 1992, EPILEPSIA, V33, P327, DOI 10.1111/j.1528-1157.1992.tb02323.x; Dodrill CB, 1998, EPILEPSIA, V39, P33, DOI 10.1111/j.1528-1157.1998.tb01271.x; DODRILL CB, 1991, NEUROLOGY, V41, P141, DOI 10.1212/WNL.41.1.141; Drane DL, 1996, BAILLIERE CLIN NEUR, V5, P877; DUNCAN JS, 1990, EPILEPSIA, V31, P584, DOI 10.1111/j.1528-1157.1990.tb06110.x; Elixhauser A, 1999, EPILEPSY RES, V37, P13, DOI 10.1016/S0920-1211(99)00036-4; FALCONER MA, 1973, NEW ENGL J MED, V289, P451, DOI 10.1056/NEJM197308302890904; Gillham R, 2000, SEIZURE-EUR J EPILEP, V9, P375, DOI 10.1053/seiz.2000.0428; GILLHAM RA, 1988, J NEUROL NEUROSUR PS, V51, P929, DOI 10.1136/jnnp.51.7.929; GILLHAM RA, 1990, EPILEPSY RES, V7, P219, DOI 10.1016/0920-1211(90)90018-Q; GILLHAM RA, 1991, J EPILEPSY, V4, P205, DOI 10.1016/0896-6974(91)90077-V; Giovagnoli AR, 1999, EPILEPSIA, V40, P904, DOI 10.1111/j.1528-1157.1999.tb00797.x; GOWERS WR, 1981, EPILEPSY OTHER CHRON; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; Jokeit H, 1999, J NEUROL NEUROSUR PS, V67, P44, DOI 10.1136/jnnp.67.1.44; Kalviainen R, 1996, CNS DRUGS, V5, P358, DOI 10.2165/00023210-199605050-00005; Kalviainen R, 1996, EPILEPSY RES, V25, P291, DOI 10.1016/S0920-1211(96)00084-8; KASTELEIJNNOLSTTRENITE DGA, 1988, EPILEPSY RES, V2, P111, DOI 10.1016/0920-1211(88)90027-7; Kilpatrick C, 1997, SEIZURE, V6, P213, DOI 10.1016/S1059-1311(97)80008-8; Klein B, 2000, NEUROLOGY, V55, P230, DOI 10.1212/WNL.55.2.230; Koh S, 1999, NEUROLOGY, V53, P915, DOI 10.1212/WNL.53.5.915; LARKIN JG, 1992, BRIT J CLIN PHARMACO, V33, P111, DOI 10.1111/j.1365-2125.1992.tb04009.x; Leach JP, 1997, J NEUROL NEUROSUR PS, V62, P372, DOI 10.1136/jnnp.62.4.372; MACPHEE GJA, 1986, EUR J CLIN PHARMACOL, V30, P37, DOI 10.1007/BF00614193; MACPHEE PJ, 1994, BR J CLIN PHARM, V37, P27; Martin R, 1999, NEUROLOGY, V52, P321, DOI 10.1212/WNL.52.2.321; Meador KJ, 1999, EPILEPSIA, V40, P1279, DOI 10.1111/j.1528-1157.1999.tb00858.x; Mortimore C, 1998, SEIZURE-EUR J EPILEP, V7, P359, DOI 10.1016/S1059-1311(05)80003-2; NEYENS LGJ, 1995, PROG NEURO-PSYCHOPH, V19, P411, DOI 10.1016/0278-5846(95)00022-N; Prevey ML, 1996, ARCH NEUROL-CHICAGO, V53, P1008, DOI 10.1001/archneur.1996.00550100086018; Pulliainen V, 2000, ACTA NEUROL SCAND, V101, P73, DOI 10.1034/j.1600-0404.2000.101002073.x; PULLIAINEN V, 1995, EPILEPSIA, V36, P1195, DOI 10.1111/j.1528-1157.1995.tb01062.x; Read CL, 1998, SEIZURE-EUR J EPILEP, V7, P159, DOI 10.1016/S1059-1311(98)80073-3; SIEBELINK BM, 1988, EPILEPSY RES, V2, P117, DOI 10.1016/0920-1211(88)90028-9; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; SMITH D, 1993, EPILEPSIA, V34, P312, DOI 10.1111/j.1528-1157.1993.tb02417.x; SMITH DB, 1986, EPILEPSIA, V27, P760, DOI 10.1111/j.1528-1157.1986.tb03607.x; SMITH DB, 1987, EPILEPSIA, V28, pS50, DOI 10.1111/j.1528-1157.1987.tb05778.x; Sulzbacher S, 1999, CLIN PEDIATR, V38, P387, DOI 10.1177/000992289903800702; Sveinbjornsdottir S, 1994, Seizure, V3, P29, DOI 10.1016/S1059-1311(05)80160-8; Tasch E, 1999, ANN NEUROL, V45, P568, DOI 10.1002/1531-8249(199905)45:5<568::AID-ANA4>3.0.CO;2-P; Vermeulen J, 1995, EPILEPSY RES, V22, P65, DOI 10.1016/0920-1211(95)00047-X; VERMEULEN J, 1993, EPILEPSY RES, V15, P157, DOI 10.1016/0920-1211(93)90096-P; Wilson EA, 1996, MODERN MANAGEMENT EP	67	307	328	3	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					216	222		10.1016/S0140-6736(00)03600-X	http://dx.doi.org/10.1016/S0140-6736(00)03600-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213111				2022-12-28	WOS:000166593700035
J	Meagher, EA; Barry, OP; Lawson, JA; Rokach, J; FitzGerald, GA				Meagher, EA; Barry, OP; Lawson, JA; Rokach, J; FitzGerald, GA			Effects of vitamin e on lipid peroxidation in healthy persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; ALPHA-TOCOPHEROL; IN-VIVO; OXIDATIVE STRESS; OXIDANT STRESS; CORONARY REPERFUSION; DEHYDROASCORBIC ACID; BETA-CAROTENE; ASCORBIC-ACID; HEART-DISEASE	Context Oxidative stress may play a role in the development or exacerbation of many common diseases. However, results of prospective controlled trials of the effects of antioxidants such as vitamin E are contradictory. Objective To assess the effects of supplemental vitamin E on lipid peroxidation in vivo in healthy adults. Design Randomized, double-blind, placebo-controlled trial conducted March 1999 to June 2000. Setting A general clinical research center in a tertiary referral academic medical center. Participants Thirty healthy men and women aged 18 to 60 years. Interventions Participants were randomly assigned to receive placebo or alpha -tocopherol dosages of 200, 400, 800, 1200, or 2000 IU/d for 8 weeks (n=5 in each group), followed by an 8-week washout period. Main Outcome Measures Three indices of lipid peroxidation, urinary 4-hydroxynonenal (4-HNE) and 2 isoprostanes, iPF(2 alpha)-III and IPF2 alpha-VI, measured by gas chromatography/ mass spectrometry and compared among the 6 groups at baseline, 2, 4, 6, and 8 weeks, and 1, 3, and 8 weeks after discontinuation. Results Circulating vitamin E levels increased in a dose-dependent manner during the study. No significant effect of vitamin E on levels of urinary 4-HNE or either isoprostane was observed. Mean (SEM) baseline vs week 8 levels of iPF(2 alpha)-III were 154 (20.1) vs 168 (22.3) pg/mg of creatinine for subjects taking placebo; 165 (19.6) vs 234 (30.1) pg/mg for those taking 200 IU/d of vitamin E; and 195 (26.7) vs 213 (40.6) pg/mg for subjects taking 2000 IU/d. Corresponding iPF(2 alpha)-VI levels were 1.43 (0.6) vs 1.62 (0.4) ng/mg of creatinine for subjects taking placebo; 1.64 (0.3) vs 1.24 (0.8) ng/mg for those taking 200 IU/d of vitamin E; and 1.83 (0.3) vs 1.94 (0.9) ng/mg for those taking 2000 IU/d. Baseline vs week 8 levels of 4-HNE were 0.5 (0.04) vs 0.4 (0.05) ng/mg of creatinine for subjects taking placebo; 0.4 (0.06) vs 0.5 (0.02) ng/mg with 200 IU/d of vitamin E; and 0.2 (0.02) vs 0.2 (0.1) ng/mg with 2000 IU/d. Conclusions Our results question the rationale for vitamin E supplementation in healthy individuals. Specific quantitative indices of oxidative stress in vivo should be considered as entry criteria and for dose selection in clinical trials of antioxidant drugs and vitamins in human disease.	Univ Penn, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Florida Inst Technol, Dept Chem, Melbourne, FL 32901 USA; Florida Inst Technol, Claude Pepper Inst, Melbourne, FL 32901 USA	University of Pennsylvania; Florida Institute of Technology; Florida Institute of Technology	Meagher, EA (corresponding author), Univ Penn, Ctr Expt Therapeut, 811 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	FitzGerald, Garret A/A-4222-2010	Meagher, Emma/0000-0003-1841-4570; Barry, Orla/0000-0001-6364-3642; Rokach, Joshu/0000-0003-1814-7505	NCRR NIH HHS [M01 RR00040] Funding Source: Medline; NHLBI NIH HHS [HL 61364] Funding Source: Medline; NIDDK NIH HHS [DK 44730] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044730] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1980, JAMA, V243, P661; Audoly LP, 2000, CIRCULATION, V101, P2833, DOI 10.1161/01.CIR.101.24.2833; Bravard A, 1999, INT J RADIAT BIOL, V75, P639; Burke A, 2000, J BIOL CHEM, V275, P2499, DOI 10.1074/jbc.275.4.2499; Burton GW, 1998, AM J CLIN NUTR, V67, P669, DOI 10.1093/ajcn/67.4.669; CAMMACK J, 1991, J CHROMATOGR-BIOMED, V565, P529, DOI 10.1016/0378-4347(91)80421-8; Chopra RK, 1999, INT J VITAM NUTR RES, V69, P92, DOI 10.1024/0300-9831.69.2.92; Cognault S, 2000, NUTR CANCER, V36, P33, DOI 10.1207/S15327914NC3601_6; Delanty N, 1997, CIRCULATION, V95, P2492, DOI 10.1161/01.CIR.95.11.2492; ELWOOD PC, 1974, BRIT MED J, V1, P436, DOI 10.1136/bmj.1.5905.436; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602; Haldimann M, 1996, J TRACE ELEM MED BIO, V10, P31, DOI 10.1016/S0946-672X(96)80006-X; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; JIALAL I, 1995, ARTERIOSCL THROM VAS, V15, P190, DOI 10.1161/01.ATV.15.2.190; Julianto T, 1999, J CHROMATOGR B, V732, P227, DOI 10.1016/S0378-4347(99)00259-5; KEANEY JF, 1994, J CLIN INVEST, V93, P844, DOI 10.1172/JCI117039; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Li HW, 1999, P NATL ACAD SCI USA, V96, P13381, DOI 10.1073/pnas.96.23.13381; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; McAdam BF, 2000, J CLIN INVEST, V105, P1473, DOI 10.1172/JCI9523; McNamara PJ, 1999, FASEB J, V13, pA1549; Meagher EA, 1999, J CLIN INVEST, V104, P805, DOI 10.1172/JCI5584; Misonou H, 2000, BIOCHEMISTRY-US, V39, P6951, DOI 10.1021/bi000169p; Monsen ER, 2000, J AM DIET ASSOC, V100, P637, DOI 10.1016/S0002-8223(00)00189-9; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Obermayr RP, 1999, PFLUG ARCH EUR J PHY, V438, P365, DOI 10.1007/s004240050922; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Otero P, 1997, FREE RADICAL RES, V27, P619, DOI 10.3109/10715769709097865; Patrignani P, 2000, CIRCULATION, V102, P539, DOI 10.1161/01.CIR.102.5.539; Pennathur S, 1999, J BIOL CHEM, V274, P34621, DOI 10.1074/jbc.274.49.34621; *PERS ASP REINF ST, 1980, CIRCULATION, V62, pV85; Pratico D, 1999, BLOOD, V93, P3401, DOI 10.1182/blood.V93.10.3401.410k36_3401_3407; Pratico D, 1998, P NATL ACAD SCI USA, V95, P3449, DOI 10.1073/pnas.95.7.3449; Pratico D, 1998, AM J RESP CRIT CARE, V158, P1709, DOI 10.1164/ajrccm.158.6.9709066; Pratico D, 1998, J INVEST MED, V46, P51; Pratico D, 1996, J BIOL CHEM, V271, P8919, DOI 10.1074/jbc.271.15.8919; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; Pryor WA, 2000, FREE RADICAL BIO MED, V28, P141, DOI 10.1016/S0891-5849(99)00224-5; Reilly M, 1996, CIRCULATION, V94, P19, DOI 10.1161/01.CIR.94.1.19; Reilly MP, 1998, CIRCULATION, V98, P2822, DOI 10.1161/01.CIR.98.25.2822; Reilly MP, 1997, CIRCULATION, V96, P3314; Ruef Johannes, 1999, Thrombosis and Haemostasis, V82, P32; Shaish A, 1999, ARTERIOSCL THROM VAS, V19, P1470, DOI 10.1161/01.ATV.19.6.1470; SIAKOTOS AN, 1995, AM J MED GENET, V57, P290, DOI 10.1002/ajmg.1320570235; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Stocker R, 1999, TRENDS BIOCHEM SCI, V24, P219, DOI 10.1016/S0968-0004(99)01404-8; SUZUKAWA M, 1995, J AM COLL NUTR, V14, P46; Traber MG, 1998, AM J CLIN NUTR, V68, P847, DOI 10.1093/ajcn/68.4.847; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Valk EEJ, 2000, INT J VITAM NUTR RES, V70, P31, DOI 10.1024/0300-9831.70.2.31; Yusuf S, 2000, NEW ENGL J MED, V342, P145	58	224	231	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1178	1182		10.1001/jama.285.9.1178	http://dx.doi.org/10.1001/jama.285.9.1178			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231747	Bronze			2022-12-28	WOS:000167194700021
J	Fender, GRK; Prentice, A; Nixon, RM; Gorst, T; Duffy, SW; Day, NE; Smith, SK				Fender, GRK; Prentice, A; Nixon, RM; Gorst, T; Duffy, SW; Day, NE; Smith, SK			Management of menorrhagia: an audit of practices in the Anglia menorrhagia education study	BRITISH MEDICAL JOURNAL			English	Article									Univ Cambridge, Sch Clin Med, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2SW, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SW, England	University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Prentice, A (corresponding author), Univ Cambridge, Sch Clin Med, Dept Obstet & Gynaecol, Rosie Hosp, Box 223, Cambridge CB2 2SW, England.		Smith, Stephen K/F-6938-2012	Nixon, Richard/0000-0002-9991-7833; Smith, Stephen/0000-0003-1912-3935				COULTER A, 1991, BRIT J OBSTET GYNAEC, V98, P789, DOI 10.1111/j.1471-0528.1991.tb13484.x; Fender GRK, 1999, BRIT MED J, V318, P1246; NIXON R, IN PRESS STAT MED; *U YORK NHS CTR RE, 1995, EFF HLTH CAR MAN MEM; VESSEY MP, 1992, BRIT J OBSTET GYNAEC, V99, P402, DOI 10.1111/j.1471-0528.1992.tb13758.x	5	6	6	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					523	524		10.1136/bmj.322.7285.523	http://dx.doi.org/10.1136/bmj.322.7285.523			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230066	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000167370500025
J	Wirth, T; Bernatchez, L				Wirth, T; Bernatchez, L			Genetic evidence against panmixia in the European eel	NATURE			English	Article							POPULATION-STRUCTURE; NORTH-ATLANTIC; DIFFERENTIATION; VARIABILITY; LIFE; FLOW	The panmixia hypothesis-that all European eel (Anguilla anguilla) migrate to the Sargasso Sea for reproduction and comprise a single, randomly mating population-is widely accepted(1,2). If true, then this peculiar life history strategy would directly impact the population genetics of this species, and eels from European and north African rivers should belong to the same breeding population through the random dispersal of larvae. To date, the panmixia hypothesis has remained unchallenged: genetic studies realized on eel's mitochondrial DNA failed to detect any genetic structure(3-5); and a similar lack of structure was found using allozymes(6,7), with the exception of clinal variation imposed by selection(8,9). Here we have used highly polymorphic genetic markers that provide better resolution(10,11) to investigate genetic structure in European eel. Analysis of seven microsatellite loci among 13 samples from the north Atlantic, the Baltic Sea and the Mediterranean Sea basins reveals that there is global genetic differentiation(12). Moreover, pairwise Cavalli-Sforza and Edwards' 13 chord distances correlate significantly with coastal geographical distance. This pattern of genetic structure implies non-random mating and restricted gene flow among eels from different sampled locations, which therefore refute the hypothesis of panmixia. Consequently, the reproductive biology of European eel must be reconsidered(14,15).	Univ Laval, Dept Biol, GIROQ, Ste Foy, PQ G1K 7P4, Canada	Laval University	Wirth, T (corresponding author), Univ Laval, Dept Biol, GIROQ, Ste Foy, PQ G1K 7P4, Canada.	wirth_t@mpiib-berlin.mpg.de	Wirth, Thierry/B-4915-2008	Wirth, Thierry/0000-0002-7371-0172; Bernatchez, Louis/0000-0002-8085-9709				AVISE JC, 1990, EVOLUTION, V44, P1254, DOI [10.2307/2409286, 10.1111/j.1558-5646.1990.tb05229.x]; AVISE JC, 1986, P NATL ACAD SCI USA, V83, P4350, DOI 10.1073/pnas.83.12.4350; Castonguay Martin, 1994, Fisheries Oceanography, V3, P197, DOI 10.1111/j.1365-2419.1994.tb00097.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; COMPARINI A, 1977, MAR BIOL, V43, P109, DOI 10.1007/BF00391258; DELIGNY W, 1973, Nature (London), V246, P518, DOI 10.1038/246518a0; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; LECOMTEFINIGER R, 1994, NATURE, V370, P424, DOI 10.1038/370424a0; Lintas C, 1998, MOL MAR BIOL BIOTECH, V7, P263; Maniatis T., 1982, MOL CLONING; MANTEL N, 1967, CANCER RES, V27, P209; Marchese PJ, 1999, J GEOPHYS RES-OCEANS, V104, P29549, DOI 10.1029/1999JC900254; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PANTELOURIS EM, 1970, GENET RES, V16, P277, DOI 10.1017/S0016672300002536; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ruzzante DE, 1997, CAN J FISH AQUAT SCI, V54, P2700, DOI 10.1139/f97-170; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANG TK, 1994, MOL BIOL EVOL, V11, P250; Schmidt J., 1925, Annual Report Smithsonian Institution, V1924, P279; Shaw PW, 1999, HEREDITY, V83, P490, DOI 10.1038/sj.hdy.6885860; Tesch F.-W., 1977, EEL, V5; Tsukamoto K, 1998, NATURE, V396, P635, DOI 10.1038/25264; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williams G.C., 1984, P529	27	198	220	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1037	1040		10.1038/35059079	http://dx.doi.org/10.1038/35059079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234011				2022-12-28	WOS:000167148800044
J	Cooper, A; Lalueza-Fox, C; Anderson, S; Rambaut, A; Austin, J; Ward, R				Cooper, A; Lalueza-Fox, C; Anderson, S; Rambaut, A; Austin, J; Ward, R			Complete mitochondrial genome sequences of two extinct moas clarify ratite evolution	NATURE			English	Article							DNA-SEQUENCES; BIRDS; BIOGEOGRAPHY; PHYLOGENY; ORIGINS	The origin of the ratites, large flightless birds from the Southern Hemisphere, along with their flighted sister taxa, the South American tinamous, is central to understanding the role of plate tectonics in the distributions of modern birds and mammals. Defining the dates of ratite divergences is also critical for determining the age of modern avian orders(1-6). To resolve the ratite phylogeny and provide biogeographical data to examine these issues, we have here determined the first complete mitochondrial genome sequences of any extinct taxa-two New Zealand moa genera-along with a 1,000-base-pair sequence from an extinct Madagascan elephant-bird. For comparative data, we also generated 12 kilobases of contiguous sequence from the kiwi, cassowary, emu and two tinamou genera. This large dataset allows statistically precise estimates of molecular divergence dates and these support a Late Cretaceous vicariant speciation of ratite taxa, followed by the subsequent dispersal of the kiwi to New Zealand. This first molecular view of the break-up of Gondwana provides a new temporal framework for speciation events within other Gondwanan biota and can be used to evaluate competing biogeographical hypotheses.	Univ Oxford, Dept Biol Anthropol, Oxford OX1 6UE, England; Univ Oxford, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 6UE, England; Univ Oxford, Dept Zool, Oxford OX2 3PS, England; Univ Barcelona, Fac Biol, Seccio Antropol, E-08028 Barcelona, Spain; Nat Hist Museum, Dept Zool, London SW7 5BD, England	University of Oxford; University of Oxford; University of Oxford; University of Barcelona; Natural History Museum London	Cooper, A (corresponding author), Univ Oxford, Dept Biol Anthropol, Oxford OX1 6UE, England.		LALUEZA-FOX, CARLES/AAG-5341-2020; Anderson, Simon G/B-5244-2009; Anderson, Simon G/AGM-2359-2022; Cooper, Alan/E-8171-2012; Austin, Jeremy J/F-8729-2010; Rambaut, Andrew/B-2481-2009	LALUEZA-FOX, CARLES/0000-0002-1730-5914; Anderson, Simon G/0000-0002-8896-073X; Cooper, Alan/0000-0002-7738-7851; Austin, Jeremy J/0000-0003-4244-2942; Rambaut, Andrew/0000-0003-4337-3707				BLEDSOE A H, 1988, Annals of Carnegie Museum, V57, P73; Boles Walter E., 1997, Memoirs of the Queensland Museum, V41, P235; Cooper A, 2000, SCIENCE, V289, P1139; COOPER A, 1992, P NATL ACAD SCI USA, V89, P8741, DOI 10.1073/pnas.89.18.8741; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; Cooper A., 1993, ANCIENT DNA, P149; Cooper Alan, 1997, P345, DOI 10.1016/B978-012498315-1/50019-4; COOPER RA, 1993, TRENDS ECOL EVOL, V8, P429, DOI 10.1016/0169-5347(93)90004-9; CRACRAFT J, 1974, IBIS, V116, P494, DOI 10.1111/j.1474-919X.1974.tb07648.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Handt O, 1996, AM J HUM GENET, V59, P368; Herzer RH, 1997, NEW ZEAL J GEOL GEOP, V40, P425, DOI 10.1080/00288306.1997.9514774; HOUDE P, 1986, NATURE, V324, P563, DOI 10.1038/324563a0; Huelsenbeck John P., 1996, P19; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lawver L. A, 1991, GEOLOGICAL EVOLUTION, P533; Lee Krista, 1997, P173, DOI 10.1016/B978-012498315-1/50011-X; Martin P. G., 1993, Australian Systematic Botany, V6, P441, DOI 10.1071/SB9930441; Olson S.L., 1985, Avian Biology, V8, P79; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; SAUER E G F, 1972, Bonner Zoologische Beitraege, V23, P3; Storch G, 1993, AFRICA S AM CONNECTI, P76; van Tuinen M, 1998, MOL BIOL EVOL, V15, P370, DOI 10.1093/oxfordjournals.molbev.a025933	25	314	330	2	98	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					704	707		10.1038/35055536	http://dx.doi.org/10.1038/35055536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217857				2022-12-28	WOS:000166816400040
J	Jacobson, MZ				Jacobson, MZ			Strong radiative heating due to the mixing state of black carbon in atmospheric aerosols	NATURE			English	Article							SINGLE-SCATTERING ALBEDO; TROPICAL INDIAN-OCEAN; ANTHROPOGENIC SULFATE; SOOT; MODEL	Aerosols affect the Earth's temperature and climate by altering the radiative properties of the atmosphere. A large positive component of this radiative forcing from aerosols is due to black carbon-soot-that is released from the burning of fossil fuel and biomass, and, to a lesser extent, natural fires, but the exact forcing is affected by how black carbon is mixed with other aerosol constituents. From studies of aerosol radiative forcing, it is known that black carbon can exist in one of several possible mixing states; distinct from other aerosol particles (externally mixed(1-7)) or incorporated within them (internally mixed(1,3,7)), or a black-carbon core could be surrounded by a well mixed shell 7. But so far it has been assumed that aerosols exist predominantly as an external mixture. Here I simulate the evolution of the chemical composition of aerosols, finding that the mixing state and direct forcing of the black-carbon component approach those of an internal mixture, largely due to coagulation and growth of aerosol particles. This finding implies a higher positive forcing from black carbon than previously thought, suggesting that the warming effect from black carbon may nearly balance the net cooling effect of other anthropogenic aerosol constituents. The magnitude of the direct radiative forcing from black carbon itself exceeds that due to CH4, suggesting that black carbon may be the second most important component of global warming after CO2 in terms of direct forcing.	Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA	Stanford University	Jacobson, MZ (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.			Jacobson, Mark/0000-0002-4315-4128				ANDREAE MO, 1986, SCIENCE, V232, P1620, DOI 10.1126/science.232.4758.1620; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Cook RD, 1999, AUDIOL NEURO-OTOL, V4, P104, DOI 10.1159/000013827; Dubovik O, 1998, J GEOPHYS RES-ATMOS, V103, P31903, DOI 10.1029/98JD02276; Eck TF, 1998, J GEOPHYS RES-ATMOS, V103, P31865, DOI 10.1029/98JD00399; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Hansen JE, 1998, P NATL ACAD SCI USA, V95, P12753, DOI 10.1073/pnas.95.22.12753; Hayhoe K, 1999, SCIENCE, V286, P905, DOI 10.1126/science.286.5441.905; Haywood JM, 1998, J GEOPHYS RES-ATMOS, V103, P6043, DOI 10.1029/97JD03426; Haywood JM, 1997, J CLIMATE, V10, P1562, DOI 10.1175/1520-0442(1997)010<1562:GCMCOT>2.0.CO;2; Hegg DA, 1997, J GEOPHYS RES-ATMOS, V102, P25293, DOI 10.1029/97JD02293; Husar RB, 1997, J GEOPHYS RES-ATMOS, V102, P16889, DOI 10.1029/96JD04009; Jacobson MZ, 2000, GEOPHYS RES LETT, V27, P217, DOI 10.1029/1999GL010968; Jacobson MZ, 1997, ATMOS ENVIRON, V31, P131, DOI 10.1016/1352-2310(96)00202-6; Jayaraman A, 1998, J GEOPHYS RES-ATMOS, V103, P13827, DOI 10.1029/98JD00559; Murphy DM, 1998, NATURE, V392, P62, DOI 10.1038/32138; Myhre G, 1998, TELLUS B, V50, P463, DOI 10.1034/j.1600-0889.1998.t01-4-00005.x; Penner JE, 1998, CLIM DYNAM, V14, P839, DOI 10.1007/s003820050259; Posfai M, 1999, J GEOPHYS RES-ATMOS, V104, P21685, DOI 10.1029/1999JD900208; Russell PB, 1999, J GEOPHYS RES-ATMOS, V104, P2213, DOI 10.1029/1998JD200028; Satheesh SK, 1999, J GEOPHYS RES-ATMOS, V104, P27421, DOI 10.1029/1999JD900478	21	1742	1931	41	858	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					695	697		10.1038/35055518	http://dx.doi.org/10.1038/35055518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217854				2022-12-28	WOS:000166816400037
J	Zouni, A; Witt, HT; Kern, J; Fromme, P; Krauss, N; Saenger, W; Orth, P				Zouni, A; Witt, HT; Kern, J; Fromme, P; Krauss, N; Saenger, W; Orth, P			Crystal structure of photosystem II from Synechococcus elongatus at 3.8 angstrom resolution	NATURE			English	Article							NEAREST-NEIGHBOR ANALYSIS; 3-DIMENSIONAL STRUCTURE; COMPLEX; PROTEIN; MODEL; WATER	Oxygenic photosynthesis is the principal energy converter on earth. It is driven by photosystems I and II, two large protein-cofactor complexes located in the thylakoid membrane and acting in series. In photosystem II, water is oxidized; this event provides the overall process with the necessary electrons and protons, and the atmosphere with oxygen. To date, structural information on the architecture of the complex has been provided by electron microscopy of intact, active photosystem II at 15-30 Angstrom resolution(1), and by electron crystallography on two-dimensional crystals of D1-D2-CP47 photosystem II fragments without water oxidizing activity at 8 Angstrom resolution(2). Here we describe the X-ray structure of photosystem II on the basis of crystals fully active in water oxidation(3). The structure shows how protein subunits and cofactors are spatially organized. The larger subunits are assigned and the locations and orientations of the cofactors are defined. We also provide new information on the position, size and shape of the manganese cluster, which catalyzes water oxidation.	Free Univ Berlin, Inst Chem, D-14195 Berlin, Germany; Tech Univ Berlin, Max Volmer Inst Biophys Chem & Biochem, D-10623 Berlin, Germany	Free University of Berlin; Technical University of Berlin	Saenger, W (corresponding author), Free Univ Berlin, Inst Chem, Takustr 6, D-14195 Berlin, Germany.	witt@phosis1.chem.tu-berlin.de; saenger@chemie.fu-berlin.de	; Kern, Jan/G-2586-2013	Krauss, Norbert/0000-0002-7128-4632; Kern, Jan/0000-0002-7272-1603				AHMED A, 1995, FEBS LETT, V363, P65, DOI 10.1016/0014-5793(95)00282-E; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRY BA, 1994, MOL BIOL CYANOBACTER, P217; BUSER CA, 1992, BIOCHEMISTRY-US, V31, P11449, DOI 10.1021/bi00161a025; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Ghanotakis DF, 1999, CONCEPTS IN PHOTOBIOLOGY, P264; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Ishikawa Y, 1999, BBA-BIOENERGETICS, V1413, P147, DOI 10.1016/S0005-2728(99)00093-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; MAYES SR, 1993, BIOCHEMISTRY-US, V32, P1454, DOI 10.1021/bi00057a008; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; Nield J, 2000, J BIOL CHEM, V275, P27940; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rhee KH, 1998, NATURE, V396, P283, DOI 10.1038/24421; RHEE KH, 1998, THESIS U HEIDELBERG; Ruffle S, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P1013; SCHELVIS JPM, 1994, BBA-BIOENERGETICS, V1184, P242, DOI 10.1016/0005-2728(94)90229-1; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Shi LX, 1999, PLANT MOL BIOL, V40, P737, DOI 10.1023/A:1006286706708; Summer EJ, 1997, PLANT PHYSIOL, V113, P1359, DOI 10.1104/pp.113.4.1359; Svensson B, 1996, BIOCHEMISTRY-US, V35, P14486, DOI 10.1021/bi960764k; TOMO T, 1993, FEBS LETT, V323, P15, DOI 10.1016/0014-5793(93)81438-6; Witt HT, 1996, BER BUNSEN PHYS CHEM, V100, P1923, DOI 10.1002/bbpc.19961001202; Xiong J, 1998, PHOTOSYNTH RES, V56, P229, DOI 10.1023/A:1006061918025; Yachandra VK, 1996, CHEM REV, V96, P2927, DOI 10.1021/cr950052k; Zech SG, 1997, FEBS LETT, V414, P454, DOI 10.1016/S0014-5793(97)01054-5; Zheleva D, 1998, J BIOL CHEM, V273, P16122, DOI 10.1074/jbc.273.26.16122; Zouni A, 2000, BBA-BIOENERGETICS, V1457, P103, DOI 10.1016/S0005-2728(00)00100-6; Zouni A, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P925	30	1715	1779	6	313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					739	743		10.1038/35055589	http://dx.doi.org/10.1038/35055589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217865				2022-12-28	WOS:000166816400048
J	Pryer, KM; Schneider, H; Smith, AR; Cranfill, R; Wolf, PG; Hunt, JS; Sipes, SD				Pryer, KM; Schneider, H; Smith, AR; Cranfill, R; Wolf, PG; Hunt, JS; Sipes, SD			Horsetails and ferns are a monophyletic group and the closest living relatives to seed plants	NATURE			English	Article							PHYLOGENETIC-RELATIONSHIPS; LAND PLANTS; RBCL SEQUENCES; MITOCHONDRIAL; EVOLUTION; BIOLOGY; TOOL	Most of the 470-million-year history of plants on land belongs to bryophytes, pteridophytes and gymnosperms, which eventually yielded to the ecological dominance by angiosperms 90 Myr ago(1-3). Our knowledge of angiosperm phylogeny, particularly the branching order of the earliest lineages, has recently been increased by the concurrence of multigene sequence analyses(4-6). However, reconstructing relationships for all the main lineages of vascular plants that diverged since the Devonian period has remained a challenge. Here we report phylogenetic analyses of combined data-from morphology and from four genes-for 35 representatives from all the main lineages of land plants. We show that there are three monophyletic groups of extant vascular plants: (1) lycophytes, (2) seed plants and (3) a clade including equisetophytes (horsetails), psilotophytes (whisk ferns) and all eusporangiate and leptosporangiate ferns. Our maximum-likelihood analysis shows unambiguously that horsetails and ferns together are the closest relatives to seed plants. This refutes the prevailing view that horsetails and ferns are transitional evolutionary grades between bryophytes and seed plants(7), and has important implications for our understanding of the development and evolution of plants(8).	Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; Univ Calif Berkeley, Univ Herbarium, Berkeley, CA 94720 USA; Utah State Univ, Dept Biol, Logan, UT 84322 USA	Field Museum of Natural History (Chicago); University of California System; University of California Berkeley; Utah System of Higher Education; Utah State University	Pryer, KM (corresponding author), Field Museum Nat Hist, Dept Bot, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.		Pryer, Kathleen/X-4635-2019; Pryer, Kathleen M./ABF-4908-2020; Schneider, Harald/B-6681-2008; Wolf, Paul/F-7664-2010	Pryer, Kathleen M./0000-0002-9776-6736; Schneider, Harald/0000-0002-4548-7268; Wolf, Paul/0000-0002-4317-6976				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Barkman TJ, 2000, P NATL ACAD SCI USA, V97, P13166, DOI 10.1073/pnas.220427497; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; BREMER K, 1985, Cladistics, V1, P369, DOI 10.1111/j.1096-0031.1985.tb00434.x; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Duff RJ, 1999, AM J BOT, V86, P372, DOI 10.2307/2656759; Graham LE, 2000, P NATL ACAD SCI USA, V97, P4535, DOI 10.1073/pnas.97.9.4535; Hedderson T.A., 1998, BRYOLOGY 21 CENTURY, P65; HICKOK LG, 1995, INT J PLANT SCI, V156, P332, DOI 10.1086/297255; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P634, DOI 10.1073/pnas.91.2.634; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Kranz HD, 1996, PLANT SYST EVOL, V202, P1, DOI 10.1007/BF00985814; Lupia R, 1999, PALEOBIOLOGY, V25, P305, DOI 10.1017/S009483730002131X; MANHART JR, 1994, MOL PHYLOGENET EVOL, V3, P114, DOI 10.1006/mpev.1994.1014; MISHLER BD, 1994, ANN MO BOT GARD, V81, P451, DOI 10.2307/2399900; Pryer KM, 1995, AM FERN J, V85, P205, DOI 10.2307/1547810; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Qiu YL, 1998, NATURE, V394, P671, DOI 10.1038/29286; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Renzaglia KS, 2000, PHILOS T R SOC B, V355, P769, DOI 10.1098/rstb.2000.0615; Rothwell GW, 1999, BOT REV, V65, P188, DOI 10.1007/BF02857629; Sanderson MJ, 2000, MOL BIOL EVOL, V17, P782, DOI 10.1093/oxfordjournals.molbev.a026357; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stevenson D.W., 1996, PTERIDOLOGY PERSPECT, P435; SWOFFORD DL, 1999, PAUP PHYLOGENETIC AN; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; WAGNER WH, 1977, BRITTONIA, V29, P54, DOI 10.2307/2805741; [No title captured]	30	475	541	4	376	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					618	622		10.1038/35054555	http://dx.doi.org/10.1038/35054555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214320				2022-12-28	WOS:000166692300044
J	Koenig, WD; Haydock, J				Koenig, WD; Haydock, J			Behavioral ecology - Dividing up the kids	SCIENCE			English	Editorial Material							REPRODUCTIVE SKEW; ANIMAL SOCIETIES; MODEL; SUPPRESSION; EVOLUTION		Univ Calif, Hastings Reservat, Carmel Valley, CA 93924 USA; Univ Calif, Museum Vertebrate Zool, Carmel Valley, CA 93924 USA; Gonzaga Univ, Dept Biol, Spokane, WA 99258 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Gonzaga University	Koenig, WD (corresponding author), Univ Calif, Hastings Reservat, Carmel Valley, CA 93924 USA.		Koenig, Walter D/A-5509-2009	Koenig, Walter/0000-0001-6207-1427				Cant MA, 1998, ANIM BEHAV, V55, P163, DOI 10.1006/anbe.1997.0589; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P2291, DOI 10.1098/rspb.1998.0573; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Johnstone RA, 1999, AM NAT, V153, P315, DOI 10.1086/303169; Johnstone RA, 1999, P ROY SOC B-BIOL SCI, V266, P275, DOI 10.1098/rspb.1999.0633; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; Ragsdale JE, 1999, EVOL ECOL RES, V1, P859; Reeve HK, 2000, AM NAT, V155, P365, DOI 10.1086/303322; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; Reeve HK, 1997, AM NAT, V150, pS42, DOI 10.1086/286049; REEVE HK, 1999, P R SOC LOND B, V266, P1; VEHRENCAMP SL, 1983, AM ZOOL, V23, P327; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X; VEHRENCAMP SL, 1980, P 17 INT ORN C, V17, P869; VEHRENCAMP SL, 1979, HDB BEHAVIORAL NEURO, V3, P351	19	8	8	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2001	291	5503					442	443		10.1126/science.1058250	http://dx.doi.org/10.1126/science.1058250			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11228140				2022-12-28	WOS:000166487500026
J	Seki, K; Elphic, RC; Hirahara, M; Terasawa, T; Mukai, T				Seki, K; Elphic, RC; Hirahara, M; Terasawa, T; Mukai, T			On atmospheric loss of oxygen ions from earth through magnetospheric processes	SCIENCE			English	Article							DAYSIDE MAGNETOSHEATH; GEOTAIL OBSERVATIONS; O+ BEAMS; ESCAPE; MAGNETOTAIL; LOBE/MANTLE; VENUS; MARS	In Earth's environment, the observed polar outflow rate for O+ ions, the main source of oxygen above gravitational escape energy, corresponds to the Loss of similar to 18% of the present-day atmospheric oxygen over 3 billion years. However, part of this apparent Loss can actually be returned to the atmosphere. Examining loss rates of four escape routes with high-altitude spacecraft observations, we show that the total oxygen Loss rate inferred from current knowledge is about one order of magnitude smaller than the polar O+ outflow rate. This disagreement suggests that there may be a substantial return flux from the magnetosphere to the low-latitude ionosphere. Then the net oxygen Loss over 3 billion years drops to similar to2% of the current atmospheric oxygen content.	Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Calif Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Rikkyo Univ, Dept Phys, Toshima Ku, Tokyo 1718501, Japan; Inst Space & Astronaut Sci, Kanagawa 2298510, Japan	University of Tokyo; United States Department of Energy (DOE); Los Alamos National Laboratory; Rikkyo University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Seki, K (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.			Terasawa, Toshio/0000-0003-2507-9803; Seki, Kanako/0000-0001-5557-9062				BRACE LH, 1987, J GEOPHYS RES, V92, P15, DOI 10.1029/JA092iA01p00015; FUSELIER SA, 1991, J GEOPHYS RES-SPACE, V96, P47, DOI 10.1029/90JA01751; Hirahara M, 1996, J GEOPHYS RES-SPACE, V101, P7769, DOI 10.1029/95JA03165; Ieda A, 1998, J GEOPHYS RES-SPACE, V103, P4453, DOI 10.1029/97JA03240; LENNARTSSON W, 1989, J GEOPHYS RES, V94, P3600, DOI 10.1029/JA094iA04p03600; LUNDIN R, 1989, NATURE, V341, P609, DOI 10.1038/341609a0; Nishida A, 1998, J GEOPHYS RES-SPACE, V103, P4409, DOI 10.1029/97JA01617; Phan TD, 2000, NATURE, V404, P848, DOI 10.1038/35009050; Roelof EC, 1997, ADV SPACE RES-SERIES, V20, P361, DOI 10.1016/S0273-1177(97)00692-3; Seki K, 2000, J GEOPHYS RES-SPACE, V105, P15931, DOI 10.1029/1999JA900470; Seki K, 1998, J GEOPHYS RES-SPACE, V103, P4477, DOI 10.1029/97JA02137; Shizgal BD, 1996, REV GEOPHYS, V34, P483, DOI 10.1029/96RG02213; YAMAMOTO T, 1994, GEOPHYS RES LETT, V21, P2875, DOI 10.1029/94GL01609; Yau A. W., 1988, MODELING MAGNETOSPHE, V44, P211; Yau AW, 1997, SPACE SCI REV, V80, P1, DOI 10.1023/A:1004947203046; YOUNG DT, 1982, J GEOPHYS RES-SPACE, V87, P9077, DOI 10.1029/JA087iA11p09077; Zong QG, 1999, GEOPHYS RES LETT, V26, P3349, DOI 10.1029/1999GL003634	17	104	105	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1939	1941		10.1126/science.1058913	http://dx.doi.org/10.1126/science.1058913			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239148				2022-12-28	WOS:000167401600038
J	Cannon, MJ; Dollard, SC; Smith, DK; Klein, RS; Schuman, P; Rich, JD; Vlahov, D; Pellett, PE				Cannon, MJ; Dollard, SC; Smith, DK; Klein, RS; Schuman, P; Rich, JD; Vlahov, D; Pellett, PE		HIV Epidemiology Res Study Grp	Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; HUMAN-HERPESVIRUS-8 DNA; PREVALENCE; INDIVIDUALS; ANTIBODIES; CHILDREN; COHORT; MEN	Background: Human herpesvirus 8 (HHV-8), the causal agent of Kaposi's sarcoma, is transmitted sexually among homosexual men, but little is known of its transmission among women. Although HHV-8 has been detected in blood, there has been no clear evidence of blood-borne transmission. Methods: We identified risk factors for HHV-8 infection in 1295 women in Baltimore, Detroit, New York, and Providence, Rhode Island, who reported high-risk sexual behavior or drug use. HHV-8 serologic studies were performed with two enzyme-linked immunosorbent assays. Results: In univariate analyses, HHV-8 was associated with black race, Hispanic ethnic background, a lower level of education, and infection with syphilis, the human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV). The risk of seropositivity for HHV-8 increased with the frequency of injection-drug use (P<0.001); HHV-8 seroprevalence among the women who used drugs daily was three times that among women who never injected drugs. Among the women with a low risk of sexual transmission, HHV-8 seroprevalence was 0 percent in those who had never injected drugs and 36 percent in those who had injected drugs (P<0.001). However, injection-drug use was linked less strongly to HHV-8 infection than to infection with HBV or HCV. In a multivariate analysis, independent predictors of HHV-8 seropositivity included HIV infection (odds ratio, 1.6; 95 percent confidence interval, 1.1 to 2.2), syphilis infection (odds ratio, 1.8; 95 percent confidence interval, 1.1 to 2.8), and daily injection-drug use (odds ratio, 3.2; 95 percent confidence interval, 1.4 to 7.6). Conclusions: Both injection-drug use and correlates of sexual activity were risk factors for HHV-8 infection in the women studied. The independent association of HHV-8 infection with injection-drug use suggests that HHV-8 is transmitted through needle sharing, albeit less efficiently than HBV, HCV, or HIV. (N Engl J Med 2001;344:637-43.) Copyright (C) 2001 Massachusetts Medical Society.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA USA; Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA; Wayne State Univ, Sch Med, Div Infect Dis, Detroit, MI USA; Brown Univ, Providence, RI 02912 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA; New York Acad Med, New York, NY USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Wayne State University; Brown University; Johns Hopkins University; New York Academy of Medicine	Pellett, PE (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,Mailstop G18, Atlanta, GA 30333 USA.		Cannon, Michael J/E-5894-2011	Cannon, Michael J/0000-0001-5776-5010; Pellett, Philip/0000-0002-8536-8343				Andreoni M, 1999, J NATL CANCER I, V91, P465, DOI 10.1093/jnci/91.5.465; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Blackbourn DJ, 1997, LANCET, V349, P609, DOI 10.1016/S0140-6736(96)10004-0; Chokunonga E, 2000, INT J CANCER, V85, P54, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;54::AID-IJC10&gt;3.0.CO;2-D; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Engels EA, 1999, J NATL CANCER I, V91, P1773, DOI 10.1093/jnci/91.20.1773; Ganem D, 1998, CURR CLIN TOPICS INF, V18, P237; Gessain A, 1999, INT J CANCER, V81, P189, DOI 10.1002/(SICI)1097-0215(19990412)81:2&lt;189::AID-IJC4&gt;3.0.CO;2-E; Jones RE, 1999, B RHEUM DIS, V48, P1; Kedes DH, 1997, JAMA-J AM MED ASSOC, V277, P478, DOI 10.1001/jama.277.6.478; Koelle DM, 1997, J INFECT DIS, V176, P94, DOI 10.1086/514045; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;817::AID-IJC2&gt;3.0.CO;2-X; Melbye M, 1998, INT J CANCER, V77, P543, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;543::AID-IJC12&gt;3.0.CO;2-7; Operskalski EA, 1997, LANCET, V349, P1327, DOI 10.1016/S0140-6736(05)62544-5; PAU CP, 1993, AIDS, V7, P337, DOI 10.1097/00002030-199303000-00005; Pau CP, 1998, J CLIN MICROBIOL, V36, P1574, DOI 10.1128/JCM.36.6.1574-1577.1998; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Pellett PE, 1999, J CLIN MICROBIOL, V37, P1298, DOI 10.1128/JCM.37.5.1298-1301.1999; Penn I, 1997, TRANSPLANTATION, V64, P669, DOI 10.1097/00007890-199709150-00001; Renwick N, 1998, AIDS, V12, P2481, DOI 10.1097/00002030-199818000-00018; Rezza G, 1998, INT J CANCER, V77, P361, DOI 10.1002/(SICI)1097-0215(19980729)77:3&lt;361::AID-IJC9&gt;3.0.CO;2-M; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; Smith NA, 1999, J INFECT DIS, V180, P600, DOI 10.1086/314926; Sosa C, 1998, J INFECT DIS, V178, P547, DOI 10.1086/517471; Spira TJ, 2000, J CLIN MICROBIOL, V38, P2174; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9	27	130	138	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2001	344	9					637	643		10.1056/NEJM200103013440904	http://dx.doi.org/10.1056/NEJM200103013440904			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405TR	11228278				2022-12-28	WOS:000167177100004
J	Hinchcliffe, EH; Miller, FJ; Cham, M; Khodjakov, A; Sluder, G				Hinchcliffe, EH; Miller, FJ; Cham, M; Khodjakov, A; Sluder, G			Requirement of a centrosomal activity for cell cycle progression through G(1) into S phase	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; SPINDLE POLES; REPRODUCTION; CENTRIOLE; MICROTUBULES; CHECKPOINT; CYTOPLASM; DIVISION; ANAPHASE; MITOSIS	Centrosomes were microsurgically removed from BSC-1 African green monkey kidney cells before the completion of S phase, Karyoplasts (acentrosomal cells) entered and completed mitosis, However, postmitotic karyoplasts arrested before S phase, whereas adjacent control cells divided repeatedly. Postmitotic karyoplasts assembled a microtubule-organizing center containing gamma -tubulin and pericentrin, but did not regenerate centrioles. These observations reveal the existence of an activity associated with core centrosomal structures-distinct from elements of the microtubule-organizing center-that is required for the somatic cell cycle to progress through G(1) into S phase. Once the cell is in S phase, these core structures are not needed for the G(2)-M phase transition.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; Wadsworth Ctr, Lab Cell Regulat, Albany, NY 12201 USA	University of Massachusetts System; University of Massachusetts Worcester; Wadsworth Center	Sluder, G (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059363, R01 GM059363-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; BAILLY E, 1992, NATURE, V355, P300, DOI 10.1038/355300a0; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; GUNDUZ N, 1985, CYTOMETRY, V6, P597, DOI 10.1002/cyto.990060615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hinchcliffe EH, 1998, J CELL BIOL, V140, P1417, DOI 10.1083/jcb.140.6.1417; HINCHCLIFFE EH, UNPUB; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; MANIOTIS A, 1991, CELL, V67, P495, DOI 10.1016/0092-8674(91)90524-3; Marshall WF, 1999, CURR BIOL, V9, pR218, DOI 10.1016/S0960-9822(99)80133-X; MCNIVEN MA, 1984, CELL, V37, P753, DOI 10.1016/0092-8674(84)90411-2; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Pagano RE, 1998, ANN NY ACAD SCI, V845, P152, DOI 10.1111/j.1749-6632.1998.tb09668.x; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Pockwinse SM, 1997, P NATL ACAD SCI USA, V94, P3022, DOI 10.1073/pnas.94.7.3022; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Rieder CL, 1999, METHOD CELL BIOL, V61, P297; Rodionov VI, 1997, NATURE, V386, P170, DOI 10.1038/386170a0; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; STEFFEN W, 1986, J CELL BIOL, V102, P1679, DOI 10.1083/jcb.102.5.1679; Vaughn KC, 1998, INT REV CYTOL, V181, P75, DOI 10.1016/S0074-7696(08)60417-9	28	289	295	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1547	1550		10.1126/science.1056866	http://dx.doi.org/10.1126/science.1056866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222860				2022-12-28	WOS:000167153400045
J	King, LB; Monroe, JG				King, LB; Monroe, JG			Immunology - B cell receptor rehabilitation - Pausing to reflect	SCIENCE			English	Editorial Material							ESCAPE TOLERANCE; ANTIGEN; LYMPHOCYTES; APOPTOSIS; EXPRESSION; SELECTION; INDUCTION; SITE		Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	King, LB (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.							Chen C, 1997, IMMUNITY, V6, P97, DOI 10.1016/S1074-7613(00)80673-1; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; Melamed D, 1998, CELL, V92, P173, DOI 10.1016/S0092-8674(00)80912-5; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; NORVELL A, 1995, J IMMUNOL, V154, P4404; Norvell A, 1996, J IMMUNOL, V156, P1328; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; Retter MW, 1998, J EXP MED, V188, P1231, DOI 10.1084/jem.188.7.1231; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	15	12	15	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1503	1505		10.1126/science.291.5508.1503	http://dx.doi.org/10.1126/science.291.5508.1503			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11234081				2022-12-28	WOS:000167153400032
J	Fahrer, AM; Bazan, JF; Papathanasiou, P; Nelms, KA; Goodnow, CC				Fahrer, AM; Bazan, JF; Papathanasiou, P; Nelms, KA; Goodnow, CC			A genomic view of immunology	NATURE			English	Article							FAMILY	The outstanding problems facing immunology are whole system issues: curing allergic and autoimmune disease and developing vaccines to stimulate stronger immune responses against pathogenic organisms and cancer. We hope that the human genome sequence will reveal the molecular checks and balances that ensure both an effective immunogenic response against pathogenic microorganisms and a suitably tolerogenic response to self antigens and innocuous environmental antigens. Three synergistic approaches-sequence homology searches, messenger RNA expression profiling on microarrays, and mutagenesis in mice-provide the best opportunities to reveal, in the genome sequence, key proteins and pathways for targeting by new immunomodulatory treatments.	Australian Natl Univ, John Curtin Sch Med Res, ACRF Genet Lab, Canberra, ACT 2601, Australia; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia; DNAX Res Inst Mol & Cellular Biol Inc, Dept Mol Biol, Palo Alto, CA 94304 USA	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Fahrer, AM (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, ACRF Genet Lab, Canberra, ACT 2601, Australia.		Goodnow, Christopher C/V-8108-2018; Bazan, J. Fernando/B-4562-2010; Fahrer, Aude M/C-9318-2009	Goodnow, Christopher C/0000-0001-5296-6155; Fahrer, Aude/0000-0001-8556-0223				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Fischer D, 1999, CURR OPIN STRUC BIOL, V9, P208, DOI 10.1016/S0959-440X(99)80029-3; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Goodnow CC, 1999, COLD SPRING HARB SYM, V64, P313, DOI 10.1101/sqb.1999.64.313; Henry J, 1999, IMMUNOL TODAY, V20, P285, DOI 10.1016/S0167-5699(98)01418-2; Justice MJ, 2000, NAT REV GENET, V1, P109, DOI 10.1038/35038549; Mueller DL, 2000, CURR BIOL, V10, pR227, DOI 10.1016/S0960-9822(00)00400-0; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; OPPMANN B, IN PRESS IMMUNITY; Screaton G, 2000, CURR OPIN IMMUNOL, V12, P316, DOI 10.1016/S0952-7915(00)00093-5; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446	16	35	39	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					836	838		10.1038/35057020	http://dx.doi.org/10.1038/35057020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237003	Bronze			2022-12-28	WOS:000166938800050
J	Moreno, PI; Jacobson, GL; Lowell, TV; Denton, GH				Moreno, PI; Jacobson, GL; Lowell, TV; Denton, GH			Interhemispheric climate links revealed by a late-glacial cooling episode in southern Chile	NATURE			English	Article							HISTORY; FORESTS; POLLEN	Understanding the relative timings of climate events in the Northern and Southern hemispheres is a prerequisite for determining the causes of abrupt climate changes. But climate records from the Patagonian Andes(1-4) and New Zealand(5-8) for the period of transition from glacial to interglacial conditions-about 14.6-10 kyr before present, as determined by radiocarbon dating-show varying degrees of correlation with similar records from the Northern Hemisphere. It is necessary to resolve these apparent discrepancies in order to be able to assess the relative roles of Northern Hemisphere ice sheets and oceanic, atmospheric and astronomical influences in initiating climate change in the late-glacial period. Here we report pollen records from three sites in the Lake District of southern Chile (41 degrees S) from which we infer conditions similar to modern climate between about 13 and 12.2 C-14 kyr before present (BP), followed by cooling events at about 12.2 and 11.4 (14)Ckyr BP, and then by a warming at about 9.8 (14)Ckyr BP. These events were nearly synchronous with important palaeoclimate changes recorded in the North Atlantic region(9), supporting the idea that interhemispheric linkage through the atmosphere was the primary control on climate during the last deglaciation. In other regions of the Southern Hemisphere, where climate events are not in phase with those in the Northern Hemisphere, local oceanic influences may have counteracted the effects that propagated through the atmosphere.	Univ Maine, Inst Quaternary & Climate Studies, Orono, ME 04469 USA; Univ Maine, Dept Biol Sci, Orono, ME 04469 USA; Univ Maine, Dept Geol Sci, Orono, ME 04469 USA; Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University System of Ohio; University of Cincinnati	Moreno, PI (corresponding author), Univ Maine, Inst Quaternary & Climate Studies, Orono, ME 04469 USA.	pimoreno@uchile.cl	Moreno, Patricio I/D-2317-2012	Moreno, Patricio I/0000-0002-1333-6238; Lowell, Thomas/0000-0001-7826-0636				Ariztegui D, 1997, J QUATERNARY SCI, V12, P333, DOI 10.1002/(SICI)1099-1417(199707/08)12:4<333::AID-JQS312>3.3.CO;2-S; Bennett KD, 2000, SCIENCE, V290, P325, DOI 10.1126/science.290.5490.325; Bjorck S, 1998, J QUATERNARY SCI, V13, P283, DOI 10.1002/(SICI)1099-1417(199807/08)13:4<283::AID-JQS386>3.0.CO;2-A; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1990, QUATERNARY SCI REV, V9, P305, DOI 10.1016/0277-3791(90)90026-7; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; Charles CD, 1996, EARTH PLANET SC LETT, V142, P19, DOI 10.1016/0012-821X(96)00083-0; DENTON GH, 1994, SCIENCE, V264, P1434, DOI 10.1126/science.264.5164.1434; Denton GH, 1999, GEOGR ANN A, V81A, P107, DOI 10.1111/j.0435-3676.1999.00055.x; Denton GH, 1996, SCIENCE, V271, P669, DOI 10.1126/science.271.5249.669; Dillehay T. D., 1997, ARCHAEOLOGICAL CONTE, VII; LOWELL TV, 1995, SCIENCE, V269, P1541, DOI 10.1126/science.269.5230.1541; Lusk CH, 1999, PLANT ECOL, V140, P111, DOI 10.1023/A:1009764705942; Lusk CH, 1996, REV CHIL HIST NAT, V69, P401; MERCER JH, 1976, QUATERNARY RES, V6, P125, DOI 10.1016/0033-5894(76)90047-8; MERCER JH, 1972, SCIENCE, V176, P1118, DOI 10.1126/science.176.4039.1118; Newnham RM, 2000, GEOLOGY, V28, P759, DOI 10.1130/0091-7613(2000)028<0759:FRPROL>2.3.CO;2; PAEZ MM, 1994, REV CHIL HIST NAT, V67, P417; PORTER SC, 1981, QUATERNARY RES, V16, P263, DOI 10.1016/0033-5894(81)90013-2; Ramirez C, 1989, MONTE VERDE LATE PLE, P53; Singer C, 1998, SCIENCE, V281, P812, DOI 10.1126/science.281.5378.812; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; VILLAGRAN MC, 1980, DISERTATIONES BOTANI, V54, P1; Zhou MM, 1996, REV PALAEOBOT PALYNO, V91, P283, DOI 10.1016/0034-6667(95)00076-3	24	123	127	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					804	808		10.1038/35057252	http://dx.doi.org/10.1038/35057252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236990				2022-12-28	WOS:000166938800036
J	Abel, ED; Peroni, O; Kim, JK; Kim, YB; Boss, O; Hadro, E; Minnemann, T; Shulman, GI; Kahn, BB				Abel, ED; Peroni, O; Kim, JK; Kim, YB; Boss, O; Hadro, E; Minnemann, T; Shulman, GI; Kahn, BB			Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver	NATURE			English	Article							SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; FATTY-ACIDS; RESISTANCE; EXPRESSION; LEPTIN; MICE; RATS; PATHOGENESIS; ACTIVATION	The earliest defect in developing type 2 diabetes is insulin resistance(1,2), characterized by decreased glucose transport and metabolism in muscle and adipocytes(3,4). The glucose transporter GLUT4 mediates insulin-stimulated glucose uptake in adipocytes and muscle by rapidly moving from intracellular storage sites to the plasma membrane(4). In insulin-resistant states such as obesity and type 2 diabetes, GLUT4 expression is decreased in adipose tissue but preserved in muscle(3,4). Because skeletal muscle is the main site of insulin-stimulated glucose uptake, the role of adipose tissue GLUT4 downregulation in the pathogenesis of insulin resistance and diabetes is unclear. To determine the role of adipose GLUT4 in glucose homeostasis, we used Cre/loxP DNA recombination to generate mice with adipose-selective reduction of GLUT4 (G4A(-/-)). Here we show that these mice have normal growth and adipose mass despite markedly impaired insulin-stimulated glucose uptake in adipocytes. Although GLUT4 expression is preserved in muscle, these mice develop insulin resistance in muscle and liver, manifested by decreased biological responses and impaired activation of phosphoinositide-3-OH kinase. G4A(-/-) mice develop glucose intolerance and hyperinsulinaemia. Thus, downregulation of GLUT4 and glucose transport selectively in adipose tissue can cause insulin resistance and thereby increase the risk of developing diabetes.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrine, Diabet Unit, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Yale University; Howard Hughes Medical Institute; Yale University	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrine, Diabet Unit, 99 Brookline Ave, Boston, MA 02215 USA.		Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Kim, Jason/0000-0002-7185-042X; Abel, E. Dale/0000-0001-5290-0738	NIDDK NIH HHS [R01 DK040936, R01 DK043051] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Burcelin R, 1999, DIABETES, V48, P1264, DOI 10.2337/diabetes.48.6.1264; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; CUSHMAN SW, 1978, J LIPID RES, V19, P269; DeFronzo RA, 1997, DIABETES REV, V5, P177; DONOGHUE MJ, 1991, J CELL BIOL, V115, P423, DOI 10.1083/jcb.115.2.423; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim YB, 1999, DIABETES, V48, P310, DOI 10.2337/diabetes.48.2.310; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Roden M, 1999, ANNU REV MED, V50, P277, DOI 10.1146/annurev.med.50.1.277; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Sivitz WI, 1997, ENDOCRINOLOGY, V138, P3395, DOI 10.1210/en.138.8.3395; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; Tozzo E, 1997, ENDOCRINOLOGY, V138, P1604, DOI 10.1210/en.138.4.1604; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	25	882	920	2	83	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					729	733		10.1038/35055575	http://dx.doi.org/10.1038/35055575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217863				2022-12-28	WOS:000166816400046
J	Peters, C; Bayer, MJ; Buhler, S; Andersen, JS; Mann, M; Mayer, A				Peters, C; Bayer, MJ; Buhler, S; Andersen, JS; Mann, M; Mayer, A			Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion	NATURE			English	Article							PROTEIN-KINASE-C; SNARE COMPLEX; VACUOLAR ACIDIFICATION; H+-ATPASE; V-ATPASE; RELEASE; DOCKING; VESICLE; CA2+; NSF	SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) and Rab-GTPases, together with their cofactors, mediate the attachment step in the membrane fusion of vesicles. But how bilayer mixing-the subsequent core process of fusion-is catalysed remains unclear. Ca2+/calmodulin controls this terminal process in many intracellular fusion events. Here we identify V0, the membrane-integral sector of the vacuolar H+-ATPase, as a target of calmodulin on yeast vacuoles. Between docking and bilayer fusion, V0 sectors from opposing membranes form complexes. V0 trans-complex formation occurs downstream from trans-SNARE pairing, and depends on both the Rab-GTPase Ypt7 and calmodulin. The maintenance of existing complexes and completion of fusion are independent of trans-SNARE pairs. Reconstituted proteolipids form sealed channels, which can expand to form aqueous pores in a Ca2+/calmodulin-dependent fashion. V0 trans-complexes may therefore form a continuous, proteolipid-lined channel at the fusion site. We propose that radial expansion of such a protein pore may be a mechanism for intracellular membrane fusion.	Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; Univ So Denmark, Dept Mol Biol, DK-5230 Odense M, Denmark	Eberhard Karls University of Tubingen; Max Planck Society; University of Southern Denmark	Mayer, A (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, Spemannstr 37-39, D-72076 Tubingen, Germany.	andreas.mayer@tuebingen.mpg.de	Mayer, Andreas/AAE-4315-2020; Andersen, Jens S/L-2100-2015; Mann, Matthias/A-3454-2013	Mayer, Andreas/0000-0001-6131-313X; Andersen, Jens S/0000-0002-6091-140X; Mann, Matthias/0000-0003-1292-4799				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; Brugger B, 2000, EMBO J, V19, P1272, DOI 10.1093/emboj/19.6.1272; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 1999, J BIOL CHEM, V274, P26469, DOI 10.1074/jbc.274.37.26469; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; CHERNOMORDIK LV, 1995, CURR OPIN STRUC BIOL, V5, P541, DOI 10.1016/0959-440X(95)80041-7; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Conchon S, 1999, EMBO J, V18, P3934, DOI 10.1093/emboj/18.14.3934; Coorssen JR, 1998, J CELL BIOL, V143, P1845, DOI 10.1083/jcb.143.7.1845; Dunant Y, 1998, NEUROCHEM RES, V23, P709, DOI 10.1023/A:1022451224748; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; GARCIASEGURA LM, 1986, NEUROSCIENCE, V19, P63, DOI 10.1016/0306-4522(86)90006-0; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hartinger J, 1996, ANAL BIOCHEM, V240, P126, DOI 10.1006/abio.1996.0339; Harvey WR, 1997, J EXP BIOL, V200, P203; Henkel AW, 1995, J NEUROSCI, V15, P8246; Holroyd C, 1999, MOL BIOL CELL, V10, P3035, DOI 10.1091/mbc.10.9.3035; ISRAEL M, 1987, J NEUROCHEM, V49, P975, DOI 10.1111/j.1471-4159.1987.tb00989.x; ISRAEL M, 1991, J NEUROCHEM, V57, P2047, DOI 10.1111/j.1471-4159.1991.tb06420.x; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kane PM, 2000, J EXP BIOL, V203, P81; KIBBLE VA, EUR J PHYSL, V431, P464; KLIONSKY DJ, 1992, J BIOL CHEM, V267, P3416; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Mayer A, 1999, CURR OPIN CELL BIOL, V11, P447, DOI 10.1016/S0955-0674(99)80064-7; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MORANO KA, 1994, J CELL SCI, V107, P2813; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; PLATTNER H, 1993, SIGNAL TRANSDUCTION, P19; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; ZIMMERBERG J, 1993, ANNU REV BIOPH BIOM, V22, P433, DOI 10.1146/annurev.bb.22.060193.002245	51	407	416	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					581	588		10.1038/35054500	http://dx.doi.org/10.1038/35054500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214310				2022-12-28	WOS:000166692300034
J	Beattie, TF				Beattie, TF			To blow or not to blow?	LANCET			English	Editorial Material							NASAL FOREIGN-BODIES		Royal Hosp Sick Children, Dept Accid & Emergency, Edinburgh EH9 1LF, Midlothian, Scotland		Beattie, TF (corresponding author), Royal Hosp Sick Children, Dept Accid & Emergency, Edinburgh EH9 1LF, Midlothian, Scotland.							Botma P, 2000, J LARYNGOL OTOL, V114, P598; GUAZZO E, 1985, NEW ENGL J MED, V312, P725; Kadish HA, 1997, AM J EMERG MED, V15, P54, DOI 10.1016/S0735-6757(97)90049-8; Kalan A, 2000, POSTGRAD MED J, V76, P484, DOI 10.1136/pmj.76.898.484; Tong MCF, 1996, INT J PEDIATR OTORHI, V35, P207, DOI 10.1016/0165-5876(95)01305-9	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2001	357	9252					250	250		10.1016/S0140-6736(00)03609-6	http://dx.doi.org/10.1016/S0140-6736(00)03609-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214125				2022-12-28	WOS:000166693400007
J	Smith, R				Smith, R			Hyperplastic callus and osteogenesis imperfects	LANCET			English	Editorial Material									Nuffield Orthopaed Ctr, Oxford OX3 7LD, England	Nuffield Orthopaedic Centre	Smith, R (corresponding author), Nuffield Orthopaed Ctr, Oxford OX3 7LD, England.							Brady AF, 1997, CLIN DYSMORPHOL, V6, P329, DOI 10.1097/00019605-199710000-00005; Byers Peter H., 1993, P317; Dobrocky I, 1999, EUR RADIOL, V9, P665, DOI 10.1007/s003300050729; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Gong YQ, 1996, AM J HUM GENET, V59, P146; Kaplan FS, 2000, J BONE MINER RES, V15, P2084, DOI 10.1359/jbmr.2000.15.11.2084; Nakamura K, 1997, ARCH ORTHOP TRAUM SU, V116, P500, DOI 10.1007/BF00387587; Robey PG, 2000, J CLIN INVEST, V105, P1489, DOI 10.1172/JCI10256; Smith R, 1999, CURR ORTHOPAED, V13, P218, DOI 10.1016/S0268-0890(99)90006-3	9	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					248	249		10.1016/S0140-6736(00)03607-2	http://dx.doi.org/10.1016/S0140-6736(00)03607-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214123				2022-12-28	WOS:000166693400005
J	Blackburn, GL				Blackburn, GL			Pasteur's quadrant and malnutrition	NATURE			English	Article								Basic science has been the wellspring of advances in technology in everything from cellular phones to nutrient-fortified foods. Biochemistry and food technology afford new techniques that enrich nutritional science and aid in the fight against malnutrition. Bionutrition, the term used to describe the application of these techniques, can be the source of innovations that will help eradicate malnutrition globally. Which areas of bionutrition research are most likely to yield tomorrow's breakthroughs?	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Blackburn, GL (corresponding author), Beth Israel Deaconess Med Ctr, 1 Autumn St Kennedy 152, Boston, MA 02215 USA.	gblackbu@caregroup.harvard.edu						[Anonymous], 1999, WORLD HLTH REPORT 19; Blackburn GL, 1997, AM J CLIN NUTR, V66, P1067, DOI 10.1093/ajcn/66.5.1067; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; Collins S, 1998, AM J CLIN NUTR, V68, P193, DOI 10.1093/ajcn/68.1.193; Golden MHN, 1998, BRIT MED BULL, V54, P433, DOI 10.1093/oxfordjournals.bmb.a011699; HARPER AE, 2000, AM J CLIN NUTR S, V71, pS16; *INT FOOD POL RES, 1995, 2020 VIS FOOD AGR EN; James P, 2000, ENDING MALNUTRITION; Oomah BD., 1998, FUNCTIONAL FOODS BIO, P91; Reid M, 2000, AM J PHYSIOL-ENDOC M, V278, pE405, DOI 10.1152/ajpendo.2000.278.3.E405; Scrimshaw Nevin S., 1997, American Journal of Clinical Nutrition, V66, p464S; Stokes D. E., 1997, PASTEURS QUADRANT BA; SWAILS WS, 1996, NUTR SUBSTRATES CURR, P85; WATERLOW JC, 1984, T ROY SOC TROP MED H, V78, P436, DOI 10.1016/0035-9203(84)90053-1; *WHO, 1999, MAN SEVERE MALNUTRIT	15	20	20	2	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					397	401		10.1038/35053187	http://dx.doi.org/10.1038/35053187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201754				2022-12-28	WOS:000166434300062
J	Prins, MWJ; Welters, WJJ; Weekamp, JW				Prins, MWJ; Welters, WJJ; Weekamp, JW			Fluid control in multichannel structures by electrocapillary pressure	SCIENCE			English	Article								We demonstrate control of fluid motion in three-dimensional structures with thousands of microchannels. Fluids are manipulated via an electrocapillary pressure, originating from electrostatic control of the solid/fluid interfacial tension in the microchannels. Reversible fluid displacement has been achieved for all channel orientations with respect to gravity. The velocities of several centimeters per second are nearly two orders of magnitude higher than the velocities demonstrated by other electrofluidic actuation principles.	Philips Res Eindhoven, NL-5656 AA Eindhoven, Netherlands	Philips; Philips Research	Prins, MWJ (corresponding author), Philips Res Eindhoven, Prof Holstlaan 4, NL-5656 AA Eindhoven, Netherlands.	menno.prins@philips.com						ADAMSOM AW, 1997, PHYSICAL CHEM SURFAC; BERGE B, 1993, CR ACAD SCI II, V317, P157; COLGATE E, 1990, J VAC SCI TECHNOL A, V8, P3625, DOI 10.1116/1.576516; Gallardo BS, 1999, SCIENCE, V283, P57, DOI 10.1126/science.283.5398.57; Janocha B, 2000, LANGMUIR, V16, P3349, DOI 10.1021/la990518k; Lee J, 2000, J MICROELECTROMECH S, V9, P171, DOI 10.1109/84.846697; Lippmann G., 1875, ANN CHIM PHYS, V5, P494; Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534; Prins MWJ, 1999, J MICROMECH MICROENG, V9, P362, DOI 10.1088/0960-1317/9/4/312; Schasfoort RBM, 1999, SCIENCE, V286, P942, DOI 10.1126/science.286.5441.942; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Verheijen HJJ, 1999, LANGMUIR, V15, P6616, DOI 10.1021/la990548n; 1998, P IEEE, V86, P1536	13	313	341	6	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					277	280		10.1126/science.291.5502.277	http://dx.doi.org/10.1126/science.291.5502.277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209071				2022-12-28	WOS:000166352900036
J	Drescher, M; Hentschel, M; Kienberger, R; Tempea, G; Spielmann, C; Reider, GA; Corkum, PB; Krausz, F				Drescher, M; Hentschel, M; Kienberger, R; Tempea, G; Spielmann, C; Reider, GA; Corkum, PB; Krausz, F			X-ray pulses approaching the attosecond frontier	SCIENCE			English	Article							ORDER HARMONIC-GENERATION; ABOVE-THRESHOLD IONIZATION; TI-SAPPHIRE LASER; NONLINEAR OPTICS; PHASE-CONTROL; LIGHT-PULSES; RARE-GASES; REGIME; FIELDS; HELIUM	Single soft-x-ray pulses of similar to 90-electron volt (eV) photon energy are produced by high-order harmonic generation with 7-femtosecond (fs), 770-nanometer (1.6 eV) Laser pulses and are characterized by photoionizing krypton in the presence of the driver laser pulse. By detecting photoelectrons ejected perpendicularly to the Laser polarization, broadening of the photoelectron spectrum due to absorption and emission of Laser photons is suppressed, permitting the observation of a Laser-induced downshift of the energy spectrum with sub-laser-cycle resolution in a cross correlation measurement. We measure isolated x-ray pulses of 1.8 (+0.7/-1.2) fs in duration, which are shorter than the oscillation cycle of the driving Laser Light (2.6 fs). Our techniques for generation and measurement offer sub-femtosecond resolution over a wide range of x-ray wavelengths, paving the way to experimental attosecond science. Tracing atomic processes evolving faster than the exciting light field is within reach.	Vienna Tech Univ, Inst Photon, A-1040 Vienna, Austria; Univ Bielefeld, Fak Phys, D-33615 Bielefeld, Germany; Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada	Technische Universitat Wien; University of Bielefeld; National Research Council Canada	Krausz, F (corresponding author), Vienna Tech Univ, Inst Photon, Gusshausstr 27, A-1040 Vienna, Austria.		Spielmann, Christian/G-9476-2013	Spielmann, Christian/0000-0002-5223-4170				Apolonski A, 2000, PHYS REV LETT, V85, P740, DOI 10.1103/PhysRevLett.85.740; Baltuska A, 1997, APPL PHYS B-LASERS O, V65, P175, DOI 10.1007/s003400050262; BECKER U, 1996, VUV SOFT XRAY PHOTOI, P152; Bouhal A, 1997, J OPT SOC AM B, V14, P950, DOI 10.1364/JOSAB.14.000950; Brabec T, 2000, REV MOD PHYS, V72, P545, DOI 10.1103/RevModPhys.72.545; Cheng Z, 1999, OPT LETT, V24, P247, DOI 10.1364/OL.24.000247; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; Constant E, 1997, PHYS REV A, V56, P3870, DOI 10.1103/PhysRevA.56.3870; CORKUM PB, 1989, PHYS REV LETT, V62, P1259, DOI 10.1103/PhysRevLett.62.1259; CORKUM PB, 1994, OPT LETT, V19, P1870, DOI 10.1364/OL.19.001870; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Diels J. C., 1996, ULTRASHORT LASER PUL; Dietrich P, 2000, OPT LETT, V25, P16, DOI 10.1364/OL.25.000016; FARKAS G, 1992, PHYS LETT A, V168, P447, DOI 10.1016/0375-9601(92)90534-S; FREEMAN RR, 1987, PHYS REV LETT, V59, P1092, DOI 10.1103/PhysRevLett.59.1092; GALLAGHER TF, 1988, PHYS REV LETT, V61, P2304, DOI 10.1103/PhysRevLett.61.2304; HANSCH TW, 1990, OPT COMMUN, V80, P71, DOI 10.1016/0030-4018(90)90509-R; HARRIS SE, 1993, OPT COMMUN, V100, P487, DOI 10.1016/0030-4018(93)90250-9; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Kan C, 1997, PHYS REV LETT, V79, P2971, DOI 10.1103/PhysRevLett.79.2971; Kobayashi Y, 1998, OPT LETT, V23, P64, DOI 10.1364/OL.23.000064; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; LHUILLIER A, 1993, PHYS REV LETT, V70, P774, DOI 10.1103/PhysRevLett.70.774; MACKLIN JJ, 1993, PHYS REV LETT, V70, P766, DOI 10.1103/PhysRevLett.70.766; Morgner U, 1999, OPT LETT, V24, P411, DOI 10.1364/OL.24.000411; Moshammer R, 1997, PHYS REV LETT, V79, P3621, DOI 10.1103/PhysRevLett.79.3621; Nisoli M, 1997, APPL PHYS B-LASERS O, V65, P189, DOI 10.1007/s003400050263; Papadogiannis NA, 1999, PHYS REV LETT, V83, P4289, DOI 10.1103/PhysRevLett.83.4289; Poppe A, 2001, APPL PHYS B-LASERS O, V72, P373, DOI 10.1007/s003400000526; Sartania S, 1997, OPT LETT, V22, P1562, DOI 10.1364/OL.22.001562; Schafer KJ, 1997, PHYS REV LETT, V78, P638, DOI 10.1103/PhysRevLett.78.638; SCHINS JM, 1994, PHYS REV LETT, V73, P2180, DOI 10.1103/PhysRevLett.73.2180; Schins JM, 1996, J OPT SOC AM B, V13, P197, DOI 10.1364/JOSAB.13.000197; Schnurer M, 2000, APPL PHYS B-LASERS O, V70, pS227, DOI 10.1007/s003400000286; Schnurer M, 1999, PHYS REV LETT, V83, P722, DOI 10.1103/PhysRevLett.83.722; Schnurer M, 1998, PHYS REV LETT, V80, P3236, DOI 10.1103/PhysRevLett.80.3236; Scrinzi A, 2001, PHYS REV LETT, V86, P412, DOI 10.1103/PhysRevLett.86.412; Shirakawa A, 1999, APPL PHYS LETT, V74, P2268, DOI 10.1063/1.123820; Spielmann C, 1998, IEEE J SEL TOP QUANT, V4, P249, DOI 10.1109/2944.686730; Spielmann C, 1997, SCIENCE, V278, P661, DOI 10.1126/science.278.5338.661; Steinmeyer G, 1999, SCIENCE, V286, P1507, DOI 10.1126/science.286.5444.1507; Sutter DH, 1999, OPT LETT, V24, P631, DOI 10.1364/OL.24.000631; VANDENHEUVELL HBV, 1988, MULTIPHOTON PROCESSE, P26; Xu L, 1996, OPT LETT, V21, P2008, DOI 10.1364/OL.21.002008; YABLONOVITCH E, 1988, PHYS REV LETT, V60, P795, DOI 10.1103/PhysRevLett.60.795	45	671	696	1	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1923	1927		10.1126/science.1058561	http://dx.doi.org/10.1126/science.1058561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239146				2022-12-28	WOS:000167401600036
J	Morse, MA; Califf, RM; Sugarman, J				Morse, MA; Califf, RM; Sugarman, J			Monitoring and ensuring safety during clinical research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICINE	Increased numbers of clinical trials, many of which are large, multicenter, and sometimes international, and the marked shift of funding for clinical trials to industry have made apparent the inadequacy of mechanisms for protecting human subjects that were developed when clinical research was generally carried out on a small scale at single institutions. To address concerns regarding the protection of human subjects, a group of professionals with expertise in various aspects of clinical trials was assembled in May 2000, Participants described and evaluated the mechanisms by which clinical trials are monitored, focusing on adverse event reporting and the processes by which various parties with oversight responsibilities interact in the course of these trials. In this article, we describe the manner in which adverse event reporting might function to enhance safety and the role of data monitoring committees in using aggregate data from these reports, outline the problems that now exist for institutional review boards as they are faced with multiple adverse event reports from clinical trials while conducting continuing review, and offer recommendations for improving the current approach.	Duke Univ, Med Ctr, Ctr Study Med Eth & Humanities, Durham, NC 27710 USA; Duke Univ, Dept Med, Durham, NC 27710 USA; Duke Univ, Dept Philosophy, Durham, NC 27710 USA; Duke Univ, Duke Clin Res Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Sugarman, J (corresponding author), Duke Univ, Med Ctr, Ctr Study Med Eth & Humanities, Box 3040, Durham, NC 27710 USA.	sugar001@mc.duke.edu		Sugarman, Jeremy/0000-0001-7022-8332				ARMSTRONG PW, 1995, CIRCULATION, V91, P901, DOI 10.1161/01.CIR.91.3.901; Burman WJ, 2001, ANN INTERN MED, V134, P152, DOI 10.7326/0003-4819-134-2-200101160-00016; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; ELLIS J, 1995, LANCET, V346, P407, DOI 10.1016/S0140-6736(95)92781-6; Faden RR, 1996, JAMA-J AM MED ASSOC, V276, P403; Gordon Valery M, 1998, IRB, V20, P1, DOI 10.2307/3564020; Levin A, 1998, ANN INTERN MED, V128, P334, DOI 10.7326/0003-4819-128-4-199802150-00057; *NAT COMM PROT HUM, 1998, ETH RES HUM SUBJ SEL, P19; *NIH, 2001, GUID REP ADV EV I RE; *NIH, 2001, NIH POL DAT SAF MON; *PRENTICE ED, 1997, IRB, V19, P1; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; United States Department of Health and Human Services, 1991, FED REGISTER, V56, P28012; Whitehead J, 1999, STAT MED, V18, P3425, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3425::AID-SIM369>3.0.CO;2-D; WITTES J, 1993, STAT MED, V12, P419, DOI 10.1002/sim.4780120504; 1987, FED REG, V52, P2303; 1987, FED REG, V52, P8831; 1987, FED REG, V52, P23031; 1996, FED REG, V61, P51529; 1991, FED REG, V56, P29756	20	64	65	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1201	1205		10.1001/jama.285.9.1201	http://dx.doi.org/10.1001/jama.285.9.1201			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231751				2022-12-28	WOS:000167194700025
J	Tarduno, JA; Cottrell, RD; Smirnov, AV				Tarduno, JA; Cottrell, RD; Smirnov, AV			High geomagnetic intensity during the mid-Cretaceous from Thellier analyses of single plagioclase crystals	SCIENCE			English	Article							EARTHS MAGNETIC-FIELD; SUBMARINE BASALTIC GLASS; REVERSAL FREQUENCY; INDIAN-OCEAN; LA REUNION; PALEOINTENSITY; ISLAND; HAWAII; MANTLE	Recent numerical simulations have yielded the most efficient geodynamo, having the Largest dipole intensity when reversal frequency is Low. Reliable paleointensity data are Limited but heretofore have suggested that reversal frequency and paleointensity are decoupled. We report data from 56 Thellier-Thellier experiments on plagioclase crystals separated from basalts of the Rajmahal Traps (113 to 116 million years old) of India that formed during the Cretaceous Normal Polarity Superchron. These data suggest a time-averaged paleomagnetic dipole moment of 12.5 +/- 1.4 x 10(22) amperes per square meter, three times greater than mean Cenozoic and Early Cretaceous-Late Jurassic dipole moments when geomagnetic reversals were frequent. This result supports a correlation between intervals of Low reversal frequency and high geomagnetic field strength.	Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA	University of Rochester	Tarduno, JA (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.			Smirnov, Aleksey/0000-0002-9915-5138; Cottrell, Rory/0000-0003-4174-6389; Tarduno, John/0000-0002-0490-0124				Bol'shakov A. S., 1987, Izvestiya Academy of Sciences USSR, Physics of the Solid Earth, V23, P324; Bol'shakov A. S., 1981, Izvestiya Academy of Sciences USSR, Physics of the Solid Earth, V17, P754; BOLSHAKOV AS, 1983, IZV EARTH PHYS, V19, P976; CANDE SC, 1995, J GEOPHYS RES, V100, P6096; CHAUVIN A, 1991, J GEOPHYS RES-SOLID, V96, P1981, DOI 10.1029/90JB02223; COE RS, 1973, J GEOMAGN GEOELECTR, V25, P415, DOI 10.5636/jgg.25.415; COE RS, 1967, J GEOMAGN GEOELECTR, V19, P157, DOI 10.5636/jgg.19.157; COE RS, 1978, J GEOPHYS RES, V83, P1740, DOI 10.1029/JB083iB04p01740; Cottrell RD, 1999, EARTH PLANET SC LETT, V169, P1, DOI 10.1016/S0012-821X(99)00068-0; Cottrell RD, 2000, J GEOPHYS RES-SOL EA, V105, P23579, DOI 10.1029/2000JB900219; COX A, 1968, J GEOPHYS RES, V73, P3247, DOI 10.1029/JB073i010p03247; Fisher N. I., 1987, STAT ANAL SPHERICAL; Glatzmaier GA, 1999, NATURE, V401, P885, DOI 10.1038/44776; GRADSTEIN FM, 1994, J GEOPHYS RES-SOL EA, V99, P24051, DOI 10.1029/94JB01889; Juarez MT, 1998, NATURE, V394, P878, DOI 10.1038/29746; Kent R. W., 1997, GEOPHYS MONOGR SER, V100, P145; KLOOTWIJK CT, 1971, TECTONOPHYSICS, V12, P449, DOI 10.1016/0040-1951(71)90045-X; KONO M, 1974, J GEOPHYS RES, V79, P1135, DOI 10.1029/JB079i008p01135; KONO M, 1995, EARTHS CENTRAL PART, P75; Kosterov AA, 1997, J GEOPHYS RES-SOL EA, V102, P24859, DOI 10.1029/97JB01519; Laj C, 1999, J GEOPHYS RES-SOL EA, V104, P15317, DOI 10.1029/1999JB900113; LARSON RL, 1991, EARTH PLANET SC LETT, V107, P437, DOI 10.1016/0012-821X(91)90091-U; MCFADDEN PL, 1991, J GEOPHYS RES-SOLID, V96, P3923, DOI 10.1029/90JB02275; Mejia V, 1996, GEOPHYS RES LETT, V23, P475, DOI 10.1029/96GL00018; OGG JG, 1995, AGU REFERENCE SHELF, V1, P240; PICK T, 1993, NATURE, V366, P238, DOI 10.1038/366238a0; PREVOT M, 1990, EARTH PLANET SC LETT, V97, P129, DOI 10.1016/0012-821X(90)90104-6; PREVOT M, 1985, J GEOPHYS RES-SOLID, V90, P417, DOI 10.1029/JB090iB12p10417; Rais A, 1996, EARTH PLANET SC LETT, V140, P173, DOI 10.1016/0012-821X(96)00024-6; Selkin PA, 2000, PHILOS T R SOC A, V358, P1065, DOI 10.1098/rsta.2000.0574; Sherwood GJ, 1996, J SOUTHE ASIAN EARTH, V13, P123, DOI 10.1016/0743-9547(96)00013-X; SHERWOOD GJ, 1991, STUD GEOPHYS GEOD, V35, P325, DOI 10.1007/BF01613978; Thellier O., 1959, ANN GEOPHYS-ITALY, V15, P285	33	131	139	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1779	1783		10.1126/science.1057519	http://dx.doi.org/10.1126/science.1057519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230692				2022-12-28	WOS:000167320600057
J	Patel, V; Abas, M; Broadhead, J; Todd, C; Reeler, A				Patel, V; Abas, M; Broadhead, J; Todd, C; Reeler, A			Depression in developing countries: lessons from Zimbabwe	BRITISH MEDICAL JOURNAL			English	Article							COMMON MENTAL-DISORDERS; PRIMARY-CARE PATIENTS; RANDOMIZED CONTROLLED TRIAL; PSYCHIATRIC MORBIDITY; DEVELOPING-WORLD; HEALTH-CARE; HARARE; WOMEN; QUESTIONNAIRE; MODELS		Univ Zimbabwe, Sch Med, Dept Community Med, Harare, Zimbabwe; Univ Zimbabwe, Sch Med, Dept Psychiat, Harare, Zimbabwe	University of Zimbabwe; University of Zimbabwe	Patel, V (corresponding author), Sangath Ctr, 841-1Alto, Porvorim 403521, Goa, India.		Abas, Melanie A/B-1076-2011	abas, melanie/0000-0003-1716-5584				ABAS M, 1994, BRIT J PSYCHIAT, V164, P293, DOI 10.1192/bjp.164.3.293; ABAS M, 1994, BRIT MED J, V308, P1052, DOI 10.1136/bmj.308.6936.1052; Abas MA, 1997, PSYCHOL MED, V27, P59, DOI 10.1017/S0033291796004163; ARAYA R, 1994, BRIT J PSYCHIAT, V165, P530, DOI 10.1192/bjp.165.4.530; Broadhead JC, 1998, PSYCHOL MED, V28, P29, DOI 10.1017/S0033291797005618; BROWN GW, 1995, PSYCHOL MED, V25, P7, DOI 10.1017/S003329170002804X; Coulehan JL, 1997, ARCH INTERN MED, V157, P1113, DOI 10.1001/archinte.157.10.1113; GOLDBERG DP, 1995, MENTAL ILLNESS GEN H, P323; HALL A, 1987, CENT AFR J MED, V33, P239; Jacob KS, 1998, PSYCHOL MED, V28, P145, DOI 10.1017/S0033291797005710; Kishore J, 1996, Indian J Psychiatry, V38, P137; Lee S, 2000, AM J PSYCHIAT, V157, P380, DOI 10.1176/appi.ajp.157.3.380; Mumford DB, 1997, BRIT J PSYCHIAT, V170, P473, DOI 10.1192/bjp.170.5.473; Murthy RS, 1998, PREVENTING MENTAL ILLNESS, P117; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; NATIONS MK, 1988, SOC SCI MED, V26, P1245, DOI 10.1016/0277-9536(88)90156-6; Nhiwatiwa S, 1998, J EPIDEMIOL COMMUN H, V52, P262, DOI 10.1136/jech.52.4.262; Ormel J., 1999, COMMON MENTAL DISORD, P34; PATEL V, 1995, PSYCHOL MED, V25, P1191, DOI 10.1017/S003329170003316X; Patel V, 1997, ACTA PSYCHIAT SCAND, V95, P469, DOI 10.1111/j.1600-0447.1997.tb10134.x; Patel V, 1996, LANCET, V347, P742, DOI 10.1016/S0140-6736(96)90083-5; Patel V, 2000, PSYCHOL MED, V30, P743, DOI 10.1017/S0033291799002147; Patel V, 1999, SOC SCI MED, V49, P1461, DOI 10.1016/S0277-9536(99)00208-7; Patel V, 1997, SOC PSYCH PSYCH EPID, V32, P97, DOI 10.1007/BF00788927; Patel V., 1995, Central African Journal of Medicine, V41, P209; Patel V, 1996, INT J METHOD PSYCH, V6, P153, DOI 10.1002/(SICI)1234-988X(199610)6:3<153::AID-MPR157>3.3.CO;2-H; Patel V, 1998, PSYCHOL MED, V28, P135, DOI 10.1017/S0033291797005941; Patel V, 1998, BRIT J PSYCHIAT, V172, P53, DOI 10.1192/bjp.172.1.53; Patel V, 1997, BRIT J PSYCHIAT, V171, P60, DOI 10.1192/bjp.171.1.60; Patel V, 1998, CULTURE COMMON MENTA; Reeler A. P., 1998, TORTURE, V8, P120; REELER AP, 1993, CENT AFR J MED, V39, P1; REELER AP, 1992, CENT AFR J MED, V38, P1; REYNOLDS J, 1993, SOC SCI MED, V36, P657, DOI 10.1016/0277-9536(93)90062-9; Sumathipala A, 2000, PSYCHOL MED, V30, P747, DOI 10.1017/S0033291799002160; SWARTZ L, 1985, BRIT J PSYCHIAT, V146, P391, DOI 10.1192/bjp.146.4.391; Todd C, 1999, PSYCHOL MED, V29, P97, DOI 10.1017/S0033291798007661; World Health Organization, 1998, MENT DIS PRIM CAR WH	38	117	119	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	2001	322	7284					482	484		10.1136/bmj.322.7284.482	http://dx.doi.org/10.1136/bmj.322.7284.482			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406YD	11222428	Green Published, Green Accepted			2022-12-28	WOS:000167243000025
J	Bock, JB; Matern, HT; Peden, AA; Scheller, RH				Bock, JB; Matern, HT; Peden, AA; Scheller, RH			A genomic perspective on membrane compartment organization	NATURE			English	Article								Now that whole genome sequences are available for many eukaryotic organisms from yeast to man, we can form broad hypotheses on the basis of the relative expansion of protein families. To investigate the molecular mechanisms responsible for the organization of membrane compartments, we identified members of the SNARE, coat complex, Rab and Sec1 protein families in four eukaryotic genomes. Of these families only the Rab family expanded from the unicellular yeast to the multicellular fly and worm. All families were expanded in humans, where we find 35 SNAREs, 60 Rabs and 53 coat complex subunits. In addition, we were able to resolve the SNARE class of proteins into four distinct subfamilies.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Scheller, RH (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA.	scheller@cmgm.stanford.edu		Peden, Andrew/0000-0003-0144-7712				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; [Anonymous], 1997, NATURE, V387, pS; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Skolnick J, 2000, NAT BIOTECHNOL, V18, P283, DOI 10.1038/73723; STEIN L, IN PRESS NUCL ACIDS	9	497	523	9	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					839	841		10.1038/35057024	http://dx.doi.org/10.1038/35057024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237004	Bronze			2022-12-28	WOS:000166938800051
J	Moller, P; Madland, DG; Sierk, AJ; Iwamoto, A				Moller, P; Madland, DG; Sierk, AJ; Iwamoto, A			Nuclear fission modes and fragment mass asymmetries in a five-dimensional deformation space	NATURE			English	Article							POTENTIAL-ENERGY SURFACES; GROUND-STATE MASSES; HEAVY; BARRIER; STABILITY; URANIUM	Nuclei undergoing fission can be described by a multi-dimensional potential-energy surface that guides the nuclear shape evolution-from the ground state, through intermediate saddle points and finally to the configurations of separated fission fragments. Until now, calculations have lacked adequate exploration of the shape parameterization of sufficient dimensionality to yield features in the potential-energy surface (such as multiple minima, valleys, saddle points and ridges) that correspond to characteristic observables of the fission process. Here we calculate and analyse five-dimensional potential-energy landscapes based on a grid of 2,610,885 deformation points. We rnd that observed fission features-such as the distributions of fission fragment mass and kinetic energy, and the different energy thresholds for symmetric and asymmetric fission-are very closely related to topological features in the calculated five-dimensional energy landscapes.	Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Japan Atom Energy Res Inst, Dept Mat Sci, Tokai, Ibaraki 3191195, Japan	United States Department of Energy (DOE); Los Alamos National Laboratory; Japan Atomic Energy Agency	Moller, P (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	moller@moller.lanl.gov						ABOUSSIR Y, 1995, ATOM DATA NUCL DATA, V61, P127, DOI 10.1016/S0092-640X(95)90014-4; Armbruster P, 1999, REP PROG PHYS, V62, P465, DOI 10.1088/0034-4885/62/4/001; Bohr N, 1939, PHYS REV, V56, P426, DOI 10.1103/PhysRev.56.426; BOLSTERL.M, 1972, PHYS REV C, V5, P1050, DOI 10.1103/PhysRevC.5.1050; BRITT HC, 1963, PHYS REV, V129, P2239, DOI 10.1103/PhysRev.129.2239; Dematte L, 1997, NUCL PHYS A, V617, P331, DOI 10.1016/S0375-9474(97)00032-8; FRANKEL S, 1947, PHYS REV, V72, P914, DOI 10.1103/PhysRev.72.914; Hahn O, 1939, NATURWISSENSCHAFTEN, V27, P11, DOI 10.1007/BF01488241; Hayes B, 2000, AM SCI, V88, P481; HOFFMAN DC, 1974, ANNU REV NUCL PART S, V24, P151, DOI 10.1146/annurev.ns.24.120174.001055; HULET EK, 1986, PHYS REV LETT, V56, P313, DOI 10.1103/PhysRevLett.56.313; KONECNY E, 1974, 3 P IAEA S PHYS CHEM, V2, P3; KRAPPE HJ, 1979, PHYS REV C, V20, P992, DOI 10.1103/PhysRevC.20.992; KRATZ KL, 1993, ASTROPHYS J, V403, P216, DOI 10.1086/172196; KUDYAEV GA, 1987, SOV J NUCL PHYS+, V45, P951; Mamdouh A, 1998, NUCL PHYS A, V644, P389, DOI 10.1016/S0375-9474(98)00576-4; Meitner L, 1939, NATURE, V143, P239, DOI 10.1038/143239a0; MEITNER L, 1950, NATURE, V165, P561, DOI 10.1038/165561a0; MOLLER P, 1995, ATOM DATA NUCL DATA, V59, P185, DOI 10.1006/adnd.1995.1002; MOLLER P, 1987, NUCL PHYS A, V469, P1, DOI 10.1016/0375-9474(87)90083-2; MOLLER P, 1990, NUCL PHYS A, V514, P1, DOI 10.1016/0375-9474(90)90330-O; MOLLER P, 1989, NUCL PHYS A, V492, P349, DOI 10.1016/0375-9474(89)90403-X; Moller P, 2000, PHYS REV C, V61, DOI 10.1103/PhysRevC.61.047602; MOLLER P, 1970, PHYS LETT B, VB 31, P283, DOI 10.1016/0370-2693(70)90171-1; Moller P, 1997, ATOM DATA NUCL DATA, V66, P131, DOI 10.1006/adnd.1997.0746; MOLLER P, 1994, NUCL PHYS A, V575, P381, DOI 10.1016/0375-9474(94)90197-X; MOLLER P, 1977, NUCL PHYS A, V281, P354, DOI 10.1016/0375-9474(77)90031-8; Nagame Y, 1997, RADIOCHIM ACTA, V78, P3; NILSSON SG, 1969, NUCL PHYS A, VA131, P1, DOI 10.1016/0375-9474(69)90809-4; NIX JR, 1972, ANNU REV NUCL PART S, V22, P65, DOI 10.1146/annurev.ns.22.120172.000433; OHTSUKI T, 1993, PHYS REV C, V48, P1667, DOI 10.1103/PhysRevC.48.1667; PASHKEVICH VV, 1969, NUCL PHYS A, VA133, P400, DOI 10.1016/0375-9474(69)90641-1; Schmidt KH, 2000, NUCL PHYS A, V665, P221, DOI 10.1016/S0375-9474(99)00384-X; STRUTINS.VM, 1968, NUCL PHYS A, VA122, P1, DOI 10.1016/0375-9474(68)90699-4; STRUTINSKY VM, 1967, NUCL PHYS A, VA 95, P420, DOI 10.1016/0375-9474(67)90510-6; Zhao YL, 1998, J ALLOY COMPD, V271, P327, DOI 10.1016/S0925-8388(98)00081-4	37	275	279	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					785	790		10.1038/35057204	http://dx.doi.org/10.1038/35057204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236985	Green Published			2022-12-28	WOS:000166938800031
J	Sachidanandam, R; Weissman, D; Schmidt, SC; Kakol, JM; Stein, LD; Marth, G; Sherry, S; Mullikin, JC; Mortimore, BJ; Willey, DL; Hunt, SE; Cole, CG; Coggill, PC; Rice, CM; Ning, ZM; Rogers, J; Bentley, DR; Kwok, PY; Mardis, ER; Yeh, RT; Schultz, B; Cook, L; Davenport, R; Dante, M; Fulton, L; Hillier, L; Waterston, RH; McPherson, JD; Gilman, B; Schaffner, S; Van Etten, WJ; Reich, D; Higgins, J; Daly, MJ; Blumenstiel, B; Baldwin, J; Stange-Thomann, NS; Zody, MC; Linton, L; Lander, ES; Altshuler, D				Sachidanandam, R; Weissman, D; Schmidt, SC; Kakol, JM; Stein, LD; Marth, G; Sherry, S; Mullikin, JC; Mortimore, BJ; Willey, DL; Hunt, SE; Cole, CG; Coggill, PC; Rice, CM; Ning, ZM; Rogers, J; Bentley, DR; Kwok, PY; Mardis, ER; Yeh, RT; Schultz, B; Cook, L; Davenport, R; Dante, M; Fulton, L; Hillier, L; Waterston, RH; McPherson, JD; Gilman, B; Schaffner, S; Van Etten, WJ; Reich, D; Higgins, J; Daly, MJ; Blumenstiel, B; Baldwin, J; Stange-Thomann, NS; Zody, MC; Linton, L; Lander, ES; Altshuler, D		Int SNP Map Working Grp	A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms	NATURE			English	Article							LIPOPROTEIN-LIPASE GENE; COMMON DISEASE GENES; LINKAGE DISEQUILIBRIUM; CANDIDATE GENES; DNA-SEQUENCES; SNP MAP; DIVERSITY; IDENTIFICATION; POPULATIONS; DISCOVERY	We describe a map of 1.42 million single nucleotide polymorphisms (SNPs) distributed throughout the human genome, providing an average density on available sequence of one SNP every 1.9 kilobases. These SNPs were primarily discovered by two projects: The SNP Consortium and the analysis of clone overlaps by the International Human Genome Sequencing Consortium. The map integrates all publicly available SNPs with described genes and other genomic features. We estimate that 60,000 SNPs fall within exon (coding and untranslated regions), and 85% of exons are within 5 kb of the nearest SNP. Nucleotide diversity varies greatly across the genome, in a manner broadly consistent with a standard population genetic model of human history. This high-density SNP map provides a public resource for defining haplotype variation across the genome, and should help to identify biomedically important genes for diagnosis and therapy.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	Cold Spring Harbor Laboratory; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Altshuler, D (corresponding author), 9 Cambridge Ctr, Cambridge, MA 02139 USA.	drb@sanger.ac.uk; altshul@genome.wi.mit.edu	Kwok, Pui-Yan/F-7725-2014; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; Ning, Zemin/D-2411-2013; McPherson, John D/D-2633-2017; Schaffner, Stephen F/D-1189-2011; Mardis, Elaine/W-2202-2019; sachidanandam, ravi/Q-6916-2019	Kwok, Pui-Yan/0000-0002-5087-3059; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; McPherson, John D/0000-0001-8049-9347; sachidanandam, ravi/0000-0001-9844-4459; Hunt, Sarah/0000-0002-8350-1235; Schaffner, Stephen/0000-0001-6699-3568; Schultz, Brian/0000-0003-4964-976X; Ning, Zemin/0000-0003-4359-776X; Sherry, Stephen/0000-0002-7982-076X	NATIONAL LIBRARY OF MEDICINE [Z01LM000158] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cargill M, 1999, NAT GENET, V23, P373, DOI 10.1038/15564; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1999, GENOME RES, V9, P210; COLLINS FS, 1991, CLIN RES, V39, P615; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; Eaves IA, 2000, NAT GENET, V25, P320; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Gu ZJ, 1998, HUM MUTAT, V12, P221, DOI 10.1002/(SICI)1098-1004(1998)12:4<221::AID-HUMU1>3.0.CO;2-I; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Horton R, 1998, J MOL BIOL, V282, P71, DOI 10.1006/jmbi.1998.2018; Hudson R, 1991, OXFORD SURVEYS EVOLU, V7, P1; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kimmel M, 1998, GENETICS, V148, P1921; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI WH, 1991, GENETICS, V129, P513; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; MARTH GT, UNPUB NATURE GENET; MILLER RD, IN PRESS GENOMICS; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Nachman MW, 1998, GENETICS, V150, P1133; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Reich DE, 1998, P NATL ACAD SCI USA, V95, P11026; REICH DE, UNPUB NATURE; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TAJIMA F, 1983, GENETICS, V105, P437; Templeton AR, 2000, GENETICS, V156, P1259; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Yang ZY, 2000, NAT GENET, V26, P13, DOI 10.1038/79113; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	44	2185	2393	2	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					928	933		10.1038/35057149	http://dx.doi.org/10.1038/35057149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237013	Bronze			2022-12-28	WOS:000166938800060
J	Tupler, R; Perini, G; Green, MR				Tupler, R; Perini, G; Green, MR			Expressing the human genome	NATURE			English	Article							TRANSCRIPTION FACTOR	We have searched the human genome for genes encoding new proteins that may be involved in three nuclear gene expression processes: transcription, pre-messenger RNA splicing and polyadenylation. A plethora of potential new factors are implicated by sequence in nuclear gene expression, revealing a substantial but selective increase in complexity compared with Drosophila melanogaster and Caenorhabditis elegans. Although the raw genomic information has limitations, its availability offers new experimental approaches for studying gene expression.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; Univ Pavia, I-27100 Pavia, Italy; Univ Bologna, Dipartimento Biol Evoluz & Sperimentale, I-40126 Bologna, Italy	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Pavia; University of Bologna	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct, 373 Plantat St, Worcester, MA 01605 USA.		Tupler, Rossella/C-9500-2015	Tupler, Rossella/0000-0002-3797-1789				Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45; Berk AJ, 2000, CELL, V103, P5, DOI 10.1016/S0092-8674(00)00098-2; Burge CB, 1999, RNA WORLD, P525; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Inaba T, 1996, NATURE, V382, P541, DOI 10.1038/382541a0; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; Mount SM, 2000, J CELL BIOL, V150, pF37, DOI 10.1083/jcb.150.2.F37; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Ouellette Michel M., 1995, Current Opinion in Biotechnology, V6, P65, DOI 10.1016/0958-1669(95)80011-5; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2	15	280	290	1	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					832	833		10.1038/35057011	http://dx.doi.org/10.1038/35057011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237001	Bronze			2022-12-28	WOS:000166938800048
J	Root, MJ; Kay, MS; Kim, PS				Root, MJ; Kay, MS; Kim, PS			Protein design of an HIV-1 entry inhibitor	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COILED-COIL; POTENT INHIBITORS; SYNTHETIC PEPTIDE; ENVELOPE GLYCOPROTEIN; ATOMIC-STRUCTURE; GP41; FUSION; DOMAIN; EPITOPE	Human immunodeficiency virus type-1 (HIV-1) membrane fusion is promoted by the formation of a trimer-of-hairpins structure that brings the amino- and carboxyl-terminal regions of the gp41 envelope glycoprotein ectodomain into close proximity. Peptides derived from the carboxyl-terminal region (called C-peptides) potently inhibit HIV-1 entry by binding to the gp41 amino-terminal region. To test the converse of this inhibitory strategy, we designed a small protein, denoted 5-Helix, that binds the C-peptide region of gp41. The 5-Helix protein displays potent (nanomolar) inhibitory activity against diverse HIV-1 variants and may serve as the basis for a new class of antiviral agents. The inhibitory activity of 5-Helix also suggests a strategy for generating an HIV-1 neutralizing antibody response that targets the carboxyl-terminal region of the gp41 ectodomain.	MIT, Dept Biol, Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Kim, PS (corresponding author), Merck Res Labs, 770 Sumneytown Pike, W Point, PA 19486 USA.				NIGMS NIH HHS [P01 GM56552] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056552] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER S, 1984, SCIENCE, V226, P1328, DOI 10.1126/science.6505693; [Anonymous], UNPUB; BLACKLOW SC, 1995, BIOCHEMISTRY-US, V34, P14955, DOI 10.1021/bi00046a001; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chang KM, 1998, MICROSYST TECHNOL, V5, P93, DOI 10.1007/s005420050148; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; D'Souza MP, 2000, JAMA-J AM MED ASSOC, V284, P215, DOI 10.1001/jama.284.2.215; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; HUGHSON FM, 1997, CURR BIOL, V7, P565; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; LaCasse RA, 1999, SCIENCE, V283, P357, DOI 10.1126/science.283.5400.357; Lambert DM, 1996, P NATL ACAD SCI USA, V93, P2186, DOI 10.1073/pnas.93.5.2186; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; PAI E, 2000, Patent No. 0061618; Purtscher M, 1996, AIDS, V10, P587, DOI 10.1097/00002030-199606000-00003; RAPAPORT D, 1995, EMBO J, V14, P5524, DOI 10.1002/j.1460-2075.1995.tb00239.x; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; ROOT MJ, UNPUB; Singh M, 1999, J MOL BIOL, V290, P1031, DOI 10.1006/jmbi.1999.2796; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Yao QZ, 1996, VIROLOGY, V223, P103, DOI 10.1006/viro.1996.0459; Zhao X, 2000, P NATL ACAD SCI USA, V97, P14172, DOI 10.1073/pnas.260499197	37	360	415	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					884	888		10.1126/science.1057453	http://dx.doi.org/10.1126/science.1057453			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11229405				2022-12-28	WOS:000166771700048
J	Durham, H; Loff, B				Durham, H; Loff, B			Japan's "comfort women"	LANCET			English	Editorial Material									Australian Red Cross, Dept Int Humanitarian Law, Melbourne, Vic 3181, Australia; Monash Univ, Alfred Hosp, Sch Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Durham, H (corresponding author), Australian Red Cross, Dept Int Humanitarian Law, Melbourne, Vic 3181, Australia.		Loff, Bebe/G-9241-2014	Loff, Bebe/0000-0003-1963-6503					0	3	3	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					302	302		10.1016/S0140-6736(00)03624-2	http://dx.doi.org/10.1016/S0140-6736(00)03624-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214145				2022-12-28	WOS:000166693400038
J	Hurskainen, R; Teperi, J; Rissanen, P; Aalto, AM; Grenman, S; Kivela, A; Kujansuu, E; Vuorma, S; Yliskoski, M; Paavonen, J				Hurskainen, R; Teperi, J; Rissanen, P; Aalto, AM; Grenman, S; Kivela, A; Kujansuu, E; Vuorma, S; Yliskoski, M; Paavonen, J			Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial	LANCET			English	Article							ENDOMETRIAL RESECTION; VAGINAL HYSTERECTOMY; SHORT-FORM; HEALTH; MANAGEMENT; ABLATION; OUTCOMES; WOMEN	Background Heavy menstrual blood loss is a common reason for women to seek medical care. The levonorgestrel-releasing intrauterine system (IUS) is an effective medical treatment for menorrhagia. We report a randomised comparison of this approach with hysterectomy in terms of the quality of life of women with menorrhagia and cost-effectiveness. Methods Of 598 women referred with menorrhagia to five university hospitals in Finland, 236 were eligible and agreed to take part. They were randomly assigned treatment with the levonorgestrel-releasing IUS (n=119) or hysterectomy (n=117). The amount of menstrual blood loss was objectively measured. The primary outcome measure was health-related quality of life at 12-month follow-up. Analyses were by intention to treat. Findings In the group assigned the levonorgestrel-releasing IUS, 24 (20%) women had had hysterectomy and 81 (68%) continued to use the system at 12 months. Of the women assigned to the hysterectomy group, 107 underwent the operation. Health-related duality of life improved significantly in both the IUS and hysterectomy groups (change 0.10 [95% CI 0.06-0.14] in both groups) as did other indices of psychological wellbeing. There were no significant differences between the treatment groups except that women with hysterectomy suffered less pain. Overall costs were about three times higher for the hysterectomy group than for the IUS group. Interpretation The significant improvement in health-related quality of life highlights the importance of treating menorrhagia. During the first year the levonorgestrel-releasing IUS was a cost-effective alternative to hysterectomy in treatment of this disorder.	STAKES, Natl Res & Dev Ctr Welf & Hlth, Helsinki 00531, Finland; Helsinki Univ Hosp, Dept Obstet, Helsinki, Finland; Helsinki Univ Hosp, Dept Gynaecol, Helsinki, Finland; Univ Turku, Dept Obstet & Gynaecol, Oulu, Finland; Univ Hosp Tampere, Tampere, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Turku; Tampere University; Tampere University Hospital	Hurskainen, R (corresponding author), STAKES, Natl Res & Dev Ctr Welf & Hlth, Box 220, Helsinki 00531, Finland.	ritve.hurskainen@stakes.fi		Paavonen, Jorma/0000-0003-4775-606X				Aalto A, 1999, STAKES RES REPORTS, V101; Alexander DA, 1996, BRIT MED J, V312, P280; ANDERSSON JK, 1990, BRIT J OBSTET GYNAEC, V97, P690, DOI 10.1111/j.1471-0528.1990.tb16240.x; Barrington JW, 1997, BRIT J OBSTET GYNAEC, V104, P614, DOI 10.1111/j.1471-0528.1997.tb11542.x; BECK AT, 1974, PSYCHOL REP, V34, P1184; Cooper KG, 1999, LANCET, V354, P1859, DOI 10.1016/S0140-6736(99)04101-X; COULTER A, 1991, BRIT J OBSTET GYNAEC, V98, P789, DOI 10.1111/j.1471-0528.1991.tb13484.x; Crosignani PG, 1997, OBSTET GYNECOL, V90, P257, DOI 10.1016/S0029-7844(97)00226-3; Crosignani PG, 1997, AM J OBSTET GYNECOL, V177, P95, DOI 10.1016/S0002-9378(97)70445-9; DICKER RC, 1982, AM J OBSTET GYNECOL, V144, P841, DOI 10.1016/0002-9378(82)90362-3; Drummond M F, 1991, Int J Technol Assess Health Care, V7, P561; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hurskainen R, 1998, ACTA OBSTET GYN SCAN, V77, P201, DOI 10.1034/j.1600-0412.1998.770214.x; KOOPMANSCHAP MA, 1994, HEALTH ECON, V3, P385, DOI 10.1002/hec.4730030606; Lahteenmaki P, 1998, BMJ-BRIT MED J, V316, P1122, DOI 10.1136/bmj.316.7138.1122; MCCOY NL, 1985, MATURITAS, V7, P203, DOI 10.1016/0378-5122(85)90041-6; OConnor H, 1997, LANCET, V349, P897, DOI 10.1016/S0140-6736(96)07285-6; OHIMAA A, 1998, EUR PLEN M HANN GERM, P57; Ohinmaa A, 1996, EUROQOL PLEN M BARC, P161; *ORG EC COOP DEV, 1993, PURCH POW PAR; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Sculpher MJ, 1996, BRIT J OBSTET GYNAEC, V103, P142, DOI 10.1111/j.1471-0528.1996.tb09666.x; Spielberger C., 1983, STAI MANUAL; WANG S L, 1992, Advances in Contraception, V8, P105, DOI 10.1007/BF01849748; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WIKLUND I, 1993, AM J OBSTET GYNECOL, V168, P824, DOI 10.1016/S0002-9378(12)90828-5; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	27	210	223	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2001	357	9252					273	277		10.1016/S0140-6736(00)03615-1	http://dx.doi.org/10.1016/S0140-6736(00)03615-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	397JW	11214131				2022-12-28	WOS:000166693400013
J	McAlindon, T				McAlindon, T			Glucosamine for osteoarthritis: dawn of a new era?	LANCET			English	Editorial Material							GLUCOSAMINE; KNEE		Boston Univ, Med Ctr, Arthrit Ctr, Boston, MA 01228 USA	Boston University	McAlindon, T (corresponding author), Boston Univ, Med Ctr, Arthrit Ctr, Boston, MA 01228 USA.							Adams JG, 1999, CLIN RADIOL, V54, P502, DOI 10.1016/S0009-9260(99)90846-2; Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Buckland-Wright JC, 1999, J RHEUMATOL, V26, P2664; CONSTANTZ RB, 1998, TXB RHEUMATOLOGY; Deal CL, 1999, RHEUM DIS CLIN N AM, V25, P379, DOI 10.1016/S0889-857X(05)70074-0; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; MCCARTY MF, 1994, MED HYPOTHESES, V42, P323, DOI 10.1016/0306-9877(94)90007-8; NEWMAN NM, 1985, LANCET, V2, P11; Odding E, 1998, ANN RHEUM DIS, V57, P203, DOI 10.1136/ard.57.4.203; Reginster J Y, 2000, Curr Rheumatol Rep, V2, P472, DOI 10.1007/s11926-000-0023-9; VANSAASE JLCM, 1989, ANN RHEUM DIS, V48, P271, DOI 10.1136/ard.48.4.271; Zeidler H, 1991, J Rheumatol Suppl, V28, P2	12	24	28	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					247	248		10.1016/S0140-6736(00)03606-0	http://dx.doi.org/10.1016/S0140-6736(00)03606-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214122				2022-12-28	WOS:000166693400004
J	Burkholder, WF; Kurtser, I; Grossman, AD				Burkholder, WF; Kurtser, I; Grossman, AD			Replication initiation proteins regulate a developmental checkpoint in Bacillus subtilis	CELL			English	Article							ESCHERICHIA-COLI; DNAA PROTEIN; CHROMOSOMAL REPLICATION; TRANSCRIPTION FACTOR; NUCLEOTIDE-SEQUENCE; SENSOR KINASE; SPORULATION; GENE; SPO0A; KINC	We identified a signaling pathway that prevents initiation of sporulation in Bacillus subtillis when replication initiation Is impaired. We isolated mutations that allow a replication initiation mutant (dnaA) to sporulate. These mutations affect a small open reading frame, sda, that was overexpressed in replication initiation mutants and appears to be directly regulated by DnaA. Mutations in replication initiation genes inhibit the onset of sporulation by preventing activation of a transcription factor required for sporulation, Spo0A. Deletion of sda restored activation of Spo0A in replication initiation mutants. Overexpression of sda in otherwise wild-type cells inhibited activation of Spo0A and sporulation. Purified Sda inhibited a histidine kinase needed for activation of Spo0A. Our results indicate that control of sda by DnaA establishes a checkpoint that inhibits activation of Spo0 and prevents futile attempts to initiate sporulation.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Grossman, AD (corresponding author), MIT, Dept Biol, Bldg 68,Room 530, Cambridge, MA 02139 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041934, R01GM041934] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41934] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONIEWSKI C, 1990, J BACTERIOL, V172, P86, DOI 10.1128/JB.172.1.86-93.1990; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; BRUAND C, 1995, MICROBIOL-UK, V141, P321, DOI 10.1099/13500872-141-2-321; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Burkholder WF, 2000, PROKARYOTIC DEVELOPMENT, P151; Christensen BB, 1999, J BACTERIOL, V181, P2683, DOI 10.1128/JB.181.9.2683-2688.1999; DAWES IW, 1970, J BACTERIOL, V103, P529, DOI 10.1128/JB.103.3.529-535.1970; DUNN G, 1978, J GEN MICROBIOL, V108, P189, DOI 10.1099/00221287-108-2-189; FUKUOKA T, 1990, J BIOCHEM-TOKYO, V107, P732, DOI 10.1093/oxfordjournals.jbchem.a123117; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; Garnerone AM, 1999, J BIOL CHEM, V274, P32500, DOI 10.1074/jbc.274.45.32500; GARRITY DB, 1993, J BACTERIOL, V175, P6512, DOI 10.1128/jb.175.20.6512-6517.1993; GROSS JD, 1968, COLD SPRING HARB SYM, V33, P307, DOI 10.1101/SQB.1968.033.01.034; GUZMAN P, 1988, J BACTERIOL, V170, P1598, DOI 10.1128/jb.170.4.1598-1609.1988; HANSEN FG, 1991, RES MICROBIOL, V142, P161, DOI 10.1016/0923-2508(91)90025-6; Harwood C.R., 1990, MOL BIOL METHODS BAC; HAUSER PM, 1995, J BACTERIOL, V177, P3923, DOI 10.1128/jb.177.14.3923-3931.1995; Hoch J.A., 1995, 2 COMPONENT SIGNAL T, DOI [10.1128/9781555818319, DOI 10.1128/9781555818319]; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; IRETON K, 1992, P NATL ACAD SCI USA, V89, P8808, DOI 10.1073/pnas.89.18.8808; IRETON K, 1994, EMBO J, V13, P1566, DOI 10.1002/j.1460-2075.1994.tb06419.x; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; KARAMATA D, 1970, MOL GEN GENET, V108, P277, DOI 10.1007/BF00283358; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; KEYNAN A, 1976, J BACTERIOL, V128, P8, DOI 10.1128/JB.128.1.8-14.1976; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; KOBAYASHI K, 1995, J BACTERIOL, V177, P176, DOI 10.1128/jb.177.1.176-182.1995; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; LEDEAUX JR, 1995, J BACTERIOL, V177, P861, DOI 10.1128/jb.177.3.861-863.1995; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; Lemon KP, 2000, J BACTERIOL, V182, P2989, DOI 10.1128/JB.182.10.2989-2991.2000; Levin PA, 2000, PROKARYOTIC DEVELOPMENT, P167; MANDELSTAM J, 1971, BIOCHEM J, V125, P635, DOI 10.1042/bj1250635; MANDELSTAM J, 1974, J BACTERIOL, V120, P38, DOI 10.1128/JB.120.1.38-42.1974; Messer W, 1997, MOL MICROBIOL, V24, P1, DOI 10.1046/j.1365-2958.1997.3171678.x; Messer W., 1996, ESCHERICHIA COLI SAL, V2nd ed., P1579; Miller J.H., 1972, EXPT MOL GENETICS; MORIYA S, 1990, EMBO J, V9, P2905, DOI 10.1002/j.1460-2075.1990.tb07481.x; Moriya S, 1999, PLASMID, V41, P17, DOI 10.1006/plas.1998.1381; OGASAWARA N, 1986, NUCLEIC ACIDS RES, V14, P9989, DOI 10.1093/nar/14.24.9989; PEREGO M, 1989, J BACTERIOL, V171, P6187, DOI 10.1128/jb.171.11.6187-6196.1989; PEREGO M, 1988, MOL MICROBIOL, V2, P689, DOI 10.1111/j.1365-2958.1988.tb00079.x; Roth A, 1998, MOL MICROBIOL, V28, P395, DOI 10.1046/j.1365-2958.1998.00813.x; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; TRACH KA, 1993, MOL MICROBIOL, V8, P69, DOI 10.1111/j.1365-2958.1993.tb01204.x; Wang L, 1997, GENE DEV, V11, P2569, DOI 10.1101/gad.11.19.2569; WINSTON S, 1980, P NATL ACAD SCI-BIOL, V77, P2834, DOI 10.1073/pnas.77.5.2834; YORK K, 1992, J BACTERIOL, V174, P2648, DOI 10.1128/jb.174.8.2648-2658.1992; Yoshiakwa H., 1993, P507; Zapf J, 1998, BIOCHEMISTRY-US, V37, P7725, DOI 10.1021/bi9729615	54	156	163	1	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					269	279		10.1016/S0092-8674(01)00211-2	http://dx.doi.org/10.1016/S0092-8674(01)00211-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207367	Bronze, Green Published			2022-12-28	WOS:000166879700010
J	Maquat, LE; Carmichael, GG				Maquat, LE; Carmichael, GG			Quality control of mRNA function	CELL			English	Review							IDENTIFICATION; TRANSCRIPTION; TRANSPORT; PROTEINS		Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06030 USA	University of Rochester; University of Connecticut	Maquat, LE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu; gcarmich@neuron.uchc.edu		Maquat, Lynne/0000-0002-2789-2075				Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Carmichael GG, 2000, BLOOD CELL MOL DIS, V26, P57; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Hirose Y, 2000, GENE DEV, V14, P1415; Jacobson A, 2000, COLD SPRING HARBOR M, V39, P827; Johnson C, 2000, J CELL BIOL, V150, P417, DOI 10.1083/jcb.150.3.417; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2000, COLD SPRING HARBOR M, V39, P849; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Proudfoot N, 2000, TRENDS BIOCHEM SCI, V25, P290, DOI 10.1016/S0968-0004(00)01591-7; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	18	255	271	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					173	176		10.1016/S0092-8674(01)00202-1	http://dx.doi.org/10.1016/S0092-8674(01)00202-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207359	Bronze			2022-12-28	WOS:000166879700001
J	Marmorstein, LY; Kinev, AV; Chan, GKT; Bochar, DA; Beniya, H; Epstein, JA; Yen, TJ; Shiekhattar, R				Marmorstein, LY; Kinev, AV; Chan, GKT; Bochar, DA; Beniya, H; Epstein, JA; Yen, TJ; Shiekhattar, R			A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression	CELL			English	Article							SUSCEPTIBILITY GENE BRCA2; CHROMOSOME CONDENSATION; OVARIAN-CANCER; NUCLEAR MATRIX; RAD51 PROTEIN; CENP-F; BREAST; MUTATIONS; MICE; INTERACTS	Germline mutations of the human BRCA2 gene confer susceptibility to breast cancer. Although the function of the BRCA2 protein remains to be determined, murine cells homozygous for BRCA2 inactivation display chromosomal aberrations. We have isolated a 2 MDa BRCA2-containing complex and identified a structural DNA binding component, designated as BRCA2-Associated Factor 35 (BRAF35). BRAF35 contains a nonspecific DNA binding HMG domain and a kinesin-like coiled coil domain. Similar to BRCA2, BRAF35 mRNA expression levels in mouse embryos are highest in proliferating tissues with high mitotic index. Strikingly, nuclear staining revealed a close association of BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation. Importantly, antibody microinjection experiments suggest a role for BRCA2/BRAF35 complex in modulation of cell cycle progression.	Wistar Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Cardiovasc, Philadelphia, PA 19104 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	The Wistar Institute; University of Pennsylvania; Fox Chase Cancer Center	Shiekhattar, R (corresponding author), Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.		Kinev, Alexander V/K-3970-2013; Chan, Gordon/AAN-7784-2020; Bochar, Daniel A/A-9224-2009	Chan, Gordon/0000-0003-0497-9407; Yen, Tim/0000-0003-2159-0997				Aguilera A, 2000, YEAST, V16, P731, DOI 10.1002/1097-0061(20000615)16:8<731::AID-YEA586>3.0.CO;2-L; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; COLLINS N, 1995, ONCOGENE, V10, P1673; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; EASTON DF, 1993, AM J HUM GENET, V52, P678; Friedman LS, 1998, CANCER RES, V58, P1338; Goggins M, 1996, CANCER RES, V56, P5360; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; GUDMUNDSSON J, 1995, CANCER RES, V55, P4830; Harlow E., 1988, ANTIBODIES LAB MANUA; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; JENKINS RB, 1993, CANCER GENET CYTOGEN, V71, P76, DOI 10.1016/0165-4608(93)90205-Z; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; LUTZ B, 1994, DEVELOPMENT, V120, P25, DOI 10.1242/dev.120.1.25; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; NICKERSON JA, 1990, P NATL ACAD SCI USA, V87, P2259, DOI 10.1073/pnas.87.6.2259; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Spain BH, 1999, P NATL ACAD SCI USA, V96, P13920, DOI 10.1073/pnas.96.24.13920; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang ZJ, 1999, BRIT J CANCER, V80, P70, DOI 10.1038/sj.bjc.6690323; Wattler F, 1999, GENOMICS, V60, P172, DOI 10.1006/geno.1999.5913; West KL, 1999, NUCLEIC ACIDS RES, V27, P984, DOI 10.1093/nar/27.4.984; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yu VPCC, 2000, GENE DEV, V14, P1400	42	116	119	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					247	257		10.1016/S0092-8674(01)00209-4	http://dx.doi.org/10.1016/S0092-8674(01)00209-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207365	Bronze			2022-12-28	WOS:000166879700008
J	McSween, HY; Grove, TL; Lentz, RCF; Dann, JC; Holzheid, AH; Riciputi, LR; Ryan, JG				McSween, HY; Grove, TL; Lentz, RCF; Dann, JC; Holzheid, AH; Riciputi, LR; Ryan, JG			Geochemical evidence for magmatic water within Mars from pyroxenes in the Shergotty meteorite	NATURE			English	Article							SNC METEORITES; MANTLE; H2O; CONSTRAINTS; SUBDUCTION; ERUPTION; LITHIUM; BORON; MODEL	Observations of martian surface morphology have been used to argue that an ancient ocean once existed on Mars(1). It has been thought that significant quantities of such water could have been supplied to the martian surface through volcanic outgassing, but this suggestion is contradicted by the low magmatic water content that is generally inferred from chemical analyses of igneous martian meteorites(2). Here, however, we report the distributions of trace elements within pyroxenes of the Shergotty meteorite-a basalt body ejected 175 million years ago from Mars(3) - as well as hydrous and anhydrous crystallization experiments that, together, imply that water contents of pre-eruptive magma on Mars could have been up to 1.8%. We found that in the Shergotty meteorite, the inner cores of pyroxene minerals (which formed at depth in the martian crust) are enriched in soluble trace elements when compared to the outer rims (which crystallized on or near to the martian surface). This implies that water was present in pyroxenes at depth but was largely lost as pyroxenes were carried to the surface during magma ascent. We conclude that ascending magmas possibly delivered significant quantities of water to the martian surface in recent times, reconciling geologic and petrologic constraints on the outgassing history of Mars.	Univ Tennessee, Dept Geol Sci, Knoxville, TN 37996 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Oak Ridge Natl Lab, Div Chem & Analyt Sci, Oak Ridge, TN 37831 USA; Univ S Florida, Dept Geol, Tampa, FL 33620 USA	University of Tennessee System; University of Tennessee Knoxville; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Oak Ridge National Laboratory; State University System of Florida; University of South Florida	McSween, HY (corresponding author), Univ Tennessee, Dept Geol Sci, Knoxville, TN 37996 USA.	mcsween@utk.edu	Holzheid, Astrid/S-5513-2018; Grove, Timothy/M-9638-2013	Holzheid, Astrid/0000-0001-5154-9886; Grove, Timothy/0000-0003-0628-1969; Ryan, Jeffrey/0000-0003-3969-1761				ANDERSEN DJ, 1993, COMPUT GEOSCI, V19, P1333, DOI 10.1016/0098-3004(93)90033-2; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Brenan JM, 1998, GEOCHIM COSMOCHIM AC, V62, P3337, DOI 10.1016/S0016-7037(98)00224-5; Hale VPS, 1999, GEOCHIM COSMOCHIM AC, V63, P1459, DOI 10.1016/S0016-7037(99)00095-2; HAMILTON DL, 1964, J PETROL, V5, P21, DOI 10.1093/petrology/5.1.21; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Herd CDK, 2000, METEORIT PLANET SCI, V35, pA70; JOHNSON MC, 1991, GEOCHIM COSMOCHIM AC, V55, P349, DOI 10.1016/0016-7037(91)90423-3; JONES JH, 1989, P LUNAR PLANET SCI C, V19, P465; KARLSSON KR, 1992, SCIENCE, V255, P1409, DOI 10.1126/science.11537889; King PL, 1999, GEOCHIM COSMOCHIM AC, V63, P3635, DOI 10.1016/S0016-7037(99)00162-3; Lodders K, 1997, ICARUS, V126, P373, DOI 10.1006/icar.1996.5653; LONGHI J, 1991, P LUNAR PLANET SCI, V21, P695; McCoy TJ, 1999, EARTH PLANET SC LETT, V173, P397, DOI 10.1016/S0012-821X(99)00241-1; MCKAY G, 2000, LUNAR PLANET SCI, P31; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; MCSWEEN HY, 1993, SCIENCE, V259, P1890, DOI 10.1126/science.259.5103.1890; Minitti ME, 2000, GEOCHIM COSMOCHIM AC, V64, P2535, DOI 10.1016/S0016-7037(00)00366-5; Moore G, 1998, AM MINERAL, V83, P36; Mouginis-Mark P.J., 1992, MARS PP, P424; Mustard JF, 1997, J GEOPHYS RES-PLANET, V102, P25605, DOI 10.1029/97JE02354; Mysen BO, 1998, AM MINERAL, V83, P942; NEAL CR, 1989, GEOCHIM COSMOCHIM AC, V53, P1035, DOI 10.1016/0016-7037(89)90208-1; NEWMAN S, 1988, J VOLCANOL GEOTH RES, V35, P75, DOI 10.1016/0377-0273(88)90007-8; SEYFRIED WE, 1984, GEOCHIM COSMOCHIM AC, V48, P557, DOI 10.1016/0016-7037(84)90284-9; SISSON TW, 1993, CONTRIB MINERAL PETR, V113, P143, DOI 10.1007/BF00283225; STOLPER E, 1979, GEOCHIM COSMOCHIM AC, V43, P1475, DOI 10.1016/0016-7037(79)90142-X; WANKE H, 1994, PHILOS T R SOC A, V349, P285, DOI 10.1098/rsta.1994.0132; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; WILSON L, 1981, J GEOPHYS RES, V86, P2971, DOI 10.1029/JB086iB04p02971	30	157	158	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2001	409	6819					487	490		10.1038/35054011	http://dx.doi.org/10.1038/35054011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206539				2022-12-28	WOS:000166570500040
J	Laurance, WF; Cochrane, MA; Bergen, S; Fearnside, PM; Delamonica, P; Barber, C; D'Angelo, S; Fernandes, T				Laurance, WF; Cochrane, MA; Bergen, S; Fearnside, PM; Delamonica, P; Barber, C; D'Angelo, S; Fernandes, T			Environment - The future of the Brazilian Amazon	SCIENCE			English	Editorial Material							FORESTS; RESPONSES		Smithsonian Trop Res Inst, Balboa, Panama; Natl Inst Amazonian Res, BDFFP, BR-69011970 Manaus, Amazonas, Brazil; Michigan State Univ, BSRSI, E Lansing, MI 48823 USA; Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA; INPA, Dept Ecol, BR-69011970 Manaus, Amazonas, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; Institute Nacional de Pesquisas da Amazonia; Michigan State University; Oregon State University; Institute Nacional de Pesquisas da Amazonia	Laurance, WF (corresponding author), Smithsonian Trop Res Inst, Apartado 2072, Balboa, Panama.		Fearnside, Philip M/D-6559-2011; Laurance, William F/B-2709-2012; Fearnside, Philip M/GQA-6023-2022; Cochrane, Mark A/A-1735-2018	Fearnside, Philip M/0000-0003-3672-9082; Laurance, William F/0000-0003-4430-9408; Fearnside, Philip M/0000-0003-3672-9082; Cochrane, Mark A/0000-0002-4573-568X; Fernandes, Tito/0000-0001-6556-581X				[Anonymous], 2000, DEFORESTATION ESTIMA; FEARNSIDE PM, 1989, BIOSCIENCE, V39, P387, DOI 10.2307/1311068; Fearnside PM, 1999, BIOMASS BIOENERG, V16, P171, DOI 10.1016/S0961-9534(98)00071-3; Fearnside PM, 1997, ECOL ECON, V20, P53, DOI 10.1016/S0921-8009(96)00066-3; Fearnside PM, 2000, CLIMATIC CHANGE, V46, P115, DOI 10.1023/A:1005569915357; GOODMAN G, 1990, FUTURE AMAZONIA DEST; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; Laurance WF, 1998, TRENDS ECOL EVOL, V13, P411, DOI 10.1016/S0169-5347(98)01433-5; Laurance WF, 1999, TRENDS ECOL EVOL, V14, P457, DOI 10.1016/S0169-5347(99)01731-0; Nepstad D., 1999, FLAMES RAIN FOREST O; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439	12	556	593	6	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2001	291	5503					438	439		10.1126/science.291.5503.438	http://dx.doi.org/10.1126/science.291.5503.438			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11228139				2022-12-28	WOS:000166487500023
J	Hamano, H; Kawa, S; Horiuchi, A; Unno, H; Furuya, N; Akamatsu, T; Fukushima, M; Nikaido, T; Nakayama, K; Usuda, N; Kiyosawa, K				Hamano, H; Kawa, S; Horiuchi, A; Unno, H; Furuya, N; Akamatsu, T; Fukushima, M; Nikaido, T; Nakayama, K; Usuda, N; Kiyosawa, K			High serum IgG4 concentrations in patients with sclerosing pancreatitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOIMMUNE CHRONIC-PANCREATITIS; MEMBRANOUS NEPHROPATHY; PEMPHIGUS-VULGARIS; IMMUNE-COMPLEXES; STEROID-THERAPY; CHOLANGITIS; DISEASE; AUTOANTIBODIES; SUBCLASSES; ANTIBODIES	Background: Sclerosing pancreatitis is a unique form of pancreatitis that is characterized by irregular narrowing of the main pancreatic duct, lymphoplasmacytic inflammation of the pancreas, and hypergammaglobulinemia and that responds to glucocorticoid treatment. Preliminary studies suggested that serum IgG4 concentrations are elevated in this disease but not in other diseases of the pancreas or biliary tract. Methods: We measured serum IgG4 concentrations using single radial immunodiffusion and an enzyme-linked immunosorbent assay in 20 patients with sclerosing pancreatitis, 20 age- and sex-matched normal subjects, and 154 patients with pancreatic cancer, ordinary chronic pancreatitis, primary biliary cirrhosis, primary sclerosing cholangitis, or Sjogren's syndrome. Serum concentrations of immune complexes and the IgG4 subclass of immune complexes were determined by means of an enzyme-linked immunosorbent assay with monoclonal rheumatoid factor. Results: The median serum IgG4 concentration in the patients with sclerosing pancreatitis was 663 mg per deciliter (5th and 95th percentiles, 136 and 1150), as compared with 51 mg per deciliter (5th and 95th percentiles, 15 and 128) in normal subjects (P<0.001). The serum IgG4 concentrations in the other groups of patients were similar to those in the normal subjects. In patients with sclerosing pancreatitis, serum concentrations of immune complexes and the IgG4 subclass of immune complexes were significantly higher before glucocorticoid therapy than after four weeks of such therapy. Glucocorticoid therapy induced clinical remissions and significantly decreased serum concentrations of IgG4, immune complexes, and the IgG4 subclass of immune complexes. Conclusions: Patients with sclerosing pancreatitis have high serum IgG4 concentrations, providing a useful means of distinguishing this disorder from other diseases of the pancreas or biliary tract. (N Engl J Med 2001;344:732-8.) Copyright (C) 2001 Massachusetts Medical Society.	Shinshu Univ, Sch Med, Dept Internal Med 2, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Obstet & Gynecol, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Organ Generat, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Anat, Matsumoto, Nagano 3908621, Japan; Fujita Hlth Univ, Sch Med, Dept Anat, Toyoake, Aichi 47011, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University; Shinshu University; Fujita Health University	Kawa, S (corresponding author), Shinshu Univ, Sch Med, Dept Internal Med 2, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.							AALBERSE RC, 1993, ALLERGY, V48, P559, DOI 10.1111/j.1398-9995.1993.tb00749.x; BHOL K, 1994, DERMATOLOGY, V189, P85, DOI 10.1159/000246938; Ding X, 1999, J INVEST DERMATOL, V112, P739, DOI 10.1046/j.1523-1747.1999.00585.x; DOI T, 1991, NEPHRON, V57, P131, DOI 10.1159/000186239; EPSTEIN O, 1982, GASTROENTEROLOGY, V83, P1177; Erkelens GW, 1999, LANCET, V354, P43, DOI 10.1016/S0140-6736(99)00603-0; GABRIEL A, 1977, J CLIN INVEST, V59, P990, DOI 10.1172/JCI108722; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayashibara Hiroshi, 1993, Acta Paediatrica Japonica, V35, P113; Horiuchi A, 1996, AM J GASTROENTEROL, V91, P2607; Horiuchi A, 1998, AM J GASTROENTEROL, V93, P260, DOI 10.1016/S0002-9270(97)00067-1; HUSSAIN R, 1992, J IMMUNOL, V148, P2731; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; Ito T, 1997, DIGEST DIS SCI, V42, P1458, DOI 10.1023/A:1018862626221; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; MONTEFUSCO PP, 1984, AM J SURG, V147, P822, DOI 10.1016/0002-9610(84)90212-5; Motoo Y, 1997, INT J PANCREATOL, V21, P85; NAKANO S, 1978, AM J DIG DIS, V23, P75; OKAZAKI K, 1986, GASTROENTEROLOGY, V91, P409, DOI 10.1016/0016-5085(86)90576-7; Oliveira DBG, 1998, LANCET, V351, P670, DOI 10.1016/S0140-6736(97)04122-6; ROCK B, 1989, NEW ENGL J MED, V320, P1463, DOI 10.1056/NEJM198906013202206; Rosner B., 2010, FUNDAMENTALS BIOSTAT; SARLES H, 1961, AM J DIG DIS, V6, P688, DOI 10.1007/BF02232341; SARLES H, 1965, GUT, V6, P545, DOI 10.1136/gut.6.6.545; SHIRAKATA Y, 1990, Journal of Dermatology (Tokyo), V17, P661; SJOGREN I, 1979, ACTA MED SCAND, V205, P139; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415; vanGulik TM, 1997, GASTROINTEST ENDOSC, V46, P417, DOI 10.1016/S0016-5107(97)70034-8; Wakabayashi T, 1998, DIGEST DIS SCI, V43, P2415, DOI 10.1023/A:1026621913192; WALDRAM R, 1975, LANCET, V1, P550; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; ZWEIG MH, 1993, CLIN CHEM, V39, P561; ZWEIG MH, 1993, CLIN CHEM, V39, P1589	33	1804	1956	7	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2001	344	10					732	738		10.1056/NEJM200103083441005	http://dx.doi.org/10.1056/NEJM200103083441005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408AX	11236777				2022-12-28	WOS:000167305300005
J	Foch, M; Banys, P				Foch, M; Banys, P			Liver transplantation and opioid dependence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C VIRUS-INFECTION; HEPATITIS-C; UNITED-STATES; DRUG-USERS; CIRRHOSIS; OUTCOMES	Context Chronic hepatitis C is the leading cause for liver transplantation in the United States. Intravenous drug use, the major risk factor, accounts for approximately 60% of hepatitis C virus transmission. Information from the United Network of Organ Sharing (UNOS) does not address substance use among liver transplantation patients. Objective To identify addiction-related criteria for admission to the UNOS liver trans plantation waiting list and posttransplantation problems experienced by patients who are prescribed maintenance methadone. Design, Setting, and Participants Mail survey of all 97 adult US liver transplantation programs (belonging to UNOS) in March 2000 with telephone follow-up conducted in May and June 2000. Main Outcome Measures Programs' acceptance and management of patients with past or present substance use disorder. Results Of the 97 programs surveyed, 87 (90%) responded. All accept applicants with a history of alcoholism or other addictions, including heroin dependence. Eighty eight percent of the responding programs require at least 6 months of abstinence from alcohol; 83% from illicit drugs. Ninety-four percent have addiction treatment requirements. Consultations from substance abuse specialists are obtained by 86%. Patients receiving methadone maintenance are accepted by 56% of the responding programs. Approximately 180 patients receiving methadone maintenance are reported to have undergone liver transplantation. Conclusions Most liver transplantation programs have established policies for patients with substance use disorders. Opiate-dependent patients receiving opiate replacement therapy seem underrepresented in transplantation programs. Little anecdotal evidence for negative impact of opiate replacement therapy on liver transplantation outcome was found. Policies requiring discontinuation of methadone in 32% of all programs contradict the evidence base for efficacy of long-term replacement therapies and potentially result in relapse of previously stable patients.	Vet Affairs Med Ctr, Mental Hlth Serv, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Banys, P (corresponding author), Vet Affairs Med Ctr, Mental Hlth Serv, 116-E,4150 Clement St, San Francisco, CA 94121 USA.				NIDA NIH HHS [P50DA09253] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA009253] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alter MJ, 1999, J HEPATOL, V31, P88, DOI 10.1016/S0168-8278(99)80381-X; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Alter MJ, 1998, J ACQ IMMUN DEF SYND, V18, pS6, DOI 10.1097/00042560-199802001-00003; Ball J.C., 2012, EFFECTIVENESS METHAD; Berlakovich GA, 2000, TRANSPLANT INT, V13, P129, DOI 10.1007/s001470050298; Bonis PAL, 1999, AM J GASTROENTEROL, V94, P1605, DOI 10.1111/j.1572-0241.1999.01151.x; CHETWYND J, 1995, NEW ZEAL MED J, V108, P364; De Maria N, 1998, HEPATO-GASTROENTEROL, V45, P1364; DOHERTY B, 2001, AM METH TREATM ORG N; GORDON MJ, 1987, TRANSPLANTATION, V43, P459; GORDON MJV, 1986, TRANSPLANTATION, V42, P556; Hebert MF, 1997, ADV DRUG DELIVER REV, V27, P201, DOI 10.1016/S0169-409X(97)00043-4; Hu KQ, 1999, HEPATOLOGY, V29, P1311, DOI 10.1002/hep.510290424; KREEK MJ, 1992, RES P ARNMD, V70, P205; KREEK MJ, 1972, ANN INTERN MED, V77, P598, DOI 10.7326/0003-4819-77-4-598; LEVENSON JL, 1993, PSYCHOSOMATICS, V34, P314, DOI 10.1016/S0033-3182(93)71865-4; Lucey MR, 1997, HEPATOLOGY, V25, P1223, DOI 10.1002/hep.510250526; MOODY DE, 1997, DRUG METAB DISPOS, V25, P147; *NAT I DRUG AB, 1997, PUBL NAT I DRUG AB; *NIH CONS DEV C LI, 1984, HEPATOLOGY, V4, pS1; *NIH CONS STAT, 2001, EFF MED TREATM OP AD; O'Connor PG, 2000, ANN INTERN MED, V133, P40, DOI 10.7326/0003-4819-133-1-200007040-00008; Pageaux GP, 1999, GUT, V45, P421, DOI 10.1136/gut.45.3.421; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; STEVENS J, 1983, SURG GYNECOL OBSTET, V156, P651; Van Thiel D H, 1999, Forum (Genova), V9, P157	26	45	45	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2001	285	8					1056	1058		10.1001/jama.285.8.1056	http://dx.doi.org/10.1001/jama.285.8.1056			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403ME	11209177	Bronze			2022-12-28	WOS:000167046400028
J	Steiner, A; Walsh, B; Pickering, RM; Wiles, R; Ward, J; Brooking, JI				Steiner, A; Walsh, B; Pickering, RM; Wiles, R; Ward, J; Brooking, JI		Southampton NLU Evaluation Team	Therapeutic nursing or unblocking beds? A randomised controlled trial of a post-acute intermediate care unit	BRITISH MEDICAL JOURNAL			English	Article								Objectives To compare post-acute intermediate care in an inpatient nurse-led unit with conventional post-acute care on general medical wards of an acute hospital and to examine the model of care in a nurse-led unit. Design Randomised controlled trial with six month follow up. Setting Urban teaching hospital and surrounding area, including nine community hospitals. Participants 238 patients accepted for admission to nurse-led unit. Interventions Care in nurse-led unit or usual pest-acute care. Main outcome measures Patients' length of stay, functional status, subsequent move to more dependent living arrangement. Results Inpatient length of stay was significantly longer in the nurse-led unit than in general medical wards (14.3 days longer (95% confidence interval 7.8 to 20.7)), but this difference became non-significant when transfers to community hospitals were included in the measure of initial length of stay (4.5 days longer (- 3.6 to 12.5)). No differences were observed in mortality, functional status, or living arrangements at any time. Patients in the nurse-led unit received significantly fewer minor medical investigations and, after controlling for length of stay, significantly fewer major reviews, tests, or drug changes. Conclusions The nurse-led unit seemed to be a safe alternative to conventional management, but a full accounting of such units' place. in the local continuum of care and the costs associated with acute hospitals managing post-acute patients is needed if nurse-led units are to become an effective part of the government's recent commitment to intermediate care.	Univ Southampton, Dept Geriatr Med, Southampton SO17 1BJ, Hants, England; Univ Southampton, Dept Social Work Studies, Southampton SO17 1BJ, Hants, England; Univ Southampton, Sch Nursing & Midwifery, Southampton SO17 1BJ, Hants, England; Southampton Gen Hosp, Hlth Care Res Unit, Med Stat Grp, Southampton SO16 6YD, Hants, England; Univ Southampton, Sch Hlth Profess & Rehabil Sci, Southampton SO9 5NH, Hants, England; Southampton Gen Hosp, Dept Geriatr Med, Elderly Care Res Unit, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton; University of Southampton; University of Southampton	Steiner, A (corresponding author), Univ Calif Santa Cruz, Dept Community Studies, 1156 High St, Santa Cruz, CA 95064 USA.			Walsh, Bronagh/0000-0003-1008-0545				Alfano G J, 1969, Nurs Clin North Am, V4, P487; Altman DG, 1995, EUR J CANCER, V31A, P1934, DOI 10.1016/0959-8049(95)00470-X; *AUD COMM, 2000, WAY GO HOM REH REM S; Audit Commission, 1997, COM AG IMPR CAR SERV; Department of Health, 2000, NHS PLAN PLAN INV PL; EVANS A, 1994, DEV NURSING LED IN P; Griffiths P, 2000, INT J NURS STUD, V37, P153, DOI 10.1016/S0020-7489(99)00061-9; Griffiths P, 1998, J ADV NURS, V27, P1184, DOI 10.1046/j.1365-2648.1998.00655.x; GRIFFITHS P, 1995, EVALUATION NURSING L; HALL LE, 1975, LONGITUDINAL EFFECTS; LIPLEY N, 2000, NURS STAND, V14, P5; PEARSON A, 1983, CLIN NURSING UNIT; PEARSON A, 1992, NURSING BEDS EVALUAT; PEARSON A, 1988, PRIMARY NURSING BURF; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Resau L S, 1995, J Neurosci Nurs, V27, P57; STEINER A, IN PRESS AGE AGEING; Steiner A, 1997, INTERMEDIATE CARE CO; VAUGHAN B, 1999, INTERMEDIATE CAR MOD; WALSH B, 1999, J CLIN EFFECTIVENESS, V3, P88; WOODDAUPHINEE S, 1987, J CHRON DIS, V40, P491, DOI 10.1016/0021-9681(87)90005-1; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203	22	43	43	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	2001	322	7284					453	459		10.1136/bmj.322.7284.453	http://dx.doi.org/10.1136/bmj.322.7284.453			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406YD	11222419	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000167243000015
J	Fries, P; Reynolds, JH; Rorie, AE; Desimone, R				Fries, P; Reynolds, JH; Rorie, AE; Desimone, R			Modulation of oscillatory neuronal synchronization by selective visual attention	SCIENCE			English	Article							FIELD POTENTIAL OSCILLATIONS; CORTICAL AREAS; NEURAL MECHANISMS; CORTEX; RESPONSES; V4; MODEL; V2; ACTIVATION; STIMULUS	In crowded visual scenes, attention is needed to select relevant stimuli. To study the underlying mechanisms, we recorded neurons in cortical area V4 while macaque monkeys attended to behaviorally relevant stimuli and ignored distracters. Neurons activated by the attended stimulus showed increased gamma-frequency (35 to 90 hertz) synchronization but reduced low-frequency (<17 hertz) synchronization compared with neurons at nearby V4 sites activated by distracters. Because postsynaptic integration times;are short, these Localized changes in synchronization may serve to amplify behaviorally relevant signals in the cortex.	NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Salk Institute	Fries, P (corresponding author), NIMH, Neuropsychol Lab, NIH, Bldg 49,Room 1B80,9000 Rpckville Pike, Bethesda, MD 20892 USA.		Desimone, Robert/G-1121-2018; Fries, Pascal/E-3196-2010	Fries, Pascal/0000-0002-4270-1468	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002036] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmed B, 1998, CEREB CORTEX, V8, P462, DOI 10.1093/cercor/8.5.462; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; Crick F., 1990, Seminars in the Neurosciences, V2, P263; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; FROST JD, 1967, ELECTROEN CLIN NEURO, V23, P89; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Makeig S, 1996, COGNITIVE BRAIN RES, V4, P15, DOI 10.1016/0926-6410(95)00042-9; Maldonado PE, 2000, CEREB CORTEX, V10, P1117, DOI 10.1093/cercor/10.11.1117; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; NIEBUR E, 1993, VISION RES, V33, P2789, DOI 10.1016/0042-6989(93)90236-P; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; TREUE S, 2000, 30 ANN M SOC NEUR NE; Worden MS, 2000, J NEUROSCI, V20	34	1919	1946	1	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1560	1563		10.1126/science.1055465	http://dx.doi.org/10.1126/science.1055465			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222864				2022-12-28	WOS:000167153400049
J	Sato, T; Kamiyama, T; Takahashi, T; Kurahashi, K; Yamada, K				Sato, T; Kamiyama, T; Takahashi, T; Kurahashi, K; Yamada, K			Observation of d(x2-y2)-like superconducting gap in an electron-doped high-temperature superconductor	SCIENCE			English	Article							ANGLE-RESOLVED PHOTOEMISSION; FERMI-SURFACE; QUASI-PARTICLES; ANISOTROPY; STATE; SPECTROSCOPY; BEHAVIOR	High-resolution angle-resolved photoemission spectroscopy of the electron-doped high-temperature superconductor Nd2-xCexCuO4 (x = 0.15, transition temperature T-c = 22 K) has found the quasiparticle signature as well as the anisotropic d(x2-y2)-like superconducting gap. The spectral line shape at the superconducting state shows a strong anisotropic nature of the many-body interaction. The result suggests that the electron-hole symmetry is present in the high-temperature superconductors.	Kyoto Univ, Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Kyoto University; Tohoku University	Takahashi, T (corresponding author), Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan.	t.takahashi@msp.phys.tohoku.ac.jp	Yamada, Kazuyoshi/C-2728-2009; Tohoku, Arpes/A-4890-2010; Takahashi, Takashi T/E-5080-2010; Sato, Takafumi/E-5094-2010	Sato, Takafumi/0000-0002-4544-5463				Alff L, 1999, PHYS REV LETT, V83, P2644, DOI 10.1103/PhysRevLett.83.2644; ANDERSON RO, 1993, PHYS REV LETT, V70, P3163, DOI 10.1103/PhysRevLett.70.3163; ANDREONE A, 1994, PHYS REV B, V49, P6392, DOI 10.1103/PhysRevB.49.6392; Bogdanov PV, 2000, PHYS REV LETT, V85, P2581, DOI 10.1103/PhysRevLett.85.2581; Borisenko SV, 2000, PHYS REV LETT, V84, P4453, DOI 10.1103/PhysRevLett.84.4453; Ding H, 1996, PHYS REV B, V54, pR9678, DOI 10.1103/PhysRevB.54.R9678; DING H, 1995, PHYS REV LETT, V74, P2784, DOI 10.1103/PhysRevLett.74.2784; Fedorov AV, 1999, PHYS REV LETT, V82, P2179, DOI 10.1103/PhysRevLett.82.2179; Fretwell HM, 2000, PHYS REV LETT, V84, P4449, DOI 10.1103/PhysRevLett.84.4449; GUNNARSSON O, 1990, PHYS REV B, V42, P8707, DOI 10.1103/PhysRevB.42.8707; Hayashi F, 1998, J PHYS SOC JPN, V67, P3234, DOI 10.1143/JPSJ.67.3234; HUANG Q, 1990, NATURE, V347, P369, DOI 10.1038/347369a0; Kaminski A, 2000, PHYS REV LETT, V84, P1788, DOI 10.1103/PhysRevLett.84.1788; Kashiwaya S, 1998, PHYS REV B, V57, P8680, DOI 10.1103/PhysRevB.57.8680; KING DM, 1994, PHYS REV LETT, V73, P3298, DOI 10.1103/PhysRevLett.73.3298; Kokales JD, 2000, PHYS REV LETT, V85, P3696, DOI 10.1103/PhysRevLett.85.3696; Mesot J, 1999, PHYS REV LETT, V83, P840, DOI 10.1103/PhysRevLett.83.840; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Norman MR, 1997, PHYS REV LETT, V79, P3506, DOI 10.1103/PhysRevLett.79.3506; Parks R., 1969, SUPERCONDUCTIVITY; Prozorov R, 2000, PHYS REV LETT, V85, P3700, DOI 10.1103/PhysRevLett.85.3700; SAKISAKA Y, 1990, PHYS REV B, V42, P4189, DOI 10.1103/PhysRevB.42.4189; SHEN ZX, 1993, PHYS REV LETT, V70, P1553, DOI 10.1103/PhysRevLett.70.1553; TOKURA Y, 1989, NATURE, V337, P345, DOI 10.1038/337345a0; Tsuei CC, 2000, PHYS REV LETT, V85, P182, DOI 10.1103/PhysRevLett.85.182; Valla T, 1999, SCIENCE, V285, P2110, DOI 10.1126/science.285.5436.2110; WU DH, 1993, PHYS REV LETT, V70, P85, DOI 10.1103/PhysRevLett.70.85	27	97	99	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1517	1519		10.1126/science.1058021	http://dx.doi.org/10.1126/science.1058021			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222851				2022-12-28	WOS:000167153400036
J	Stryker, MP				Stryker, MP			Neuroscience - Drums keep pounding a rhythm in the brain	SCIENCE			English	Editorial Material							VISUAL-CORTEX; ATTENTION; RESPONSES		Univ Calif San Francisco, Dept Physiol, Keck Ctr Integrat Neurosci, San Francisco, CA 94943 USA	University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, Dept Physiol, Keck Ctr Integrat Neurosci, San Francisco, CA 94943 USA.	stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831	NATIONAL EYE INSTITUTE [R37EY002874] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY002874, R37 EY002874-22] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CRICK F, 1990, COLD SH Q B, V55, P953; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; FOX K, 1990, J NEUROPHYSIOL, V64, P1413, DOI 10.1152/jn.1990.64.5.1413; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; STRYKER MP, 1989, NATURE, V338, P297, DOI 10.1038/338297a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	12	8	8	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1506	1507		10.1126/science.291.5508.1506	http://dx.doi.org/10.1126/science.291.5508.1506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11234083	Green Accepted			2022-12-28	WOS:000167153400034
J	Aldiss, BW				Aldiss, BW			Desperately seeking aliens	NATURE			English	Editorial Material								Belief that intelligent life is commonplace in the Universe was taken for granted by scholars and scientists until well into the nineteenth century. Space travel since the late 1950s reignited the debate, which even now attracts discussion by serious, professional scientists. And although statisticians might lobby that life must surely exist somewhere in the Universe, the evolution of what we perceive as 'intelligent life' seems utterly improbable - elsewhere as well as on Earth. Can we free ourselves of our animist fantasies and accept that all alien forms of intelligent life are, and always have been, imaginary?.			Aldiss, BW (corresponding author), 39 St Andrews Rd, Oxford OX3 9DL, England.							Arrhenius S, 1918, DESTINIES STARS; Barrow J., 1998, ANTHROPIC COSMOLOGIC; BARROW JD, 1986, ANTHR COSMOLOGICAL P; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; Gove PB., 1941, IMAGINARY VOYAGE PRO; Heidmann J., 1995, EXTRATERRESTRIAL INT; LOTT SM, 1956, ESCAPE VENUS; Lovejoy C.O., 1981, LIFE UNIVERSE; MAYR E, 1982, COMMUNICATION    DEC; NICOLSON MH, 1960, VOYAGES MOON; Ward P., 2000, RARE EARTH WHY COMPL; WHEWELL W, 1855, PLURALITY WORLDS	12	2	2	1	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1080	1082		10.1038/35059207	http://dx.doi.org/10.1038/35059207			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234021				2022-12-28	WOS:000167148800055
J	Harlow, HJ; Lohuis, T; Beck, TDI; Iaizzo, PA				Harlow, HJ; Lohuis, T; Beck, TDI; Iaizzo, PA			Muscle strength in overwintering bears - Unlike humans, bears retain their muscle tone when moribund for long periods.	NATURE			English	Article							SKELETAL-MUSCLE; WINTER SLEEP; IMMOBILIZATION; METABOLISM		Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; Colorado Div Wildlife, Dolores, CO 81323 USA; Univ Minnesota, Dept Anesthesiol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Physiol, Minneapolis, MN 55455 USA	University of Wyoming; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Harlow, HJ (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.							Berg HE, 1997, J APPL PHYSIOL, V82, P182, DOI 10.1152/jappl.1997.82.1.182; BOOTH FW, 1973, PFLUG ARCH EUR J PHY, V342, P231, DOI 10.1007/BF00591371; Brass TJ, 1996, J MED ENG TECHNOL, V20, P67, DOI 10.3109/03091909609008382; MUSACCHIA XJ, 1983, AVIAT SPACE ENVIR MD, V54, P1015; NELSON RA, 1975, MAYO CLIN PROC, V50, P141; NELSON RA, 1973, AM J PHYSIOL, V224, P491, DOI 10.1152/ajplegacy.1973.224.2.491; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; NICKS DK, 1989, J ANAT, V163, P1; QUINLAN JG, 1989, MUSCLE NERVE, V12, P119, DOI 10.1002/mus.880120206; SIGG MD, 1998, PROGR ANESTHESIOL, V12, P127; Tinker DB, 1998, PHYSIOL ZOOL, V71, P414, DOI 10.1086/515429	11	120	125	1	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					997	997		10.1038/35059165	http://dx.doi.org/10.1038/35059165			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234052	Bronze			2022-12-28	WOS:000167148800030
J	Balkwill, F; Mantovani, A				Balkwill, F; Mantovani, A			Inflammation and cancer: back to Virchow?	LANCET			English	Review							TUMOR-NECROSIS-FACTOR; HUMAN OVARIAN-CANCER; HODGKINS-LYMPHOMA; MULTIPLE-MYELOMA; BREAST-CARCINOMA; FACTOR-ALPHA; EXPRESSION; CELLS; CHEMOATTRACTANT; MICE	The response of the body to a cancer is not a unique mechanism but has many parallels with inflammation and wound healing, This article reviews the links between cancer and inflammation and discusses the implications of these links for cancer prevention and treatment. We suggest that the inflammatory cells and cytokines found in tumours are more likely to contribute to tumour growth, progression, and immunosuppression than they are to mount an effective host antitumour response, Moreover cancer susceptibility and severity may be associated with functional polymorphisms of inflammatory cytokine genes, and deletion or inhibition of inflammatory cytokines inhibits development of experimental cancer. If genetic damage is the "match that lights the fire" of cancer, some types of inflammation may provide the "fuel that feeds the flames". Over the past ten years Information about the cytokine and chemokine network has led to development of a range of cytokine/chemokine antagonists targeted at: inflammatory and allergic diseases, The first of these to enter the clinic, tumour necrosis factor antagonists, have shown encouraging efficacy. In this article we have provided a rationale for the use of cytokine and chemokine blockade, and further investigation of non-steroidal anti-inflammatory drugs, in the chemoprevention and treatment of malignant diseases.	St Bartholomews & Royal London Sch Med & Dent, Imperial Canc Res Fund, Translat Oncol Lab, London EC1M 6BQ, England; Milan State Univ, Inst Gen Pathol, Milan, Italy; Ist Ric Farmacol Mario Negri, Dept Immunol & Cell Biol, Milan, Italy	Cancer Research UK; University of London; Queen Mary University London; University of Milan; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Balkwill, F (corresponding author), St Bartholomews & Royal London Sch Med & Dent, Imperial Canc Res Fund, Translat Oncol Lab, Charterhouse Sq, London EC1M 6BQ, England.		Mantovani, Alberto/HCI-7449-2022; Sroka, Isis C/A-2949-2009; Califano, Andrea/F-7239-2012	Mantovani, Alberto/0000-0001-5578-236X; Balkwill, Frances/0000-0002-5587-9759				Allavena P, 2000, IMMUNOL REV, V177, P141, DOI 10.1034/j.1600-065X.2000.17714.x; Barber MD, 2000, BRIT J CANCER, V83, P1443, DOI 10.1054/bjoc.2000.1479; BATAILLE R, 1995, BLOOD, V86, P685, DOI 10.1182/blood.V86.2.685.bloodjournal862685; Burke F, 1996, CYTOKINE, V8, P578, DOI 10.1006/cyto.1996.0077; Cossman J, 1999, BLOOD, V94, P411, DOI 10.1182/blood.V94.2.411; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Endres MJ, 1999, J EXP MED, V189, P1993, DOI 10.1084/jem.189.12.1993; Gambacorti-Passerini C, 2000, JNCI-J NATL CANCER I, V92, P1641, DOI 10.1093/jnci/92.20.1641; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gulumian M, 1999, MOL CELL BIOCHEM, V196, P69, DOI 10.1023/A:1006918212866; HANGHNEGAHDAR H, 2000, J LEUKOCYTE BIOL, V67, P53; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jaiswal M, 2000, CANCER RES, V60, P184; Keane M P, 1999, Chem Immunol, V72, P86, DOI 10.1159/000058728; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; KOMORI A, 1993, CANCER RES, V53, P1982; Koong AC, 2000, CANCER RES, V60, P883; Korner H, 2000, J EXP MED, V191, P89, DOI 10.1084/jem.191.1.89; Langman MJS, 2000, BRIT MED J, V320, P1642, DOI 10.1136/bmj.320.7250.1642; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Leek RD, 1998, BRIT J CANCER, V77, P2246, DOI 10.1038/bjc.1998.373; Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4; Luboshits G, 1999, CANCER RES, V59, P4681; Maini RN, 2000, ANNU REV MED, V51, P207, DOI 10.1146/annurev.med.51.1.207; MALIK STA, 1990, EUR J CANCER, V26, P1031, DOI 10.1016/0277-5379(90)90044-T; MALIK STA, 1989, INT J CANCER, V44, P918, DOI 10.1002/ijc.2910440529; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Mazzucchelli L, 1999, J CLIN INVEST, V104, pR49, DOI 10.1172/JCI7830; MEDRANO EE, 1993, P NATL ACAD SCI USA, V90, P1790, DOI 10.1073/pnas.90.5.1790; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; NAYLOR MS, 1993, J CLIN INVEST, V91, P2194, DOI 10.1172/JCI116446; Negus RPM, 1997, AM J PATHOL, V150, P1723; NEGUS RPM, 1995, J CLIN INVEST, V95, P2391, DOI 10.1172/JCI117933; O'Byrne KJ, 2000, EUR J CANCER, V36, P151, DOI 10.1016/S0959-8049(99)00241-5; Oh BR, 2000, J UROLOGY, V163, P1584, DOI 10.1016/S0022-5347(05)67683-5; OPDENAKKER G, 1992, IMMUNOL TODAY, V13, P463, DOI 10.1016/0167-5699(92)90079-M; PADURA IM, 1991, CANCER RES, V51, P2239; Parkin D, 1999, INFECT HUMAN CANC; Peng LM, 1997, CANCER RES, V57, P4849; Pinedo HM, 1998, LANCET, V352, P1775, DOI 10.1016/S0140-6736(98)05095-8; Reddy BS, 1996, CANCER RES, V56, P4566; Roberts RA, 1999, CARCINOGENESIS, V20, P1397, DOI 10.1093/carcin/20.8.1397; Robertson FM, 1996, CARCINOGENESIS, V17, P1719, DOI 10.1093/carcin/17.8.1719; RUTLEDGE BJ, 1995, J IMMUNOL, V155, P4838; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Sica A, 2000, J IMMUNOL, V164, P733, DOI 10.4049/jimmunol.164.2.733; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; SNYDERMAN R, 1984, IMMUNOL TODAY, V5, P240, DOI 10.1016/0167-5699(84)90097-5; Sozzani S, 1998, BLOOD, V92, P4036, DOI 10.1182/blood.V92.11.4036.423k17_4036_4039; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; THUN MJ, 1993, CANCER RES, V53, P1322; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; Tricot G, 2000, LANCET, V355, P248, DOI 10.1016/S0140-6736(00)00019-2; van den Berg A, 1999, AM J PATHOL, V154, P1685, DOI 10.1016/S0002-9440(10)65424-7; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; Vidal-Vanaclocha F, 2000, P NATL ACAD SCI USA, V97, P734, DOI 10.1073/pnas.97.2.734; Wang JM, 1998, INT J CANCER, V75, P900, DOI 10.1002/(SICI)1097-0215(19980316)75:6<900::AID-IJC13>3.0.CO;2-6; Warzocha K, 1998, BLOOD, V91, P3574; Warzocha K, 1997, J CLIN ONCOL, V15, P499, DOI 10.1200/JCO.1997.15.2.499	65	5592	5895	20	688	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					539	545		10.1016/S0140-6736(00)04046-0	http://dx.doi.org/10.1016/S0140-6736(00)04046-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229684				2022-12-28	WOS:000167011700027
J	Edwards, MH; Kurras, GJ; Tolstoy, M; Bohnenstiehl, DR; Coakley, BJ; Cochran, JR				Edwards, MH; Kurras, GJ; Tolstoy, M; Bohnenstiehl, DR; Coakley, BJ; Cochran, JR			Evidence of recent volcanic activity on the ultraslow-spreading Gakkel ridge	NATURE			English	Article							OCEANIC CRUSTAL THICKNESS; MID-ATLANTIC RIDGE; EAST PACIFIC RISE; ARCTIC-OCEAN; SATELLITE ALTIMETRY; RIFT-VALLEY; LAVA-FIELD; GRAVITY	Seafloor spreading is accommodated by volcanic and tectonic processes along the global mid-ocean ridge system. As spreading rate decreases the influence of volcanism also decreases(1-4), and it is unknown whether significant volcanism occurs at all at ultraslow spreading rates (<1.5 cm yr(-1)). Here we present three-dimensional sonar maps of the Gakkel ridge, Earth's slowest-spreading mid-ocean ridge, located in the Arctic basin under the Arctic Ocean ice canopy. We acquired this data using hull-mounted sonars attached to a nuclear-powered submarine, the USS Hawkbill. Sidescan data for the ultraslow-spreading (<similar to>1.0 cm yr(-1)) eastern Gakkel ridge depict two young volcanoes covering approximately 720 km(2) of an otherwise heavily sedimented axial valley. The western volcano coincides with the average location of epicentres for more than 250 teleseismic events detected(5,26) in 1999, suggesting that an axial eruption was imaged shortly after its occurrence. These findings demonstrate that eruptions along the ultraslow-spreading Gakkel ridge are focused at discrete locations and appear to be more voluminous and occur more frequently than was previously thought.	Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Geol & Geophys, Honolulu, HI 96822 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Tulane Univ, Dept Geol, New Orleans, LA 70118 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Columbia University; Tulane University	Edwards, MH (corresponding author), Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, POST 815, Honolulu, HI 96822 USA.							BALLARD RD, 1977, GEOL SOC AM BULL, V88, P507, DOI 10.1130/0016-7606(1977)88<507:MATOTI>2.0.CO;2; BOWN JW, 1994, EARTH PLANET SC LETT, V121, P435, DOI 10.1016/0012-821X(94)90082-5; CHADWICK WW, 1991, NATURE, V350, P416, DOI 10.1038/350416a0; Chayes D.N., 1998, EOS T AM GEOPHYS UN, V79, pF854; CHEN YJ, 1992, GEOPHYS RES LETT, V19, P753, DOI 10.1029/92GL00161; Coakley BJ, 1998, EARTH PLANET SC LETT, V162, P81, DOI 10.1016/S0012-821X(98)00158-7; COLES RL, 1990, ARCTIC OCEAN REGION, V1, P119; Crane K, 1997, MAR GEOPHYS RES, V19, P319, DOI 10.1023/A:1004298425881; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; Hall LS, 1996, EARTH PLANET SC LETT, V142, P241, DOI 10.1016/0012-821X(96)00089-1; JOHNSON HP, 1990, REV GEOPHYS, V28, P357, DOI 10.1029/RG028i004p00357; KRISTOFFERSEN Y, 1982, TECTONOPHYSICS, V89, P161, DOI 10.1016/0040-1951(82)90037-3; LAXON S, 1994, SCIENCE, V265, P621, DOI 10.1126/science.265.5172.621; MACDONALD KC, 1989, GEOLOGY, V17, P212, DOI 10.1130/0091-7613(1989)017<0212:AKRELF>2.3.CO;2; MCALLISTER E, 1996, GEOL SOC SPEC PUBL, V188, P29; Muller C., 2000, EOS T AM GEOPHYS UN, V81, P265, DOI [10.1029/00EO00186, DOI 10.1029/00EO00186]; REID I, 1981, MAR GEOPHYS RES, V5, P165; Simkin T, 1970, Science, V169, P429, DOI 10.1126/science.169.3944.429; Smith DK, 1999, J GEOPHYS RES-SOL EA, V104, P25379, DOI 10.1029/1999JB900177; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; SPARKS DW, 1993, J GEOPHYS RES-SOL EA, V98, P21977, DOI 10.1029/93JB02397; STEIN RS, 1991, J GEOPHYS RES-SOL EA, V96, P21789, DOI 10.1029/91JB02118; THIEDE J, 1990, ARCTIC OCEAN REGION, V1, P427; TOLSTOY M, 2000, EOS, V81, pF1346; URICK RJ, 1983, PRINCIPLES UNDERWATE, P136; VOGT PR, 1979, J GEOPHYS RES, V84, P1071, DOI 10.1029/JB084iB03p01071	26	66	72	1	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					808	812		10.1038/35057258	http://dx.doi.org/10.1038/35057258			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236991	Green Published			2022-12-28	WOS:000166938800037
J	Collins, R; MacMahon, S				Collins, R; MacMahon, S			Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials	LANCET			English	Review							ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; THROMBOLYTIC THERAPY; RANDOMIZED-TRIAL; BLOOD-PRESSURE; HYPERTENSION; PREVENTION; RISK; PREECLAMPSIA; ANTIOXIDANTS	This two-part review is intended principally for practising clinicians who want to know why some types of evidence about the effects of treatment on survival, and on other major aspects of chronic disease outcome, are much more reliable than others. Although there are a few striking examples of treatments for serious disease which really do work extremely well, most claims for big improvements turn out to be evanescent. Unrealistic expectations about the chances of discovering large treatment effects could misleadingly suggest that evidence from small :randomised trials or from non-randomised studies will suffice. By contrast, the reliable assessment of any more moderate effects of treatment on major outcomes-which are usually all that can realistically be expected from most treatments for most common serious conditions-requires studies that guarantee both strict control of bias (which, in general, requires proper randomisation and appropriate analysis, with no unduly data-dependent emphasis on specific parts of the overall evidence) and strict control of random error (which, in general, requires large numbers of deaths or of some other relevant outcome). Past failures to produce such evidence, and to interpret it appropriately, have already led to many premature deaths and much unnecessary suffering.	Radcliffe Infirm, Nuffield Dept Clin Med, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Nuffield Dept Clin Med, Epidemiol Studies Unit, Oxford OX2 6HE, England; Univ Sydney, Inst Int Hlth, Sydney, NSW 2006, Australia	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; University of Sydney	Collins, R (corresponding author), Radcliffe Infirm, Nuffield Dept Clin Med, Clin Trial Serv Unit, Oxford OX2 6HE, England.			MacMahon, Stephen/0000-0003-2064-7699				Abrams D, 1999, LANCET, V353, P2014, DOI 10.1016/S0140-6736(98)12263-8; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; [Anonymous], 1992, Lancet, V339, P1; [Anonymous], 1980, JAMA, V243, P661; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Armitage P, 1982, Stat Med, V1, P345, DOI 10.1002/sim.4780010412; BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191, DOI 10.1056/nejm198511073131904; BARNETT HJM, 1987, NEW ENGL J MED, V316, P817, DOI 10.1056/NEJM198703263161320; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Berger AK, 2000, J AM COLL CARDIOL, V36, P366, DOI 10.1016/S0735-1097(00)00723-3; BEROYZ G, 1994, LANCET, V343, P619; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Bucher HC, 1996, JAMA-J AM MED ASSOC, V275, P1113, DOI 10.1001/jama.275.14.1113; CANNER PL, 1980, NEW ENGL J MED, V303, P1038; CHALMERS TC, 1977, NEW ENGL J MED, V297, P1091, DOI 10.1056/NEJM197711172972004; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; Clarke M, 1998, LANCET, V351, P1451; CLELAND JGF, 1995, BRIT HEART J, V74, P215; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; COLLINS R, 1987, STAT MED, V6, P245, DOI 10.1002/sim.4780060308; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COLLINS R, 1995, LANCET, V345, P669; COLLINS R, 1996, OXFORD TXB MED, V1, P21; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V; Davies C, 1998, LANCET, V351, P1487, DOI 10.1016/S0140-6736(05)78869-3; DEVITA C, 1994, LANCET, V343, P1115; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; FELDMAN AM, 1993, NEW ENGL J MED, V329, P149, DOI 10.1056/NEJM199307153290301; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Food and Drug Administration, 1998, FED REGISTER, V63, P56802; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Francis T, 1955, AM J PUBLIC HEALTH N, V45, P1; GELMERS HJ, 1984, ACTA NEUROL SCAND, V69, P232, DOI 10.1111/j.1600-0404.1984.tb07806.x; GOLDRING S, 1987, NEW ENGL J MED, V316, P817, DOI 10.1056/NEJM198703263161319; GUBITZ GJ, 1999, COCHRANE LIB; Gurfinkel E, 1997, LANCET, V350, P404, DOI 10.1016/S0140-6736(97)07201-2; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; HORN J, 2000, COCHRANE LIB; IMPERIALE T F, 1991, Journal of the American Medical Association, V266, P260, DOI 10.1001/jama.266.2.260; KAY R, 1995, NEW ENGL J MED, V333, P1588, DOI 10.1056/NEJM199512143332402; KEIRSE MJNC, 1988, ACTA OBSTET GYN SCAN, V67, P731, DOI 10.3109/00016349809004298; KNIGHT M, 2000, COCHRANE LIB; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LAYTON AM, 1994, LANCET, V344, P164, DOI 10.1016/S0140-6736(94)92759-6; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4; Packard CJ, 1998, CIRCULATION, V97, P1440; Peto R, 1999, LANCET, V354, P73, DOI 10.1016/S0140-6736(05)75340-X; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; POCOCK SJ, 1990, STAT MED, V9, P657, DOI 10.1002/sim.4780090612; ROGERS WJ, 1992, NEW ENGL J MED, V327, P227; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; TEO KK, 1991, BMJ-BRIT MED J, V303, P1499, DOI 10.1136/bmj.303.6816.1499; TEO KK, 1993, JAMA-J AM MED ASSOC, V270, P1589, DOI 10.1001/jama.270.13.1589; Thiemann DR, 2000, CIRCULATION, V101, P2239, DOI 10.1161/01.CIR.101.19.2239; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; White HD, 2000, LANCET, V356, P2028, DOI 10.1016/S0140-6736(00)03397-3; YUSUF S, 1985, EUR HEART J, V6, P556, DOI 10.1093/oxfordjournals.eurheartj.a061905; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; YUSUF S, 1988, LANCET, V1, P1088	74	235	239	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2001	357	9253					373	380		10.1016/S0140-6736(00)03651-5	http://dx.doi.org/10.1016/S0140-6736(00)03651-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11211013				2022-12-28	WOS:000166897900036
J	Garg, AX; Norman, G; Sperotable, L				Garg, AX; Norman, G; Sperotable, L			How medical students learn spatial anatomy	LANCET			English	Article								Despite its importance in clinical tasks, spatial learning is poorly understood. We did a randomised, single-blind study on 146 medical students to assess the effectiveness of student-controlled multiple views on the spatial learning process. High spatial ability of the student, and self-directed examination of an object from multiple different perspectives improves spatial learning.	London Hlth Sci Ctr, Div Nephrol, London, ON N6A 4G5, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; Univ Toronto, Fac Med, Toronto, ON, Canada	London Health Sciences Centre; McMaster University; University of Toronto	Garg, AX (corresponding author), London Hlth Sci Ctr, Div Nephrol, Westminister Campus Rm 2942, London, ON N6A 4G5, Canada.		Garg, Amit X/G-3295-2011					BULTHOFF HH, 1995, CEREB CORTEX, V5, P247, DOI 10.1093/cercor/5.3.247; Garg A, 1999, ACAD MED, V74, pS87, DOI 10.1097/00001888-199910000-00049; MCGEE MG, 1979, PSYCHOL BULL, V86, P889, DOI 10.1037/0033-2909.86.5.889; ROCHFORD K, 1985, MED EDUC, V19, P13, DOI 10.1111/j.1365-2923.1985.tb01134.x; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599	5	215	216	0	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					363	364		10.1016/S0140-6736(00)03649-7	http://dx.doi.org/10.1016/S0140-6736(00)03649-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11211004				2022-12-28	WOS:000166897900020
J	Marchevsky, M; Higgins, MJ; Bhattacharya, S				Marchevsky, M; Higgins, MJ; Bhattacharya, S			Two coexisting vortex phases in the peak effect regime in a superconductor	NATURE			English	Article							FLUX-LINE-LATTICE; METASTABILITY; BI2SR2CACU2O8; DRIVEN	The critical current in the vortex phase of a type-II superconductor such as NbSe2 displays a striking anomaly in the vicinity of the superconductor-to-normal-metal transition. Instead of going to zero smoothly, it rebounds to a sharp and pronounced maximum, just before vanishing at the transition. This counter-intuitive phenomenon, known as the peak effect(1-3), has remained an unsolved problem for 40 years. Here we use a scanning a.c. Hall microscope to visualize the real-space distribution of the critical current in NbSe2. We show that in the peak-effect regime two distinct vortex-matter phases with intrinsically different pinning strengths coexist on a macroscopic scale. The composition of the two-phase mixture and the transformation of one phase into another are responsible for the history effects(4-6) and anomalous voltage response(4,5) commonly seen when external parameters such as temperature, magnetic field or transport current are varied. We argue that the observed phase coexistence is, in fact, the hallmark of a disorder-driven non-thermal phase transition.	NEC Res Inst, Princeton, NJ 08540 USA; Tata Inst Fundamental Res, Mumbai 400005, India	NEC Corporation; Tata Institute of Fundamental Research (TIFR)	Marchevsky, M (corresponding author), NEC Res Inst, 4 Independence Way, Princeton, NJ 08540 USA.							Banerjee SS, 1999, PHYS REV B, V59, P6043, DOI 10.1103/PhysRevB.59.6043; BHATTACHARYA S, 1993, PHYS REV LETT, V70, P2617, DOI 10.1103/PhysRevLett.70.2617; CHANG AM, 1992, APPL PHYS LETT, V61, P1974, DOI 10.1063/1.108334; Gammel PL, 1998, PHYS REV LETT, V80, P833, DOI 10.1103/PhysRevLett.80.833; GILCHRIST J, 1993, PHYSICA C, V212, P43, DOI 10.1016/0921-4534(93)90484-8; Henderson W, 1998, PHYS REV LETT, V81, P2352, DOI 10.1103/PhysRevLett.81.2352; Henderson W, 1996, PHYS REV LETT, V77, P2077, DOI 10.1103/PhysRevLett.77.2077; Khaykovich B, 1996, PHYS REV LETT, V76, P2555, DOI 10.1103/PhysRevLett.76.2555; Paltiel Y, 2000, NATURE, V403, P398, DOI 10.1038/35000145; PIPPARD AB, 1969, PHILOS MAG, V19, P217, DOI 10.1080/14786436908217779; Ravikumar G, 1999, PHYSICA C, V322, P145, DOI 10.1016/S0921-4534(99)00427-X; Soibel A, 2000, NATURE, V406, P282, DOI 10.1038/35018532; WORDENWEBER R, 1986, PHYS REV B, V33, P3172, DOI 10.1103/PhysRevB.33.3172; ZELDOV E, 1995, NATURE, V375, P373, DOI 10.1038/375373a0	14	105	106	1	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					591	594		10.1038/35054512	http://dx.doi.org/10.1038/35054512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214312				2022-12-28	WOS:000166692300036
J	Murthy, KHM; Smith, SA; Ganesh, VK; Judge, KW; Mullin, N; Barlow, PN; Ogata, CM; Kotwal, GJ				Murthy, KHM; Smith, SA; Ganesh, VK; Judge, KW; Mullin, N; Barlow, PN; Ogata, CM; Kotwal, GJ			RETRACTED: Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans (Retracted article. See vol. 175, pg. 1992, 2018)	CELL			English	Article; Retracted Publication							FACTOR-H; SITES; IDENTIFICATION; INHIBITION; RESIDUES; REVEALS; C3; LOCALIZATION; MECHANISM; DOMAINS	Vaccinia virus complement control protein (VCP) inhibits both pathways of complement activation through binding the third and fourth components. A homolog of mammalian regulators of complement activation, its ability to bind heparin endows VCP with additional activities of significance to viral infectivity. The structure of VCP reveals a highly extended molecule with a putative heparin recognition site at its C-terminal end. A second duster of positive charges provides a possibly overlapping binding site for both heparin and complement components. Experiments suggested by the structure indicate that VCP can bind heparin and control complement simultaneously. This, the structure of any intact regulator of complement activation, along with attendant functional insights, will stimulate the design of new therapeutic inhibitors of complement.	Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; Univ Edinburgh, Edinburgh Ctr Prot Technol, Edinburgh EH9 3JJ, Midlothian, Scotland; Brookhaven Natl Lab, Howard Hughes Med Inst, Upton, NY 11973 USA	University of Alabama System; University of Alabama Birmingham; University of Louisville; University of Edinburgh; Howard Hughes Medical Institute; United States Department of Energy (DOE); Brookhaven National Laboratory	Murthy, KHM (corresponding author), Univ Alabama Birmingham, Ctr Biophys Sci & Engn, 1918 Univ Blvd, Birmingham, AL 35294 USA.	murthy@onyx.cmc.uab.edu	Barlow, Paul N/G-2853-2011					AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; ALMOHANNA PR, 2001, IN PRESS TRANSPLANTA; ALSENZ J, 1990, CURR TOP MICROBIOL, V153, P235; BARLOW PN, 1992, BIOCHEMISTRY-US, V31, P3626, DOI 10.1021/bi00129a011; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; BARLOW PN, 1991, BIOCHEMISTRY-US, V30, P997, DOI 10.1021/bi00218a016; *BIOS TECHN, 2000, INSIGHT, V2; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; BRUNGER AT, 1990, XPLOR MANUAL; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; COYNE KE, 1992, J IMMUNOL, V149, P2906; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FISHELSON Z, 1991, MOL IMMUNOL, V28, P545, DOI 10.1016/0161-5890(91)90169-K; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; HENDERSON CE, 2000, IN PRESS J MOL BIOL; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HESSING M, 1990, J IMMUNOL, V144, P204; HILLARP A, 1988, J BIOL CHEM, V263, P12759; Howard J, 1998, J LEUKOCYTE BIOL, V64, P68, DOI 10.1002/jlb.64.1.68; Hughes-Jones Nevin C, 1986, IMMUNOBIOLOGY COMPLE, P21; ISAACS SN, 1992, P NATL ACAD SCI USA, V89, P628, DOI 10.1073/pnas.89.2.628; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kirkitadze MD, 1999, BIOCHEM J, V344, P167, DOI 10.1042/0264-6021:3440167; Kotwal G J, 1994, Am Biotechnol Lab, V12, P76; Kotwal GJ, 2000, IMMUNOL TODAY, V21, P242, DOI 10.1016/S0167-5699(00)01606-6; Kotwal GJ, 1998, MOL CELL BIOCHEM, V185, P39, DOI 10.1023/A:1006844624825; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; Krych M, 1998, J BIOL CHEM, V273, P8623, DOI 10.1074/jbc.273.15.8623; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Makrides SC, 1998, PHARMACOL REV, V50, P59; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; MCKENZIE R, 1992, J INFECT DIS, V166, P1245, DOI 10.1093/infdis/166.6.1245; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396; MOLINA H, 1995, J IMMUNOL, V154, P5426; Murthy H. M. Krishna, 1996, V56, P127; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; OTWINOWSKI Z, 1991, ISOMORPHOUS REPLACEM, P101; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PANGBURN MK, 1986, IMMUNOBIOLOGY COMPLE; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Prodinger WM, 1998, J IMMUNOL, V161, P4604; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Reynolds DN, 2000, ADVANCES IN ANIMAL VIROLOGY, P337; Sahu A, 1998, J IMMUNOL, V160, P5596; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Sharp AH, 1996, NEUROBIOL DIS, V3, P3, DOI 10.1006/nbdi.1996.0002; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; Soames CJ, 1996, BIOCHEM J, V315, P523, DOI 10.1042/bj3150523; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wiles AP, 1997, J MOL BIOL, V272, P253, DOI 10.1006/jmbi.1997.1241	62	116	118	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					301	311		10.1016/S0092-8674(01)00214-8	http://dx.doi.org/10.1016/S0092-8674(01)00214-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207370				2022-12-28	WOS:000166879700013
J	Perna, NT; Plunkett, G; Burland, V; Mau, B; Glasner, JD; Rose, DJ; Mayhew, GF; Evans, PS; Gregor, J; Kirkpatrick, HA; Posfai, G; Hackett, J; Klink, S; Boutin, A; Shao, Y; Miller, L; Grotbeck, EJ; Davis, NW; Limk, A; Dimalanta, ET; Potamousis, KD; Apodaca, J; Anantharaman, TS; Lin, JY; Yen, G; Schwartz, DC; Welch, RA; Blattner, FR				Perna, NT; Plunkett, G; Burland, V; Mau, B; Glasner, JD; Rose, DJ; Mayhew, GF; Evans, PS; Gregor, J; Kirkpatrick, HA; Posfai, G; Hackett, J; Klink, S; Boutin, A; Shao, Y; Miller, L; Grotbeck, EJ; Davis, NW; Limk, A; Dimalanta, ET; Potamousis, KD; Apodaca, J; Anantharaman, TS; Lin, JY; Yen, G; Schwartz, DC; Welch, RA; Blattner, FR			Genome sequence of enterohaemorrhagic Escherichia coli O157 : H7	NATURE			English	Article							SHIGA-LIKE TOXIN; SUBINHIBITORY CONCENTRATIONS; HEMORRHAGIC COLITIS; ALIGNMENT; EVOLUTION; REGIONS; GENES; K-12	The bacterium Escherichia coli O157:H7 is a worldwide threat to public health and has been implicated in many outbreaks of haemorrhagic colitis, some of which included fatalities caused by haemolytic uraemic syndrome(1,2). Close to 75,000 cases of O157:H7 infection are now estimated to occur annually in the United States(3). The severity of disease, the lack of effective treatment and the potential for large-scale outbreaks from contaminated food supplies have propelled intensive research on the pathogenesis and detection of E. coli O157:H7 (ref. 4). Here we have sequenced the genome of E. coli O157:H7 to identify candidate genes responsible for pathogenesis, to develop better methods of strain detection and to advance our understanding of the evolution of E. coli, through comparison with the genome of the non-pathogenic laboratory strain E. coli K-12 (ref. 5). We rnd that lateral gene transfer is far more extensive than previously anticipated. In fact, 1,387 new genes encoded in strain-specific clusters of diverse sizes were found in O157:H7. These include candidate virulence factors, alternative metabolic capacities, several prophages and other new functions-all of which could be targets for surveillance.	Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biostat, Madison, WI 53706 USA; Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; Cereon Genom LLC, Cambridge, MA 02139 USA; Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Perna, NT (corresponding author), Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA.		Plunkett, Guy/B-8058-2009; Mayhew, George F/B-4042-2016	Plunkett, Guy/0000-0003-1422-469X; Mayhew, George F/0000-0003-0609-6018; Perna, Nicole/0000-0001-8208-0929	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063250] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK063250] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alm RA, 1999, J MOL MED, V77, P834, DOI 10.1007/s001099900067; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Blaisdell JO, 1999, J BACTERIOL, V181, P6396, DOI 10.1128/JB.181.20.6396-6402.1999; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLATTNER FR, 1997, MICROB COMP GENOMICS, V2, P174; Boyd EF, 1997, J BACTERIOL, V179, P1985, DOI 10.1128/jb.179.6.1985-1991.1997; CAMPBELL A, 1983, LAMBDA, V2, P365; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Grif K, 1998, EUR J CLIN MICROBIOL, V17, P761, DOI 10.1007/s100960050181; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mahillon J, 1998, GENE, V223, P47, DOI 10.1016/S0378-1119(98)00365-5; McDonough MA, 1999, MOL MICROBIOL, V34, P1058, DOI 10.1046/j.1365-2958.1999.01669.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Ohnishi M, 1999, DNA Res, V6, P361, DOI 10.1093/dnares/6.6.361; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; SHARP PM, 1992, P NATL ACAD SCI USA, V89, P9836, DOI 10.1073/pnas.89.20.9836; SU CY, 1995, ANN INTERN MED, V123, P698, DOI 10.7326/0003-4819-123-9-199511010-00009; WALTERSPIEL JN, 1992, INFECTION, V20, P25, DOI 10.1007/BF01704889	30	1574	3721	7	199	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					529	533		10.1038/35054089	http://dx.doi.org/10.1038/35054089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206551	Bronze			2022-12-28	WOS:000166570500052
J	Wohlgenannt, M; Tandon, K; Mazumdar, S; Ramasesha, S; Vardeny, ZV				Wohlgenannt, M; Tandon, K; Mazumdar, S; Ramasesha, S; Vardeny, ZV			Formation cross-sections of singlet and triplet excitons in pi-conjugated polymers	NATURE			English	Article							LADDER-TYPE POLY(PARA-PHENYLENE); HUBBARD MODELS; ELECTROLUMINESCENCE; EXCITATIONS	Electroluminescence in organic light-emitting diodes arises from a charge-transfer reaction between the injected positive and negative charges by which they combine to form singlet excitons that subsequently decay radiatively. The quantum yield of this process (the number of photons generated per electron or hole injected) is often thought(1) to have a statistical upper limit of 25 per cent. This is based on the assumption that the formation cross-section of singlet excitons, sigma (s), is approximately the same as that of any one of the three equivalent non-radiative triplet exciton states, sigma (T); that is, sigma (S)/sigma (T) approximate to 1. However, recent experimental(2) and theoretical(3) work suggests that sigma (S)/sigma (T) may be greater than 1. Here we report direct measurements of sigma (S)/sigma (T) for a large number of pi -conjugated polymers and oligomers. We have found that there exists a strong systematic, but not monotonic, dependence of sigma (S)/sigma (T) on the optical gap of the organic materials. We present a detailed physical picture of the charge-transfer reaction for correlated pi -electrons, and quantify this process using exact valence bond calculations. The calculated sigma (S)/sigma (T) reproduces the experimentally observed trend. The calculations also show that the strong dependence of sigma (S)/sigma (T) on the optical gap is a signature of the discrete excitonic energy spectrum, in which higher energy excitonic levels participate in the charge recombination process.	Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA; Indian Inst Sci, Solid State & Struct Chem Unit, Bangalore 560012, Karnataka, India; Univ Arizona, Dept Phys, Tucson, AZ 85721 USA	Utah System of Higher Education; University of Utah; Indian Institute of Science (IISC) - Bangalore; University of Arizona	Vardeny, ZV (corresponding author), Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA.							CAMPBELL DK, 1982, PHYS REV B, V26, P6862, DOI 10.1103/PhysRevB.26.6862; CAMPBELL DK, 1988, PHYS REV B, V38, P12043, DOI 10.1103/PhysRevB.38.12043; Cao Y, 1999, NATURE, V397, P414, DOI 10.1038/17087; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Gallagher FB, 1997, PHYS REV B, V56, P15025, DOI 10.1103/PhysRevB.56.15025; Graupner W, 1998, PHYS REV LETT, V81, P3259, DOI 10.1103/PhysRevLett.81.3259; Kim JS, 2000, J APPL PHYS, V88, P1073, DOI 10.1063/1.373779; Lavrentiev MY, 1999, PHYS REV B, V59, P9987, DOI 10.1103/PhysRevB.59.9987; Monkman AP, 2000, CHEM PHYS LETT, V327, P111, DOI 10.1016/S0009-2614(00)00845-9; PARISER R, 1953, J CHEM PHYS, V21, P767, DOI 10.1063/1.1699030; POPLE JA, 1953, T FARADAY SOC, V49, P1375, DOI 10.1039/tf9534901375; Rohlfing M, 1999, PHYS REV LETT, V82, P1959, DOI 10.1103/PhysRevLett.82.1959; Shuai Z, 2000, PHYS REV LETT, V84, P131, DOI 10.1103/PhysRevLett.84.131; SOOS ZG, 1984, PHYS REV B, V29, P5410, DOI 10.1103/PhysRevB.29.5410; SOOS ZG, 1993, PHYS REV LETT, V71, P1609, DOI 10.1103/PhysRevLett.71.1609; Wohlgenannt M, 1999, PHYS REV B, V60, P5321, DOI 10.1103/PhysRevB.60.5321; [No title captured]	17	432	450	2	111	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					494	497		10.1038/35054025	http://dx.doi.org/10.1038/35054025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206541				2022-12-28	WOS:000166570500042
J	Marsh, AG; Maxson, RE; Manahan, DT				Marsh, AG; Maxson, RE; Manahan, DT			High macromolecular synthesis with low metabolic cost in Antarctic sea urchin embryos	SCIENCE			English	Article							STRONGYLOCENTROTUS-PURPURATUS; PROTEIN-METABOLISM; ENERGY-METABOLISM; GROWTH; LARVAE; GASTROPODA; RATES	Assessing the energy costs of development in extreme environments is important for understanding how organisms can exist at the margins of the biosphere. Macromolecular turnover rates of RNA and protein were measured at -1.5 degreesC during early development of an Antarctic sea urchin. Contrary to expectations of tow synthesis with tow metabolism at low temperatures, protein and RNA synthesis rates exhibited temperature compensation and were equivalent to rates in temperate sea urchin embryos. High protein metabolism with a tow metabolic rate is energetically possible in this Antarctic sea urchin because the energy cost of protein turnover, 0.45 joules per milligram of protein, is 1/25th the values reported for other animals.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, USC Norris Hosp Inst, Dept Biochem & Mol Biol, Sch Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Manahan, DT (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.							BERG WE, 1970, EXP CELL RES, V60, P218, DOI 10.1016/0014-4827(70)90508-2; CLARKE A, 1983, OCEANOGR MAR BIOL, V21, P341; Davidson E. H., 1986, GENE ACTIVITY EARLY; FRY BJ, 1970, DEV BIOL, V21, P125, DOI 10.1016/0012-1606(70)90065-5; GOUSTIN AS, 1981, DEV BIOL, V82, P32, DOI 10.1016/0012-1606(81)90426-7; HAWKINS AJS, 1989, PHYSIOL ZOOL, V62, P745, DOI 10.1086/physzool.62.3.30157925; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; Houlihan D.F., 1991, Advances in Comparative and Environmental Physiology, V7, P1; ITO M, 1988, DEV BIOL, V129, P147, DOI 10.1016/0012-1606(88)90169-8; Leong PKK, 1999, J EXP BIOL, V202, P2051; LYNDON AR, 1989, ARCH INT PHYSL BIOCH, V97, pC31; Marsh AG, 1999, MAR ECOL PROG SER, V184, P1, DOI 10.3354/meps184001; Marsh AG, 1999, J EXP BIOL, V202, P2041; MARSH AJ, UNPUB; REEDS PJ, 1987, ANIM PROD, V45, P149, DOI 10.1017/S0003356100018754; REIGER JC, 1977, DEV BIOL, V57, P270; SHILLING FM, 1994, BIOL BULL, V187, P398, DOI 10.2307/1542296; SIEMS WG, 1992, CELL BIOCHEM FUNCT, V10, P61, DOI 10.1002/cbf.290100110; Thieringer HA, 1998, BIOESSAYS, V20, P49; Vavra J, 1999, BIOL BULL, V196, P177, DOI 10.2307/1542563; Weiser W., 1994, BIOL REV, V68, P1; WELBORN JR, 1995, J EXP BIOL, V198, P1791; WU RS, 1974, DEV BIOL, V41, P352, DOI 10.1016/0012-1606(74)90312-1	23	84	86	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1950	1952		10.1126/science.1056341	http://dx.doi.org/10.1126/science.1056341			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239152				2022-12-28	WOS:000167401600042
J	Schwetz, BA				Schwetz, BA			New measures to manage risks associated with Accutane	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1146	1146		10.1001/jama.285.9.1146	http://dx.doi.org/10.1001/jama.285.9.1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231734				2022-12-28	WOS:000167194700005
J	Tate, DF; Wing, RR; Winett, RA				Tate, DF; Wing, RR; Winett, RA			Using Internet technology to deliver a behavioral weight loss program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the North-American-Association-for-the-Study-of-Obesity	NOV 14-18, 1999	CHARLESTON, SC	N Amer Assoc Study Obes			PHYSICAL-ACTIVITY; HEALTH BEHAVIOR; SMOKING-CESSATION; INTERVENTION; TELEVISION; REDUCTION; PURCHASES; EXERCISE; RISK	Context Rapid increases in access to the Internet have made it a viable mode for public health intervention. No controlled studies have evaluated this resource for weight loss. Objective To determine whether a structured Internet behavioral weight loss program produces greater initial weight loss and changes in waist circumference than a weight loss education Web site. Design Randomized controlled trial conducted from April to December 1999. Setting and Participants Ninety-one healthy, overweight adult hospital employees aged 18 to 60 years with a body mass index of 25 to 36 kg/m(2). Analyses were performed for the 65 who had complete follow-up data. Interventions Participants were randomly assigned to a 6-month weight loss program of either Internet education (education; n=32 with complete data) or Internet behavior therapy (behavior therapy; n=33 with complete data). All participants were given 1 face-to-face group weight loss session and access to a Web site with organized links to Internet weight loss resources. Participants in the behavior therapy group received additional behavioral procedures, including a sequence of 24 weekly behavioral lessons via e-mail, weekly online submission of self-monitoring diaries with individualized therapist feedback via e-mail, and an online bulletin board. Main Outcome Measures Body weight and waist circumference, measured at 0, 3, and 6 months, compared the 2 intervention groups. Results Repeated-measures analyses showed that the behavior therapy group lost more weight than the education group (P=.005). The behavior therapy group lost a mean (SD) of 4.0 (2.8) kg by 3 months and 4.1 (4.5) kg by 6 months. Weight loss in the education group was 1.7 (2.7) kg at 3 months and 1.6 (3.3) kg by 6 months. More participants in the behavior therapy than education group achieved the 5% weight loss goal (45% vs 22%; P=.05) by 6 months. Changes in waist circumference were also greater in the behavior therapy group than in the education group at both 3 months (P=.001) and 6 months (P =.005). Conclusions Participants who were given a structured behavioral treatment program with weekly contact and individualized feedback had better weight loss compared with those given links to educational Web sites. Thus, the Internet and e-mail appear to be viable methods for delivery of structured behavioral weight loss programs.	Miriam Hosp, Brown Med Sch, Weight Control & Diabet Res Ctr, Providence, RI 02906 USA; Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; Virginia Polytechnic Institute & State University	Tate, DF (corresponding author), Miriam Hosp, Brown Med Sch, Weight Control & Diabet Res Ctr, 14 3rd St,RISE Bldg, Providence, RI 02906 USA.	dtate@lifespan.org	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213				ABRAMS DB, 1983, J CONSULT CLIN PSYCH, V51, P226, DOI 10.1037/0022-006X.51.2.226; BLACKBURN GL, 1995, EATING DISORDERS OBE, P406; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BURNETT KF, 1985, J CONSULT CLIN PSYCH, V53, P698, DOI 10.1037/0022-006X.53.5.698; CAMERON R, 1990, CAN J PUBLIC HEALTH, V81, P275; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Harvey-Berino J, 1998, BEHAV THER, V29, P505, DOI 10.1016/S0005-7894(98)80046-4; Hellerstedt WL, 1997, AM J HEALTH PROMOT, V11, P177, DOI 10.4278/0890-1171-11.3.177; HESKA S, 1999, OBES RES, V7, pS19; Jeffery RW, 1998, J CONSULT CLIN PSYCH, V66, P777, DOI 10.1037/0022-006X.66.5.777; JEFFERY RW, 1990, HEALTH PSYCHOL, V9, P585, DOI 10.1037/0278-6133.9.5.585; JEFFERY RW, 1982, BEHAV THER, V13, P24, DOI 10.1016/S0005-7894(82)80047-6; JEFFERY RW, 1982, ADDICT BEHAV, V7, P57, DOI 10.1016/0306-4603(82)90025-9; KLEM ML, 1988, J CONSULT CLIN PSYCH, V56, P142; Leermakers EA, 1998, INT J OBESITY, V22, P1103, DOI 10.1038/sj.ijo.0800734; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Marcus BH, 1998, ANN BEHAV MED, V20, P174, DOI 10.1007/BF02884958; Meyers AW, 1996, J CONSULT CLIN PSYCH, V64, P172, DOI 10.1037/0022-006X.64.1.172; MILLER WC, 1993, INT J SPORTS MED, V14, P401, DOI 10.1055/s-2007-1021199; O'Loughlin J, 1998, PREV MED, V27, P288, DOI 10.1006/pmed.1998.0265; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; PROCHASKA JO, 1993, HEALTH PSYCHOL, V12, P399, DOI 10.1037/0278-6133.12.5.399; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sherwood NE, 1998, AM J HEALTH PROMOT, V13, P12, DOI 10.4278/0890-1171-13.1.12; STUNKARD AJ, 1980, AM J PSYCHIAT, V137, P252; TAYLOR CB, 1991, BEHAV THER, V22, P229, DOI 10.1016/S0005-7894(05)80178-9; TAYLOR H, 1999, HARRIS POLL ONLINE P; THOMAS R, 1995, WEIGHING OPTIONS CRI; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; WINETT RA, 1991, J APPL BEHAV ANAL, V24, P95, DOI 10.1901/jaba.1991.24-95; Winett RA, 1997, COMPUT HUM BEHAV, V13, P371, DOI 10.1016/S0747-5632(97)00015-0; WING RR, 1984, BEHAV THER, V15, P550, DOI 10.1016/S0005-7894(84)80056-8	34	621	628	3	83	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1172	1177		10.1001/jama.285.9.1172	http://dx.doi.org/10.1001/jama.285.9.1172			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	406BH	11231746				2022-12-28	WOS:000167194700020
J	Nogee, LM; Dunbar, AE; Wert, SE; Askin, F; Hamvas, A; Whitsett, JA				Nogee, LM; Dunbar, AE; Wert, SE; Askin, F; Hamvas, A; Whitsett, JA			A mutation in the surfactant protein C gene associated with familial interstitial lung disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B SP-B; EPITHELIAL-CELLS; IN-VITRO; PNEUMONITIS; PRECURSOR; FETAL; CDNA; FORM		Johns Hopkins Univ, Sch Med, Dept Pediat, Div Neonatol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Univ Cincinnati, Coll Med, Div Neonatol, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Div Pulm Biol, Cincinnati, OH USA; Washington Univ, Sch Med, Dept Pediat, Div Newborn Med, St Louis, MO 63110 USA	Johns Hopkins University; Johns Hopkins University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Washington University (WUSTL)	Nogee, LM (corresponding author), Johns Hopkins Univ Hosp, CMSC 210,600 N Wolfe St, Baltimore, MD 21287 USA.	lnogee@jhmi.edu	Hamvas, Aaron/R-5721-2019	Hamvas, Aaron/0000-0002-5749-7797	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056387, R01HL054187, R29HL054703, P01HL056387, R01HL054703] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-54187, HL-56387, HL-54703] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAATZ JE, 1992, CHEM PHYS LIPIDS, V63, P91, DOI 10.1016/0009-3084(92)90026-L; BAATZ JE, 1990, BIOCHEMISTRY-US, V29, P6714, DOI 10.1021/bi00480a022; BANERJEE SK, 1995, BIOTECHNIQUES, V18, P768; Beers MF, 1998, J BIOL CHEM, V273, P15287, DOI 10.1074/jbc.273.24.15287; Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J; Buchino J J, 1987, Am J Med Genet Suppl, V3, P285; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; FAN LL, 1992, J PEDIATR-US, V121, P867, DOI 10.1016/S0022-3476(05)80330-0; FAN LL, 1993, PEDIATR PULM, V16, P184, DOI 10.1002/ppul.1950160309; FARRELL PM, 1975, AM REV RESPIR DIS, V111, P657; GLASSER SW, 1988, J BIOL CHEM, V263, P10326; GLASSER SW, 1988, J BIOL CHEM, V263, P9; Howenstine Michelle S., 1999, Current Opinion in Pediatrics, V11, P200, DOI 10.1097/00008480-199906000-00004; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Katzenstein ALA, 2000, AM J SURG PATHOL, V24, P1, DOI 10.1097/00000478-200001000-00001; KATZENSTEIN ALA, 1995, AM J SURG PATHOL, V19, P439, DOI 10.1097/00000478-199504000-00005; Kavantzas N, 1999, Clin Exp Pathol, V47, P96; KELLER A, 1992, AM J RESP CELL MOL, V6, P601, DOI 10.1165/ajrcmb/6.6.601; KELLER A, 1991, BIOCHEM J, V277, P493, DOI 10.1042/bj2770493; LEONG ASY, 1993, APPL IMMUNOHISTO M M, V1, P267; Lin S, 1996, J BIOL CHEM, V271, P19689, DOI 10.1074/jbc.271.33.19689; Na C.-L, 1998, Microscopy and Microanalysis, V4, P852, DOI 10.1017/S1431927600024387; Nicholson AG, 1998, HISTOPATHOLOGY, V33, P203, DOI 10.1046/j.1365-2559.1998.00488.x; Nogee LM, 2000, AM J RESP CRIT CARE, V161, P973, DOI 10.1164/ajrccm.161.3.9903153; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; Ross GF, 1999, AM J PHYSIOL-LUNG C, V277, pL1104, DOI 10.1152/ajplung.1999.277.6.L1104; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; SCHROEDER SA, 1992, CHEST, V101, P1065, DOI 10.1378/chest.101.4.1065; SHARIEF N, 1994, PEDIATR PULM, V17, P359, DOI 10.1002/ppul.1950170604; STAHLMAN MT, 1992, PEDIATR RES, V31, P364, DOI 10.1203/00006450-199204000-00012; STILLWELL PC, 1980, CHEST, V77, P165, DOI 10.1378/chest.77.2.165; VORBROKER DK, 1995, AM J PHYSIOL-LUNG C, V268, pL647, DOI 10.1152/ajplung.1995.268.4.L647; WARR RG, 1987, P NATL ACAD SCI USA, V84, P7915, DOI 10.1073/pnas.84.22.7915; WHITSETT JA, 1986, PEDIATR RES, V20, P460, DOI 10.1203/00006450-198605000-00016; WHITSETT JA, 1987, J BIOL CHEM, V262, P15618	36	593	622	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2001	344	8					573	579		10.1056/NEJM200102223440805	http://dx.doi.org/10.1056/NEJM200102223440805			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403LU	11207353				2022-12-28	WOS:000167044600005
J	Sanz, JL; Chiappe, LM; Fernandez-Jalvo, Y; Ortega, F; Sanchez-Chillon, B; Poyato-Ariza, FJ; Perez-Moreno, BP				Sanz, JL; Chiappe, LM; Fernandez-Jalvo, Y; Ortega, F; Sanchez-Chillon, B; Poyato-Ariza, FJ; Perez-Moreno, BP			Palaeontology - An Early Cretaceous pellet	NATURE			English	Article							BIRD BONES		Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, E-28049 Madrid, Spain; Nat Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA; CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Sanz, JL (corresponding author), Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, E-28049 Madrid, Spain.		Sánchez, Begoña/K-2257-2014; Ortega, Francisco/K-3255-2015; Ortega, Francisco/B-5760-2009; Chillón, Begoña Sánchez/AAB-6021-2019; Sanz, Jose Luis/O-1421-2019	Ortega, Francisco/0000-0002-7431-354X; Ortega, Francisco/0000-0002-7431-354X; Chiappe, Luis/0000-0001-9661-0601; Sanz, Jose Luis/0000-0002-5214-5725; SANCHEZ, BEGONA/0000-0002-1839-4453				Andrews P, 1998, NATURE, V393, P629, DOI 10.1038/31356; Andrews P. O, 1990, CAVES FOSSILS; Behrensmeyer A.K., 1991, TAPHONOMY RELEASING, P291, DOI [DOI 10.1007/978-1-4899-5034-5, 10.1007/978-1-4899-5034-5_6, DOI 10.1007/978-1-4899-5034-5_6]; Bochenski ZM, 1998, J ARCHAEOL SCI, V25, P425, DOI 10.1006/jasc.1997.0213; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Davis PG, 1997, INT J OSTEOARCHAEOL, V7, P388, DOI 10.1002/(SICI)1099-1212(199707/08)7:4<388::AID-OA357>3.0.CO;2-H; FISHER DC, 1981, PALEOBIOLOGY, V7, P262, DOI 10.1017/S0094837300004048; PEREZMORENO BP, 1994, NATURE, V370, P363, DOI 10.1038/370363a0; Poyato-Ariza FJ, 1998, PALAEOGEOGR PALAEOCL, V144, P65, DOI 10.1016/S0031-0182(98)00085-6; SANZ JL, IN PRESS PALAEOBIOLO, V2	10	31	32	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					998	1000		10.1038/35059172	http://dx.doi.org/10.1038/35059172			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405FT	11234054				2022-12-28	WOS:000167148800032
J	Hamprecht, K; Maschmann, J; Vochem, M; Dietz, K; Speer, CP; Jahn, G				Hamprecht, K; Maschmann, J; Vochem, M; Dietz, K; Speer, CP; Jahn, G			Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding	LANCET			English	Article							BREAST-MILK; VIRUS INFECTION; PREMATURE-INFANTS; NESTED PCR; DNA; SEQUELAE; WHEY	Background Breastfeeding practices strongly influence the epidemiology of human cytomegalovirus infection. By contrast with term neonates. few data are available on transmission of infection from mothers to preterm infants during breastfeeding. Methods 151 mothers and their 176 preterm infants (gestational age at birth <32 weeks or birthweight <1500 g) were prospectively screened for cytomegalovirus infection by serology. virus culture, and PCR. The roles of cell-free and cell-associated cytomegalovirus excretion during lactation were analysed longitudinally in relation to transmission, by maximum-likelihood estimates. Findings Of the 69 seronegative breastfeeding control mothers, none had detectable cytomegalovirus DNA in breastmilk and none of their 80 infants shed the virus in urine. The proportion of cytomegalovirus reactivation in seropositive breastfeeding mothers was 96% (73 of 76). The early appearance of viral DNA in milk whey (median 3.5 days post partum in transmitters; 8 days in non-transmitters: p=0.025) and infectious virus in milk whey (10 days and 16 days, respectively: p=0.005) were risk factors for transmission. The cumulative rate of transmission was 37% (27 of 73 mothers; 33 infants). The infection of the neonates had a mean incubation time of 42 days (95% CI 28-69). About 50% of the infected infants had no symptoms, but four had sepsis-like the symptoms. Interpretation The proportion of cytomegalovirus reactivation during lactation almost equals maternal seroprevalence. Breastfeeding as a source of postnatal cytomegalovirus infection in preterm infants has been underestimated and may be associated with a symptomatic infection.	Univ Tubingen Hosp, Inst Med Virol & Epidemiol Viral Dis, D-72076 Tubingen, Germany; Childrens Univ Hosp Tubingen, Dept Neonatol, Tubingen, Germany; Univ Wurzburg, Childrens Hosp, D-97070 Wurzburg, Germany; Univ Tubingen Hosp, Dept Med Biometry, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Hamprecht, K (corresponding author), Univ Tubingen Hosp, Inst Med Virol & Epidemiol Viral Dis, Calwerstr 7-6, D-72076 Tubingen, Germany.		Dietz, Klaus/R-9268-2016	Dietz, Klaus/0000-0001-8503-9737				ADLER SP, 1986, CRIT REV CL LAB SCI, V23, P1; Asanuma H, 1996, MICROBIOL IMMUNOL, V40, P201, DOI 10.1111/j.1348-0421.1996.tb03335.x; BALLARD RA, 1979, AM J DIS CHILD, V133, P482, DOI 10.1001/archpedi.1979.02130050026005; DIOSI P, 1967, LANCET, V2, P1063, DOI 10.1016/S0140-6736(67)90338-8; DWORSKY M, 1983, PEDIATRICS, V72, P295; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; GILBERT GL, 1989, LANCET, V1, P1228, DOI 10.1016/S0140-6736(89)92330-1; HAMIRECHT K, 1998, J CLIN VIROL, V11, P125; Hamprecht K, 1998, J VIROL METHODS, V70, P167, DOI 10.1016/S0166-0934(97)00179-1; Hamprecht K, 1997, J VIROL METHODS, V69, P125, DOI 10.1016/S0166-0934(97)00148-1; Hamprecht K, 2000, ADV EXP MED BIOL, V478, P231; HAYES K, 1972, NEW ENGL J MED, V287, P177, DOI 10.1056/NEJM197207272870407; HOTSUBO T, 1994, MICROBIOL IMMUNOL, V38, P809, DOI 10.1111/j.1348-0421.1994.tb01862.x; KUMAR ML, 1984, J PEDIATR-US, V104, P669, DOI 10.1016/S0022-3476(84)80941-5; LANG DJ, 1969, NEW ENGL J MED, V280, P1145, DOI 10.1056/NEJM196905222802103; PARYANI SG, 1985, J PEDIATR-US, V107, P451, DOI 10.1016/S0022-3476(85)80533-3; Prix L, 1998, EUR J CLIN MICROBIOL, V17, P525, DOI 10.1007/BF01691140; REYNOLDS DW, 1973, NEW ENGL J MED, V289, P1, DOI 10.1056/NEJM197307052890101; Schanler RJ, 1999, CLIN PERINATOL, V26, P379, DOI 10.1016/S0095-5108(18)30058-7; Sinzger C, 1996, INTERVIROLOGY, V39, P302, DOI 10.1159/000150502; STAGNO S, 1994, P NATL ACAD SCI USA, V91, P2384, DOI 10.1073/pnas.91.7.2384; STAGNO S, 1980, NEW ENGL J MED, V302, P1073, DOI 10.1056/NEJM198005083021908; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Vochem M, 1998, PEDIATR INFECT DIS J, V17, P53, DOI 10.1097/00006454-199801000-00012; YEAGER AS, 1983, J PEDIATR-US, V102, P918, DOI 10.1016/S0022-3476(83)80025-0; 2000, STAT BUNDESAMT	27	293	307	1	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					513	518		10.1016/S0140-6736(00)04043-5	http://dx.doi.org/10.1016/S0140-6736(00)04043-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229670				2022-12-28	WOS:000167011700011
J	Lander, ES; Int Human Genome Sequencing Consortium; Linton, LM; Birren, B; Nusbaum, C; Zody, MC; Baldwin, J; Devon, K; Dewar, K; Doyle, M; FitzHugh, W; Funke, R; Gage, D; Harris, K; Heaford, A; Howland, J; Kann, L; Lehoczky, J; LeVine, R; McEwan, P; McKernan, K; Meldrim, J; Mesirov, JP; Miranda, C; Morris, W; Naylor, J; Raymond, C; Rosetti, M; Santos, R; Sheridan, A; Sougnez, C; Stange-Thomann, N; Stojanovic, N; Subramanian, A; Wyman, D; Rogers, J; Sulston, J; Ainscough, R; Beck, S; Bentley, D; Burton, J; Clee, C; Carter, N; Coulson, A; Deadman, R; Deloukas, P; Dunham, A; Dunham, I; Durbin, R; French, L; Grafham, D; Gregory, S; Hubbard, T; Humphray, S; Hunt, A; Jones, M; Lloyd, C; McMurray, A; Matthews, L; Mercer, S; Milne, S; Mullikin, JC; Mungall, A; Plumb, R; Ross, M; Shownkeen, R; Sims, S; Waterston, RH; Wilson, RK; Hillier, LW; McPherson, JD; Marra, MA; Mardis, ER; Fulton, LA; Chinwalla, AT; Pepin, KH; Gish, WR; Chissoe, SL; Wendl, MC; Delehaunty, KD; Miner, TL; Delehaunty, A; Kramer, JB; Cook, LL; Fulton, RS; Johnson, DL; Minx, PJ; Clifton, SW; Hawkins, T; Branscomb, E; Predki, P; Richardson, P; Wenning, S; Slezak, T; Doggett, N; Cheng, JF; Olsen, A; Lucas, S; Elkin, C; Uberbacher, E; Frazier, M; Gibbs, RA; Muzny, DM; Scherer, SE; Bouck, JB; Sodergren, EJ; Worley, KC; Rives, CM; Gorrell, JH; Metzker, ML; Naylor, SL; Kucherlapati, RS; Nelson, DL; Weinstock, GM; Sakaki, Y; Fujiyama, A; Hattori, M; Yada, T; Toyoda, A; Itoh, T; Kawagoe, C; Watanabe, H; Totoki, Y; Taylor, T; Weissenbach, J; Heilig, R; Saurin, W; Artiguenave, F; Brottier, P; Bruls, T; Pelletier, E; Robert, C; Wincker, P; Rosenthal, A; Platzer, M; Nyakatura, G; Taudien, S; Rump, A; Yang, HM; Yu, J; Wang, J; Huang, GY; Gu, J; Hood, L; Rowen, L; Madan, A; Qin, SZ; Davis, RW; Federspiel, NA; Abola, AP; Proctor, MJ; Myers, RM; Schmutz, J; Dickson, M; Grimwood, J; Cox, DR; Olson, MV; Kaul, R; Raymond, C; Shimizu, N; Kawasaki, K; Minoshima, S; Evans, GA; Athanasiou, M; Schultz, R; Roe, BA; Chen, F; Pan, HQ; Ramser, J; Lehrach, H; Reinhardt, R; McCombie, WR; de la Bastide, M; Dedhia, N; Blocker, H; Hornischer, K; Nordsiek, G; Agarwala, R; Aravind, L; Bailey, JA; Bateman, A; Batzoglou, S; Birney, E; Bork, P; Brown, DG; Burge, CB; Cerutti, L; Chen, HC; Church, D; Clamp, M; Copley, RR; Doerks, T; Eddy, SR; Eichler, EE; Furey, TS; Galagan, J; Gilbert, JGR; Harmon, C; Hayashizaki, Y; Haussler, D; Hermjakob, H; Hokamp, K; Jang, WH; Johnson, LS; Jones, TA; Kasif, S; Kaspryzk, A; Kennedy, S; Kent, WJ; Kitts, P; Koonin, EV; Korf, I; Kulp, D; Lancet, D; Lowe, TM; McLysaght, A; Mikkelsen, T; Moran, JV; Mulder, N; Pollara, VJ; Ponting, CP; Schuler, G; Schultz, JR; Slater, G; Smit, AFA; Stupka, E; Szustakowki, J; Thierry-Mieg, D; Thierry-Mieg, J; Wagner, L; Wallis, J; Wheeler, R; Williams, A; Wolf, YI; Wolfe, KH; Yang, SP; Yeh, RF; Collins, F; Guyer, MS; Peterson, J; Felsenfeld, A; Wetterstrand, KA; Patrinos, A; Morgan, MJ				Lander, ES; Int Human Genome Sequencing Consortium; Linton, LM; Birren, B; Nusbaum, C; Zody, MC; Baldwin, J; Devon, K; Dewar, K; Doyle, M; FitzHugh, W; Funke, R; Gage, D; Harris, K; Heaford, A; Howland, J; Kann, L; Lehoczky, J; LeVine, R; McEwan, P; McKernan, K; Meldrim, J; Mesirov, JP; Miranda, C; Morris, W; Naylor, J; Raymond, C; Rosetti, M; Santos, R; Sheridan, A; Sougnez, C; Stange-Thomann, N; Stojanovic, N; Subramanian, A; Wyman, D; Rogers, J; Sulston, J; Ainscough, R; Beck, S; Bentley, D; Burton, J; Clee, C; Carter, N; Coulson, A; Deadman, R; Deloukas, P; Dunham, A; Dunham, I; Durbin, R; French, L; Grafham, D; Gregory, S; Hubbard, T; Humphray, S; Hunt, A; Jones, M; Lloyd, C; McMurray, A; Matthews, L; Mercer, S; Milne, S; Mullikin, JC; Mungall, A; Plumb, R; Ross, M; Shownkeen, R; Sims, S; Waterston, RH; Wilson, RK; Hillier, LW; McPherson, JD; Marra, MA; Mardis, ER; Fulton, LA; Chinwalla, AT; Pepin, KH; Gish, WR; Chissoe, SL; Wendl, MC; Delehaunty, KD; Miner, TL; Delehaunty, A; Kramer, JB; Cook, LL; Fulton, RS; Johnson, DL; Minx, PJ; Clifton, SW; Hawkins, T; Branscomb, E; Predki, P; Richardson, P; Wenning, S; Slezak, T; Doggett, N; Cheng, JF; Olsen, A; Lucas, S; Elkin, C; Uberbacher, E; Frazier, M; Gibbs, RA; Muzny, DM; Scherer, SE; Bouck, JB; Sodergren, EJ; Worley, KC; Rives, CM; Gorrell, JH; Metzker, ML; Naylor, SL; Kucherlapati, RS; Nelson, DL; Weinstock, GM; Sakaki, Y; Fujiyama, A; Hattori, M; Yada, T; Toyoda, A; Itoh, T; Kawagoe, C; Watanabe, H; Totoki, Y; Taylor, T; Weissenbach, J; Heilig, R; Saurin, W; Artiguenave, F; Brottier, P; Bruls, T; Pelletier, E; Robert, C; Wincker, P; Rosenthal, A; Platzer, M; Nyakatura, G; Taudien, S; Rump, A; Yang, HM; Yu, J; Wang, J; Huang, GY; Gu, J; Hood, L; Rowen, L; Madan, A; Qin, SZ; Davis, RW; Federspiel, NA; Abola, AP; Proctor, MJ; Myers, RM; Schmutz, J; Dickson, M; Grimwood, J; Cox, DR; Olson, MV; Kaul, R; Raymond, C; Shimizu, N; Kawasaki, K; Minoshima, S; Evans, GA; Athanasiou, M; Schultz, R; Roe, BA; Chen, F; Pan, HQ; Ramser, J; Lehrach, H; Reinhardt, R; McCombie, WR; de la Bastide, M; Dedhia, N; Blocker, H; Hornischer, K; Nordsiek, G; Agarwala, R; Aravind, L; Bailey, JA; Bateman, A; Batzoglou, S; Birney, E; Bork, P; Brown, DG; Burge, CB; Cerutti, L; Chen, HC; Church, D; Clamp, M; Copley, RR; Doerks, T; Eddy, SR; Eichler, EE; Furey, TS; Galagan, J; Gilbert, JGR; Harmon, C; Hayashizaki, Y; Haussler, D; Hermjakob, H; Hokamp, K; Jang, WH; Johnson, LS; Jones, TA; Kasif, S; Kaspryzk, A; Kennedy, S; Kent, WJ; Kitts, P; Koonin, EV; Korf, I; Kulp, D; Lancet, D; Lowe, TM; McLysaght, A; Mikkelsen, T; Moran, JV; Mulder, N; Pollara, VJ; Ponting, CP; Schuler, G; Schultz, JR; Slater, G; Smit, AFA; Stupka, E; Szustakowki, J; Thierry-Mieg, D; Thierry-Mieg, J; Wagner, L; Wallis, J; Wheeler, R; Williams, A; Wolf, YI; Wolfe, KH; Yang, SP; Yeh, RF; Collins, F; Guyer, MS; Peterson, J; Felsenfeld, A; Wetterstrand, KA; Patrinos, A; Morgan, MJ		Int Human Genome Sequencing Conso	Initial sequencing and analysis of the human genome	NATURE			English	Review							OLFACTORY RECEPTOR GENES; HIGH-FREQUENCY RETROTRANSPOSITION; COMPLETE NUCLEOTIDE-SEQUENCE; WILLIAMS-BEUREN-SYNDROME; DNA REGULATORY MOTIFS; SMALL NUCLEAR-RNA; LOW-COPY REPEATS; PHYSICAL MAP; CODON USAGE; LINKAGE DISEQUILIBRIUM	The human genome holds an extraordinary trove of information about human development, physiology, medicine and evolution. Here we report the results of an international collaboration to produce and make freely available a draft sequence of the human genome. We also present an initial analysis of the data, describing some of the insights that can be gleaned from the sequence.	Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02142 USA; Sanger Ctr, Hinxton CB10 1RQ, Cambs, England; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77225 USA; RIKEN, Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Genoscope, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; Genome Therapeut Corp, GTC Sequencing Ctr, Waltham, MA 02453 USA; Inst Mol Biotechnol, Dept Genome Anal, D-07745 Jena, Germany; Chinese Acad Sci, Inst Genet, Ctr Human Genome, Beijing Genom Inst, Beijing 100101, Peoples R China; So China Natl Human Genome Res Ctr, Shanghai 201203, Peoples R China; No China Natl Human Genome Res Ctr, Beijing 100176, Peoples R China; Inst Syst Biol, Multimegabase Sequencing Ctr, Seattle, WA 98105 USA; Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Stanford Human Genome Ctrr, Sch Med, Stanford, CA 94305 USA; Univ Washington, Genome Ctr, Seattle, WA 98195 USA; Keio Univ, Sch Med, Dept Biol Mol, Shinjuku Ku, Tokyo 1608582, Japan; Univ Texas, SW Med Ctr, Dallas, TX 75235 USA; Univ Oklahoma, Adv Ctr Genome Technol, Dept Chem & Biochem, Norman, OK 73019 USA; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Cold Spring Harbor Lab, Lita Annenberg Hazen Genome Ctr, Cold Spring Harbor, NY 11724 USA; GBF, German Res Ctr Biotechnol, D-38124 Braunschweig, Germany; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; EMBL, European Bioinformat Inst, Cambridge CB10 1SD, England; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; MIT, Dept Biol, Cambridge, MA 02139 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Calif Santa Cruz, Dept Comp Sci, Santa Cruz, CA 95064 USA; Affymetrix Inc, Berkeley, CA 94710 USA; RIKEN, Yokoham Inst, Genom Sci Ctr, Genom Explorat Res Grp,Tsurumi Ku, Kanagawa 2300045, Japan; Univ Calif Santa Cruz, Dept Comp Sci, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Dublin Trinity Coll, Dept Genet, Smurfit Inst, Dublin 2, Ireland; Compaq Comp Corp, Cambridge Res Lab, Cambridge, MA 02142 USA; MIT, Genome Ctr, Cambridge, MA 02142 USA; Univ Calif Santa Cruz, Dept Math, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA; Weizmann Inst Sci, Crown Human Genet Ctr, IL-71600 Rehovot, Israel; Weizmann Inst Sci, Dept Mol Genet, IL-71600 Rehovot, Israel; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Oxford, Dept Human Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England; Inst Syst Biol, Seattle, WA 98105 USA; NHGRI, NIH, Bethesda, MD 20892 USA; US DOE, Off Sci, Germantown, MD 20874 USA; Wellcome Trust Res Labs, London NW1 2BE, England	Massachusetts Institute of Technology (MIT); Whitehead Institute; Wellcome Trust Sanger Institute; Washington University (WUSTL); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; RIKEN; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Institute for Systems Biology (ISB); Stanford University; Stanford University; Stanford University; University of Washington; University of Washington Seattle; Keio University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma - Norman; Max Planck Society; Cold Spring Harbor Laboratory; Helmholtz Association; Helmholtz-Center for Infection Research; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Case Western Reserve University; University Hospitals of Cleveland; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); University of California System; University of California Santa Cruz; Affymetrix; RIKEN; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Trinity College Dublin; Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Weizmann Institute of Science; Weizmann Institute of Science; Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Oxford; Institute for Systems Biology (ISB); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); United States Department of Energy (DOE)	Lander, ES (corresponding author), Whitehead Inst Biomed Res, Ctr Genome Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lander@genome.wi.mit.edu; jes@sanger.ac.uk; bwaterst@watson.wustl.edu; fc23a@nih.gov	Ganesh, Dunna Sai/AGX-5170-2022; Fukami, Kaoru/N-7896-2015; Maggi, Leonard/L-5217-2019; Hermjakob, Henning/AFM-3497-2022; Deloukas, Panos/B-2922-2013; Ponting, Chris/AAV-2621-2021; Marra, Marco A/B-5987-2008; Wilson, Richard K./AAF-4139-2019; Schmutz, Jeremy/N-3173-2013; Mardis, Elaine/W-2202-2019; Itoh, Takehiko/E-8873-2014; Taylor, Todd/A-7121-2009; Stupka, Elia/J-6279-2012; Szustakowski, Joseph/HGB-2712-2022; Schultz, Joerg/B-9346-2008; Hattori, Masahira/AAD-3785-2019; Mungall, Andrew J./U-7067-2018; Baum, Dana A./B-3720-2008; Santoyo-Lopez, Javier/C-9714-2012; Lowe, Todd Michael/ABJ-5261-2022; Kucherlapati, Raju/ABC-8807-2021; Hattori, Masahira/C-6958-2016; 郑, 征/C-8514-2011; Glöckner, Gernot/A-7800-2010; Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Seaman, Steven/A-2755-2013; Bork, Peer/F-1813-2013; McPherson, John D/D-2633-2017; Weinstock, George M/C-6314-2013; Li, Shuangding/C-1455-2011; Gish, Warren/C-8123-2012; THIERRY-MIEG, Jean/F-1975-2017; Durbin, Richard/AAE-7178-2019; Bateman, Alex/E-6518-2011; Mesirov, Jill/AGF-7626-2022; Deschamps, Stephane/R-3806-2019; Duan, Yanwu/A-5786-2015; Hokamp, Karsten/C-5534-2009; Burge, Christopher B./AAH-2177-2020; Li, Wei/A-8544-2009; Bateman, Alex/H-2861-2019; Grimwood, Jane/ABD-5737-2021; Mikkelsen, Tarjei S/A-1306-2007; Wolfe, Kenneth H/B-4653-2009; Wendl, Michael C/A-2741-2008; Smith, Andy/A-7512-2011; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Maggi, Leonard/0000-0003-0138-0984; Hermjakob, Henning/0000-0001-8479-0262; Deloukas, Panos/0000-0001-9251-070X; Marra, Marco A/0000-0001-7146-7175; Wilson, Richard K./0000-0002-1992-1358; Schmutz, Jeremy/0000-0001-8062-9172; Itoh, Takehiko/0000-0002-6113-557X; Taylor, Todd/0000-0003-4247-6253; Stupka, Elia/0000-0003-3154-4011; Mungall, Andrew J./0000-0002-0905-2742; Baum, Dana A./0000-0002-2777-1708; Santoyo-Lopez, Javier/0000-0003-1988-5059; Hattori, Masahira/0000-0001-9467-0344; Glöckner, Gernot/0000-0002-9061-1061; Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Seaman, Steven/0000-0003-3349-3334; Bork, Peer/0000-0002-2627-833X; McPherson, John D/0000-0001-8049-9347; Weinstock, George M/0000-0002-2997-4592; THIERRY-MIEG, Jean/0000-0002-0396-6789; Durbin, Richard/0000-0002-9130-1006; Duan, Yanwu/0000-0002-6000-0534; Bateman, Alex/0000-0002-6982-4660; Mikkelsen, Tarjei S/0000-0002-8133-3135; Smith, Andy/0000-0001-8580-278X; Rubin, Irit/0000-0003-2377-3498; Hunt, Adrienne/0000-0002-1227-0310; Worley, Kim/0000-0002-0282-1000; Gregory, Simon/0000-0002-7805-1743; McLysaght, Aoife/0000-0003-2552-6220; McKernan, Kevin/0000-0002-3908-1122; McCombie, W. Richard/0000-0003-1899-0682; Thierry-Mieg, Danielle/0000-0001-9568-4211; Reinhardt, Richard/0000-0001-9376-2132; Pan, Huaqin/0000-0002-7166-108X; Mulder, Nicola J/0000-0003-4905-0941; Galagan, James/0000-0003-0542-3291; Wolfe, Kenneth/0000-0003-4992-4979; Steward, Charles/0000-0001-8829-5349; Kulp, David/0000-0001-6540-0222; Ponting, Chris/0000-0003-0202-7816; Pelletier, Eric/0000-0003-4228-1712; Szustakowski, Joseph/0000-0001-7900-3973; Hokamp, Karsten/0000-0001-7464-2370; Kaul, Rajinder/0000-0002-7895-9284; Eddy, Sean/0000-0001-6676-4706; Wang, Jun/0000-0002-8540-8931; Qureshi, Matloob/0000-0003-2208-4236; Gilbert, James/0000-0001-8079-3159; Aravind, L/0000-0003-0771-253X; Koculi, Eda/0000-0001-9477-555X; Brown, Dan/0000-0002-5205-5762; Glusman, Gustavo/0000-0001-8060-5955; Martin, Sancha/0000-0001-6213-5259; Slater, Guy/0000-0002-4202-8285; Wang, Jun/0000-0002-2113-5874; Dunham, Ian/0000-0003-2525-5598; Cheng, Jan-Fang/0000-0001-7315-7613; Rump, Andreas/0000-0001-7116-6364; Birney, Ewan/0000-0001-8314-8497; Sai Ganesh, Dunna/0000-0002-3570-7466; Chinwalla, Asif/0000-0001-7831-3996; Furey, Terry/0000-0001-5546-9672; Schultz, Brian/0000-0003-4964-976X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; ADAMS MD, 1995, NATURE, V377, P3; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; ANDERSON S, 1981, NUCLEIC ACIDS RES, V9, P3015, DOI 10.1093/nar/9.13.3015; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 1966, VERTEBRATE PALEONTOL; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Aravind L, 1999, CURR OPIN GENET DEV, V9, P688, DOI 10.1016/S0959-437X(99)00028-3; Arcot SS, 1998, J MOL BIOL, V281, P843, DOI 10.1006/jmbi.1998.1984; ARNOLD N, 1995, GENOMICS, V26, P147, DOI 10.1016/0888-7543(95)80095-4; Attwood TK, 2000, NUCLEIC ACIDS RES, V28, P225, DOI 10.1093/nar/28.1.225; Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053; Bachellerie J. P., 1998, MODIFICATION EDITING, P255; Bailey LC, 1998, GENOME RES, V8, P362, DOI 10.1101/gr.8.4.362; BAINS W, 1992, MUTAT RES, V267, P43, DOI 10.1016/0027-5107(92)90109-F; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bateman A, 2000, ADV PROTEIN CHEM, V54, P137, DOI 10.1016/S0065-3233(00)54005-4; Bateman A, 1996, PROTEIN SCI, V5, P1939, DOI 10.1002/pro.5560050923; Beck S, 1999, NAT BIOTECHNOL, V17, P1144, DOI 10.1038/70651; Bentley DR, 1996, SCIENCE, V274, P533, DOI 10.1126/science.274.5287.533; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BERRY R, 1995, NAT GENET, V10, P415, DOI 10.1038/ng0895-415; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Birney E, 1996, NUCLEIC ACIDS RES, V24, P2730, DOI 10.1093/nar/24.14.2730; Bishop J. ., 1990, GENOME; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bouck J, 1998, GENOME RES, V8, P1074, DOI 10.1101/gr.8.10.1074; Bouck JB, 2000, NAT GENET, V25, P31, DOI 10.1038/75563; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Brand-Arpon V, 1999, GENOMICS, V56, P98, DOI 10.1006/geno.1998.5690; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; Buckley L. J., 1992, Smart Materials and Structures, V1, P1, DOI 10.1088/0964-1726/1/1/001; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Carlo T, 1996, RNA, V2, P342; Casavant NC, 2000, GENETICS, V154, P1809; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chan MF, 2000, CURR TOP MICROBIOL, V249, P75; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; CHENG Y, 2000, ISMB, V8, P93; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; CHISSOE SL, 1995, GENOMICS, V27, P67, DOI 10.1006/geno.1995.1008; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; CHURCHILL GA, 1989, B MATH BIOL, V51, P79; Clark JB, 1997, P NATL ACAD SCI USA, V94, P11428, DOI 10.1073/pnas.94.21.11428; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; Cook-Deegan Robert M., 1994, GENE WARS SCI POLITI; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; CORDONNIER A, 1995, J VIROL, V69, P5890, DOI 10.1128/JVI.69.9.5890-5897.1995; Correns C., 1899, BERICHTE DTSCH BOT G, V17, P410; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COX D, IN PRESS SCIENCE; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; DEININGER PL, 1983, ANAL BIOCHEM, V129, P216, DOI 10.1016/0003-2697(83)90072-6; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; DEVFRIES H, 1900, ACAD SCI PARIS, V130, P845; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIETRICH W, 1992, GENETICS, V131, P423; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Drews J, 1999, NAT BIOTECHNOL, V17, P406, DOI 10.1038/8531; Dunham I, 2000, YEAST, V17, P218, DOI 10.1002/1097-0061(20000930)17:3<218::AID-YEA37>3.0.CO;2-X; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; DURET L, 1995, J MOL EVOL, V40, P308, DOI 10.1007/BF00163235; Eddy SR, 1999, CURR OPIN GENET DEV, V9, P695, DOI 10.1016/S0959-437X(99)00022-2; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; Eichler EE, 1999, GENOME RES, V9, P1048, DOI 10.1101/gr.9.11.1048; Eliot T.S., 1936, TS ELIOT COLLECTED P; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Eyre-Walker A, 1999, GENETICS, V152, P675; Fahrer AM, 2001, NATURE, V409, P836, DOI 10.1038/35057020; FAN W, 1999, SCIENCE, V286, pA1255; Feil R, 1999, TRENDS GENET, V15, P431, DOI 10.1016/S0168-9525(99)01822-3; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FICKETT JW, 1992, GENOMICS, V13, P1056, DOI 10.1016/0888-7543(92)90019-O; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; FIERS W, 1978, NATURE, V273, P113, DOI 10.1038/273113a0; FILIPSKI J, 1987, FEBS LETT, V217, P184, DOI 10.1016/0014-5793(87)80660-9; Firestein S, 2000, NATURE, V404, P552, DOI 10.1038/35007167; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FRASER JRE, 1996, EXTRACELLULAR MATRIX, V2, P141; Fuchs T, 2001, HUM GENET, V108, P1, DOI 10.1007/s004390000436; Gao LI, 1997, NUCLEIC ACIDS RES, V25, P4740, DOI 10.1093/nar/25.23.4740; Gardiner K, 1996, TRENDS GENET, V12, P519, DOI 10.1016/S0168-9525(97)81400-X; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GARDNER RC, 1981, NUCLEIC ACIDS RES, V9, P2871, DOI 10.1093/nar/9.12.2871; GEARHART J, 1997, CELLS EMBRYOS EVOLUT; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Gelfand MS, 1996, P NATL ACAD SCI USA, V93, P9061, DOI 10.1073/pnas.93.17.9061; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gilad Y, 2000, NAT GENET, V26, P221, DOI 10.1038/79957; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; GONOS ES, 1990, FEBS LETT, V276, P138, DOI 10.1016/0014-5793(90)80527-P; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; GREEN P, 1993, SCIENCE, V259, P1711, DOI 10.1126/science.8456298; Green P, 1997, GENOME RES, V7, P410, DOI 10.1101/gr.7.5.410; Gregory TR, 1999, GENOME RES, V9, P317; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Guthrie C., 1982, MOL BIOL YEAST SACCH, P487; GUTTMAN A, 1990, ANAL CHEM, V62, P137, DOI 10.1021/ac00201a010; Guy J, 2000, HUM MOL GENET, V9, P2029, DOI 10.1093/hmg/9.13.2029; Guyer M, 1998, GENOME RES, V8, P413; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hagmann M, 2000, SCIENCE, V288, P945; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; Haring E, 2000, J MOL EVOL, V51, P577, DOI 10.1007/s002390010121; Hartl DL, 2000, NAT REV GENET, V1, P145, DOI 10.1038/35038580; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HATLEN L, 1971, J MOL BIOL, V56, P535, DOI 10.1016/0022-2836(71)90400-1; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; HOLMQUIST GP, 1994, TRENDS ECOL EVOL, V9, P65, DOI 10.1016/0169-5347(94)90277-1; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; HOULGATTE R, 1995, GENOME RES, V5, P272, DOI 10.1101/gr.5.3.272; Hubbard T, 2000, NATURE, V403, P825, DOI 10.1038/35002770; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Hughes AL, 1999, J MOL EVOL, V48, P565, DOI 10.1007/PL00006499; Hurst LD, 2000, BIOESSAYS, V22, P105, DOI 10.1002/(SICI)1521-1878(200002)22:2<105::AID-BIES1>3.0.CO;2-S; Hurvitz JR, 1999, NAT GENET, V23, P94, DOI 10.1038/12699; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; *INT SNP MAP WORK, 2000, NATURE, V407, P513; JANIN J, 1985, METHOD ENZYMOL, V115, P420; Jenczewski E, 1999, MOL ECOL, V8, P1317, DOI 10.1046/j.1365-294X.1999.00697.x; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; JU JY, 1995, P NATL ACAD SCI USA, V92, P4347, DOI 10.1073/pnas.92.10.4347; Jurka J, 1999, GENETICA, V107, P239, DOI 10.1023/A:1003989620068; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; KENT WJ, 2001, UCSCCRL0017; KEVLES DJ, 1992, CODE COPDES SCI SOCI; Kickhoefer VA, 1996, TRENDS CELL BIOL, V6, P174, DOI 10.1016/0962-8924(96)10014-3; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Koga A, 2000, GENETICS, V155, P273; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; KOOP BF, 1992, GENOMICS, V13, P1209, DOI 10.1016/0888-7543(92)90039-U; Kordis D, 1997, EUR J BIOCHEM, V246, P772, DOI 10.1111/j.1432-1033.1997.00772.x; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; KULP D, 1996, ISMB, V4, P134; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; LANDER E S, 1988, Genomics, V2, P231; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Lee LG, 1997, NUCLEIC ACIDS RES, V25, P2816, DOI 10.1093/nar/25.14.2816; LEWIN B, 1990, GENES, V4, P466; LEWIS B, 1980, GENE EXPRESSION; Li TH, 1999, GENE, V239, P367, DOI 10.1016/S0378-1119(99)00384-4; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; LI WH, 1998, MOL EVOLUTION; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; LINDGREN V, 1985, NATURE, V314, P115, DOI 10.1038/314115a0; LITTLE RD, 1989, GENOMICS, V4, P376, DOI 10.1016/0888-7543(89)90345-5; LIU WM, 1995, NUCLEIC ACIDS RES, V23, P1758, DOI 10.1093/nar/23.10.1758; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; LUCKEY JA, 1990, NUCLEIC ACIDS RES, V18, P4417, DOI 10.1093/nar/18.15.4417; LUNDGREN R, 1991, CANCER GENET CYTOGEN, V51, P57, DOI 10.1016/0165-4608(91)90008-I; Lynn A, 2000, GENOME RES, V10, P1319, DOI 10.1101/gr.138100; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; Mahairas GG, 1999, P NATL ACAD SCI USA, V96, P9739, DOI 10.1073/pnas.96.17.9739; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Malik HS, 2000, GENETICS, V154, P193; MANUELIDIS L, 1984, CHROMOSOMA, V91, P28, DOI 10.1007/BF00286482; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Marshall E, 1998, SCIENCE, V281, P1774, DOI 10.1126/science.281.5384.1774; Marshall E, 2000, SCIENCE, V290, P242; Marshall E, 1998, SCIENCE, V281, P1121; MARSHALL E, 1995, SCIENCE, V267, P783, DOI 10.1126/science.7846520; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; MARTINGALLARDO A, 1992, NAT GENET, V1, P34, DOI 10.1038/ng0492-34; Mateu E, 2001, AM J HUM GENET, V68, P103, DOI 10.1086/316940; MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; McGuire AM, 2000, GENOME RES, V10, P744, DOI 10.1101/gr.10.6.744; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; McLysaght A, 2000, YEAST, V17, P22, DOI 10.1002/(SICI)1097-0061(200004)17:1<22::AID-YEA5>3.0.CO;2-S; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; Meldrum D, 2000, GENOME RES, V10, P1081, DOI 10.1101/gr.101400; Meldrum D, 2000, GENOME RES, V10, P1288, DOI 10.1101/gr.157400; Metzker ML, 1996, SCIENCE, V271, P1420, DOI 10.1126/science.271.5254.1420; MEUNIERROTIVAL M, 1982, P NATL ACAD SCI-BIOL, V79, P355, DOI 10.1073/pnas.79.2.355; MIKI Y, 1992, CANCER RES, V52, P643; MILNER RJ, 1983, NUCLEIC ACIDS RES, V11, P5497, DOI 10.1093/nar/11.16.5497; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Montgomery KT, 2001, NATURE, V409, P945, DOI 10.1038/35057174; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Moran JV, 1999, GENETICA, V107, P39, DOI 10.1023/A:1004035023356; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Mott R, 1999, J COMPUT BIOL, V6, P91, DOI 10.1089/cmb.1999.6.91; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Murray AW, 2001, NATURE, V409, P844, DOI 10.1038/35057033; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nadeau JH, 1998, MAMM GENOME, V9, P491, DOI 10.1007/s003359900806; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; NADEAU JH, 1989, TRENDS GENET, V5, P82, DOI 10.1016/0168-9525(89)90031-0; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Natl. Res. Council, 1988, MAPP SEQ HUM GEN; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Nusbaum C, 1999, NAT GENET, V22, P388, DOI 10.1038/11967; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Ohno S., 1970, P1; Okada N, 1997, GENE, V205, P229, DOI 10.1016/S0378-1119(97)00409-5; OKEEFE C, 2000, COMP GENOMICS, P29; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Olivieri NF, 1998, HUM MOL GENET, V7, P1655, DOI 10.1093/hmg/7.10.1655; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; Onyango P, 2000, GENOME RES, V10, P1697, DOI 10.1101/gr.161800; Osoegawa K, 2000, GENOME RES, V10, P116; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; PALCA J, 1986, NATURE, V321, P371; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Paterson AH, 1996, NAT GENET, V14, P380, DOI 10.1038/ng1296-380; Pavelitz T, 1999, EMBO J, V18, P3783, DOI 10.1093/emboj/18.13.3783; Pennisi E, 1999, SCIENCE, V283, P1822, DOI 10.1126/science.283.5409.1822; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Pletcher MT, 2000, GENOME RES, V10, P1463, DOI 10.1101/gr.146600; PODUGOLNIKOVA OA, 1983, HUM GENET, V63, P183, DOI 10.1007/BF00291542; Pollard TD, 2001, NATURE, V409, P842, DOI 10.1038/35057029; Ponting CP, 2000, ADV PROTEIN CHEM, V54, P185, DOI 10.1016/S0065-3233(00)54007-8; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Porter TL, 1997, RRD POLYM SCI, V1, P1; Potier MC, 1998, GENOMICS, V51, P417, DOI 10.1006/geno.1998.5389; Prak ETL, 2000, NAT REV GENET, V1, P134; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; PUTNEY SD, 1983, NATURE, V302, P718, DOI 10.1038/302718a0; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; REEVE MA, 1995, NATURE, V376, P796, DOI 10.1038/376796a0; Regnier V, 1997, HUM MOL GENET, V6, P9, DOI 10.1093/hmg/6.1.9; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; RILES L, 1993, GENETICS, V134, P81; Ritchie RJ, 1998, HUM MOL GENET, V7, P1253, DOI 10.1093/hmg/7.8.1253; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rosenblum BB, 1997, NUCLEIC ACIDS RES, V25, P4500, DOI 10.1093/nar/25.22.4500; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ruiz-Perez VL, 2000, NAT GENET, V24, P283, DOI 10.1038/73508; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sacksteder KA, 2000, AM J HUM GENET, V66, P1736, DOI 10.1086/302919; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; SARICH VM, 1973, SCIENCE, V179, P1144, DOI 10.1126/science.179.4078.1144; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Saunders AJ, 1999, SCIENCE, V286; Schmid CW, 1998, NUCLEIC ACIDS RES, V26, P4541, DOI 10.1093/nar/26.20.4541; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Seri M, 2000, NAT GENET, V26, P103; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; SHARP PM, 1994, CURR OPIN GENET DEV, V4, P851, DOI 10.1016/0959-437X(94)90070-1; SHASHOUA VE, 1991, ANN NY ACAD SCI, V627, P94; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; SIDOW A, 1994, CURR BIOL, V4, P596, DOI 10.1016/S0960-9822(00)00131-7; Sidow A, 1991, CURR OPIN GENET DEV, V1, P451, DOI 10.1016/S0959-437X(05)80191-1; SIMMONS GM, 1992, MOL BIOL EVOL, V9, P1050; SINSHEIMER RL, 1989, GENOMICS, V5, P954, DOI 10.1016/0888-7543(89)90142-0; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Skrabanek L, 1998, CURR OPIN GENET DEV, V8, P694, DOI 10.1016/S0959-437X(98)80039-7; Smaglik P, 2000, NATURE, V405, P264, DOI 10.1038/35012771; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; Solovyev V, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P294; SORENSEN PD, 1991, NUCLEIC ACIDS RES, V19, P4147, DOI 10.1093/nar/19.15.4147; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Su┬ll D., 1995, TRNA STRUCTURE BIOSY; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; SWERDLOW H, 1990, J CHROMATOGR, V516, P61, DOI 10.1016/S0021-9673(01)90204-3; SYLVESTER JE, 1986, HUM GENET, V73, P193, DOI 10.1007/BF00401226; TABOR S, 1990, J BIOL CHEM, V265, P8322; TABOR S, 1989, J BIOL CHEM, V264, P6447; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; Thomas JW, 2000, GENOME RES, V10, P624, DOI 10.1101/gr.10.5.624; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Timofeeva M. Ya., 1993, Molekulyarnaya Biologiya (Moscow), V27, P861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Trachtulec Z, 1997, GENOMICS, V44, P1, DOI 10.1006/geno.1997.4839; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; Tschermak-Seysenegg Ev, 1900, BERICHTE DTSCH BOTAN, V18, P232; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Tycowski KT, 1998, MOL CELL, V2, P629, DOI 10.1016/S1097-2765(00)80161-6; van Geel M, 1999, GENOMICS, V61, P55, DOI 10.1006/geno.1999.5942; Van Laer L, 1998, NAT GENET, V20, P194; VANARSDELL SW, 1984, MOL CELL BIOL, V4, P492, DOI 10.1128/MCB.4.3.492; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf YI, 2000, TRENDS GENET, V16, P333, DOI 10.1016/S0168-9525(00)02059-X; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wolfsberg TG, 2001, NATURE, V409, P824, DOI 10.1038/35057000; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; ZACHAU HG, 1993, GENE, V135, P167, DOI 10.1016/0378-1119(93)90062-8; Zhang J, 1999, GENETICS, V153, P1403; Zhang JZ, 2000, P NATL ACAD SCI USA, V97, P4701, DOI 10.1073/pnas.080071397; Zhao S, 2000, GENOMICS, V63, P321, DOI 10.1006/geno.1999.6082; Zimonjic DB, 1997, P NATL ACAD SCI USA, V94, P11461, DOI 10.1073/pnas.94.21.11461; Zoubak S, 1996, GENE, V174, P95, DOI 10.1016/0378-1119(96)00393-9; 1995, NATURE, V375, P93	449	15724	16468	62	3069	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					860	921		10.1038/35057062	http://dx.doi.org/10.1038/35057062			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237011	hybrid, Green Published			2022-12-28	WOS:000166938800058
J	Pollard, TD				Pollard, TD			Genomics, the cytoskeleton and motility	NATURE			English	Article							BETA-ACTIN; PSEUDOGENES; PROTEINS	The draft human genome sequence is an important step in cataloguing the molecular hardware that supports the processes of life. Here I look at what we have learned from the draft sequence about our cytoskeletal and motility systems. Most cytoskeletal and motility proteins were discovered previously by biochemical isolation, traditional cloning methods or random sequences of complementary DNAs. The ongoing challenges of assembling and annotating genes for motor proteins with long, fragmented coding sequences emphasize the importance of expert knowledge of related proteins and confirmatory evidence from cDNA sequences.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Pollard, TD (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							BERG JS, IN PRESS MOL BIOL CE; Brinkman FSL, 2000, NATURE, V406, P933, DOI 10.1038/35023188; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Kreis T., 1999, GUIDEBOOK CYTOSKELET, V2nd; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; Schafer DA, 1999, ANNU REV CELL DEV BI, V15, P341, DOI 10.1146/annurev.cellbio.15.1.341; SCHROER TA, 1994, J CELL BIOL, V127, P1777, DOI 10.1083/jcb.127.6.1777; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3; Ueyama H, 1996, CYTOGENET CELL GENET, V74, P221, DOI 10.1159/000134420	10	42	45	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					842	843		10.1038/35057029	http://dx.doi.org/10.1038/35057029			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237005	Bronze			2022-12-28	WOS:000166938800052
J	Woods, P				Woods, P			Radioactivity - Are protons leaving in pairs?	SCIENCE			English	Editorial Material							2-PROTON EMISSION		Univ Edinburgh, Dept Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland	University of Edinburgh	Woods, P (corresponding author), Univ Edinburgh, Dept Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland.							Bain CR, 1996, PHYS LETT B, V373, P35, DOI 10.1016/0370-2693(96)00109-8; Blank B, 2000, PHYS REV LETT, V84, P1116, DOI 10.1103/PhysRevLett.84.1116; BOCHKAREV OV, 1989, NUCL PHYS A, V505, P215, DOI 10.1016/0375-9474(89)90371-0; del Campo JG, 2001, PHYS REV LETT, V86, P43, DOI 10.1103/PhysRevLett.86.43; GOLDANSKY VI, 1960, NUCL PHYS, V19, P482, DOI 10.1016/0029-5582(60)90258-3; Grigorenko LV, 2000, PHYS REV LETT, V85, P22, DOI 10.1103/PhysRevLett.85.22; KRYGER RA, 1995, PHYS REV LETT, V74, P860, DOI 10.1103/PhysRevLett.74.860; Sherr R, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.064323; Woods PJ, 1997, ANNU REV NUCL PART S, V47, P541, DOI 10.1146/annurev.nucl.47.1.541	9	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					995	+		10.1126/science.1059051	http://dx.doi.org/10.1126/science.1059051			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232587				2022-12-28	WOS:000166860100031
J	Demetriou, M; Granovsky, M; Quaggin, S; Dennis, JW				Demetriou, M; Granovsky, M; Quaggin, S; Dennis, JW			Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation	NATURE			English	Article							MEMBRANE MICRODOMAINS; RECEPTOR; BINDING; LECTIN; ENCEPHALOMYELITIS; COSTIMULATION; GALECTIN-1; APOPTOSIS; BIOSYNTHESIS; SEGREGATION	T-cell activation requires clustering of a threshold number of T-cell receptors (TCRs) at the site of antigen presentation, a number that is reduced by CD28 co-receptor recruitment of signalling proteins to TCRs(1-5). Here we demonstrate that a deficiency in beta1,6 N-acetylglucosaminyltransferase V (Mgat5), an enzyme in the N-glycosylation pathway, lowers T-cell activation thresholds by directly enhancing TCR clustering. Mgat5-deficient mice showed kidney autoimmune disease, enhanced delayed-type hypersensitivity, and increased susceptibility to experimental autoimmune encephalomyelitis. Recruitment of TCRs to agonist-coated beads, TCR signalling, actin microfilament re-organization, and agonist-induced proliferation were all enhanced in Mgat5(-/-) T cells. Mgat5 initiates GlcNAc beta1,6 branching on N-glycans, thereby increasing N-acetyllactosamine(6), the ligand for galectins(7,8), which are proteins known to modulate T-cell proliferation and apoptosis(9,10). Indeed, galectin-3 was associated with the TCR complex at the cell surface, an interaction dependent on Mgat5. Pre-treatment of wild-type T cells with lactose to compete for galectin binding produced a phenocopy of Mgat5(-/-) TCR clustering. These data indicate that a galectin-glycoprotein lattice strengthened by Mgat5-modified glycans restricts TCR recruitment to the site of antigen presentation. Dysregulation of Mgat5 in humans may increase susceptibility to autoimmune diseases, such as multiple sclerosis.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave,R988, Toronto, ON M5G 1X5, Canada.		Dennis, James/E-7268-2013					Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; CUMMINGS RD, 1984, J BIOL CHEM, V259, P6253; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Granovsky M, 2000, NAT MED, V6, P306; HUBBARD SC, 1986, P NATL ACAD SCI USA, V83, P1852, DOI 10.1073/pnas.83.6.1852; Karsan A, 1998, J CLIN INVEST, V101, P2438, DOI 10.1172/JCI905; KNIBBS RN, 1993, J BIOL CHEM, V268, P14940; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; OFFNER H, 1990, J NEUROIMMUNOL, V28, P177, DOI 10.1016/0165-5728(90)90032-I; Oliveira-dos-Santos AJ, 1999, J IMMUNOL, V162, P4490; Pace KE, 1999, J IMMUNOL, V163, P3801; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; Reif K, 1998, IMMUNITY, V8, P395, DOI 10.1016/S1074-7613(00)80545-2; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; SATO S, 1992, J BIOL CHEM, V267, P6983; TREVILLYAN JM, 1990, J IMMUNOL, V145, P3223; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Vespa GNR, 1999, J IMMUNOL, V162, P799; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WALL KA, 1988, P NATL ACAD SCI USA, V85, P5644, DOI 10.1073/pnas.85.15.5644; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	30	691	703	3	52	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					733	739		10.1038/35055582	http://dx.doi.org/10.1038/35055582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217864				2022-12-28	WOS:000166816400047
J	Graham, DW; Lupton, JE; Spera, FJ; Christie, DM				Graham, DW; Lupton, JE; Spera, FJ; Christie, DM			Upper-mantle dynamics revealed by helium isotope variations along the southeast Indian ridge	NATURE			English	Article							CONVECTION; BASALTS; TRACER	Helium isotope variations in igneous rocks are important for relating isotopic heterogeneity to convective mixing in the Earth's mantle. High He-3/He-4 ratios at many ocean islands, along with lower and relatively uniform values in mid-ocean-ridge basalts (MORBs), are thought to result from a well mixed upper-mantle source for MORB and a distinct deeper-mantle source for ocean island basalts(1). At finer scales, He-3/He-4 variations along mid-ocean ridges have been related to underlying mantle heterogeneity(2,3), but relationships between the scales of geochemical segmentation and mantle convection remain enigmatic. Here we present helium isotope data for MORB glasses recovered along similar to5,800 km of the southeast Indian ridge, and develop an approach to quantitatively relate spatial variations in geochemical and geophysical parameters at the Earth's surface. A point-to-point correlation analysis reveals structure in the helium isotope data at length scales of similar to 150 and similar to 400 km that appears to be related to secondary convection in the underlying mantle.	Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; NOAA, Pacific Marine Environm Lab, Hatfield Marine Sci Ctr, Newport, OR 97365 USA; Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Barbara	Graham, DW (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA.		Graham, David/C-3612-2014	Graham, David/0000-0002-7411-1905; spera, frank/0000-0002-6876-9313				ALLEGRE CJ, 1986, NATURE, V323, P123, DOI 10.1038/323123a0; Anderson DL, 1998, TECTONOPHYSICS, V284, P1, DOI 10.1016/S0040-1951(97)00169-8; BAUDRY N, 1991, EARTH PLANET SC LETT, V102, P430, DOI 10.1016/0012-821X(91)90033-E; CAMASSA R, 1991, PHYSICA D, V51, P472, DOI 10.1016/0167-2789(91)90253-6; DANCKWERTS PV, 1952, APPL SCI RES, V3, P279, DOI 10.1007/BF03184936; DUNCAN RA, 1992, GEOPHYS MONOGR SER, V70, P91; GRAHAM D, 1990, NATURE, V347, P545, DOI 10.1038/347545a0; GRAHAM D, 1990, P 7 INT C GEOCHR COM, V27, P41; Graham DW, 1999, EARTH PLANET SC LETT, V167, P297, DOI 10.1016/S0012-821X(99)00030-8; GRIPP AE, 1990, GEOPHYS RES LETT, V17, P1109, DOI 10.1029/GL017i008p01109; GURNIS M, 1986, GEOPHYS RES LETT, V13, P1474, DOI 10.1029/GL013i013p01474; HAXBY WF, 1986, J GEOPHYS RES-SOLID, V91, P3507, DOI 10.1029/JB091iB03p03507; Hirschmann MM, 1996, CONTRIB MINERAL PETR, V124, P185, DOI 10.1007/s004100050184; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; KLEIN EM, 1991, J GEOPHYS RES-SOLID, V96, P2089, DOI 10.1029/90JB01384; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; LUPTON JE, 1983, ANNU REV EARTH PL SC, V11, P371, DOI 10.1146/annurev.ea.11.050183.002103; LUPTON JE, 1993, GEOPHYS RES LETT, V20, P1851, DOI 10.1029/93GL01271; MAHONEY JJ, 1994, EARTH PLANET SC LETT, V121, P173, DOI 10.1016/0012-821X(94)90039-6; OLDENBURG CM, 1989, J GEOPHYS RES-SOLID, V94, P9215, DOI 10.1029/JB094iB07p09215; PRIEBE LMD, 1998, THESIS OREGON STATE; PYLE DG, 1994, THESIS OREGON STATE; RICHTER FM, 1979, EARTH PLANET SC LETT, V43, P212, DOI 10.1016/0012-821X(79)90204-8; Sempere JC, 1997, J GEOPHYS RES-SOL EA, V102, P15489, DOI 10.1029/97JB00171; SEMPERE JC, 1991, GEOLOGY, V19, P429, DOI 10.1130/0091-7613(1991)019<0429:AAD>2.3.CO;2; Small C, 1999, MAR GEOL, V161, P1, DOI 10.1016/S0025-3227(99)00051-1; SOURSPAGE RE, 2000, THESIS OREGON STATE; Sturm ME, 1999, J GEOPHYS RES-SOL EA, V104, P5097, DOI 10.1029/1998JB900107; Taylor GI, 1935, PROC R SOC LON SER-A, V151, P0421, DOI 10.1098/rspa.1935.0158; VANKEKEN PE, 1995, J GEOPHYS RES-SOL EA, V100, P20291, DOI 10.1029/95JB01152	30	40	41	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					701	703		10.1038/35055529	http://dx.doi.org/10.1038/35055529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217856				2022-12-28	WOS:000166816400039
J	Vester, U; Kranz, B; Treichel, U; Hoyer, PF				Vester, U; Kranz, B; Treichel, U; Hoyer, PF			Basiliximab in paediatric liver-transplant recipients	LANCET			English	Letter							RECEPTOR		Univ Essen Gesamthsch, Dept Paediat Nephrol, D-45122 Essen, Germany; Univ Essen Gesamthsch, Dept Gastroenterol & Hepatol, D-45122 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Vester, U (corresponding author), Univ Essen Gesamthsch, Dept Paediat Nephrol, D-45122 Essen, Germany.							Johnston A, 2000, TRANSPLANT P, V32, p53S, DOI 10.1016/S0041-1345(00)00864-2; Mahalati K, 1999, TRANSPLANTATION, V68, P55, DOI 10.1097/00007890-199907150-00011; Strehlau J, 2000, LANCET, V356, P1327, DOI 10.1016/S0140-6736(00)02822-1; TREICHEL U, 1994, J CELL PHYSIOL, V158, P527, DOI 10.1002/jcp.1041580319; WALDMANN TA, 1991, J BIOL CHEM, V266, P2681	5	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					388	389		10.1016/S0140-6736(05)71516-6	http://dx.doi.org/10.1016/S0140-6736(05)71516-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11211017	Bronze			2022-12-28	WOS:000166897900040
J	Constantinou, A; Davies, AA; West, SC				Constantinou, A; Davies, AA; West, SC			Branch migration and Holliday junction resolution catalyzed by activities from mammalian cells	CELL			English	Article							HOMOLOGY-DIRECTED REPAIR; DOUBLE-STRAND BREAKS; RUVB-LIKE PROTEIN; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; IN-VITRO; GENETIC-RECOMBINATION; RESOLVING ENZYME; DNA HELICASE; RUVABC	During homologous recombination, DNA strand exchange leads to Holliday junction formation. The movement, or branch migration, of this junction along DNA extends the length of the heteroduplex joint. In prokaryotes, branch migration and Holliday junction resolution are catalyzed by the RuvA and RuvB proteins, which form a complex with RuvC resolvase to form a "resolvasome". Mammalian cell-free extracts have now been fractionated to reveal analogous activities. An ATP-dependent branch migration activity, which migrates junctions through >2700 bp, cofractionates with the Holliday junction resolvase during several chromatographic steps. Together, the two activities promote concerted branch migration/resolution reactions similar to those catalyzed by E. coli RuvABC, highlighting the preservation of this essential pathway in recombination and DNA repair from prokaryotes to mammals.	Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England		West, SC (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.		Constantinou, Angelos/E-5337-2013	Constantinou, Angelos/0000-0002-2994-8140; West, Stephen/0000-0001-8848-9418				Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; BENSON FE, 1994, J BIOL CHEM, V269, P5195; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P3084, DOI 10.1093/nar/26.13.3084; Chakraverty RK, 1999, BIOESSAYS, V21, P286; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; Davies AA, 1998, CURR BIOL, V8, P725, DOI 10.1016/S0960-9822(98)70282-9; Doe CL, 2000, MOL GEN GENET, V263, P889, DOI 10.1007/s004380000256; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; ELBOROUGH KM, 1990, EMBO J, V9, P2931, DOI 10.1002/j.1460-2075.1990.tb07484.x; Fogg JM, 1999, BIOCHEMISTRY-US, V38, P11349, DOI 10.1021/bi990926n; Garcia AD, 2000, P NATL ACAD SCI USA, V97, P8926, DOI 10.1073/pnas.150238697; HYDE H, 1994, J BIOL CHEM, V269, P5202; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lilley DMJ, 1999, NAT STRUCT BIOL, V6, P897, DOI 10.1038/13255; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Makino Y, 1999, J BIOL CHEM, V274, P15329, DOI 10.1074/jbc.274.22.15329; MANDAL TN, 1993, J BACTERIOL, V175, P4325, DOI 10.1128/JB.175.14.4325-4334.1993; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; Rothstein R, 2000, GENE DEV, V14, P1; Schofield MJ, 1998, BIOCHEMISTRY-US, V37, P7733, DOI 10.1021/bi980399s; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; SYMINGTON LS, 1985, P NATL ACAD SCI USA, V82, P7247, DOI 10.1073/pnas.82.21.7247; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; van Gool AJ, 1999, GENE DEV, V13, P1861, DOI 10.1101/gad.13.14.1861; WEST SC, 1982, MOL GEN GENET, V187, P209, DOI 10.1007/BF00331119; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Whitby MC, 1997, J MOL BIOL, V272, P509, DOI 10.1006/jmbi.1997.1286; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; White MF, 1996, J MOL BIOL, V257, P330, DOI 10.1006/jmbi.1996.0166; Zerbib D, 1998, J MOL BIOL, V281, P621, DOI 10.1006/jmbi.1998.1959	52	114	116	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					259	268		10.1016/S0092-8674(01)00210-0	http://dx.doi.org/10.1016/S0092-8674(01)00210-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207366	Bronze			2022-12-28	WOS:000166879700009
J	West, SA; Murray, MG; Machado, CA; Griffin, AS; Herre, EA				West, SA; Murray, MG; Machado, CA; Griffin, AS; Herre, EA			Testing Hamilton's rule with competition between relatives	NATURE			English	Article							VISCOUS POPULATIONS; INCLUSIVE FITNESS; KIN SELECTION; FIG WASPS; ENVIRONMENT; EVOLUTION; CONFLICT; ALTRUISM	Hamilton's(1,2) theory of kin selection suggests that individuals should show less aggression, and more altruism, towards closer kin. Recent theoretical work has, however, suggested that competition between relatives can counteract kin selection for altruism(3-11). Unfortunately, factors that tend to increase the average relatedness of interacting individuals-such as limited dispersal-also tend to increase the amount of competition between relatives. Therefore, in most natural systems, the conflicting influences of increased competition and increased relatedness are confounded, limiting attempts to test theory(4,8-10). Fig wasp taxa exhibit varying levels of aggression among non-dispersing males that show a range of average relatedness levels. Thus, across species, the effects of relatedness and competition between relatives can be separated. Here we report that-contrary to Hamilton's original prediction(1,2,12) but in agreement with recent theory(5-11) - the level of fighting between males shows no correlation with the estimated relatedness of interacting males, but is negatively correlated with future mating opportunities.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; Smithsonian Trop Res Inst, Balboa, Panama	University of Edinburgh; Rutgers State University New Brunswick; Smithsonian Institution; Smithsonian Tropical Research Institute	West, SA (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		West, Stuart A/M-3608-2014; Machado, Carlos A/B-8855-2009; Griffin, Ashleigh/C-6244-2014	West, Stuart A/0000-0003-2152-3153; Machado, Carlos A/0000-0003-1546-7415; Griffin, Ashleigh/0000-0001-7674-9825; Murray, Martyn/0000-0003-4371-388X				CARCAMO HA, 1994, OIKOS, V70, P412, DOI 10.2307/3545779; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; DUNN PO, 1995, P ROY SOC B-BIOL SCI, V259, P339, DOI 10.1098/rspb.1995.0050; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; Frank, 1998, FDN SOCIAL EVOLUTION; Grafen A, 1984, BEHAV ECOLOGY EVOLUT, V2, P62; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HAMILTON WD, 1979, REPROD COMPETITION M, P167; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Herre EA, 1997, SOCIAL COMPETITION C, P226; KELLY JK, 1994, THEOR POPUL BIOL, V46, P32, DOI 10.1006/tpbi.1994.1018; Machado CA, 1996, J BIOGEOGR, V23, P531, DOI 10.1111/j.1365-2699.1996.tb00015.x; Machado CA, 1998, THESIS U CALIFORNIA; Magrath RD, 1997, BEHAV ECOL SOCIOBIOL, V41, P185, DOI 10.1007/s002650050378; MURRAY MG, 1987, ANIM BEHAV, V35, P488, DOI 10.1016/S0003-3472(87)80274-9; MURRAY MG, 1989, ANIM BEHAV, V38, P186, DOI 10.1016/S0003-3472(89)80081-8; MURRAY MG, 1984, J THEOR BIOL, V111, P237, DOI 10.1016/S0022-5193(84)80208-8; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; QUELLER DC, 1992, TRENDS ECOL EVOL, V7, P322, DOI 10.1016/0169-5347(92)90120-Z; READ AF, 1995, P ROY SOC B-BIOL SCI, V260, P359, DOI 10.1098/rspb.1995.0105; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; VINCTENT SL, 1991, POLYMORPHISM FIGHTIN; West SA, 2000, P ROY SOC B-BIOL SCI, V267, P257, DOI 10.1098/rspb.2000.0995; West SA, 1998, J EVOLUTION BIOL, V11, P531, DOI 10.1007/s000360050104; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; YANG ZB, 1994, J MOL EVOL, V39, P105	30	204	214	1	91	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					510	513		10.1038/35054057	http://dx.doi.org/10.1038/35054057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206546	Green Published			2022-12-28	WOS:000166570500047
J	Vergote, I; De Brabanter, J; Fyles, A; Bertelsen, K; Einhorn, N; Sevelda, P; Gore, ME; Kaern, J; Verrelst, H; Sjovall, K; Timmerman, D; Vandewalle, J; Van Gramberen, M; Trope, CG				Vergote, I; De Brabanter, J; Fyles, A; Bertelsen, K; Einhorn, N; Sevelda, P; Gore, ME; Kaern, J; Verrelst, H; Sjovall, K; Timmerman, D; Vandewalle, J; Van Gramberen, M; Trope, CG			Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma	LANCET			English	Article							ADJUVANT TREATMENT; CANCER; SURVIVAL; NEOPLASMS; SPREAD; TRIALS	Background Previous studies on prognostic factors in stage I invasive epithelial ovarian carcinoma have been too small for robust conclusions to be reached. We undertook a retrospective study in a large international database to identify the most important prognostic variables. Methods 1545 patients with invasive epithelial ovarian cancer (International Federation of Gynaecology and Obstetrics [FIGO] stage I) were included. The records of these patients were examined and data extracted for univariate and multivariate analysis of disease-free survival in relation to various clinical and pathological variables. Findings The multivariate analyses identified degree of differentiation as the most powerful prognostic indicator of disease-free survival (moderately vs well differentiated hazard ratio 3.13 [95% CI 1.68-5.85], poorly vs well differentiated 8.89 [4.96-15.9]), followed by rupture before surgery (2.65 [1.53-4.56]), rupture during surgery (1.64 [1.07-2.51]), FIGO 1973 stage Ib vs Ia 1.70 [1.01-2.85]) and age (per year 1.02 [1.00-1.03]). When the effects of these factors were accounted for. none of the following were of prognostic value: histological type, dense adhesions, extracapsular growth, ascites, FIGO stage 1988, and size of tumour. Interpretation Degree of differentiation, the most powerful prognostic indicator in stage I ovarian cancer, should be used in decisions on therapy in clinical practice and in the FIGO classification of stage I ovarian cancer. Rupture should be avoided during primary surgery of malignant ovarian tumours confined to the ovaries.	Univ Hosp Leuven, Dept Gynaecol Oncol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Dept Elect Engn, Louvain, Belgium; Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; Odense Univ Hosp, DK-5000 Odense, Denmark; Karolinska Hosp, S-10401 Stockholm, Sweden; Univ Hosp, Vienna, Austria; Royal Marsden NHS Trust, London, England; Norwegian Radium Hosp, Oslo, Norway	KU Leuven; University Hospital Leuven; KU Leuven; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Southern Denmark; Odense University Hospital; Karolinska Institutet; Karolinska University Hospital; University Hospital Vienna; Royal Marsden NHS Foundation Trust; University of Oslo	Vergote, I (corresponding author), Univ Hosp Leuven, Dept Gynaecol Oncol, B-3000 Louvain, Belgium.	Ignace.Vergote@UZ.Kuleuven.ac.be	Timmerman, Dirk/AAD-2363-2019	Timmerman, Dirk/0000-0002-3707-6645; Fyles, Anthony/0000-0002-3633-2483				Ahmed FY, 1996, J CLIN ONCOL, V14, P2968, DOI 10.1200/JCO.1996.14.11.2968; BAAK JPA, 1986, ANAL QUANT CYTOL, V8, P354; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; BEREK JS, 1995, LANCET, V346, P200, DOI 10.1016/S0140-6736(95)91264-9; BERTELSEN K, 1993, INT J GYNECOL CANCER, V3, P211, DOI 10.1046/j.1525-1438.1993.03040211.x; Bolis G, 1995, ANN ONCOL, V6, P887, DOI 10.1093/oxfordjournals.annonc.a059355; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Cox D. R., 1984, ANAL SURVIVAL DATA; DELACUESTA RS, 1994, OBSTET GYNECOL, V84, P1; DEMBO AJ, 1990, OBSTET GYNECOL, V75, P263; FAREWELL VT, 1980, BIOMETRIKA, V67, P273, DOI 10.2307/2335471; FINN CB, 1992, BRIT J OBSTET GYNAEC, V99, P54, DOI 10.1111/j.1471-0528.1992.tb14393.x; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; Kindermann G, 1995, GEBURTSH FRAUENHEILK, V55, P687, DOI 10.1055/s-2007-1022315; Kodama S, 1997, INT J GYNECOL OBSTET, V56, P147, DOI 10.1016/S0020-7292(96)02798-1; Lehner R, 1998, OBSTET GYNECOL, V92, P967, DOI 10.1016/S0029-7844(98)00323-8; Leminen A, 1999, GYNECOL ONCOL, V75, P387, DOI 10.1006/gyno.1999.5596; MAIMAN M, 1991, OBSTET GYNECOL, V77, P563; PETTERSSON F, 1986, ANN REPORT RESULTS T, P110; Schueler JA, 1996, GYNECOL ONCOL, V62, P59, DOI 10.1006/gyno.1996.0190; Serov SF, 1973, INT HISTOLOGICAL CLA, P17; SEVELDA P, 1990, CANCER-AM CANCER SOC, V65, P2349, DOI 10.1002/1097-0142(19900515)65:10<2349::AID-CNCR2820651031>3.0.CO;2-#; SJOVALL K, 1994, INT J GYNECOL CANCER, V4, P333, DOI 10.1046/j.1525-1438.1994.04050333.x; TRIMBOS JB, 1993, CANCER, V72, P828, DOI 10.1002/1097-0142(19930801)72:3<828::AID-CNCR2820720331>3.0.CO;2-T; Trope C, 2000, ANN ONCOL, V11, P281, DOI 10.1023/A:1008399414923; VEGOTE IB, 1993, AM J OBSTET GYNECOL, V169, P40; WEBB MJ, 1973, AM J OBSTET GYNECOL, V116, P222, DOI 10.1016/0002-9378(73)91054-5; YOUNG RC, 1990, NEW ENGL J MED, V322, P1021, DOI 10.1056/NEJM199004123221501; 1973, ANN REPORT RESULTS T; 1998, J EPIDEMIOL BIOSTAT, V3, P1	30	457	472	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					176	182		10.1016/S0140-6736(00)03590-X	http://dx.doi.org/10.1016/S0140-6736(00)03590-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213094				2022-12-28	WOS:000166593700010
J	Schneider, SH				Schneider, SH			Earth systems engineering and management	NATURE			English	Article							STABILIZATION	Imagine that we could let the world's economy continue to grow, bring the disadvantaged classes up from poverty and at the same time not threaten the atmosphere or global ecosystems with unprecedented build-up of greenhouse gases and the projected climatic risks of such growth. Earth systems engineering and management may just be such a panacea, some have suggested. But could we anticipate the costs or ever truly predict the consequences?	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Inst Int Studies, Stanford, CA 94305 USA	Stanford University; Stanford University	Schneider, SH (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							Allenby B., 1998, J IND ECOL, V2, P73, DOI DOI 10.1162/JIEC.1998.2.3.73; Budyko M. I., 1977, CLIMATIC CHANGES, DOI [DOI 10.1029/SP010, 10.1029/SP010]; GLAZOVSKY N, 1990, ARAL CRISIS ORIGIN P; Govindasamy B, 2000, GEOPHYS RES LETT, V27, P2141, DOI 10.1029/1999GL006086; Grubb M, 1994, INTEGRATIVE ASSESSME, P513; Hoffert MI, 1998, NATURE, V395, P881, DOI 10.1038/27638; *INT PAN CLIM CHAN, 1995, IPCC WORK GROUP 1; Johansson T.B., 1993, RENEWABLE ENERGY SOU; Keith DW, 2000, IEEE TECHNOL SOC MAG, V19, P25, DOI 10.1109/44.890079; KELLOGG WW, 1974, SCIENCE, V186, P1163, DOI 10.1126/science.186.4170.1163; MARCHETTI C, 1977, CLIMATIC CHANGE, V1, P59, DOI 10.1007/BF00162777; McKibben W, 1989, END NATURE; Monastersky R., 1995, SCI NEWS, V148, P220; NORDHAUS WD, 1992, SCIENCE, V258, P1315, DOI 10.1126/science.258.5086.1315; *PAN POL IMPL GREE, 1992, POL IMPL GREEN WARM; ROSENBERG NJ, 1998, CARBON SEQUESTRATION; Schneider SH, 1996, CLIMATIC CHANGE, V33, P291, DOI 10.1007/BF00142577; SOCOLOW RE, 1997, 302 PUCEES; WATSON AJ, 1994, NATURE, V371, P143, DOI 10.1038/371143a0; Watson RT, 2000, LAND USE LAND USE CH; World Commission on Environment and Development, 1987, OUR COMMON FUTURE; [No title captured]	22	53	57	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					417	+		10.1038/35053203	http://dx.doi.org/10.1038/35053203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201758	Bronze			2022-12-28	WOS:000166434300066
J	Beckingham, IJ; Bornman, PC				Beckingham, IJ; Bornman, PC			ABC of diseases of liver, pancreas, and biliary system - Acute pancreatitis	BRITISH MEDICAL JOURNAL			English	Review									Queens Med Ctr, Dept Surg, Nottingham NG7 2UH, England; Univ Cape Town, ZA-7700 Rondebosch, South Africa	University of Nottingham; University of Cape Town	Beckingham, IJ (corresponding author), Queens Med Ctr, Dept Surg, Nottingham NG7 2UH, England.							BRADLEY EL, 1997, SURG PANCREAS, P245; GLAZER G, 1998, GUT S2, V42; 1997, EUR J GASTROENTEROL, V9, P1	3	36	40	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					595	598		10.1136/bmj.322.7286.595	http://dx.doi.org/10.1136/bmj.322.7286.595			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238158	Green Published			2022-12-28	WOS:000167499900029
J	Kelly, CJG; Ogilvie, A; Evans, JR; Shapiro, D; Wallace, AM; Davies, DL				Kelly, CJG; Ogilvie, A; Evans, JR; Shapiro, D; Wallace, AM; Davies, DL			Lesson of the week - Raised cortisol excretion rate in urine and contamination by topical steroids	BRITISH MEDICAL JOURNAL			English	Review							CUSHINGS-SYNDROME		Univ Glasgow, Western Infirm, Dept Med & Biochem, Gardiner Inst, Glasgow G11 6NT, Lanark, Scotland; Stracathro Hosp, Dept Med, Brechin DD9 7QA, Angus, Scotland; Stracathro Hosp, Dept Biochem Med, Brechin DD9 7QA, Angus, Scotland; Glasgow Royal Infirm, Dept Clin Biochem, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow; University of Glasgow	Kelly, CJG (corresponding author), Univ Glasgow, Western Infirm, Dept Med & Biochem, Gardiner Inst, Glasgow G11 6NT, Lanark, Scotland.							LEIBOWITZ G, 1996, CLIN ENDOCRINOL OXF, V44, P712; MENGDEN T, 1992, CLIN INVESTIGATOR, V70, P545; Newell-Price J, 1999, LANCET, V353, P2087, DOI 10.1016/S0140-6736(99)99091-8	3	3	4	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					594	594		10.1136/bmj.322.7286.594	http://dx.doi.org/10.1136/bmj.322.7286.594			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238157	Green Published, Green Accepted			2022-12-28	WOS:000167499900028
J	Shah, S; Peat, JK; Mazurski, EJ; Wang, H; Sindhusake, D; Bruce, C; Henry, RL; Gibson, PG				Shah, S; Peat, JK; Mazurski, EJ; Wang, H; Sindhusake, D; Bruce, C; Henry, RL; Gibson, PG			Effect of peer led programme for asthma education in adolescents: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; CHILDREN; QUESTIONNAIRE; PREVALENCE; MANAGEMENT; KNOWLEDGE; IMPACT; HEALTH	Objective To determine the effect of a peer led programme for asthma education on duality of life and related morbidity in adolescents with asthma. Design Cluster randomised controlled trial. Setting Six high schools in rural Australia. Participants 272 students with recent wheeze, recruited from a cohort of 1515 students from two school years (mean age 12.5 and 15.5 years); 251 (92.3%) completed the study. Intervention A structured education programme for peers comprising three steps (the "Triple A Program"). Main outcome measures (Quality of life, school absenteeism, asthma attacks, and lung function. Results When adjusted for year and sex, mean total quality of life scores showed significant improvement in the intervention than control group. Clinically important improvement in quality of life (> 0.5 units) occurred in 25% of students with asthma in the intervention group compared with 12% in the control group (P = 0.01). The number needed to treat was 8 (95% confidence interval 4.5 to 35.7). The effect of the intervention was greatest in students in year 10 and in females. Significant improvements occurred in the activities domain (41% v, 28%) and in the emotions domain (39% v 19%) in males in the intervention group. School absenteeism significantly decreased in the intervention group only Asthma attacks at school increased in the control group only. Conclusion The triple A programme leads to a clinically relevant improvement in quality of life and related morbidity in students with asthma. Wider dissemination of this programme in schools could play an important part in reducing the burden of asthma in adolescents.	John Hunter Hosp, Airway Res Ctr, Dept Resp & Sleep Med, Newcastle, NSW 2310, Australia; Univ New S Wales, Sch Paediat, Randwick, NSW 2031, Australia; Auburn Hosp & Community Hlth Serv, Primary Hlth Care Educ & Res Unit, Auburn, NSW 2144, Australia; Childrens Hosp Westmead, Westmead, NSW 2145, Australia; Westmead Hosp, Dept Publ Hlth & Community Med, Westmead, NSW 2145, Australia	John Hunter Hospital; University of New South Wales Sydney; University of Sydney; University of Sydney	Shah, S (corresponding author), Westmead Hosp, Dept Publ Hlth & Community Med, Westmead, NSW 2145, Australia.		Shah, Smita/F-1342-2011; Shah, Smita/ABA-6688-2021; Praena-Crespo, Manuel/E-7172-2010; gibson, peter/G-6194-2014	Shah, Smita/0000-0002-7675-1834; Praena-Crespo, Manuel/0000-0002-1928-9663; gibson, peter/0000-0001-5865-489X				CRANE J, 1995, INT ARCH ALLERGY IMM, V107, P450, DOI 10.1159/000237077; FORERO R, 1992, J ADOLESCENT HEALTH, V13, P707, DOI 10.1016/1054-139X(92)90068-M; FOTHERINGHAM MJ, 1995, J PAEDIATR CHILD H, V31, P72, DOI 10.1111/j.1440-1754.1995.tb00750.x; Gibson PG, 1998, J ADOLESCENT HEALTH, V22, P66, DOI 10.1016/S1054-139X(97)00203-6; GIBSON PG, 1995, ARCH DIS CHILD, V73, P321, DOI 10.1136/adc.73.4.321; GRAETZ B, 1995, J PEDIATR PSYCHOL, V20, P205, DOI 10.1093/jpepsy/20.2.205; HIBBERT ME, 1989, PEDIATR PULM, V7, P101, DOI 10.1002/ppul.1950070209; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; Millistein S. G., 1993, PROMOTING HLTH ADOLE; NUTBEAM D, 1991, YOUTH HLTH PROMOTION, P89; RINGSBERG KC, 1990, EUR RESPIR J, V3, P33; SHAH S, 1994, J PAEDIATR CHILD H, V30, P312, DOI 10.1111/j.1440-1754.1994.tb00652.x; Shah S, 1998, HEALTH PROMOT J AUST, V8, P177; Siersted HC, 1998, BRIT MED J, V316, P651, DOI 10.1136/bmj.316.7132.651; TAYLOR WR, 1992, PEDIATRICS, V90, P657; Tobler N. S., 1992, J ADDICT DIS, V11, P12, DOI [10.1300/J069v11n03_01, DOI 10.1300/J069V11N03_01]; WALLERSTEIN N, 1988, HEALTH EDUC QUART, V15, P379, DOI 10.1177/109019818801500402; YOON R, 1993, THORAX, V48, P1110, DOI 10.1136/thx.48.11.1110	19	150	153	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					583	585		10.1136/bmj.322.7286.583	http://dx.doi.org/10.1136/bmj.322.7286.583			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238152	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000167499900022
J	Luo, ZY; Zhang, QS; Oderaotoshi, Y; Curran, DP				Luo, ZY; Zhang, QS; Oderaotoshi, Y; Curran, DP			Fluorous mixture synthesis: A fluorous-tagging strategy for the synthesis and separation of mixtures of organic compounds	SCIENCE			English	Article							PHASE COMBINATORIAL SYNTHESIS; MAPPICINE KETONE; LIBRARIES; CHEMISTRY; DECONVOLUTION; ISONITRILES; MOLECULES; PRODUCTS; REAGENTS	The solution-phase synthesis of organic compounds as mixtures rather than in individual pure form offers efficiency advantages that are negated by the difficulty in separating and identifying the components of the final mixture. Here, a Strategy for mixture synthesis that addresses these separation and identification problems is presented. A series of organic substrates was tagged with a series of fluorous tags of increasing fluorine content. The compounds were then mixed, and multistep reactions were conducted to make enantiomers or analogs of the natural product mappicine. The resulting tagged products were then demixed by fluorous chromatography (eluting in order of increasing fluorine content) to provide the individual pure components of the mixture, which were detagged to release the final products.	Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Combinatorial Chem, Pittsburgh, PA 15260 USA; Fluorous Technol, Pittsburgh, PA 15238 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Curran, DP (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.			Zhang, Qisheng/0000-0001-9808-5038				An HY, 2000, CHEM REV, V100, P3311, DOI 10.1021/cr990014r; Balkenhohl F, 1996, ANGEW CHEM INT EDIT, V35, P2289; Boger DL, 1998, J AM CHEM SOC, V120, P1218, DOI 10.1021/ja973007y; Boger DL, 1998, J AM CHEM SOC, V120, P7220, DOI 10.1021/ja9803557; Booth RJ, 1999, ACCOUNTS CHEM RES, V32, P18, DOI 10.1021/ar970311n; CARELL T, 1994, ANGEW CHEM INT EDIT, V33, P2059, DOI 10.1002/anie.199420591; Curran DP, 1999, J AM CHEM SOC, V121, P9069, DOI 10.1021/ja991496r; Curran DP, 1996, J AM CHEM SOC, V118, P2531, DOI 10.1021/ja953287m; Curran DP, 1998, ANGEW CHEM INT EDIT, V37, P1175, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1174::AID-ANIE1174>3.0.CO;2-P; CURRAN DP, UNPUB; de Frutos O, 2000, J COMB CHEM, V2, P639, DOI 10.1021/cc000032i; Eliel EL., 1994, STEREOCHEMISTRY ORGA; Flynn DL, 1999, MED RES REV, V19, P408, DOI 10.1002/(SICI)1098-1128(199909)19:5<408::AID-MED7>3.0.CO;2-J; FURKA A, 1996, COMBINATORIAL PEPTID, P111; GOVINDACHARI TR, 1974, J CHEM SOC PERK T 1, P1215, DOI 10.1039/p19740001215; Griffey RH, 1998, TETRAHEDRON, V54, P4067, DOI 10.1016/S0040-4020(98)00135-5; HORVATH IT, 1994, SCIENCE, V266, P72, DOI 10.1126/science.266.5182.72; Horvath IT, 1998, ACCOUNTS CHEM RES, V31, P641, DOI 10.1021/ar970342i; Houghten RA, 1999, J MED CHEM, V42, P3743, DOI 10.1021/jm990174v; Josien H, 1997, TETRAHEDRON, V53, P8881, DOI 10.1016/S0040-4020(97)00575-9; Josien H, 1998, CHEM-EUR J, V4, P67, DOI 10.1002/(SICI)1521-3765(199801)4:1<67::AID-CHEM67>3.0.CO;2-F; Kaldor SW, 1997, CURR OPIN CHEM BIOL, V1, P101, DOI 10.1016/S1367-5931(97)80115-9; Lam KS, 1997, CHEM REV, V97, P411, DOI 10.1021/cr9600114; NICOLAOU KC, 1995, ANGEW CHEM INT EDIT, V34, P2289, DOI 10.1002/anie.199522891; Studer A, 1997, SCIENCE, V275, P823, DOI 10.1126/science.275.5301.823; VEDEJS E, 1997, J AM CHEM SOC, V119, P2284	26	307	312	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1766	1769		10.1126/science.1057567	http://dx.doi.org/10.1126/science.1057567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230688				2022-12-28	WOS:000167320600053
J	Caicedo, A; Roper, SD				Caicedo, A; Roper, SD			Taste receptor cells that discriminate between bitter stimuli	SCIENCE			English	Article							RAT; TRANSDUCTION; CALCIUM	Recent studies showing that single taste bud cells express multiple bitter taste receptors have reignited a Long-standing controversy over whether single gustatory receptor cells respond selectively or broadly to tastants. We examined calcium responses of rat taste receptor cells in situ to a panel of bitter compounds to determine whether individual cells distinguish between bitter stimuli. Most bitter-responsive taste cells were activated by only one out of five compounds tested. In taste cells that responded to multiple stimuli, there were no significant associations between any two stimuli. Bitter sensation does not; appear to occur through the activation of a homogeneous population of broadly tuned bitter-sensitive taste cells. Instead, different bitter stimuli may activate different subpopulations of bitter-sensitive taste cells.	Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; Rocky Mt Taste & Smell Ctr, Denver, CO 80262 USA; Ctr Int Fis, Lab Biofis, Bogota, Colombia; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33136 USA	University of Miami; University of Miami	Caicedo, A (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, 1600 NW 10th Ave, Miami, FL 33136 USA.		Caicedo, Alejandro/F-1202-2010; Caicedo, Alejandro/AAC-8544-2020	Roper, Stephen/0000-0001-6049-8320	NIDCD NIH HHS [R01 DC000374, DC00374, DC04525-01, F32 DC000374, R03 DC004525] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000374, R03DC004525, F32DC000374] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADLERE, 2000, CELL, V100, P693; AKABAS MH, 1988, SCIENCE, V242, P1047, DOI 10.1126/science.3194756; BARTOSHUK LM, 1977, SENS PROCESS, V1, P177; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; CAICEDOA, 2000, J NEUROSCI, V20, P7978; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; DELWICHEJF, 2000, 12 INT S OLF TAST 14; Dess NK, 2000, PHYSIOL BEHAV, V69, P247, DOI 10.1016/S0031-9384(99)00246-2; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; HWANG PM, 1990, P NATL ACAD SCI USA, V87, P7395, DOI 10.1073/pnas.87.19.7395; IWASAKI K, 1981, CHEM SENSES, V6, P119, DOI 10.1093/chemse/6.2.119; KOH SD, 1961, J COMP PHYSIOL PSYCH, V54, P223, DOI 10.1037/h0048474; Krimm RF, 1998, J COMP NEUROL, V398, P13; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MCBURNEY DH, 1972, PERCEPT PSYCHOPHYS, V11, P228, DOI 10.3758/BF03206255; Ogura T, 1997, J NEUROSCI, V17, P3580; Patton HD, 1944, J COMP PSYCHOL, V37, P35, DOI 10.1037/h0054668; Pfaffmann C., 1959, HDB PHYSL NEUROPHYSI, V1, P507; Richter CP, 1941, AM J PHYSIOL, V134, P0157, DOI 10.1152/ajplegacy.1941.134.1.157; Scott TR, 1999, J NEUROPHYSIOL, V81, P60, DOI 10.1152/jn.1999.81.1.60; Thaw AK, 1996, CHEM SENSES, V21, P189, DOI 10.1093/chemse/21.2.189; TOBACH E, 1974, BEHAV GENET, V4, P405, DOI 10.1007/BF01066160; Whitehead MC, 1999, NEUROSCIENCE, V93, P931, DOI 10.1016/S0306-4522(99)00115-3	25	141	146	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1557	1560		10.1126/science.1056670	http://dx.doi.org/10.1126/science.1056670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222863	Green Accepted			2022-12-28	WOS:000167153400048
J	Olshansky, SJ; Carnes, BA; Desesquelles, A				Olshansky, SJ; Carnes, BA; Desesquelles, A			Demography - Prospects for human longevity	SCIENCE			English	Editorial Material							MORTALITY; METHUSELAH		Univ Illinois, Sch Publ Hlth, Chicago, IL 60637 USA; Univ Illinois, Ctr Aging, Chicago, IL 60637 USA; Univ Chicago, Ctr Aging, Natl Opin Res Ctr, Chicago, IL 60637 USA; Inst Natl Etud Demog, F-75980 Paris 20, France	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Olshansky, SJ (corresponding author), Univ Illinois, Sch Publ Hlth, Chicago, IL 60637 USA.				NIA NIH HHS [AG00894-01, AG13698-01] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*BOARD TRUST FED O, 1999, 1999 ANN REP; Carnes BA, 1997, EXP GERONTOL, V32, P615, DOI 10.1016/S0531-5565(97)00056-9; GOSS SH, UNPUB; HORIUCHI S, 1990, DIFFERENTIAL MORTALI, P64; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; Keyfitz N, 1985, APPL MATH DEMOGRAPHY; Lee R, 2000, POPUL DEV REV, V26, P137, DOI 10.1111/j.1728-4457.2000.00137.x; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; MANTON K, 1991, POPUL DEV REV, V17, P309; Martin L. G., 1994, DEMOGRAPHY AGING; Olshansky S.J., 1996, HLTH MORTALITY ELDER, P39; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Olshansky SJ, 1997, POPUL BULL, V52, P2; POLLARD JH, 1988, DEMOGRAPHY, V25, P265, DOI 10.2307/2061293; Taeuber C. M., 1993, INT POPULATION REPOR; VAUPEL JW, 1986, AM J PUBLIC HEALTH, V76, P430, DOI 10.2105/AJPH.76.4.430; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366; WILSON ME, 1994, DIS EVOLUTION GLOBAL	18	166	168	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1491	1492		10.1126/science.291.5508.1491	http://dx.doi.org/10.1126/science.291.5508.1491			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405HF	11234076				2022-12-28	WOS:000167153400025
J	Rogers, JA				Rogers, JA			Electronics - Toward paperlike displays	SCIENCE			English	Editorial Material							INK		Bell Labs, Lucent Technol, Condensed Matter Phys Res, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Rogers, JA (corresponding author), Bell Labs, Lucent Technol, Condensed Matter Phys Res, 600 Mt Ave, Murray Hill, NJ 07974 USA.		Rogers, John/L-2798-2016					Comiskey B, 1998, NATURE, V394, P253, DOI 10.1038/28349; Gelinck GH, 2000, APPL PHYS LETT, V77, P1487, DOI 10.1063/1.1290728; KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628; Rogers JA, 2000, SYNTHETIC MET, V115, P5, DOI 10.1016/S0379-6779(00)00292-7; ROGERS JA, IN PRESS P NATL ACAD; ROGERS JA, 2000, FALL 2000 MRS M; Service RF, 2000, SCIENCE, V287, P415, DOI 10.1126/science.287.5452.415; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123	8	81	110	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1502	1503		10.1126/science.291.5508.1502	http://dx.doi.org/10.1126/science.291.5508.1502			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11234080				2022-12-28	WOS:000167153400031
J	Ohtani, N; Zebedee, Z; Huot, TJG; Stinson, JA; Sugimoto, M; Ohashi, Y; Sharrocks, AD; Peters, G; Hara, E				Ohtani, N; Zebedee, Z; Huot, TJG; Stinson, JA; Sugimoto, M; Ohashi, Y; Sharrocks, AD; Peters, G; Hara, E			Opposing effects of Ets and Id proteins on p16(INK4a) expression during cellular senescence	NATURE			English	Article							LOOP-HELIX PROTEINS; REPLICATIVE SENESCENCE; IMMORTALIZATION; BINDING; P16; INHIBITORS; TELOMERES; INK4A; P53	The p16(INK4a) cyclin-dependent kinase inhibitor(1) is implicated in replicative senescence, the state of permanent growth arrest provoked by cumulative cell divisions or as a response to constitutive Ras-Raf-MEK signalling in somatic cells(2-8). Some contribution to senescence presumably underlies the importance of p16(INK4a) as a tumour suppressor(9) but the mechanisms regulating its expression in these different contexts remain unknown. Here we demonstrate a role for the Ets1 and Ets2 transcription factors(10) based on their ability to activate the p16(INK4a) promoter through an ETS-binding site and their patterns of expression during the lifespan of human diploid fibroblasts. The induction of p16(INK4a) by Ets2, which is abundant in young human diploid fibroblasts, is potentiated by signalling through the Ras-Raf-MEK kinase cascade and inhibited by a direct interaction with the helix-loop-helix protein Id1 (ref. 11). In senescent cells, where the Ets2 levels and MEK signalling decline, the marked increase in p16(INK4a) expression is consistent with the reciprocal reduction of Id1 and accumulation of Ets1.	Christie Hosp NHS Trust, Paterson Inst Canc Res, CRC, Cell Cycle Grp, Manchester M20 4BX, Lancs, England; Imperial Canc Res Fund, London WC2A 3PX, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; Nihon Schering KK, Mol Biol Lab, Osaka 5320004, Japan; Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; Cancer Research UK; University of Manchester; Juntendo University; University of Manchester	Hara, E (corresponding author), Christie Hosp NHS Trust, Paterson Inst Canc Res, CRC, Cell Cycle Grp, Manchester M20 4BX, Lancs, England.	Ehara@picr.man.ac.uk	Ohtani, Naoko/AAB-1891-2021	Ohtani, Naoko/0000-0001-8934-0797; Sugimoto, Masataka/0000-0001-8737-8097				Alani RM, 1999, P NATL ACAD SCI USA, V96, P9637, DOI 10.1073/pnas.96.17.9637; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Foos G, 1998, J BIOL CHEM, V273, P18871, DOI 10.1074/jbc.273.30.18871; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Hara E, 1996, DEV GENET, V18, P161; Hara E, 1996, MOL CELL BIOL, V16, P859; HARA E, 1994, J BIOL CHEM, V269, P2139; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Loughran O, 1996, ONCOGENE, V13, P561; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Reznikoff CA, 1996, CANCER RES, V56, P2886; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sugimoto M, 1999, GENE DEV, V13, P3027, DOI 10.1101/gad.13.22.3027; Takahashi Y, 2000, GENE DEV, V14, P804; Yates PR, 1999, EMBO J, V18, P968, DOI 10.1093/emboj/18.4.968; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	28	500	535	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1067	1070		10.1038/35059131	http://dx.doi.org/10.1038/35059131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234019				2022-12-28	WOS:000167148800052
J	Wilson, TL				Wilson, TL			The search for extraterrestrial intelligence	NATURE			English	Article							OPTICAL SETI; SIGNALS	As far as we know, humanity is alone in the Universe: there is no definite evidence for the existence of extraterrestrial life, let alone extraterrestrial civilizations (ETCs) capable of communicating or travelling over interstellar distances. Yet popular speculation about the existence of ETCs abounds, including reports of alien visitations either now or in the past. But there is a middle way. It is now possible to put limits on the existence of ETCs of varying capabilities, within arbitrary distances from the Solar System, and conceive of real-world strategies whereby we might communicate with ETCs, or they with us.	Max Planck Inst Radioastron, D-53121 Bonn, Germany; Univ Arizona, Steward Observ, Sub Millimeter Telescope Observ, Tucson, AZ USA	Max Planck Society; University of Arizona	Wilson, TL (corresponding author), Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany.	twilson@as.arizona.edu						Baum L. Frank, 2019, WIZARD OZ; BRACEWELL RN, 1974, GALACTIC CLUB; BRIN GD, 1983, Q J ROY ASTRON SOC, V24, P283; COCCONI G, 1959, NATURE, V184, P844, DOI 10.1038/184844a0; COHEN N, 1995, ASTR SOC P, V74, P313; CORDES JM, 1995, ASTR SOC P, V74, P325; Drake F.D., 1965, CURRENT ASPECTS EXOB, P323, DOI DOI 10.1016/B978-1-4832-0047-7.50015-0; Dyson FJ, 1966, PERSPECTIVES MODERN, P641; GLASER PE, 1968, SCIENCE, V162, P857, DOI 10.1126/science.162.3856.857; HART MH, 1975, Q J ROY ASTRON SOC, V16, P128; Howard A, 2000, ASTR SOC P, V213, P545; Kardashev N. S., 1964, ASTRON REP+, V8, P217; KARDASHEV NS, 1979, NATURE, V278, P28, DOI 10.1038/278028a0; Kingsley SA, 1996, P SOC PHOTO-OPT INS, V2704, P102, DOI 10.1117/12.243436; KUIPER TBH, 1977, SCIENCE, V196, P616, DOI 10.1126/science.196.4290.616; Leigh D, 2000, ASTR SOC P, V213, P459; LePage J, 2000, SCI AM, V283, P40; Mauersberger R, 1996, ASTRON ASTROPHYS, V306, P141; MCDONOUGH TR, 1995, ASTR SOC P, V74, P419; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; MORRISON P, 1974, INTERSTELLAR COMMUNI, P168; OLIVER BM, 1987, IAA87606 INT ASTR FE, P1; OLIVER BM, 1973, PROJECT CYCLOPS; PIERSON T, 1995, ASP C SER, V74, P443; Rohlfs K., 1999, TOOLS RADIO ASTRONOM; SAGAN C, 1975, SCI AM, V232, P80, DOI 10.1038/scientificamerican0575-80; SULLIVAN WT, 1978, SCIENCE, V199, P377, DOI 10.1126/science.199.4327.377; TARTER J, 1995, ASTR SOC P, V74, P457; TARTER J, 1986, SEARCH EXTRATERRESTR, P79; TOWNES CH, 1983, P NATL ACAD SCI USA, V80, P1147, DOI 10.1073/pnas.80.4.1147; Vogt SS, 2000, ASTROPHYS J, V536, P902, DOI 10.1086/308981; Ward P., 2000, RARE EARTH WHY COMPL; Welch WJ, 2000, P SOC PHOTO-OPT INS, V4015, P8, DOI 10.1117/12.390410; WERTHIMER D, 1995, ASTR SOC P, V74, P293; WILSON TL, 2000, TOOLS RADIO ASTRONOM, P15	35	13	13	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1110	1114		10.1038/35059235	http://dx.doi.org/10.1038/35059235			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234025				2022-12-28	WOS:000167148800059
J	Jeffords, JM; Daschle, T				Jeffords, JM; Daschle, T			Policy issues - Political issues in the genome era	SCIENCE			English	Article							GENETICS		US Senate, Washington, DC 20510 USA									*AM MAN ASS, 2000, 2000 WORKPL TEST SUR; Frank L, 2000, SCIENCE, V290, P31, DOI 10.1126/science.290.5489.31; Fuller BP, 1999, SCIENCE, V285, P1359, DOI 10.1126/science.285.5432.1359; *GALLORG, 2000, 131007 I HLTH FREED; JONES NL, 2000, RL30006 CRS LONG; King DS, 1999, J MED ETHICS, V25, P176, DOI 10.1136/jme.25.2.176; MILLER PS, 2000, J HLTH CARE LAW POLI, V3, P255; *NAT CTR GEN RES, 1998, ATT GEN TEST; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; 2000, FED REG         0210, V65, P6877	10	19	21	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1249	+		10.1126/science.1058370	http://dx.doi.org/10.1126/science.1058370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233448				2022-12-28	WOS:000166993400027
J	Cheung, VG; Nowak, N; Jang, W; Kirsch, IR; Zhao, S; Chen, XN; Furey, TS; Kim, UJ; Kuo, WL; Olivier, M; Conroy, J; Kasprzyk, A; Massa, H; Yonescu, R; Sait, S; Thoreen, C; Snijders, A; Lemyre, E; Bailey, JA; Bruzel, A; Burrill, WD; Clegg, SM; Collins, S; Dhami, P; Friedman, C; Han, CS; Herrick, S; Lee, J; Ligon, AH; Lowry, S; Morley, M; Narasimhan, S; Osoegawa, K; Peng, Z; Plajzer-Frick, I; Quade, BJ; Scott, D; Sirotkin, K; Thorpe, AA; Gray, JW; Hudson, J; Pinkel, D; Ried, T; Rowen, L; Shen-Ong, GL; Strausberg, RL; Birney, E; Callen, DF; Cheng, JF; Cox, DR; Doggett, NA; Carter, NP; Eichler, EE; Haussler, D; Korenberg, JR; Morton, CC; Albertson, D; Schuler, G; de Jong, PJ; Trask, BJ				Cheung, VG; Nowak, N; Jang, W; Kirsch, IR; Zhao, S; Chen, XN; Furey, TS; Kim, UJ; Kuo, WL; Olivier, M; Conroy, J; Kasprzyk, A; Massa, H; Yonescu, R; Sait, S; Thoreen, C; Snijders, A; Lemyre, E; Bailey, JA; Bruzel, A; Burrill, WD; Clegg, SM; Collins, S; Dhami, P; Friedman, C; Han, CS; Herrick, S; Lee, J; Ligon, AH; Lowry, S; Morley, M; Narasimhan, S; Osoegawa, K; Peng, Z; Plajzer-Frick, I; Quade, BJ; Scott, D; Sirotkin, K; Thorpe, AA; Gray, JW; Hudson, J; Pinkel, D; Ried, T; Rowen, L; Shen-Ong, GL; Strausberg, RL; Birney, E; Callen, DF; Cheng, JF; Cox, DR; Doggett, NA; Carter, NP; Eichler, EE; Haussler, D; Korenberg, JR; Morton, CC; Albertson, D; Schuler, G; de Jong, PJ; Trask, BJ		BAC Resource Consortium	Integration of cytogenetic landmarks into the draft sequence of the human genome	NATURE			English	Article							IN-SITU HYBRIDIZATION; PHYSICAL MAPS; RESOURCE; CLONES	We have placed 7,600 cytogenetically defined landmarks on the draft sequence of the human genome to help with the characterization of genes altered by gross chromosomal aberrations that cause human disease. The landmarks are large-insert clones mapped to chromosome bands by fluorescence in situ hybridization. Each clone contains a sequence tag that is positioned on the genomic sequence. This genome-wide set of sequence-anchored clones allows structural and functional analyses of the genome. This resource represents the first comprehensive integration of cytogenetic, radiation hybrid, linkage and sequence maps of the human genome; provides an independent validation of the sequence map(1,2) and framework for contig order and orientation; surveys the genome for large-scale duplications, which are likely to require special attention during sequence assembly; and allows a stringent assessment of sequence differences between the dark and light bands of chromosomes. It also provides insight into large-scale chromatin structure and the evolution of chromosomes and gene families and will accelerate our understanding of the molecular bases of human disease and cancer.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; NCI, NIH, Bethesda, MD 20889 USA; Inst Genom Res, Rockville, MD 20850 USA; Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Dept Human Genet, Los Angeles, CA 90048 USA; Univ Calif Santa Cruz, Dept Comp Sci, Santa Cruz, CA 95064 USA; CALTECH, Dept Biol, Pasadena, CA 91125 USA; Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA; Stanford Univ, Genome Lab, Stanford, CA 94305 USA; Sanger Ctr, Cambridge CB10 1SA, England; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Case Western Reserve Univ, Dept Human Genet, Cleveland, OH 44106 USA; Los Alamos Natl Lab, Joint Genome Inst, Los Alamos, NM 87545 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Joint Genome Inst, Berkeley, CA 94720 USA; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; Res Genet Inc, Huntsville, AL 35801 USA; Inst Syst Biol, Seattle, WA 98105 USA; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia; Univ Calif Santa Cruz, Dept Comp Sci, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	Fred Hutchinson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Roswell Park Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); J. Craig Venter Institute; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Santa Cruz; California Institute of Technology; University of California System; University of California San Francisco; Stanford University; Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Institute for Systems Biology (ISB); Womens & Childrens Hospital Australia; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Trask, BJ (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N C3-168,POB 19024, Seattle, WA 98109 USA.	btrask@fhcrc.org	Callen, David F/G-1975-2012; Shen-Ong, Grace/C-8327-2014; Cheung, Vivian G./AAT-3115-2020	Han, Cliff/0000-0003-1972-0692; Callen, David/0000-0002-6189-9991; Birney, Ewan/0000-0001-8314-8497; Furey, Terry/0000-0001-5546-9672	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM061354] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; CASPERSSON T, 1968, EXP CELL RES, V49, P219, DOI 10.1016/0014-4827(68)90538-7; Cheung VG, 1999, GENOME RES, V9, P989, DOI 10.1101/gr.9.10.989; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kirsch IR, 2000, SEMIN HEMATOL, V37, P420, DOI 10.1053/shem.2000.16450; Kirsch IR, 2000, NAT GENET, V24, P339, DOI 10.1038/74149; KORENBERG JR, 1995, CYTOGENET CELL GENET, V69, P196, DOI 10.1159/000133962; Korenberg JR, 1999, GENOME RES, V9, P994, DOI 10.1101/gr.9.10.994; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leversha MA, 1999, CHROMOSOME RES, V7, P571, DOI 10.1023/A:1009249830811; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MITELMAN F, 1998, CATALOG CHROMOSOME A; Mitelman F, 1995, INT SYSTEM HUMAN CYT; Morley M, 2001, NUCLEIC ACIDS RES, V29, P144, DOI 10.1093/nar/29.1.144; OHYASHIKI K, 1986, CANCER RES, V46, P3642; OLIVIER M, IN PRESS SCIENCE; OSOEGAWA K, IN PRESS GENOME RES; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Schuler GD, 1998, TRENDS BIOTECHNOL, V16, P456, DOI 10.1016/S0167-7799(98)01232-3; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; STREINER DL, 1989, J PERS ASSESS, V53, P81, DOI 10.1207/s15327752jpa5301_9; Trask B, 1999, GENOME ANAL, V4, P303; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; TRASK BJ, 1989, AM J HUM GENET, V45, P738; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	30	231	247	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					953	958		10.1038/35057192	http://dx.doi.org/10.1038/35057192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237021	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000166938800068
J	Gangui, A				Gangui, A			Perspectives: Cosmology - In support of inflation	SCIENCE			English	Editorial Material							DOPPLER PEAKS		Inst Astron & Space Phys, RA-1428 Buenos Aires, DF, Argentina	Instituto de Astronomia y Fisica del Espacio (IAFE)	Gangui, A (corresponding author), Inst Astron & Space Phys, Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.							Bahcall NA, 1999, SCIENCE, V284, P1481, DOI 10.1126/science.284.5419.1481; Balbi A, 2000, ASTROPHYS J, V545, pL1, DOI 10.1086/317323; de Bernardis P, 2000, NATURE, V404, P955, DOI 10.1038/35010035; Durrer R, 1996, PHYS REV LETT, V76, P579, DOI 10.1103/PhysRevLett.76.579; Hanany S, 2000, ASTROPHYS J, V545, pL5, DOI 10.1086/317322; HEDMAN M, IN PRESS ASTROPHYS J; JAFFE AH, IN PRESS PHYS REV LE; Magueijo J, 1996, PHYS REV LETT, V76, P2617, DOI 10.1103/PhysRevLett.76.2617; Pen UL, 1997, PHYS REV LETT, V79, P1611, DOI 10.1103/PhysRevLett.79.1611; POGOSIAN L, PREPRINT; SCOTT D, 1995, SCIENCE, V268, P829, DOI 10.1126/science.268.5212.829; Seife C, 2000, SCIENCE, V288, P595, DOI 10.1126/science.288.5466.595; WEINBERG S, PREPRINT; [No title captured]	14	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					837	838		10.1126/science.1058912	http://dx.doi.org/10.1126/science.1058912			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11225632	Green Submitted			2022-12-28	WOS:000166771700030
J	Mauron, A				Mauron, A			Is the genome the secular equivalent of the soul?	SCIENCE			English	Review									Univ Geneva, Ctr Med Univ Geneva, Fac Med, Bioeth Res & Teaching Unit, CH-1211 Geneva 4, Switzerland	University of Geneva	Mauron, A (corresponding author), Univ Geneva, Ctr Med Univ Geneva, Fac Med, Bioeth Res & Teaching Unit, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.							DELBRUCK M, 1971, MICROBES LIFE, P50; FORD NM, 1991, DID I BEGING CONCEPT; MALHERBE JF, 1991, ETHIQUE RENNES, V2, P79; Mauron A., 1996, CONCEIVING EMBRYO ET, P55; Mayr E., 1982, GROWTH BIOL THOUGHT; Nelkin D., 1995, DNA MYSTIQUE GENE CU	6	39	42	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					831	832		10.1126/science.1058768	http://dx.doi.org/10.1126/science.1058768			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11225630	Green Published			2022-12-28	WOS:000166771700026
J	Seo, DK; Corbett, JD				Seo, DK; Corbett, JD			Perspectives: Chemistry - Aromatic metal clusters	SCIENCE			English	Editorial Material									Iowa State Univ, Ames Lab, Ames, IA 50011 USA; Iowa State Univ, Dept Chem, Ames, IA 50011 USA	Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University	Seo, DK (corresponding author), Iowa State Univ, Ames Lab, Ames, IA 50011 USA.							BOLDYREV AI, COMMUNICATION; Corbett J.D., 2000, ANGEW CHEM, V112, P682; FUKUI K, 1982, ANGEW CHEM INT EDIT, V21, P801, DOI 10.1002/anie.198208013; Haussermann U, 1999, ANGEW CHEM INT EDIT, V38, P2017, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<2017::AID-ANIE2017>3.0.CO;2-O; Kauzlarich S.M., 1996, CHEM STRUCTURE BONDI; Li X, 2001, SCIENCE, V291, P859, DOI 10.1126/science.291.5505.859; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mattausch H, 1998, ANGEW CHEM INT EDIT, V37, P499, DOI 10.1002/(SICI)1521-3773(19980302)37:4<499::AID-ANIE499>3.0.CO;2-J; NESPER R, 1986, J SOLID STATE CHEM, V62, P199, DOI 10.1016/0022-4596(86)90232-X; Schmid G, 1996, J CHEM SOC DALTON, P589, DOI 10.1039/dt9960000589; Seo DK, 2000, J AM CHEM SOC, V122, P9621, DOI 10.1021/ja001886+	11	41	41	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					841	842		10.1126/science.1058418	http://dx.doi.org/10.1126/science.1058418			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11229404				2022-12-28	WOS:000166771700033
J	Shay, JW; Wright, WE				Shay, JW; Wright, WE			Perspectives: Aging - When do telomeres matter?	SCIENCE			English	Editorial Material							CELLULAR SENESCENCE; EPITHELIAL-CELLS; LIFE-SPAN; MECHANISM; TIME		Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Shay, JW (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.		Shay, Jerry W/F-7878-2011					Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Farwell DG, 2000, AM J PATHOL, V156, P1537, DOI 10.1016/S0002-9440(10)65025-0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169; Jarrard DF, 1999, CANCER RES, V59, P2957; Jones CJ, 2000, MOL CELL BIOL, V20, P5690, DOI 10.1128/MCB.20.15.5690-5699.2000; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; LOO DT, 1987, SCIENCE, V236, P200, DOI 10.1126/science.3494308; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; RAMIREZ RD, IN PRESS GENES DEV; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; WRIGHT WE, 1995, TRENDS CELL BIOL, V5, P293, DOI 10.1016/S0962-8924(00)89044-3; WRIGHT WE, IN PRESS CURR OPIN G	18	57	63	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					839	840		10.1126/science.1058546	http://dx.doi.org/10.1126/science.1058546			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11225633				2022-12-28	WOS:000166771700031
J	Yoshihara, Y; Nagao, H; Mori, K				Yoshihara, Y; Nagao, H; Mori, K			Perspectives: Neurobiology - Sniffing out odors with multiple dendrites	SCIENCE			English	Editorial Material							OLFACTORY-BULB; PATTERN		Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan; RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Saitama 3510198, Japan	University of Tokyo; RIKEN	Yoshihara, Y (corresponding author), RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Saitama 3510198, Japan.		Yoshihara, Yoshihiro/N-6481-2015	Yoshihara, Yoshihiro/0000-0002-0319-7166; Mori, Kensaku/0000-0001-7853-9370				BAIER H, 1994, J NEUROSCI, V14, P219; Christensen TA, 1997, J NEUROPHYSIOL, V77, P775, DOI 10.1152/jn.1997.77.2.775; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORI K, 1995, PROG NEUROBIOL, V45, P585, DOI 10.1016/0301-0082(94)00058-P; SATOU M, 1990, PROG NEUROBIOL, V34, P115, DOI 10.1016/0301-0082(90)90004-Z; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	11	8	9	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					835	+		10.1126/science.1058773	http://dx.doi.org/10.1126/science.1058773			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11225631				2022-12-28	WOS:000166771700029
J	Dematteis, M; Pepin, JL; Jeanmart, M; Deschaux, C; Labarre-Vila, A; Levy, P				Dematteis, M; Pepin, JL; Jeanmart, M; Deschaux, C; Labarre-Vila, A; Levy, P			Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study	LANCET			English	Article							NERVE-CONDUCTION ABNORMALITIES; CHROMOSOME 17P11.2 DUPLICATION; SENSORY NEUROPATHY TYPE-1; HEREDITARY MOTOR; DIAPHRAGMATIC WEAKNESS; APNEA SYNDROME; SEVERITY; DEFICITS; GENE	Background Charcot-Marie-Tooth (CMT) disease is a genetically heterogeneous group of hereditary motor and sensory polyneuropathies in which sleep apnoea has rarely been reported and no causal relation shown. We looked for an association between the most common subtype of CMT disease (CMT1A) and sleep apnoea syndrome. Methods Having diagnosed sleep apnoea and CMT in one family member (index case), we prospectively investigated 13 further members not previously suspected of having neuropathy or apnoeas. All had a neurological examination, electroneuromyography, polysomnography, and genetic testing for CMT disease. Findings 11 of the 14 family members had the autosomal dominant demyelinating form of CMT disease with PMP22 gene duplication on chromosome 17. Whatever their neurological disability, all 11 individuals had sleep apnoea syndrome with a mean (SD) apnoea-hypopnoea index of 46.6/h (28.5) of sleep (normal value <15/h). The remaining three family members were free from neuropathy and sleep apnoea syndrome. Sleep apnoea and neuropathy severity were highly correlated; the compound muscle action potential (CMAP) amplitude of the median nerve was inversely correlated with the apnoea-hypopnoea index (r=-0.69, p=0.029). The severity of neuropathy and sleep apnoea were higher in male CMT individuals and were correlated with age and body mass index. No wake or sleep diaphragmatic dysfunction was shown. Interpretation We think that sleep apnoea syndrome is related to a pharyngeal neuropathy. Upper airway dysfunction, previously described in the CMT2C subtype, might be a clinical expression of the CMT1A subtype, to which familiar susceptibility could predispose.	Univ Hosp Grenoble, Sleep & Physiol Resp Expt Theor & Appliquee Lab, Grenoble, France; Univ Hosp Grenoble, Dept Neurophysiol, Grenoble, France; Univ Hosp Grenoble, Electroneuromyog Lab, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Levy, P (corresponding author), CHU Grenoble, Hop Michallon, Sleep Lab, Explorat Fonctionnelles Cardio Resp, F-38043 Grenoble 09, France.	patrick.levy@imag.fr	PEPIN, Jean-Louis/M-6549-2014; LEVY, Patrick/AAX-2802-2020	LEVY, Patrick/0000-0003-3174-7935; Pepin, Jean Louis/0000-0003-3832-2358				[Anonymous], 1992, SLEEP, V15, P174; Argod J, 1998, AM J RESP CRIT CARE, V158, P1778, DOI 10.1164/ajrccm.158.6.9804157; Birouk N, 1997, BRAIN, V120, P813, DOI 10.1093/brain/120.5.813; CARTER GT, 1992, MUSCLE NERVE, V15, P459, DOI 10.1002/mus.880150407; CHAN CK, 1987, CHEST, V91, P567, DOI 10.1378/chest.91.4.567; DEMPSEY JA, 1991, LUNG SCI FDN, P1615; Dray TG, 1999, ARCH NEUROL-CHICAGO, V56, P863, DOI 10.1001/archneur.56.7.863; DYCK PJ, 1994, ANN NEUROL, V35, P608, DOI 10.1002/ana.410350515; DYCK PJ, 1989, NEUROLOGY, V39, P1302, DOI 10.1212/WNL.39.10.1302; Fabrizi GM, 1998, MUSCLE NERVE, V21, P869, DOI 10.1002/(SICI)1097-4598(199807)21:7<869::AID-MUS4>3.0.CO;2-4; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; GILCHRIST D, 1989, CHEST, V96, P1197, DOI 10.1378/chest.96.5.1197; GUTMANN L, 1983, MUSCLE NERVE, V6, P515, DOI 10.1002/mus.880060708; HARDIE R, 1990, J NEUROL NEUROSUR PS, V53, P348, DOI 10.1136/jnnp.53.4.348; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; IONASESCU VV, 1995, MUSCLE NERVE, V18, P267, DOI 10.1002/mus.880180302; Kamholz J, 2000, BRAIN, V123, P222, DOI 10.1093/brain/123.2.222; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; LAROCHE CM, 1988, THORAX, V43, P478, DOI 10.1136/thx.43.6.478; LARSSON H, 1992, AM REV RESPIR DIS, V146, P1246, DOI 10.1164/ajrccm/146.5_Pt_1.1246; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Mayer P, 1999, AM J RESP CRIT CARE, V159, P213, DOI 10.1164/ajrccm.159.1.9709051; NAEGELE B, 1995, SLEEP, V18, P43; OSANAI S, 1992, INTERNAL MED, V31, P1267, DOI 10.2169/internalmedicine.31.1267; Pareyson D, 1999, MUSCLE NERVE, V22, P1498, DOI 10.1002/(SICI)1097-4598(199911)22:11<1498::AID-MUS4>3.0.CO;2-9; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Popovic RM, 1998, J APPL PHYSIOL, V84, P1055, DOI 10.1152/jappl.1998.84.3.1055; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; ROY EP, 1989, MUSCLE NERVE, V12, P52, DOI 10.1002/mus.880120110; Thomas PK, 1997, BRAIN, V120, P465, DOI 10.1093/brain/120.3.465; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	35	70	72	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2001	357	9252					267	272		10.1016/S0140-6736(00)03614-X	http://dx.doi.org/10.1016/S0140-6736(00)03614-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214130				2022-12-28	WOS:000166693400012
J	Krot, AN; Meibom, A; Russell, SS; Alexander, CMO; Jeffries, TE; Keil, K				Krot, AN; Meibom, A; Russell, SS; Alexander, CMO; Jeffries, TE; Keil, K			A new astrophysical setting for chondrule formation	SCIENCE			English	Article							QUEEN-ALEXANDRA RANGE-94411; METAL GRAINS; SOLAR NEBULA; CONSTRAINTS; GENERATION; CHONDRITES; METEORITES; MODEL	Chondrules in the metal-rich meteorites Hammadah al Hamra 237 and QUE 94411 have recorded highly energetic thermal events that resulted in complete vaporization of a dusty region of the solar nebula (dust/gas ratio of about 10 to 50 times solar). These chondrules formed under oxidizing conditions before condensation of iron-nickel metal, at temperatures greater than or equal to 1500 K, and were isolated from the cooling gas before condensation of moderately volatile elements such as manganese, sodium, potassium. and sulfur. This astrophysical environment is fundamentally different from conventional models for chondrule formation by localized, brief, repetitive heating events that resulted in incomplete melting of solid precursors initially residing at ambient temperatures below approximately 650 K.	Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Stanford Univ, Stanford, CA 94305 USA; Nat Hist Museum, Dept Mineral, London SW7 5BD, England; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	University of Hawaii System; University of Hawaii Manoa; Stanford University; Natural History Museum London; Carnegie Institution for Science	Krot, AN (corresponding author), Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.		Alexander, Conel M. O'D./N-7533-2013; Jeffries, Teresa/F-4415-2014	Alexander, Conel M. O'D./0000-0002-8558-1427; Jeffries, Teresa/0000-0001-6417-1704; Meibom, Anders/0000-0002-4542-2819; Russell, Sara/0000-0001-5531-7847				ALEXANDER CMO, 1994, GEOCHIM COSMOCHIM AC, V58, P3451, DOI 10.1016/0016-7037(94)90098-1; Alexander CMO, 2000, METEORIT PLANET SCI, V35, P859, DOI 10.1111/j.1945-5100.2000.tb01469.x; ALEXANDER CMO, 1995, CHONDRULES PROTOPLAN, P233; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BOSS AP, 2000, CHONDRULES PROTOPLAN, P29; Campbell AJ, 2000, METEORIT PLANET SCI, V35, pA38; Campbell AJ, 2001, GEOCHIM COSMOCHIM AC, V65, P163, DOI 10.1016/S0016-7037(00)00526-3; CONNOLLY HC, 1995, GEOCHIM COSMOCHIM AC, V59, P3231, DOI 10.1016/0016-7037(95)00207-G; Connolly HC, 1998, SCIENCE, V280, P62, DOI 10.1126/science.280.5360.62; CONNOLLY HC, 1995, CHONDRULES PROTOPLAN, P129; Desch SJ, 2000, ICARUS, V143, P87, DOI 10.1006/icar.1999.6245; Greshake A, 2000, METEORIT PLANET SCI, V35, pA65; GROSSMAN JN, 1995, CHONDRULES PROTOPLAN, P243; Herzog GF, 2000, METEORIT PLANET SCI, V35, pA71; HEWINS RH, 1991, GEOCHIM COSMOCHIM AC, V55, P935, DOI 10.1016/0016-7037(91)90152-U; HEWINS RH, 1995, CHONDRULES PROTOPLAN; HOOD LL, 1995, CHONDRULES PROTOPLAN, P265; HORANYI M, 2000, CHONDRULES PROTOPLAN, P303; Jones R. H., 2000, Protostars and planets 4, P927; JONES RH, 1995, CHONDRULES PROTOPLAN, P163; Krot A. N., 2000, Protostars and planets 4, P1019; KROT AN, 1995, GEOCHIM COSMOCHIM AC, V59, P4951, DOI 10.1016/0016-7037(95)00337-1; KROT AN, 2000, LUNAR PLANET SCI, V3; KROT AN, UNPUB; Meibom A, 2000, METEORIT PLANET SCI, V35, pA107; Meibom A, 2000, SCIENCE, V288, P839, DOI 10.1126/science.288.5467.839; Petaev MI, 2001, METEORIT PLANET SCI, V36, P93, DOI 10.1111/j.1945-5100.2001.tb01812.x; Rubin A.E., 1995, CHONDRULES PROTOPLAN, P173; Rubin AE, 2000, EARTH-SCI REV, V50, P3, DOI 10.1016/S0012-8252(99)00067-7; Russell SS, 2000, METEORIT PLANET SCI, V35, pA139; SHU F, IN PRESS ASTROPHYS J; WASSON JT, 1995, GEOCHIM COSMOCHIM AC, V59, P1847, DOI 10.1016/0016-7037(95)00087-G; Weidenschilling SJ, 1998, SCIENCE, V279, P681, DOI 10.1126/science.279.5351.681; Weisberg MK, 1998, METEORIT PLANET SCI, V33, pA166; WEISBERG MK, IN PRESS METEORIT PL; Woolum DS, 1999, METEORIT PLANET SCI, V34, P897, DOI 10.1111/j.1945-5100.1999.tb01408.x; ZIPFEL J, 1998, LUNAR PLANET SCI, V29	38	81	84	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1776	1779		10.1126/science.291.5509.1776	http://dx.doi.org/10.1126/science.291.5509.1776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230691				2022-12-28	WOS:000167320600056
J	Pfeifer, BA; Admiraal, SJ; Gramajo, H; Cane, DE; Khosla, C				Pfeifer, BA; Admiraal, SJ; Gramajo, H; Cane, DE; Khosla, C			Biosynthesis of complex polyketides in a metabolically engineered strain of E-coli	SCIENCE			English	Article							COA; SYNTHASE; PROPIONATE; EXPRESSION; PEPTIDE; DOMAIN; GENE	The macrocyclic core of the antibiotic erythromycin, 6-deoxyerythronolide B (6dEB), is a complex natural product synthesized by the soil bacterium Saccharopolyspora erythraea through the action of a multifunctional polyketide synthase (PKS). The engineering potential of modular PKSs is hampered by the Limited capabilities for molecular biological manipulation of organisms (principally actinomycetes) in which complex polyketides have thus far been produced. To address this problem, a derivative of Escherichia coli has been genetically engineered. The resulting cellular catalyst converts exogenous propionate into 6dEB with a specific productivity that compares well with a high-producing mutant of S. erythraea that has been incrementally enhanced over decades for the industrial production of erythromycin.	Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Brown Univ, Dept Chem, Providence, RI 02912 USA; Fac Ciencias Bioquim & Farmaceut, Dept Microbiol, RA-2000 Rosario, Santa Fe, Argentina	Stanford University; Stanford University; Stanford University; Brown University	Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	ck@chemeng.stanford.edu		Khosla, Chaitan/0000-0001-6529-495X	NCI NIH HHS [CA 66736] Funding Source: Medline; NIGMS NIH HHS [GM 22172] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022172] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADMIRAAL SJ, NPUB; CAFFREY P, 1992, FEBS LETT, V304, P225, DOI 10.1016/0014-5793(92)80624-P; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; CORTES J, 1995, SCIENCE, V268, P1487, DOI 10.1126/science.7770773; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; GRAMAJO H, UNPUB; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Horswill AR, 1999, J BACTERIOL, V181, P5615, DOI 10.1128/JB.181.18.5615-5623.1999; Horswill AR, 1999, MICROBIOL-UK, V145, P1381, DOI 10.1099/13500872-145-6-1381; Jacobsen JR, 1998, BIOCHEMISTRY-US, V37, P4928, DOI 10.1021/bi9729920; KAO CM, 1994, SCIENCE, V265, P509, DOI 10.1126/science.8036492; Kao CM, 1996, BIOCHEMISTRY-US, V35, P12363, DOI 10.1021/bi9616312; KAO CM, 1995, J AM CHEM SOC, V117, P9105, DOI 10.1021/ja00140a043; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; MANIATIS T, 1982, MOL CLONING LABORATO, P440; Minas W, 1998, BIOTECHNOL PROGR, V14, P561, DOI 10.1021/bp980055t; Mootz HD, 1997, CURR OPIN CHEM BIOL, V1, P543, DOI 10.1016/S1367-5931(97)80051-8; OHagan D., 1991, POLYKETIDE METABOLIT; PIEPER R, 1995, NATURE, V378, P263, DOI 10.1038/378263a0; Pohl NL, 1998, J AM CHEM SOC, V120, P11206, DOI 10.1021/ja9830290; Rodriguez E, 1999, MICROBIOL-SGM, V145, P3109, DOI 10.1099/00221287-145-11-3109; Tsang AW, 1998, J BACTERIOL, V180, P6511, DOI 10.1128/JB.180.24.6511-6518.1998	24	563	635	5	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1790	1792		10.1126/science.1058092	http://dx.doi.org/10.1126/science.1058092			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230695				2022-12-28	WOS:000167320600060
J	Arnon, SS; Schechter, R; Inglesby, TV; Henderson, DA; Bartlett, JG; Ascher, MS; Eitzen, E; Fine, AD; Hauer, J; Layton, M; Lillibridge, S; Osterholm, MT; O'Toole, T; Parker, G; Perl, TM; Russell, PK; Swerdlow, DL; Tonat, K				Arnon, SS; Schechter, R; Inglesby, TV; Henderson, DA; Bartlett, JG; Ascher, MS; Eitzen, E; Fine, AD; Hauer, J; Layton, M; Lillibridge, S; Osterholm, MT; O'Toole, T; Parker, G; Perl, TM; Russell, PK; Swerdlow, DL; Tonat, K		Working Grp Civilian Biodefense	Botulinum toxin as a biological weapon - Medical and public health management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CLOSTRIDIUM-BOTULINUM; UNITED-STATES; A BOTULISM; FOODBORNE BOTULISM; INFANT BOTULISM; PHAGE LIBRARIES; WOUND BOTULISM; LARGE OUTBREAK; WARFARE; RECOGNITION	Objective The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if botulinum toxin is used as a biological weapon against a civilian population. Participants The working group included 23 representatives from academic, government, and private institutions with expertise in public health, emergency management, and clinical medicine. Evidence The primary authors (S.S.A. and R.S.) searched OLDMEDLINE and MEDLINE (1960-March 1999) and their professional collections for literature concerning use of botulinum toxin as a bioweapon. The literature was reviewed, and opinions were sought from the working group and other experts on diagnosis and management of botulism. Additional MEDLINE searches were conducted through April 2000 during the review and revisions of the consensus statement. Consensus Process The first draft of the working group's consensus statement was a synthesis of information obtained in the formal evidence-gathering process. The working group convened to review the first draft in May 1999. Working group members reviewed subsequent drafts and suggested additional revisions. The final statement incorporates all relevant evidence obtained in the literature search in conjunction with final consensus recommendations supported by all working group members. Conclusions An aerosolized or food borne botulin um toxin weapon would cause acute symmetric, descending flaccid paralysis with prominent bulbar palsies such as diplopia, dysarthria, dysphonia, and dysphagia that would typically present 12 to 72 hours after exposure. Effective response to a deliberate release of botulinum toxin will depend on timely clinical diagnosis, case reporting, and epidemiological investigation. Persons potentially exposed to botulinum toxin should be closely observed, and those with signs of botulism require prompt treatment with antitoxin and supportive care that may include assisted ventilation for weeks or months. Treatment with antitoxin should not be delayed for microbiological testing.	Calif Dept Hlth Serv, Infant Botulism Treatment & Prevent Program, Berkeley, CA 94704 USA; Calif Dept Hlth Serv, Viral & Rickettsial Dis Lab, Berkeley, CA 94704 USA; Johns Hopkins Univ, Sch Med, Ctr Civilian Biodef Studies, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; New York City Dept Hlth, Bur Communicable Dis, New York, NY 10013 USA; Sci Applicat Int Corp, Mclean, VA 22102 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Infect Control Advisory Network Inc, Eden Prairie, MN USA; US Dept HHS, Off Emergency Preparedness, Rockville, MD USA	California Department of Health Care Services; California Department of Health Care Services; Johns Hopkins University; Johns Hopkins University; New York City Department of Health & Mental Hygiene; Science Applications International Corporation (SAIC); Centers for Disease Control & Prevention - USA	Arnon, SS (corresponding author), Calif Dept Hlth Serv, Infant Botulism Treatment & Prevent Program, 2151 Berkeley Way,Room 506, Berkeley, CA 94704 USA.	sarnon@dhs.ca.gov						Alibek Ken., 1999, BIOHAZARD; Amersdorfer P, 2000, METH MOL B, V145, P219; AMON SS, 1998, TXB PEDIAT INFECT DI, P1570; Angulo FJ, 1998, J INFECT DIS, V178, P172, DOI 10.1086/515615; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; ARNON SS, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P477; Arnon Stephen S., 1995, P257; AURELI P, 1986, J INFECT DIS, V154, P207, DOI 10.1093/infdis/154.2.207; Aureli P, 1996, LANCET, V348, P1594, DOI 10.1016/S0140-6736(05)66220-4; Bavari S, 1998, VACCINE, V16, P1850, DOI 10.1016/S0264-410X(98)00175-3; BELLER M, 1993, BOTULISM ALASKA GUID; Bermudez Joseph, 2001, ARMED FORCES N KOREA; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; BOZHEYEVA G, 1999, 1 MONT I INT STUD CT; Bryden John, 1989, DEADLY ALLIES CANADA; Burrows WD, 1999, ENVIRON HEALTH PERSP, V107, P975, DOI 10.1289/ehp.99107975; Byrne MP, 2000, BIOCHIMIE, V82, P955, DOI 10.1016/S0300-9084(00)01173-1; *CDCP, 2001, HDB EP CLIN LAB WORK; Cherington M, 1998, MUSCLE NERVE, V21, P701, DOI 10.1002/(SICI)1097-4598(199806)21:6<701::AID-MUS1>3.0.CO;2-B; CHOU JH, 1988, INT J EPIDEMIOL, V17, P899, DOI 10.1093/ije/17.4.899; COCHRANE RC, 1945, BIOL WARFARE RES US, V2; Consky E, 1994, THERAPY BOTULINUM TO, P211; CORDESMAN A, 1998, WEAPONS MASS DESTRUC, P18; DEZFULIAN M, 1984, J CLIN MICROBIOL, V19, P645, DOI 10.1128/JCM.19.5.645-648.1984; DOLMAN CE, 1961, J INFECT DIS, V109, P107, DOI 10.1093/infdis/109.2.107; DORSEY EL, 1964, 62 US ARM BIOL LAB; DUCHEN LW, 1972, P ROY SOC MED, V65, P196, DOI 10.1177/003591577206500244; Felz MW, 2000, NEW ENGL J MED, V342, P90, DOI 10.1056/NEJM200001133420204; Foster Leslie, 2000, Neurology, V54, pA178; FRANCIOSA G, 1994, J CLIN MICROBIOL, V32, P1911, DOI 10.1128/JCM.32.8.1911-1917.1994; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; FRANZ DR, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P473; Franz DR., 1997, DEFENSE TOXIN WEAPON; GANGAROSA EJ, 1971, AM J EPIDEMIOL, V93, P93, DOI 10.1093/oxfordjournals.aje.a121239; GEIGER JC, 1922, PUBLIC HLTH B, V127; GEISSLER E, 1999, SIPRI CHEM BIOL WARF, V18; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; GIMENEZ DF, 1970, ZENTBL BAKTERIOLOG P, V215, P221; GREENMAN L, 1994, NEW STATESMAN SOC, V7, P13, DOI 10.1038/ng0594-13; GUNNISON J. B., 1930, JOUR INFECT DIS, V46, P335, DOI 10.1093/infdis/46.4.335; HALL JD, 1985, J CLIN MICROBIOL, V21, P654, DOI 10.1128/JCM.21.4.654-655.1985; Hatheway C.L., 1998, TOPLEY WILSONS MICRO, P731; Hauschild AHW, 1993, CLOSTRIDIUM BOTULINU, P69; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; HERRERO BA, 1967, EXP MOL PATHOL, V6, P84, DOI 10.1016/0014-4800(67)90007-X; Hibbs RG, 1996, CLIN INFECT DIS, V23, P337, DOI 10.1093/clinids/23.2.337; HILL EV, 1947, COMMUNICATION   1212; HOLZER E, 1962, Med Klin, V57, P1735; HOOPER RR, 1983, MIL MED, V148, P901; HUGHES JM, 1981, ANN INTERN MED, V95, P442, DOI 10.7326/0003-4819-95-4-442; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Kazdobina I S, 1995, Gig Sanit, P9; KELLER MA, 1982, AM J DIS CHILD, V136, P320, DOI 10.1001/archpedi.1982.03970400038012; Khan AS, 2000, LANCET, V356, P1179, DOI 10.1016/S0140-6736(00)02769-0; KOENIG MG, 1967, AM J MED, V42, P208, DOI 10.1016/0002-9343(67)90020-4; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; MACDONALD KL, 1986, AM J EPIDEMIOL, V124, P794, DOI 10.1093/oxfordjournals.aje.a114455; MACDONALD KL, 1985, JAMA-J AM MED ASSOC, V253, P1275, DOI 10.1001/jama.253.9.1275; MANN JM, 1982, AM J EPIDEMIOL, V115, P598, DOI 10.1093/oxfordjournals.aje.a113341; MANN JM, 1981, AM J PUBLIC HEALTH, V71, P266, DOI 10.2105/AJPH.71.3.266; Marks C, 1996, NEW ENGL J MED, V335, P730, DOI 10.1056/NEJM199609053351008; Maselli RA, 2000, MUSCLE NERVE, V23, P1137, DOI 10.1002/1097-4598(200007)23:7<1137::AID-MUS21>3.0.CO;2-7; MCCROSKEY LM, 1991, J CLIN MICROBIOL, V29, P2618, DOI 10.1128/JCM.29.11.2618-2620.1991; Meyer K.F., 1965, 65 YEARS HUMAN BOTUL; MIDDLEBROOK JL, 1997, MED ASPECTS CHEM B 1, V3, P643; MIDURA TF, 1972, APPL MICROBIOL, V24, P165, DOI 10.1080/10803920252931230; MILLER J, 1999, NY TIMES        0602, pA1; Miller J., 1999, NY TIMES        0602, pA10; MONTECUCCO C, 1995, CURR TOP MICROBIOL I, V195, P1; National Institute of Occupational Safety and Health, 1996, REG TOX EFF CHEM SUB; OLSON KR, 1999, POISONING DRUG OVERD; OMAHONY M, 1990, EPIDEMIOL INFECT, V104, P389, DOI 10.1017/S0950268800047403; Robin L, 1996, NEW ENGL J MED, V335, P823, DOI 10.1056/NEJM199609123351117; SANTOS JI, 1981, PEDIATRICS, V68, P50; SARVAS H, 1993, J CLIN IMMUNOL, V13, P145, DOI 10.1007/BF00919271; SCHANTZ EJ, 1992, MICROBIOL REV, V56, P80, DOI 10.1128/MMBR.56.1.80-99.1992; SCHREINER MS, 1991, PEDIATRICS, V87, P159; Schulze J, 1999, LANCET, V354, P1792, DOI 10.1016/S0140-6736(99)02881-0; SCOTT AB, 1988, MOVEMENT DISORD, V3, P333, DOI 10.1002/mds.870030409; SCOTT AB, 1980, J PEDIAT OPHTH STRAB, V17, P21, DOI 10.3928/0191-3913-19800101-06; SEALS JE, 1981, AM J EPIDEMIOL, V113, P436, DOI 10.1093/oxfordjournals.aje.a113111; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Shapiro RL, 1997, JAMA-J AM MED ASSOC, V278, P433, DOI 10.1001/jama.278.5.433; SIEGEL LS, 1988, J CLIN MICROBIOL, V26, P2351, DOI 10.1128/JCM.26.11.2351-2356.1988; Siegel LS, 1993, CLOSTRIDIUM BOTULINU, P323; Silberstein S, 2000, HEADACHE, V40, P445, DOI 10.1046/j.1526-4610.2000.00066.x; SMART JK, 1997, TXB MILITARY MED 1, V3; SMART JL, 1980, VET REC, V107, P445, DOI 10.1136/vr.107.19.445; Smith L.D.S., 1977, BOTULISM ORGANISM IT; SMITHSON AE, 1999, 32HL STIMS CTR, P7; STCLAIR EH, 1975, J PEDIATR-US, V87, P658; STLOUIS ME, 1988, ANN INTERN MED, V108, P363, DOI 10.7326/0003-4819-108-3-363; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4; TELZAK EE, 1990, J INFECT DIS, V161, P340, DOI 10.1093/infdis/161.2.340; TERRANOVA W, 1978, AM J EPIDEMIOL, V108, P150, DOI 10.1093/oxfordjournals.aje.a112599; Townes JM, 1996, ANN INTERN MED, V125, P558, DOI 10.7326/0003-4819-125-7-199610010-00004; Tucker Jonathan B., 2000, TOXIC TERROR ASSESSI; *UN SEC COUNC, 1995, 10 UN SEC COUNC; *US DEP STAT, 2001, PATT GLOB TERR 1999; WANNEMACHER RW, 1993, 9120 US ARM BIOM RES; WEBER JT, 1993, CLIN INFECT DIS, V16, P635, DOI 10.1093/clind/16.5.635; Wictome M, 1999, APPL ENVIRON MICROB, V65, P3787; Wiener SL, 1996, MIL MED, V161, P251, DOI 10.1093/milmed/161.5.251; WOODRUFF BA, 1992, J INFECT DIS, V166, P1281, DOI 10.1093/infdis/166.6.1281; WuDunn S., 1998, N Y TIMES       0526, VA1, pA10; WUDUNN S, 1998, NY TIMES        0410, pA1; Zilinskas RA, 1997, JAMA-J AM MED ASSOC, V278, P418, DOI 10.1001/jama.278.5.418	108	1021	1094	5	202	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2001	285	8					1059	1070		10.1001/jama.285.8.1059	http://dx.doi.org/10.1001/jama.285.8.1059			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	403ME	11209178				2022-12-28	WOS:000167046400029
J	Labrador, M; Mongelard, F; Plata-Rengifo, P; Baxter, EM; Corces, VG; Gerasimova, TI				Labrador, M; Mongelard, F; Plata-Rengifo, P; Baxter, EM; Corces, VG; Gerasimova, TI			Molecular biology - Protein encoding by both DNA strands	NATURE			English	Article							PRE-MESSENGER-RNAS; CHROMATIN INSULATOR		Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Labrador, M (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.			Mongelard, Fabien/0000-0002-5929-6120; Labrador-San Jose, Mariano/0000-0002-8075-2717; Corces, Victor/0000-0001-5140-4337				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Buchner K, 2000, GENETICS, V155, P141; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Burge CB, 1999, RNA WORLD, P525; Caudevilla C, 1998, P NATL ACAD SCI USA, V95, P12185, DOI 10.1073/pnas.95.21.12185; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; Harvey AJ, 1997, MOL CELL BIOL, V17, P2835, DOI 10.1128/MCB.17.5.2835; SOLNICK D, 1985, CELL, V42, P157, DOI 10.1016/S0092-8674(85)80111-2	10	61	63	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1000	1000		10.1038/35059000	http://dx.doi.org/10.1038/35059000			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234000				2022-12-28	WOS:000167148800033
J	Tan, HL; Bink-Boelkens, MTE; Bezzina, CR; Viswanathan, PC; Beaufort-Krol, GCM; van Tintelen, PJ; van den Berg, MP; Wilde, AAM; Balser, JR				Tan, HL; Bink-Boelkens, MTE; Bezzina, CR; Viswanathan, PC; Beaufort-Krol, GCM; van Tintelen, PJ; van den Berg, MP; Wilde, AAM; Balser, JR			A sodium-channel mutation causes isolated cardiac conduction disease	NATURE			English	Article							ST-SEGMENT ELEVATION; LONG-QT SYNDROME; BRUGADA-SYNDROME; MOLECULAR MECHANISM; ARRHYTHMIA; CURRENTS; BLOCK; SCN5A	Cardiac conduction disorders slow the heart rhythm and cause disability in millions of people worldwide. Inherited mutations in SCN5A, the gene encoding the human cardiac sodium (Na+) channel, have been associated with rapid heart rhythms that occur suddenly and are life-threatening(1-3); however, a chief function of the Na+ channel is to initiate cardiac impulse conduction. Here we provide the first functional characterization of an SCN5A mutation that causes a sustained, isolated conduction defect with pathological slowing of the cardiac rhythm. By analysing the SCN5A coding region, we have identified a single mutation in five affected family members; this mutation results in the substitution of cysteine 514 for glycine (G514C) in the channel protein. Biophysical characterization of the mutant channel shows that there are abnormalities in voltage-dependent 'gating' behaviour that can be partially corrected by dexamethasone, consistent with the salutary effects of glucocorticoids on the clinical phenotype. Computational analysis predicts that the gating defects of G514C selectively slow myocardial conduction, but do not provoke the rapid cardiac arrhythmias associated previously with SCN5A mutations.	Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA; Univ Amsterdam, Acad Med Ctr, Expt & Mol Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; Beatrix Childrens Hosp, Dept Pediat Cardiol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Med Genet, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Cardiol, NL-9700 RB Groningen, Netherlands; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; University of Groningen; University of Groningen; Vanderbilt University	Balser, JR (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA.	jeff.balser@mcmail.vanderbilt.edu	van Tintelen, J. Peter/J-8926-2012; van Tintelen, J. Peter/AAJ-9962-2021	van den Berg, Maarten/0000-0002-1493-2998; Bezzina, Connie/0000-0002-0633-3514				Alings M, 1999, CIRCULATION, V99, P666, DOI 10.1161/01.CIR.99.5.666; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bezzina C, 1999, CIRC RES, V85, P1206; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; CASCIO WE, 1995, J CARDIOVASC ELECTR, V6, P1039, DOI 10.1111/j.1540-8167.1995.tb00381.x; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; DAVIGNON A, 1980, PEDIATR CARDIOL, V1, P123, DOI 10.1007/BF02083144; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; DOMINGUEZ G, 1970, CIRC RES, V26, P565, DOI 10.1161/01.RES.26.5.565; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; HORN R, 1981, NATURE, V291, P426, DOI 10.1038/291426a0; Johns DC, 1997, J BIOL CHEM, V272, P31598, DOI 10.1074/jbc.272.50.31598; Kambouris NG, 1998, CIRCULATION, V97, P640, DOI 10.1161/01.CIR.97.7.640; KRISHNAN SC, 1991, CIRC RES, V69, P277, DOI 10.1161/01.RES.69.2.277; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; Priori SG, 1999, CIRCULATION, V99, P518, DOI 10.1161/01.CIR.99.4.518; Priori SG, 2000, LANCET, V355, P808, DOI 10.1016/S0140-6736(99)05277-0; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; VELKDKAMP MW, 2000, CIRC RES, V86, pE91; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140	24	285	306	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1043	1047		10.1038/35059090	http://dx.doi.org/10.1038/35059090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234013				2022-12-28	WOS:000167148800046
J	Bendayan, M				Bendayan, M			Worth its weight in gold	SCIENCE			English	Article							FREEZE-SUBSTITUTION; CRYOFIXATION; ANTIBODY		Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Bendayan, M (corresponding author), Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada.	bendayam@alize.ere.umontreal.ca						Bendayan M, 2000, BIOTECH HISTOCHEM, V75, P203; BENDAYAN M, 1995, PROG HISTOCHEM CYTOC, V29, P1; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568, DOI 10.1038/9872; Coons AH, 1941, P SOC EXP BIOL MED, V47, P200, DOI 10.3181/00379727-47-13084P; ELIASSON M, 1988, J BIOL CHEM, V263, P4323; FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081; HAINFELD JF, 1987, SCIENCE, V236, P450, DOI 10.1126/science.3563522; KELLENBERGER E, 1991, J MICROSC-OXFORD, V161, P183, DOI 10.1111/j.1365-2818.1991.tb03083.x; Mayer G, 2001, PROG HISTOCHEM CYTO, V36, P11, DOI 10.1016/S0079-6336(01)80002-4; SJOSTRAND FS, 1990, J STRUCT BIOL, V103, P135, DOI 10.1016/1047-8477(90)90017-7	10	58	64	3	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1363	+		10.1126/science.291.5507.1363	http://dx.doi.org/10.1126/science.291.5507.1363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233453				2022-12-28	WOS:000166993400042
J	McGuffin, P; Riley, B; Plomin, R				McGuffin, P; Riley, B; Plomin, R			Genomics and behavior - Toward behavioral genomics	SCIENCE			English	Article									Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England	University of London; King's College London	McGuffin, P (corresponding author), Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, De Crespigny Pk, London SE5 8AF, England.		McGuffin, Peter/A-1565-2012; Plomin, Robert/B-8911-2008	McGuffin, Peter/0000-0002-9888-2907; Plomin, Robert/0000-0002-0756-3629				Arranz MJ, 2000, LANCET, V355, P1615, DOI 10.1016/S0140-6736(00)02221-2; Battey J, 1999, NAT GENET, V21, P73, DOI 10.1038/5012; EDWARDS JH, 1965, ANN HUM GENET, V29, P77, DOI 10.1111/j.1469-1809.1965.tb00501.x; McGuffin P, 2001, AM J MED GENET, V105, P39, DOI 10.1002/1096-8628(20010108)105:1<39::AID-AJMG1054>3.0.CO;2-T; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Plomin R, 2000, PSYCHOL BULL, V126, P806, DOI 10.1037/0033-2909.126.6.806; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Plomin R., 2001, BEHAV GENET, V4th; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729	11	113	122	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1232	+		10.1126/science.1057264	http://dx.doi.org/10.1126/science.1057264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233447				2022-12-28	WOS:000166993400025
J	Crow, JF				Crow, JF			The beanbag lives on	NATURE			English	Editorial Material									Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Crow, JF (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.							Dawkins, 1989, SELFISH GENE REVISED; HALDANE JBS, 1964, PERSPECT BIOL MED, V7, P343; Madhi SA, 2021, SAFETY EFFICACY CHAD, DOI 10.1101/2021.02.10.21251247; NAGYLAKI T, 1989, GENETICS, V122, P253	4	25	26	1	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					771	771		10.1038/35057409	http://dx.doi.org/10.1038/35057409			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236977				2022-12-28	WOS:000166938800019
J	Noctor, SC; Flint, AC; Weissman, TA; Dammerman, RS; Kriegstein, AR				Noctor, SC; Flint, AC; Weissman, TA; Dammerman, RS; Kriegstein, AR			Neurons derived from radial glial cells establish radial units in neocortex	NATURE			English	Article							RAT CEREBRAL-CORTEX; VENTRICULAR ZONE; MIGRATION; ORGANIZATION; LINEAGE; PROLIFERATION; PATTERNS	The neocortex of the adult brain consists of neurons and glia that are generated by precursor cells of the embryonic ventricular zone. In general, glia are generated after neurons during development(1), but radial glia are an exception to this rule. Radial glia are generated before neurogenesis and guide neuronal migration(2). Radial glia are mitotically active throughout neurogenesis(3), and disappear or become astrocytes when neuronal migration is complete(4,5). Although the lineage relationships of cortical neurons and glia have been explored(6,7), the clonal relationship of radial glia to other cortical cells remains unknown. It has been suggested that radial glia may be neuronal precursors(5,8-10), but this has not been demonstrated in vivo. We have used a retroviral vector encoding enhanced green fluorescent protein to label precursor cells in vivo and have examined clones 1-3 days later using morphological, immunohistochemical and electrophysiological techniques. Here we show that clones consist of mitotic radial glia and postmitotic neurons, and that neurons migrate along clonally related radial glia. Time-lapse images show that proliferative radial glia generate neurons. Our results support the concept that a lineage relationship between neurons and proliferative radial glia may underlie the radial organization of neocortex.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Kriegstein, AR (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St, New York, NY 10032 USA.	ark17@columbia.edu		Flint, Alexander/0000-0002-3721-2694; Weissman, Tamily/0000-0001-9361-6071				ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; [Anonymous], 1970, Anat Rec, V166, P257; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Bittman K, 1997, J NEUROSCI, V17, P7037; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Cai L, 1997, J NEUROSCI, V17, P2088; Chanas-Sacre G, 2000, J NEUROSCI RES, V61, P357, DOI 10.1002/1097-4547(20000815)61:4<357::AID-JNR1>3.0.CO;2-7; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gould E, 1997, J NEUROSCI, V17, P2492; GRAY GE, 1992, DEVELOPMENT, V114, P271; GRESSENS P, 1993, DEV BRAIN RES, V76, P272, DOI 10.1016/0165-3806(93)90218-Y; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1988, DEV BRAIN RES, V38, P183, DOI 10.1016/0165-3806(88)90043-0; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; PRICE J, 1988, DEVELOPMENT, V104, P473; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; TAKAHASHI T, 1993, J NEUROSCI, V13, P820	30	1426	1460	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					714	720		10.1038/35055553	http://dx.doi.org/10.1038/35055553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217860				2022-12-28	WOS:000166816400043
J	Matsumoto, Y; Murakami, M; Shono, T; Hasegawa, T; Fukumura, T; Kawasaki, M; Ahmet, P; Chikyow, T; Koshihara, S; Koinuma, H				Matsumoto, Y; Murakami, M; Shono, T; Hasegawa, T; Fukumura, T; Kawasaki, M; Ahmet, P; Chikyow, T; Koshihara, S; Koinuma, H			Room-temperature ferromagnetism in transparent transition metal-doped titanium dioxide	SCIENCE			English	Article							MAGNETORESISTANCE; SYSTEMS; TIO2	Dilute magnetic semiconductors and wide gap oxide semiconductors are appealing materials for magnetooptical devices, From a combinatorial screening approach looking at the solid solubility of transition metals in titanium dioxides and of their magnetic properties, we report on the observation of transparent ferromagnetism in cobalt-doped anatase thin films with the concentration of cobalt between 0 and 8%, Magnetic microscopy images reveal a magnetic domain structure in the films, indicating the existence of ferromagnetic long-range ordering, The materials remain ferromagnetic above room temperature with a magnetic moment of 0.32 Bohr magnetons per cobalt atom, The film is conductive and exhibits a positive magnetoresistance of 60% at 2 kelvin.	Tokyo Inst Technol, Ceram Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan; Tokyo Inst Technol, Dept Innovat & Engineered Mat, Yokohama, Kanagawa 2268502, Japan; Natl Inst Res Inorgan Mat, Tsukuba, Ibaraki 3050044, Japan; Natl Res Inst Met, Tsukuba, Ibaraki 3050047, Japan; Tokyo Inst Technol, Dept Mat Sci, Meguro Ku, Tokyo 152, Japan; Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan; Tokyo Inst Technol, Frontier Collaborat Res Ctr, Yokohama, Kanagawa 2268503, Japan; Waseda Univ, Japan Sci & Technol, CREST, Shinjyuku Ku, Tokyo 1698555, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; National Institute for Materials Science; National Institute for Materials Science; Tokyo Institute of Technology; Kanagawa Academy Science & Technology; Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Waseda University	Koinuma, H (corresponding author), Tokyo Inst Technol, Ceram Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan.		Chikyow, Toyohiro/AAF-9603-2019; Koshihara, Shinya/ABA-1213-2021; Matsumoto, Yuji/H-2056-2011; Fukumura, Tomoteru/C-2081-2009; Kawasaki, Masashi/B-5826-2008; Koshihara, Shinya/B-5095-2015	Chikyow, Toyohiro/0000-0003-3860-4806; Fukumura, Tomoteru/0000-0002-8957-3520; Matsumoto, Yuji/0000-0003-1819-5566; Koshihara, Shinya/0000-0002-7119-2017				BRICENO G, 1995, SCIENCE, V270, P273, DOI 10.1126/science.270.5234.273; CHASE MW, 1985, J PHYS CHEM REF DATA, V14, P1; CHAUVET O, 1995, SOLID STATE COMMUN, V93, P667, DOI 10.1016/0038-1098(94)00845-0; FORRO L, 1994, J APPL PHYS, V75, P633, DOI 10.1063/1.355801; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Fukumura T, 1999, APPL PHYS LETT, V75, P3366, DOI 10.1063/1.125353; FURDYNA JK, 1988, J APPL PHYS, V64, pR29, DOI 10.1063/1.341700; Jin Z., UNPUB; KIM H, 1996, APPL PHYS LETT, V69, P25; Matsumoto Y, 1999, JPN J APPL PHYS 2, V38, pL603, DOI 10.1143/JJAP.38.L603; MATSUMOTO Y, 2000, SPIE P, V3941, P19; Mitani S, 1997, J MAGN MAGN MATER, V165, P141, DOI 10.1016/S0304-8853(96)00490-8; MURAKAMI M, UNPUB; Ohno H, 1998, SCIENCE, V281, P951, DOI 10.1126/science.281.5379.951; Sato K, 2000, JPN J APPL PHYS 2, V39, pL555, DOI 10.1143/JJAP.39.L555; WOLFE R, 1970, J APPL PHYS, V41, P1218, DOI 10.1063/1.1658881; XIAO JQ, 1992, PHYS REV LETT, V68, P3749, DOI 10.1103/PhysRevLett.68.3749	17	2245	2346	13	840	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					854	856		10.1126/science.1056186	http://dx.doi.org/10.1126/science.1056186			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11228146				2022-12-28	WOS:000166771700038
J	Powell, PA; Wesley, C; Spencer, S; Cagan, RL				Powell, PA; Wesley, C; Spencer, S; Cagan, RL			Scabrous complexes with Notch to mediate boundary formation	NATURE			English	Article							DEVELOPING DROSOPHILA RETINA; EYE DEVELOPMENT; PRONEURAL GENE; EXPRESSION; PROTEIN; RECEPTOR; ENHANCER; DELTA; PHOTORECEPTORS; NEUROGENESIS	The mechanisms that establish and sharpen pattern across epithelia are poorly understood. In the developing nervous system, the first pattern elements appear as 'proneural clusters'. In the morphogenetic furrow of the immature Drosophila retina proneural clusters emerge in a wave as a patterned array of 6-10-cell groups, which are recognizable by expression of Atonal, a basic helix-loop-helix transcription factor that is required to establish and pattern the first cell fate(1-3). The establishment and subsequent patterning of Atonal expression requires activity of the signalling transmembrane receptor Notch(2,4). Here we present in vivo and biochemical evidence that the secreted protein Scabrous associates with Notch, and can stabilize Notch protein at the surface. The result is a regulation of Notch activity that sharpens proneural cluster boundaries and ensures establishment of single pioneer neurons.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Rockefeller Univ, Genet Lab, New York, NY 10021 USA	Washington University (WUSTL); Rockefeller University	Cagan, RL (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, 660 S Euclid Ave,Campus Box 8103, St Louis, MO 63110 USA.		Cagan, Ross Leigh/AAV-9528-2021	Cagan, Ross/0000-0001-5297-450X				BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; BAKER NE, 1995, MECH DEVELOP, V49, P173, DOI 10.1016/0925-4773(94)00314-D; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; ELLIS MC, 1994, DEVELOPMENT, V120, P1959; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; HART AC, 1993, NATURE, V361, P732, DOI 10.1038/361732a0; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Ju BG, 2000, NATURE, V405, P191, DOI 10.1038/35012090; KIDD S, 1989, GENE DEV, V3, P1113, DOI 10.1101/gad.3.8.1113; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lee EC, 2000, CURR BIOL, V10, P931, DOI 10.1016/S0960-9822(00)00622-9; Lee EC, 1998, GENETICS, V150, P663; Lee EC, 1996, MOL CELL BIOL, V16, P1179; Lee EC, 1996, BIOCHEM BIOPH RES CO, V225, P720, DOI 10.1006/bbrc.1996.1241; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; Parks AL, 2000, DEVELOPMENT, V127, P1373; RABINOW L, 1990, GENETICS, V125, P41; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Wesley CS, 1999, MOL CELL BIOL, V19, P5743; Wesley CS, 2000, J CELL BIOL, V149, P683, DOI 10.1083/jcb.149.3.683	29	67	68	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					626	630		10.1038/35054566	http://dx.doi.org/10.1038/35054566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214322				2022-12-28	WOS:000166692300046
J	Chow, KM; Hui, ACF; Szeto, CC; Wang, AYM; Li, PKT				Chow, KM; Hui, ACF; Szeto, CC; Wang, AYM; Li, PKT			A confused uraemic woman	LANCET			English	Editorial Material							STATUS EPILEPTICUS		Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Li, PKT (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.		Wang, Angela Y/B-9944-2008; Ming, Chow Kai/Y-5568-2019; Szeto, Cheuk Chun/N-4954-2015; Li, Philip K. T./D-4051-2017	Ming, Chow Kai/0000-0001-5310-5197; Szeto, Cheuk Chun/0000-0002-8898-8505; Wang, Angela Yee-Moon/0000-0003-2508-7117				CASCINO GD, 1993, EPILEPSIA, V34, pS21, DOI 10.1111/j.1528-1157.1993.tb05903.x; CELESIA GG, 1976, JAMA-J AM MED ASSOC, V235, P1571, DOI 10.1001/jama.235.15.1571; GUBERMAN A, 1986, NEUROLOGY, V36, P1284, DOI 10.1212/WNL.36.10.1284; Lynch MW, 1996, CURR OPIN NEUROL, V9, P97, DOI 10.1097/00019052-199604000-00007; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340	5	5	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					278	278		10.1016/S0140-6736(00)03616-3	http://dx.doi.org/10.1016/S0140-6736(00)03616-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214132				2022-12-28	WOS:000166693400014
J	Weng, JY; McClelland, J; Pentland, A; Sporns, O; Stockman, I; Sur, M; Thelen, E				Weng, JY; McClelland, J; Pentland, A; Sporns, O; Stockman, I; Sur, M; Thelen, E			Artificial intelligence - Autonomous mental development by robots and animals	SCIENCE			English	Editorial Material									Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; MIT, Media Lab, Cambridge, MA 02139 USA; Indiana Univ, Dept Psychol, Bloomington, IN 47405 USA; Michigan State Univ, Dept Audiol & Speech Sci, E Lansing, MI 48824 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Michigan State University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT); Indiana University System; Indiana University Bloomington; Michigan State University; Massachusetts Institute of Technology (MIT)	Weng, JY (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA.		Sporns, Olaf/A-1667-2010	Sporns, Olaf/0000-0001-7265-4036				Almassy N, 1998, CEREB CORTEX, V8, P346, DOI 10.1093/cercor/8.4.346; Elman JL, 1997, RETHINKING INNATENES; HWNG WS, 2000, IEE T PATTERN ANAL M, V22, P11; Kuhn T., 1996, STRUCTURE SCI REVOLU; *MICH STAT U, 2000, P WORKSH DEV LEARN 5; ROY D, 1999, WORKSH INT SPEECH IM; THELEN E, IN PRESS BEHAV BRAIN; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; WANG X, 1995, NATURE, V378, P13; WENG J, 1998, LEARNING COMPUTER VI; WENG J, 1999, P 2 INT S HUM ROB TO, P57	11	358	382	6	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2001	291	5504					599	600		10.1126/science.291.5504.599	http://dx.doi.org/10.1126/science.291.5504.599			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11229402				2022-12-28	WOS:000166616000026
J	Wiese, C; Wilde, A; Moore, MS; Adam, SA; Merdes, A; Zheng, YX				Wiese, C; Wilde, A; Moore, MS; Adam, SA; Merdes, A; Zheng, YX			Role of importin-beta in coupling ran to downstream targets in microtubule assembly	SCIENCE			English	Article							NUCLEAR-PROTEIN IMPORT; GTP-BOUND RAN; MITOTIC SPINDLE; CYTOPLASMIC DYNEIN; EGG EXTRACTS; NUMA; COMPLEX; ORGANIZATION; ASTERS; P97	The guanosine triphosphatase Ran stimulates assembly of microtubule asters and spindles in mitotic Xenopus egg extracts. A carboxyl-terminal region of the nuclear-mitotic apparatus protein (NuMA), a nuclear protein required for organizing mitotic spindle poles, mimics Ran's ability to induce asters. This NuMA fragment also specifically interacted with the nuclear transport factor, importin-beta. We show that importin-beta is an inhibitor of microtubule aster assembly in Xenopus egg extracts and that Ran regulates the interaction between importin-beta and NuMA, Importin-beta therefore Links NUMA to regulation by Ran. This suggests that similar mechanisms regulate nuclear import during interphase and spindle assembly during mitosis.	Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Carnegie Inst Washington, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD 21210 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	University of Edinburgh; Carnegie Institution for Science; Howard Hughes Medical Institute; Baylor College of Medicine; Northwestern University	Merdes, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.			Wilde, Andrew/0000-0002-9812-3847	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312, R01GM047866] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56312, GM47866, GM53678] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen SSL, 1997, J CELL BIOL, V139, P975, DOI 10.1083/jcb.139.4.975; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Harborth J, 1999, EMBO J, V18, P1689, DOI 10.1093/emboj/18.6.1689; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; MOORE MA, UNPUB; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; VERDE F, 1991, J CELL BIOL, V112, P1177, DOI 10.1083/jcb.112.6.1177; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; WIESE C, UNPUB; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; WILDE A, IN PRESS NATURE CELL; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405	26	265	274	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2001	291	5504					653	656		10.1126/science.1057661	http://dx.doi.org/10.1126/science.1057661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11229403				2022-12-28	WOS:000166616000044
J	Blackman, EG; Frank, A; Markiel, JA; Thomas, JH; Van Horn, HM				Blackman, EG; Frank, A; Markiel, JA; Thomas, JH; Van Horn, HM			Dynamos in asymptotic-giant-branch stars as the origin of magnetic fields shaping planetary nebulae	NATURE			English	Article							WHITE-DWARFS; ROTATION; MODELS; EVOLUTION; INTERFACE	Planetary nebulae are thought to be formed when a slow wind from the progenitor giant star is overtaken by a subsequent fast wind generated as the star enters its white dwarf stage(1). A shock forms near the boundary between the winds, creating the relatively dense shell characteristic of a planetary nebula. A spherically symmetric wind will produce a spherically symmetric shell, yet over half of known planetary nebulae are not spherical; rather, they are elliptical or bipolar in shape(2). A magnetic field could launch and collimate a bipolar outflow, but the origin of such a field has hitherto been unclear, and some previous work has even suggested that a field could not be generated(3). Here we show that an asymptotic-giant-branch (AGB) star can indeed generate a strong magnetic field, having as its origin a dynamo at the interface between the rapidly rotating core and the more slowly rotating envelope of the star. The fields are strong enough to shape the bipolar outflows that produce the observed bipolar planetary nebulae. Magnetic braking of the stellar core during this process may also explain the puzzlingly(4) slow rotation of most white dwarf stars.	Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; Univ Rochester, CEK Mees Observ, Rochester, NY 14627 USA; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Univ Rochester, Dept Mech Engn, Rochester, NY 14627 USA	University of Rochester; University of Rochester; University of Washington; University of Washington Seattle; University of Rochester	Thomas, JH (corresponding author), Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA.			Blackman, Eric/0000-0002-9405-8435; Frank, Adam/0000-0002-4948-7820				Alcolea J, 2000, ASTR SOC P, V199, P347; Balick B, 1998, ASTRON J, V116, P360, DOI 10.1086/300429; BALICK B, 1987, ASTRON J, V94, P671, DOI 10.1086/114504; Behr BB, 2000, ASTROPHYS J, V528, P849, DOI 10.1086/308219; Blackman EG, 1996, PHYS REV LETT, V77, P2694, DOI 10.1103/PhysRevLett.77.2694; BLACKMAN EG, IN PRESS ASTROPHYS J; CHEVALIER RA, 1994, ASTROPHYS J, V421, P225, DOI 10.1086/173640; COX AN, 1999, ALLENS ASTROPHYSICAL, P389; Garcia-Segura G, 1999, ASTROPHYS J, V517, P767, DOI 10.1086/307205; GURZADYAN GA, 1969, PLANETARY NEBULAE; ICKE V, 1992, ASTRON ASTROPHYS, V253, P224; Koester D, 1998, ASTRON ASTROPHYS, V338, P612; Konigl A., 2000, Protostars and planets 4, P759; KWOK S, 1978, ASTROPHYS J, V219, pL125, DOI 10.1086/182621; Lery T, 1998, ASTRON ASTROPHYS, V337, P603; Livio M, 1998, ASTROPHYS J, V505, P339, DOI 10.1086/306153; Manchado A, 2000, ASTR SOC P, V199, P17; Markiel JA, 1999, ASTROPHYS J, V523, P827, DOI 10.1086/307774; Matt S, 2000, ASTROPHYS J, V545, P965, DOI 10.1086/317843; MELLEMA G, 1991, ASTRON ASTROPHYS, V252, P718; Palen S, 2000, ASTROPHYS J, V531, P391, DOI 10.1086/308435; PARKER EN, 1993, ASTROPHYS J, V408, P707, DOI 10.1086/172631; PASCOLI G, 1987, ASTRON ASTROPHYS, V180, P191; PETERSON RC, 1983, ASTROPHYS J, V275, P737, DOI 10.1086/161571; PICK M, 1999, ESA SP, P183; PINSONNEAULT MH, 1991, ASTROPHYS J, V367, P239, DOI 10.1086/169623; SAHAI J, 2000, ASP C SER, V199, P209; SOKER N, 1989, ASTROPHYS J, V339, P268, DOI 10.1086/167294; SOKER N, 1992, PUBL ASTRON SOC PAC, V104, P923, DOI 10.1086/133076; THOMAS JH, 1995, ASTROPHYS J, V453, P403, DOI 10.1086/176400; Trammell SR, 2000, ASTR SOC P, V199, P147; Tsinganos K, 2000, ASTRON ASTROPHYS, V356, P989	32	150	150	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					485	487		10.1038/35054008	http://dx.doi.org/10.1038/35054008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206538	Green Submitted			2022-12-28	WOS:000166570500039
J	Bell, AC; West, AG; Felsenfeld, G				Bell, AC; West, AG; Felsenfeld, G			Gene regulation - Insulators and boundaries: Versatile regulatory elements in the eukaryotic genome	SCIENCE			English	Review							ENHANCER-BLOCKING ACTIVITY; CHROMATIN DOMAIN BOUNDARY; BETA-GLOBIN LOCUS; DNA METHYLATION; IMPRINTED EXPRESSION; BITHORAX COMPLEX; CONTROL REGION; H19; PROTEIN; CTCF	Insulators mark the boundaries of chromatin domains by limiting the range of action of enhancers and silencers. Although the properties of insulators have been well studied, their role in vivo has Largely been a subject of speculation. Recent results make it possible to ascribe specific and essential functions to the insulators of Drosophila, yeast, and vertebrates. In some cases, insulator activity can Se modulated by nearby regulatory elements, bound cofactors, or covalent modification of the DNA. Not simply passive barriers, insulators are active participants in eukaryotic gene regulation.	NIDDKD, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Felsenfeld, G (corresponding author), NIDDKD, Bethesda, MD 20892 USA.	gary.felsenfeld@nih.gov		West, Adam/0000-0003-3502-7804	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK034001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barges S, 2000, DEVELOPMENT, V127, P779; Bell AC, 1999, CURR OPIN GENET DEV, V9, P191, DOI 10.1016/S0959-437X(99)80029-X; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Buchner K, 2000, GENETICS, V155, P141; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Cai HN, 2001, SCIENCE, V291, P493, DOI 10.1126/science.291.5503.493; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; DORSETT D, 1993, GENETICS, V134, P1135; Drewell RA, 2000, DEVELOPMENT, V127, P3419; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Gaszner M, 1999, GENE DEV, V13, P2098, DOI 10.1101/gad.13.16.2098; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Hagstrom K, 1996, GENE DEV, V10, P3202, DOI 10.1101/gad.10.24.3202; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hart CM, 1997, MOL CELL BIOL, V17, P999, DOI 10.1128/MCB.17.2.999; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Inoue T, 1999, J HUM GENET, V44, P152, DOI 10.1007/s100380050133; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lu L, 1997, MOL CELL BIOL, V17, P2202, DOI 10.1128/MCB.17.4.2202; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Muravyova E, 2001, SCIENCE, V291, P495, DOI 10.1126/science.291.5503.495; Palla F, 1997, P NATL ACAD SCI USA, V94, P2272, DOI 10.1073/pnas.94.6.2272; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; RECILLASTARGA F, UNPUB; REITMAN M, 1988, P NATL ACAD SCI USA, V85, P6267, DOI 10.1073/pnas.85.17.6267; Rivella S, 2000, J VIROL, V74, P4679, DOI 10.1128/JVI.74.10.4679-4687.2000; Robinett CC, 1997, MOL CELL BIOL, V17, P2866, DOI 10.1128/MCB.17.5.2866; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Srivastava M, 2000, GENE DEV, V14, P1186; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Taboit-Dameron F, 1999, TRANSGENIC RES, V8, P223, DOI 10.1023/A:1008919925303; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Torigoi E, 2000, P NATL ACAD SCI USA, V97, P2686, DOI 10.1073/pnas.050586397; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; Udvardy A, 1999, EMBO J, V18, P1, DOI 10.1093/emboj/18.1.1; Vazquez J, 2000, GENETICS, V155, P1297; Wang YL, 1997, NAT BIOTECHNOL, V15, P239, DOI 10.1038/nbt0397-239; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; Zhong XP, 1997, P NATL ACAD SCI USA, V94, P5219, DOI 10.1073/pnas.94.10.5219; Zhou JM, 1999, CELL, V99, P567, DOI 10.1016/S0092-8674(00)81546-9	52	295	324	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2001	291	5503					447	450		10.1126/science.291.5503.447	http://dx.doi.org/10.1126/science.291.5503.447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11228144				2022-12-28	WOS:000166487500030
J	Nathens, AB; Jurkovich, GJ; Maier, RV; Grossman, DC; MacKenzie, EJ; Moore, M; Rivara, FP				Nathens, AB; Jurkovich, GJ; Maier, RV; Grossman, DC; MacKenzie, EJ; Moore, M; Rivara, FP			Relationship between trauma center volume and outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the American-College-of-Surgeons-Committee-on-Trauma	MAR09, 2000	RENO, NV	Amer Coll Surg Comm Trauma			NEW-YORK-STATE; INJURY SEVERITY SCORE; IN-HOSPITAL MORTALITY; GLASGOW-COMA-SCALE; SURGICAL VOLUME; NATIONAL SURVEY; SYSTEMS; IMPACT; EXPERIENCE; SURGERY	Context The premise underlying regionalization of trauma care is that larger volumes of trauma patients cared for in fewer institutions will lead to improved outcomes. However, whether a relationship exists between institutional volume and trauma outcomes remains unknown. Objective To evaluate the association between trauma center volume and outcomes of trauma patients. Design Retrospective cohort study. Setting Thirty-one academic level I or level II trauma centers across the United States participating in the University Healthsystem Consortium Trauma Benchmarking Study. Patients Consecutive patients with penetrating abdominal injury (PAI; n=478) discharged between November 1, 1997, and July 31, 1998, or with multisystem blunt trauma (minimum of head injury and lower-extremity long-bone fractures; n=541) discharged between June 1 and December 31, 1998. Main Outcome Measures Inpatient mortality and hospital length of stay (LOS), comparing high-volume (>650 trauma admissions/y) and low-volume (less than or equal to 650 admissions/y) centers. Results After multivariate adjustment for patient characteristics and injury severity, the relative odds of death was 0.02 (95% confidence interval [CI], 0.002-0.25) for patients with PAI admitted with shock to high-volume centers compared with low-volume centers. No benefit was evident in patients without shock (P=.50). The adjusted odds of death in patients with multisystem blunt trauma who presented with coma to a high-volume center was 0.49 (95% CI, 0.26-0.93) vs low-volume centers. No benefit was observed in patients without coma (P=.05). Additionally, a shorter LOS was observed in patients with PAI and New Injury Severity Scores of 16 or higher (difference in adjusted mean LOS, 1.6 days [95% CI, -1.5 to 4.7 days]) and in all patients with multisystem blunt trauma admitted to higher-volume centers (difference in adjusted mean LOS, 3.3 days [95% CI, 0.91-5.70 days]). Conclusions Our results indicate that a strong association exists between trauma center volume and outcomes, with significant improvements in mortality and LOS when volume exceeds 650 cases per year. These benefits are only evident in patients at high risk for adverse outcomes.	Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; Univ Hlth Syst Consortium, Chicago, IL USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Johns Hopkins University	Nathens, AB (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Box 359796,325 9th Ave, Seattle, WA 98104 USA.	anathens@u.washington.edu			PHS HHS [R49/CCR002570] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM COLL SURG COMM, 1998, RES OPT CAR INJ PAT; *ASS ADV AUT MED, 1990, AAAM ABBR INJ SCAL 1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAZZOLI GJ, 1995, JAMA-J AM MED ASSOC, V273, P395; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer JD, 1999, SURGERY, V125, P250, DOI 10.1067/msy.1999.95211; Brenneman FD, 1998, J TRAUMA, V44, P580, DOI 10.1097/00005373-199804000-00003; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Cooper A, 2000, J TRAUMA, V48, P16, DOI 10.1097/00005373-200001000-00004; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P365; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003; KONVOLINKA CW, 1995, AM J SURG, V170, P333, DOI 10.1016/S0002-9610(99)80299-2; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; SMITH RF, 1990, J TRAUMA, V30, P1066, DOI 10.1097/00005373-199009000-00002; Solomon RA, 1996, STROKE, V27, P13, DOI 10.1161/01.STR.27.1.13; Tepas JJ, 1998, J TRAUMA, V44, P827, DOI 10.1097/00005373-199805000-00014; WEST JG, 1988, JAMA-J AM MED ASSOC, V259, P3597, DOI 10.1001/jama.259.24.3597; WEST JG, 1979, ARCH SURG-CHICAGO, V114, P455	23	410	413	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1164	1171		10.1001/jama.285.9.1164	http://dx.doi.org/10.1001/jama.285.9.1164			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	406BH	11231745	Bronze			2022-12-28	WOS:000167194700019
J	Krige, JEJ; Beckingham, IJ				Krige, JEJ; Beckingham, IJ			ABC of diseases of liver, pancreas, and biliary system - Liver abscesses and hydatid disease	BRITISH MEDICAL JOURNAL			English	Review									Groote Schuur Hosp, Cape Town, South Africa; Univ Cape Town, ZA-7700 Rondebosch, South Africa; Queens Med Ctr, Dept Surg, Nottingham NG7 2UH, England	University of Cape Town; University of Cape Town; University of Nottingham	Krige, JEJ (corresponding author), Groote Schuur Hosp, Cape Town, South Africa.		Krige, Jake E/G-3496-2015	Krige, Jake E/0000-0002-7057-9156				KRIGE JEJ, 1998, CURRENT SURG THERAPY, P326; Krige JEJ, 1995, DIAGNOSIS MANAGEMENT, P196	2	52	57	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					537	540		10.1136/bmj.322.7285.537	http://dx.doi.org/10.1136/bmj.322.7285.537			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230072	Green Published			2022-12-28	WOS:000167370500032
J	Vincent, C; Neale, G; Woloshynowych, M				Vincent, C; Neale, G; Woloshynowych, M			Adverse events in British hospitals: preliminary retrospective record review	BRITISH MEDICAL JOURNAL			English	Article							QUALITY	Objectives To examine the feasibility of detecting adverse events through record review in British hospitals and to make preliminary estimates of the incidence and costs of adverse events. Design Retrospective review of 1014 medical and nursing records. Setting Two acute hospitals in Greater London area. Main outcome measure Number of adverse events. Results 110 (10.8%) patients experienced an adverse event, with an overall rate of adverse events of 11.7% when multiple adverse events were included. About half of these events were judged preventable with ordinary standards of care. A third of adverse events led to moderate or greater disability or death, Conclusions These results suggest that adverse events are a serious source of harm to patients and a large drain an NHS resources, Some are major events; others are frequent, minor events that go unnoticed in routine clinical care but together have massive economic consequences.	UCL, Dept Psychol, Clin Risk Unit, London WC1E 6BT, England	University of London; University College London	Vincent, C (corresponding author), UCL, Dept Psychol, Clin Risk Unit, Mortimer St, London WC1E 6BT, England.	c.vincent@ucl.ac.uk	Vincent, Charles A/D-1134-2010	Vincent, Charles A/0000-0003-0270-0222				BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Donaldson L., 2005, ORG MEMORY REPORT EX; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; THOMAS EJ, IN PRESS CLIN RISK M; Vincent C, 1997, BRIT MED J, V314, P1775, DOI 10.1136/bmj.314.7097.1775; Weingart SN, 2000, BRIT MED J, V320, P774, DOI 10.1136/bmj.320.7237.774; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	8	1170	1203	2	39	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					517	519		10.1136/bmj.322.7285.517	http://dx.doi.org/10.1136/bmj.322.7285.517			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230064	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-28	WOS:000167370500023
J	Liu, FGR; Miyamoto, MM; Freire, NP; Ong, PQ; Tennant, MR; Young, TS; Gugel, KF				Liu, FGR; Miyamoto, MM; Freire, NP; Ong, PQ; Tennant, MR; Young, TS; Gugel, KF			Molecular and morphological supertrees for eutherien (placental) mammals	SCIENCE			English	Article							PHYLOGENETIC INFERENCE; COMBINING DATA; TREES; CHARACTERS; SUPPORT; GENES; TAXA	A Large body of diverse comparative data now exists for a major phylogenetic synthesis of the higher-level relationships among eutherian (placental) mammals. We present such a phylogenetic synthesis using the composite trees or supertrees from the combined and separate analyses of their published molecular and morphological source phylogenies. Our combined and separate supertrees largely support the same suprafamilial taxa and orders, but different interordinal clades. These similarities and differences reinforce the continuing contributions of morphological studies. while highlighting the growing influence of molecular information on the field. As current summaries of past research, our supertrees emphasize opportunities for future work, while providing a step toward the eventual integration of the data and characters themselves.	Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Univ Florida, Hlth Sci Ctr Lib, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Miyamoto, MM (corresponding author), Univ Florida, Dept Zool, Box 118525, Gainesville, FL 32611 USA.	miyamoto@zoo.ufl.edu		Young, Timothy/0000-0002-3449-0998				[Anonymous], 1999, WALKERS MAMMALS WORL; BAUM BR, 1992, TAXON, V41, P3, DOI 10.2307/1222480; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Bininda-Emonds ORP, 2000, MOL PHYLOGENET EVOL, V16, P113, DOI 10.1006/mpev.2000.0772; BININDAEMONDS ORP, IN PRESS SYST BIOL; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; de Jong WW, 1998, TRENDS ECOL EVOL, V13, P270, DOI 10.1016/S0169-5347(98)01335-4; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Liu FGR, 1999, SYST BIOL, V48, P54, DOI 10.1080/106351599260436; McKenna MC, 1997, CLASSIFICATION MAMMA; Mitchell A, 2000, SYST BIOL, V49, P202, DOI 10.1093/sysbio/49.2.202; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; PURVIS A, 1995, SYST BIOL, V44, P251, DOI 10.1093/sysbio/44.2.251; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; Sanderson MJ, 1998, TRENDS ECOL EVOL, V13, P105, DOI 10.1016/S0169-5347(97)01242-1; Shoshani J, 1998, MOL PHYLOGENET EVOL, V9, P572, DOI 10.1006/mpev.1998.0520; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Springer MS, 1999, SYST BIOL, V48, P65, DOI 10.1080/106351599260445; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Stanhope MJ, 1998, MOL PHYLOGENET EVOL, V9, P501, DOI 10.1006/mpev.1998.0517; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; Szalay F. S., 1993, MAMMAL PHYLOGENY PLA; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Waddell PJ, 1999, SYST BIOL, V48, P31, DOI 10.1080/106351599260427; WILSON E, 1993, MAMMAL SPECIES WORLD	29	174	191	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1786	1789		10.1126/science.1056346	http://dx.doi.org/10.1126/science.1056346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230694				2022-12-28	WOS:000167320600059
J	Breddin, HK; Hach-Wunderle, V; Nakov, R; Kakkar, VV				Breddin, HK; Hach-Wunderle, V; Nakov, R; Kakkar, VV		CORTES Investigators	Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENOUS UNFRACTIONATED HEPARIN; PROXIMAL VENOUS THROMBOSIS; INITIAL TREATMENT; PULMONARY-EMBOLISM; STANDARD HEPARIN; NULL HYPOTHESIS; CLINICAL-TRIALS; DOUBLE-BLIND; METAANALYSIS; DALTEPARIN	Background: Low-molecular-weight heparins are frequently used to treat venous thromboembolism, but optimal dosing regimens and clinical outcomes need further definition. Methods: In this multicenter, open-label study with blinded adjudication of end points, we randomly assigned patients with acute deep-vein thrombosis to one of three treatment regimens: intravenous administration of unfractionated heparin; subcutaneous administration of a low-molecular-weight heparin, reviparin, twice a day for one week; or subcutaneous administration of reviparin once a day for four weeks. The primary end point was evidence of regression of the thrombus on venography on day 21; secondary end points were recurrent venous thromboembolism, major bleeding within 90 days after enrollment, and death. Results: Of the patients receiving unfractionated heparin, 40.2 percent (129 of 321) had thrombus regression, as compared with 53.4 percent (175 of 328) of the patients receiving reviparin twice daily and 53.5 percent (167 of 312) of the patients receiving reviparin once daily. With regard to thrombus regression, reviparin administered twice daily was significantly more effective than unfractionated heparin (relative likelihood of thrombus regression, 1.28; 97.5 percent confidence interval, 1.08 to 1.52), as was reviparin administered once daily (relative likelihood, 1.29; 97.5 percent confidence interval, 1.08 to 1.53). Mortality and the frequency of episodes of major bleeding were similar in the three groups. Conclusions: In acute deep-vein thrombosis, reviparin regimens are more effective than unfractionated heparin in reducing the size of the thrombus. Reviparin is also more effective than unfractionated heparin for the prevention of recurrent thromboembolism and equally safe. (N Engl J Med 2001;344:626-31.) Copyright (C) 2001 Massachusetts Medical Society.	Int Inst Thrombosis & Vasc Dis, D-60598 Frankfurt, Germany		Breddin, HK (corresponding author), Int Inst Thrombosis & Vasc Dis, Ferdinand-Schrey-Weg 6, D-60598 Frankfurt, Germany.							ALBADA J, 1989, CIRCULATION, V80, P935, DOI 10.1161/01.CIR.80.4.935; Bernardi E, 2000, THROMB HAEMOSTASIS, V84, P22, DOI 10.1055/s-0037-1613961; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Charbonnier BA, 1998, THROMB HAEMOSTASIS, V79, P897; Dahl OE, 1997, THROMB HAEMOSTASIS, V77, P26; DUROUX P, 1991, THROMB HAEMOSTASIS, V65, P251; ENCKE A, 1988, BRIT J SURG, V75, P1058; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Fiessinger JN, 1996, THROMB HAEMOSTASIS, V76, P195; Harenberg J, 2000, THROMB HAEMOSTASIS, V83, P652; HOLMSTROM M, 1992, THROMB RES, V67, P49; HUISMAN MV, 1989, CHEST, V95, P498, DOI 10.1378/chest.95.3.498; HULL RD, 1990, NEW ENGL J MED, V322, P1260, DOI 10.1056/NEJM199005033221802; HULL RD, 1986, NEW ENGL J MED, V315, P1109, DOI 10.1056/NEJM198610303151801; HULL RD, 1992, NEW ENGL J MED, V326, P975, DOI 10.1056/NEJM199204093261502; KAKKAR VV, 1993, LANCET, V341, P259, DOI 10.1016/0140-6736(93)92614-Y; Kirchmaier CM, 1998, INT ANGIOL, V17, P135; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Koopman MMW, 1997, NEW ENGL J MED, V337, P1251; LEIZOROVICZ A, 1994, BMJ-BRIT MED J, V309, P299, DOI 10.1136/bmj.309.6950.299; LENSING AWA, 1995, ARCH INTERN MED, V155, P601, DOI 10.1001/archinte.155.6.601; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; LINDMARKER P, 1994, THROMB HAEMOSTASIS, V72, P186; LOPACIUK S, 1992, THROMB HAEMOSTASIS, V68, P14; MARDER VJ, 1977, J LAB CLIN MED, V89, P1018; Partsch H, 1996, J VASC SURG, V24, P774, DOI 10.1016/S0741-5214(96)70012-5; PINI M, 1994, THROMB HAEMOSTASIS, V72, P191; PRANDONI P, 1992, LANCET, V339, P441, DOI 10.1016/0140-6736(92)91054-C; SALZMAN EW, 1975, NEW ENGL J MED, V292, P1046, DOI 10.1056/NEJM197505152922002; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; SIMONNEAU G, 1993, ARCH INTERN MED, V153, P1541, DOI 10.1001/archinte.153.13.1541; SPIRO T, 1997, THROMB HAEMOST S, V77, P373; tenCate JW, 1997, NEW ENGL J MED, V337, P657; VANDENBELT AG, 2000, COCHRANE DATABASE SY; YANAGAWA T, 1994, BIOMETRICS, V50, P859, DOI 10.2307/2532800; YANAGAWA T, 1995, BIOMETRICS, V51, P392	36	165	168	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2001	344	9					626	631		10.1056/NEJM200103013440902	http://dx.doi.org/10.1056/NEJM200103013440902			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405TR	11228276				2022-12-28	WOS:000167177100002
J	McAuley, J				McAuley, J			Does essential tremor originate in the cerebral cortex?	LANCET			English	Editorial Material							MOTOR		Royal London Hosp, Dept Neurol, London E1 1BB, England; King Georges Hosp, Dept Neurol, Illford, England	Barts Health NHS Trust; Royal London Hospital; King George Hospital	McAuley, J (corresponding author), Royal London Hosp, Dept Neurol, London E1 1BB, England.							Bible RJ, 1990, TREMOR; Elble RJ, 2000, LANCET, V355, P1113, DOI 10.1016/S0140-6736(00)02054-7; Halliday DM, 2000, LANCET, V355, P1149, DOI 10.1016/S0140-6736(00)02064-X; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093/brain/119.2.363; MATTHEWS PBC, 1993, J PHYSIOL-LONDON, V462, P503, DOI 10.1113/jphysiol.1993.sp019566; McAuley JH, 2000, BRAIN, V123, P1545, DOI 10.1093/brain/123.8.1545; McAuley JH, 1997, EXP BRAIN RES, V114, P525, DOI 10.1007/PL00005662; Volkmann J, 1996, NEUROLOGY, V46, P1359, DOI 10.1212/WNL.46.5.1359; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0	9	8	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					492	494		10.1016/S0140-6736(00)04036-8	http://dx.doi.org/10.1016/S0140-6736(00)04036-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229663				2022-12-28	WOS:000167011700004
J	Devlin, RH; Biagi, CA; Yesaki, TY; Smailus, DE; Byatt, JC				Devlin, RH; Biagi, CA; Yesaki, TY; Smailus, DE; Byatt, JC			Growth of domesticated transgenic fish - A growth-hormone transgene boosts the size of wild but not domesticated trout.	NATURE			English	Article							ONCORHYNCHUS-KISUTCH; GENE CONSTRUCT; SALMON; ENHANCEMENT; SELECTION; RELEASE		Fisheries & Oceans Canada, W Vancouver, BC V7V 1N6, Canada; Monsanto Corp, St Louis, MO 63198 USA	Fisheries & Oceans Canada; Monsanto	Devlin, RH (corresponding author), Fisheries & Oceans Canada, 4160 Marine Dr, W Vancouver, BC V7V 1N6, Canada.		Biagi, Carlo/AAN-2030-2020	Biagi, Carlo/0000-0002-6345-9674				Devlin RH, 1995, AQUACULTURE, V137, P161, DOI 10.1016/0044-8486(95)01090-4; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; Devlin RH, 1997, TRANSGENIC ANIMALS G, P105; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; Eisen EJ, 1995, J ANIM BREED GENET, V112, P401, DOI 10.1111/j.1439-0388.1995.tb00579.x; HERSHBERGER WK, 1990, AQUACULTURE, V85, P1; McLean E, 1997, AQUACULTURE, V156, P113, DOI 10.1016/S0044-8486(97)00071-9; Muir WM, 1999, P NATL ACAD SCI USA, V96, P13853, DOI 10.1073/pnas.96.24.13853; PURSEL VG, 1989, SCIENCE, V244, P1281, DOI 10.1126/science.2499927; Rahman MA, 1998, TRANSGENIC RES, V7, P357, DOI 10.1023/A:1008837105299	10	164	178	0	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					781	782		10.1038/35057314	http://dx.doi.org/10.1038/35057314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236982				2022-12-28	WOS:000166938800026
J	Hedges, JI; Baldock, JA; Gelinas, Y; Lee, C; Peterson, M; Wakeham, SG				Hedges, JI; Baldock, JA; Gelinas, Y; Lee, C; Peterson, M; Wakeham, SG			Evidence for non-selective preservation of organic matter in sinking marine particles	NATURE			English	Article							CHEMICAL-COMPOSITION; AMINO-ACIDS; FLUX; SOILS; C-13	The sinking of particulate organic matter from ocean surface waters transports carbon to the ocean interior(1,2), where almost all is then recycled. The unrecycled fraction of this organic matter can become buried in ocean sediments, thus sequestering carbon and so influencing atmospheric carbon dioxide concentrations(3). The processes controlling the extensive biodegradation of sinking particles remain unclear, partly because of the difficulty in resolving the composition of the residual organic matter at depth with existing chromatographic techniques(4). Here, using solid-state C-13 NMR spectroscopy(5), we characterize the chemical structure of organic carbon in both surface plankton and sinking particulate matter from the Pacific Ocean(4) and the Arabian Sea(6). We found that minimal changes occur in bulk organic composition, despite extensive (>98%) biodegradation, and that aminoacid-like material predominates throughout the water column in both regions. The compositional similarity between phytoplankton biomass and the small remnant of organic matter reaching the ocean interior indicates that the formation of unusual biochemicals, either by chemical recombination(7) or microbial biosynthesis(8), is not the main process controlling the preservation of particulate organic carbon within the water column at these two sites. We suggest instead that organic matter might be protected from degradation by the inorganic matrix of sinking particles.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; CSIRO Land & Water, Glen Osmond, SA 5064, Australia; SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA; Skidaway Inst Oceanog, Savannah, GA 31411 USA	University of Washington; University of Washington Seattle; Commonwealth Scientific & Industrial Research Organisation (CSIRO); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography	Hedges, JI (corresponding author), Univ Washington, Sch Oceanog, Box 357940, Seattle, WA 98195 USA.	jihedges@u.washington.edu	Gélinas, Yves/K-4019-2013; Baldock, Jeffrey A/G-1362-2010; Lee, Cindy/B-1456-2009	Gélinas, Yves/0000-0001-5751-8378; Baldock, Jeffrey A/0000-0002-6428-8555; Lee, Cindy/0000-0002-7608-6213				ANDERSON LA, 1995, DEEP-SEA RES, V38, P143; ARMSTRONG RA, IN PRESS DEEP SEA RE; Baldock J., 2000, HDB SOIL SCI, pB25, DOI DOI 10.1038/194324B0; BISHOP JKB, 1977, DEEP-SEA RES, V24, P511, DOI 10.1016/0146-6291(77)90526-4; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; Broecker W.S., 1982, TRACERS SEA; COWIE GL, 1992, LIMNOL OCEANOGR, V37, P703, DOI 10.4319/lo.1992.37.4.0703; De Leeuw J.W., 1993, ORG GEOCHEM, V11, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; HATCHER PG, 1983, NATURE, V305, P498, DOI 10.1038/305498a0; Hedges J. I., 1988, Humic substances and their role in the environment., P45; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; HERNES PJ, IN PRESS DEEP SEA RE; Honjo S, 1999, DEEP-SEA RES PT II, V46, P1859, DOI 10.1016/S0967-0645(99)00047-8; ITTEKKOT V, 1992, GEOL SOC SPEC PUBL, V64, P167, DOI DOI 10.1144/GSL.SP.1992.064.01.11; KINCHESH P, 1995, EUR J SOIL SCI, V46, P125, DOI 10.1111/j.1365-2389.1995.tb01819.x; Knicker H, 1996, ORG GEOCHEM, V24, P661, DOI 10.1016/0146-6380(96)00057-5; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Lee C, 1998, DEEP-SEA RES PT II, V45, P2489, DOI 10.1016/S0967-0645(98)00079-4; Lee C, 2000, DEEP-SEA RES PT I, V47, P1535, DOI 10.1016/S0967-0637(99)00116-8; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; MURRAY JW, 1994, SCIENCE, V266, P58, DOI 10.1126/science.266.5182.58; Nelson PN, 1999, AUST J SOIL RES, V37, P289, DOI 10.1071/S98076; PARSONS TR, 1961, J FISH RES BOARD CAN, V18, P1001, DOI 10.1139/f61-063; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; Smith SL, 1998, DEEP-SEA RES PT II, V45, P1905, DOI 10.1016/S0967-0645(98)00058-7; STEVENSON F. J, 1994, HUMUS CHEM; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; Wilson M. A., 1987, NMR TECHNIQUES APPL	31	268	275	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					801	804		10.1038/35057247	http://dx.doi.org/10.1038/35057247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236989				2022-12-28	WOS:000166938800035
J	Ralph, D				Ralph, D			Applied physics - A new twist for magnets	SCIENCE			English	Editorial Material							MULTILAYER; EXCITATION		Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	Cornell University	Ralph, D (corresponding author), Cornell Univ, Dept Phys, Ithaca, NY 14853 USA.		Ralph, Daniel C/G-3251-2010					Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; Myers EB, 1999, SCIENCE, V285, P867, DOI 10.1126/science.285.5429.867; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Sun JZ, 1999, J MAGN MAGN MATER, V202, P157, DOI 10.1016/S0304-8853(99)00289-9; Tsoi M, 2000, NATURE, V406, P46, DOI 10.1038/35017512; Tsoi M, 1998, PHYS REV LETT, V80, P4281, DOI 10.1103/PhysRevLett.80.4281; Weber W, 2001, SCIENCE, V291, P1015, DOI 10.1126/science.1057430; Wegrowe JE, 1999, EUROPHYS LETT, V45, P626, DOI 10.1209/epl/i1999-00213-1	9	7	7	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					999	1000		10.1126/science.1059019	http://dx.doi.org/10.1126/science.1059019			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232589				2022-12-28	WOS:000166860100033
J	Liu, C; Dutton, Z; Behroozi, CH; Hau, LV				Liu, C; Dutton, Z; Behroozi, CH; Hau, LV			Observation of coherent optical information storage in an atomic medium using halted light pulses	NATURE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; DISPERSIVE PROPERTIES; GROUP-VELOCITY; PROPAGATION; GAS	Electromagnetically induced transparency(1-3) is a quantum interference effect that permits the propagation of light through an otherwise opaque atomic medium; a 'coupling' laser is used to create the interference necessary to allow the transmission of resonant pulses from a 'probe' laser. This technique has been used(4-6) to slow and spatially compress light pulses by seven orders of magnitude, resulting in their complete localization and containment within an atomic cloud(4). Here we use electromagnetically induced transparency to bring laser pulses to a complete stop in a magnetically trapped, cold cloud of sodium atoms. Within the spatially localized pulse region, the atoms are in a superposition state determined by the amplitudes and phases of the coupling and probe laser fields. Upon sudden turn-off of the coupling laser, the compressed probe pulse is effectively stopped; coherent information initially contained in the laser fields is 'frozen' in the atomic medium for up to 1 ms. The coupling laser is turned back on at a later time and the probe pulse is regenerated: the stored coherence is read out and transferred back into the radiation field. We present a theoretical model that reveals that the system is self-adjusting to minimize dissipative loss during the 'read' and 'write' operations. We anticipate applications of this phenomenon for quantum information processing.	Rowland Inst Sci Inc, Cambridge, MA 02142 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Liu, C (corresponding author), Rowland Inst Sci Inc, 100 Edwin H Land Blvd, Cambridge, MA 02142 USA.							Arimondo E, 1996, PROG OPTICS, V35, P257, DOI 10.1016/S0079-6638(08)70531-6; Budker D, 1999, PHYS REV LETT, V83, P1767, DOI 10.1103/PhysRevLett.83.1767; DiVincenzo DP, 2000, QUANTPH0002077; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Fleischhauer M, 1996, PHYS REV A, V54, P794, DOI 10.1103/PhysRevA.54.794; GROBE R, 1994, PHYS REV LETT, V73, P3183, DOI 10.1103/PhysRevLett.73.3183; HARRIS SE, 1994, PHYS REV LETT, V72, P52, DOI 10.1103/PhysRevLett.72.52; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; HARRIS SE, 1992, PHYS REV A, V46, pR29, DOI 10.1103/PhysRevA.46.R29; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Hau LV, 1998, PHYS REV A, V58, pR54, DOI [10.1103/PhysRevA.58, 10.1103/PhysRevA.58.R54]; KASAPI A, 1995, PHYS REV LETT, V74, P2447, DOI 10.1103/PhysRevLett.74.2447; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Scully M.O., 1997, QUANTUM OPT; XIAO M, 1995, PHYS REV LETT, V74, P666, DOI 10.1103/PhysRevLett.74.666	15	1947	2033	7	214	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					490	493		10.1038/35054017	http://dx.doi.org/10.1038/35054017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206540	Green Published			2022-12-28	WOS:000166570500041
J	Dekker, G; Sibai, B				Dekker, G; Sibai, B			Primary, secondary, and tertiary prevention of pre-eclampsia	LANCET			English	Article							LOW-DOSE ASPIRIN; PREGNANCY-INDUCED HYPERTENSION; MEAN ARTERIAL-PRESSURE; RISK-FACTORS; GROWTH-RETARDATION; NULLIPAROUS WOMEN; EARLY PREDICTION; FETAL; PATERNITY; CALCIUM	Preeclampsia remains one of the major obstetrical problems in less-developed countries. The causes of this condition are still unknown, thus effective primary prevention is not possible at this stage. Research in the past decade has Identified some major risk factors for preeclampsia, and manipulation of these factors might result in a decrease in its frequency, In the early 1990s aspirin was thought to be the wonder drug in secondary prevention of pre-eclampsia, Results of large trials have shown that this is not the case: if there is an indication for using aspirin it is in the patient at a very high risk of developing severe early-onset disease. The calcium story followed a more or less similar pattern, with the difference that existing evidence shows that women with a low dietary calcium intake are likely to benefit from calcium supplementation. proper antenatal care and timed delivery are of utmost importance in tertiary prevention of preeclampsia. There is evidence to suggest that the intrinsic direct effect of moderate degrees of maternal hypertension is beneficial to the fetus. Severe hypertension needs treatment. If antihypertensive is indicated, there is no clear choice of a drug. Hydralazine should no longer be thought of as the primary drug, most studies show a preference for calcium channel blockers.	Univ Adelaide, Lyell McEwin Hosp, N Western Adelaide Hlth Serv, Elizabeth Vale, SA 5112, Australia; Univ Cincinnati, Dept Obstet & Gynecol, Cincinnati, OH 45221 USA	Lyell McEwin Hospital; University of Adelaide; University System of Ohio; University of Cincinnati	Dekker, G (corresponding author), Univ Adelaide, Lyell McEwin Hosp, N Western Adelaide Hlth Serv, Elizabeth Vale, SA 5112, Australia.	gustaaf.dekker@adelaide.edu.au						ATALLAH AN, 2000, COCHRANE LIB; BEROYZ G, 1994, LANCET, V343, P619; Bosio PM, 1999, OBSTET GYNECOL, V94, P978, DOI 10.1016/S0029-7844(99)00430-5; Campbell DM, 1999, HYPERTENS PREGNANCY, V18, P197, DOI 10.3109/10641959909016193; Chappell L, 1998, BRIT J OBSTET GYNAEC, V105, P379, DOI 10.1111/j.1471-0528.1998.tb10118.x; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Chien PFW, 2000, BRIT J OBSTET GYNAEC, V107, P196, DOI 10.1111/j.1471-0528.2000.tb11690.x; Conde-Agudelo A, 2000, BRIT J OBSTET GYNAEC, V107, P75, DOI 10.1111/j.1471-0528.2000.tb11582.x; CONDEAGUDELO A, 1993, AM J OBSTET GYNECOL, V169, P509, DOI 10.1016/0002-9378(93)90609-M; Crowther CA, 1999, AUST NZ J OBSTET GYN, V39, P12, DOI 10.1111/j.1479-828X.1999.tb03434.x; DAWES MG, 1991, BRIT J OBSTET GYNAEC, V98, P189, DOI 10.1111/j.1471-0528.1991.tb13367.x; DEKKER GA, 1991, AM J OBSTET GYNECOL, V165, P160, DOI 10.1016/0002-9378(91)90245-M; Dekker GA, 1999, CLIN OBSTET GYNECOL, V42, P422, DOI 10.1097/00003081-199909000-00002; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; DEKKER GA, 1993, AM J OBSTET GYNECOL, V168, P214, DOI 10.1016/S0002-9378(12)90917-5; DEKKER GA, 1998, OBSTET GYNECOL SURV, V58, P377; DerSimonian R, 1999, JAMA-J AM MED ASSOC, V282, P664, DOI 10.1001/jama.282.7.664; DULEY L, 1995, LANCET, V345, P1455; Dumont A, 1999, AM J OBSTET GYNECOL, V180, P135, DOI 10.1016/S0002-9378(99)70163-8; Emeagi J, 1999, BRIT MED J, V319, P316, DOI 10.1136/bmj.319.7205.316; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; HALLIGAN A, 1994, BRIT J OBSTET GYNAEC, V101, P488, DOI 10.1111/j.1471-0528.1994.tb13147.x; Halligan AWF, 1999, BRIT J OBSTET GYNAEC, V106, P1113, DOI 10.1111/j.1471-0528.1999.tb08133.x; Harrington K, 1997, BRIT J OBSTET GYNAEC, V104, P674, DOI 10.1111/j.1471-0528.1997.tb11977.x; Hauth JC, 2000, OBSTET GYNECOL, V95, P24, DOI 10.1016/S0029-7844(99)00462-7; Hauth JC, 1995, J MATERNAL FETAL MED, V4, P218; KAPLANSKI G, 1993, BLOOD, V81, P2492; Khedun SM, 1997, PHARMACOL THERAPEUT, V74, P221, DOI 10.1016/S0163-7258(97)82005-0; KNIGHT M, 2000, COCHRANE LIB; Koelman CA, 2000, J REPROD IMMUNOL, V46, P155, DOI 10.1016/S0165-0378(99)00062-5; LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905; Leeda M, 1998, AM J OBSTET GYNECOL, V179, P135, DOI 10.1016/S0002-9378(98)70263-7; Leitich H, 1997, BRIT J OBSTET GYNAEC, V104, P450, DOI 10.1111/j.1471-0528.1997.tb11497.x; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Madretsma GS, 1996, IMMUNOPHARMACOLOGY, V35, P47, DOI 10.1016/0162-3109(96)00122-1; Magee LA, 1999, BMJ-BRIT MED J, V318, P1332, DOI 10.1136/bmj.318.7194.1332; Many A, 1999, Obstet Gynecol Surv, V54, P723, DOI 10.1097/00006254-199911000-00024; MARCOUX S, 1991, AM J EPIDEMIOL, V133, P1266, DOI 10.1093/oxfordjournals.aje.a115838; MARU JJ, 1977, AM J OBSTET GYNECOL, V128, P489; MASSE J, 1993, AM J OBSTET GYNECOL, V169, P501, DOI 10.1016/0002-9378(93)90608-L; MOODLEY J, 1994, HYPERTENS PREGNANCY, V13, P245, DOI 10.3109/10641959409072226; MURPHY JF, 1986, LANCET, V1, P992; Olsen SF, 2000, BRIT J OBSTET GYNAEC, V107, P382, DOI 10.1111/j.1471-0528.2000.tb13235.x; Paarlberg KM, 1998, AM J OBSTET GYNECOL, V179, P1559, DOI 10.1016/S0002-9378(98)70024-9; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; ROBILLARD PY, 1993, J REPROD IMMUNOL, V24, P1, DOI 10.1016/0165-0378(93)90032-D; ROBILLARD PY, 1994, LANCET, V344, P973, DOI 10.1016/S0140-6736(94)91638-1; Robillard PY, 1999, EUR J OBSTET GYN R B, V84, P37, DOI 10.1016/S0301-2115(98)00250-4; SIBAI BM, 1995, AM J OBSTET GYNECOL, V172, P642, DOI 10.1016/0002-9378(95)90586-3; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Steyn DW, 1997, LANCET, V350, P1267; STONE JL, 1994, OBSTET GYNECOL, V83, P357; Tremellen KP, 1998, BIOL REPROD, V58, P1217, DOI 10.1095/biolreprod58.5.1217; Trupin LS, 1996, EPIDEMIOLOGY, V7, P240, DOI 10.1097/00001648-199605000-00004; Tubbergen P, 1999, J REPROD IMMUNOL, V45, P81, DOI 10.1016/S0165-0378(99)00040-6; Van Rijn M, 1999, OBSTET GYNECOL, V94, P929, DOI 10.1016/S0029-7844(99)00467-6; VILLAR MA, 1989, AM J OBSTET GYNECOL, V160, P419, DOI 10.1016/0002-9378(89)90463-8; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; WALSH SW, 1994, HYPERTENS PREGNANCY, V13, P1, DOI 10.3109/10641959409084168; Walton DL, 1999, NEW ENGL J MED, V341, P2033, DOI 10.1056/NEJM199912303412701	61	180	192	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					209	215		10.1016/S0140-6736(00)03599-6	http://dx.doi.org/10.1016/S0140-6736(00)03599-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213110				2022-12-28	WOS:000166593700034
J	Le Van Quyen, M; Martinerie, J; Navarro, V; Boon, P; D'Have, M; Adam, C; Renault, B; Varela, F; Baulac, M				Le Van Quyen, M; Martinerie, J; Navarro, V; Boon, P; D'Have, M; Adam, C; Renault, B; Varela, F; Baulac, M			Anticipation of epileptic seizures from standard EEG recordings	LANCET			English	Article							CEREBRAL-BLOOD-FLOW; REAL-TIME; SIMILARITY; PREDICTION; CHAOS	Background New methods derived from non-linear analysis of intracranial recordings permit the anticipation of an epileptic seizure several minutes before the seizure. Nevertheless, anticipation of seizures based on standard scalp electroencephalographical (EEG) signals has not been reported yet. The accessibility to preictal changes from standard EEGs is essential for expanding the clinical applicability of these methods. Methods We analysed 26 scalp-EEG/video recordings, from 60 min before a seizure, in 23 patients with temporal-lobe epilepsy. For five patients, simultaneous scalp and intracranial EEG recordings were assessed. Long-term changes before seizure onset were identified by a measure of non-linear similarity, which is very robust in spite of large artifacts and runs in real-time. Findings In 25 of 26 recordings, measurement of non-linear changes in EEG signals allowed the anticipation of a seizure several minutes before it occurred (mean 7 min). These preictal changes in the scalp EEG correspond well with concurrent changes in depth recordings. Interpretation Scalp-EEG recordings retain sufficient dynamical information which can be used for the analysis of preictal changes leading to seizures. Seizure anticipation strategies in real-time can now be envisaged for diverse clinical applications, such as devices for patient warning, for efficacy of ictal-single photon emission computed tomography procedures, and eventual treatment interventions for preventing seizures.	Hop La Pitie Salpetriere, Lab Neurosci Cognit & Imagerie Cerebrale, F-75651 Paris 13, France; Hop La Pitie Salpetriere, CNRS, UPR 640, Unite Epileptol, F-75651 Paris 13, France; Univ Ghent, Dept Neurol, Epilepsy Monitoring Unit, B-9000 Ghent, Belgium; Univ Ghent, Clin Neurophysiol Lab, B-9000 Ghent, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Ghent University; Ghent University	Varela, F (corresponding author), Hop La Pitie Salpetriere, Lab Neurosci Cognit & Imagerie Cerebrale, F-75651 Paris 13, France.	fv@ccr.jussieu.fr	Navarro, Vincent/G-1534-2013	Navarro, Vincent/0000-0003-0077-8114; Boon, Paul/0000-0002-4180-8896				Akinbi MS, 1999, ANN PHARMACOTHER, V33, P99, DOI 10.1345/aph.17306; ALARCON G, 1994, J NEUROL NEUROSUR PS, V57, P233; [Anonymous], 1989, SEIZURE EPILEPSY; Baumgartner C, 1998, J NUCL MED, V39, P978; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; DEPAULIS A, 1994, PROG NEUROBIOL, V42, P33, DOI 10.1016/0301-0082(94)90020-5; DEVINSKY O, 1995, EPILEPSIA, V36, P1089, DOI 10.1111/j.1528-1157.1995.tb00467.x; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Kantz H., 2003, NONLINEAR TIME SERIE, V2nd ed; KATZ A, 1991, ELECTROEN CLIN NEURO, V79, P153, DOI 10.1016/0013-4694(91)90054-8; Le van Quyen M, 1999, PHYSICA D, V127, P250; Le Van Quyen M, 2000, EUR J NEUROSCI, V12, P2124, DOI 10.1046/j.1460-9568.2000.00088.x; Le Van Quyen M, 1999, NEUROREPORT, V10, P2149; Lehnertz K, 1998, PHYS REV LETT, V80, P5019, DOI 10.1103/PhysRevLett.80.5019; Manuca R, 1996, PHYSICA D, V99, P134, DOI 10.1016/S0167-2789(96)00139-X; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; Osorio I, 1998, EPILEPSIA, V39, P615, DOI 10.1111/j.1528-1157.1998.tb01430.x; QUESNEY LF, 1987, SURGICAL TREATMENT E, P129; ROGOWSKI Z, 1981, BIOL CYBERN, V42, P9, DOI 10.1007/BF00335153; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Schreiber T, 1997, PHYS REV LETT, V79, P1475, DOI 10.1103/PhysRevLett.79.1475; Schreiber T, 1996, PREDICTABILITY COMPL; Spencer SS, 1998, EPILEPSIA, V39, P114, DOI 10.1111/j.1528-1157.1998.tb01349.x; TAKEN F, 1981, LECT NOTES MATH DYNA; Theiler J, 1996, ELECTROEN CLIN NEURO, V98, P213, DOI 10.1016/0013-4694(95)00240-5; Weinand ME, 1997, J NEUROSURG, V86, P226, DOI 10.3171/jns.1997.86.2.0226	27	243	248	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					183	188		10.1016/S0140-6736(00)03591-1	http://dx.doi.org/10.1016/S0140-6736(00)03591-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213095				2022-12-28	WOS:000166593700011
J	Nicolelis, MAL				Nicolelis, MAL			Actions from thoughts	NATURE			English	Article							MOTOR CORTEX; STIMULATION; PLASTICITY; SEIZURES; NEURONS	Real-time direct interfaces between the brain and electronic and mechanical devices could one day be used to restore sensory and motor functions lost through injury or disease. Hybrid brain-machine interfaces also have the potential to enhance our perceptual, motor and cognitive capabilities by revolutionizing the way we use computers and interact with remote environments.	Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Dept Expt Psychol, Durham, NC 27710 USA; Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Nicolelis, MAL (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27710 USA.	nicoleli@neuro.duke.edu						BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; CHAPIN KJ, 2000, NEURLA PROSTHESES RE; Fanselow EE, 2000, J NEUROSCI, V20, P8160; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghazanfar AA, 1999, TRENDS COGN SCI, V3, P377, DOI 10.1016/S1364-6613(99)01379-0; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; MEAD C, 1989, ANAL VLSI NEURAL SYS; MERZENICH MM, 1974, LARYNGOSCOPE, V84, P1887, DOI 10.1002/lary.5540841105; MOXON KA, 2000, NEURAL PROSTHESES RE; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; Pfingst BE, 2001, METH NE FRO NEUROSCI, P3; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; RAMACHANDRAN VS, 1993, P NATL ACAD SCI USA, V90, P10413, DOI 10.1073/pnas.90.22.10413; SCHMIDT EM, 1980, ANN BIOMED ENG, V8, P339, DOI 10.1007/BF02363437; Schutz S, 1999, NATURE, V398, P298, DOI 10.1038/18585; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; SRINIVASAN MA, 1994, VIRTUAL REALITY SCI, P161; UTHMAN BM, 1990, EPILEPSIA, V31, pS44, DOI 10.1111/j.1528-1157.1990.tb05849.x; Webber WRS, 1996, ELECTROEN CLIN NEURO, V98, P250, DOI 10.1016/0013-4694(95)00277-4; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; WOLPAW JR, 1991, ELECTROEN CLIN NEURO, V78, P252, DOI 10.1016/0013-4694(91)90040-B; Wu CWH, 1999, J NEUROSCI, V19, P7679, DOI 10.1523/JNEUROSCI.19-17-07679.1999; ZABARA J, 1992, EPILEPSIA, V33, P1005, DOI 10.1111/j.1528-1157.1992.tb01751.x	30	454	480	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					403	407		10.1038/35053191	http://dx.doi.org/10.1038/35053191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201755	Bronze			2022-12-28	WOS:000166434300063
J	Bojke, C; Gravelle, H; Wilkin, D				Bojke, C; Gravelle, H; Wilkin, D			Is bigger better for primary care groups and trusts?	BRITISH MEDICAL JOURNAL			English	Article							INTEGRATION; RISK		Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Univ York, Ctr Hlth Econ, Natl Primary Care Res & Dev Ctr, York YO10 5DD, N Yorkshire, England	University of Manchester; University of York - UK	Wilkin, D (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.			Gravelle, Hugh/0000-0002-7753-4233				Bachmann MO, 1996, BRIT MED J, V313, P1054; BOJKE C, 2001, IS BIGGER BETTER PRI; BOJKE G, 2001, IS BIGGER BETTER PRI; CRUMP BJ, 1991, BRIT MED J, V302, P1582, DOI 10.1136/bmj.302.6792.1582; Dynan L, 1998, J HEALTHC MANAG, V43, P242, DOI 10.1097/00115514-199805000-00008; Garside P, 1994, Health Serv J, V104, P22; Garside P, 1999, BRIT MED J, V318, P345, DOI 10.1136/bmj.318.7180.345; Goddard M., 1997, MERGERS NHS MADE HEA; Goldsmith J C, 1994, Healthc Forum J, V37, P26; KALUZNY AD, 1995, PARTNERS DANCE FORMI; KILLORAN A, 1998, WHAT CAN WE LEARN TO; Martin S, 1998, SOC SCI MED, V47, P1547, DOI 10.1016/S0277-9536(98)00231-7; MAYS N, 1996, PURCHASER PLURALITY; McClenahan J., 1999, HLTH CARE UK 1999 20, P94; Robinson JC, 1996, HEALTH AFFAIR, V15, P7, DOI 10.1377/hlthaff.15.1.7; *SEC STAT HLTH, 1996, PRIM CAR FUT; *SECR STAT HLTH, 1996, PRIM CAR FUT; Secretary of State for Health, 1997, NEW NHS MOD DEP; SHORTELL SM, 1998, HLTH SERV RES, V45, P177; Walston SL, 1996, HEALTH CARE MANAGE R, V21, P83; Weil T P, 2000, Health Serv Manage Res, V13, P137; WILKIN D, 2000, NATL TRACKER SURVEY	22	29	31	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					599	602B		10.1136/bmj.322.7286.599	http://dx.doi.org/10.1136/bmj.322.7286.599			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238160	Green Published, Green Accepted			2022-12-28	WOS:000167499900030
J	Pan, ZW; Dai, ZR; Wang, ZL				Pan, ZW; Dai, ZR; Wang, ZL			Nanobelts of semiconducting oxides	SCIENCE			English	Article							NITRIDE NANORODS; HIGH-TEMPERATURE; CARBON NANOTUBE; LASER-ABLATION; NANOWIRES; GROWTH; WIRES	Ultralong beltlike (or ribbonlike) nanostructures (so-called nanobelts) were successfully synthesized for semiconducting oxides of zinc, tin, indium, cadmium, and gallium by simply evaporating the desired commercial metal oxide powders at high temperatures, The as-synthesized oxide nanobelts are pure, structurally uniform, and single crystalline, and most of them are free from defects and dislocations. They have a rectanglelike cross section with typical widths of 30 to 300 nanometers, width-to-thickness ratios of 5 to 10, and Lengths of up to a few millimeters. The beltlike morphology appears to be a distinctive and common structural characteristic for the family of semiconducting oxides with cations of different valence states and materials of distinct crystallographic structures. The nanobelts could be an ideal system for fully understanding dimensionally confined transport phenomena in functional oxides and building functional devices along individual nanobelts.	Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Wang, ZL (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.		Dai, Zurong/E-6732-2010; Dee, Chang Fu/G-4842-2010; Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022	Dee, Chang Fu/0000-0003-1015-9181; Wang, Zhong Lin/0000-0002-5530-0380; Dai, Zurong/0000-0002-4209-8718; Pan, Zhengwei/0000-0002-3854-958X				DAI HJ, 1995, NATURE, V375, P769, DOI 10.1038/375769a0; Dekker C, 1999, PHYS TODAY, V52, P22, DOI 10.1063/1.882658; Duan XF, 2000, J AM CHEM SOC, V122, P188, DOI 10.1021/ja993713u; Duan XF, 2000, ADV MATER, V12, P298, DOI 10.1002/(SICI)1521-4095(200002)12:4<298::AID-ADMA298>3.0.CO;2-Y; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; FELDMAN Y, 1995, SCIENCE, V267, P222, DOI 10.1126/science.267.5195.222; Galasso FS, 1970, STRUCTURE PROPERTIES, V1st; Ginley DS, 2000, MRS BULL, V25, P15, DOI 10.1557/mrs2000.256; Han WQ, 1997, SCIENCE, V277, P1287, DOI 10.1126/science.277.5330.1287; Han WQ, 1997, APPL PHYS LETT, V71, P2271, DOI 10.1063/1.120550; Hirsch PB, 1977, ELECT MICROSCOPY THI; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Lee ST, 1999, MRS BULL, V24, P36, DOI 10.1557/S088376940005288X; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Pan ZW, 2000, ADV MATER, V12, P1186, DOI 10.1002/1521-4095(200008)12:16<1186::AID-ADMA1186>3.0.CO;2-F; SEARS GW, 1956, ACTA METALL, V3, P268; TRENTLER TJ, 1995, SCIENCE, V270, P1791, DOI 10.1126/science.270.5243.1791; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Wang ZL, 2000, APPL PHYS LETT, V77, P3349, DOI 10.1063/1.1327281; YAMAZOE N, 1991, SENSOR ACTUAT B-CHEM, V5, P7, DOI 10.1016/0925-4005(91)80213-4; Yang PD, 1997, J MATER RES, V12, P2981, DOI 10.1557/JMR.1997.0393; Yu DP, 1998, SOLID STATE COMMUN, V105, P403, DOI 10.1016/S0038-1098(97)10143-0; Zhang HZ, 1999, SOLID STATE COMMUN, V109, P677, DOI 10.1016/S0038-1098(99)00015-0	23	5678	5989	57	1766	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2001	291	5510					1947	1949		10.1126/science.1058120	http://dx.doi.org/10.1126/science.1058120			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239151				2022-12-28	WOS:000167401600041
J	Mange, KC; Joffe, MM; Feldman, HI				Mange, KC; Joffe, MM; Feldman, HI			Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	32nd Annual Meeting of the American-Society-of-Nephrology	NOV 01-08, 1999	MIAMI, FLORIDA	Amer Soc Nephrol			ACTIVATION	Background: The effect on allograft survival of the transplantation of kidneys from living donors without the previous initiation of long-term dialysis is controversial. Methods: Using data from the U.S. Renal Data System, we performed a retrospective cohort study of 8481 patients who were or who were not treated by long-term dialysis before receiving a kidney transplant from a living donor. The relative rate of allograft failure for patients who received a transplant without previously undergoing long-term dialysis, as compared with patients who underwent long-term dialysis before transplantation, was assessed by proportional-hazards analysis, with adjustment for potential confounding variables, including the transplantation center and median household income. The association between the receipt of a kidney transplant from a living donor without previous dialysis ("preemptive'' transplantation) and the risk of biopsy-confirmed acute rejection within six months after transplantation was evaluated by conditional logistic-regression analysis, with adjustment for the transplantation center. Results: Transplantation of a kidney from a living donor without previous long-term dialysis was associated with a 52 percent reduction in the risk of allograft failure during the first year after transplantation (rate ratio, 0.48; P=0.002), an 82 percent reduction during the second year (rate ratio, 0.18; P=0.001), and an 86 percent reduction during subsequent years (rate ratio, 0.14; P=0.001), as compared with transplantation after dialysis. The reduction in the rate of allograft failure during the first year was attenuated when adjustment was made for the timing of acute rejection within the first year (rate ratio, 0.69; 95 percent confidence interval, 0.44 to 1.10; P=0.10). Increasing duration of dialysis was associated with increasing odds of rejection within six months after transplantation (P=0.001). Conclusions: Preemptive transplantation of kidneys from living donors without the previous initiation of dialysis is associated with longer allograft survival than transplantation performed after the initiation of dialysis. (N Engl J Med 2001;344:726-31.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Hosp Univ Penn, Dept Med, Div Renal Electrolyte & Hypertens, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Mange, KC (corresponding author), 700 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007006, P50DK045191] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-07006, DK-45191] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEAURAIN G, 1989, KIDNEY INT, V36, P636, DOI 10.1038/ki.1989.240; CACCIARELLI TV, 1993, TRANSPLANT P, V25, P2474; Collett D, 1994, MODELLING SURVIVAL D; COX DR, 1972, J R STAT SOC B, V34, P187; DAMMIN GJ, 1957, ANN NY ACAD SCI, V64, P967, DOI 10.1111/j.1749-6632.1957.tb52488.x; DESCAMPSLATSCHA B, 1995, J IMMUNOL, V154, P882; Donnelly P, 1996, TRANSPLANT P, V28, P3566; FEHRMAN I, 1979, TRANSPLANT P, V11, P152; Feldman HI, 1998, NEPHROL DIAL TRANSPL, V13, P704, DOI 10.1093/ndt/13.3.704; Feldman HI, 1996, J AM SOC NEPHROL, V7, P151; FRYD D, 1987, TRANSPLANT P, V19, P1557; Gjertson D W, 1991, Clin Transpl, P225; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Kaul H, 2000, AM J KIDNEY DIS, V35, P611, DOI 10.1016/S0272-6386(00)70006-0; LEWIS SL, 1987, AM J KIDNEY DIS, V9, P381, DOI 10.1016/S0272-6386(87)80141-5; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Mange K. C., 1998, Journal of the American Society of Nephrology, V9, p686A; Schurman SJ, 1997, J PEDIATR-US, V130, P455, DOI 10.1016/S0022-3476(97)70210-5; STACHOWSKI J, 1993, NEPHRON, V64, P369, DOI 10.1159/000187356; *USRDS, 1999, REN DAT SYST USRDS 1, pG31; *USRDS, 1999, REN DAT SYST USRDS 1, P101; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	22	354	362	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2001	344	10					726	731		10.1056/NEJM200103083441004	http://dx.doi.org/10.1056/NEJM200103083441004			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408AX	11236776				2022-12-28	WOS:000167305300004
J	Sterling, TR; Vlahov, D; Astemborski, J; Hoover, DR; Margolick, JB; Quinn, TC				Sterling, TR; Vlahov, D; Astemborski, J; Hoover, DR; Margolick, JB; Quinn, TC			Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	13th International AIDS Conference	JUL 09-SEP 14, 2000	DURBAN, SOUTH AFRICA				VIRAL LOAD; NATURAL-HISTORY; SEX-DIFFERENCES; ANTIRETROVIRAL THERAPY; SERUM LEVELS; VIRUS LOAD; DRUG-USERS; SEROCONVERSION; INFECTION; DISEASE	Background: It is unclear whether there are differences between men and women with human immunodeficiency virus type 1 (HIV-1) infection in the plasma level of viral RNA (the viral load). In men, the initial viral load after seroconversion predicts the likelihood of progression to the acquired immunodeficiency syndrome (AIDS), but the relation between the two has not been assessed in women. Currently, the guidelines for initiating antiretroviral therapy are applied uniformly to women and men. Methods: From 1988 through 1998, the viral load and the CD4+ lymphocyte count were measured approximately every six months in 156 male and 46 female injection-drug users who were followed prospectively after HIV-1 seroconversion. Results: The median initial viral load was 50,766 copies of HIV-1 RNA per milliliter in the men but only 15,103 copies per milliliter in the women (P<0.001). The median initial CD4+ count did not differ significantly according to sex (659 and 672 cells per cubic millimeter, respectively). HIV-1 infection progressed to AIDS in 29 men and 15 women, and the risk of progression did not differ significantly according to sex. For each increase of 1 log in the viral load (on a base 10 scale), the hazard ratio for progression to AIDS was 1.55 (95 percent confidence interval, 0.97 to 2.47) among the men and 1.43 (95 percent confidence interval, 0.76 to 2.69) among the women. The median initial viral load was 77,822 HIV-1 RNA copies per milliliter in the men in whom AIDS developed and 40,634 copies per milliliter in the men in whom it did not; the corresponding values in the women were 17,149 and 12,043 copies per milliliter. Given the recommendation that treatment should be initiated when the viral load reaches 20,000 copies per milliliter, 74 percent of the men but only 37 percent of the women in our study would have been eligible for therapy at the first visit after seroconversion (P<0.001). Conclusions: Although the initial level of HIV-1 RNA was lower in women than in men, the rates of progression to AIDS were similar. Treatment guidelines that are based on the viral load, rather than the CD4+ lymphocyte count, will lead to differences in eligibility for antiretroviral treatment according to sex. (N Engl J Med 2001;344:720-5.) Copyright (C) 2001 Massachusetts Medical Society.	Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA; Rutgers State Univ, Dept Stat, Piscataway, NJ USA; NIAID, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; New York Academy of Medicine; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sterling, TR (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, 1830 E Monument St,Rm 444, Baltimore, MD 21287 USA.		Quinn, Thomas/A-2494-2010		NIAID NIH HHS [K23 AI01654] Funding Source: Medline; NIDA NIH HHS [R0-1 DA04334, R0-1 DA08009] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI001654, Z01AI000361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004334] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anastos K, 1999, AIDS, V13, P1717, DOI 10.1097/00002030-199909100-00016; Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; ANASTOS K, 2000, 13 INT AIDS C DURB S, P332; [Anonymous], 1992, MMWR MORB MORTAL WKL, V41, P1; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brown AE, 1997, J INFECT DIS, V176, P794, DOI 10.1086/517304; Bush CE, 1996, J CLIN MICROBIOL, V34, P970, DOI 10.1128/JCM.34.4.970-972.1996; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; CHAISSON RE, 1995, NEW ENGL J MED, V333, P751, DOI 10.1056/NEJM199509213331202; Craib KJP, 1997, J INFECT DIS, V176, P798, DOI 10.1086/517305; Evans JS, 1997, J INFECT DIS, V175, P795, DOI 10.1086/513973; Farzadegan H, 1996, J ACQ IMMUN DEF SYND, V13, P448, DOI 10.1097/00042560-199612150-00008; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; GIORGI JV, 1990, CLIN IMMUNOL IMMUNOP, V55, P173, DOI 10.1016/0090-1229(90)90096-9; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Henry K, 2000, ANN INTERN MED, V132, P306, DOI 10.7326/0003-4819-132-4-200002150-00009; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; Junghans C, 1999, LANCET, V353, P589, DOI 10.1016/S0140-6736(05)75645-2; JURRIAANS S, 1994, VIROLOGY, V204, P223, DOI 10.1006/viro.1994.1526; Katzenstein DA, 1997, NEW ENGL J MED, V337, P1097; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Lyles CM, 1999, J INFECT DIS, V180, P1018, DOI 10.1086/314980; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MELNICK SL, 1994, JAMA-J AM MED ASSOC, V272, P1915, DOI 10.1001/jama.272.24.1915; MONTANER J, 2000, 13 INT AIDS C DURB S, P45; Moore RD, 1999, LANCET, V353, P463, DOI 10.1016/S0140-6736(98)05379-3; *NIH, 1998, MMWR-MORBID MORTAL W, V47, P1; Pezzotti P, 1999, J ACQ IMMUN DEF SYND, V20, P275, DOI 10.1097/00042560-199903010-00010; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406	33	249	256	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2001	344	10					720	725		10.1056/NEJM200103083441003	http://dx.doi.org/10.1056/NEJM200103083441003			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408AX	11236775				2022-12-28	WOS:000167305300003
J	Tsubono, Y; Nishino, Y; Komatsu, S; Hsieh, C; Kanemura, S; Tsuji, I; Nakatsuka, H; Fukao, A; Satoh, H; Hisamichi, S				Tsubono, Y; Nishino, Y; Komatsu, S; Hsieh, C; Kanemura, S; Tsuji, I; Nakatsuka, H; Fukao, A; Satoh, H; Hisamichi, S			Green tea and the risk of gastric cancer in Japan.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STOMACH-CANCER; CONSUMPTION; SHANGHAI; CARCINOMA; CHINA	Background: Although laboratory experiments and case-control studies have suggested that the consumption of green tea provides protection against gastric cancer, few prospective studies have been performed. Methods: In January 1984, a total of 26,311 residents in three municipalities of Miyagi Prefecture, in northern Japan (11,902 men and 14,409 women 40 years of age or older), completed a self-administered questionnaire that included questions about the frequency of consumption of green tea. During 199,748 person-years of follow-up, through December 1992, we identified 419 cases of gastric cancer (in 296 men and 123 women). We used Cox regression to estimate the relative risk of gastric cancer according to the consumption of green tea. Results: Green-tea consumption was not associated with the risk of gastric cancer. After adjustment for sex, age, presence or absence of a history of peptic ulcer, smoking status, alcohol consumption, other dietary elements, and type of health insurance, the relative risks associated with drinking one or two, three or four, and five or more cups of green tea per day, as compared with less than one cup per day, were 1.1 (95 percent confidence interval, 0.8 to 1.6), 1.0 (95 percent confidence interval, 0.7 to 1.4), and 1.2 (95 percent confidence interval, 0.9 to 1.6), respectively (P for trend = 0.13). The results were similar after the 117 cases of gastric cancer that were diagnosed in the first three years of follow-up had been excluded, with respective relative risks of 1.2 (95 percent confidence interval, 0.8 to 1.8), 1.0 (95 percent confidence interval, 0.7 to 1.5), and 1.4 (95 percent confidence interval, 1.0 to 1.9) (P for trend = 0.07). Conclusions: In a population-based, prospective cohort study in Japan, we found no association between green-tea consumption and the risk of gastric cancer. (N Engl J Med 2001;344:632-6.) Copyright (C) 2001 Massachusetts Medical Society.	Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Environm Hlth Sci, Sendai, Miyagi 9808575, Japan; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Sendai Coll, Fac Phys Educ, Sendai, Miyagi, Japan; Univ Massachusetts, Med Ctr, Ctr Canc, Div Biostat & Epidemiol, Worcester, MA USA; Miyagi Univ, Sch Nursing, Sendai, Miyagi, Japan; Yamagata Univ, Sch Med, Dept Publ Hlth, Yamagata 99023, Japan	Tohoku University; Tohoku University; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Worcester; Miyagi University; Yamagata University	Tsubono, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 9808575, Japan.		Kanemura, Seiki/AAS-5390-2021	Kanemura, Seiki/0000-0003-0454-0322				Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; *AM I CANC RES, 1997, WORLD CANC RES FUND, P467; Asaka M, 1997, GASTROENTEROLOGY, V113, pS56, DOI 10.1016/S0016-5085(97)80013-3; EUROGAST, 1993, LANCET, V341, P16681; FORMAN D, 1993, LANCET, V341, P1359; Galanis DJ, 1998, INT J EPIDEMIOL, V27, P173, DOI 10.1093/ije/27.2.173; Goldbohm RA, 1996, J NATL CANCER I, V88, P93, DOI 10.1093/jnci/88.2.93; HORIBA N, 1991, J ENDODONT, V17, P122, DOI 10.1016/S0099-2399(06)81743-7; Inoue M, 1998, CANCER CAUSE CONTROL, V9, P209, DOI 10.1023/A:1008890529261; Ji BT, 1996, CANCER, V77, P2449, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2449::AID-CNCR6>3.0.CO;2-H; KONO S, 1988, JPN J CANCER RES, V79, P1067, DOI 10.1111/j.1349-7006.1988.tb01528.x; LEE HH, 1990, ANTICANCER RES, V10, P875; PISANI P, 1993, INT J CANCER, V55, P891, DOI 10.1002/ijc.2910550604; Rothman K., 1998, MODERN EPIDEMIOLOGY; *SAS I, 1996, SAS STAT SOFTWARE CH; TAJIMA K, 1985, JPN J CANCER RES, V76, P705; Takano A, 1997, IARC SCI PUBL, V7, P386; Willett W., 2012, NUTR EPIDEMIOLOGY; Yam TS, 1997, FEMS MICROBIOL LETT, V152, P169, DOI 10.1016/S0378-1097(97)00197-3; Yang CS, 1997, ENVIRON HEALTH PERSP, V105, P971, DOI 10.2307/3433312; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; YU GP, 1995, CANCER CAUSE CONTROL, V6, P532, DOI 10.1007/BF00054162; YU GP, 1991, CANCER CAUSE CONTROL, V2, P169, DOI 10.1007/BF00056210	23	169	176	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2001	344	9					632	636		10.1056/NEJM200103013440903	http://dx.doi.org/10.1056/NEJM200103013440903			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405TR	11228277				2022-12-28	WOS:000167177100003
J	Lee, SJ; Fairclough, D; Antin, JH; Weeks, JC				Lee, SJ; Fairclough, D; Antin, JH; Weeks, JC			Discrepancies between patient and physician estimates for the success of stem cell transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MARROW TRANSPLANTATION; SHARED DECISION-MAKING; NON-HODGKINS-LYMPHOMA; CANCER-PATIENTS; INFORMED CONSENT; ADJUVANT THERAPY; DISEASE; EXPECTATIONS; PROGNOSIS; REMISSION	Context Stem cell transplantation is associated with considerable morbidity and mortality. The extent to which patients and their physicians correctly estimate these risks is unknown. Objective To measure the expectations of patients and physicians prior to stem cell transplantation and correlate them with actual outcomes after transplantation. Design Prospective cohort study with baseline questionnaire administered July 1996 through November 1999 and follow-up to May 2000. Setting Tertiary care transplant center in the United States. Participants Of 458 surveys mailed, evaluable returned surveys were included for 313 autologous and allogeneic stem cell transplantation patients and their physicians, Main Outcome Measures Patient and physician expectations prior to transplantation (measured on 6-point Likert scales) of treatment related mortality, cure with transplantation, and cure without transplantation; actual treatment-related mortality and disease-free survival among patients with at least 1 year of follow-up after transplantation (n=263). Results Both patients and physicians were fairly accurate in estimating treatment-related mortality when actual mortality was less than 30%. However, in situations in which mortality was higher than 30%, such as with allogeneic transplantation for intermediate or advanced disease, physician expectations were lower, while patients remained optimistic. Similarly, physicians provided lower estimates of disease-free survival in cases of intermediate or advanced disease while patient expectations remained high and constant regardless of disease stage. Conclusions Patients and their physicians have the most concordant and accurate expectations when the outcome of stem cell transplantation is likely to be favorable, However, patients with more advanced disease fail to recognize the higher risks associated with their situations.	Dana Farber Canc Inst, Dept Adult Oncol, Ctr Outcomes & Policy Res, Boston, MA 02115 USA; AMC Canc Res Ctr, Denver, CO USA	Harvard University; Dana-Farber Cancer Institute; AMC Cancer Research Center	Lee, SJ (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Ctr Outcomes & Policy Res, 44 Binney St, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [K07CA075267] Funding Source: NIH RePORTER; NCI NIH HHS [CA75267-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDRYKOWSKI MA, 1995, BONE MARROW TRANSPL, V15, P573; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; FREEDMAN AS, 1993, J CLIN ONCOL, V11, P931, DOI 10.1200/JCO.1993.11.5.931; Freedman AS, 1996, BLOOD, V88, P2780, DOI 10.1182/blood.V88.7.2780.bloodjournal8872780; FREEDMAN AS, 1990, J CLIN ONCOL, V8, P784, DOI 10.1200/JCO.1990.8.5.784; Frosch DL, 1999, AM J PREV MED, V17, P285, DOI 10.1016/S0749-3797(99)00097-5; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; MAZUR DJ, 1988, J GEN INTERN MED, V3, P370, DOI 10.1007/BF02595796; MIYAJI NT, 1993, SOC SCI MED, V36, P249, DOI 10.1016/0277-9536(93)90008-R; Ravdin PM, 1998, J CLIN ONCOL, V16, P515, DOI 10.1200/JCO.1998.16.2.515; *SAS I INC, 1997, SAS SYST SOFTW; SIMINOFF LA, 1989, J CLIN ONCOL, V7, P1192, DOI 10.1200/JCO.1989.7.9.1192; SOIFFER RJ, 1992, J CLIN ONCOL, V10, P1191, DOI 10.1200/JCO.1992.10.7.1191; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; TOBIAS JS, 1993, BRIT MED J, V307, P1199, DOI 10.1136/bmj.307.6913.1199; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; WHEELER C, 1990, J CLIN ONCOL, V8, P648, DOI 10.1200/JCO.1990.8.4.648; Woolf SH, 1997, J FAM PRACTICE, V45, P205	20	94	94	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2001	285	8					1034	1038		10.1001/jama.285.8.1034	http://dx.doi.org/10.1001/jama.285.8.1034			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403ME	11209174	Bronze			2022-12-28	WOS:000167046400025
J	Broecker, WS				Broecker, WS			Paleoclimate - Was the medieval warm period global?	SCIENCE			English	Editorial Material							ICE-AGE; TEMPERATURES; CIRCULATION; ATLANTIC		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Broecker, WS (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	broecker@ldeo.columbia.edu						Bond GC, 1999, GEOPH MONOG SERIES, V112, P35; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Broecker WS, 1999, SCIENCE, V286, P1132, DOI 10.1126/science.286.5442.1132; CLOW G, COMMUNICATION; Greene AM, 1999, GEOPHYS RES LETT, V26, P1909, DOI 10.1029/1999GL900380; Grove J. M., 1988, LITTLE ICE AGE, P1; HOLZHAUSER H, 1997, ESF PROJECT EUROPEAN, V16, P35; Hormes A, 1998, RADIOCARBON, V40, P809; HORMES A, IN PRESS HOLOCENE; HORMES A, 2001, 14C PERSPECTIVE GLAC, P176; Huang SP, 1997, GEOPHYS RES LETT, V24, P1947, DOI 10.1029/97GL01846; Lotter AF, 2000, PALAEOGEOGR PALAEOCL, V159, P349, DOI 10.1016/S0031-0182(00)00093-6; MAISCH M, 1999, GLETSCHER SCHWEIZER, P221; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; PORTER SC, IN PRESS QUAT SCI RE; Rothlisberger F., 1980, GEOGR HELV, V35, P21; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; Stine S, 1998, WATER TRANS, V31, P43; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; ZAUCKER F, 1992, J GEOPHYS RES-ATMOS, V97, P2765, DOI 10.1029/91JD01699	21	223	240	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1497	1499		10.1126/science.291.5508.1497	http://dx.doi.org/10.1126/science.291.5508.1497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11234078				2022-12-28	WOS:000167153400029
J	Cole, J				Cole, J			Paleoclimate - A slow dance for El Nino	SCIENCE			English	Editorial Material							CLIMATE; BALANCE; ONSET; BP		Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA	University of Arizona	Cole, J (corresponding author), Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA.			Cole, Julia/0000-0002-3389-7809				Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Cole JE, 1998, GEOPHYS RES LETT, V25, P4529, DOI 10.1029/1998GL900145; Correge T, 2000, PALEOCEANOGRAPHY, V15, P465, DOI 10.1029/1999PA000409; DeVries TJ, 1997, SCIENCE, V276, P965, DOI 10.1126/science.276.5314.965; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; MCGLONE MS, 1992, EL NINO HIST PALEOCL, P435; Otto-Bliesner BL, 1999, GEOPHYS RES LETT, V26, P87, DOI 10.1029/1998GL900236; OTTOBLIESNER B, COMMUNICATION; Overpeck J, 2000, P NATL ACAD SCI USA, V97, P1335, DOI 10.1073/pnas.97.4.1335; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Sandweiss DH, 1996, SCIENCE, V273, P1531, DOI 10.1126/science.273.5281.1531; SHULMEISTER J, 1995, HOLOCENE, V5, P10, DOI 10.1177/095968369500500102; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597	15	37	42	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1496	1497		10.1126/science.1059111	http://dx.doi.org/10.1126/science.1059111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11234077				2022-12-28	WOS:000167153400028
J	Mandelboim, O; Lieberman, N; Lev, M; Paul, L; Arnon, TI; Bushkin, Y; Davis, DM; Strominger, JL; Yewdell, JW; Porgador, A				Mandelboim, O; Lieberman, N; Lev, M; Paul, L; Arnon, TI; Bushkin, Y; Davis, DM; Strominger, JL; Yewdell, JW; Porgador, A			Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells	NATURE			English	Article							NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-SUPERFAMILY; MOLECULAR-CLONING; RECEPTOR; CYTOTOXICITY; ANTIGEN; MEMBER; ACID	Natural killer (NK) cells destroy virus-infected and tumour cells, apparently without the need for previous antigen stimulation(1). In part, target cells are recognized by their diminished expression of major histocompatibility complex (MHC) class I molecules, which normally interact with inhibitory receptors on the NK cell surface(2-8). NK cells also express triggering receptors that are specific for non-MHC ligands; but the nature of the ligands recognized on target cells is undefined(9-14). NKp46 is thought to be the main activating receptor for human NK cells(9,15). Here we show that a soluble NKp46-immunoglobulin fusion protein binds to both the haemagglutinin of influenza virus and the haemagglutinin-neuraminidase of parainfluenza virus. In a substantial subset of NK cells, recognition by NKp46 is required to lyse cells expressing the corresponding viral glycoproteins. The binding requires the sialylation of NKp46 oligosaccharides, which is consistent with the known sialic binding capacity of the viral glycoproteins. These findings indicate how NKp46-expressing NK cells may recognize target cells infected by influenza or parainfluenza without the decreased expression of target-cell MHC class I protein.	Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Ctr Canc Res, IL-84105 Beer Sheva, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel; Publ Hlth Res Inst City New York Inc, Lab Mol Immunol, New York, NY 10016 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biol, London SW7 2AZ, England; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Imperial College London; Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Porgador, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel.	angel@bgumail.bgu.ac.il	yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Davis, Daniel/0000-0002-9182-291X; Porgador, Angel/0000-0003-1540-4449; Mandelboim, Ofer/0000-0002-9354-1855; Arnon, Tal/0000-0003-4629-5820	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000653, Z01AI000653] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALSHEIKHLY A, 1983, SCAND J IMMUNOL, V17, P129, DOI 10.1111/j.1365-3083.1983.tb00775.x; ALSHEIKHLY AR, 1985, SCAND J IMMUNOL, V22, P529, DOI 10.1111/j.1365-3083.1985.tb01912.x; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Bottino C, 2000, HUM IMMUNOL, V61, P1, DOI 10.1016/S0198-8859(99)00162-7; BRAND CM, 1972, NATURE-NEW BIOL, V238, P145, DOI 10.1038/newbio238145a0; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; DANDREA A, 1995, J IMMUNOL, V155, P2306; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; DELAU WBM, 1993, J IMMUNOL, V150, P4911; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; MAISNER A, 1995, VIROLOGY, V210, P479, DOI 10.1006/viro.1995.1365; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; PETERHANS E, 1983, VIROLOGY, V128, P366, DOI 10.1016/0042-6822(83)90263-5; PINOLA M, 1994, J IMMUNOL, V152, P3586; Porgador A, 1997, P NATL ACAD SCI USA, V94, P13140, DOI 10.1073/pnas.94.24.13140; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; YEWDELL J, 1982, J IMMUNOL, V128, P2670; YEWDELL JW, 1983, J VIROL, V48, P239, DOI 10.1128/JVI.48.1.239-248.1983	29	717	758	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1055	1060		10.1038/35059110	http://dx.doi.org/10.1038/35059110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234016				2022-12-28	WOS:000167148800049
J	Nisbet, EG; Sleep, NH				Nisbet, EG; Sleep, NH			The habitat and nature of early life	NATURE			English	Review							ARCHEAN STROMATOLITES; ASTEROID IMPACTS; WARRAWOONA GROUP; EARLY EVOLUTION; SULFUR CYCLE; NORTH-POLE; ORIGIN; CARBON; PHOTOSYNTHESIS; ROCKS	Earth is over 4,500 million years old. Massive bombardment of the planet took place for the first 500-700 million years, and the largest impacts would have been capable of sterilizing the planet. Probably until 4,000 million years ago or later, occasional impacts might have heated the ocean over 100 degreesC. Life on Earth dates from before about 3,800 million years ago, and is likely to have gone through one or more hot-ocean 'bottlenecks'. Only hyperthermophiles (organisms optimally living in water at 80-110 degreesC) would have survived. It is possible that early life diversified near hydrothermal vents, but hypotheses that life first occupied other pre-bottleneck habitats are tenable (including transfer from Mars on ejecta from impacts there). Early hyperthermophile life, probably near hydrothermal systems, may have been non-photosynthetic, and many housekeeping proteins and biochemical processes may have an original hydrothermal heritage. The development of anoxygenic and then oxygenic photosynthesis would have allowed life to escape the hydrothermal setting. By about 3,500 million years ago, most of the principal biochemical pathways that sustain the modern biosphere had evolved, and were global in scope.	Univ London, Royal Holloway, Dept Geol, Egham TW20 0EX, Surrey, England; Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	University of London; Royal Holloway University London; Stanford University	Nisbet, EG (corresponding author), Univ London, Royal Holloway, Dept Geol, Egham TW20 0EX, Surrey, England.							Ahrens T. J., 1990, ORIGIN EARTH, P211; Awramik S.M., 1992, EARLY ORGANIC EVOLUT, P435; BARLEY ME, 1993, PRECAMBRIAN RES, V60, P47, DOI 10.1016/0301-9268(93)90044-3; BEKKI S, 1995, GEOPHYS RES LETT, V22, P913, DOI 10.1029/95GL00534; Bell DR, 2000, GEOCHIM COSMOCHIM AC, V64, P2109, DOI 10.1016/S0016-7037(99)00440-8; BEUKES NJ, 1989, SEDIMENTOLOGY, V36, P383, DOI 10.1111/j.1365-3091.1989.tb00615.x; Blankenship RE, 1998, TRENDS BIOCHEM SCI, V23, P94, DOI 10.1016/S0968-0004(98)01186-4; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; CAMPBELL IH, 1983, GEOPHYS RES LETT, V10, P1061, DOI 10.1029/GL010i011p01061; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Carr M.H, 1996, WATER MARS; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CAS RAF, 1992, ECON GEOL BULL SOC, V87, P511, DOI 10.2113/gsecongeo.87.3.511; CATLING DC, 2000, EOS, V81, pF809; COHEN Y, 1975, NATURE, V257, P489, DOI 10.1038/257489a0; DARWIN C, 1959, NOTES REC R SOC LOND, V14, P1; DeLong EF, 2000, NATURE, V407, P577, DOI 10.1038/35036677; DESMARAIS DJ, 1994, CHEM GEOL, V114, P303; DOOLITTLE WE, 2000, SCIAM, P72; Doolittle WF, 1996, P NATL ACAD SCI USA, V93, P8797, DOI 10.1073/pnas.93.17.8797; Drake MJ, 2000, GEOCHIM COSMOCHIM AC, V64, P2363, DOI 10.1016/S0016-7037(00)00372-0; FORTERRE P, 1992, FRONTIERS OF LIFE, P221; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GOGARTENBOEKELS M, 1995, ORIGINS LIFE EVOL B, V25, P251, DOI 10.1007/BF01581588; Graham DE, 2000, P NATL ACAD SCI USA, V97, P3304, DOI 10.1073/pnas.050564797; Grassineau NV, 2001, P ROY SOC B-BIOL SCI, V268, P113, DOI 10.1098/rspb.2000.1338; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Habicht KS, 1996, NATURE, V382, P342, DOI 10.1038/382342a0; Halliday AN, 2000, EARTH PLANET SC LETT, V176, P17, DOI 10.1016/S0012-821X(99)00317-9; Hayes J. M., 1994, EARLY LIFE EARTH, P220; Holland HD., 1999, GEOCHEM NEWS, V100, P20; HUNTEN DM, 1993, SCIENCE, V259, P915, DOI 10.1126/science.259.5097.915; JACOB F, 1983, EVOLUTION MOL MEN, P31; Joshi HM, 1996, P NATL ACAD SCI USA, V93, P14515, DOI 10.1073/pnas.93.25.14515; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; Knoll AH, 1999, SCIENCE, V285, P1025, DOI 10.1126/science.285.5430.1025; KRESS ME, 2000, EOS, V81, pF809; LEWIS CS, 1943, PERELANDRA VOYAGE VE; Lewis JS., 1984, PLANETS THEIR ATMOSP; LORIMER GH, 1981, ANNU REV PLANT PHYS, V32, P349, DOI 10.1146/annurev.pp.32.060181.002025; LORIMER GH, 1973, NATURE, V243, P359, DOI 10.1038/243359a0; Lovelock J.E., 1988, AGES GAIA; LOWE DR, 1994, GEOLOGY, V22, P387, DOI 10.1130/0091-7613(1994)022<0387:AOODSO>2.3.CO;2; MARGULIS L, 1979, LIFE ORIGIN EVOLUTIO, P101; MARTIN A, 1980, PRECAMBRIAN RES, V13, P337, DOI 10.1016/0301-9268(80)90049-2; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Melosh H.J., 1990, ORIGIN EARTH, P69; MILTON J, 1908, NATURE UNIMPAIRED TI; Mitchell L, 1943, AM MINERAL, V28, P356; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; NEWMAN JH, 1980, APOLOGIA PRO VITA SU; Nisbet E, 2000, NATURE, V405, P625, DOI 10.1038/35015187; Nisbet E.G., 1996, Geological Society Special Publication, V118, P239, DOI 10.1144/GSL.SP.1996.118.01.15; NISBET EG, 1995, NATURE, V373, P479, DOI 10.1038/373479a0; Nisbet EG, 1999, P ROY SOC B-BIOL SCI, V266, P2375, DOI 10.1098/rspb.1999.0934; NISBET EG, 1986, NATURE, V322, P206, DOI 10.1038/322206a0; Nisbet EG, 1996, NATURE, V382, P404, DOI 10.1038/382404a0; Nisbet EG., 1995, GEOL SOC LOND SPEC P, V95, P27; NISGBET EG, 1987, YOUNG EARTH INTRO AR; Nutman AP, 1997, GEOCHIM COSMOCHIM AC, V61, P2475, DOI 10.1016/S0016-7037(97)00097-5; OHMOTO H, 1997, GEOCHEM NEWS, V93, P12; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; PIERSON BK, 1994, NOBEL S, V84, P161; Pringault O, 1998, MICROBIOL-UK, V144, P1051, DOI 10.1099/00221287-144-4-1051; Rasmussen B, 2000, NATURE, V405, P676, DOI 10.1038/35015063; Rasmussen B, 1999, GEOLOGY, V27, P115, DOI 10.1130/0091-7613(1999)027<0115:RSOTAA>2.3.CO;2; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Sagan C, 1997, SCIENCE, V276, P1217, DOI 10.1126/science.276.5316.1217; Schidlowski M, 1998, P SOC PHOTO-OPT INS, V3441, P149, DOI 10.1117/12.319832; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHIDLOWSKI M, 1984, J GEOL SOC LONDON, V141, P243, DOI 10.1144/gsjgs.141.2.0243; Schidlowski M., 1992, EARLY ORGANIC EVOLUT, P147; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; Sleep NH, 1998, J GEOPHYS RES-PLANET, V103, P28529, DOI 10.1029/98JE01809; SLEEP NH, IN PRESS J GEOPHYS R, V106; SLEEP NH, IN PRESS P NATL ACAD; Smith JV, 1999, P NATL ACAD SCI USA, V96, P3479, DOI 10.1073/pnas.96.7.3479; Stern RA, 1998, GEOSCI CAN, V25, P27; Stetter KO, 1996, CIBA F SYMP, V202, P1; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; TOLBERT NE, 1994, REGULATION ATMOSPHER, P8; Trieloff M, 2000, SCIENCE, V288, P1036, DOI 10.1126/science.288.5468.1036; Vellai T, 1999, P ROY SOC B-BIOL SCI, V266, P1571, DOI 10.1098/rspb.1999.0817; WALKER JCG, 1987, NATURE, V329, P710, DOI 10.1038/329710a0; WALKER JCG, 1988, CHEM CYCLES EVOLUTIO, V2, P55; WALSH MM, 1992, PRECAMBRIAN RES, V54, P271, DOI 10.1016/0301-9268(92)90074-X; Walter M.R., 1983, EARTHS EARLIEST BIOS, P187; WATSON AJ, 1984, EARTH PLANET SC LETT, V68, P1, DOI 10.1016/0012-821X(84)90135-3; WESTALL F, IN PRESS PRECAMBRIAN; WETHERILL GW, 1990, ANNU REV EARTH PL SC, V18, P205, DOI 10.1146/annurev.ea.18.050190.001225; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550; WILKS ME, 1985, CAN J EARTH SCI, V22, P792, DOI 10.1139/e85-086; Williamson JR, 2000, NATURE, V407, P306, DOI 10.1038/35030271; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOLERY TJ, 1988, CHEM CYDES EVOLUTION, V3, P76; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; YUNG YL, 1989, J GEOPHYS RES-ATMOS, V94, P14971, DOI 10.1029/JD094iD12p14971; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	115	559	590	9	383	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1083	1091		10.1038/35059210	http://dx.doi.org/10.1038/35059210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234022				2022-12-28	WOS:000167148800056
J	Claverie, JM				Claverie, JM			Gene number - What if there are only 30,000 human genes?	SCIENCE			English	Article							DNA-SEQUENCE; GENOME SEQUENCE		Struct Genet Informat Lab, CNRS AVENTIS, UMR 1889, F-13402 Marseille, France	Sanofi-Aventis; Sanofi France	Claverie, JM (corresponding author), Struct Genet Informat Lab, CNRS AVENTIS, UMR 1889, 31 Chemin Joseph Aiguier, F-13402 Marseille, France.	Jean-Michel.Claverie@igs.cnrs-mrs.fr	Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019	Claverie, Jean-Michel/0000-0003-1424-0315; 				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AUDIC S, 2000, WORKSH M PLANCK I MO; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Brenner S, 2000, SCIENCE, V287, P2173, DOI 10.1126/science.287.5461.2173; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Fickett JW, 2000, CURR OPIN BIOTECH, V11, P19, DOI 10.1016/S0958-1669(99)00049-X; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Huang LL, 1999, CRIT REV EUKAR GENE, V9, P175, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.20; Liang F, 2000, NAT GENET, V26, P501; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wheeler DL, 2001, NUCLEIC ACIDS RES, V29, P11, DOI 10.1093/nar/29.1.11	20	208	220	5	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1255	1257		10.1126/science.1058969	http://dx.doi.org/10.1126/science.1058969			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233450				2022-12-28	WOS:000166993400029
J	Bentley, DR; Deloukas, P; Dunham, A; French, L; Gregory, SG; Humphray, SJ; Mungall, AJ; Ross, MT; Carter, NP; Dunham, I; Scott, CE; Ashcroft, KJ; Atkinson, AL; Aubin, K; Beare, DM; Bethel, G; Brady, N; Brook, JC; Burford, DC; Burrill, WD; Burrows, C; Butler, AP; Carder, C; Catanese, JJ; Clee, CM; Clegg, SM; Cobley, V; Coffey, AJ; Cole, CG; Collins, JE; Conquer, JS; Cooper, RA; Culley, KM; Dawson, E; Dearden, FL; Durbin, RM; de Jong, PJ; Dhami, PD; Earthrowl, ME; Edwards, CA; Evans, RS; Gillson, CJ; Ghori, J; Green, L; Gwilliam, R; Halls, KS; Hammond, S; Harper, GL; Heathcott, RW; Holden, JL; Holloway, E; Hopkins, BL; Howard, PJ; Howell, GR; Huckle, EJ; Hughes, J; Hunt, PJ; Hunt, SE; Izmajlowicz, M; Jones, CA; Joseph, SS; Laird, G; Langford, CF; Lehvaslaiho, MH; Leversha, MA; McCann, OT; McDonald, LM; McDowall, J; Maslen, GL; Mistry, D; Moschonas, NK; Neocleous, V; Pearson, DM; Phillips, KJ; Porter, KM; Prathalingam, SR; Ramsey, YH; Ranby, SA; Rice, CM; Rogers, J; Rogers, LJ; Sarafidou, T; Scott, DJ; Sharp, GJ; Shaw-Smith, CJ; Smink, LJ; Soderlund, C; Sotheran, EC; Steingruber, HE; Sulston, JE; Taylor, A; Taylor, RG; Thorpe, AA; Tinsley, E; Warry, GL; Whittaker, A; Whittaker, P; Williams, SH; Wilmer, TE; Wooster, R; Wright, CL				Bentley, DR; Deloukas, P; Dunham, A; French, L; Gregory, SG; Humphray, SJ; Mungall, AJ; Ross, MT; Carter, NP; Dunham, I; Scott, CE; Ashcroft, KJ; Atkinson, AL; Aubin, K; Beare, DM; Bethel, G; Brady, N; Brook, JC; Burford, DC; Burrill, WD; Burrows, C; Butler, AP; Carder, C; Catanese, JJ; Clee, CM; Clegg, SM; Cobley, V; Coffey, AJ; Cole, CG; Collins, JE; Conquer, JS; Cooper, RA; Culley, KM; Dawson, E; Dearden, FL; Durbin, RM; de Jong, PJ; Dhami, PD; Earthrowl, ME; Edwards, CA; Evans, RS; Gillson, CJ; Ghori, J; Green, L; Gwilliam, R; Halls, KS; Hammond, S; Harper, GL; Heathcott, RW; Holden, JL; Holloway, E; Hopkins, BL; Howard, PJ; Howell, GR; Huckle, EJ; Hughes, J; Hunt, PJ; Hunt, SE; Izmajlowicz, M; Jones, CA; Joseph, SS; Laird, G; Langford, CF; Lehvaslaiho, MH; Leversha, MA; McCann, OT; McDonald, LM; McDowall, J; Maslen, GL; Mistry, D; Moschonas, NK; Neocleous, V; Pearson, DM; Phillips, KJ; Porter, KM; Prathalingam, SR; Ramsey, YH; Ranby, SA; Rice, CM; Rogers, J; Rogers, LJ; Sarafidou, T; Scott, DJ; Sharp, GJ; Shaw-Smith, CJ; Smink, LJ; Soderlund, C; Sotheran, EC; Steingruber, HE; Sulston, JE; Taylor, A; Taylor, RG; Thorpe, AA; Tinsley, E; Warry, GL; Whittaker, A; Whittaker, P; Williams, SH; Wilmer, TE; Wooster, R; Wright, CL			The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X	NATURE			English	Article							HUMAN GENOME	We constructed maps for eight chromosomes (1, 6, 9, 10, 13, 20, X and (previously) 22), representing one-third of the genome, by building landmark maps, isolating bacterial clones and assembling contigs. By this approach, we could establish the long-range organization of the maps early in the project, and all contig extension, gap closure and problem-solving was simplified by containment within local regions. The maps currently represent more than 94% of the euchromatic (gene-containing) regions of these chromosomes in 176 contigs, and contain 96% of the chromosome-specific markers in the human gene map. By measuring the remaining gaps, we can assess chromosome length and coverage in sequenced clones.	Sanger Ctr, Cambridge CB10 1SA, England; Univ Crete, Dept Biol, CY-71409 Iraklion, Crete, Greece; Inst Mol Biol & Biotechnol, CY-71409 Iraklion, Crete, Greece; Cyprus Inst Neurol & Genet, Neurogenet Lab, CY-1683 Nicosia, Cyprus; Childrens Hosp, BACPAC Resources, Oakland, CA 94609 USA	Wellcome Trust Sanger Institute; University of Crete; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Bentley, DR (corresponding author), Sanger Ctr, Wellcome Trust Campus, Cambridge CB10 1SA, England.	drb@sanger.ac.uk	Mungall, Andrew J./U-7067-2018; Durbin, Richard/AAE-7178-2019; Deloukas, Panos/B-2922-2013	Mungall, Andrew J./0000-0002-0905-2742; Durbin, Richard/0000-0002-9130-1006; Deloukas, Panos/0000-0001-9251-070X; Dunham, Ian/0000-0003-2525-5598; Edwards, Carol/0000-0002-1887-1280; Hunt, Sarah/0000-0002-8350-1235; Hughes, Jaime/0000-0001-6045-4053; Maslen, Gareth/0000-0001-7318-3678; Carter, Emma/0000-0002-0825-2793; Moschonas, Nicholas/0000-0002-2556-537X; Gregory, Simon/0000-0002-7805-1743; Taylor, Amy/0000-0001-9811-330X				Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Jackson MS, 1996, GENOMICS, V33, P258, DOI 10.1006/geno.1996.0190; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Montgomery KT, 2001, NATURE, V409, P945, DOI 10.1038/35057174; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; 2000, NTURE, V405, P311	11	47	50	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					942	943		10.1038/35057165	http://dx.doi.org/10.1038/35057165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237015	Bronze			2022-12-28	WOS:000166938800062
J	Putterman, S; Evans, PG; Vazquez, G; Weninger, K				Putterman, S; Evans, PG; Vazquez, G; Weninger, K			Cavitation science - Is there a simple theory of sonoluminescence?	NATURE			English	Article							LIGHT-EMISSION; HYDRODYNAMIC CAVITATION		Univ Calif Los Angeles, Dept Phys, Los Angeles, CA 90095 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	University of California System; University of California Los Angeles; Harvard University	Putterman, S (corresponding author), Univ Calif Los Angeles, Dept Phys, Los Angeles, CA 90095 USA.	puherman@ritva.physics.ucla.edu	Evans, Paul G/A-9260-2009	Evans, Paul G/0000-0003-0421-6792				Barber BP, 1997, PHYS REP, V281, P65, DOI 10.1016/S0370-1573(96)00050-6; HICKLING R, 1968, PHYS FLUIDS, V11, P1586, DOI 10.1063/1.1692152; Hilgenfeldt S, 1999, PHYS FLUIDS, V11, P1318, DOI 10.1063/1.869997; Hilgenfeldt S, 1999, NATURE, V398, P402, DOI 10.1038/18842; HILLER R, 1994, SCIENCE, V266, P248, DOI 10.1126/science.266.5183.248; LOFSTEDT R, 1993, PHYS FLUIDS A-FLUID, V5, P2911, DOI 10.1063/1.858700; PETERSON FB, 1967, PHYS FLUIDS, V10, P874, DOI 10.1063/1.1762203; Putterman S, 1998, PHYS WORLD, V11, P38; Putterman SJ, 2000, ANNU REV FLUID MECH, V32, P445, DOI 10.1146/annurev.fluid.32.1.445; TEMPLE PR, 1970, THESIS U VERMONT, P37401; VASQUEZ G, 00009057; Vazquez GE, 2000, PHYS REV LETT, V85, P3037, DOI 10.1103/PhysRevLett.85.3037; Weninger KR, 2000, PHYS REV E, V61, pR1020, DOI 10.1103/PhysRevE.61.R1020; WU CC, 1993, PHYS REV LETT, V70, P3424, DOI 10.1103/PhysRevLett.70.3424; ZELDOVICH YB, 1967, PHYSICS SHOCK WAVES, V2; ZELDOVICH YB, 1967, PHYSICS SHOCK WAVES, V1	16	52	53	6	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					782	783		10.1038/35057317	http://dx.doi.org/10.1038/35057317			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236983				2022-12-28	WOS:000166938800027
J	Wickware, P; Smaglik, P				Wickware, P; Smaglik, P			Labs and companies seek their niches as work continues after the draft	NATURE			English	Article																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					961	963		10.1038/35057438	http://dx.doi.org/10.1038/35057438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237022				2022-12-28	WOS:000166938800069
J	Gillooly, DJ; Stenmark, H				Gillooly, DJ; Stenmark, H			Cell biology - A lipid oils the endocytosis machine	SCIENCE			English	Editorial Material							CLATHRIN; DOMAIN		Norwegian Radium Hosp, Dept Biochem, N-0310 Oslo, Norway	University of Oslo	Gillooly, DJ (corresponding author), Norwegian Radium Hosp, Dept Biochem, N-0310 Oslo, Norway.		Stenmark, Harald/B-8868-2008					Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Kay BK, 1999, PROTEIN SCI, V8, P435; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383	13	19	19	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					993	994		10.1126/science.291.5506.993	http://dx.doi.org/10.1126/science.291.5506.993			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232585				2022-12-28	WOS:000166860100029
J	Toh, KL; Jones, CR; He, Y; Eide, EJ; Hinz, WA; Virshup, DM; Ptacek, LJ; Fu, YH				Toh, KL; Jones, CR; He, Y; Eide, EJ; Hinz, WA; Virshup, DM; Ptacek, LJ; Fu, YH			An hPer2 phosphorylation site mutation in familiar advanced sleep phase syndrome	SCIENCE			English	Article							DROSOPHILA CLOCK GENE; CIRCADIAN CLOCK; DOUBLE-TIME; LIGHT; MUTANTS; ENCODES; MPER2	Familiar advanced sleep phase syndrome (FASPS) is an autosomal dominant circadian rhythm variant; affected individuals are "morning Larks" with a 4-hour advance of the sleep, temperature, and melatonin rhythms. Here we report Localization of the FASPS gene near the telomere of chromosome 2q. A strong candidate gene (hPer2), a human homolog of the period gene in Drosophila, maps to the same Locus. Affected individuals have a serine to glycine mutation within the casein kinase I epsilon (CKI epsilon) binding region of hPER2, which causes hypophosphorylation by CKI epsilon in vitro. Thus, a variant in human sleep behavior can be attributed to a missense mutation in a clock component, hPER2, which alters the circadian period.	Univ Utah, Dept Neurobiol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Univ Hosp Sleep Disorders Ctr, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst Ctr Children, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Toh, KL (corresponding author), Univ Utah, Dept Neurobiol, Salt Lake City, UT 84112 USA.		Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059596] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NHLBI NIH HHS [HL/HD 59596] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; CEGIELSKA A, 1994, J VIROL, V68, P269, DOI 10.1128/JVI.68.1.269-275.1994; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Duffy J. F, 1999, SLEEP, V22, pS92; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Keesler GA, 2000, NEUROREPORT, V11, P951, DOI 10.1097/00001756-200004070-00011; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klerman EB, 1996, AM J PHYSIOL-REG I, V270, pR271, DOI 10.1152/ajpregu.1996.270.1.R271; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PTACEK LJ, 1994, CELL, V77, P863; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	25	1005	1044	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					1040	1043		10.1126/science.1057499	http://dx.doi.org/10.1126/science.1057499			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232563				2022-12-28	WOS:000166860100044
J	Crawley, MJ; Brown, SL; Hails, RS; Kohn, DD; Rees, M				Crawley, MJ; Brown, SL; Hails, RS; Kohn, DD; Rees, M			Biotechnology - Transgenic crops in natural habitats	NATURE			English	Article									Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Dept Biol, Ascot SL5 7PY, Berks, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Crawley, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.		Hails, Rosemary S/E-9478-2010	Hails, Rosemary S/0000-0002-6975-1318				BROWN SL, 1999, ENV IMPACT GENETICAL, P132; CRAWLEY MJ, 1993, NATURE, V363, P620, DOI 10.1038/363620a0; HAILS RS, 1997, P ROY SOC LOND B BIO, V265, P1	3	131	172	4	50	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					682	683		10.1038/35055621	http://dx.doi.org/10.1038/35055621			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217848				2022-12-28	WOS:000166816400031
J	Nishida, H; Sawada, K				Nishida, H; Sawada, K			macho-1 encodes a localized mRNA in ascidian eggs that specifies muscle fate during embryogenesis	NATURE			English	Article							CELL LINEAGE ANALYSIS; INTRACELLULAR INJECTION; GENE-EXPRESSION; TRACER ENZYME; EMBRYOS; DIFFERENTIATION; INFORMATION; CYTOPLASM; MESODERM	Maternal information stored in particular regions of the egg cytoplasm has an important function in the determination of developmental fate during early animal development(1,2). Ascidians show mosaic development(3,4); such autonomous development has been taken as evidence that prelocalized ooplasmic factors specify tissue precursor cells during embryogenesis. Interest has been concentrated on the mechanisms underlying the formation of muscle cells in the tail, as yellow-coloured myoplasm in eggs is preferentially segregated into muscle-lineage blastomeres(5). Here we show that maternal messenger RNA of the macho-1 gene is a determinant of muscle fate in the ascidian Halocynthia roretzi. The macho-1 mRNA encodes a zinc-finger protein, and the mRNA is localized to the myoplasm of eggs. Depletion of the mRNA specifically resulted in the loss of primary muscle cells in the tail, as shown by the expression of muscle-specific molecular markers. The myoplasm of macho-1-deficient eggs lost its ability to promote muscle formation. Injection of synthesized macho-1 mRNA caused ectopic muscle formation in non-muscle-lineage cells. Our results indicate that macho-1 may be both required and sufficient for specification of muscle fate, and that the mRNA is a genuine, localized muscle determinant.	Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Nishida, H (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan.	hnishida@bio.titech.ac.jp	Nishida, Hiroki/B-1851-2008	Nishida, Hiroki/0000-0002-7249-1668				Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Davidson E. H., 1986, GENE ACTIVITY EARLY; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; HOSHI M, 1981, DEV BIOL, V86, P117, DOI 10.1016/0012-1606(81)90322-5; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kawashima T, 2000, NUCLEIC ACIDS RES, V28, P133, DOI 10.1093/nar/28.1.133; Marikawa Y, 1999, MECH DEVELOP, V89, P93, DOI 10.1016/S0925-4773(99)00210-5; MITAMIYAZAWA I, 1985, J EMBRYOL EXP MORPH, V87, P1; Mitani Y, 1999, DEV DYNAM, V215, P62, DOI 10.1002/(SICI)1097-0177(199905)215:1<62::AID-DVDY7>3.0.CO;2-X; NISHIDA H, 1985, DEV BIOL, V110, P440, DOI 10.1016/0012-1606(85)90102-2; NISHIDA H, 1992, ROUX ARCH DEV BIOL, V201, P81, DOI 10.1007/BF00420418; NISHIDA H, 1992, DEVELOPMENT, V116, P521; Nishida H, 1999, INVERTEBR REPROD DEV, V36, P41, DOI 10.1080/07924259.1999.9652676; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; NISHIDA H, 1990, DEVELOPMENT, V108, P559; Nishikata T, 1999, DEV BIOL, V209, P72, DOI 10.1006/dbio.1999.9244; NISHIKATA T, 1987, DEVELOPMENT, V99, P163; Reverberi G., 1946, Pubblicazioni della Stazione Zoologica di Napoli, V20, P199; Sasakura Y, 2000, DEV BIOL, V220, P365, DOI 10.1006/dbio.2000.9626; Satoh N, 1996, P NATL ACAD SCI USA, V93, P9315, DOI 10.1073/pnas.93.18.9315; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 1997, DEV BIOL, V192, P467, DOI 10.1006/dbio.1997.8730; SATOU Y, 1995, DEV GROWTH DIFFER, V37, P319; Wada S, 1999, DEV GROWTH DIFFER, V41, P9; WHITTAKER JR, 1990, BIOL BULL-US, V178, P222, DOI 10.2307/1541823; WHITTAKER JR, 1973, P NATL ACAD SCI USA, V70, P2096, DOI 10.1073/pnas.70.7.2096; Wilson EB., 1925, CELL DEV HEREDITY, V3rd edition; Yoshida S, 1996, DEVELOPMENT, V122, P2005	30	213	215	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					724	729		10.1038/35055568	http://dx.doi.org/10.1038/35055568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217862				2022-12-28	WOS:000166816400045
J	Oliveira, RF; Lopes, M; Carneiro, LA; Canario, AVM				Oliveira, RF; Lopes, M; Carneiro, LA; Canario, AVM			Watching fights raises fish hormone levels - Cichlid fish wrestling for dominance induce an androgen surge in male spectators.	NATURE			English	Article							TESTOSTERONE		Inst Super Psicol Aplicada, Unidade Invest Ecoetol, P-1100 Lisbon, Portugal; Univ Algarve, Ctr Ciencias Mar, P-8000 Faro, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade do Algarve	Oliveira, RF (corresponding author), Inst Super Psicol Aplicada, Unidade Invest Ecoetol, Rua Jardim Tabaco 44, P-1100 Lisbon, Portugal.		Oliveira, Rui/A-3581-2013; Canario, Adelino/C-7942-2009	Oliveira, Rui/0000-0003-1528-618X; Canario, Adelino/0000-0002-6244-6468				ANDREW RJ, 1972, NATURE, V237, P343, DOI 10.1038/237343a0; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; CHASE ID, 1994, ANIM BEHAV, V48, P393, DOI 10.1006/anbe.1994.1253; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1376, DOI 10.1073/pnas.89.4.1376; GYGER M, 1986, ANIM BEHAV, V34, P1570, DOI 10.1016/S0003-3472(86)80229-9; Oliveira RF, 1996, HORM BEHAV, V30, P2, DOI 10.1006/hbeh.1996.0002; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Pusey Anne E., 1997, P254; SCOTT AP, 1989, GEN COMP ENDOCR, V73, P46, DOI 10.1016/0016-6480(89)90054-3; SCOTT AP, 1984, GEN COMP ENDOCR, V56, P349, DOI 10.1016/0016-6480(84)90077-7; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134	11	139	144	0	34	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					475	475		10.1038/35054128	http://dx.doi.org/10.1038/35054128			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206533				2022-12-28	WOS:000166570500034
J	Raymond, PA; Bauer, JE				Raymond, PA; Bauer, JE			Riverine export of aged terrestrial organic matter to the North Atlantic Ocean	NATURE			English	Article							AMAZON RIVER; SOIL CARBON; C-14; FRACTIONS; SEDIMENT; PACIFIC; FLUXES; AMS	Global riverine discharge of organic matter represents a substantial source of terrestrial dissolved and particulate organic carbon to the oceans(1,2). This input from rivers is, by itself, more than large enough to account for the apparent steady-state replacement times of 4,00-6,000 yr for oceanic dissolved organic carbon(3-5). But paradoxically, terrestrial organic matter, derived from land plants, is not detected in seawater and sediments in quantities that correspond to its inputs(6-8). Here we present natural C-14 and C-13 data from four rivers that discharge to the western North Atlantic Ocean and rnd that these rivers are sources of old (C-14-depleted) and young (C-14-enriched) terrestrial dissolved organic carbon, and of predominantly old terrestrial particulate organic carbon. These findings contrast with limited earlier data(9) that suggested terrestrial organic matter transported by rivers might be generally enriched in C-14 from nuclear testing, and hence newly produced. We also rnd that much of the young dissolved organic carbon can be selectively degraded over the residence times of river and coastal waters, leaving an even older and more refractory component for oceanic export. Thus, pre-ageing and degradation may alter significantly the structure, distributions and quantities of terrestrial organic matter before its delivery to the oceans.	Coll William & Mary, Sch Marine Sci, Gloucester Point, VA 23062 USA	William & Mary	Raymond, PA (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.		Raymond, Peter A/C-4087-2009	Raymond, Peter A/0000-0002-8564-7860				ARAVENA R, 1992, RADIOCARBON, V34, P636, DOI 10.1017/S003382220006392X; BAUER JE, 1992, NATURE, V357, P667, DOI 10.1038/357667a0; COCH NK, 1986, NE GEOL, V8, P96; DEGENS ET, 1989, PERSPECTIVES BIOGEOC, P303; DRUFFEL ERM, 1992, J GEOPHYS RES-OCEANS, V97, P15639, DOI 10.1029/92JC01511; HEDGES JI, 1986, SCIENCE, V231, P1129, DOI 10.1126/science.231.4742.1129; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; HEDGES JI, 1992, GEOCHIM COSMOCHIM AC, V56, P1753, DOI 10.1016/0016-7037(92)90241-A; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; HEDGES JI, 1986, LIMNOL OCEANOGR, V31, P717, DOI 10.4319/lo.1986.31.4.0717; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; HOWARTH RW, 1991, ECOL APPL, V1, P27, DOI 10.2307/1941845; Kao SJ, 1996, LIMNOL OCEANOGR, V41, P1749, DOI 10.4319/lo.1996.41.8.1749; Keil RG, 1997, GEOCHIM COSMOCHIM AC, V61, P1507, DOI 10.1016/S0016-7037(97)00044-6; Levin I, 1997, RADIOCARBON, V39, P205, DOI 10.1017/S0033822200052012; Ludwig W, 1996, GLOBAL BIOGEOCHEM CY, V10, P23, DOI 10.1029/95GB02925; MEADE RH, 1985, SCIENCE, V228, P488, DOI 10.1126/science.228.4698.488; MEYBECK M, 1993, WATER AIR SOIL POLL, V70, P443, DOI 10.1007/BF01105015; MEYERSSCHULTE KJ, 1986, NATURE, V321, P61, DOI 10.1038/321061a0; Moran MA, 1999, ESTUARIES, V22, P55, DOI 10.2307/1352927; NEWBOLD JD, 1982, OIKOS, V38, P266, DOI 10.2307/3544663; OBRIEN BJ, 1981, FLUX ORGANIC CARBON, P46; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; Raymond PA, 2000, AQUAT MICROB ECOL, V22, P1, DOI 10.3354/ame022001; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; SOFER Z, 1980, ANAL CHEM, V52, P1389, DOI 10.1021/ac50058a063; SPIKER E, 1981, FLUX ORGANIC CARBON, P79; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; TRUMBORE SE, 1989, RADIOCARBON, V31, P644; VOGEL JS, 1987, NUCL INSTRUM METH B, V29, P50, DOI 10.1016/0168-583X(87)90202-3; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0	32	431	470	6	187	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					497	500		10.1038/35054034	http://dx.doi.org/10.1038/35054034			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206542				2022-12-28	WOS:000166570500043
J	Nishiguchi, S; Shiomi, S; Nakatani, S; Takeda, T; Fukuda, K; Tamori, A; Habu, D; Tanaka, T				Nishiguchi, S; Shiomi, S; Nakatani, S; Takeda, T; Fukuda, K; Tamori, A; Habu, D; Tanaka, T			Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis	LANCET			English	Article								In a prospective randomised controlled study, 90 patients with chronic active hepatitis C and compensated cirrhosis were assigned symptomatic treatment or interferon alfa (IFN-alpha). We report data on decompensation, detection of hepatocellular carcinoma, and mortality rates, IFN-alpha gave a sustained response in only a small proportion of patients, but worsening of compensated cirrhosis was prevented and development of hepatocellular carcinoma was Inhibited, increasing the survival rate. The risk ratio of IFN-alpha versus symptomatic treatment decreased by 0.250 for progression to Child-Pugh grade B, 0.256 for detection of hepatocellular carcinoma, and 0.135 for a fatal outcome.	Osaka City Univ, Sch Med, Dept Internal Med 3, Abeno Ku, Osaka 5458585, Japan; Osaka City Univ, Sch Med, Dept Publ Hlth, Abeno Ku, Osaka 5458585, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Nishiguchi, S (corresponding author), Osaka City Univ, Sch Med, Dept Internal Med 3, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.							Brunetto MR, 1998, LANCET, V351, P1535; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; Hu KQ, 1999, HEPATOLOGY, V29, P1311, DOI 10.1002/hep.510290424; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003	5	196	200	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2001	357	9251					196	197		10.1016/S0140-6736(00)03595-9	http://dx.doi.org/10.1016/S0140-6736(00)03595-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213099				2022-12-28	WOS:000166593700015
J	Brooks, R				Brooks, R			The relationship between matter and life	NATURE			English	Article								The disciplines of artificial intelligence and artificial life build computational systems inspired by various aspects of life. Despite the fact that living systems are composed only of non-living atoms there seems to be limits in the current levels of understanding within these disciplines in what is necessary to bridge the gap between non-living and living matter.	MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Brooks, R (corresponding author), MIT, Artificial Intelligence Lab, 545 Technol Sq, Cambridge, MA 02139 USA.							Adams B, 2000, IEEE INTELL SYST APP, V15, P25, DOI 10.1109/5254.867909; BROOKS RA, 1991, SCIENCE, V253, P1227, DOI 10.1126/science.253.5025.1227; Chalmers D.J., 1995, J CONSCIOUSNESS STUD, V2, P200, DOI DOI 10.1093/ACPR0F:0S0/9780195311105.003.0001; GREENBLATT R, 1967, P FALL JOINT COMP C, P801; Kitano H, 2000, NEW GENERAT COMPUT, V18, P199, DOI 10.1007/BF03037529; Langton C, 1989, ARTIFICIAL LIFE; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Matijevic J, 1998, SCIENCE, V280, P454, DOI 10.1126/science.280.5362.454; MCCORDUCK PA, 1979, MACHINES THINK; Penrose R, 1994, PSYCHE; POMERLEAU D, 1996, PHOTONICS SPECTR APR, P80; Ray TS., 1991, ARTIF LIFE, P371	13	85	88	2	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					409	411		10.1038/35053196	http://dx.doi.org/10.1038/35053196			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201756	Bronze			2022-12-28	WOS:000166434300064
J	Rice, SA				Rice, SA			Interfering for the good of a chemical reaction	NATURE			English	Article							COHERENT CONTROL; ADIABATIC PASSAGE; LASER CONTROL; SELECTIVITY	Chemistry has, throughout its history, been a science of passive control: having made the conditions as favourable as possible, the chemist is obliged to let the complex reorganization of reactant molecules into products take place unhindered. But what if one could meddle at the very heart of a reaction to affect the dynamics of molecular evolution? Welcome to the world of quantum interference control.	Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	University of Chicago	Rice, SA (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	s-rice@uchicago.edu						Abrashkevich A, 1998, PHYS REV LETT, V81, P3789, DOI 10.1103/PhysRevLett.81.3789; Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Baumert T, 1997, ADV CHEM PHYS, V101, P47, DOI 10.1002/9780470141601.ch2; BAUMERT T, 1991, PHYS REV LETT, V67, P3753, DOI 10.1103/PhysRevLett.67.3753; BONEDO NH, 1998, SCIENCE, V282, P1743; DUPONT E, 1995, PHYS REV LETT, V74, P3596, DOI 10.1103/PhysRevLett.74.3596; Gruebele M, 2000, ADV CHEM PHYS, V114, P193, DOI 10.1002/9780470141731.ch3; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Kobrak MN, 1998, PHYS REV A, V57, P2885, DOI 10.1103/PhysRevA.57.2885; Kobrak MN, 1998, J CHEM PHYS, V109, P1, DOI 10.1063/1.476550; KOSLOFF R, 1989, CHEM PHYS, V139, P201, DOI 10.1016/0301-0104(89)90012-8; KURIZKI G, 1989, PHYS REV B, V39, P3435, DOI 10.1103/PhysRevB.39.3435; PEIRCE AP, 1988, PHYS REV A, V37, P4950, DOI 10.1103/PhysRevA.37.4950; Rice S. A., 2000, OPTICAL CONTROL MOL; Schaefer H.F., 1972, ELECT STRUCTURE ATOM; SHAPIRO M, 1986, J CHEM PHYS, V84, P4103, DOI 10.1063/1.450074; Shapiro M, 1997, CHEM PHYS, V217, P325, DOI 10.1016/S0301-0104(97)00058-X; SHAPIRO M, 1992, J CHEM PHYS, V97, P6259, DOI 10.1063/1.463687; TANNOR DJ, 1985, J CHEM PHYS, V83, P5013, DOI 10.1063/1.449767; Zhu L, 1997, PHYS REV LETT, V79, P4108, DOI 10.1103/PhysRevLett.79.4108; ZHU LC, 1995, SCIENCE, V270, P77, DOI 10.1126/science.270.5233.77	22	76	84	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					422	426		10.1038/35053211	http://dx.doi.org/10.1038/35053211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201759				2022-12-28	WOS:000166434300068
J	Kasumov, AY; Kociak, M; Gueron, S; Reulet, B; Volkov, VT; Klinov, DV; Bouchiat, H				Kasumov, AY; Kociak, M; Gueron, S; Reulet, B; Volkov, VT; Klinov, DV; Bouchiat, H			Proximity-induced superconductivity in DNA	SCIENCE			English	Article							TRANSPORT	Conductivity measurements on double-stranded DNA molecules deposited by a combing process across a submicron slit between rhenium/carbon metallic contacts reveal conduction to be ohmic between room temperature and 1 kelvin. The resistance per molecule is Less than 100 kilohm and varies weakly with temperature. Below the superconducting transition temperature (1 kelvin) of the contacts, proximity-induced superconductivity is observed. These results imply that DNA molecules can be conducting down to millikelvin temperature and that phase coherence is maintained over several hundred nanometers.	Univ Paris Sud, Phys Solides Lab, CNRS, F-91405 Orsay, France; Russian Acad Sci, Inst Microelect Technol & High Pur Mat, Chernogolovka 142432, Moscow Region, Russia; Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117871, Russia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Russian Academy of Sciences; Institute of Microelectronics Technology & High-Purity Materials, RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Kasumov, AY (corresponding author), Starlab, La Tour Freins,555 Rue Engeland, B-1180 Brussels, Belgium.		Klinov, Dmitry/ABF-3830-2020; kociak, mathieu/T-3110-2018	Klinov, Dmitry/0000-0001-8288-2198; kociak, mathieu/0000-0001-8858-0449; Bouchiat, Helene/0000-0003-3178-885X; Volkov, Vladimir/0000-0002-6005-9536				ALBERTS B, 1994, BIOL CELL; Allemand JF, 1997, BIOPHYS J, V73, P2064, DOI 10.1016/S0006-3495(97)78236-5; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; COURTOIS H, 1995, PHYS REV B, V52, P1162, DOI 10.1103/PhysRevB.52.1162; Deutscher G., 1969, Superconductivity, vol.2, P1005; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; DUBOCHET J, 1971, J ULTRA MOL STRUCT R, V35, P147, DOI 10.1016/S0022-5320(71)80148-X; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; GRUNER G, 2000, IN PRESS P KIRCHB C; JEROME D, 1982, ADV PHYS, V31, P299, DOI 10.1080/00018738200101398; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; Kasumov AY, 1999, SCIENCE, V284, P1508, DOI 10.1126/science.284.5419.1508; KASUMOV AY, 2000, IN PRESS P KIRCHB C; Klinov DV, 1998, NUCLEIC ACIDS RES, V26, P4603, DOI 10.1093/nar/26.20.4603; ODINSTOV AA, IN PRESS PHYSICA B; Okahata Y, 1998, SUPRAMOL SCI, V5, P317, DOI 10.1016/S0968-5677(98)00025-X; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; PROKHOROV VV, 1999, RUSS J BIOORG CHEM+, V25, P211; Ratner M, 1999, NATURE, V397, P480, DOI 10.1038/17232; Safi I, 1995, PHYS REV B, V52, P17040, DOI 10.1103/PhysRevB.52.R17040; THOULESS DJ, 1977, PHYS REV LETT, V39, P1167, DOI 10.1103/PhysRevLett.39.1167; Wan CZ, 1999, P NATL ACAD SCI USA, V96, P6014, DOI 10.1073/pnas.96.11.6014	24	605	634	5	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					280	282		10.1126/science.291.5502.280	http://dx.doi.org/10.1126/science.291.5502.280			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209072				2022-12-28	WOS:000166352900037
J	Diggory, P; Fernandez, C; Humphrey, A; Jones, V; Murphy, M				Diggory, P; Fernandez, C; Humphrey, A; Jones, V; Murphy, M			Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article								Objective To determine whether elderly people can learn to use the inhaler used to deliver zanamivir (Relenza Diskhaler) as effectively as the Turbohaler and to identify which aspects of inhaler technique are most problematic. Design Randomised, controlled, intervention study. Setting Wards for acute elderly care in a large district general hospital. Participants 73 patients who were unfamiliar with the use of an inhaler, aged 71 to 99 (mean 83) years. Main outcome measures Initial scores and changes in scores 24 hours later using a 10 point scoring system of five aspects of inhaler technique. Results 38 patients were allocated the Relenza Diskhaler and 35 the Turbohaler. The mean total score was significantly greater in the Turbohaler than Diskhaler groups both initially (8.74 v 7.05) and after 24 hours (8.28 v 5.43). The major difference between inhalers was in loading and priming. After tuition 50% (19 of 38) of patients allocated the Diskhaler were unable to load and prime the device and 65% (24 of 37) were unable to do so 24 hours later. Of those allocated the Turbohaler, two patients were unable to load and prime the device after initial review and one after 24 hours. Conclusion Most elderly people cannot use the inhaler device used to deliver the anti-influenza drug zanamivir. Treatment with this drug is unlikely to be effective in elderly people unless the delivery system is improved.	Mayday Hosp, Dept Elderly Care Med, Croydon CR7 7YE, England; Mayday Hosp, Dept Clin Audit, Croydon CR7 7YE, England	Croydon University Hospital; Croydon University Hospital	Diggory, P (corresponding author), Mayday Hosp, Dept Elderly Care Med, Croydon CR7 7YE, England.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allen SC, 1997, AGE AGEING, V26, P83, DOI 10.1093/ageing/26.2.83; ARMITAGE JM, 1988, AGE AGEING, V17, P275, DOI 10.1093/ageing/17.4.275; *DEP HLTH, 1996, IMM INF DIS, P120; DIGGORY P, 1991, AGE AGEING, V20, P379, DOI 10.1093/ageing/20.5.379; ELIZABETH JE, 1988, GERIATR MED, V18, P11; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; HODGKINSON HM, 1972, AGE AGEING, V1, P233; Jones V, 1999, AGE AGEING, V28, P481, DOI 10.1093/ageing/28.5.481; PESSON G, 1986, EUR RESPIR J, V1, P681; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; 1996, EFFECTIVENESS MATTER, V2, P1	11	66	71	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					577	579		10.1136/bmj.322.7286.577	http://dx.doi.org/10.1136/bmj.322.7286.577			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238150	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000167499900020
J	Munch, S; deKryger, L				Munch, S; deKryger, L			Moral wounds: Complicated complications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		[Anonymous], 1999, DEATH FORETOLD PROPH; REISER SJ, 1980, ANN INTERN MED, V92, P837, DOI 10.7326/0003-4819-92-6-837	2	27	28	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1131	1132		10.1001/jama.285.9.1131	http://dx.doi.org/10.1001/jama.285.9.1131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231729				2022-12-28	WOS:000167194700001
J	Brassey, J; Elwyn, G; Price, C; Kinnersley, P				Brassey, J; Elwyn, G; Price, C; Kinnersley, P			Just in time information for clinicians: a questionnaire evaluation of the ATTRACT project	BRITISH MEDICAL JOURNAL			English	Article							DOCTORS		ATTRACT Wales, Pontypool NP4 0YP, England		Brassey, J (corresponding author), ATTRACT Wales, Mamhilad House, Pontypool NP4 0YP, England.		Elwyn, G./L-4292-2015; Elwyn, Glyn/B-4798-2009	Elwyn, Glyn/0000-0002-0917-6286; Price, Christopher/0000-0003-3566-3157				Barrie AR, 1997, BRIT MED J, V315, P1512, DOI 10.1136/bmj.315.7121.1512; Ely JW, 1999, BRIT MED J, V319, P358, DOI 10.1136/bmj.319.7206.358; FREEMANTLE N, 1997, COCHRANE COLLABORATI; McColl A, 1998, BRIT MED J, V316, P361, DOI 10.1136/bmj.316.7128.361; Smith R, 1996, BRIT MED J, V313, P1062	5	41	41	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					529	530		10.1136/bmj.322.7285.529	http://dx.doi.org/10.1136/bmj.322.7285.529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230069	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000167370500029
J	Ben-Jacob, E; Levine, H				Ben-Jacob, E; Levine, H			The artistry of nature	NATURE			English	Article							GROWTH		Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Tel Aviv University; University of California System; University of California San Diego	Ben-Jacob, E (corresponding author), Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.		Levine, Herbert/C-1704-2008	Levine, Herbert/0000-0002-8819-9055				Ball P., 1999, SELF MADE TAPESTRY P; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; Ben-Jacob E, 1998, SCI AM, V279, P82, DOI 10.1038/scientificamerican1098-82; BENJACOB E, 1990, NATURE, V343, P523, DOI 10.1038/343523a0; KESSLER DA, 1988, ADV PHYS, V37, P255, DOI 10.1080/00018738800101379	5	41	42	3	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					985	986		10.1038/35059178	http://dx.doi.org/10.1038/35059178			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234046				2022-12-28	WOS:000167148800023
J	Aach, J; Bulyk, ML; Church, GM; Comander, J; Derti, A; Shendure, J				Aach, J; Bulyk, ML; Church, GM; Comander, J; Derti, A; Shendure, J			Computational comparison of two draft sequences of the human genome	NATURE			English	Article							CONSERVATION; PROTEIN; GROWTH; GENES; TOOL	We are in the enviable position of having two distinct drafts of the human genome sequence. Although gaps, errors, redundancy and incomplete annotation mean that individually each falls short of the ideal, many of these problems can be assessed by comparison. Here we present some comparative analyses of these drafts. We look at a number of features of the sequences, including sequence gaps, continuity, consistency between the two sequences and patterns of DNA-binding protein motifs.	Harvard Univ, Sch Med, Lipper Ctr Computat Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biophys, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Boston Univ, Program Bioinformat, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University	Church, GM (corresponding author), Harvard Univ, Sch Med, Lipper Ctr Computat Genet, Boston, MA 02115 USA.	church@arep.med.harvard.edud	Shendure, Jay/AAU-3684-2021	Comander, Jason/0000-0002-4257-7145; Shendure, Jay/0000-0002-1516-1865; church, george/0000-0001-6232-9969				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; BULYK ML, 2000, THESIS HARVARD MED S; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; Davidson S, 2000, NAT BIOTECHNOL, V18, P1134, DOI 10.1038/81100; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Gusfield D., 1997, ALGORITHMS STRINGS T; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; McGuire AM, 2000, GENOME RES, V10, P744, DOI 10.1101/gr.10.6.744; Moore G. E., 1965, ELECTRONICS, V38, P1, DOI DOI 10.1109/JPROC.1998.658762; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965	20	40	43	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					856	859		10.1038/35057055	http://dx.doi.org/10.1038/35057055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237010	Bronze			2022-12-28	WOS:000166938800057
J	Clayton, JD; Kyriacou, CP; Reppert, SM				Clayton, JD; Kyriacou, CP; Reppert, SM			Keeping time with the human genome	NATURE			English	Article							MOUSE	The cloning and characterization of 'clock gene' families has advanced our understanding of the molecular control of the mammalian circadian clock. We have analysed the human genome for additional relatives, and identified new candidate genes that may expand our knowledge of the molecular workings of the circadian clock. This knowledge could lead to the development of therapies for treating jet lag and sleep disorders, and add to our understanding of the genetic contribution of clock gene alterations to sleep and neuropsychiatric disorders. The human genome will also aid in the identification of output genes that ultimately control circadian behaviours.	Massachusetts Gen Hosp, MassGen Hosp Children, Lab Dev Chronobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Leicester	Reppert, SM (corresponding author), Massachusetts Gen Hosp, MassGen Hosp Children, Lab Dev Chronobiol, Boston, MA 02114 USA.	reppert@helix.mgh.harvard.edu						Benna C, 2000, CURR BIOL, V10, pR512, DOI 10.1016/S0960-9822(00)00594-7; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Reppert SM, 2000, J BIOL RHYTHM, V15, P357, DOI 10.1177/074873000129001459; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; TOH KL, 2001, SCIENCE         0111; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Young MW, 2000, SCIENCE, V288, P451, DOI 10.1126/science.288.5465.451	15	70	79	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					829	831		10.1038/35057006	http://dx.doi.org/10.1038/35057006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237000	Bronze			2022-12-28	WOS:000166938800047
J	McPherson, JD; Marra, M; Hillier, L; Waterston, RH; Chinwalla, A; Wallis, J; Sekhon, M; Wylie, K; Mardis, ER; Wilson, RK; Fulton, R; Kucaba, TA; Wagner-McPherson, C; Barbazuk, WB; Gregory, SG; Humphray, SJ; French, L; Evans, RS; Bethel, G; Whittaker, A; Holden, JL; McCann, OT; Dunham, A; Soderlund, C; Scott, CE; Bentley, DR; Schuler, G; Chen, HC; Jang, WH; Green, ED; Idol, JR; Maduro, VVB; Montgomery, KT; Lee, E; Miller, A; Emerling, S; Kucherlapati, R; Gibbs, R; Scherer, S; Gorrell, JH; Sodergren, E; Clerc-Blankenburg, K; Tabor, P; Naylor, S; Garcia, D; de Jong, PJ; Catanese, JJ; Nowak, N; Osoegawa, K; Qin, SZ; Rowen, L; Madan, A; Dors, M; Hood, L; Trask, B; Friedman, C; Massa, H; Cheung, VG; Kirsch, IR; Reid, T; Yonescu, R; Weissenbach, J; Bruls, T; Heilig, R; Branscomb, E; Olsen, A; Doggett, N; Cheng, JF; Hawkins, T; Myers, RM; Shang, J; Ramirez, L; Schmutz, J; Velasquez, O; Dixon, K; Stone, NE; Cox, DR; Haussler, D; Kent, WJ; Furey, T; Rogic, S; Kennedy, S; Jones, S; Rosenthal, A; Wen, GP; Schilhabel, M; Gloeckner, G; Nyakatura, G; Siebert, R; Schlegelberger, B; Korenburg, J; Chen, XN; Fujiyama, A; Hattori, M; Toyoda, A; Yada, T; Park, HS; Sakaki, Y; Shimizu, N; Asakawa, S; Kawasaki, K; Sasaki, T; Shintani, A; Shimizu, A; Shibuya, K; Kudoh, J; Minoshima, S; Ramser, J; Seranski, P; Hoff, C; Poustka, A; Reinhardt, R; Lehrach, H				McPherson, JD; Marra, M; Hillier, L; Waterston, RH; Chinwalla, A; Wallis, J; Sekhon, M; Wylie, K; Mardis, ER; Wilson, RK; Fulton, R; Kucaba, TA; Wagner-McPherson, C; Barbazuk, WB; Gregory, SG; Humphray, SJ; French, L; Evans, RS; Bethel, G; Whittaker, A; Holden, JL; McCann, OT; Dunham, A; Soderlund, C; Scott, CE; Bentley, DR; Schuler, G; Chen, HC; Jang, WH; Green, ED; Idol, JR; Maduro, VVB; Montgomery, KT; Lee, E; Miller, A; Emerling, S; Kucherlapati, R; Gibbs, R; Scherer, S; Gorrell, JH; Sodergren, E; Clerc-Blankenburg, K; Tabor, P; Naylor, S; Garcia, D; de Jong, PJ; Catanese, JJ; Nowak, N; Osoegawa, K; Qin, SZ; Rowen, L; Madan, A; Dors, M; Hood, L; Trask, B; Friedman, C; Massa, H; Cheung, VG; Kirsch, IR; Reid, T; Yonescu, R; Weissenbach, J; Bruls, T; Heilig, R; Branscomb, E; Olsen, A; Doggett, N; Cheng, JF; Hawkins, T; Myers, RM; Shang, J; Ramirez, L; Schmutz, J; Velasquez, O; Dixon, K; Stone, NE; Cox, DR; Haussler, D; Kent, WJ; Furey, T; Rogic, S; Kennedy, S; Jones, S; Rosenthal, A; Wen, GP; Schilhabel, M; Gloeckner, G; Nyakatura, G; Siebert, R; Schlegelberger, B; Korenburg, J; Chen, XN; Fujiyama, A; Hattori, M; Toyoda, A; Yada, T; Park, HS; Sakaki, Y; Shimizu, N; Asakawa, S; Kawasaki, K; Sasaki, T; Shintani, A; Shimizu, A; Shibuya, K; Kudoh, J; Minoshima, S; Ramser, J; Seranski, P; Hoff, C; Poustka, A; Reinhardt, R; Lehrach, H		Int Human Genome Mapping Consortiu	A physical map of the human genome	NATURE			English	Article							DROSOPHILA-MELANOGASTER; DNA-SEQUENCE; CHROMOSOME; HYBRIDIZATION; FRAGMENTS; SHOTGUN; CONTIGS; VECTOR; CLONES; GENES	The human genome is by far the largest genome to be sequenced, and its size and complexity present many challenges for sequence assembly. The International Human Genome Sequencing Consortium constructed a map of the whole genome to enable the selection of clones for sequencing and for the accurate assembly of the genome sequence. Here we report the construction of the whole-genome bacterial artificial chromosome (BAC) map and its integration with previous landmark maps and information from mapping efforts focused on specific chromosomal regions. We also describe the integration of sequence data with the map.	Washington Univ, Sch Med, Genome Sequencing Ctr, Dept Genet, St Louis, MO 63108 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Univ Texas San Antonio, San Antonio, TX 78285 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Inst Syst Biol, Multimegabase Sequencing Ctr, Seattle, WA 98105 USA; Fred Hutchinson Canc Res Inst, Div Human Biol, Seattle, WA 98109 USA; Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; NCI, Dept Genet, Med Branch, Washington, DC USA; Genoscope, Ctr Natl Sequencage, F-91057 Evry, France; US DOE, Joint Genome Inst, Walnut Creek, CA USA; Stanford Univ, Stanford Human Genome Ctr, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Comp Sci, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Math, Santa Cruz, CA 95064 USA; British Columbia Canc Res Ctr, Vancouver, BC V5Z 4E6, Canada; Inst Mol Biotechnol, Dept Genome Anal, D-07745 Jena, Germany; Univ Kiel, Inst Human Genet, D-24098 Kiel, Germany; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; RIKEN, Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Deutsch Krebsforschungszentrum, Abt Mol Genomanal, D-69120 Heidelberg, Germany	Washington University (WUSTL); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Yeshiva University; Albert Einstein College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas at San Antonio (UTSA); Roswell Park Cancer Institute; Institute for Systems Biology (ISB); Fred Hutchinson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); CEA; UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Stanford University; Stanford University; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; British Columbia Cancer Agency; University of Kiel; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RIKEN; Keio University; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ)	McPherson, JD (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Dept Genet, 4444 Forest Pk Blvd, St Louis, MO 63108 USA.	jmcphers@watson.wustl.edu	Hattori, Masahira/C-6958-2016; Schmutz, Jeremy/N-3173-2013; Wilson, Richard K./AAF-4139-2019; Cheung, Vivian G./AAT-3115-2020; Glöckner, Gernot/A-7800-2010; Hattori, Masahira/AAD-3785-2019; Marra, Marco A/B-5987-2008; Sekhon, Mandeep/L-4665-2018; Siebert, Reiner/A-8049-2010; Sasaki, Takashi/AAD-1461-2019; McPherson, John D/D-2633-2017; Jones, Steven J/C-3621-2009; Kucherlapati, Raju/ABC-8807-2021; Mardis, Elaine/W-2202-2019	Hattori, Masahira/0000-0001-9467-0344; Schmutz, Jeremy/0000-0001-8062-9172; Wilson, Richard K./0000-0002-1992-1358; Glöckner, Gernot/0000-0002-9061-1061; Marra, Marco A/0000-0001-7146-7175; Sekhon, Mandeep/0000-0002-9993-6938; McPherson, John D/0000-0001-8049-9347; Jones, Steven J/0000-0003-3394-2208; Sasaki, Takashi/0000-0002-6275-046X; Chinwalla, Asif/0000-0001-7831-3996; Reinhardt, Richard/0000-0001-9376-2132; Gregory, Simon/0000-0002-7805-1743; Cheng, Jan-Fang/0000-0001-7315-7613; Barbazuk, William/0000-0002-0909-4563; Minoshima, Satoshi/0000-0002-0043-3047; Furey, Terry/0000-0001-5546-9672				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Bouck JB, 2000, NAT GENET, V25, P31, DOI 10.1038/75563; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; Capecchi MR, 2000, NAT GENET, V26, P159, DOI 10.1038/82825; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOGGETT NA, 1995, NATURE, V377, P335; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eeckman FH, 1995, METHOD CELL BIOL, V48, P583; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; Hoskins RA, 2000, SCIENCE, V288, P1751; *INT RAD HYBRD MAP, 2000, NEW GEN MAP HUM GEN; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LICHTER P, 1991, GENET ANAL-BIOMOL E, V8, P24, DOI 10.1016/1050-3862(91)90005-C; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Montgomery KT, 2001, NATURE, V409, P945, DOI 10.1038/35057174; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; OSOEGAWA K, IN PRESS GENOME RES; Pennisi E, 2000, SCIENCE, V287, P1179, DOI 10.1126/science.287.5456.1179; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Roest Crollius H, 1996, GENOME RES, V6, P943, DOI 10.1101/gr.6.10.943; Ross NP, 1999, ENVIRON ECOL STAT, V6, P5, DOI 10.1023/A:1009627431759; Schuler GD, 1998, TRENDS BIOTECHNOL, V16, P456, DOI 10.1016/S0167-7799(98)01232-3; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; SULSTON J, 1989, COMPUT APPL BIOSCI, V5, P101; SULSTON J, 1988, COMPUT APPL BIOSCI, V4, P125; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; *WHIT I BIOM RES, 2000, YAC STS CONT MAP HUM; WILSON REK, 1997, ANAL DNA, P398; Zhao S, 2000, GENOMICS, V63, P321, DOI 10.1006/geno.1999.6082	46	616	646	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					934	941		10.1038/35057157	http://dx.doi.org/10.1038/35057157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237014	Bronze			2022-12-28	WOS:000166938800061
J	Barbour, V				Barbour, V			Retaining trust	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Barbour, V (corresponding author), Lancet, London WC1X 8RR, England.							[Anonymous], 2001, REPORT ROYAL LIVERPO; *CENTR OFF INF, 2000, INQ MAN CAR CHILDR R	2	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					328	328						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210990				2022-12-28	WOS:000166897900006
J	Roberts, I; Evans, P; Bunn, F; Kwan, I; Crowhurst, E				Roberts, I; Evans, P; Bunn, F; Kwan, I; Crowhurst, E			Is the formalisation of blood pressure in bleeding trauma patients harmful?	LANCET			English	Editorial Material							HYDROXYETHYL STARCH; FLUID RESUSCITATION; CRYSTALLOIDS; COAGULATION; MANAGEMENT; COLLOIDS; ALBUMIN		Inst Child Hlth, Dept Epidemiol & Publ Hlth, Cochrane Injuries Grp, London WC1N, England; Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Dept Accid & Emergency, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester	Roberts, I (corresponding author), Inst Child Hlth, Dept Epidemiol & Publ Hlth, Cochrane Injuries Grp, London WC1N, England.	Ian.Roberts@ich.ucl.ac.uk	Bunn, Frances/I-8108-2015	Bunn, Frances/0000-0002-5885-918X; Evans, Phillip Adrian/0000-0002-0814-5162				ALDERSON P, 2000, COCHRANE LIB; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BLAIR SD, 1986, BRIT J SURG, V73, P783, DOI 10.1002/bjs.1800731007; BUNN F, 2000, COCHRANE LIB; CAYTEN CG, 1993, J TRAUMA, V35, P460, DOI 10.1097/00005373-199309000-00021; CHANG FC, 1995, J TRAUMA, V39, P453; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; DALRYMPLEHAY M, 1992, CLIN LAB HAEMATOL, V14, P209; de Jonge E, 1998, THROMB HAEMOSTASIS, V79, P286; DEAKIN CD, 1994, J ACCID EMERG MED, V11, P154; Dickinson K, 2000, COCHRANE LIB; Dries DJ, 1996, SHOCK, V6, P311, DOI 10.1097/00024382-199611000-00001; DUNHAM CM, 1991, RESUSCITATION, V21, P207, DOI 10.1016/0300-9572(91)90047-3; Evans PA, 1998, BRIT J ANAESTH, V81, P198, DOI 10.1093/bja/81.2.198; FORTUNE JB, 1987, J TRAUMA, V27, P243, DOI 10.1097/00005373-198703000-00003; JENNINGS TJ, 1986, J TRAUMA, V26, P544, DOI 10.1097/00005373-198606000-00009; JORGENSEN KA, 1979, THROMB RES, V16, P569, DOI 10.1016/0049-3848(79)90105-1; JORGENSEN KA, 1980, THROMB RES, V17, P13, DOI 10.1016/0049-3848(80)90289-3; KWAN I, 2000, COCHRANE LIB; LUCAS CE, 1982, ANN SURG, V196, P198, DOI 10.1097/00000658-198208000-00013; Mardel SN, 1996, LANCET, V347, P825, DOI 10.1016/S0140-6736(96)90897-1; MATTOX KL, 1989, J TRAUMA, V29, P1104, DOI 10.1097/00005373-198908000-00007; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; NICHOLL J, 1998, HEALTH TECHNOL ASSES, V2, P17; POTTER D, 1988, ANN EMERG MED, V17, P582, DOI 10.1016/S0196-0644(88)80397-4; Rainer TH, 1997, INJURY, V28, P623, DOI 10.1016/S0020-1383(97)00125-3; Schwab C W, 1983, Surg Annu, V15, P41; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7; STIBBE J, 1975, BRIT MED J, V2, P750, DOI 10.1136/bmj.2.5973.750-d; STUMP DC, 1985, TRANSFUSION, V25, P349, DOI 10.1046/j.1537-2995.1985.25485273815.x; Treib J, 1996, HAEMOSTASIS, V26, P210; Turner J., 2000, HEALTH TECHNOL ASSES, V4, P1, DOI [10.3310/hta4310, DOI 10.3310/hta4310]; Weil MH, 1999, CRIT CARE MED, V27, P3, DOI 10.1097/00003246-199901000-00002	34	100	107	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2001	357	9253					385	387		10.1016/S0140-6736(00)03653-9	http://dx.doi.org/10.1016/S0140-6736(00)03653-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11211015				2022-12-28	WOS:000166897900038
J	Moore, PD				Moore, PD			A never-ending story	NATURE			English	Editorial Material									Kings Coll London, Div Life Sci, London SE1 9NN, England	University of London; King's College London	Moore, PD (corresponding author), Kings Coll London, Div Life Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NN, England.							KREBS CJ, 2001, ECOLOGY EXPT ANAL DI; Luken J.O., 1990, DIRECTING ECOLOGICAL; Odum Eugene, 1997, ECOLOGY BRIDGE SCI S; Shugart H.H., 1998, TERRESTRIAL ECOSYSTE	4	1	2	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					565	565		10.1038/35054634	http://dx.doi.org/10.1038/35054634			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214299				2022-12-28	WOS:000166692300023
J	Murphy, WJ; Eizirik, E; Johnson, WE; Zhang, YP; Ryder, OA; O'Brien, SJ				Murphy, WJ; Eizirik, E; Johnson, WE; Zhang, YP; Ryder, OA; O'Brien, SJ			Molecular phylogenetics and the origins of placental mammals	NATURE			English	Article							ENDEMIC AFRICAN MAMMALS; TREE TOPOLOGIES; EVOLUTION; ORDER; POSITION	The precise hierarchy of ancient divergence events that led to the present assemblage of modern placental mammals has been an area of controversy among morphologists, palaeontologists and molecular evolutionists. Here we address the potential weaknesses of limited character and taxon sampling in a comprehensive molecular phylogenetic analysis of 64 species sampled across all extant orders of placental mammals. We examined sequence variation in 18 homologous gene segments (including nearly 10,000 base pairs) that were selected for maximal phylogenetic informativeness in resolving the hierarchy of early mammalian divergence. Phylogenetic analyses identify four primary superordinal clades: (I) Afrotheria (elephants, manatees, hyraxes, tenrecs, aardvark and elephant shrews); (II) Xenarthra (sloths, anteaters and armadillos); (III) Glires (rodents and lagomorphs), as a sister taxon to primates, flying lemurs and tree shrews; and (IV) the remaining orders of placental mammals (cetaceans, artiodactyls, perissodactyls, carnivores, pangolins, bats and core insectivores). Our results provide new insight into the pattern of the early placental mammal radiation.	NCI, Lab Genom Divers, Frederick, MD 21702 USA; Chinese Acad Sci, Kunming Inst Zool, Key Lab Cellular & Mol Evolut, Kunming, Peoples R China; Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Sciences; Kunming Institute of Zoology; Zoological Society of San Diego; University System of Maryland; University of Maryland College Park	O'Brien, SJ (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	obrien@mail.ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020; Eizirik, Eduardo/K-8034-2012; Johnson, Warren/D-4149-2016	Eizirik, Eduardo/0000-0002-9658-0999; Johnson, Warren/0000-0002-5954-186X; OBRIEN, STEPHEN/0000-0001-7857-0757				EASTEAL S, 1990, GENETICS, V124, P165; Eisenberg J.F., 1981, MAMMALIAN RAD; EIZIRIK E, IN PRESS J HERED; Graur D, 1996, NATURE, V379, P333, DOI 10.1038/379333a0; Gregory W. K., 1910, B AM MUS NAT HIST, V27, P1, DOI DOI 10.1007/S13364-013-0165-6; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Huchon D, 1999, MOL BIOL EVOL, V16, P577, DOI 10.1093/oxfordjournals.molbev.a026140; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Krettek A, 1995, J MOL EVOL, V41, P952; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; MADSEN O, IN PRESS NATURE; McKenna M. C., 1975, PHYLOGENY PRIMATES, P21, DOI DOI 10.1007/978-1-4684-2166-8_2; McKenna MC, 1997, CLASSIFICATION MAMMA; Mouchaty SK, 2000, MOL BIOL EVOL, V17, P60, DOI 10.1093/oxfordjournals.molbev.a026238; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; PETTIGREW JD, 1986, SCIENCE, V231, P1304, DOI 10.1126/science.3945827; Reyes A, 2000, MOL BIOL EVOL, V17, P979, DOI 10.1093/oxfordjournals.molbev.a026379; ROSE KD, 1993, MAMMAL PHYLOGENY : PLACENTALS, P81; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Stanhope MJ, 1998, MOL PHYLOGENET EVOL, V9, P501, DOI 10.1006/mpev.1998.0517; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1	30	1034	1106	5	312	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					614	618		10.1038/35054550	http://dx.doi.org/10.1038/35054550			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214319				2022-12-28	WOS:000166692300043
J	Naveilhan, P; Hassani, H; Lucas, G; Blakeman, KH; Hao, JX; Xu, XJ; Wiesenfeld-Hallin, Z; Thoren, P; Ernfors, P				Naveilhan, P; Hassani, H; Lucas, G; Blakeman, KH; Hao, JX; Xu, XJ; Wiesenfeld-Hallin, Z; Thoren, P; Ernfors, P			Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor	NATURE			English	Article							STRESS-INDUCED ANALGESIA; SCIATIC-NERVE INJURY; SUBSTANCE-P; PERIPHERAL AXOTOMY; NEUROPATHIC PAIN; FEEDING-BEHAVIOR; SPINAL-CORD; RAT; NEURONS; COMPLEMENTARY	Neuropeptide Y (NPY) is believed to exert antinociceptive actions by inhibiting the release of substance P and other 'pain neurotransmitters' in the spinal cord dorsal horn(1-3). However, the physiological significance and potential therapeutic value of NPY remain obscure(4). It is also unclear which receptor subtype(s) are involved. To identify a possible physiological role for the NPY Y1 receptor in pain transmission, we generated NPY Y1 receptor null mutant (Y1(-/-)) mice by homologous recombination techniques. Here we show that Y1(-/-) mice develop hyperalgesia to acute thermal, cutaneous and visceral chemical pain, and exhibit mechanical hypersensitivity. Neuropathic pain is increased, and the mice show a complete absence of the pharmacological analgesic effects of NPY. In the periphery, Y1 receptor activation is sufficient and required for substance P release and the subsequent development of neurogenic inflammation and plasma leakage. We conclude that the Y1 receptor is required for central physiological and pharmacological NPY-induced analgesia and that its activation is both sufficient and required for the release of substance P and initiation of neurogenic inflammation.	Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; Karolinska Inst, Huddinge Univ Hosp, Div Clin Neurophysiol, Dept Med Lab Sci & Technol, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden.		Naveilhan, Philippe/K-2377-2015; Lucas, Guilherme/N-8827-2014	Naveilhan, Philippe/0000-0003-4093-4513; Lucas, Guilherme/0000-0002-1656-9571; Ernfors, Patrik/0000-0002-1140-3986; Hygge Blakeman, Karin/0000-0001-6925-7099				Allen BJ, 1999, J NEUROPHYSIOL, V81, P1379, DOI 10.1152/jn.1999.81.3.1379; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; DUGGAN AW, 1991, NEUROSCIENCE, V44, P733, DOI 10.1016/0306-4522(91)90092-3; HUA XY, 1991, J PHARMACOL EXP THER, V258, P243; Hudspith MJ, 1999, EUR J PAIN, V3, P3, DOI 10.1016/S1090-3801(99)90213-6; Inoue H, 1997, EUR J PHARMACOL, V333, P231, DOI 10.1016/S0014-2999(97)01040-6; JANCSO N, 1968, BRIT J PHARMACOL, V33, P32, DOI 10.1111/j.1476-5381.1968.tb00471.x; JANCSO N, 1967, BRIT J PHARM CHEMOTH, V31, P138, DOI 10.1111/j.1476-5381.1967.tb01984.x; LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282; Malmberg AB, 1998, PAIN, V76, P215, DOI 10.1016/S0304-3959(98)00045-1; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; MAREK P, 1992, BRAIN RES, V578, P197, DOI 10.1016/0006-8993(92)90248-8; Munglani R, 1996, DRUGS, V52, P371, DOI 10.2165/00003495-199652030-00004; Naveilhan P, 1998, NEUROSCIENCE, V87, P289, DOI 10.1016/S0306-4522(98)00141-9; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; Parker D, 1998, EUR J NEUROSCI, V10, P2856, DOI 10.1046/j.1460-9568.1998.00295.x; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Polgar E, 1999, J NEUROSCI, V19, P2637; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; SEMOS ML, 1994, NEUROPHARMACOLOGY, V33, P1487, DOI 10.1016/0028-3908(94)90053-1; Shi TJ, 1998, REGUL PEPTIDES, V75-6, P161, DOI 10.1016/S0167-0115(98)00064-0; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; WALKER MW, 1988, J NEUROSCI, V8, P2438; WATKINS LR, 1986, ANN NY ACAD SCI, V467, P273, DOI 10.1111/j.1749-6632.1986.tb14635.x; WILCOX GL, 1991, EXCITATORY NEUROTRAN, P97; XU XJ, 1994, NEUROSCIENCE, V63, P817, DOI 10.1016/0306-4522(94)90526-6; ZHANG X, 1994, EUR J NEUROSCI, V6, P43, DOI 10.1111/j.1460-9568.1994.tb00246.x; ZHANG X, 1994, P NATL ACAD SCI USA, V91, P11738, DOI 10.1073/pnas.91.24.11738	30	149	153	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					513	517		10.1038/35054063	http://dx.doi.org/10.1038/35054063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206547				2022-12-28	WOS:000166570500048
J	Thomas, P; Griffiths, F; Kai, A; O'Dwyer, A				Thomas, P; Griffiths, F; Kai, A; O'Dwyer, A			Networks for research in primary health care	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; GENERAL-PRACTICE; PROJECT SHIP		Imperial Coll Sch Med, Dept Primary Hlth Care & Gen Practice, London W6 8RP, England; Univ Warwick, Ctr Primary Hlth Care, Coventry CV4 7AL, W Midlands, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; NHS Execut NW, NW Primary Care Res & Dev Programme, Warrington WA3 7QN, Cheshire, England	Imperial College London; University of Warwick; University of Birmingham	Thomas, P (corresponding author), Imperial Coll Sch Med, Dept Primary Hlth Care & Gen Practice, Charing Cross Campus,Reynolds Bldg, London W6 8RP, England.			Griffiths, Frances/0000-0002-4173-1438; Kai, Joe/0000-0001-9040-9384				Bradley F, 1999, BMJ-BRIT MED J, V318, P711; Clement S, 2000, BRIT J GEN PRACT, V50, P651; De Koning K, 1996, PARTICIPATORY RES HL; Department of Health, 2000, RES DEV 1 CLASS SERV; FLEMING DM, 1999, WEEKLY RETURNS REPOR; GRAY DP, 1995, BRIT J GEN PRACT, V45, P516; Griffiths F, 2000, BRIT J GEN PRACT, V50, P913; Harvey J, 2000, EVALUATION PRIMARY C; Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964; Heath I, 2000, BRIT MED J, V320, P326, DOI 10.1136/bmj.320.7231.326; Hickner J, 2000, CONDUCTING RES PRACT, P126; Jolly K, 1999, BMJ-BRIT MED J, V318, P706; Jones R, 1998, BRIT J GEN PRACT, V48, P873; Kai Joe, 1999, Health Expect, V2, P7, DOI 10.1046/j.1369-6513.1999.00033.x; MACDONALD JJ, 1992, PRIMARY HLTH CARE; MANT D, 1997, R D PRIMARY CARE NAT; *MED RES COUNC, 1997, PRIM HLTH CAR MRC TO; *NHS EX, 1999, NHS R D STRAT REV PR; Olesen F, 2000, BMJ-BRIT MED J, V320, P354, DOI 10.1136/bmj.320.7231.354; ONeill P, 1996, BMJ-BRIT MED J, V313, P919; Pratt J, 1995, PRACTITIONERS PRACTI; Robinson G, 2000, BRIT J GEN PRACT, V50, P390; Russ D, 2000, ANTIGONISH REV, P136; Thomas P, 2000, BRIT MED J, V321, P2, DOI 10.1136/bmj.321.7252.2; Thomas P, 2000, BRIT J GEN PRACT, V50, P91	25	74	76	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					588	590		10.1136/bmj.322.7286.588	http://dx.doi.org/10.1136/bmj.322.7286.588			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238155	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000167499900026
J	Blumenthal, D				Blumenthal, D			Controlling health care expenditures.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COSTS		Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Blumenthal, D (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Anderson GF, 2000, HEALTH AFFAIR, V19, P150, DOI 10.1377/hlthaff.19.3.150; ANDRESON GE, 2000, HLTH AFF MILLWOOD, V19, P191; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Blumenthal D, 1999, NEW ENGL J MED, V340, P1916, DOI 10.1056/NEJM199906173402412; Blumenthal D, 2000, DESCRIPTION ANAL VA; Bodenheimer T, 1999, NEW ENGL J MED, V340, P1202, DOI 10.1056/NEJM199904153401511; CAPLAN CF, 2000, STRUCTURING HLTH CAR; Chassin MR, 1998, MILBANK Q, V76, P565, DOI 10.1111/1468-0009.00106; CLEMMITT M, 2000, MED HLTH S, V54, P1; Donelan K, 1999, HEALTH AFFAIR, V18, P206, DOI 10.1377/hlthaff.18.3.206; EVANS RS, 1994, ARCH INTERN MED, V154, P878, DOI 10.1001/archinte.154.8.878; GABEL JR, 1999, C CONS DRIV HLTH CAR; GARBER S, 2000, MANAGED CARE EVALUAT; GLAZER J, 2000, C PRIV EMPL RISK ADJ; Hogan C, 2000, HEALTH AFFAIR, V19, P217, DOI 10.1377/hlthaff.19.6.217; *I FUT, 2000, HLTH HLTH CAR 2010 F; Iezzoni LI, 1998, NEW ENGL J MED, V339, P1933, DOI 10.1056/NEJM199812243392613; KEELER EB, 1987, HEALTH SERV RES, V22, P279; LANDERS SJ, 2000, AM MED NEWS     0814, P9; MORRIS CR, 2000, TOO MUCH GOOD THINGS; MOSKOWITZ DB, 2000, MED HLTH, P54; PEAR R, 2000, NY TIMES        0701, pA1; ROSENBAUM DE, 2000, NY TIMES        0910, pD1; Smith S, 1998, HEALTH AFFAIR, V17, P128, DOI 10.1377/hlthaff.17.5.128; Toner Robin, 2000, NY TIMES, pA1; WOOLHANDLER S, 1993, NEW ENGL J MED, V329, P400, DOI 10.1056/NEJM199308053290606; World Health Organization, 2000, HLTH SYST IMPR PERF; Zimmerman Rachel, 2000, WALL STREET J   0627, pA	28	53	53	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2001	344	10					766	769		10.1056/NEJM200103083441012	http://dx.doi.org/10.1056/NEJM200103083441012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408AX	11236784				2022-12-28	WOS:000167305300012
J	Hobson, JP; Rosenfeldt, HM; Barak, LS; Olivera, A; Poulton, S; Caron, MG; Milstien, S; Spiegel, S				Hobson, JP; Rosenfeldt, HM; Barak, LS; Olivera, A; Poulton, S; Caron, MG; Milstien, S; Spiegel, S			Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; SPHINGOSINE 1-PHOSPHATE; BETA-ARRESTIN; KINASE; PROLIFERATION; ENDOCYTOSIS; SURVIVAL	EDG-1 is a heterotrimeric guanine nucleotide binding protein-coupled receptor (GPCR) for sphingosine-1-phosphate (SPP). Cell migration toward platelet-derived growth factor (PDGF). which stimulates sphingosine kinase and increases intracellular SPP, was dependent on expression of EDG-1. Deletion of edg-1 or inhibition of sphingosine kinase suppressed chemotaxis toward PDGF and also activation of the small guanosine triphosphatase Rac, which is essential for protrusion of lamellipodia and forward movement. Moreover, PDGF activated EDG-1, as measured by translocation of beta -arrestin and phosphorylation of EDG-1. Our results reveal a role for receptor cross-communication in which activation of a GPCR by a receptor tyrosine kinase is critical for cell motility.	Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20007 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; NIMH, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA	Georgetown University; Duke University; Duke University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Spiegel, S (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20007 USA.				NCI NIH HHS [CA61774] Funding Source: Medline; NHLBI NIH HHS [HL-61365] Funding Source: Medline; NIGMS NIH HHS [GM43880] Funding Source: Medline; NINDS NIH HHS [NS19576] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880, R37GM043880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH001039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee MJ, 1998, J BIOL CHEM, V273, P22105, DOI 10.1074/jbc.273.34.22105; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Spiegel S, 2000, BBA-MOL CELL BIOL L, V1484, P107, DOI 10.1016/S1388-1981(00)00010-X; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343	19	368	383	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1800	1803		10.1126/science.1057559	http://dx.doi.org/10.1126/science.1057559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230698				2022-12-28	WOS:000167320600063
J	Kaye, JA; Melero-Montes, MD; Jick, H				Kaye, JA; Melero-Montes, MD; Jick, H			Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis	BRITISH MEDICAL JOURNAL			English	Article								Objective To estimate changes in the risk of autism and assess the relation of autism to the mumps, measles, and rubella (MMR) vaccine. Design Time trend analysis of data from the UK general practice research database (GPRD). Setting General practices in the United Kingdom. Subjects Children aged 12 years or younger diagnosed with autism 1988-99, with further analysis of boys aged 2 to 5 years born 1988-93. Main outcome measures Annual and age specific incidence for first recorded diagnoses of autism (that is, when the diagnosis of autism was first recorded) in the children aged 12 years or younger; annual, birth cohort specific risk of autism diagnosed in the 2 to 5 year old boys; coverage (prevalence) of MMR vaccination in the same birth cohorts. Results The incidence of newly diagnosed autism increased sevenfold, from 0.3 per 10 000 person years in 1988 to 2.1 per 10 000 person years in 1999, The peak incidence was among 3 and 4 year olds, and 83% (254/305) of cases were boys. In an annual birth cohort analysis of 114 boys born in 1988-93, the risk of autism in 2 to 5 year old boys increased nearly fourfold over time, from 8 (95% confidence interval 4 to 14) per 10 000 for boys born in 1988 to 29 (20 to 43) per 10 000 for boys born in 1993. For the same annual birth cohorts the prevalence of MMR vaccination was over 95%. Conclusions Because the incidence of autism among 2 to 5 year olds increased markedly among boys born in each year separately from 1988 to 1993 while MMR vaccine coverage was over 95% for successive annual birth cohorts, the data provide evidence that no correlation exists between the prevalence of MMR vaccination and the rapid increase in the risk of autism over time. The explanation for the marked increase in risk of the diagnosis of autism in the past decade remains uncertain.	Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA	Boston University	Kaye, JA (corresponding author), Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, 11 Muzzey St, Lexington, MA 02421 USA.			Jick, Hershel/0000-0003-4270-5992; Kaye, James A./0000-0002-9357-4227	NATIONAL CANCER INSTITUTE [T32CA009001] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009001] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Jick H, 1997, LANCET, V350, P1045, DOI 10.1016/S0140-6736(05)70451-7; JICK H, 1995, BRIT J GEN PRACT, V45, P107; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 1999, LANCET, V354, P949, DOI 10.1016/S0140-6736(05)75696-8; Wing L, 1997, LANCET, V350, P1761, DOI 10.1016/S0140-6736(97)09218-0	6	235	239	0	108	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	2001	322	7284					460	463		10.1136/bmj.322.7284.460	http://dx.doi.org/10.1136/bmj.322.7284.460			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406YD	11222420	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000167243000018
J	Sato, C; Ueno, Y; Asai, K; Takahashi, K; Sato, M; Engel, A; Fujiyoshi, Y				Sato, C; Ueno, Y; Asai, K; Takahashi, K; Sato, M; Engel, A; Fujiyoshi, Y			The voltage-sensitive sodium channel is a bell-shaped molecule with several cavities	NATURE			English	Article							ELECTROPHORUS-ELECTRICUS; POTASSIUM CHANNEL; SKELETAL-MUSCLE; CLASSIFICATION; INACTIVATION; CRYSTALLOGRAPHY; RECONSTRUCTION; IDENTIFICATION; MUTATIONS; RECEPTOR	Voltage-sensitive membrane channels, the sodium channel, the potassium channel and the calcium channel operate together to amplify, transmit and generate electric pulses in higher forms of life. Sodium and calcium channels are involved in cell excitation, neuronal transmission, muscle contraction and many functions that relate directly to human diseases(1-4). Sodium channels-glycosylated proteins with a relative molecular mass of about 300,000 (ref. 5)-are responsible for signal transduction and amplification, and are chief targets of anaesthetic drugs(6) and neurotoxins(1). Here we present the three-dimensional structure of the voltage-sensitive sodium channel from the eel Electrophorus electricus. The 19 Angstrom structure was determined by helium-cooled cryo-electron microscopy and single-particle image analysis of the solubilized sodium channel. The channel has a bell-shaped outer surface of 135 Angstrom in height and 100 Angstrom in side length at the square-shaped bottom, and a spherical top with a diameter of 65 Angstrom. Several inner cavities are connected to four small holes and eight orifices close to the extracellular and cytoplasmic membrane surfaces. Homologous voltage-sensitive calcium and tetrameric potassium channels, which regulate secretory processes and the membrane potential(7), may possess a related structure.	Electrotech Lab, Supermol Sci Div, Tsukuba, Ibaraki 3058568, Japan; Japan Adv Inst Sci & Technol Hokuriku, Sch Knowledge Sci, Tatsunokuchi, Ishikawa 9231211, Japan; Itoham Foods Inc, Cent Res Inst, Moriya 3020104, Japan; Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland; Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Advanced Institute of Science & Technology (JAIST); University of Basel; Kyoto University	Sato, C (corresponding author), Electrotech Lab, Supermol Sci Div, 1-1-4 Umezono, Tsukuba, Ibaraki 3058568, Japan.		Fujiyoshi, Yoshinori/E-5989-2012; Sato, Chikara/M-7183-2016; Ueno, Yutaka/L-8831-2018	Fujiyoshi, Yoshinori/0000-0002-8070-1493; Sato, Chikara/0000-0001-5543-4496; Ueno, Yutaka/0000-0002-3124-2518				Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FRANK J, 1988, J MICROSC-OXFORD, V150, P99, DOI 10.1111/j.1365-2818.1988.tb04602.x; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; GORDON RD, 1987, P NATL ACAD SCI USA, V84, P308, DOI 10.1073/pnas.84.1.308; HARAUZ G, 1986, OPTIK, V73, P146; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; Mitsuoka K, 1997, ULTRAMICROSCOPY, V68, P109, DOI 10.1016/S0304-3991(97)00020-X; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PTACEK LJ, 1991, CELL, V67, P1021; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; Sato C, 1998, J STRUCT BIOL, V121, P314, DOI 10.1006/jsbi.1998.3990; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; VANHEEL M, 1989, OPTIK, V82, P114; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VANHEEL M, 1987, ULTRAMICROSCOPY, V38, P241; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	30	200	221	2	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1047	1051		10.1038/35059098	http://dx.doi.org/10.1038/35059098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234014				2022-12-28	WOS:000167148800047
J	Bruls, T; Gyapay, G; Petit, JL; Artiguenave, F; Vico, V; Qin, SZ; Tin-Wollam, AM; Da Silva, C; Muselet, D; Mavel, D; Pelletier, E; Levy, M; Fujiyama, A; Matsuda, F; Wilson, R; Rowen, L; Hood, L; Weissenbach, J; Saurin, W; Heilig, R				Bruls, T; Gyapay, G; Petit, JL; Artiguenave, F; Vico, V; Qin, SZ; Tin-Wollam, AM; Da Silva, C; Muselet, D; Mavel, D; Pelletier, E; Levy, M; Fujiyama, A; Matsuda, F; Wilson, R; Rowen, L; Hood, L; Weissenbach, J; Saurin, W; Heilig, R			A physical map of human chromosome 14	NATURE			English	Article							HUMAN-GENOME; SEQUENCE	We report the construction of a tiling path of around 650 clones covering more than 99% of human chromosome 14. Clone overlap information to assemble the map was derived by comparing fully sequenced clones with a database of clone end sequences(1,2) (sequence tag connector strategy). We selected homogeneously distributed seed points using an auxiliary high-resolution radiation hybrid map comprising 1,895 distinct positions. The high long-range continuity and low redundancy of the tiling path indicates that the sequence tag connector approach compares favourably with alternative mapping strategies.	Genoscope, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; Inst Syst Biol, Multimegabase Sequencing Ctr, Seattle, WA 98195 USA; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; RIKEN, Genome Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Ctr Natl Genotypage, F-91057 Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Institute for Systems Biology (ISB); Washington University (WUSTL); RIKEN; CEA; UDICE-French Research Universities; Universite Paris Saclay	Heilig, R (corresponding author), Genoscope, 2 Rue Gaston Cremieux,CP 5706, F-91057 Evry, France.		Wilson, Richard K./AAF-4139-2019; Matsuda, Fumihiko/B-9893-2009	Wilson, Richard K./0000-0002-1992-1358; DA SILVA, Corinne/0000-0002-7618-7831; Petit, Jean-Louis/0000-0002-8566-0571; Pelletier, Eric/0000-0003-4228-1712				Agarwala R, 2000, GENOME RES, V10, P350, DOI 10.1101/gr.10.3.350; Batzoglou S, 1999, GENOME RES, V9, P1163, DOI 10.1101/gr.9.12.1163; Dear PH, 1998, GENOMICS, V48, P232, DOI 10.1006/geno.1997.5140; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; LANGE K, 1995, GENOME RES, V5, P136, DOI 10.1101/gr.5.2.136; Mahairas GG, 1999, P NATL ACAD SCI USA, V96, P9739, DOI 10.1073/pnas.96.17.9739; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Roach JC, 1999, NATURE, V401, P843, DOI 10.1038/44684; Siegel AF, 1999, GENOME RES, V9, P297; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0	15	16	16	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					947	948		10.1038/35057177	http://dx.doi.org/10.1038/35057177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237018	Bronze			2022-12-28	WOS:000166938800065
J	Sukharev, S; Betanzos, M; Chiang, CS; Guy, HR				Sukharev, S; Betanzos, M; Chiang, CS; Guy, HR			The gating mechanism of the large mechanosensitive channel MscL	NATURE			English	Article							ESCHERICHIA-COLI; ION-CHANNEL; SINGLE RESIDUE; PROTEIN; PRESSURE; HELIX	The mechanosensitive channel of large conductance, MscL, is a ubiquitous membrane-embedded valve involved in turgor regulation in bacteria(1-5). The crystal structure of MscL from Mycobacterium tuberculosis(6) provides a starting point for analysing molecular mechanisms of tension-dependent channel gating. Here we develop structural models in which a cytoplasmic gate is formed by a bundle of five amino-terminal helices (S1), previously unresolved in the crystal structure. When membrane tension is applied, the transmembrane barrel expands and pulls the gate apart through the S1-M1 linker. We tested these models by substituting cysteines for residues predicted to be near each other only in either the closed or open conformation. Our results demonstrate that S1 segments form the bundle when the channel is closed, and crosslinking between S1 segments prevents opening. S1 segments interact with M2 when the channel is open, and crosslinking of S1 to M2 impedes channel closing. Gating is affected by the length of the S1-M1 linker in a manner consistent with the model, revealing critical spatial relationships between the domains that transmit force from the lipid bilayer to the channel gate.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; NCI, Lab Expt & Computat Biol, DBS, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sukharev, S (corresponding author), Univ Maryland, Dept Biol, Bldg 144, College Pk, MD 20742 USA.			Sukharev, Sergei/0000-0002-4807-9665; betanzos, monica/0000-0002-0358-043X				Batiza AF, 1999, STRUCTURE, V7, pR99, DOI 10.1016/S0969-2126(99)80061-6; Blount P, 1996, BIOL CELL, V87, P1, DOI 10.1016/S0248-4900(97)89832-2; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Liu W, 1999, BIOPHYS J, V76, pA203; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Maurer JA, 2000, J BIOL CHEM, V275, P22238, DOI 10.1074/jbc.M003056200; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; PAKULA AA, 1992, P NATL ACAD SCI USA, V89, P4144, DOI 10.1073/pnas.89.9.4144; Spencer RH, 1999, CURR OPIN STRUC BIOL, V9, P448, DOI 10.1016/S0959-440X(99)80063-3; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; SUKHAREV SI, UNPUB BIOPHYS J; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2	21	286	300	2	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					720	724		10.1038/35055559	http://dx.doi.org/10.1038/35055559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217861				2022-12-28	WOS:000166816400044
J	Stern, SA; Weissman, PR				Stern, SA; Weissman, PR			Rapid collisional evolution of comets during the formation of the Oort cloud	NATURE			English	Article							OUTER SOLAR-SYSTEM; DYNAMICAL EVOLUTION; KUIPER-BELT; PLANETESIMALS; ACCRETION; ASTEROIDS	The Oort cloud(1) of comets was formed by the ejection of icy planetesimals from the region of giant planets-Jupiter, Saturn, Uranus and Neptune-during their formation(2). Dynamical simulations(3,4) have previously shown that comets reach the Oort cloud only after being perturbed into eccentric orbits that result in close encounters with the giant planets, which then eject them to distant orbits about 10(4) to 10(5) AU from the Sun (1 AU is the average Earth-Sun distance). All of the Oort cloud models constructed until now simulate its formation using only gravitational effects; these include the influence of the Sun, the planets and external perturbers such as passing stars and Galactic tides. Here we show that physical collisions between comets and small debris play a fundamental and hitherto unexplored role throughout most of the ejection process. For standard models of the protosolar nebula (starting with a minimum-mass nebula) we rnd that collisional evolution of comets is so severe that their erosional lifetimes are much shorter than the timescale for dynamical ejection. It therefore appears that collisions will prevent most comets escaping from most locations in the region of the giant planets until the disk mass there declines sufficiently that the dynamical ejection timescale is shorter than the collisional lifetime. One consequence is that the total mass of comets in the Oort cloud may be less than currently believed.	SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; CALTECH, Jet Prop Lab, Div Earth & Space Sci, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Stern, SA (corresponding author), SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA.	astern@swri.edu						BAILEY ME, 1988, MON NOT R ASTRON SOC, V235, P1; Blake GA, 1999, NATURE, V398, P213, DOI 10.1038/18372; DOHNANYI JS, 1969, J GEOPHYS RES, V74, P2531, DOI 10.1029/JB074i010p02531; DONES L, 2000, B AM ASTRON SOC, V32, P1060; DUNCAN M, 1987, ASTRON J, V94, P1330, DOI 10.1086/114571; EVERHART E, 1967, ASTRON J, V72, P716, DOI 10.1086/110299; GLADMAN B, 1990, ASTRON J, V100, P1680, DOI 10.1086/115628; Grazier KR, 1999, ICARUS, V140, P353, DOI 10.1006/icar.1999.6147; Grazier KR, 1999, ICARUS, V140, P341, DOI 10.1006/icar.1999.6146; HOLMAN MJ, 1993, ASTRON J, V105, P1987, DOI 10.1086/116574; HOUSEN KR, 1990, ICARUS, V84, P226, DOI 10.1016/0019-1035(90)90168-9; Kuiper G.P., 1951, ASTROPHYSICS TOPICAL, P357; LISSAUER JJ, 1987, ICARUS, V69, P249, DOI 10.1016/0019-1035(87)90104-7; Lissauer JJ, 1995, SPACE SCI S, P37; Mumma M. J., 1997, Astronomical Society of the Pacific Conference Series, V122, P369; Oort J. H., 1950, B ASTRON I NETH, V11, P91; POLLACK JB, 1979, ICARUS, V37, P587, DOI 10.1016/0019-1035(79)90016-2; SAFRONOV VS, 1991, ICARUS, V94, P260, DOI 10.1016/0019-1035(91)90226-J; SEKANINA Z, 1982, COMETS, P251; STERN SA, 1988, ICARUS, V73, P499, DOI 10.1016/0019-1035(88)90059-0; Stern SA, 1996, ASTRON J, V112, P1203, DOI 10.1086/118091; Stern SA, 1997, ASTROPHYS J, V490, P879, DOI 10.1086/304912; Stern SA, 2000, ASTROPHYS J, V544, pL169, DOI 10.1086/317312; Thommes EW, 1999, NATURE, V402, P635, DOI 10.1038/45185; Weissman PR, 1996, ASTR SOC P, V107, P265; WETHERILL GW, 1990, ICARUS, V88, P336, DOI 10.1016/0019-1035(90)90086-O; Wuchterl G., 2000, Protostars and planets 4, P1081	27	59	60	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					589	591		10.1038/35054508	http://dx.doi.org/10.1038/35054508			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214311				2022-12-28	WOS:000166692300035
J	Askling, J; Dickman, PW; Karlen, P; Brostrom, O; Lapidus, A; Lofberg, R; Ekbom, A				Askling, J; Dickman, PW; Karlen, P; Brostrom, O; Lapidus, A; Lofberg, R; Ekbom, A			Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study	LANCET			English	Article							ULCERATIVE-COLITIS; CROHNS-DISEASE; INCREASED RISK; COLON-CANCER; SUSCEPTIBILITY	Background Inflammatory bowel disease (IBD) and colorectal cancer might share a common cause and, therefore, relatives of patients with IBD could be at increased risk of this malignant disease. We aimed to assess cancer rates among first-degree relatives of patients with IBD to try to determine whether an association between the two diseases exists. Methods In a population-based study, we identified 114 102 first-degree relatives by registry linkage and followed them up for cancer occurrence. We used standardised incidence ratio (SIR) of cancer as relative risk. Findings 560 colorectal cancers were identified among relatives. First-degree relatives of patients with Crohn's disease or ulcerative colitis were not at increased risk of cancer (SIR 0.90, 95% CI 0.82-0.97). The relative risk was 0.96 (0.87-1.06, n=379) for colon cancer and 0.78 (0.68-0.91, 181) for rectal cancer. The SIRs were not affected by age, relation of patient, or type or extent of IBD in the patient. Relatives of patients with both IBD and colorectal cancer had an 80% increased risk of colorectal cancer. Interpretation Our results do not endorse a common cause of IBD and colorectal cancer. The slightly decreased relative risk for colorectal cancer among relatives could indicate the proportion of all colorectal cancer cases attributable to IBD.	Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden; Karolinska Inst, Soder Hosp, Dept Med, Stockholm, Sweden; Ersta Hosp, Dept Gastroenterol, Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Gastroenterol, Stockholm, Sweden; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Karolinska Institutet; Karolinska Institutet; Ersta Sjukhus; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health	Askling, J (corresponding author), Karolinska Inst, Dept Med Epidemiol, Box 281, SE-17177 Stockholm, Sweden.	johan.askling@mep.ki.se	Dickman, Paul W/B-4572-2013	Dickman, Paul W/0000-0002-5788-3380				[Anonymous], 1999, CANCER CAUSE CONTROL, V10, P167; Bayless TM, 1996, GASTROENTEROLOGY, V111, P573, DOI 10.1053/gast.1996.v111.pm8780559; Breslow N E, 1987, IARC Sci Publ, P1; EKBOM A, 1990, LANCET, V336, P357, DOI 10.1016/0140-6736(90)91889-I; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fonager K, 1998, CANCER CAUSE CONTROL, V9, P389; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; GARLAND CF, 1981, GASTROENTEROLOGY, V81, P1115; GYDE SN, 1988, GUT, V29, P206, DOI 10.1136/gut.29.2.206; Han SW, 1999, AM J GASTROENTEROL, V94, P2323, DOI 10.1111/j.1572-0241.1999.2323a.x; Karlen P, 1999, AM J GASTROENTEROL, V94, P1047; LENNARDJONES JE, 1971, SKANDIA INT S REGION, P105; Lunde A S, 1980, Vital Health Stat 2, P1; Lynch HT, 1999, J MED GENET, V36, P801; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; PERSSON PG, 1994, GASTROENTEROLOGY, V107, P1675, DOI 10.1016/0016-5085(94)90807-9; Pokorny RM, 1997, ANN SURG, V225, P718, DOI 10.1097/00000658-199706000-00009; Rhodes JM, 1996, LANCET, V347, P40, DOI 10.1016/S0140-6736(96)91563-9; Riegler G, 1998, J CLIN GASTROENTEROL, V27, P211, DOI 10.1097/00004836-199810000-00006; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SONDERGAARD JO, 1991, INT J CANCER, V47, P202, DOI 10.1002/ijc.2910470207; STJOHN DJB, 1993, ANN INTERN MED, V118, P785, DOI 10.7326/0003-4819-118-10-199305150-00005; *SWED NAT BOARD HL, 1998, HOSP DISCH REG 1987; *WHO, 1955, MAN INT CLASS DIS IN	25	73	83	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2001	357	9252					262	266		10.1016/S0140-6736(00)03612-6	http://dx.doi.org/10.1016/S0140-6736(00)03612-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214128				2022-12-28	WOS:000166693400010
J	Mollica, RF				Mollica, RF			Assessment of trauma in primary care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TORTURE		Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University	Mollica, RF (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.							BATES B, 1995, GUIDE CLIN THINKING; BATES B, 1995, GUIDE PHYSICAL EXAMI; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1999, HUMANITARIAN EMERGEN	5	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1213	1213		10.1001/jama.285.9.1213	http://dx.doi.org/10.1001/jama.285.9.1213			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231755	hybrid			2022-12-28	WOS:000167194700028
J	Becker, L; Poreda, RJ; Hunt, AG; Bunch, TE; Rampino, M				Becker, L; Poreda, RJ; Hunt, AG; Bunch, TE; Rampino, M			Impact event at the Permian-Triassic boundary: Evidence from extraterrestrial noble gases in fullerenes	SCIENCE			English	Article							MASS EXTINCTION; CRETACEOUS-TERTIARY; SOUTHWEST JAPAN; BEDDED CHERT; SEDIMENT; HISTORY; HELIUM; SEARCH; HE-3	The Permian-Triassic boundary (PTB) event, which occurred about 251.4 million years ago, is marked by the most severe mass extinction in the geologic record. Recent studies of some PTB sites indicate that the extinctions occurred very abruptly, consistent with a catastrophic, possibly extraterrestrial, cause. Fullerenes (C-60 to C-200) from sediments at the PTB contain trapped helium and argon with isotope ratios similar to the planetary component of carbonaceous chondrites. These data imply that an impact event (asteroidal or cometary) accompanied the extinction, as was the case for the Cretaceous-Tertiary extinction event about 65 million years ago.	Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; NYU, New York, NY 10003 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA	University of Washington; University of Washington Seattle; University of Rochester; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; New York University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Becker, L (corresponding author), Univ Washington, Dept Earth & Space Sci, Box 351310, Seattle, WA 98195 USA.							ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVAREZ LW, 1987, PHYS TODAY, V24, P15; Becker L, 1996, SCIENCE, V272, P249, DOI 10.1126/science.272.5259.249; BECKER L, 1994, SCIENCE, V265, P642, DOI 10.1126/science.11536660; Becker L, 1999, NATURE, V400, P227, DOI 10.1038/22250; Becker L, 2000, P NATL ACAD SCI USA, V97, P2979, DOI 10.1073/pnas.050519397; BECKER L, UNPUB; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Chijiwa T, 1999, GEOPHYS RES LETT, V26, P767, DOI 10.1029/1999GL900050; DIEDERICH F, 1992, ACCOUNTS CHEM RES, V25, P119, DOI 10.1021/ar00015a004; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; FARLEY KA, 1995, NATURE, V376, P153, DOI 10.1038/376153a0; Farley KA, 1998, SCIENCE, V280, P1250, DOI 10.1126/science.280.5367.1250; GIN YG, 2000, SCIENCE, V289, P432; HAAS J, 1986, MEM SOC GEOL ITAL, V34, P221; HEYMANN D, 1986, J GEOPHYS RES-SOLID, V91, pE135, DOI 10.1029/JB091iB13p0E135; HEYMANN D, 1994, SCIENCE, V256, P545; HOLSER WT, 1992, GEOCHIM COSMOCHIM AC, V56, P3297, DOI 10.1016/0016-7037(92)90306-4; Kakuwa Y, 1996, PALAEOGEOGR PALAEOCL, V121, P35, DOI 10.1016/0031-0182(95)00070-4; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; Marcantonio F, 1996, NATURE, V383, P705, DOI 10.1038/383705a0; Miono S, 1996, NUCL INSTRUM METH B, V109, P612, DOI 10.1016/0168-583X(95)00978-7; MIONO S, 1998, LUNAR PLANET SCI, V29; Orth C.J., 1989, P37; POREDA RJ, 1992, EARTH PLANET SC LETT, V113, P129, DOI 10.1016/0012-821X(92)90215-H; Rampino MR, 2000, GEOLOGY, V28, P643, DOI 10.1130/0091-7613(2000)028<0643:TOTEPE>2.3.CO;2; RAMPINO MR, 1996, HAZARDS DUE ASTEROID, P827; RAUP DM, 1979, SCIENCE, V206, P217, DOI 10.1126/science.206.4415.217; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; Retallack GJ, 1998, GEOLOGY, V26, P979, DOI 10.1130/0091-7613(1998)026<0979:SFEOIA>2.3.CO;2; ROBL TL, 1993, ORG GEOCHEM, V20, P249, DOI 10.1016/0146-6380(93)90042-A; SAUNDERS M, 1993, SCIENCE, V259, P1428, DOI 10.1126/science.259.5100.1428; SEPKOSKI JJ, 1989, J GEOL SOC LONDON, V146, P7, DOI 10.1144/gsjgs.146.1.0007; VISCHER H, 1996, P NATL ACAD SCI USA, V93, P2135; Ward PD, 2000, SCIENCE, V289, P1740, DOI 10.1126/science.289.5485.1740; WEILER R, 1992, GEOCHIM COMOCHIM ACT, V56, P2907; WIGNALL PB, 1993, PALAEOGEOGR PALAEOCL, V102, P215, DOI 10.1016/0031-0182(93)90068-T; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167	38	306	354	5	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1530	1533		10.1126/science.1057243	http://dx.doi.org/10.1126/science.1057243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222855				2022-12-28	WOS:000167153400040
J	Emlen, DJ				Emlen, DJ			Costs and the diversification of exaggerated animal structures	SCIENCE			English	Article							HORNED BEETLE; SEXUAL SELECTION; EVOLUTION; COMPETITION; DROSOPHILA; BODY; COLEOPTERA; SPECIATION; CHARACTER; MODELS	Sexual selection can favor production of extravagant ornaments and weapons in the contest for access to the opposite sex. Existing explanations for the diversity of sexually selected structures focus on reproductive benefits conferred by particular ornament or weapon morphologies. Here, I show that costs of weapon production also may drive patterns of weapon evolution. In beetles, production of horns reduces the size of neighboring morphological structures (antennae, eyes, pr wings, depending on the location of the horns), and these tradeoffs reveal unexpected functional associations between ecology and horn morphology. This study illustrates a critical but overlooked role of costs in sexual selection and has implications for understanding the evolution of animal morphology.	Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Emlen, DJ (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	demlen@selway.umt.edu						Andersson Malte, 1994; [Anonymous], 1982, NESTING BEHAV DUNG B; Arrow G.J., 1951, HORNED BEETLES; BALMFORD A, 1993, NATURE, V361, P628, DOI 10.1038/361628a0; BOUCOMONT A., 1932, ANN SOC ENT FRANCE, V101, P293; Britton JS, 1998, DEVELOPMENT, V125, P2149; D'Orbigny H., 1913, ANN SOC ENTOMOLOGIQU, V82, P1; Darwin C., 1871, DESCENT MAN SELECTIO; Emlen DJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P335, DOI 10.1007/s002650050393; Emlen DJ, 2000, BIOSCIENCE, V50, P403, DOI 10.1641/0006-3568(2000)050[0403:IDWEAC]2.0.CO;2; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Enrodi S., 1985, DYNASTINAE WORLD; EVANS MR, 1992, ANIM BEHAV, V43, P337, DOI 10.1016/S0003-3472(05)80229-5; Fisher R.A., 1930, GENETICAL THEORY NAT; GEIST V, 1966, BEHAVIOUR, V27, P175, DOI 10.1163/156853966X00155; Hanski I., 1991, DUNG BEETLE ECOLOGY; Howden H. F., 1963, Proceedings of the United States National Museum, V114, P1; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kawano K, 1997, ANN ENTOMOL SOC AM, V90, P453, DOI 10.1093/aesa/90.4.453; Klingenberg CP, 1998, P ROY SOC B-BIOL SCI, V265, P1135, DOI 10.1098/rspb.1998.0409; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LANDE R, 1982, EVOLUTION, V36, P213, DOI 10.1111/j.1558-5646.1982.tb05034.x; MADHAVAN K, 1969, BIOL BULL-US, V137, P321, DOI 10.2307/1540104; Matthews E., 1972, AUSTR J ZOOLOGY S, V9, P3, DOI [DOI 10.1071/AJZS009, 10.1071/AJZS009]; McIntyre P, 1998, J COMP PHYSIOL A, V183, P45, DOI 10.1007/s003590050233; MOLE S, 1993, OECOLOGIA, V93, P121, DOI 10.1007/BF00321201; MOLLER AP, 1989, NATURE, V339, P132; Moller AP, 1997, ANIM BEHAV, V54, P1545, DOI 10.1006/anbe.1997.9998; Moller AP, 1999, J EVOLUTION BIOL, V12, P296; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; Nijhout HF, 1996, AM NAT, V148, P40, DOI 10.1086/285910; OTRONEN M, 1988, ANIM BEHAV, V36, P741, DOI 10.1016/S0003-3472(88)80157-X; Otte D., 1989, SPECIATION ITS CONSE; PALMER TJ, 1978, NATURE, V274, P583, DOI 10.1038/274583a0; RASMUSSEN JL, 1994, J INSECT BEHAV, V7, P67, DOI 10.1007/BF01989828; Saino N, 1996, BEHAV ECOL, V7, P227, DOI 10.1093/beheco/7.2.227; SEHNAL F, 1993, J INSECT PHYSIOL, V39, P1051, DOI 10.1016/0022-1910(93)90129-F; Stern DL, 1999, DEVELOPMENT, V126, P1091; Stevens DJ, 1999, P ROY SOC B-BIOL SCI, V266, P1049, DOI 10.1098/rspb.1999.0742; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WU CI, 1985, EVOLUTION, V39, P66, DOI 10.1111/j.1558-5646.1985.tb04080.x	41	263	272	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1534	1536		10.1126/science.1056607	http://dx.doi.org/10.1126/science.1056607			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222856				2022-12-28	WOS:000167153400041
J	Pedersen-Bjergaard, J				Pedersen-Bjergaard, J			Molecular cytogenetics in cancer	LANCET			English	Editorial Material							HUMAN-CHROMOSOMES; LEUKEMIA; GENE; HEMATOPOIESIS; HYBRIDIZATION; MICE		Univ Copenhagen Hosp, Rigshosp, Dept Clin Genet, Sect Hematol Oncol,Cytogenet Lab, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Pedersen-Bjergaard, J (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Clin Genet, Sect Hematol Oncol,Cytogenet Lab, DK-2100 Copenhagen, Denmark.							Castilla LH, 1996, CELL, V87, P687, DOI 10.1016/S0092-8674(00)81388-4; Cheng GX, 1999, P NATL ACAD SCI USA, V96, P6318, DOI 10.1073/pnas.96.11.6318; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; DUMANOIR S, 1993, HUM GENET, V90, P590, DOI 10.1007/BF00202476; HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; MITELMAN F, 2000, MIT DAT CHROM AB CAN; NOWELL PC, 1960, SCIENCE, V132, P1497; Okuda T, 1998, BLOOD, V91, P3134, DOI 10.1182/blood.V91.9.3134.3134_3134_3143; PEDERSENBJERGAARD J, 1994, BLOOD, V83, P2780, DOI 10.1182/blood.V83.10.2780.2780; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368	13	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					491	492		10.1016/S0140-6736(00)04035-6	http://dx.doi.org/10.1016/S0140-6736(00)04035-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229662				2022-12-28	WOS:000167011700003
J	Hartman, JL; Garvik, B; Hartwell, L				Hartman, JL; Garvik, B; Hartwell, L			Cell biology - Principles for the buffering of genetic variation	SCIENCE			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; DROSOPHILA-MELANOGASTER; CYSTIC-FIBROSIS; DISEASE; GENOME; SUSCEPTIBILITY; PHENOTYPES; TRAITS; MOUSE; SCALE	Most genetic research has used inbred organisms and has not explored the complexity of natural genetic variation present in outbred populations. The translation of genotype to phenotype is complicated by gene interactions observed as epistasis, canalization, robustness, or buffering. Analysis of double mutations in inbred experimental organisms suggests some principles for gene interaction that may apply to natural variation as well. The buffering of variation in one gene is most often due to a small number of other genes that function in the same biochemical process. However, buffering can also result from genes functioning in processes extrinsic to that of the primary gene.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Hartwell, L (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.			Hartman, John/0000-0003-1176-6469	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017709, R37GM017709] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM17709] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Antonarakis SE, 2000, NAT GENET, V25, P11, DOI 10.1038/75497; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dobzhansky T, 1944, GENETICS, V29, P270; DUN RB, 1958, NATURE, V181, P1018, DOI 10.1038/1811018a0; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Gibson G, 1999, GENETICS, V151, P1081; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Hardy CFJ, 1996, MOL CELL BIOL, V16, P1832; HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635; Imasheva AG, 1999, HEREDITY, V82, P187, DOI 10.1038/sj.hdy.6884660; KACSER H, 1981, GENETICS, V97, P639; KAISER CA, 1997, MOL CELLULAR BIOL YE, P91; KIMURA M, 1991, P NATL ACAD SCI USA, V88, P5969, DOI 10.1073/pnas.88.14.5969; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LONG AD, 1995, GENETICS, V139, P1273; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Minelli A, 1998, MOL PHYLOGENET EVOL, V9, P340, DOI 10.1006/mpev.1997.0490; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; PHELAN JP, 1994, J GERONTOL, V49, pB1, DOI 10.1093/geronj/49.1.B1; Rebay I, 2000, GENETICS, V154, P695; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Steinberg MH, 1996, HEMOGLOBIN, V20, P1, DOI 10.3109/03630269609027906; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Thornhill R, 1997, BIOL REV, V72, P497, DOI 10.1017/S0006323197005082; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; vanWezel T, 1996, NAT GENET, V14, P468, DOI 10.1038/ng1296-468; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weiss K. M., 1993, GENETIC VARIATION HU; Wilkins AS, 1997, BIOESSAYS, V19, P257, DOI 10.1002/bies.950190312; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zielenski J, 1999, NAT GENET, V22, P128, DOI 10.1038/9635; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	50	557	573	4	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					1001	1004		10.1126/science.291.5506.1001	http://dx.doi.org/10.1126/science.291.5506.1001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232561				2022-12-28	WOS:000166860100035
J	Cayrel, R; Hill, V; Beers, TC; Barbuy, B; Spite, M; Spite, F; Plez, B; Andersen, J; Bonifacio, P; Francois, P; Molaro, P; Nordstrom, B; Primas, F				Cayrel, R; Hill, V; Beers, TC; Barbuy, B; Spite, M; Spite, F; Plez, B; Andersen, J; Bonifacio, P; Francois, P; Molaro, P; Nordstrom, B; Primas, F			Measurement of stellar age from uranium decay	NATURE			English	Article							METAL-POOR STARS; ABUNDANCE	The ages of the oldest stars in the Galaxy indicate when star formation began, and provide a minimum age for the Universe. Radioactive dating of meteoritic material(1) and stars(2) relies on comparing the present abundance ratios of radioactive and stable nuclear species to the theoretically predicted ratios of their production. The radioisotope Th-232 (half-life 14 Gyr) has been used to date Galactic stars(2-4), but it decays by only a factor of two over the lifetime of the Universe. U-238 (half-life 4.5 Gyr) is in principle a more precise age indicator, but even its strongest spectral line, from singly ionized uranium at a wavelength of 385.957 nm, has previously not been detected in stars(4-7). Here we report a measurement of this line in the very metal-poor star CS31082-001(8), a star which is strongly overabundant in its heavy elements. The derived uranium abundance, log(U/H) = -13.7 +/- 0.14 +/- 0.12 yields an age of 12.5 +/- 3 Gyr, though this is still model dependent. The observation of this cosmochronometer gives the most direct age determination of the Galaxy. Also, with improved theoretical and laboratory data, it will provide a highly precise lower limit to the age of the Universe.	Observ Paris Meudon, DASGAL, F-75014 Paris, France; European So Observ, D-85748 Garching, Germany; Michigan State Univ, E Lansing, MI 48824 USA; Univ Sao Paulo, BR-01060970 Sao Paulo, Brazil; Observ Paris Meudon, DASGAL, F-92195 Meudon, France; Univ Montpellier 2, GRAAL, F-34095 Montpellier, France; Univ Copenhagen, Astron Observ, DK-2100 Copenhagen, Denmark; Osservatorio Astron Trieste, I-34131 Trieste, Italy; European So Observ, Santiago 19, Chile; Univ Lund, Lund Observ, S-22100 Lund, Sweden	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; European Southern Observatory; Michigan State University; Universidade de Sao Paulo; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite de Montpellier; University of Copenhagen; Istituto Nazionale Astrofisica (INAF); European Southern Observatory; Lund University	Cayrel, R (corresponding author), Observ Paris Meudon, DASGAL, F-75014 Paris, France.		Molaro, Paolo/AAE-8956-2021; Nordstrom, Birgitta/M-6900-2014; Plez, Bertrand/G-6697-2011; Barbuy, Beatriz L. S./O-4665-2015; Beers, Timothy/D-1193-2019	Molaro, Paolo/0000-0002-0571-4163; Nordstrom, Birgitta/0000-0001-6023-4288; Plez, Bertrand/0000-0002-0398-4434; 				Argast D, 2000, ASTRON ASTROPHYS, V356, P873; BEERS TC, 1992, ASTRON J, V103, P1987, DOI 10.1086/116207; BLAISE J, 1992, TABLES INT CONSTANTE, V20; CHEN HL, 1981, J CHEM PHYS, V74, P6063, DOI 10.1063/1.441048; Cowan JJ, 1999, ASTROPHYS J, V521, P194, DOI 10.1086/307512; Fouque P, 2000, ASTRON ASTROPHYS SUP, V141, P313, DOI 10.1051/aas:2000123; FRANCOIS P, 1993, ASTRON ASTROPHYS, V274, P821; Goriely S, 1999, ASTRON ASTROPHYS, V346, P798; MCWILLIAM A, 1995, ASTRON J, V109, P2757, DOI 10.1086/117486; ODORICO S, 2000, P SOC PHOTO-OPT INS, V4005, P121; Pfeiffer B, 1997, Z PHYS A-HADRON NUCL, V357, P235, DOI 10.1007/s002180050237; Sneden C, 1996, ASTROPHYS J, V467, P819, DOI 10.1086/177656; Sneden C, 2000, ASTROPHYS J, V533, pL139, DOI 10.1086/312631; SNEDEN C, IN PRESS REV MEX AST; TILTON GR, 1988, METEORITES EARLY SOL, P249; Westin J, 2000, ASTROPHYS J, V530, P783, DOI 10.1086/308407	18	327	332	1	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					691	692		10.1038/35055507	http://dx.doi.org/10.1038/35055507			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217852				2022-12-28	WOS:000166816400035
J	Preston, BT; Stevenson, IR; Pemberton, JM; Wilson, K				Preston, BT; Stevenson, IR; Pemberton, JM; Wilson, K			Dominant rams lose out by sperm depletion - A waning success in siring counters a ram's high score in competition for ewes.	NATURE			English	Article									Univ Stirling, Inst Biol Sci, Stirling FK9 4LA, Scotland; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Stirling; University of Edinburgh	Preston, BT (corresponding author), Univ Stirling, Inst Biol Sci, Stirling FK9 4LA, Scotland.	b.t.preston@stir.ac.uk	Pemberton, Josephine M/F-3100-2010; Wilson, Kenneth/B-7452-2008	Wilson, Kenneth/0000-0001-5264-6522				Andersson Malte, 1994; Clutton-Brock J., 1990, Bulletin of the British Museum (Natural History) Zoology, V56, P1; FULKERSON WJ, 1982, J REPROD FERTIL, V66, P129, DOI 10.1530/jrf.0.0660129; *GENST 5 COMM, 1993, GENST 5 REL 3 REF MA; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Grubb P., 1974, P195; Jewell P.A., 1974, P224; MOLLER AP, 1989, BIOL J LINN SOC, V38, P119, DOI 10.1111/j.1095-8312.1989.tb01569.x; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; Pemberton JM, 1999, BIOL J LINN SOC, V68, P289, DOI 10.1111/j.1095-8312.1999.tb01170.x; STEVENSON IR, 1994, THESIS U CAMBRIDGE; SYNNOTT AL, 1981, J REPROD FERTIL, V61, P355, DOI 10.1530/jrf.0.0610355; THWAITES CJ, 1995, ANIM REPROD SCI, V37, P299, DOI 10.1016/0378-4320(94)01343-K	13	279	284	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					681	682		10.1038/35055617	http://dx.doi.org/10.1038/35055617			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217847	Green Published			2022-12-28	WOS:000166816400030
J	Scolding, N				Scolding, N			New cells from old	LANCET			English	Editorial Material							NEURAL STEM-CELLS; BRAIN		Univ Bristol, Inst Clin Neurosci, Frenchay Hosp, Bristol BS16 1JE, Avon, England	University of Bristol	Scolding, N (corresponding author), Univ Bristol, Inst Clin Neurosci, Frenchay Hosp, Bristol BS16 1JE, Avon, England.							Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Chief Medical Officer's Expert Group, 2000, STEM CELL RES MED PR; Folkerth RD, 1996, NEUROLOGY, V46, P1219, DOI 10.1212/WNL.46.5.1219; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Mezey E, 2000, EUR J PHARMACOL, V405, P297, DOI 10.1016/S0014-2999(00)00561-6; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Richards T, 2000, BRIT MED J, V321, P1427, DOI 10.1136/bmj.321.7274.1427; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhang SC, 1999, P NATL ACAD SCI USA, V96, P4089, DOI 10.1073/pnas.96.7.4089; 2000, NATURE, V408, P275	19	10	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					329	330		10.1016/S0140-6736(00)03637-0	http://dx.doi.org/10.1016/S0140-6736(00)03637-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210992				2022-12-28	WOS:000166897900008
J	Uz, BM; Yoder, JA; Osychny, V				Uz, BM; Yoder, JA; Osychny, V			Pumping of nutrients to ocean surface waters by the action of propagating planetary waves	NATURE			English	Article							SARGASSO SEA; MESOSCALE EDDIES; NORTH PACIFIC; ROSSBY WAVES; TOPEX/POSEIDON; VARIABILITY; ALTIMETER	Primary productivity in the oceans is limited by the lack of nutrients in surface waters. These nutrients are mostly supplied from nutrient-rich subsurface waters through upwelling and vertical mixing(1), but in the ocean gyres these mechanisms do not fully account for the observed productivity(2). Recently, the upward pumping of nutrients, through the action of eddies, has been shown to account for the remainder of the primary productivity; however, these were regional studies which focused on mesoscale (100-km-scale) eddies(3-6). Here we analyse remotely sensed chlorophyll and sea-surface-height data collected over two years and show that 1,000-km-scale planetary waves, which propagate in a westward direction in the oceans, are associated with about 5 to 20% of the observed variability in chlorophyll concentration (after low-frequency and large-scale variations are removed from the data). Enhanced primary production is the likely explanation for this observation, and if that is the case, propagating disturbances introduce nutrients to surface waters on a global scale-similar to the nutrient pumping that occurs within distinct eddies.	Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island	Uz, BM (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, S Ferry Rd, Narragansett, RI 02882 USA.	m.uz@gso.uri.edu						BARBER RT, 1992, ENVIR SCI R, V43, P89; Chelton DB, 1998, J PHYS OCEANOGR, V28, P433, DOI 10.1175/1520-0485(1998)028<0433:GVOTFB>2.0.CO;2; Chelton DB, 1996, SCIENCE, V272, P234, DOI 10.1126/science.272.5259.234; Cipollini P, 1997, GEOPHYS RES LETT, V24, P889, DOI 10.1029/97GL00758; Emery W.J., 2001, DATA ANAL METHODS PH; HALLIWELL GR, 1991, J PHYS OCEANOGR, V21, P635, DOI 10.1175/1520-0485(1991)021<0635:WPSAFI>2.0.CO;2; HAYWARD TL, 1987, DEEP-SEA RES, V34, P1593, DOI 10.1016/0198-0149(87)90111-7; JENKINS WJ, 1985, J MAR RES, V43, P465, DOI 10.1357/002224085788438702; Lim J. S., 1990, 2 DIMENSIONAL SIGNAL, P42; McClain CR, 1998, SEA TECHNOL, V39, P10; McGillicuddy DJ, 1999, J GEOPHYS RES-OCEANS, V104, P13381, DOI 10.1029/1999JC900021; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; McGillicuddy DJ, 1997, DEEP-SEA RES PT I, V44, P1427, DOI 10.1016/S0967-0637(97)00024-1; MCGILLICUDDY DJ, IN PRESS DEEP SEA RE; Polito PS, 1997, J GEOPHYS RES-OCEANS, V102, P3215, DOI 10.1029/96JC03349; Siegel DA, 1999, J GEOPHYS RES-OCEANS, V104, P13359, DOI 10.1029/1999JC900051; Stammer D, 1997, J PHYS OCEANOGR, V27, P1743, DOI 10.1175/1520-0485(1997)027<1743:GCOOVE>2.0.CO;2; VANWOERT ML, 1993, J GEOPHYS RES-OCEANS, V98, P14619, DOI 10.1029/93JC00936; Zang XY, 1999, J PHYS OCEANOGR, V29, P2183, DOI 10.1175/1520-0485(1999)029<2183:TODRFN>2.0.CO;2; 1979, IEEE PROGRAMS DIGITA	20	117	124	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					597	600		10.1038/35054527	http://dx.doi.org/10.1038/35054527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214314				2022-12-28	WOS:000166692300038
J	Levy, JA				Levy, JA			What can be achieved with an HIV vaccine?	LANCET			English	Editorial Material							INFECTION; MEASLES; IMMUNITY; VIRUS; TRANSMISSION; INDIVIDUALS; CHILDREN		Univ Calif San Francisco, Dept Med, Div Haematol Oncol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Levy, JA (corresponding author), Univ Calif San Francisco, Dept Med, Div Haematol Oncol, San Francisco, CA 94143 USA.							Damien B, 1998, J MED VIROL, V56, P85, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt;85::AID-JMV14&gt;3.0.CO;2-V; Fiscus SA, 1996, JAMA-J AM MED ASSOC, V275, P1483, DOI 10.1001/jama.275.19.1483; FOGEL A, 1978, J PEDIATR-US, V92, P26, DOI 10.1016/S0022-3476(78)80064-X; HADLER SC, 1986, NEW ENGL J MED, V315, P209, DOI 10.1056/NEJM198607243150401; HARCOURT GC, 1980, J INFECT DIS, V142, P145, DOI 10.1093/infdis/142.2.145; Levy JA, 1998, HIV PATHOGENESIS AID; Nathanson N, 1999, AIDS, V13, pS113; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PEDERSEN IR, 1989, VACCINE, V7, P345, DOI 10.1016/0264-410X(89)90199-0; PLOTKIN SA, 1998, VACCINES; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; ROWLANDJONES SL, 1995, CURR OPIN IMMUNOL, V7, P448, DOI 10.1016/0952-7915(95)80087-5; Shearer GM, 1996, IMMUNOL TODAY, V17, P21, DOI 10.1016/0167-5699(96)80564-0; Stranford SA, 1999, P NATL ACAD SCI USA, V96, P1030, DOI 10.1073/pnas.96.3.1030; SUTTER RW, 1991, LANCET, V338, P715, DOI 10.1016/0140-6736(91)91442-W; Vardas E, 1999, J CLIN VIROL, V13, P173, DOI 10.1016/S1386-6532(99)00026-8; Whittle HC, 1999, LANCET, V353, P98, DOI 10.1016/S0140-6736(98)02364-2; WILKINS J, 1969, AM J DIS CHILD, V118, P275, DOI 10.1001/archpedi.1969.02100040277025	18	21	23	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2001	357	9251					223	224		10.1016/S0140-6736(00)03601-1	http://dx.doi.org/10.1016/S0140-6736(00)03601-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213112				2022-12-28	WOS:000166593700036
J	Umans-Eckenhausen, MAW; Defesche, JC; Sijbrands, EJG; Scheerder, RLJM; Kastelein, JJP				Umans-Eckenhausen, MAW; Defesche, JC; Sijbrands, EJG; Scheerder, RLJM; Kastelein, JJP			Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands	LANCET			English	Article							CHOLESTEROL; MUTATIONS	Background Familial hypercholesterolaemia is a common lipid disorder that predisposes for premature cardiovascular disease (CVD). We set up a screening programme in the Netherlands in 1994 to: establish the feasibility of active family screening supported by DNA diagnostics; assess whether or not active identification of these patients with familial hypercholesterolaemia would lead to more cholesterol-lowering treatment; and compare diagnosis by DNA analysis with that by cholesterol measurement. Methods Both DNA analysis and measurement of cholesterol concentrations were used to screen families in which a functional mutation in the LDL-receptor gene had been detected. Findings In the first 5 years, 5442 relatives of 237 people with familial hypercholesterolaemia were screened; 2039 individuals were identified as heterozygous by LDL-receptor gene mutation analysis. At the time of examination. 667 of these adults with familial hypercholesterolaemia (39%) received some form of lipid-lowering treatment; 1 year later, this percentage had increased to 93%. In addition, laboratory analysis showed that for carriers as well as noncarriers 18% would have been misdiagnosed by cholesterol measurement alone, with sex-specific and age-specific 90th percentiles of the general Dutch population as diagnostic criteria. Interpretation Targeted family screening with DNA analysis proved to be highly effective in identifying patients with hypercholesterolaemia. Most of the identified patients sought treatment and were successfully started on cholesterol-lowering treatment to lower the risk of premature CVD. Our findings could have wider relevance for the screening of other prevalent genetic population at large.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1100 DE Amsterdam, Netherlands; Fdn Identificat Persons Inherited Hypercholestero, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, POB 27700, NL-1100 DE Amsterdam, Netherlands.	e.vandongen@amc.uva.ni	Sijbrands, Eric/A-1065-2009; Kastelein, John/AAF-7950-2020	Sijbrands, Eric/0000-0001-8857-7389; 				ASSOULINE L, 1995, PEDIATRICS, V96, P239; Defesche J., 2000, LIPIDS VASCULAR DIS, V6, P65; DEFESCHE JC, 1993, ARCH INTERN MED, V153, P2349, DOI 10.1001/archinte.153.20.2349; *FAM HYP FH, WHOHGNCONS987 FAM HY; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; Gould AL, 1998, CIRCULATION, V97, P946; KOTZE MJ, 1992, CLIN GENET, V42, P43; Kotze MJ, 1998, CLIN GENET, V54, P74; KWITEROVICH PO, 1989, ARTERIOSCLEROSIS, V9, pI111; LEONARD JV, 1977, BRIT MED J, V1, P1566, DOI 10.1136/bmj.1.6076.1566; Lombardi MP, 2000, CLIN GENET, V57, P116, DOI 10.1034/j.1399-0004.2000.570205.x; Maat-Kievit A, 1999, PRENATAL DIAG, V19, P450, DOI 10.1002/(SICI)1097-0223(199905)19:5<450::AID-PD568>3.0.CO;2-L; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; Sijbrands EJG, 2000, ATHEROSCLEROSIS, V149, P421, DOI 10.1016/S0021-9150(99)00336-6; Vatta M, 2000, CURR OPIN CARDIOL, V15, P12, DOI 10.1097/00001573-200001000-00003; VERSCHUREN WMM, 1994, INT J EPIDEMIOL, V23, P948, DOI 10.1093/ije/23.5.948; Vuorio AF, 1997, ARTERIOSCL THROM VAS, V17, P3332, DOI 10.1161/01.ATV.17.11.3332; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6	20	337	345	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					165	168		10.1016/S0140-6736(00)03587-X	http://dx.doi.org/10.1016/S0140-6736(00)03587-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213091				2022-12-28	WOS:000166593700007
J	Stein, E; Tessier-Lavigne, M				Stein, E; Tessier-Lavigne, M			Hierarchical organization of guidance receptors: Silencing of netrin attraction by slit through a Robo/DCC receptor complex	SCIENCE			English	Article							REPULSIVE AXON GUIDANCE; GROWTH CONE GUIDANCE; COLORECTAL-CANCER; DCC; ROUNDABOUT; DROSOPHILA; REPELLENT; PROTEINS; PATTERNS; ENCODES	Axonal growth cones that cross the nervous system midline change their responsiveness to midline guidance cues: They become repelled by the repellent Slit and simultaneously lose responsiveness to the attractant netrin. These mutually reinforcing changes help to expel growth cones from the midline by making a once-attractive environment appear repulsive. Mere; we provide evidence that these two changes are causally Linked: In the growth cones of embryonic Xenopus spinal axons, activation of the Slit receptor Roundabout (Robo) silences the attractive effect of netrin-1, but not its growth-stimulatory effect, through direct binding of the cytoplasmic domain of Robe to that of the netrin receptor DCC. Biologically, this hierarchical silencing mechanism helps to prevent a tug-of-war between attractive and repulsive signals in the growth cone that might cause confusion. Molecularly, silencing is enabled by a modular and interlocking design of the cytoplasmic domains of these potentially antagonistic receptors that predetermines the outcome of their simultaneous activation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	marctl@itsa.ucsf.edu	Stein, Elke/E-8107-2013	Stein, Elke/0000-0001-8965-5692				Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Erskine L, 2000, J NEUROSCI, V20, P4975; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Schultz J, 1997, PROTEIN SCI, V6, P249; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; TABTI N, 1994, NEUROSCI LETT, V173, P21, DOI 10.1016/0304-3940(94)90141-4; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	28	455	463	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1928	1938		10.1126/science.1058445	http://dx.doi.org/10.1126/science.1058445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239147				2022-12-28	WOS:000167401600037
J	de Fockert, JW; Rees, G; Frith, CD; Lavie, N				de Fockert, JW; Rees, G; Frith, CD; Lavie, N			The role of working memory in visual selective attention	SCIENCE			English	Article							PERCEPTUAL LOAD; SYSTEM; AREA	The hypothesis that working memory is crucial for reducing distraction by maintaining the prioritization of relevant information was tested in neuroimaging and psychological experiments with humans. Participants performed a selective attention task that required them to ignore distracter faces while holding in working memory a sequence of digits that were in the same order (Low memory Load) or a different order thigh memory Load) on every trial. Higher memory Load, associated with increased prefrontal activity, resulted in greater interference effects on behavioral performance from the distracter faces, plus increased face-related activity in the visual cortex. These findings confirm a major role for working memory in the control of visual selective attention.	UCL, Dept Psychol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	de Fockert, JW (corresponding author), UCL, Dept Psychol, Gower St, London WC1E 6BT, England.	j.de-fockert@ucl.ac.uk	Rees, Geraint/C-1493-2008; Frith, Chris D/A-2171-2009	Rees, Geraint/0000-0002-9623-7007; Frith, Chris D/0000-0002-8665-0690	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 1997, PSYCHOL SCI, V8, P395, DOI 10.1111/j.1467-9280.1997.tb00432.x; Lavie N, 2000, J EXP PSYCHOL HUMAN, V26, P1038, DOI 10.1037//0096-1523.26.3.1038; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Shallice T., 1991, FRONTAL LOBE FUNCTIO; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Talairach J., 1988, COPLANAR STEREOTAXIC; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135; YOUNG AW, 1986, J EXP PSYCHOL HUMAN, V12, P466, DOI 10.1037/0096-1523.12.4.466	22	646	660	2	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1803	1806		10.1126/science.1056496	http://dx.doi.org/10.1126/science.1056496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	408HK	11230699	Green Submitted, Green Accepted			2022-12-28	WOS:000167320600064
J	Kamradt, T; Mitchison, NA				Kamradt, T; Mitchison, NA			Advances in immunology: Tolerance and autoimmunity.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MYELIN BASIC-PROTEIN; REGULATORY T-CELLS; CHIMERIC MONOCLONAL-ANTIBODY; COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; VIRUS-INFECTION; IMMUNE-SYSTEM		Deutsch Rheumaforschungszentrum, D-10117 Berlin, Germany; Free Univ Berlin, Klinikum Charite, Med Klin Schwerpunkt Rheumatol & Klin Immunol, Berlin, Germany; UCL, Sch Med, Dept Immunol, London W1N 8AA, England	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; University College London; UCL Medical School	Kamradt, T (corresponding author), Deutsch Rheumaforschungszentrum, Schumannstr 21-22, D-10117 Berlin, Germany.	kamradt@drfz.de	Kamradt, Thomas/E-9971-2018	Kamradt, Thomas/0000-0001-8443-5893				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; Akkaraju S, 1997, J EXP MED, V186, P2005, DOI 10.1084/jem.186.12.2005; Albert LJ, 1999, NEW ENGL J MED, V341, P2068, DOI 10.1056/NEJM199912303412707; Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; [Anonymous], 1999, Neurology, V53, P457; Asadullah K, 1998, J CLIN INVEST, V101, P783, DOI 10.1172/JCI1476; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Badley AD, 1997, J EXP MED, V185, P55, DOI 10.1084/jem.185.1.55; BARKER CF, 1977, ADV IMMUNOL, V25, P1; Barrett JH, 1999, ARTHRITIS RHEUM, V42, P1219, DOI 10.1002/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; BITAR DM, 1988, CELL IMMUNOL, V112, P364, DOI 10.1016/0008-8749(88)90305-X; Blanas E, 1996, SCIENCE, V274, P1707, DOI 10.1126/science.274.5293.1707; Bousquet J, 1998, ANN ALLERG ASTHMA IM, V81, P401, DOI 10.1016/S1081-1206(10)63136-5; BRACKMANN HH, 1977, LANCET, V2, P933; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Buer J, 1998, J EXP MED, V187, P177, DOI 10.1084/jem.187.2.177; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Chaillous L, 2000, LANCET, V356, P545, DOI 10.1016/S0140-6736(00)02579-4; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chang JT, 1999, J EXP MED, V189, P969, DOI 10.1084/jem.189.6.969; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0; CHILLER JM, 1970, P NATL ACAD SCI USA, V65, P551, DOI 10.1073/pnas.65.3.551; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Cooley HM, 1997, ARTHRITIS RHEUM, V40, P1712, DOI 10.1002/art.1780400923; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; CROSS AH, 1995, J CLIN INVEST, V95, P2783, DOI 10.1172/JCI117982; De Swert LFA, 1999, EUR J PEDIATR, V158, P89, DOI 10.1007/s004310051024; Delves PJ, 2000, NEW ENGL J MED, V343, P37, DOI 10.1056/NEJM200007063430107; Delves PJ, 2000, NEW ENGL J MED, V343, P108, DOI 10.1056/NEJM200007133430207; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 1998, SEMIN NEUROL, V18, P295, DOI 10.1055/s-2008-1040880; Ebers GC, 1999, LANCET, V353, P678; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Falb D, 1996, EUR J IMMUNOL, V26, P966; FERBER I, 1994, SCIENCE, V263, P674, DOI 10.1126/science.8303275; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; FORSTER I, 1995, IMMUNITY, V2, P573, DOI 10.1016/1074-7613(95)90002-0; Fox CJ, 2000, AM J HUM GENET, V67, P67, DOI 10.1086/302995; FRANCO A, 1994, EUR J IMMUNOL, V24, P940, DOI 10.1002/eji.1830240424; FUJINAMI RS, 1983, P NATL ACAD SCI-BIOL, V80, P2346, DOI 10.1073/pnas.80.8.2346; FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848; Genain CP, 1996, SCIENCE, V274, P2054, DOI 10.1126/science.274.5295.2054; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Gibbon C, 1997, ARCH DIS CHILD, V77, P384, DOI 10.1136/adc.77.5.384; Glynne R, 2000, IMMUNOL REV, V176, P216; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Grogan JL, 1999, J IMMUNOL, V163, P3764; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Hemmer B, 1999, NAT MED, V5, P1375; Hemmer B, 1998, J IMMUNOL, V160, P3631; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; HOYNE GF, 1993, J EXP MED, V178, P1783, DOI 10.1084/jem.178.5.1783; Hu W, 1998, EUR J IMMUNOL, V28, P2444, DOI 10.1002/(SICI)1521-4141(199808)28:08<2444::AID-IMMU2444>3.0.CO;2-N; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; JAHNKE U, 1985, SCIENCE, V229, P282, DOI 10.1126/science.2409602; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kalden JR, 1998, ADV IMMUNOL, V68, P333, DOI 10.1016/S0065-2776(08)60564-7; KAMRADT T, 1991, J IMMUNOL, V147, P3296; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; KELLER RJ, 1993, LANCET, V341, P927, DOI 10.1016/0140-6736(93)91215-8; KITZE B, 1988, J NEUROIMMUNOL, V20, P237, DOI 10.1016/0165-5728(88)90166-X; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Klinman NR, 1996, IMMUNITY, V5, P189, DOI 10.1016/S1074-7613(00)80314-3; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 2000, SCIENCE, V287, P2501, DOI 10.1126/science.287.5462.2501; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; KURTZKE JF, 1994, CLIN MICROBIOL REV, V7, P141; Laabi Y, 2000, SCIENCE, V289, P883, DOI 10.1126/science.289.5481.883; Lafaille JJ, 1997, J EXP MED, V186, P307, DOI 10.1084/jem.186.2.307; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; LAMB JR, 1983, J EXP MED, V157, P1434, DOI 10.1084/jem.157.5.1434; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; LEVINE S, 1972, P SOC EXP BIOL MED, V139, P506; Luhder F, 2000, P NATL ACAD SCI USA, V97, P12204, DOI 10.1073/pnas.200348397; Lyons PA, 2000, IMMUNITY, V13, P107, DOI 10.1016/S1074-7613(00)00012-1; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Maier B, 2000, EUR J IMMUNOL, V30, P448, DOI 10.1002/1521-4141(200002)30:2&lt;448::AID-IMMU448&gt;3.0.CO;2-9; MARIANI G, 1994, THROMB HAEMOSTASIS, V72, P155; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; McKown KM, 1999, ARTHRITIS RHEUM, V42, P1204, DOI 10.1002/1529-0131(199906)42:6<1204::AID-ANR17>3.0.CO;2-U; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Mitchell DA, 1999, J IMMUNOL, V162, P5676; Mitchison NA, 2000, P NATL ACAD SCI USA, V97, P8750, DOI 10.1073/pnas.97.16.8750; Morel L, 1999, IMMUNITY, V11, P131, DOI 10.1016/S1074-7613(00)80088-6; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; NAGLERANDERSON C, 1986, P NATL ACAD SCI USA, V83, P7443, DOI 10.1073/pnas.83.19.7443; NAPARSTEK Y, 1993, ANNU REV IMMUNOL, V11, P79, DOI 10.1146/annurev.immunol.11.1.79; NAQUET P, 1988, J IMMUNOL, V140, P2569; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Neuhaus O, 2000, P NATL ACAD SCI USA, V97, P7452, DOI 10.1073/pnas.97.13.7452; Norman PS, 1997, INT ARCH ALLERGY IMM, V113, P224, DOI 10.1159/000237553; Nussenblatt RB, 1997, AM J OPHTHALMOL, V123, P583, DOI 10.1016/S0002-9394(14)71070-0; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; OLDSTONE MBA, 1991, CELL, V65, P319, DOI 10.1016/0092-8674(91)90165-U; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Pakala SV, 1999, J EXP MED, V189, P1053, DOI 10.1084/jem.189.7.1053; Pakala SV, 1997, J EXP MED, V186, P299, DOI 10.1084/jem.186.2.299; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROSEN FS, 1987, CIBA F SYMP, V129, P135; Ross TM, 2000, NAT IMMUNOL, V1, P127, DOI 10.1038/77802; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Seddon B, 1999, J EXP MED, V189, P279, DOI 10.1084/jem.189.2.279; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SODERSTROM M, 1993, SCAND J IMMUNOL, V37, P355, DOI 10.1111/j.1365-3083.1993.tb02565.x; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Tindle R W, 1994, Curr Top Microbiol Immunol, V186, P217; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tough DF, 1997, J EXP MED, V185, P2089, DOI 10.1084/jem.185.12.2089; Traynor AE, 2000, LANCET, V356, P701, DOI 10.1016/S0140-6736(00)02627-1; TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Van de Keere F, 1998, J EXP MED, V188, P1875, DOI 10.1084/jem.188.10.1875; VANEDEN W, 1985, P NATL ACAD SCI USA, V82, P5117; Vingsbo-Lundberg C, 1998, NAT GENET, V20, P401, DOI 10.1038/3887; Warren KG, 1997, J NEUROL SCI, V152, P31, DOI 10.1016/S0022-510X(97)00130-5; Webb LMC, 1996, EUR J IMMUNOL, V26, P2320, DOI 10.1002/eji.1830261008; WEINER HL, 1993, SCIENCE, V259, P1321, DOI 10.1126/science.7680493; Wells HG, 1911, J INFECT DIS, V9, P147, DOI 10.1093/infdis/9.2.147; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252	152	271	280	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2001	344	9					655	664		10.1056/NEJM200103013440907	http://dx.doi.org/10.1056/NEJM200103013440907			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405TR	11228281				2022-12-28	WOS:000167177100007
J	Fernandez, A; Davis, SB; Wendt, JOL; Cenni, R; Young, RS; Witten, ML				Fernandez, A; Davis, SB; Wendt, JOL; Cenni, R; Young, RS; Witten, ML			Public health - Particulate emission from biomass combustion	NATURE			English	Article									Univ Arizona, Dept Environm Chem & Engn, Tucson, AZ 85721 USA; Univ Stuttgart, Inst Verfahrenstech & Dampfkesselwesen, D-70569 Stuttgart, Germany; Univ Arizona, Arizona Hlth Sci Ctr, Dept Pediat, Lung Injury Lab, Tucson, AZ 85721 USA	University of Arizona; University of Stuttgart; University of Arizona; University of Arizona Health Sciences	Fernandez, A (corresponding author), Univ Arizona, Dept Environm Chem & Engn, Tucson, AZ 85721 USA.	wendt@u.arizona.edu						Adamson IYR, 2000, TOXICOL APPL PHARM, V166, P111, DOI 10.1006/taap.2000.8955; Cenni R, 1998, WASTE MANAGE, V18, P433, DOI 10.1016/S0956-053X(98)00127-5; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; FERNANDEZ A, UNPUB J AIR WASTE MA; Lighty JS, 2000, J AIR WASTE MANAGE, V50, P1565, DOI 10.1080/10473289.2000.10464197	5	32	37	0	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					998	998		10.1038/35059169	http://dx.doi.org/10.1038/35059169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234053	Bronze			2022-12-28	WOS:000167148800031
J	Futreal, PA; Kasprzyk, A; Birney, E; Mullikin, JC; Wooster, R; Stratton, MR				Futreal, PA; Kasprzyk, A; Birney, E; Mullikin, JC; Wooster, R; Stratton, MR			Cancer and genomics	NATURE			English	Article								Identification of the genes that cause oncogenesis is a central aim of cancer research. We searched the proteins predicted from the draft human genome sequence for paralogues of known tumour suppressor genes, but no novel genes were identified. We then assessed whether it was possible to search directly for oncogenic sequence changes in cancer cells by comparing cancer genome sequences against the draft genome. Apparently chimaeric transcripts (from oncogenic fusion genes generated by chromosomal translocations, the ends of which mapped to different genomic locations) were detected to the same degree in both normal and neoplastic tissues, indicating a significant level of false positives. Our experiment underscores the limited amount and variable quality of DNA sequence from cancer cells that is currently available.	Sanger Ctr, Canc Genome Project, Cambridge CB10 1SA, England; Sanger Ctr, Informat Div, Cambridge CB10 1SA, England; EBI, EMBL, Cambridge CB10 1SD, England; Inst Canc Res, Sutton SM2 5NG, Surrey, England	University of Cambridge; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Sanger Ctr, Canc Genome Project, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk		Birney, Ewan/0000-0001-8314-8497				Bell RS, 1999, CAN J SURG, V42, P259; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Higginson John., 1992, HUMAN CANC EPIDEMIOL; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495	6	106	113	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					850	852		10.1038/35057046	http://dx.doi.org/10.1038/35057046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237008	Bronze			2022-12-28	WOS:000166938800055
J	Judson, HF				Judson, HF			Talking about the genome - Biologists must take responsibility for the correct use of language in genetics.	NATURE			English	Editorial Material									George Washington Univ, Ctr Hist Recent Sci, Washington, DC 20052 USA	George Washington University	Judson, HF (corresponding author), George Washington Univ, Ctr Hist Recent Sci, Washington, DC 20052 USA.								0	10	12	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					769	769		10.1038/35057406	http://dx.doi.org/10.1038/35057406			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236976				2022-12-28	WOS:000166938800018
J	Baker, PA; Rigsby, CA; Seltzer, GO; Fritz, SC; Lowenstein, TK; Bacher, NP; Veliz, C				Baker, PA; Rigsby, CA; Seltzer, GO; Fritz, SC; Lowenstein, TK; Bacher, NP; Veliz, C			Tropical climate changes at millennial and orbital timescales on the Bolivian Altiplano	NATURE			English	Article							SEA-SURFACE TEMPERATURE; ICE-AGE; GLACIAL MAXIMUM; SOUTH-AMERICA; CENTRAL ANDES; CALIBRATION; ATLANTIC; HISTORY; OCEAN; PALEOTEMPERATURE	Tropical South America is one of the three main centres of the global, zonal overturning circulation of the equatorial atmosphere (generally termed the 'Walker' circulation(1)). Although this area plays a key role in global climate cycles, little is known about South American climate history. Here we describe sediment cores and down-hole logging results of deep drilling in the Salar de Uyuni, on the Bolivian Altiplano, located in the tropical Andes. We demonstrate that during the past 50,000 years the Altiplano underwent important changes in effective moisture at both orbital (20,000-year) and millennial timescales. Long-duration wet periods, such as the Last Glacial Maximum-marked in the drill core by continuous deposition of lacustrine sediments-appear to have occurred in phase with summer insolation maxima produced by the Earth's precessional cycle. Short-duration, millennial events correlate well with North Atlantic cold events, including Heinrich events 1 and 2, as well as the Younger Dryas episode. At both millennial and orbital timescales, cold sea surface temperatures in the high-latitude North Atlantic were coeval with wet conditions in tropical South America, suggesting a common forcing.	Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA; E Carolina Univ, Dept Geol, Greenville, NC 27858 USA; Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; SUNY Binghamton, Dept Geol Sci, Binghamton, NY 13902 USA	Duke University; University of North Carolina; East Carolina University; Syracuse University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Baker, PA (corresponding author), Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA.							Abbott MB, 1997, QUATERNARY RES, V47, P169, DOI 10.1006/qres.1997.1881; BAKER P, IN PRESS SCIENCE; Bard E, 1998, GEOCHIM COSMOCHIM AC, V62, P2025, DOI 10.1016/S0016-7037(98)00130-6; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Baucom PC, 1999, J SEDIMENT RES, V69, P597, DOI 10.2110/jsr.69.597; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BETTS AK, 1992, J GEOPHYS RES-ATMOS, V97, P2529, DOI 10.1029/91JD02974; BILLS BG, 1994, GEOPHYS RES LETT, V21, P293, DOI 10.1029/93GL03544; BLODGETT TA, 1997, EARTH INTERACTIONS; Clapperton CM, 1993, QUATERNARY GEOLOGY G; Geyh MA, 1998, RADIOCARBON, V40, P921, DOI 10.1017/S0033822200018890; GROVE MJ, 2000, THESIS DUKE U; HASTENRATH S, 1994, CLIMATE DYNAMICS TRO; Hostetler SW, 1999, NATURE, V399, P673, DOI 10.1038/21401; Klein AG, 1999, QUATERNARY SCI REV, V18, P63, DOI 10.1016/S0277-3791(98)00095-X; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Nobre P, 1996, J CLIMATE, V9, P2464, DOI 10.1175/1520-0442(1996)009<2464:VOSSTW>2.0.CO;2; Pierrehumbert RT, 1999, GEOPHYS RES LETT, V26, P1345, DOI 10.1029/1999GL900183; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Servain J, 2000, INT J CLIMATOL, V20, P939, DOI 10.1002/1097-0088(200007)20:9<939::AID-JOC511>3.0.CO;2-V; SERVANT M, 1995, CR ACAD SCI II, V320, P729; Servant M., 1978, CAH ORSTOM SER GEOL, V10, P9; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Sylvestre F, 1999, QUATERNARY RES, V51, P54, DOI 10.1006/qres.1998.2017; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; ZHAO M, 1995, PALEOCEANOGRAPHY, V10, P661, DOI 10.1029/94PA03354; Zhou JY, 1998, J CLIMATE, V11, P1020, DOI 10.1175/1520-0442(1998)011<1020:DAMCEO>2.0.CO;2	29	360	369	4	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					698	701		10.1038/35055524	http://dx.doi.org/10.1038/35055524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217855	Green Published			2022-12-28	WOS:000166816400038
J	Cohen, CD; Keuneke, C; Schlemann, U; Schroppel, B; Siegert, S; Rascher, W; Gross, M; Schlondorff, D				Cohen, CD; Keuneke, C; Schlemann, U; Schroppel, B; Siegert, S; Rascher, W; Gross, M; Schlondorff, D			Hyponatraemia as a complication of colonoscopy	LANCET			English	Article							VASOPRESSIN	A case of colonoscopy-induced hyponatraemic encephalopathy led us to study the risk of hyponatraemia after gastrointestinal endoscopy. We assessed 40 patients before and after colonoscopy. 20 gastroscopy patients served as controls. Our findings show a high incidence (7.5%) of hyponatraemia after colonoscopy, In association with raised serum concentrations of arginine vasopressin. Physicians should be aware of this complication, since it may contribute to psychological and neurological symptoms after colonoscopy.	Univ Munich, Med Poliklin, D-80336 Munich, Germany; Univ Erlangen Nurnberg, Dept Paediat, Erlangen, Germany	University of Munich; University of Erlangen Nuremberg	Schlondorff, D (corresponding author), Univ Munich, Med Poliklin, Pettenkoferstr 8A, D-80336 Munich, Germany.							CHUNG HM, 1986, ARCH INTERN MED, V146, P333, DOI 10.1001/archinte.146.2.333; COHEN SM, 1994, DIS COLON RECTUM, V37, P689, DOI 10.1007/BF02054413; HAMPTON KK, 1991, CLIN SCI, V81, P257, DOI 10.1042/cs0810257; RASCHER W, 1986, ACTA PAEDIATR SCAND, V75, P111, DOI 10.1111/j.1651-2227.1986.tb10166.x; SCHROPPEL B, IN PRESS GASTROINTES	5	39	43	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					282	283		10.1016/S0140-6736(00)03619-9	http://dx.doi.org/10.1016/S0140-6736(00)03619-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214135				2022-12-28	WOS:000166693400017
J	Durand, M; Grattan, J				Durand, M; Grattan, J			Effects of volcanic air pollution on health	LANCET			English	Editorial Material									Univ Wales, Inst Geog & Earth Sci, Aberystwyth SY23 4HD, Ceredigion, Wales	Aberystwyth University	Durand, M (corresponding author), Univ Wales, Inst Geog & Earth Sci, Aberystwyth SY23 4HD, Ceredigion, Wales.		Grattan, John/N-2167-2014	Grattan, John/0000-0003-3004-6598				ALLARD P, 1994, NATURE, V368, P326, DOI 10.1038/368326a0; Baxter PJ, 1999, SCIENCE, V283, P1142, DOI 10.1126/science.283.5405.1142; BAXTER PJ, 1990, LANCET, V336, P176, DOI 10.1016/0140-6736(90)91695-7; BLONG RGC, 1904, VOLCANIC HAZARDS SOU; Bruno N, 1999, B VOLCANOL, V60, P405, DOI 10.1007/s004450050240; CAMUFFO D, 1995, NAT HAZARDS, V11, P135, DOI 10.1007/BF00634530; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; Durand M, 1999, ENVIRON GEOCHEM HLTH, V21, P371, DOI 10.1023/A:1006700921208; DURAND M, 2000, THESIS U WALES ABERY; Grattan J., 1998, QUATERNAIRE, V9, P25; MARTIN D, 1986, J GEOPHYS RES-SOLID, V91, P2249, DOI 10.1029/JB091iB12p12249; PETERSEN J, 1996, AK96058 NIWA MIN ENV; WELLBURN A, 1994, AIR POLLUTION CLIMAT	13	33	33	1	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2001	357	9251					164	164		10.1016/S0140-6736(00)03586-8	http://dx.doi.org/10.1016/S0140-6736(00)03586-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213090				2022-12-28	WOS:000166593700006
J	Thorrold, SR; Latkoczy, C; Swart, PK; Jones, CM				Thorrold, SR; Latkoczy, C; Swart, PK; Jones, CM			Natal homing in a marine fish metapopulation	SCIENCE			English	Article							WEAKFISH CYNOSCION-REGALIS; CORAL-REEF FISH; MASS-SPECTROMETRY; OTOLITHS; RECRUITMENT; POPULATION; SIGNATURES; SALMON; BAY	Identifying natal origins of marine fishes is challenging because of difficulties in conducting mark-recapture studies in marine systems. We used natural geochemical signatures in otoliths (ear bones) to determine natal sources in weakfish (Cynoscion regalis), an estuarine-spawning marine fish, in eastern North America. Spawning site fidelity ranged from 60 to 81%, comparable to estimates of natal homing in birds and anadromous fishes. These data were in contrast to genetic analyses of population structure in weakfish. Our findings highlight the need for consideration of spatial processes in fisheries models and have implications for the design of marine reserves in coastal regions.	Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; Old Dominion Univ, Lab Isotope & Trace Element Res, Norfolk, VA 23529 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Geol & Geophys, Miami, FL 33149 USA	Old Dominion University; Old Dominion University; University of Miami	Thorrold, SR (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.		Swart, Peter/K-7041-2016; Thorrold, Simon R/B-7565-2012	Swart, Peter/0000-0002-6743-6162; Thorrold, Simon R/0000-0002-1533-7517				Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2000, FISH RES, V46, P343, DOI 10.1016/S0165-7836(00)00158-2; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; CORDES JF, 2000, THESIS COLLEGE WILLI; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; CRAWFORD MK, 1989, FISH B-NOAA, V87, P205; Fogarty MJ, 1999, TRENDS ECOL EVOL, V14, P133, DOI 10.1016/S0169-5347(98)01579-1; GRAVES JE, 1992, FISH B-NOAA, V90, P469; Gunther D, 1999, J ANAL ATOM SPECTROM, V14, P1363, DOI 10.1039/a901648a; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Kennedy BP, 1997, NATURE, V387, P766, DOI 10.1038/42835; LowerreBarbieri SK, 1996, T AM FISH SOC, V125, P532, DOI 10.1577/1548-8659(1996)125<0532:VSAAAF>2.3.CO;2; LOWERREBARBIERI SK, 1995, FISH B-NOAA, V93, P643; McQuinn IH, 1997, REV FISH BIOL FISHER, V7, P297, DOI 10.1023/A:1018491828875; MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071; Nevitt G., 1998, INTEGR BIOL, V1, P215, DOI [10.1002/(SICI)1520-6602(1998)1:6%3C215:AID-INBI3%3E3.0.CO;2-V, DOI 10.1002/(SICI)1520-6602(1998)1:6<215::AID-INBI3>3.0.C0;2-V]; Nichols James D., 1996, P147; OBANNON BK, 1999, CURRENT FISHERY STAT; QUINN TP, 1993, FISH RES, V18, P29, DOI 10.1016/0165-7836(93)90038-9; Rosenthal Y, 1999, ANAL CHEM, V71, P3248, DOI 10.1021/ac981410x; ROWE PM, 1994, MAR ECOL PROG SER, V110, P105, DOI 10.3354/meps110105; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Thorrold SR, 1998, MAR ECOL PROG SER, V173, P253, DOI 10.3354/meps173253; Thorrold SR, 1998, LIMNOL OCEANOGR, V43, P1826; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438	26	521	543	1	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					297	299		10.1126/science.291.5502.297	http://dx.doi.org/10.1126/science.291.5502.297			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209078				2022-12-28	WOS:000166352900043
J	Zhao, YD; Christensen, SK; Fankhauser, C; Cashman, JR; Cohen, JD; Weigel, D; Chory, J				Zhao, YD; Christensen, SK; Fankhauser, C; Cashman, JR; Cohen, JD; Weigel, D; Chory, J			A role for flavin monooxygenase-like enzymes in auxin biosynthesis	SCIENCE			English	Article							CONTAINING MONO-OXYGENASE; ARABIDOPSIS-THALIANA; HALF-REACTION; NITRILASE; GENE; ELONGATION; TOBACCO; ROOT; INDOLE-3-ACETONITRILE; OVERPRODUCTION	Although auxin is known to regulate many processes in plant development and has been studied for over a century, the mechanisms whereby plants produce it have remained elusive. Here we report the characterization of a dominant Arabidopsis mutant,yucca, which contains elevated Levels of free auxin. YUCCA encodes a flavin monooxygenase-like enzyme and belongs to a family that includes at Least nine other homologous Arabidopsis genes, a subset of which appears to have redundant functions, Results from tryptophan analog feeding experiments and biochemical assays indicate that YUCCA catalyzes hydroxylation of the amino group of tryptamine, a rate-limiting step in tryptophan-dependent auxin biosynthesis.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Human Biomol Res Inst, San Diego, CA 92121 USA; Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of Minnesota System; University of Minnesota Twin Cities	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.		Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Fankhauser, Christian/C-4291-2018; Fankhauser, Christian/ABE-8757-2021; Weigel, Detlef/AAR-3312-2021; Cohen, Jerry/AAF-3737-2020	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Fankhauser, Christian/0000-0003-4719-5901; Fankhauser, Christian/0000-0003-4719-5901; Cohen, Jerry/0000-0003-2816-8676	NIGMS NIH HHS [2R01GM52413, R01GM36426] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036426, R01GM052413] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTEL B, 1994, P NATL ACAD SCI USA, V91, P6649, DOI 10.1073/pnas.91.14.6649; Bartel Bonnie, 1997, Annu Rev Plant Physiol Plant Mol Biol, V48, P51, DOI 10.1146/annurev.arplant.48.1.51; BARTLING D, 1992, EUR J BIOCHEM, V205, P417, DOI 10.1111/j.1432-1033.1992.tb16795.x; BEATY NB, 1981, J BIOL CHEM, V256, P4619; BEATY NB, 1981, J BIOL CHEM, V256, P4611; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Brunelle A, 1997, DRUG METAB DISPOS, V25, P1001; CASHMAN JR, 1995, CHEM RES TOXICOL, V8, P165, DOI 10.1021/tx00044a001; CELENZA JL, 1995, GENE DEV, V9, P2131, DOI 10.1101/gad.9.17.2131; CHEN KH, 1988, PLANT PHYSIOL, V86, P822, DOI 10.1104/pp.86.3.822; Davies Peter J., 1995, P1; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Gallois P, 1995, Methods Mol Biol, V49, P39; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; King JJ, 1995, PLANT CELL, V7, P2023, DOI 10.1105/tpc.7.12.2023; Lehman A, 1996, CELL, V85, P183, DOI 10.1016/S0092-8674(00)81095-8; Mathur J, 1998, METH MOL B, V82, P31; Normanly J, 1997, PLANT CELL, V9, P1781, DOI 10.1105/tpc.9.10.1781; Pitts RJ, 1998, PLANT J, V16, P553, DOI 10.1046/j.1365-313x.1998.00321.x; ROMANO CP, 1995, PLANT MOL BIOL, V27, P1071, DOI 10.1007/BF00020881; ROMANO CP, 1991, GENE DEV, V5, P438, DOI 10.1101/gad.5.3.438; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Schmidt RC, 1996, PLANT J, V9, P683, DOI 10.1046/j.1365-313X.1996.9050683.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Zhao Y., UNPUB; ZIEGLER DM, 1988, DRUG METAB REV, V19, P1, DOI 10.3109/03602538809049617	26	821	894	13	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					306	309		10.1126/science.291.5502.306	http://dx.doi.org/10.1126/science.291.5502.306			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209081				2022-12-28	WOS:000166352900046
J	Lievre, M; Menard, J; Bruckert, E; Cogneau, J; Delahaye, F; Giral, P; Leitersdorf, E; Luc, G; Masana, L; Moulin, P; Passa, P; Pouchain, D; Siest, G				Lievre, M; Menard, J; Bruckert, E; Cogneau, J; Delahaye, F; Giral, P; Leitersdorf, E; Luc, G; Masana, L; Moulin, P; Passa, P; Pouchain, D; Siest, G			Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; PREVENTION; STATINS; MEN		Fac Med Laennec, Clin Pharmacol Unit, F-69376 Lyon 08, France; Hop Europeen Georges Pompidou, Dept Internal Med, F-75908 Paris, France; Hop La Pitie Salpetriere, Dept Endocrinol, F-75651 Paris 13, France; Lyons Cardiol Hosp, F-69500 Bron, France; Hadassah Univ Hosp, Div Med, IL-91120 Jerusalem, Israel; INSERM, F-59019 Lille, France; Hosp Univ St Joan, Dept Internal Med, Tarragona 42201, Spain; Hop St Louis, Diabetol Unit, F-75475 Paris, France; INSERM, U525, Drugs Ctr, F-54000 Nancy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; Hebrew University of Jerusalem; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lievre, M (corresponding author), Fac Med Laennec, Clin Pharmacol Unit, BP 8071, F-69376 Lyon 08, France.		MASANA, LUIS/M-7002-2019	MASANA, LUIS/0000-0002-0789-4954; COGNEAU, Joel/0000-0003-1673-7528; SIEST, Gerard/0000-0002-3001-760X				Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fey R, 1996, LANCET, V347, P1389, DOI 10.1016/S0140-6736(96)91019-3; Hopf G, 1997, LANCET, V350, P891, DOI 10.1016/S0140-6736(05)62079-X; Langer A, 1997, LANCET, V350, P890, DOI 10.1016/S0140-6736(05)62078-8; Muldoon MF, 1997, BRIT MED J, V315, P1554, DOI 10.1136/bmj.315.7122.1554; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Ulrich S, 2000, BMJ-BRIT MED J, V320, P1134, DOI 10.1136/bmj.320.7242.1134; Viberti G, 1997, LANCET, V350, P214; 1997, LANCET, V350, P155	9	64	65	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					603	605		10.1136/bmj.322.7286.603	http://dx.doi.org/10.1136/bmj.322.7286.603			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238162	Green Published			2022-12-28	WOS:000167499900031
J	Freed, CR; Greene, PE; Breeze, RE; Tsai, WY; DuMouchel, W; Kao, R; Dillon, S; Winfield, H; Culver, S; Trojanowski, JQ; Eidelberg, D; Fahn, S				Freed, CR; Greene, PE; Breeze, RE; Tsai, WY; DuMouchel, W; Kao, R; Dillon, S; Winfield, H; Culver, S; Trojanowski, JQ; Eidelberg, D; Fahn, S			Transplantation of embryonic dopamine neurons for severe Parkinson's disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FETAL NIGRAL TRANSPLANTATION; LONG-TERM SURVIVAL; MESENCEPHALIC TISSUE; GRAFTS; IMPROVEMENT; CELLS	Background: Transplantation of human embryonic dopamine neurons into the brains of patients with Parkinson's disease has proved beneficial in open clinical trials. However, whether this intervention would be more effective than sham surgery in a controlled trial is not known. Methods: We randomly assigned 40 patients who were 34 to 75 years of age and had severe Parkinson's disease (mean duration, 14 years) to receive a transplant of nerve cells or undergo sham surgery; all were to be followed in a double-blind manner for one year. In the transplant recipients, cultured mesencephalic tissue from four embryos was implanted into the putamen bilaterally. In the patients who underwent sham surgery, holes were drilled in the skull but the dura was not penetrated. The primary outcome was a subjective global rating of the change in the severity of disease, scored on a scale of -3.0 to 3.0 at one year, with negative scores indicating a worsening of symptoms and positive scores an improvement. Results: The mean (+/-SD) scores on the global rating scale for improvement or deterioration at one year were 0.0+/-2.1 in the transplantation group and -0.4+/-1.7 in the sham-surgery group. Among younger patients (60 years old or younger), standardized tests of Parkinson's disease revealed significant improvement in the transplantation group as compared with the sham-surgery group when patients were tested in the morning before receiving medication (P = 0.01 for scores on the Unified Parkinson's Disease Rating Scale; P = 0.006 for the Schwab and England score). There was no significant improvement in older patients in the transplantation group. Fiber outgrowth from the transplanted neurons was detected in 17 of the 20 patients in the transplantation group, as indicated by an increase in F-18-fluorodopa uptake on positron-emission tomography or postmortem examination. After improvement in the first year, dystonia and dyskinesias recurred in 15 percent of the patients who received transplants, even after reduction or discontinuation of the dose of levodopa. Conclusions: Human embryonic dopamine-neuron transplants survive in patients with severe Parkinson's disease and result in some clinical benefit in younger but not in older patients. (N Engl J Med 2001;344:710-9.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Colorado, Sch Med, Div Clin Pharmacol, Denver, CO 80262 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA; AT&T Shannon Lab, Florham Park, NJ USA; Univ Penn, Med Ctr, Philadelphia, PA 19104 USA; N Shore Univ Hosp, Manhasset, NY USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Columbia University; AT&T; University of Pennsylvania; Northwell Health; North Shore University Hospital	Freed, CR (corresponding author), Univ Colorado, Sch Med, Div Clin Pharmacol, C-237,4200 E 9th Ave, Denver, CO 80262 USA.		Eidelberg, David/F-5214-2011	Eidelberg, David/0000-0002-0854-864X	NCRR NIH HHS [5 M01 RR00069] Funding Source: Medline; NINDS NIH HHS [R01 NS 32368] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032368] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417, DOI 10.1152/jn.1985.53.6.1417; ANSARI AA, 1995, TRANSPL P, V27, P1401; BREEZE RE, 1995, NEUROSURGERY, V36, P1044, DOI 10.1227/00006123-199505000-00027; BROOKS DJ, 1990, ANN NEUROL, V28, P547, DOI 10.1002/ana.410280412; Clarkson ED, 1998, BRAIN RES, V806, P60, DOI 10.1016/S0006-8993(98)00717-3; COHEN J, 1994, SCIENCE, V263, P600, DOI 10.1126/science.8303261; COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703; Defer GL, 1996, BRAIN, V119, P41, DOI 10.1093/brain/119.1.41; Fahn S, 1999, NEUROLOGY, V52, pA405; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Freed C. R., 1998, Society for Neuroscience Abstracts, V24, P559; Freed C. R., 1999, Society for Neuroscience Abstracts, V25, P212; FREED CR, 1993, ADV NEUROL, V60, P721; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; Freed CR, 1999, NEUROLOGY, V52, pA272; FREED CR, 1990, ARCH NEUROL-CHICAGO, V47, P505, DOI 10.1001/archneur.1990.00530050021007; Freed CR, 1995, CLIN IMMUNOLOGY PRIN, P1677; FREED CR, 1991, INTRACEREBRAL TRANSP, V69, P77; FREEMAN TB, 1995, ANN NEUROL, V38, P379, DOI 10.1002/ana.410380307; Greene P., 1999, MOVEMENT DISORD, V14, P904; HASTIC TJ, 1990, GEN ADDITIVE MODELS; Hauser RA, 1999, ARCH NEUROL-CHICAGO, V56, P179, DOI 10.1001/archneur.56.2.179; Ishikawa T, 1996, J NUCL MED, V37, P1760; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kopyov OV, 1996, CELL TRANSPLANT, V5, P327, DOI 10.1016/0963-6897(95)02035-7; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; PESCHANSKI M, 1994, BRAIN, V117, P487, DOI 10.1093/brain/117.3.487; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Ramsay J.O., 1997, FUNCTIONAL DATA ANAL; Schwab J., 1968, 3 S PARK DIS, P152; SPENCER DD, 1992, NEW ENGL J MED, V327, P1541, DOI 10.1056/NEJM199211263272201; TAKIKAWA S, 1994, J NUCL MED, V35, P955; Wenning GK, 1997, ANN NEUROL, V42, P95, DOI 10.1002/ana.410420115; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203	38	1703	1815	5	158	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2001	344	10					710	719		10.1056/NEJM200103083441002	http://dx.doi.org/10.1056/NEJM200103083441002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408AX	11236774				2022-12-28	WOS:000167305300002
J	Dixon, JE; King, MA				Dixon, JE; King, MA			Chronic thromboembolic pulmonary hypertension.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Ohio State Univ, Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Dixon, JE (corresponding author), Ohio State Univ, Med Ctr, Columbus, OH 43210 USA.								0	3	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2001	344	9					644	644		10.1056/NEJM200103013440905	http://dx.doi.org/10.1056/NEJM200103013440905			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405TR	11228279				2022-12-28	WOS:000167177100005
J	Mitton, S				Mitton, S			Light brought to a standstill	LANCET			English	Editorial Material									Univ Cambridge, St Edmunds Coll, Cambridge CB3 0BN, England	University of Cambridge	Mitton, S (corresponding author), Univ Cambridge, St Edmunds Coll, Cambridge CB3 0BN, England.		Mitton, Simon A/A-5899-2012	Mitton, Simon A/0000-0003-3695-9806				Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; WALSWORTH R, 2001, PHY REV LETT, V86, P783	2	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					496	496		10.1016/S0140-6736(00)04039-3	http://dx.doi.org/10.1016/S0140-6736(00)04039-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229666				2022-12-28	WOS:000167011700007
J	Paabo, S				Paabo, S			Genomics and society - The human genome and our view of ourselves	SCIENCE			English	Article							EVOLUTION; SEQUENCE		Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Max Planck Society	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	paabo@eva.mpg.de						Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Klein R.G., 1999, HUMAN CAREER; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	6	69	76	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1219	+		10.1126/science.1056972	http://dx.doi.org/10.1126/science.1056972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233444				2022-12-28	WOS:000166993400022
J	Jimenez-Sanchez, G; Childs, B; Valle, D				Jimenez-Sanchez, G; Childs, B; Valle, D			Human disease genes	NATURE			English	Article							BIOLOGY	The complete human genome sequence will facilitate the identification of all genes that contribute to disease. We propose that the functional classification of disease genes and their products will reveal general principles of human disease. We have determined functional categories for nearly 1,000 documented disease genes, and found striking correlations between the function of the gene product and features of disease, such as age of onset and mode of inheritance. As knowledge of disease genes grows, including those contributing to complex traits, more sophisticated analyses will be possible; their results will yield a deeper understanding of disease and an enhanced integration of medicine with biology.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Valle, D (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Dept Pediat, Baltimore, MD 21205 USA.	dvalle@jhmi.edu						Antonarakis SE, 2000, NAT GENET, V25, P11, DOI 10.1038/75497; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BRUSILOW SW, 1989, CURRENT THERAPY NEON, P164; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Childs B, 2000, ANNU REV GENOM HUM G, V1, P1, DOI 10.1146/annurev.genom.1.1.1; JIMENEZSANCHEZ G, 2001, METABOLIC MOL BASES, P167; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; TREACY E, 1995, AM J HUM GENET, V56, P359	9	270	281	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					853	855		10.1038/35057050	http://dx.doi.org/10.1038/35057050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237009	Bronze			2022-12-28	WOS:000166938800056
J	Leidig-Bruckner, G; Hosch, S; Dodidou, P; Ritschel, D; Conradt, C; Klose, C; Otto, G; Lange, R; Theilmann, L; Zimmerman, R; Pritsch, M; Ziegler, R				Leidig-Bruckner, G; Hosch, S; Dodidou, P; Ritschel, D; Conradt, C; Klose, C; Otto, G; Lange, R; Theilmann, L; Zimmerman, R; Pritsch, M; Ziegler, R			Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study	LANCET			English	Article							PRIMARY BILIARY-CIRRHOSIS; QUALITY-OF-LIFE; BONE LOSS; HEART-TRANSPLANTATION; CYCLOSPORINE-A; RECIPIENTS; DEFORMITY; WOMEN; MECHANISMS; PREVENTION	Background Osteoporosis and related fractures are a major complication after organ transplantation. The aim of this study was to find out the frequency and predictors of osteoporotic fractures after cardiac or liver transplantation. Methods 235 consecutive patients who had a cardiac transplant (n=105; 88 men, 17 women) or a liver transplant (130; 75 men, 55 women) were followed. Vertebral fractures were assessed by a standardised analysis of spinal radiographs before and annually after transplantation. Clinical and non-vertebral fracture data were noted from hospital records. Findings in the first and second years after transplantation, the proportion of patients (Kaplan-Meier estimates) who had at least one Vertebral fracture was slightly higher in the cardiac group (first year 21%, second year 27%) than in the liver group (first year 14%, second year 21%). in the third and fourth years, one third of patients from both groups had had one or more vertebral fractures. Non-vertebral fractures occurred in nine patients (7%) after liver transplantation and avascular necrosis of the hip head in three patients (3%) after cardiac transplantation. In both groups, no dose-dependent effect of immunosuppressive therapy on fracture development could be identified. Independent predictors assessed by multivariate analysis were age (hazard ratio [95% CI] increase of 5 years, 1.71 [1.1-2.7]) and lumbar bane-mineral density (decrease of 1 SD t score, 1.97 [1.2-3.2]) in cardiac transplantation patients, and vertebral fractures before transplantation (6.07 [1.7-21.7]) in the liver group. Interpretation The high frequency of osteoporotic fractures in the 2 years after transplantation and the limitations of reliable fracture-risk predictions, show the need to investigate preventive therapies.	Univ Heidelberg, Dept Internal Med, D-69115 Heidelberg, Germany; Univ Heidelberg, Dept Endocrinol & Metab, D-69115 Heidelberg, Germany; Univ Heidelberg, Dept Gastroenterol, D-69115 Heidelberg, Germany; Univ Heidelberg, Dept Cardiol, D-69115 Heidelberg, Germany; Univ Heidelberg, Dept Med Biometry, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Surg, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Thorac & Cardiac Surg, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Leidig-Bruckner, G (corresponding author), Univ Heidelberg, Dept Internal Med, Bergheimer Str 58, D-69115 Heidelberg, Germany.							Braith RW, 1996, J AM COLL CARDIOL, V28, P1471, DOI 10.1016/S0735-1097(96)00347-6; BURKHARDT R, 1981, LANCET, V1, P844; CUMMINGS SR, 1995, J BONE MINER RES, V10, P518; CVETKOVIC M, 1994, TRANSPLANTATION, V57, P1231, DOI 10.1097/00007890-199404270-00016; DEQUEKER J, 1995, BONE, V17, P247, DOI 10.1016/8756-3282(95)00224-2; EASTELL R, 1991, HEPATOLOGY, V14, P296, DOI 10.1002/hep.1840140215; Ebeling PR, 1999, J BONE MINER RES, V14, P342, DOI 10.1359/jbmr.1999.14.3.342; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; LEE AH, 1994, AM J MED, V96, P35, DOI 10.1016/0002-9343(94)90113-9; Leidig-Bruckner G, 2000, OSTEOPOROSIS INT, V11, P102, DOI 10.1007/PL00004172; LeidigBruckner G, 1997, J BONE MINER RES, V12, P663, DOI 10.1359/jbmr.1997.12.4.663; MCDONALD JA, 1991, HEPATOLOGY, V14, P613, DOI 10.1002/hep.1840140407; MEYS E, 1994, AM J MED, V97, P445, DOI 10.1016/0002-9343(94)90324-7; MINNE HW, 1988, BONE MINER, V3, P335; MUCHMORE JS, 1991, TRANSPLANT P, V23, P1184; NAVASA M, 1994, BRIT J RHEUMATOL, V33, P52; Navasa M, 1996, J HEPATOL, V25, P129, DOI 10.1016/S0168-8278(96)80064-X; Negri AL, 1996, TRANSPLANT P, V28, P3321; Park KM, 1996, TRANSPLANT P, V28, P1738; Pilmore H, 1998, AM J NEPHROL, V18, P57, DOI 10.1159/000013305; PORAYKO MK, 1991, TRANSPLANT P, V23, P1462; Ramsey-Goldman R, 1999, J BONE MINER RES, V14, P456, DOI 10.1359/jbmr.1999.14.3.456; RICH GM, 1992, J HEART LUNG TRANSPL, V11, P950; Riemens SC, 1996, OSTEOPOROSIS INT, V6, P213, DOI 10.1007/BF01622737; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; SAMBROOK PN, 1994, OSTEOPOROSIS INT, V4, P273, DOI 10.1007/BF01623351; Scheidt-Nave C, 1998, MED KLIN, V93, P46, DOI 10.1007/BF03041999; Shane E, 1996, J CLIN ENDOCR METAB, V81, P1740, DOI 10.1210/jc.81.5.1740; Shane E, 1997, J CLIN ENDOCR METAB, V82, P1497, DOI 10.1210/jc.82.5.1497; Shane E, 1998, J HEART LUNG TRANSPL, V17, P1089; Thiebaud D, 1996, EUR J CLIN INVEST, V26, P549, DOI 10.1046/j.1365-2362.1996.00170.x; VanCleemput J, 1996, TRANSPLANTATION, V61, P1495, DOI 10.1097/00007890-199605270-00015; Vedi S, 1999, J BONE MINER RES, V14, P281, DOI 10.1359/jbmr.1999.14.2.281	33	184	196	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					342	347		10.1016/S0140-6736(00)03641-2	http://dx.doi.org/10.1016/S0140-6736(00)03641-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210996				2022-12-28	WOS:000166897900012
J	Tu, SM; Millikan, RE; Mengistu, B; Delpassand, ES; Amato, RJ; Pagliaro, LC; Daliani, D; Papandreou, CN; Smith, TL; Kim, J; Podoloff, DA; Logothetis, CJ				Tu, SM; Millikan, RE; Mengistu, B; Delpassand, ES; Amato, RJ; Pagliaro, LC; Daliani, D; Papandreou, CN; Smith, TL; Kim, J; Podoloff, DA; Logothetis, CJ			Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial	LANCET			English	Article							PROGNOSTIC FACTORS; CLINICAL-TRIALS; CANCER; METASTASES; EFFICACY; PAMIDRONATE; CRITERIA; SURVIVAL	Background Prostate carcinoma is linked to osteoblastic metastasis. We therefore investigated the value of bone-targeted consolidation therapy in selected patients with advanced androgen-independent carcinoma of the prostate. Methods 103 patients received induction chemotherapy, consisting of ketoconazole and doxorubicin alternating with estramustine and vinblastine. After two or three cycles of induction chemotherapy, we randomly assigned 72 patients who were clinically stable or responders to receive doxorubicin with or without strontium-89 (Sr-89) every week for 6 weeks. Findings Overall 62 of the 103 (60%, 95% CI 50-70) patients had a 50% or greater reduction in serum prostate-specific antigen concentration that was maintained for at least 8 weeks, and 43 (42%, 32-52) had an 80% or greater reduction. 49 (52%) patients with bone pain at registration had complete resolution of pain. After follow-up of 67 patients until death, the estimated median survival for all 103 patients was 17.5 months (range 0.5-37.7). For the 36 patients randomly assigned to receive Sr-89 and doxorubicin, the median survival time was 27.7 months (4.9-37.7), and for the 36 who received doxorubicin alone it was 16.8 months (4.4-34.2) (p=0.0014). The hazard ratio was 2.76 (95% CI 1.44-5.29). Interpretation Bone-targeted consolidation therapy consisting of one dose of Sr-89 plus doxorubicin once a week for 6 weeks, when given to patients with stable or responding advanced androgen-independent carcinoma of the prostate after induction chemotherapy, improved overall survival.	Univ Texas, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Nucl Med, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Tu, SM (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	stu@notes.mdacc.tmc.edu	Millikan, Randall/AAL-9377-2021		NCI NIH HHS [CA 16672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amato R J, 1995, Urol Oncol, V1, P168, DOI 10.1016/1078-1439(95)00058-5; Batson OV, 1940, ANN SURG, V112, P138, DOI 10.1097/00000658-194007000-00016; Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; Ellerhorst JA, 1997, CLIN CANCER RES, V3, P2371; GALASKO CSB, 1981, BONE METASTASIS, V6, P49; GLOTZMAN D, 1997, CANCER S, V80, P1581; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; JACOBSSON H, 1991, INT J RADIAT ONCOL, V20, P1297, DOI 10.1016/0360-3016(91)90241-U; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KEMENY N, 1997, CANC MED, V2, P1941; Koeneman KS, 1999, PROSTATE, V39, P246; Liu PY, 1999, CONTROL CLIN TRIALS, V20, P343, DOI 10.1016/S0197-2456(99)00009-4; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; NEWLING DWW, 1993, CANCER, V72, P3793, DOI 10.1002/1097-0142(19931215)72:12+<3793::AID-CNCR2820721706>3.0.CO;2-U; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; POLLEN JJ, 1981, CANCER, V47, P2585, DOI 10.1002/1097-0142(19810601)47:11<2585::AID-CNCR2820471113>3.0.CO;2-U; PORTER AT, 1993, INT J RADIAT ONCOL, V25, P805, DOI 10.1016/0360-3016(93)90309-J; PUTNAM JB, 1983, ANN THORAC SURG, V36, P516, DOI 10.1016/S0003-4975(10)60679-0; Robinson R G, 1989, Radiographics, V9, P271; Sabbatini P, 1999, J CLIN ONCOL, V17, P948, DOI 10.1200/JCO.1999.17.3.948; SELLA A, 1994, J CLIN ONCOL, V12, P683, DOI 10.1200/JCO.1994.12.4.683; SIMON R, 1985, CANCER TREAT REP, V69, P1375; SOLOWAY MS, 1988, CANCER, V61, P195, DOI 10.1002/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y; STANLEY KE, 1980, J NATL CANCER I, V65, P25; Tannock IF, 1996, J NATL CANCER I, V88, P206, DOI 10.1093/jnci/88.3-4.206; Tannock IF, 1996, J CLIN ONCOL, V14, P1756, DOI 10.1200/JCO.1996.14.6.1756; Tu S M, 1996, Urol Oncol, V2, P191, DOI 10.1016/S1078-1439(97)00013-6; Tu SM, 1998, CLIN CANCER RES, V4, P1193; [No title captured]	30	278	285	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2001	357	9253					336	341		10.1016/S0140-6736(00)03639-4	http://dx.doi.org/10.1016/S0140-6736(00)03639-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210994				2022-12-28	WOS:000166897900010
J	Reginster, JY; Deroisy, R; Rovati, LC; Lee, RL; Lejeune, E; Bruyere, O; Giacovelli, G; Henrotin, Y; Dacre, JE; Gossett, C				Reginster, JY; Deroisy, R; Rovati, LC; Lee, RL; Lejeune, E; Bruyere, O; Giacovelli, G; Henrotin, Y; Dacre, JE; Gossett, C			Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial	LANCET			English	Article							OSTEO-ARTHRITIS; DRUGS; RECOMMENDATIONS; CHONDROITIN	Background Treatment of osteoarthritis is usually limited to short-term symptom control. We assessed the effects of the specific drug glucosamine sulphate on the long-term progression of osteoarthritis joint structure changes and symptoms. Methods We did a randomised, double-blind placebo controlled trial, in which 212 patients with knee osteoarthritis were randomly assigned 1500 mg sulphate oral glucosamine or placebo once daily for 3 years. Weightbearing, anteroposterior radiographs of each knee in full extension were taken at enrolment and after 1 and 3 years. Mean joint-space width of the medial compartment of the tibiofemoral joint was assessed by digital image analysis, whereas minimum Joint-space width-ie, at the narrowest point-was measured by visual inspection with a magnifying lens. Symptoms were scored by the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index. Findings The 106 patients on placebo had a progressive joint-space narrowing, with a mean joint-space loss after 3 years of -0.31 mm (95% CI -0.48 to -0.13). There was no significant joint-space loss in the 106 patients on glucosamine sulphate: -0.06 mm (-0.22 to 0.09). Similar results were reported with minimum joint-space narrowing. As assessed by WOMAC scores, symptoms worsened slightly in patients on placebo compared with the improvement observed after treatment with glucosamine sulphate. There were no differences in safety or reasons for early withdrawal between the treatment and placebo groups. symptoms worsened compared with the Interpretation The long-term combined structure-modifying and symptom-modifying effects of gluosamine sulphate suggest that it could be a disease modifying agent in osteoarthritis.	Univ Liege, Bone & Cartilage Metab Res Unit, WHO, Collaborating Ctr Publ Aspects Osteoarticular Dis, B-4020 Liege, Belgium; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; Rotta Res Lab SpA, Dept Clin Pharmacol, Monza, Italy; UCL, Whittington Hosp, Dept Rheumatol, London, England	University of Liege; World Health Organization; Georgetown University; University of London; University College London	Reginster, JY (corresponding author), Univ Liege, Bone & Cartilage Metab Res Unit, WHO, Collaborating Ctr Publ Aspects Osteoarticular Dis, B-4020 Liege, Belgium.	jyreginster@ulg.ac.be	Bruyere, Olivier/H-8302-2019	Bruyere, Olivier/0000-0003-4269-9393; Rovati, Lucio/0000-0002-3425-1583				Adams ME, 1999, LANCET, V354, P353, DOI 10.1016/S0140-6736(99)90040-5; Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Bassleer C, 1998, OSTEOARTHR CARTILAGE, V6, P427, DOI 10.1053/joca.1998.0146; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Buckland-Wright JC, 1999, J RHEUMATOL, V26, P2664; BYRNE J, 1993, OSTEOARTHR CARTILAGE, V1, P60; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; DACRE JE, 1989, BRIT J RHEUMATOL, V28, P506; Dieppe PA, 1997, OSTEOARTHR CARTILAGE, V5, P87, DOI 10.1016/S1063-4584(97)80002-7; Dodge GR, 1999, ARTHRITIS RHEUM, V42, pS253; Dougados M, 1996, ANN RHEUM DIS, V55, P552; HAMERMAN D, 1989, NEW ENGL J MED, V320, P1322; LEQUESNE M, 1994, J RHEUMATOL, V21, P65; Lequesne M., 1995, OSTEOARTHRITIC DISOR, P427; LETHBRIDGECEIKU M, 1995, ARTHRITIS RHEUM, V38, P426; Mazzuca SA, 1997, OSTEOARTHR CARTILAGE, V5, P217, DOI 10.1016/S1063-4584(97)80017-9; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; Muller-Fassbender H, 1994, Osteoarthritis Cartilage, V2, P61, DOI 10.1016/S1063-4584(05)80007-X; Neuhauser K. B., 1994, Arthritis and Rheumatism, V37, pS423; Noack W, 1994, Osteoarthritis Cartilage, V2, P51, DOI 10.1016/S1063-4584(05)80006-8; Piperno M, 1998, OSTEOARTHR CARTILAGE, V6, P252, DOI 10.1053/joca.1998.0118; RASHAD S, 1989, LANCET, V2, P519; ROVATI LC, 1997, OSTEOARTHR CARTILAGE, V5, P72; Sandy JD, 1998, BIOCHEM J, V335, P59, DOI 10.1042/bj3350059; SETNIKAR I, 1991, ARZNEIMITTEL-FORSCH, V41-1, P157; Shikhman AR, 1999, ARTHRITIS RHEUM, V42, pS381; Towheed TE, 2000, JAMA-J AM MED ASSOC, V283, P1483, DOI 10.1001/jama.283.11.1483	29	851	931	2	97	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2001	357	9252					251	256		10.1016/S0140-6736(00)03610-2	http://dx.doi.org/10.1016/S0140-6736(00)03610-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214126				2022-12-28	WOS:000166693400008
J	Benner, SA				Benner, SA			Natural progression	NATURE			English	Editorial Material									Univ Florida, Dept Chem, Div Biochem, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Benner, SA (corresponding author), Univ Florida, Dept Chem, Div Biochem, POB 117200, Gainesville, FL 32611 USA.							Behe Michael, 1996, DARWINS BLACK BOX; Benner SA, 1998, ADV ENZYME REGUL, V38, P155, DOI 10.1016/S0065-2571(97)00019-8; Benner SA, 1997, CHEM REV, V97, P2725, DOI 10.1021/cr940469a; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; GOH, 2000, J MOL BIOL, V299, P283; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0	6	8	8	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					459	459		10.1038/35054149	http://dx.doi.org/10.1038/35054149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206523				2022-12-28	WOS:000166570500022
J	Ivanisevic, A; Yeh, JY; Mawst, L; Kuech, TF; Ellis, AB				Ivanisevic, A; Yeh, JY; Mawst, L; Kuech, TF; Ellis, AB			Semiconductor devices - Light-emitting diodes as chemical sensors	NATURE			English	Article							SILICON		Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ellis, AB (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.							Boroditsky M, 2000, J APPL PHYS, V87, P3497, DOI 10.1063/1.372372; Harper J, 1996, ANAL CHEM, V68, P3713, DOI 10.1021/ac960642y; Janata J, 1998, ACCOUNTS CHEM RES, V31, P241, DOI 10.1021/ar9700668; Kelly MT, 1996, NATURE, V382, P214, DOI 10.1038/382214b0; Krier A, 2000, J PHYS D APPL PHYS, V33, P1656, DOI 10.1088/0022-3727/33/14/304; Kunugi Y, 1998, CHEM MATER, V10, P1487, DOI 10.1021/cm980114y; Lorenz JK, 1998, LANGMUIR, V14, P1680, DOI 10.1021/la971196s; Ohyama T, 2000, SENSOR ACTUAT B-CHEM, V64, P142, DOI 10.1016/S0925-4005(99)00497-9; Ponce FA, 1997, NATURE, V386, P351, DOI 10.1038/386351a0; Seker F, 2000, CHEM REV, V100, P2505, DOI 10.1021/cr980093r; Stringfellow GB, 1997, SEMICONDUCT SEMIMET, V48, P1, DOI 10.1016/S0080-8784(08)62402-3	11	27	27	0	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					476	476		10.1038/35054131	http://dx.doi.org/10.1038/35054131			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206534				2022-12-28	WOS:000166570500035
J	Karner, MB; DeLong, EF; Karl, DM				Karner, MB; DeLong, EF; Karl, DM			Archaeal dominance in the mesopelagic zone of the Pacific Ocean	NATURE			English	Article							MARINE PLANKTONIC ARCHAEA; IN-SITU HYBRIDIZATION; VERTICAL-DISTRIBUTION; BACTERIA; PROBES; BACTERIOPLANKTON; PICOPLANKTON; ANTARCTICA; SEQUENCES	The ocean's interior is Earth's largest biome. Recently, cultivation-independent ribosomal RNA gene surveys have indicated a potential importance for archaea(1) in the subsurface ocean(2-4). But quantitative data on the abundance of specific microbial groups in the deep sea are lacking(5,6). Here we report a year-long study of the abundance of two specific archaeal groups (pelagic euryarchaeota and pelagic crenarchaeota)(2) in one of the ocean's largest habitats. Monthly sampling was conducted throughout the water column (surface to 4,750 m) at the Hawai'i Ocean Time-series station(7). Below the euphotic zone (>150 m), pelagic crenarchaeota comprised a large fraction of total marine picoplankton, equivalent in cell numbers to bacteria at depths greater than 1,000 m. The fraction of crenarchaeota increased with depth, reaching 39% of total DNA-containing picoplankton detected. The average sum of archaea plus bacteria detected by rRNA-targeted fluorescent probes ranged from 63 to 90% of total cell numbers at all depths throughout our survey. The high proportion of cells containing significant amounts of rRNA suggests that most pelagic deep-sea microorganisms are metabolically active. Furthermore, our results suggest that the global oceans harbour approximately 1.3 x 10(28) archaeal cells, and 3.1 x 10(28) bacterial cells. Our data suggest that pelagic crenarchaeota represent one of the ocean's single most abundant cell types.	Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	University of Hawaii System; Monterey Bay Aquarium Research Institute	Karner, MB (corresponding author), Univ Hawaii, Dept Oceanog, 1000 Pope Rd, Honolulu, HI 96822 USA.		Karl, David/AFP-3837-2022	Karl, David/0000-0002-6660-6721				AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DELONG EF, 1994, NATURE, V371, P695, DOI 10.1038/371695a0; Fuhrman JA, 1997, MAR ECOL PROG SER, V150, P275, DOI 10.3354/meps150275; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Fuhrman Jed. A., 1998, Aquatic Ecology, V32, P3, DOI 10.1023/A:1009974817127; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; HICKS RE, 1992, APPL ENVIRON MICROB, V58, P2158, DOI 10.1128/AEM.58.7.2158-2163.1992; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Karner M, 1997, APPL ENVIRON MICROB, V63, P1208, DOI 10.1128/AEM.63.4.1208-1213.1997; LEE SH, 1994, LIMNOL OCEANOGR, V39, P869, DOI 10.4319/lo.1994.39.4.0869; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Massana R, 1998, LIMNOL OCEANOGR, V43, P607, DOI 10.4319/lo.1998.43.4.0607; MENARD HW, 1966, J GEOPHYS RES, V71, P4305, DOI 10.1029/JZ071i018p04305; Murray AE, 1999, AQUAT MICROB ECOL, V20, P129, DOI 10.3354/ame020129; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Nagata T, 2000, LIMNOL OCEANOGR, V45, P426, DOI 10.4319/lo.2000.45.2.0426; OLSEN GJ, 1994, NATURE, V371, P657, DOI 10.1038/371657a0; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Simon M, 1999, AQUAT MICROB ECOL, V18, P275, DOI 10.3354/ame018275; Stein JL, 1996, P NATL ACAD SCI USA, V93, P6228, DOI 10.1073/pnas.93.13.6228; WILLIAMS PM, 1980, OCEANOL ACTA, V3, P471; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; ZWEIFEL UL, 1995, APPL ENVIRON MICROB, V61, P2180, DOI 10.1128/AEM.61.6.2180-2185.1995	26	1087	1156	11	225	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					507	510		10.1038/35054051	http://dx.doi.org/10.1038/35054051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206545				2022-12-28	WOS:000166570500046
J	Fish, D				Fish, D			Anticipation of epileptic seizures from standard electro-encephalographic recordings	LANCET			English	Editorial Material									Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England	University of London; University College London	Fish, D (corresponding author), Inst Neurol, Dept Clin Neurol, Queen Sq, London WC1N 3BG, England.							Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Bertram EH, 1997, EPILEPSIA, V38, P95, DOI 10.1111/j.1528-1157.1997.tb01083.x; FISH DR, 1993, BRAIN, V116, P397, DOI 10.1093/brain/116.2.397; JACKSON GD, 1994, NEUROLOGY, V44, P850, DOI 10.1212/WNL.44.5.850; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2001	357	9251					160	161		10.1016/S0140-6736(00)03584-4	http://dx.doi.org/10.1016/S0140-6736(00)03584-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213088				2022-12-28	WOS:000166593700004
J	Carroll, SB				Carroll, SB			Chance and necessity: the evolution of morphological complexity and diversity	NATURE			English	Review							COMPLETE GENOME SEQUENCE; BODY; GENES; ARTHROPODS; ORIGIN; TRENDS; DIRECTIONALITY; RADIATION; ARCHAEON; FOSSILS	The primary foundation for contemplating the possible forms of life elsewhere in the Universe is the evolutionary trends that have marked life on Earth. For its first three billion years, life on Earth was a world of microscopic forms, rarely achieving a size greater than a millimetre or a complexity beyond two or three cell types. But in the past 600 million years, the evolution of much larger and more complex organisms has transformed the biosphere. Despite their disparate forms and physiologies, the evolution and diversification of plants, animals, fungi and other macroforms has followed similar global trends. One of the most important features underlying evolutionary increases in animal and plant size, complexity and diversity has been their modular construction from reiterated parts. Although simple filamentous and spherical forms may evolve wherever cellular life exists, the evolution of motile, modular mega-organisms might not be a universal pattern.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@facstaff.wisc.edu						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AKAM M, 1987, DEVELOPMENT, V101, P1; Akam M, 2000, P NATL ACAD SCI USA, V97, P4438, DOI 10.1073/pnas.97.9.4438; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Ambrose BA, 2000, MOL CELL, V5, P569, DOI 10.1016/S1097-2765(00)80450-5; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; [Anonymous], 1995, HOME UNIVERSE SEARCH; Bateson W., 1894, MAT STUDY VARIATION; BENTON MJ, TENDS ECOL EVOL, V12, P490; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonner JT., 1988, EVOLUTION COMPLEXITY; Bonner JT, 1998, INTEGR BIOL, V1, P28; Briggs D.E.G., 1994, FOSSILS BURGESS SHAL; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Budd GE, 1999, BIOESSAYS, V21, P326, DOI 10.1002/(SICI)1521-1878(199904)21:4<326::AID-BIES9>3.0.CO;2-0; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Butterfield NJ, 2000, PALEOBIOLOGY, V26, P386, DOI 10.1666/0094-8373(2000)026<0386:BPNGNS>2.0.CO;2; CARLSON SJ, 1992, PALEOBIOLOGY, V18, P344, DOI 10.1017/S0094837300010885; Carroll S. B., 2001, DNA DIVERSITY MOL GE; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; CISNE JL, 1974, EVOLUTION, V28, P337, DOI 10.1111/j.1558-5646.1974.tb00757.x; Conway Morris S., 1998, CRUCIBLE CREATION BU; COPE ED, 1871, P AM PHILOS SOC, V12, P229; DAVIDSON EH, 1995, SCIENCE, V270, P1319, DOI 10.1126/science.270.5240.1319; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DeRobertis EM, 1997, NATURE, V387, P25, DOI 10.1038/387025a0; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FOOTE M, 1992, SCIENCE, V258, P1816, DOI 10.1126/science.258.5089.1816; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Goffeau A, 1997, NATURE, V387, P5, DOI DOI 10.1038/387005B0.PUBMED:9169864; GOULD SJ, 1988, J PALEONTOL, V62, P319, DOI 10.1017/S0022336000059126; Gould SJ, 1996, FULL HOUSE; Graham L, 1993, ORIGIN LAND PLANTS; Gregory WK, 1935, Q REV BIOL, V10, P272, DOI 10.1086/394485; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; Hawking Stephen W., 1988, BRIEF HIST TIME BIG; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Kirk DL., 1998, VOLVOX MOL GENETIC O; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; KNOLL AH, 1994, P NATL ACAD SCI USA, V91, P6743, DOI 10.1073/pnas.91.15.6743; Knoll AH, 2000, PALEOBIOLOGY, V26, P1, DOI 10.1666/0094-8373(2000)26[1:DITHOL]2.0.CO;2; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Ma H, 2000, CELL, V101, P5, DOI 10.1016/S0092-8674(00)80618-2; MACFADDEN BJ, 1986, PALEOBIOLOGY, V12, P355, DOI 10.1017/S0094837300003109; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; MCSHEA DW, 1991, BIOL PHILOS, V6, P303, DOI 10.1007/BF00132234; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; McShea DW, 1996, EVOLUTION, V50, P477, DOI 10.1111/j.1558-5646.1996.tb03861.x; MCSHEA DW, 1993, EVOLUTION, V47, P730, DOI 10.1111/j.1558-5646.1993.tb01229.x; Monod J., 1971, CHANCE NECESSITY; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Qiu YL, 1998, NATURE, V394, P671, DOI 10.1038/29286; Raff R.A., 1996, SHAPE LIFE; Raff RA, 2000, EVOL DEV, V2, P102, DOI 10.1046/j.1525-142x.2000.00035.x; RAUP DM, 1983, PALEOBIOLOGY, V9, P107, DOI 10.1017/S0094837300007491; Rensch B., 1960, EVOLUTION SPECIES LE; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; Saunders WB, 1999, SCIENCE, V286, P760, DOI 10.1126/science.286.5440.760; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; SMITH AB, 1994, SYSTEMATICS FOSSIL R; SMITH J M, 1970, Studium Generale, V23, P266; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; Stebbins G. Ledyard, 1969, BASIS PROGR EVOLUTIO; Stewart I., 1998, LIFES OTHER SECRET; THOMAS RDK, 1993, EVOLUTION, V47, P341, DOI 10.1111/j.1558-5646.1993.tb02098.x; Thomas RDK, 2000, SCIENCE, V288, P1239, DOI 10.1126/science.288.5469.1239; VALENTINE JW, 1994, PALEOBIOLOGY, V20, P131, DOI 10.1017/S0094837300012641; VALENTINE JW, 1994, P NATL ACAD SCI USA, V91, P6751, DOI 10.1073/pnas.91.15.6751; Wagner PJ, 1996, EVOLUTION, V50, P990, DOI 10.1111/j.1558-5646.1996.tb02341.x; Weatherbee SD, 1999, CELL, V97, P283, DOI 10.1016/S0092-8674(00)80737-0	91	325	329	4	107	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1102	1109		10.1038/35059227	http://dx.doi.org/10.1038/35059227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234024				2022-12-28	WOS:000167148800058
J	Mattiello, JA; Munz, M				Mattiello, JA; Munz, M			Four types of acute post-traumatic intracranial hemorrhage.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Temple Univ, Philadelphia, PA 19140 USA; Ft Wayne Neurol Ctr, Ft Wayne, IN 46805 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Mattiello, JA (corresponding author), Temple Univ, Philadelphia, PA 19140 USA.								0	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2001	344	8					580	580		10.1056/NEJM200102223440806	http://dx.doi.org/10.1056/NEJM200102223440806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403LU	11207354				2022-12-28	WOS:000167044600006
J	Galas, DJ				Galas, DJ			Sequence interpretation - Making sense of the sequence	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; ARABIDOPSIS-THALIANA; GENOME SEQUENCE; PREDICTION; GENES; DNA		Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA	Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of Applied Life Sciences	Galas, DJ (corresponding author), Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA.	David_Galas@kgi.edu						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Claverie JM, 1997, HUM MOL GENET, V6, P1735, DOI 10.1093/hmg/6.10.1735; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; HAUSSLER D, 1998, TRENDS BIOCH SCI S, V23, P12; Hubbard T, 2000, NATURE, V403, P825, DOI 10.1038/35002770; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Lewis S, 2000, CURR OPIN STRUC BIOL, V10, P349, DOI 10.1016/S0959-440X(00)00095-6; Pavy N, 1999, BIOINFORMATICS, V15, P887, DOI 10.1093/bioinformatics/15.11.887; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; 2000, GENOME RES, V10	21	21	23	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1257	+		10.1126/science.291.5507.1257	http://dx.doi.org/10.1126/science.291.5507.1257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233451				2022-12-28	WOS:000166993400030
J	Gomis-Ruth, FX; Moncalian, G; Perez-Luque, R; Gonzalez, A; Cabezon, E; de la Cruz, F; Coll, M				Gomis-Ruth, FX; Moncalian, G; Perez-Luque, R; Gonzalez, A; Cabezon, E; de la Cruz, F; Coll, M			The bacterial conjugation protein TrwB resembles ring helicases and F-1-ATPase	NATURE			English	Article							CRYSTAL-STRUCTURE; DNA; MECHANISM; SUBUNITS; PRIMASE; DOMAIN; GENE; CELL; ATP	The transfer of DNA across membranes and between cells is a central biological process; however, its molecular mechanism remains unknown. In prokaryotes, trans-membrane passage by bacterial conjugation, is the main route for horizontal gene transfer. It is the means for rapid acquisition of new genetic information, including antibiotic resistance by pathogens. Transkingdom gene transfer from bacteria to plants(1) or fungi(2) and even bacterial sporulation(3) are special cases of conjugation. An integral membrane DNA-binding protein, called TrwB in the Escherichia coli R388 conjugative system, is essential for the conjugation process. This large multimeric protein is responsible for recruiting the relaxosome DNA-protein complex, and participates in the transfer of a single DNA strand during cell mating. Here we report the three-dimensional structure of a soluble variant of TrwB. The molecule consists of two domains: a nucleotide-binding domain of alpha/beta topology, reminiscent of RecA and DNA ring helicases, and an all-alpha domain. Six equivalent protein monomers associate to form an almost spherical quaternary structure that is strikingly similar to F-1-ATPase. A central channel, 20 Angstrom in width, traverses the hexamer.	CSIC, Inst Mol Biol Barcelona, ES-08034 Barcelona, Spain; Univ Cantabria, CSIC, Lab CIB, Dept Biol Mol, Santander 39011, Spain; DESY, EMBL Hamburg Outstn, D-22603 Hamburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Coll, M (corresponding author), CSIC, Inst Mol Biol Barcelona, Jordi Girona 18-26, ES-08034 Barcelona, Spain.	mcccri@ibmb.csic.es	Moncalian, Gabriel/K-3493-2014; Coll, Miquel/L-5999-2014; de la Cruz, Fernando/L-2812-2014; Cabezon, Elena/K-5874-2014	Moncalian, Gabriel/0000-0002-3007-6490; Coll, Miquel/0000-0003-4471-8674; de la Cruz, Fernando/0000-0003-4758-6857; Cabezon, Elena/0000-0002-6177-5016; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Perez Luque, Rosa/0000-0003-0759-0608				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEGG KJ, 1995, J BACTERIOL, V177, P6211, DOI 10.1128/jb.177.21.6211-6222.1995; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; LLOSA M, 1994, J MOL BIOL, V235, P448, DOI 10.1006/jmbi.1994.1005; Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; RANEY KD, 1995, J BIOL CHEM, V270, P22236, DOI 10.1074/jbc.270.38.22236; Sastre JI, 1998, J BACTERIOL, V180, P6039, DOI 10.1128/JB.180.22.6039-6042.1998; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Sheldrick GM, 1997, METHOD ENZYMOL, V276, P628, DOI 10.1016/S0076-6879(97)76083-X; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; STACHEL SE, 1986, CELL, V47, P155, DOI 10.1016/0092-8674(86)90437-X; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740; Zechner E. L., 2000, HORIZONTAL GENE POOL, P87	31	271	278	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					637	641		10.1038/35054586	http://dx.doi.org/10.1038/35054586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214325				2022-12-28	WOS:000166692300049
J	Romanov, SR; Kozakiewicz, BK; Holst, CR; Stampfer, MR; Haupt, LM; Tlsty, TD				Romanov, SR; Kozakiewicz, BK; Holst, CR; Stampfer, MR; Haupt, LM; Tlsty, TD			Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes	NATURE			English	Article							TELOMERE DYSFUNCTION; EXPRESSION; IMMORTALIZATION; INACTIVATION; PASSAGE; ARREST; GROWTH; P16; P53	Senescence and genomic integrity are thought to be important barriers in the development of malignant lesions(1). Human fibroblasts undergo a limited number of cell divisions before entering an irreversible arrest, called senescence(2). Here we show that human mammary epithelial cells (HMECs) do not conform to this paradigm of senescence. In contrast to fibroblasts, HMECs exhibit an initial growth phase that is followed by a transient growth plateau (termed selection or M0; refs 3-5), from which proliferative cells emerge to undergo further population doublings (similar to 20-70), before entering a second growth plateau (previously termed senescence or M1; refs 4-6). We rnd that the first growth plateau exhibits characteristics of senescence but is not an insurmountable barrier to further growth. HMECs emerge from senescence, exhibit eroding telomeric sequences and ultimately enter telomere-based crisis to generate the types of chromosomal abnormalities seen in the earliest lesions of breast cancer. Growth past senescent barriers may be a pivotal event in the earliest steps of carcinogenesis, providing many genetic changes that predicate oncogenic evolution. The differences between epithelial cells and fibroblasts provide new insights into the mechanistic basis of neoplastic transformation.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, UCSF Comprehens Canc Ctr, San Francisco, CA 94143 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tlsty, TD (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	ttlsty@itsa.ucsf.edu	Haupt, Larisa M/C-6066-2017	Haupt, Larisa M/0000-0002-7735-8110; Holst, Charles/0000-0001-8010-1677				Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; BERG JW, 1995, CANCER, V75, P257, DOI 10.1002/1097-0142(19950101)75:1+<257::AID-CNCR2820751311>3.0.CO;2-Y; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Burbano RR, 2000, CANCER GENET CYTOGEN, V119, P62, DOI 10.1016/S0165-4608(99)00175-2; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Foster SA, 1996, ONCOGENE, V12, P1773; Foster SA, 1998, MOL CELL BIOL, V18, P1793, DOI 10.1128/MCB.18.4.1793; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Hara E, 1996, MOL CELL BIOL, V16, P859; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Huschtscha LI, 1998, CANCER RES, V58, P3508; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Meyer KM, 1999, ONCOGENE, V18, P5795, DOI 10.1038/sj.onc.1202977; PANDIS N, 1995, CANCER, V76, P250, DOI 10.1002/1097-0142(19950715)76:2<250::AID-CNCR2820760215>3.0.CO;2-W; PIGNOLO RJ, 1994, IN VITRO CELL DEV-AN, V30A, P471; SHAY JW, 1989, EXP CELL RES, V184, P109, DOI 10.1016/0014-4827(89)90369-8; SHAY JW, 1993, BREAST CANCER RES TR, V25, P83, DOI 10.1007/BF00662404; Stampfer MR, 1997, MOL BIOL CELL, V8, P2391, DOI 10.1091/mbc.8.12.2391; Stoeber K, 1998, EMBO J, V17, P7219, DOI 10.1093/emboj/17.24.7219; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; TLSTY TD, IN PRESS J MAMMARY G; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; WALEN KH, 1989, CANCER GENET CYTOGEN, V37, P249, DOI 10.1016/0165-4608(89)90056-3; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665	28	372	390	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					633	637		10.1038/35054579	http://dx.doi.org/10.1038/35054579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214324	Green Published			2022-12-28	WOS:000166692300048
J	Vendruscolo, M; Paci, E; Dobson, CM; Karplus, M				Vendruscolo, M; Paci, E; Dobson, CM; Karplus, M			Three key residues form a critical contact network in a protein folding transition state	NATURE			English	Article							FREE-ENERGY; DYNAMICS; KINETICS; BINDING; SINGLE; DOMAIN; ORDER	Determining how a protein folds is a central problem in structural biology. The rate of folding of many proteins is determined by the transition state, so that a knowledge of its structure is essential for understanding the protein folding reaction. Here we use mutation measurements-which determine the role of individual residues in stabilizing the transition state(1,2)-as restraints in a Monte Carlo sampling procedure to determine the ensemble of structures that make up the transition state. We apply this approach to the experimental data for the 98-residue protein acylphosphatase(3), and obtain a transition-state ensemble with the native-state topology and an average root-mean-square deviation of 6 Angstrom from the native structure. Although about 20 residues with small positional fluctuations form the structural core of this transition state, the native-like contact network of only three of these residues is sufficient to determine the overall fold of the protein. This result reveals how a nucleation mechanism involving a small number of key residues can lead to folding of a polypeptide chain to its unique native-state structure.	Univ Oxford, Oxford Ctr Mol Sci, New Chem Lab, Oxford OX1 3QT, England; Univ Strasbourg 1, ISIS, Lab Chim Biophys, F-67000 Strasbourg, France; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	University of Oxford; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University	Dobson, CM (corresponding author), Univ Oxford, Oxford Ctr Mol Sci, New Chem Lab, S Parks Rd, Oxford OX1 3QT, England.		Paci, Emanuele/B-1893-2010; Vendruscolo, Michele/F-5901-2012	Paci, Emanuele/0000-0002-4891-2768; Vendruscolo, Michele/0000-0002-3616-1610				Alm E, 1999, P NATL ACAD SCI USA, V96, P11305, DOI 10.1073/pnas.96.20.11305; Berry R. S., 1988, ADV CHEM PHYS, V90, P75; BOCZKO EM, 1995, SCIENCE, V269, P393, DOI 10.1126/science.7618103; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; Clementi C, 2000, P NATL ACAD SCI USA, V97, P5871, DOI 10.1073/pnas.100547897; Daggett V, 1996, J MOL BIOL, V257, P430, DOI 10.1006/jmbi.1996.0173; Domany E, 1999, PHYSICA A, V263, P158, DOI 10.1016/S0378-4371(98)00494-4; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FERSHT AR, 1994, P NATL ACAD SCI USA, V91, P10426, DOI 10.1073/pnas.91.22.10426; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; Galzitskaya OV, 1999, P NATL ACAD SCI USA, V96, P11299, DOI 10.1073/pnas.96.20.11299; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; Li L, 2000, NAT STRUCT BIOL, V7, P336; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Micheletti C, 1999, PHYS REV LETT, V82, P3372, DOI 10.1103/PhysRevLett.82.3372; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; Shoemaker BA, 1999, J MOL BIOL, V287, P675, DOI 10.1006/jmbi.1999.2613; Taddei N, 2000, J MOL BIOL, V300, P633, DOI 10.1006/jmbi.2000.3870; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Vendruscolo M, 1998, FOLD DES, V3, P329, DOI 10.1016/S1359-0278(98)00045-5; Vendruscolo M, 1998, J CHEM PHYS, V109, P11101, DOI 10.1063/1.477748; Villegas V, 1998, J MOL BIOL, V283, P1027, DOI 10.1006/jmbi.1998.2158; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0; WUTHRICH K, 1989, SCIENCE, V243, P45, DOI 10.1126/science.2911719; Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43940; Zhou YQ, 1999, J MOL BIOL, V285, P1371, DOI 10.1006/jmbi.1998.2374	30	370	379	0	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					641	645		10.1038/35054591	http://dx.doi.org/10.1038/35054591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214326				2022-12-28	WOS:000166692300050
J	Honma, T; Goto, K				Honma, T; Goto, K			Complexes of MADS-box proteins are sufficient to convert leaves into floral organs	NATURE			English	Article							HOMEOTIC GENE APETALA3; ARABIDOPSIS-THALIANA; FLOWER DEVELOPMENT; ANTIRRHINUM-MAJUS; IN-VITRO; TRANSCRIPTION; DOMAIN; PISTILLATA; IDENTITY; EXPRESSION	Genetic studies, using floral homeotic mutants, have led to the ABC model of flower development. This model proposes that the combinatorial action of three sets of genes, the A, B and C function genes, specify the four floral organs (sepals, petals, stamens and carpels) in the concentric floral whorls(1,2). However, attempts to convert vegetative organs into floral organs by altering the expression of ABC genes have been unsuccessful(3-5). Here we show that the class B proteins of Arabidopsis, PISTILLATA (PI) and APETALA3 (AP3), interact with APETALA1 (AP1, a class A protein) and SEPALLATA3 (SEP3, previously AGL9), and with AGAMOUS (AG, a class C protein) through SEP3. We also show that vegetative leaves of triply transgenic plants, 35S::PI;35S::AP3;35S::AP1 or 35S::PI;35S::AP3;35S::SEP3, are transformed into petaloid organs and that those of 35S::PI; 35S::AP3;35S::SEP3;35S::AG are transformed into staminoid organs. Our findings indicate that the formation of ternary and quaternary complexes of ABC proteins may be the molecular basis of the ABC model, and that the flower-specific expression of SEP3 restricts the action of the ABC genes to the flower.	Kyoto Univ, Chem Res Inst, Kyoto 6110011, Japan	Kyoto University	Goto, K (corresponding author), Res Inst Biol Sci, Kayo Cho, Okayama 7161241, Japan.							Bartel P. L., 1993, CELLULAR INTERACTION, P153; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Cho SC, 1999, PLANT MOL BIOL, V40, P419, DOI 10.1023/A:1006273127067; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Hill TA, 1998, DEVELOPMENT, V125, P1711; Honma T, 2000, DEVELOPMENT, V127, P2021; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Krizek BA, 1996, DEVELOPMENT, V122, P11; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Mandel MA, 1998, SEX PLANT REPROD, V11, P22, DOI 10.1007/s004970050116; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Pan SQ, 1999, PLANT CELL, V11, P1591, DOI 10.1105/tpc.11.8.1591; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Riechmann JL, 1997, BIOL CHEM, V378, P1079; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; Rubinelli P, 1998, PLANT MOL BIOL, V37, P607, DOI 10.1023/A:1005964431302; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; SHIRAISHI H, 1993, PLANT J, V4, P385, DOI 10.1046/j.1365-313X.1993.04020385.x; Smyth D, 2000, TRENDS PLANT SCI, V5, P315, DOI 10.1016/S1360-1385(00)01690-3; Tilly JJ, 1998, DEVELOPMENT, V125, P1647; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	31	858	989	13	215	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					525	529		10.1038/35054083	http://dx.doi.org/10.1038/35054083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206550				2022-12-28	WOS:000166570500051
J	Trimble, EL				Trimble, EL			Prospects for improving staging of ovarian cancers	LANCET			English	Editorial Material							CARCINOMA		NCI, Canc Therapy Evaluat Programme, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Trimble, EL (corresponding author), NCI, Canc Therapy Evaluat Programme, Bethesda, MD 20892 USA.	tt6m@nih.gov	Trimble, Edward/J-9647-2019	Trimble, Edward/0000-0001-5028-0598				[Anonymous], 1994, Gynecol Oncol, V55, pS4; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P207, DOI 10.1016/S0020-7292(00)00300-3; BUCHSBAUM HJ, 1989, SURG GYNECOL OBSTET, V169, P226; Munoz KA, 1997, J CLIN ONCOL, V15, P3408, DOI 10.1200/JCO.1997.15.11.3408; OMURA GA, 1989, J CLIN ONCOL, V7, P457, DOI 10.1200/JCO.1989.7.4.457; Shimizu Y, 1998, GYNECOL ONCOL, V70, P2, DOI 10.1006/gyno.1998.5051; SUTTON GP, 1991, GYNECOL ONCOL, V41, P230, DOI 10.1016/0090-8258(91)90314-U; THIGPEN T, 1993, CANCER-AM CANCER SOC, V71, P606; Young RC, 1998, SEMIN ONCOL, V25, P335	9	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					159	160		10.1016/S0140-6736(00)03583-2	http://dx.doi.org/10.1016/S0140-6736(00)03583-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213087				2022-12-28	WOS:000166593700003
J	Ellis, J; Wilson, I				Ellis, J; Wilson, I			New physics with the compact linear collider	NATURE			English	Article								Probing beyond the established picture of particle physics will require some radical re-thinking of accelerator designs. If accelerators are to reach the ever-higher energies that theorists would dearly like to see explored, the technological spin-offs of this engineering feat could be as surprising as the new subatomic physics.	CERN, Theoret Studies Div, CH-1211 Geneva 23, Switzerland	European Organization for Nuclear Research (CERN)	Ellis, J (corresponding author), CERN, Theoret Studies Div, CH-1211 Geneva 23, Switzerland.		Ellis, John/J-2222-2012	Ellis, John/0000-0002-7399-0813				AUTIN B, 1999, 9902 CERN; BOSSART R, 1998, CERNPS9860; Braun H.H., 1999, 9906 CERN; BRINKMANN R, 1997, DESY97048; *CLIC, 2000, 2000047 CLIC CERNPS; *CLIC, 1999, 9947 CERNPS LP; DELAHAYE JP, 1997, CERNPS9751; ELLIS J, HEPPH0009355; ELLIS JR, 1998, CERNEP9803; *JLC, 1992, 9216 JLC KEK; *NLC, 1996, 474 NLC SLAC; *NLC, 1996, UCRLID124161 NLC; URAKAWA H, 1997, 1997 PART ACC C PAC; WILSON I, 2000, 2000057 CERNPS; WILSON I, 2000, 2000044 CERNPS	15	23	24	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					431	435		10.1038/35053224	http://dx.doi.org/10.1038/35053224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201761	Green Submitted			2022-12-28	WOS:000166434300070
J	Burnett, A; Peel, M				Burnett, A; Peel, M			Asylum seekers and refugees in Britain - The health of survivors of torture and organised violence	BRITISH MEDICAL JOURNAL			English	Article							DETENTION; ABUSE		Med Fdn Care Victims Torture, London NW5 3EJ, England		Burnett, A (corresponding author), Med Fdn Care Victims Torture, London NW5 3EJ, England.							American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; *AMN INT, 1997, ARM TORT EL TORT SPR; *AMN INT, 1995, PRIS VOIC ASYL SEEK; Amnesty Internation, 2000, ANN REP 2000; Bracken P., 1998, RETHINKING TRAUMA WA, P38; BRACKEN PJ, 1995, SOC SCI MED, V40, P1073, DOI 10.1016/0277-9536(94)00181-R; BURNETT A, 1999, GUIDELINES HEALTHCAR; DANNESKIOLDSAMS.B, 1992, TORTURE S, V1, pS33; Eisenman DP, 2000, WESTERN J MED, V172, P301, DOI 10.1136/ewjm.172.5.301; FORREST D, 1995, LANCET, V345, P225, DOI 10.1016/S0140-6736(95)90225-2; Forrest D M, 1999, J Clin Forensic Med, V6, P4, DOI 10.1016/S1353-1131(99)90169-4; GORSTUNSWORTH C, 1996, COMMON EXPERIENCES T; GROTH AN, 1980, AM J PSYCHIAT, V137, P806; Hinshelwood G, 1997, GENDER BASED PERSECU; HOWITT J, 1996, CLIN FORENSIC MED; KASTRUP M, 1992, TORTURE S, V1, pS22; MONTGOMERY E, 1994, DAN MED BULL, V41, P588; Peel M, 2000, LANCET, V355, P2069, DOI 10.1016/S0140-6736(00)02368-0; POURGOURIDES C, 1996, 2ND EXILE MENT HLTH; Richters Annemiek, 1998, RETHINKING TRAUMA WA, P112; Shackman J, 1995, OPENMIND, V73, P18; SUMMERFIELD D, 1991, LANCET, V338, P58, DOI 10.1016/0140-6736(91)90051-P; Summerfield D., 1995, BEYOND TRAUMA, P17, DOI DOI 10.1007/9781-47579421-2_2; Summerfield D, 1996, IMPACT WAR ATROCITY; *UN CONV TORT OTH, 1988, HUM RIGHTS COMP INT; Watters C., 1998, CURRENT ISSUES UK AS, P282; Weber Leanne., 2000, DECIDING DETAIN DECI; *WHO, 1992, 45 M WORLD HLTH ASS; *WHO, 1993, GUID IMPL HIV AIDS C	29	85	86	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					606	609		10.1136/bmj.322.7286.606	http://dx.doi.org/10.1136/bmj.322.7286.606			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238163	Green Published			2022-12-28	WOS:000167499900033
J	Blendon, RJ; Altman, DE; Benson, JM; Brodie, M				Blendon, RJ; Altman, DE; Benson, JM; Brodie, M			The implications of the 2000 election.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Henry J Kaiser Family Fdn, Menlo Pk, CA 94025 USA	Harvard University; Harvard T.H. Chan School of Public Health	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA.							Aldrich John H., 1995, WHY PARTIES ORIGIN T, P159; BURNHAM WD, 1997, ELECTION 1996 REPORT, P10; BUSH, 2000, NATL J, V32, P3056; CARNEY EN, 2000, NATL J, V32, P3555; Cigler Allen J., 1995, INTEREST GROUP POLIT, P393; CUNNINGHAM R, 1999, MED HLTH S, V53, pS1; Gore A, 2000, NEW ENGL J MED, V343, P1184, DOI 10.1056/NEJM200010193431611; HAMILTON LH, 2000, WASHINGTON POST 1119, pB1; HENRY J, 2000, KAISER FAMILY FDN HA; JACOBS LR, 1999, PUBLIC OPIN, P299; JOHNSON H, 1997, SYSTEM AM WAY POLITI, P194; JONES CO, 1994, PRESIDENCY SEPARATED, P147; KINGDON JW, 1995, AGENDAS ALTERNATIVES, P62; *LEAG WOM VOT ED F, 2000, HLTH ISS 2000 PRES E; MARKUS GB, 1993, CLASSICS VOTING BEHA, P140; Monroe AD, 1998, PUBLIC OPIN QUART, V62, P6, DOI 10.1086/297828; NIEMI RG, 1993, CLASSICS VOTING BEHA, P93; POLSBY NW, 1991, PRESIDENTIAL ELECTIO, P322; SCRAFINI MW, 2000, NATL J, V32, P1038; VICTOR K, 2000, NATL J, V32, P3560	20	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2001	344	9					679	684		10.1056/NEJM200103013440913	http://dx.doi.org/10.1056/NEJM200103013440913			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405TR	11228287				2022-12-28	WOS:000167177100013
J	Abramsky, L; Hall, S; Levitan, J; Marteau, TM				Abramsky, L; Hall, S; Levitan, J; Marteau, TM			What parents are told after prenatal diagnosis of a sex chromosome abnormality: interview and questionnaire study	BRITISH MEDICAL JOURNAL			English	Article							DECISIONS; ANEUPLOIDY; CHILDREN	Objective To investigate how the prenatal diagnosis of a sex chromosome anomaly is first communicated to parents, Design Health professionals were interviewed by telephone and the conversation was taped; parents were sent questionnaires at 1 month after diagnosis and those who responded were sent another at 6 months. Participants 29 health professionals who had recently informed parents that a sex chromosome anomaly had been identified in an apparently anatomically normal, viable fetus. 23 mothers and partners who had been informed of such a diagnosis. Main outcome measures Health professionals' knowledge about sex chromosome anomalies and parents' responses to information provided by health professionals. Results Analysis of the telephone interviews identified great variation in what different healthcare professionals know, think, and say about the same sex chromosome anomaly, The small numbers and the low response rate for the questionnaire (39% for women and 30% for men) meant that statistical analysis was not appropriate. Conclusions It is essential for obstetric units to have an established protocol for giving results and for all staff who communicate results to parents to have accurate, up to date information about the condition identified.	Univ London Imperial Coll Sci Technol & Med, Dept Med & Community Genet, N thames Perinatal Publ Hlth Unit, Harrow HA1 3UJ, Middx, England; Guys Hosp, Sch Med, Psychol & Genet Res Grp, London SE1 9RT, England; Kings Coll Hosp, Sch Med, Psychol & Genet Res Grp, London SE1 9RT, England; St Thomas Hosp, Sch Med, Psychol & Genet Res Grp, London SE1 9RT, England	Imperial College London; Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; Guy's & St Thomas' NHS Foundation Trust	Abramsky, L (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med & Community Genet, N thames Perinatal Publ Hlth Unit, Northwick Pk Site, Harrow HA1 3UJ, Middx, England.		Hall, Sue/C-3584-2009	Marteau, Theresa/0000-0003-3025-1129	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abramsky L, 1997, PRENATAL DIAG, V17, P363, DOI 10.1002/(SICI)1097-0223(199704)17:4<363::AID-PD79>3.0.CO;2-O; Anderson G, 1999, NURS ETHICS, V6, P126, DOI 10.1191/096973399671284106; Bentley DR, 2000, MED RES REV, V20, P189, DOI 10.1002/(SICI)1098-1128(200005)20:3<189::AID-MED2>3.0.CO;2-#; Christian SM, 2000, PRENATAL DIAG, V20, P37; CLAYTONSMITH J, 1989, J OBSTET GYNAECOL, V10, P5, DOI 10.3109/01443618909151082; EDWARDSBECKETT J, 1992, CHILD CARE HLTH DEV, V18, P355, DOI 10.1111/j.1365-2214.1992.tb00365.x; GARRETT C, 1994, PRENATAL DIAGNOSIS H, P86; Gotz MJ, 1999, PSYCHOL MED, V29, P953, DOI 10.1017/S0033291799008594; Joint Working Party of the Royal College of Obstetricians and Gynaecologists and the Royal College of Paediatrics and Child Health, 1997, FET ABN GUID SCREEN; MARTEAU TM, 1989, BRIT J SOC PSYCHOL, V28, P89, DOI 10.1111/j.2044-8309.1989.tb00849.x; Meschede D, 1998, AM J MED GENET, V80, P330, DOI 10.1002/(SICI)1096-8628(19981204)80:4<330::AID-AJMG6>3.0.CO;2-7; PENNINGTON BF, 1982, CHILD DEV, V53, P1182, DOI 10.2307/1129006; PUCK MH, 1981, AM J MED GENET, V9, P129, DOI 10.1002/ajmg.1320090207; Ratcliffe SG, 1991, SEX CHROMOSOME ANEUP, P1; REIF M, 1985, HUM GENET, V70, P193; ROBINSON A, 1992, AM J MED GENET, V44, P365, DOI 10.1002/ajmg.1320440319; ROBINSON A, 1989, AM J MED GENET, V34, P552, DOI 10.1002/ajmg.1320340420; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683	18	78	82	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	2001	322	7284					463	466		10.1136/bmj.322.7284.463	http://dx.doi.org/10.1136/bmj.322.7284.463			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406YD	11222421	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000167243000019
J	Slep, KC; Kercher, MA; He, W; Cowan, CW; Wensel, TG; Sigler, PB				Slep, KC; Kercher, MA; He, W; Cowan, CW; Wensel, TG; Sigler, PB			Structural determinants for regulation of phosphodiesterase by a G protein at 2.0 angstrom	NATURE			English	Article							HETEROTRIMERIC G-PROTEIN; PHOTORECEPTOR G-PROTEIN; CGMP-PHOSPHODIESTERASE; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; GAMMA-SUBUNIT; EFFECTOR-BINDING; ADENYLYL-CYCLASE; TRANSDUCIN; ACTIVATION	A multitude of heptahelical receptors use heterotrimeric G proteins to transduce signals to specific effector target molecules. The G protein transducin, G(t), couples photon-activated rhodopsin with the effector cyclic GMP phosophodiesterase (PDE) in the vertebrate phototransduction cascade. The interactions of the G(t) alpha -subunit (alpha (t)) with the inhibitory PDE gamma -subunit (PDE gamma) are central to effector activation, and also enhance visual recovery in cooperation with the GTPase-activating protein regulator of G-protein signalling (RGS)-9 (refs 1-3). Here we describe the crystal structure at 2.0 Angstrom of rod transducin alpha -GDP . AlF4- in complex with the effector molecule PDE gamma and the GTPase-activating protein RGS9. In addition, we present the independently solved crystal structures of the RGS9 RGS domain both alone and in complex with alpha (t/i1). GDP . AlF4-. These structures reveal insights into effector activation, synergistic GTPase acceleration, RGS9 specificity and RGS activity. Effector binding to a nucleotide-dependent site on at sequesters PDE gamma residues implicated in PDE inhibition, and potentiates recruitment of RGS9 for hydrolytic transition state stabilization and concomitant signal termination.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Yale University; Howard Hughes Medical Institute; Yale University; Baylor College of Medicine	Slep, KC (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Cowan, Christopher W/I-2497-2014	Wensel, Theodore/0000-0003-3518-9352				ANGLESON JK, 1993, NEURON, V11, P939, DOI 10.1016/0896-6273(93)90123-9; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; de Alba E, 1999, J MOL BIOL, V291, P927, DOI 10.1006/jmbi.1999.2989; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; McEntaffer RL, 1999, BIOCHEMISTRY-US, V38, P4931, DOI 10.1021/bi982636x; Muradov KG, 2000, J BIOL CHEM, V275, P6969, DOI 10.1074/jbc.275.10.6969; Natochin M, 1998, J BIOL CHEM, V273, P4300, DOI 10.1074/jbc.273.8.4300; Natochin M, 1998, J BIOL CHEM, V273, P21808, DOI 10.1074/jbc.273.34.21808; Nekrasova ER, 1997, BIOCHEMISTRY-US, V36, P7638, DOI 10.1021/bi970427r; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sowa ME, 2000, P NATL ACAD SCI USA, V97, P1483, DOI 10.1073/pnas.030409597; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Yan SZ, 1997, J BIOL CHEM, V272, P18849, DOI 10.1074/jbc.272.30.18849	30	213	220	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1071	1077		10.1038/35059138	http://dx.doi.org/10.1038/35059138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234020				2022-12-28	WOS:000167148800053
J	Tuthill, PG; Monnier, JD; Danchi, WC				Tuthill, PG; Monnier, JD; Danchi, WC			A dusty torus around the luminous young star LkH alpha 101	NATURE			English	Article							HERBIG AE/BE STARS; PROTOSTELLAR DISKS; INFRARED-EMISSION; PHOTOEVAPORATION	A star forms when a cloud of dust and gas collapses. It is generally believed that this collapse first produces a flattened rotating disk(1,2), through which matter is fed onto the embryonic star at the centre of the disk. When the temperature and density at the centre of the star pass a critical threshold, thermonuclear fusion begins. The remaining disk, which can still contain up to 0.3 times the mass of the star(3-5), is then sculpted and eventually dissipated by the radiation and wind from the newborn star. But this picture of the structure and evolution of the disk remains speculative because of the lack of morphological data of sufficient resolution and uncertainties regarding the underlying physical processes. Here we present images of a young star, LkH alpha 101, in which the structure of the inner accretion disk is resolved. We rnd that the disk is almost face-on, with a central gap (or cavity) and a hot inner edge. The cavity is bigger than previous theoretical predictions(6), and we infer that the position of the inner edge is probably determined by sublimation of dust grains by direct stellar radiation, rather than by disk-reprocessing or viscous-heating processes as usually assumed(29).	Univ Sydney, Sch Phys, Dept Astron, Sydney, NSW 2006, Australia; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	University of Sydney; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Tuthill, PG (corresponding author), Univ Sydney, Sch Phys, Dept Astron, Sydney, NSW 2006, Australia.	gekko@physics.usyd.edu.au		Tuthill, Peter/0000-0001-7026-6291				Akeson RL, 2000, ASTROPHYS J, V543, P313, DOI 10.1086/317111; BARSONY M, 1990, ASTROPHYS J, V362, P674, DOI 10.1086/169305; BARSONY M, 1991, ASTROPHYS J, V379, P221, DOI 10.1086/170496; BOHM T, 1994, ASTRON ASTROPHYS, V290, P167; CASSEN PM, 1981, ICARUS, V48, P377, DOI 10.1016/0019-1035(81)90052-X; COHEN M, 1982, ASTROPHYS J, V253, P707, DOI 10.1086/159671; GULL SF, 1984, IEE PROC-F, V131, P646, DOI 10.1049/ip-f-1.1984.0099; HARRIS S, 1976, MON NOT R ASTRON SOC, V174, P601, DOI 10.1093/mnras/174.3.601; HARTMANN L, 1993, ASTROPHYS J, V407, P219, DOI 10.1086/172507; HERBIG GH, 1971, ASTROPHYS J, V169, P537, DOI 10.1086/151171; HILLENBRAND LA, 1992, ASTROPHYS J, V397, P613, DOI 10.1086/171819; HOLLENBACH D, 1994, ASTROPHYS J, V428, P654, DOI 10.1086/174276; Hou JL, 1997, ASTRON ASTROPHYS, V327, P725; Kessel O, 1998, ASTRON ASTROPHYS, V337, P832; LYNDENBELL D, 1974, MON NOT R ASTRON SOC, V168, P603, DOI 10.1093/mnras/168.3.603; Millan-Gabet R, 2001, ASTROPHYS J, V546, P358, DOI 10.1086/318239; Millan-Gabet R, 1999, ASTROPHYS J, V513, pL131, DOI 10.1086/311926; Miroshnichenko A, 1999, ASTROPHYS J, V520, pL115, DOI 10.1086/312159; Miroshnichenko A, 1997, ASTROPHYS J, V475, pL41, DOI 10.1086/310456; PANAGIA N, 1973, ASTRON J, V78, P929, DOI 10.1086/111498; Pezzuto S, 1997, ASTROPHYS J, V485, P290, DOI 10.1086/304398; SHU FH, 1990, ASTROPHYS J, V358, P495, DOI 10.1086/169003; SIVIA DS, 1987, THESIS CAMBRIDGE U; Stine PC, 1998, ASTRON J, V116, P890, DOI 10.1086/300473; TEREBEY S, 1984, ASTROPHYS J, V286, P529, DOI 10.1086/162628; Tuthill PG, 2000, PUBL ASTRON SOC PAC, V112, P555, DOI 10.1086/316550; Tuthill PG, 2000, ASTROPHYS J, V543, P284, DOI 10.1086/317082; Tuthill PG, 1999, NATURE, V398, P487, DOI 10.1038/19033; YORKE HW, 1995, ASTROPHYS J, V443, P199, DOI 10.1086/175514	29	108	110	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1012	1014		10.1038/35059014	http://dx.doi.org/10.1038/35059014			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234003	Green Submitted			2022-12-28	WOS:000167148800036
J	Isles, AR; Baum, MJ; Ma, D; Keverne, EB; Allen, ND				Isles, AR; Baum, MJ; Ma, D; Keverne, EB; Allen, ND			Genetic imprinting - Urinary odour preferences in mice	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; KIN RECOGNITION		Babraham Inst, Lab Cognit & Dev Neurosci, Cambridge CB2 4AT, England; Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England; Boston Univ, Dept Biol, Boston, MA 02215 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Boston University	Isles, AR (corresponding author), Babraham Inst, Lab Cognit & Dev Neurosci, Cambridge CB2 4AT, England.		allen, nick d/A-4336-2010	Isles, Anthony/0000-0002-7587-5712; Allen, Nicholas/0000-0003-4009-186X				Amadou C, 1999, IMMUNOL REV, V167, P211, DOI 10.1111/j.1600-065X.1999.tb01394.x; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; BARNARD CJ, 1989, ANIM BEHAV, V38, P35, DOI 10.1016/S0003-3472(89)80063-6; FAN WF, 1995, GENOMICS, V27, P119, DOI 10.1006/geno.1995.1013; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; SUNDBERG H, 1982, BEHAV NEURAL BIOL, V34, P113, DOI 10.1016/S0163-1047(82)91501-1; WALDMAN B, 1988, TRENDS ECOL EVOL, V3, P8, DOI 10.1016/0169-5347(88)90075-4; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818	10	67	68	1	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					783	784		10.1038/35057323	http://dx.doi.org/10.1038/35057323			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236984				2022-12-28	WOS:000166938800029
J	Ferey, G				Ferey, G			Materials science - The simplicity of complexity - Rational design of giant pores	SCIENCE			English	Editorial Material							FRAMEWORK		Inst Lavoisier, CNRS, UMR 8637, F-78035 Versailles, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ferey, G (corresponding author), Inst Lavoisier, CNRS, UMR 8637, F-78035 Versailles, France.	ferey@chimie.uvsq.fr						Cheetham AK, 1999, ANGEW CHEM INT EDIT, V38, P3268, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3268::AID-ANIE3268>3.0.CO;2-U; Chen BL, 2001, SCIENCE, V291, P1021, DOI 10.1126/science.1056598; Ferey G, 2000, J SOLID STATE CHEM, V152, P37, DOI 10.1006/jssc.2000.8667; Ferey G, 1999, SCIENCE, V283, P1125, DOI 10.1126/science.283.5405.1125; Han SX, 1999, ACTA CRYSTALLOGR A, V55, P332, DOI 10.1107/S0108767398010009; Khan MI, 2000, J SOLID STATE CHEM, V152, P105, DOI 10.1006/jssc.2000.8705; MULLER A, 2000, ANGEW CHEM INT EDIT, V39, P1616; Reineke TM, 2000, J AM CHEM SOC, V122, P4843, DOI 10.1021/ja000363z; Wells A. F., 1977, 3 DIMENSIONAL NETS P; WELLS AF, 1979, AM CRYSTALLOGRAPHIC, V8; Yaghi OM, 2000, J SOLID STATE CHEM, V152, P1, DOI 10.1006/jssc.2000.8733	11	84	84	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2001	291	5506					994	995		10.1126/science.1059200	http://dx.doi.org/10.1126/science.1059200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232586				2022-12-28	WOS:000166860100030
J	Kielpinski, D; Meyer, V; Rowe, MA; Sackett, CA; Itano, WM; Monroe, C; Wineland, DJ				Kielpinski, D; Meyer, V; Rowe, MA; Sackett, CA; Itano, WM; Monroe, C; Wineland, DJ			A decoherence-free quantum memory using trapped ions	SCIENCE			English	Article							FREE SUBSPACES; COMPUTATION; MOTION; CODES	We demonstrate a decoherence-free quantum memory of one qubit. By encoding the qubit into the decoherence-free subspace (DFS) of a pair of trapped 9Be(+) ions, we protect the qubit from environment-induced dephasing that limits the storage time of a qubit composed of a single ion. We measured the storage time under ambient conditions and under interaction with an engineered noisy environment and observed that encoding into the DFS increases the storage time by up to an order of magnitude. The encoding reversibly transfers an arbitrary qubit stored in a single ion to the DFS of two ions.	Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA; Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	National Institute of Standards & Technology (NIST) - USA; University of Michigan System; University of Michigan	Kielpinski, D (corresponding author), Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA.		Itano, Wayne/AAV-8781-2020; Sackett, Charles/AAD-1452-2019; Monroe, Christopher R/G-8105-2011	Sackett, Charles/0000-0001-6741-0571; Kielpinski, David/0000-0002-2816-6892				Bacon D, 2000, PHYS REV LETT, V85, P1758, DOI 10.1103/PhysRevLett.85.1758; Beige A, 2000, PHYS REV LETT, V85, P1762, DOI 10.1103/PhysRevLett.85.1762; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Giulini D., 1996, DECOHERENCE APPEARAN; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; King BE, 1998, PHYS REV LETT, V81, P1525, DOI 10.1103/PhysRevLett.81.1525; Kwiat PG, 2000, SCIENCE, V290, P498, DOI 10.1126/science.290.5491.498; Lidar DA, 1998, PHYS REV LETT, V81, P2594, DOI 10.1103/PhysRevLett.81.2594; Lidar DA, 1999, PHYS REV LETT, V82, P4556, DOI 10.1103/PhysRevLett.82.4556; Maitre X, 1997, PHYS REV LETT, V79, P769, DOI 10.1103/PhysRevLett.79.769; Nagerl HC, 1999, PHYS REV A, V60, P145, DOI 10.1103/PhysRevA.60.145; Palma GM, 1996, P ROY SOC A-MATH PHY, V452, P567, DOI 10.1098/rspa.1996.0029; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; SHOR PW, 1994, P 35 ANN S FDN COMP, P116; STEANE A, 2000, 5 INT C QUANT COMM M; Turchette QA, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063418; Zanardi P, 1997, PHYS REV LETT, V79, P3306, DOI 10.1103/PhysRevLett.79.3306; Zanardi P, 1998, PHYS REV LETT, V81, P4752, DOI 10.1103/PhysRevLett.81.4752; 1998, FORTSCHR PHYS, V46; 2000, FORTSCHR PHYS, V48; [No title captured]	25	403	407	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					1013	1015		10.1126/science.1057357	http://dx.doi.org/10.1126/science.1057357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232562				2022-12-28	WOS:000166860100036
J	de Winter, W; Oxnard, CE				de Winter, W; Oxnard, CE			Evolutionary radiations and convergences in the structural organization of mammalian brains	NATURE			English	Article							LOCOMOTION	The sizes of mammalian brain components seem to be mostly related to the sizes of the whole brain (and body), suggesting a one-dimensional scale of encephalization(1-3). Previous multivariate study of such data concludes that evolutionary selection for enlargement of any one brain part is constrained to selection for a concerted enlargement of the whole brain(4). However, interactions between structurally related pairs of brain parts(5) confirm reports of differential change in brain nuclei(6), and imply mosaic rather than concerted evolution. Here we analyse a large number of variables simultaneously using multi-dimensional methods(7). We show that the relative proportions of different systems of functionally integrated brain structures vary independently between different mammalian orders, demonstrating separate evolutionary radiations in mammalian brain organization(8). Within each major order we identify clusters of unrelated species that occupy similar behavioural niches and have convergently evolved similar brain proportions. We conclude that within orders, mosaic brain organization is caused by selective adaptation, whereas between orders it suggests an interplay between selection and constraints.	Univ Western Australia, Dept Anat & Human Biol, Perth, WA 6907, Australia	University of Western Australia	Oxnard, CE (corresponding author), Univ Western Australia, Dept Anat & Human Biol, Perth, WA 6907, Australia.							Altringham JD, 1996, BATS BIOL BEHAV; Armstrong E., 1982, P131; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Brooks V.B., 1986, NEURAL BASIS MOTOR C; BUTLER AB, 1996, COMP VERTEBRATE NEUR, pCH30; CANT JGH, 1986, FOLIA PRIMATOL, V46, P1, DOI 10.1159/000156232; Cleveland WS., 1993, VISUALIZING DATA; DEACON TW, 1990, AM ZOOL, V30, P629; DEWINTER W, 1997, AM J PHYS ANTHOL S, V24, P243; DEWINTER W, 1997, THESIS U W AUSTR; Eisenberg J.F., 1981, MAMMALIAN RAD; Eisenberg J. F., 1975, PHYLOGENY PRIMATES, P47; ERIKSON GE, 1963, S ZOOL SOC LOND, V10, P134; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Gray Jeffrey A., 1995, P1165; Jerison HJ., 1973, EVOLUTION BRAIN INTE; KAAS JH, 1995, BRAIN BEHAV EVOLUT, V46, P187, DOI 10.1159/000113273; KRZANOWSKI WJ, 1994, MULTIVARIATE STAT; MARTIN RD, 1990, PRIMATE ORIGINS EVOL, pCH8; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; MITTERMEIER RA, 1978, FOLIA PRIMATOL, V30, P161, DOI 10.1159/000155862; NORBERG UM, 1988, BIOL J LINN SOC, V33, P383, DOI 10.1111/j.1095-8312.1988.tb00451.x; Oxnard C. E., 1984, ORDER MAN BIOMATHEMA; PASSINGHAM RE, 1975, BRAIN BEHAV EVOLUT, V11, P1, DOI 10.1159/000123620; Schieber M.H., 1999, FUNDAMENTAL NEUROSCI, P931; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Stephan H., 1991, INSECTIVORA	27	161	166	0	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					710	714		10.1038/35055547	http://dx.doi.org/10.1038/35055547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217859				2022-12-28	WOS:000166816400042
J	Skyler, JS; Cefalu, WT; Kourides, IA; Landschulz, WH; Balagtas, CC; Cheng, SL; Gelfand, RA				Skyler, JS; Cefalu, WT; Kourides, IA; Landschulz, WH; Balagtas, CC; Cheng, SL; Gelfand, RA		Inhaled Insulin Phase II Study Grp	Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study	LANCET			English	Article							AEROSOL; ABSORPTION; INHALATION; CHILDREN; DELIVERY; ANALOG; LUNG	Background Effective glycaemic control in type 1 diabetes mellitus usually requires two or more insulin injections daily. Inhaled intrapulmonary delivery of insulin offers a potential new way to deliver meal-related insulin, eliminating the need for preprandial injections. Methods 73 patients with type 1 diabetes mellitus were studied in an open-label, proof-of-concept, parallel-group randomised trial. Patients in the experimental group received preprandial inhaled insulin plus a bedtime subcutaneous ultralente insulin injection. Patients in the control group received their usual insulin regimen of two to three injections per day. Participants monitored their blood glucose four times daily, and adjusted insulin doses weekly to achieve preprandial glucose targets of 5.6-8.9 mmol/L. The primary outcome measure was change in glycosylated haemoglobin (HbA(1c)) after 12 weeks. Secondary outcomes were fasting and postprandial glucose response to a mixed meal; hypoglycaemia frequency and severity; pulmonary function; and patients' satisfaction. Findings Changes in HbA(1c) were indistinguishable between groups (difference 0.2% [95% CI -0.2 to 0.5]). Changes in fasting and postprandial glucose concentrations, and occurrence and severity of hypoglycaemia were also similar between groups. Inhaled insulin was well tolerated and had no effect on pulmonary function (ie, spirometry, lung volumes, diffusion capacity, and oxygen saturation). Interpretation This proof-of-concept study shows that preprandial insulin can be given by inhalation in individuals with insulin-deficient type 1 diabetes as a less invasive alternative to conventional preprandial insulin injections.	Univ Miami, Sch Med, Dept Med, Miami, FL 33136 USA; Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; Pfizer Inc, Pfizer Cent Res, Groton, CT 06340 USA	University of Miami; University of Vermont; Pfizer	Skyler, JS (corresponding author), Univ Miami, Sch Med, Dept Med, 1500 NW 12th Ave,Suite 1012 E, Miami, FL 33136 USA.		Skyler, Jay S/F-4211-2016	Skyler, Jay/0000-0003-1136-8110				BERGER M, 1982, DIABETES CARE, V5, P77, DOI 10.2337/diacare.5.2.77; BINDER C, 1984, DIABETES CARE, V7, P188, DOI 10.2337/diacare.7.2.188; BLAKESLEE S, 1994, NY TIMES A      0228, P1; CEFALU WT, IN PRESS ANN INTERN; DIMITRIADIS GD, 1983, DIABETES CARE, V6, P374, DOI 10.2337/diacare.6.4.374; ELLIOTT RB, 1987, AUST PAEDIATR J, V23, P293; Gansslen M., 1925, KLIN WOCHENSCHR, V4, P71; Genuth S, 1999, DIABETES CARE, V22, P99; Heinemann L, 1998, DIABETES CARE, V21, P1910, DOI 10.2337/diacare.21.11.1910; HIRSCH IB, 1990, DIABETES CARE, V13, P1265, DOI 10.2337/diacare.13.12.1265; HOWEY DC, 1994, DIABETES, V43, P396, DOI 10.2337/diabetes.43.3.396; KINMONTH AL, 1980, BRIT MED J, V280, P604, DOI 10.1136/bmj.280.6214.604; KOHLER D, 1987, ATEMWEG LUNGENKRANK, V13, P230; LAUBE BL, 1993, JAMA-J AM MED ASSOC, V269, P2106, DOI 10.1001/jama.269.16.2106; MOSES AC, 1983, DIABETES, V32, P1040, DOI 10.2337/diabetes.32.11.1040; PATTON JS, 1992, ADV DRUG DELIVER REV, V8, P179, DOI 10.1016/0169-409X(92)90002-8; Patton JS, 1999, ADV DRUG DELIVER REV, V35, P235, DOI 10.1016/S0169-409X(98)00074-X; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; SALZMAN R, 1985, NEW ENGL J MED, V312, P1078, DOI 10.1056/NEJM198504253121702; Schade DS, 1983, INTENSIVE INSULIN TH; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SKYLER JS, 1988, MED CLIN N AM, V72, P1337, DOI 10.1016/S0025-7125(16)30710-6; TATTERSALL RB, 1994, DIABETIC MED, V11, P618, DOI 10.1111/j.1464-5491.1994.tb00324.x; WIGLEY FM, 1971, DIABETES, V20, P552, DOI 10.2337/diab.20.8.552	24	209	217	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					331	335		10.1016/S0140-6736(00)03638-2	http://dx.doi.org/10.1016/S0140-6736(00)03638-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210993				2022-12-28	WOS:000166897900009
J	Pawloski, JR; Hess, DT; Stamler, JS				Pawloski, JR; Hess, DT; Stamler, JS			Export by red blood cells of nitric oxide bioactivity	NATURE			English	Article							HUMAN-ERYTHROCYTE MEMBRANE; ANION-EXCHANGE PROTEIN; S-NITROSOHEMOGLOBIN; HEMOGLOBIN BINDING; CYTOPLASMIC FRAGMENT; MOLECULAR MECHANISMS; BAND-3 INHIBITORS; TRANSPORT SITE; IDENTIFICATION; TRANSLOCATION	Previous studies support a model in which the physiological O-2 gradient is transduced by haemoglobin into the coordinate release from red blood cells of O-2 and nitric oxide (NO)-derived vasoactivity to optimize oxygen delivery in the arterial periphery(1,2). But whereas both O-2 and NO diffuse into red blood cells, only O-2 can diffuse out(3-5). Thus, for the dilation of blood vessels by red blood cells, there must be a mechanism to export NO-related vasoactivity, and current models of NO-mediated intercellular communication should be revised. Here we show that in human erythrocytes haemoglobin-derived S-nitrosothiol (SNO), generated from imported NO, is associated predominantly with the red blood cell membrane, and principally with cysteine residues in the haemoglobin-binding cytoplasmic domain of the anion exchanger AE1. Interaction with AE1 promotes the deoxygenated structure in SNO-haemoglobin, which subserves NO group transfer to the membrane. Furthermore, we show that vasodilatory activity is released from this membrane precinct by deoxygenation. Thus, the oxygen-regulated cellular mechanism that couples the synthesis and export of haemoglobin-derived NO bioactivity operates, at least in part, through formation of AE1-SNO at the membrane-cytosol interface.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 2612, Durham, NC 27710 USA.	STAML001@mc.duke.edu		Stamler, Jonathan/0000-0002-6866-1572				CHETRITE G, 1985, J MOL BIOL, V185, P639, DOI 10.1016/0022-2836(85)90076-2; CZERWINSKI M, 1988, EUR J BIOCHEM, V174, P647, DOI 10.1111/j.1432-1033.1988.tb14147.x; FALKE JJ, 1986, BIOCHEMISTRY-US, V25, P7899, DOI 10.1021/bi00372a017; FALKE JJ, 1986, BIOCHEMISTRY-US, V25, P7888, DOI 10.1021/bi00372a015; GALANTER WL, 1991, BIOCHIM BIOPHYS ACTA, V1079, P146, DOI 10.1016/0167-4838(91)90119-K; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; HSU L, 1983, ARCH BIOCHEM BIOPHYS, V227, P31, DOI 10.1016/0003-9861(83)90345-4; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KONDO T, 1989, METHOD ENZYMOL, V171, P217; LIU SQJ, 1993, AM J PHYSIOL, V264, pC1155, DOI 10.1152/ajpcell.1993.264.5.C1155; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; LOW PS, 1986, BIOCHIM BIOPHYS ACTA, V864, P145, DOI 10.1016/0304-4157(86)90009-2; MACARA IG, 1983, J BIOL CHEM, V258, P1785; McMahon TJ, 2000, J BIOL CHEM, V275, P16738, DOI 10.1074/jbc.M000532200; McMahon TJ, 1999, METHOD ENZYMOL, V301, P99; OKUBO K, 1994, J BIOL CHEM, V269, P1918; Pawloski JR, 1998, CIRCULATION, V97, P263, DOI 10.1161/01.CIR.97.3.263; RAUENBUEHLER PB, 1982, BIOCHIM BIOPHYS ACTA, V692, P361, DOI 10.1016/0005-2736(82)90385-6; SALHANY JM, 1980, BIOCHEMISTRY-US, V19, P1447, DOI 10.1021/bi00548a028; SAYARE M, 1981, J BIOL CHEM, V256, P3152; Shingles R, 1997, J BIOENERG BIOMEMBR, V29, P611, DOI 10.1023/A:1022491220299; Soszynski M, 1997, BIOCHEM MOL BIOL INT, V43, P319; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; TELEN MJ, 1987, VOX SANG, V52, P236, DOI 10.1111/j.1423-0410.1987.tb03035.x; Vaughn MW, 2000, J BIOL CHEM, V275, P2342, DOI 10.1074/jbc.275.4.2342; WALDER JA, 1984, J BIOL CHEM, V259, P238	28	467	477	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					622	626		10.1038/35054560	http://dx.doi.org/10.1038/35054560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214321				2022-12-28	WOS:000166692300045
J	Abbott, GW; Butler, MH; Bendahhou, S; Dalakas, MC; Ptacek, LJ; Goldstein, SAN				Abbott, GW; Butler, MH; Bendahhou, S; Dalakas, MC; Ptacek, LJ; Goldstein, SAN			MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis	CELL			English	Article							GATED ION CHANNELS; LONG QT SYNDROME; K+ CHANNELS; RAT-BRAIN; MESSENGER-RNA; FUNCTIONAL EXPRESSION; IK(A) CHANNELS; INACTIVATION; GENE; MUTATIONS	The subthreshold, voltage-gated potassium channel of skeletal muscle is shown to contain MinK-related peptide 2 (MiRP2) and the pore-forming subunit Kv3.4. MiRP2-Kv3.4 channels differ from Kv3.4 channels in unitary conductance, voltage-dependent activation, recovery from inactivation, steady-state open probability, and block by a peptide toxin. Thus, MiRP2-Kv3.4 channels set resting membrane potential (RMP) and do not produce afterhyperpolarization or cumulative inactivation to limit action potential frequency. A mis-sense mutation is identified in the gene for MiRP2 (KCNE3) in two families with periodic paralysis and found to segregate with the disease. Mutant MiRP2-Kv3.4 complexes exhibit reduced current density and diminished capacity to set RMP. Thus, MiRP2 operates with a classical potassium channel subunit to govern skeletal muscle function and pathophysiology.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; NINDS, NIH, Bethesda, MD 20892 USA	Yale University; Yale University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, 333 Cedar St, New Haven, CT 06536 USA.	steve.goldstein@yale.edu	Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061	NCRR NIH HHS [MO1-RR00064] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; ADRIAN RH, 1970, J PHYSIOL-LONDON, V208, P645, DOI 10.1113/jphysiol.1970.sp009140; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Arcangeli A, 1999, J NEUROBIOL, V40, P214; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BEAM KG, 1983, J GEN PHYSIOL, V81, P485, DOI 10.1085/jgp.81.4.485; Beck EJ, 1998, J GEN PHYSIOL, V112, P71, DOI 10.1085/jgp.112.1.71; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; Camacho J, 1996, BIOPHYS J, V71, P171, DOI 10.1016/S0006-3495(96)79214-7; CANNON SC, 1993, NEURON, V10, P317, DOI 10.1016/0896-6273(93)90321-H; CHABALA LD, 1993, J GEN PHYSIOL, V102, P713, DOI 10.1085/jgp.102.4.713; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; CUMMINS TR, 1993, NEURON, V10, P667, DOI 10.1016/0896-6273(93)90168-Q; Cummins TR, 1996, BIOPHYS J, V71, P227, DOI 10.1016/S0006-3495(96)79219-6; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; ESCOBAR ALM, 1993, MUSCLE NERVE, V16, P579, DOI 10.1002/mus.880160602; FONTAINE B, 1994, NAT GENET, V6, P267, DOI 10.1038/ng0394-267; Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549; LAYZER RB, 1982, ANN NEUROL, V11, P547, DOI 10.1002/ana.410110602; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; LESAGE F, 1992, FEBS LETT, V310, P162, DOI 10.1016/0014-5793(92)81320-L; London B, 1997, CIRC RES, V81, P870; Marom S, 1998, J MEMBRANE BIOL, V161, P105, DOI 10.1007/s002329900318; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Ptacek L, 1998, AM J MED, V105, P58, DOI 10.1016/S0002-9343(98)00123-5; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; Ptacek LJ, 1999, SEMIN NEUROL, V19, P363, DOI 10.1055/s-2008-1040851; PTACEK LJ, 1994, CELL, V77, P863; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RIZZO MA, 1992, J NEUROPHYSIOL, V68, P1708, DOI 10.1152/jn.1992.68.5.1708; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SCHROTER KH, 1991, FEBS LETT, V278, P211, DOI 10.1016/0014-5793(91)80119-N; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Tawil R, 2000, ANN NEUROL, V47, P46, DOI 10.1002/1531-8249(200001)47:1<46::AID-ANA9>3.3.CO;2-8; VAZQUEZ M, 1988, EUR J PHYSL, V436, P95; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Vullhorst D, 1998, FEBS LETT, V421, P259, DOI 10.1016/S0014-5793(97)01577-9; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; Wymore RS, 1997, CIRC RES, V80, P261, DOI 10.1161/01.RES.80.2.261; Xu HD, 1996, J GEN PHYSIOL, V108, P405, DOI 10.1085/jgp.108.5.405; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017	55	220	245	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					217	231		10.1016/S0092-8674(01)00207-0	http://dx.doi.org/10.1016/S0092-8674(01)00207-0			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207363	Green Published, Bronze			2022-12-28	WOS:000166879700006
J	Bockrath, M; Liang, WJ; Bozovic, D; Hafner, JH; Lieber, CM; Tinkham, M; Park, HK				Bockrath, M; Liang, WJ; Bozovic, D; Hafner, JH; Lieber, CM; Tinkham, M; Park, HK			Resonant electron scattering by defects in single-walled carbon nanotubes	SCIENCE			English	Article							TIGHT-BINDING MODEL; QUANTUM WIRES; BACKSCATTERING; MICROSCOPY; GROWTH	We report the characterization of defects in individual metallic single-walled carbon nanotubes by transport measurements and scanned gate microscopy. A sizable fraction of metallic nanotubes grown by chemical vapor deposition exhibits strongly gate voltage-dependent resistance at room temperature. Scanned gate measurements reveal that this behavior originates from resonant electron scattering by defects in the nanotube as the Fermi Level is varied by the gate voltage. The reflection coefficient at the peak of a scattering resonance was determined to be about 0.5 at room temperature. An intratube quantum dot device formed by two defects is demonstrated by Low-temperature transport measurements.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Park, HK (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.		Hafner, Jason H/A-7959-2008; Park, Hongkun/R-9842-2019	Hafner, Jason H/0000-0002-6943-4232; Park, Hongkun/0000-0001-9576-8829				Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Bockrath M, 1997, SCIENCE, V275, P1922, DOI 10.1126/science.275.5308.1922; Charlier JC, 1996, PHYS REV B, V53, P11108, DOI 10.1103/PhysRevB.53.11108; Chico L, 1996, PHYS REV LETT, V76, P971, DOI 10.1103/PhysRevLett.76.971; Chico L, 1998, PHYS REV LETT, V81, P1278, DOI 10.1103/PhysRevLett.81.1278; Chico L, 1996, PHYS REV B, V54, P2600, DOI 10.1103/PhysRevB.54.2600; Choi HJ, 2000, PHYS REV LETT, V84, P2917, DOI 10.1103/PhysRevLett.84.2917; Clauss W, 1999, EUROPHYS LETT, V47, P601, DOI 10.1209/epl/i1999-00431-5; Collins PG, 1997, SCIENCE, V278, P100, DOI 10.1126/science.278.5335.100; Crespi VH, 1997, PHYS REV LETT, V79, P2093, DOI 10.1103/PhysRevLett.79.2093; Dekker C, 1999, PHYS TODAY, V52, P22, DOI 10.1063/1.882658; GRABERT H, 1992, SINGLE CHARGE TUNNEL; Hafner JH, 1999, J AM CHEM SOC, V121, P9750, DOI 10.1021/ja992761b; Hafner JH, 1998, CHEM PHYS LETT, V296, P195, DOI 10.1016/S0009-2614(98)01024-0; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; Kostyrko T, 1999, PHYS REV B, V60, P10735, DOI 10.1103/PhysRevB.60.10735; Kostyrko T, 1999, PHYS REV B, V59, P3241, DOI 10.1103/PhysRevB.59.3241; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; McEuen PL, 1999, PHYS REV LETT, V83, P5098, DOI 10.1103/PhysRevLett.83.5098; Odom TW, 2000, J PHYS CHEM B, V104, P2794, DOI 10.1021/jp993592k; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Tans SJ, 2000, NATURE, V404, P834, DOI 10.1038/35009026; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Tombler TW, 2000, NATURE, V405, P769, DOI 10.1038/35015519; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241	27	390	395	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					283	285		10.1126/science.291.5502.283	http://dx.doi.org/10.1126/science.291.5502.283			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209073				2022-12-28	WOS:000166352900038
J	Tanaka, H; Okano, Y; Kobayashi, H; Suzuki, W; Kobayashi, A				Tanaka, H; Okano, Y; Kobayashi, H; Suzuki, W; Kobayashi, A			A three-dimensional synthetic metallic crystal composed of single-component molecules	SCIENCE			English	Article							TTF	Molecular metals normally require charge transfer between two different chemical species. We prepared crystals of [Ni(tmdt)(2)] (tmdt, trimethylenetetrathiafulvalenedithiolate) and carried out crystal structure analyses and resistivity measurements. The analyses and measurements revealed that these single-component molecular crystals are metallic from room temperature down to 0.6 kelvin. Ab initio molecular orbital calculations suggested that pi molecular orbitals form conduction bands. The compact molecular arrangement, intermolecular overlap integrals of the highest occupied and Lowest unoccupied molecular orbitals, and tight-binding electronic band structure calculation revealed that [Ni(tmdt)(2)] is a three-dimensional synthetic metal composed of planar molecules.	Univ Tokyo, Grad Sch Sci, Res Ctr Spectrochem, Bunkyo Ku, Tokyo 1130033, Japan; Inst Mol Sci, Okazaki, Aichi 4448585, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Kobayashi, A (corresponding author), Univ Tokyo, Grad Sch Sci, Res Ctr Spectrochem, Bunkyo Ku, Tokyo 1130033, Japan.		Tanaka, Hisashi/F-8212-2017	Tanaka, Hisashi/0000-0003-0604-5528				AKAMATU H, 1950, J CHEM PHYS, V18, P810, DOI 10.1063/1.1747780; Barclay TM, 1997, J AM CHEM SOC, V119, P2633, DOI 10.1021/ja9636294; Belo D, 2001, CHEM-EUR J, V7, P511; Binet L, 1996, J CHEM SOC PERK T 1, P783, DOI 10.1039/p19960000783; BROSSARD L, 1986, PHYSICA B & C, V143, P378, DOI 10.1016/0378-4363(86)90145-2; ELEY DD, 1948, NATURE, V162, P819, DOI 10.1038/162819a0; FERRARIS J, 1973, J AM CHEM SOC, V95, P948, DOI 10.1021/ja00784a066; Ferraro J. R., 1992, SYNTHESIS STRUCTURE; JEROME D, 1980, J PHYS LETT L, V95, P1416; Kobayashi A, 1999, J AM CHEM SOC, V121, P10763, DOI 10.1021/ja9921017; KROGMANN K, 1968, Z ANORG ALLG CHEM, V358, P67, DOI 10.1002/zaac.19683580108; Kumasaki M, 1998, J MATER CHEM, V8, P301, DOI 10.1039/a704518b; Narvor N. L., 1996, J CHEM SOC CHEM COMM, P1363; Schon JH, 2000, NATURE, V406, P702, DOI 10.1038/35021011	14	444	444	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					285	287		10.1126/science.291.5502.285	http://dx.doi.org/10.1126/science.291.5502.285			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209074				2022-12-28	WOS:000166352900039
J	Weine, S				Weine, S			From war zone to contact zone: Culture and refugee mental health services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Illinois, Coll Med, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Weine, S (corresponding author), Univ Illinois, Coll Med, Chicago, IL 60680 USA.							CLIFFORD J, 2000, SITE SPECIFICITY ETH, P52; Clifford James, 1997, ROUTES TRAVELS TRANS; WEINE S, 1999, HIST IS NIGHTMARE LI; Weine SM, 2000, J NERV MENT DIS, V188, P416, DOI 10.1097/00005053-200007000-00004	4	13	13	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1214	1214		10.1001/jama.285.9.1214	http://dx.doi.org/10.1001/jama.285.9.1214			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231756	hybrid			2022-12-28	WOS:000167194700029
J	Kutateladze, T; Overduin, M				Kutateladze, T; Overduin, M			Structural mechanism of endosome docking by the FYVE domain	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CRYSTAL-STRUCTURE; EEA1; BINDING; LOCALIZATION; RECOGNITION; FUSION; HRS	The recruitment of trafficking and signaling proteins to membranes containing phosphatidylinositol 3-phosphate [Ptdlns(3)P] is mediated by FYVE domains. Here, the solution structure of the FYVE domain of the early endosome antigen 1 protein (EEA1) in the free state was compared with the structures of the domain complexed with Ptdlns(3)P and mixed micelles. The multistep binding mechanism involved nonspecific insertion of a hydrophobic Loop into the Lipid bilayer, positioning and activating the binding pocket. Ligation of Ptdlns(3)P then induced a global structural change, drawing the protein termini over the bound phosphoinositide by extension of a hinge. Specific recognition of the 3-phosphate was determined indirectly and directly by two clusters of conserved arginines.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Kutateladze, T (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, 4200 E 9th Ave, Denver, CO 80262 USA.	tatiana.kutateladze@uchsc.edu		Overduin, Michael/0000-0002-3114-6585; Kutateladze, Tatiana/0000-0001-7375-6990	NATIONAL CANCER INSTITUTE [R01CA085716] Funding Source: NIH RePORTER; NCI NIH HHS [CA85716] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Callaghan J, 1999, BIOCHEM J, V338, P539, DOI 10.1042/0264-6021:3380539; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Hayakawa A, 2000, J BIOL CHEM, V275, P29636, DOI 10.1074/jbc.M002696200; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048	18	138	140	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1793	1796		10.1126/science.291.5509.1793	http://dx.doi.org/10.1126/science.291.5509.1793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230696				2022-12-28	WOS:000167320600061
J	Sondermann, H; Scheufler, C; Schneider, C; Hohfeld, J; Hartl, FU; Moarefi, I				Sondermann, H; Scheufler, C; Schneider, C; Hohfeld, J; Hartl, FU; Moarefi, I			Structure of a Bag/Hsc70 complex: Convergent functional evolution of Hsp70 nucleotide exchange factors	SCIENCE			English	Article							APOPTOTIC PROTEIN BAG-1; MOLECULAR CHAPERONES; ATP HYDROLYSIS; DNAK; BINDING; HSC70; RECEPTOR; RELEASE; SYSTEM; CYCLE	Bag (Bcl2-associated athanogene) domains occur in a class of cofactors of the eukaryotic chaperone 70-kilodalton heat shock protein (Hsp70) family. Binding of the Bag domain to the Hsp70 adenosine triphosphatase (ATPase) domain promotes adenosine 5'-triphosphate-dependent release of substrate from Hsp70 in vitro. In a 1.9 angstrom crystal structure of a complex with the ATPase of the 70-kilodalton heat shock cognate protein (Hsc70), the Bag domain forms a three-helix bundle. inducing a, conformational switch in the ATPase that is incompatible with nucleotide binding. The same switch is observed in the bacterial Hsp70 homolog DnaK upon;binding of the structurally unrelated nucleotide exchange factor GrpE, Thus, functional convergence has allowed proteins with different architectures to trigger a conserved conformational shift in Hsp70 that leads to nucleotide exchange.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Univ Bonn, Inst Zellbiol, D-53121 Bonn, Germany	Max Planck Society; University of Bonn	Moarefi, I (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany.	ismail@moarefi.com	Hartl, F. Ulrich/Y-8206-2019	Scheufler, Clemens/0000-0002-3693-3529				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bardelli A, 1996, EMBO J, V15, P6205, DOI 10.1002/j.1460-2075.1996.tb01009.x; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CYR DM, 1992, J BIOL CHEM, V267, P20927; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; HA JH, 1995, BIOCHEMISTRY-US, V34, P11635, DOI 10.1021/bi00036a040; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu R, 1998, J BIOL CHEM, V273, P16985, DOI 10.1074/jbc.273.27.16985; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; SONDERMANN H, UNPUB; Stuart JK, 1998, J BIOL CHEM, V273, P22506, DOI 10.1074/jbc.273.35.22506; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Zeiner M, 1997, EMBO J, V16, P5483, DOI 10.1093/emboj/16.18.5483	36	340	356	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1553	1557		10.1126/science.1057268	http://dx.doi.org/10.1126/science.1057268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222862				2022-12-28	WOS:000167153400047
J	Thoma-Uszynski, S; Stenger, S; Takeuchi, O; Ochoa, MT; Engele, M; Sieling, PA; Barnes, PF; Rollinghoff, M; Bolcskei, PL; Wagner, M; Akira, S; Norgard, MV; Belisle, JT; Godowski, PJ; Bloom, BR; Modlin, RL				Thoma-Uszynski, S; Stenger, S; Takeuchi, O; Ochoa, MT; Engele, M; Sieling, PA; Barnes, PF; Rollinghoff, M; Bolcskei, PL; Wagner, M; Akira, S; Norgard, MV; Belisle, JT; Godowski, PJ; Bloom, BR; Modlin, RL			Induction of direct antimicrobial activity through mammalian toll-like receptors	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR INFECTION; ALVEOLAR MACROPHAGES; MURINE MACROPHAGES; HOST-DEFENSE; LIPOPOLYSACCHARIDE; LIPOPROTEINS; ACTIVATION; MECHANISMS	The mammalian innate immune system retains from Drosophila a family of homologous Toll-like receptors (TLRs) that mediate responses to microbial ligands. Here, we show that TLR2 activation Leads to killing of intracellular Mycobacterium tuberculosis in both mouse and human macrophages, through distinct mechanisms. In mouse macrophages, bacterial lipoprotein activation of TLR2 Leads to a nitric oxide-dependent killing of intracellular tubercle bacilli, but in human monocytes and alveolar macrophages, this pathway was nitric oxide-independent. Thus, mammalian TLRs respond (as Drosophila Toll receptors do) to microbial ligands and also have the ability to activate antimicrobial effector pathways at the site of infection.	Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Div Dermatol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Erlangen Nurnberg, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany; Osaka Univ, Dept Host Def, Osaka, Japan; Univ Texas Hlth Ctr, Dept Med, Tyler, TX 75708 USA; Univ Texas Hlth Ctr, Dept Cell Biol, Tyler, TX 75708 USA; Univ Texas Hlth Ctr, Dept Immunol, Tyler, TX 75708 USA; Klinikum Nurnberg, Med Clin 3, D-90419 Nurnberg, Germany; Univ Texas, SW Med Ctr, Dallas, TX 75235 USA; Colorado State Univ, Ft Collins, CO 80523 USA; Genentech Inc, Dept Mol Biol, S San Francisco, CA 94080 USA; Harvard Univ, Sch Publ Hlth, Off Dean, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; Osaka University; Klinikum Nurnberg Nord; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Colorado State University; Roche Holding; Genentech; Harvard University; Harvard T.H. Chan School of Public Health	Modlin, RL (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Div Dermatol, Los Angeles, CA 90095 USA.		Modlin, Robert L/M-7941-2014; Akira, Shizuo/C-3134-2009; Belisle, John T/B-8944-2017; Takeuchi, Osamu/D-6007-2011; Takeuchi, Osamu/AAG-9359-2019	Modlin, Robert L/0000-0003-4720-031X; Belisle, John T/0000-0002-2539-2798; Takeuchi, Osamu/0000-0002-1260-6232; Ochoa, Maria T/0000-0001-6550-5008	NIAID NIH HHS [AI 07118, AI 22553, AI 47868] Funding Source: Medline; NIAMS NIH HHS [AR 40312] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI022553, R37AI047868, R01AI047868, R01AI022553, R37AI147868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040312] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; COUTO MA, 1994, INFECT IMMUN, V62, P2375, DOI 10.1128/IAI.62.6.2375-2378.1994; ENGELE M, UNPUB; HIRSCH CS, 1994, J IMMUNOL, V152, P743; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Jullien D, 1997, J IMMUNOL, V158, P800; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; STENGER S, 1991, EUR J IMMUNOL, V21, P1669, DOI 10.1002/eji.1830210713; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	23	548	579	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1544	1547		10.1126/science.291.5508.1544	http://dx.doi.org/10.1126/science.291.5508.1544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222859				2022-12-28	WOS:000167153400044
J	Bjornstad, ON; Sait, SM; Stenseth, NC; Thompson, DJ; Begon, M				Bjornstad, ON; Sait, SM; Stenseth, NC; Thompson, DJ; Begon, M			The impact of specialized enemies on the dimensionality of host dynamics	NATURE			English	Article							INDIAN MEAL MOTH; PLODIA-INTERPUNCTELLA; POPULATION REGULATION; TIME-SERIES; CYCLES; TRANSMISSION; MODELS; AGE	Although individual species persist within a web of interactions with other species, data are usually gathered only from the focal species itself. We ask whether evidence of a species' interactions be detected and understood from patterns in the dynamics of that species alone. Theory predicts that strong coupling between a prey and a specialist predator/parasite should lead to an increase in the dimensionality of the prey's dynamics, whereas weak coupling should not. Here we describe a rare test of this prediction. Two natural enemies were added separately to replicate populations of a moth. For biological reasons that we identify here, the prediction of increased dimensionality was confirmed when a parasitoid wasp was added (although this increase had subtleties not previously appreciated), but the prediction failed for an added virus. Thus, an imprint of the interactions may be discerned within time-series data from component species of a system.	Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Univ Liverpool, Sch Biol Sci, Populat & Evolutionary Biol Res Grp, Liverpool L69 3BX, Merseyside, England; Univ Oslo, Dept Biol, Div Zool, N-0316 Oslo, Norway	National Center for Ecological Analysis & Synthesis; University of Liverpool; University of Oslo	Bjornstad, ON (corresponding author), Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16802 USA.	onb1@psu.edu	Stenseth, Nils Chr./G-5212-2016; Bjornstad, Ottar N/I-4518-2012; Thompson, David J/C-3520-2008	Stenseth, Nils Chr./0000-0002-1591-5399; Begon, Mike/0000-0003-1715-5327				Begon M, 1996, NATURE, V381, P311, DOI 10.1038/381311a0; Berryman A. A., 2008, POPULATION SYSTEMS G; Bjornstad ON, 1998, J ANIM ECOL, V67, P110, DOI 10.1046/j.1365-2656.1998.00168.x; Bjornstad ON, 1999, P NATL ACAD SCI USA, V96, P5066, DOI 10.1073/pnas.96.9.5066; Bjornstad ON, 1999, ECOLOGY, V80, P1278; Boots M, 1998, ECOL ENTOMOL, V23, P118, DOI 10.1046/j.1365-2311.1998.00115.x; Briggs CJ, 2000, J ANIM ECOL, V69, P352, DOI 10.1046/j.1365-2656.2000.00398.x; CHENG B, 1994, PHILOS T R SOC A, V348, P325, DOI 10.1098/rsta.1994.0094; CHENG B, 1992, J ROY STAT SOC B MET, V54, P427; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Ellner SP, 1998, AM NAT, V151, P425, DOI 10.1086/286130; FREE CA, 1977, J ANIM ECOL, V46, P543, DOI 10.2307/3829; GREEN PJ, 1994, NONPARAMETRIC REGRES, P182; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; GURNEY WSC, 1983, J ANIM ECOL, V52, P479, DOI 10.2307/4567; GURNEY WSC, 1985, THEOR POPUL BIOL, V28, P150, DOI 10.1016/0040-5809(85)90026-7; HARVEY JA, 1994, ECOLOGY, V75, P1420, DOI 10.2307/1937465; HASSELL MP, 1986, J ANIM ECOL, V55, P923, DOI 10.2307/4425; Knell RJ, 1998, J ANIM ECOL, V67, P592, DOI 10.1046/j.1365-2656.1998.00219.x; MURDOCH W W, 1975, P1; Murdoch WW, 1996, ECOLOGY, V77, P2001, DOI 10.2307/2265696; Nicholson A. J., 1935, P ZOOL SOC LOND, V105, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Royama T., 1992, ANAL POPULATION ECOL; SAIT SM, 1994, J INVERTEBR PATHOL, V63, P107, DOI 10.1006/jipa.1994.1020; SAIT SM, 1994, J ANIM ECOL, V63, P861, DOI 10.2307/5263; Sait SM, 1997, ECOL ENTOMOL, V22, P225, DOI 10.1046/j.1365-2311.1997.t01-1-00051.x; SAIT SM, 1995, ECOL ENTOMOL, V20, P199, DOI 10.1111/j.1365-2311.1995.tb00447.x; SAIT SM, 1994, J ANIM ECOL, V63, P541, DOI 10.2307/5220; SCHAFFER WM, 1981, ECOL MONOGR, V51, P383, DOI 10.2307/2937321; SOKAL RR, 1995, BIOMETRY, V1, P887; Stenseth NC, 1997, P NATL ACAD SCI USA, V94, P5147, DOI 10.1073/pnas.94.10.5147; TABASHNIK BE, 1994, J ECON ENTOMOL, V87, P834, DOI 10.1093/jee/87.4.834; TURCHIN P, 1990, NATURE, V344, P660, DOI 10.1038/344660a0; VENABLES WN, 1994, MODERN APPL STAT SPL, P1; WEI WW, 1989, TIME SERIES ANAL; YAO QW, 1994, J ROY STAT SOC B MET, V56, P701	38	60	68	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1001	1006		10.1038/35059003	http://dx.doi.org/10.1038/35059003			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234001				2022-12-28	WOS:000167148800034
J	Hedenfalk, I; Duggan, D; Chen, YD; Radmacher, M; Bittner, M; Simon, R; Meltzer, P; Gusterson, B; Esteller, M; Kallioniemi, OP; Wilfond, B; Borg, A; Trent, J; Raffeld, M; Yakhini, Z; Ben-Dor, A; Dougherty, E; Kononen, J; Bubendorf, L; Fehrle, W; Pittaluga, S; Gruvberger, S; Loman, N; Johannsoson, O; Olsson, H; Sauter, G				Hedenfalk, I; Duggan, D; Chen, YD; Radmacher, M; Bittner, M; Simon, R; Meltzer, P; Gusterson, B; Esteller, M; Kallioniemi, OP; Wilfond, B; Borg, A; Trent, J; Raffeld, M; Yakhini, Z; Ben-Dor, A; Dougherty, E; Kononen, J; Bubendorf, L; Fehrle, W; Pittaluga, S; Gruvberger, S; Loman, N; Johannsoson, O; Olsson, H; Sauter, G			Gene-expression profiles in hereditary breast cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUSCEPTIBILITY GENE; SPORADIC BREAST; OVARIAN-CANCER; BRCA1; MUTATIONS; GRADE; CLASSIFICATION; APOPTOSIS; FEATURES; CARRIERS	Background: Many cases of hereditary breast cancer are due to mutations in either the BRCA1 or the BRCA2 gene. The histopathological changes in these cancers are often characteristic of the mutant gene. We hypothesized that the genes expressed by these two types of tumors are also distinctive, perhaps allowing us to identify cases of hereditary breast cancer on the basis of gene-expression profiles. Methods: RNA from samples of primary tumors from seven carriers of the BRCA1 mutation, seven carriers of the BRCA2 mutation, and seven patients with sporadic cases of breast cancer was compared with a microarray of 6512 complementary DNA clones of 5361 genes. Statistical analyses were used to identify a set of genes that could distinguish the BRCA1 genotype from the BRCA2 genotype. Results: Permutation analysis of multivariate classification functions established that the gene-expression profiles of tumors with BRCA1 mutations, tumors with BRCA2 mutations, and sporadic tumors differed significantly from each other. An analysis of variance between the levels of gene expression and the genotype of the samples identified 176 genes that were differentially expressed in tumors with BRCA1 mutations and tumors with BRCA2 mutations. Given the known properties of some of the genes in this panel, our findings indicate that there are functional differences between breast tumors with BRCA1 mutations and those with BRCA2 mutations. Conclusions: Significantly different groups of genes are expressed by breast cancers with BRCA1 mutations and breast cancers with BRCA2 mutations. Our results suggest that a heritable mutation influences the gene-expression profile of the cancer. (N Engl J Med 2001;344:539-48.) Copyright (C) 2001 Massachusetts Medical Society.	NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; Lund Univ, Dept Oncol, Lund, Sweden; Univ Glasgow, Western Infirm, Dept Pathol, Glasgow G11 6NT, Lanark, Scotland; Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Div Tumor Biol, Baltimore, MD 21205 USA; NCI, Dept Pathol, Bethesda, MD USA; Agilent Labs, Dept Chem & Biol Syst, Palo Alto, CA USA; Texas A&M Univ, Dept Elect Engn, College Stn, TX USA; NIH, Natl Human Genome Inst, Canc Genet Branch, Bethesda, MD USA; Univ Basel, Inst Pathol, Basel, Switzerland; Lund Univ, Dept Oncol, Lund, Sweden	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Lund University; University of Glasgow; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Agilent Technologies; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Basel; Lund University	Trent, J (corresponding author), NHGRI, Canc Genet Branch, NIH, Bldg 49,Rm 4A22, Bethesda, MD 20892 USA.	jtrent@nih.gov	Bubendorf, Lukas/G-5299-2015; Bubendorfl, Lukas/H-5880-2011; gusterson, barry a/D-3752-2009; Kallioniemi, Olli P/H-5111-2011; Esteller, Manel/L-5956-2014	Bubendorf, Lukas/0000-0001-5970-1803; Kallioniemi, Olli P/0000-0002-3231-0332; Esteller, Manel/0000-0003-4490-6093; Hedenfalk, Ingrid/0000-0002-6840-3397; Kononen, Juha/0000-0002-0157-2137; Olsson, Hakan/0000-0002-8794-9635; Yakhini, Zohar/0000-0002-0420-5412				Agnarsson BA, 1998, BREAST CANCER RES TR, V47, P121, DOI 10.1023/A:1005853022804; Andl T, 1998, CANCER RES, V58, P5; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Catteau A, 1999, ONCOGENE, V18, P1957, DOI 10.1038/sj.onc.1202509; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; DeRisi J, 1996, NAT GENET, V14, P457; EASTON DF, 1995, AM J HUM GENET, V56, P265; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Hacia JG, 1998, NUCLEIC ACIDS RES, V26, P4975, DOI 10.1093/nar/26.21.4975; Hakansson S, 1997, AM J HUM GENET, V60, P1068; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; Johannsson OT, 1997, EUR J CANCER, V33, P362, DOI 10.1016/S0959-8049(96)00469-8; Kainu T, 2000, P NATL ACAD SCI USA, V97, P9603, DOI 10.1073/pnas.97.17.9603; Karp SE, 1997, CANCER-AM CANCER SOC, V80, P435, DOI 10.1002/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lakhani SR, 2000, CLIN CANCER RES, V6, P782; Lakhani SR, 1998, JNCI-J NATL CANCER I, V90, P1138, DOI 10.1093/jnci/90.15.1138; Lakhani SR, 1997, LANCET, V349, P1505; Liu HT, 1999, BIOCHEM BIOPH RES CO, V254, P203, DOI 10.1006/bbrc.1998.9893; Loman N, 1998, CANCER, V83, P310, DOI 10.1002/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W; Marcus JN, 1997, BREAST CANCER RES TR, V44, P275, DOI 10.1023/A:1005830230664; Marcus JN, 1996, CANCER-AM CANCER SOC, V77, P697, DOI 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Schrag D, 2000, JAMA-J AM MED ASSOC, V283, P617, DOI 10.1001/jama.283.5.617; Seitz S, 1997, ONCOGENE, V14, P741, DOI 10.1038/sj.onc.1200881; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Tirkkonen M, 1997, CANCER RES, V57, P1222; TUKEY JW, 1993, CONTROL CLIN TRIALS, V14, P266, DOI 10.1016/0197-2456(93)90225-3; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wooster R, 1996, NATURE, V379, P749, DOI 10.1038/379749a0; Yu VPCC, 2000, GENE DEV, V14, P1400	41	1214	1276	0	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2001	344	8					539	548		10.1056/NEJM200102223440801	http://dx.doi.org/10.1056/NEJM200102223440801			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403LU	11207349				2022-12-28	WOS:000167044600001
J	Mitrovica, JX; Tamisiea, ME; Davis, JL; Milne, GA				Mitrovica, JX; Tamisiea, ME; Davis, JL; Milne, GA			Recent mass balance of polar ice sheets inferred from patterns of global sea-level change	NATURE			English	Article							GLACIAL ISOSTATIC-ADJUSTMENT; TRENDS; FIELD; RISE	Global sea level is an indicator of climate change(1-3), as it is sensitive to both thermal expansion of the oceans and a reduction of land-based glaciers. Global sea-level rise has been estimated by correcting observations from tide gauges for glacial isostatic adjustment-the continuing sea-level response due to melting of Late Pleistocene ice-and by computing the global mean of these residual trends(4-9). In such analyses, spatial patterns of sealevel rise are assumed to be signals that will average out over geographically distributed tide-gauge data. But a long history of modelling studies(10-12) has demonstrated that non-uniform- that is, non-eustatic-sea-level redistributions can be produced by variations in the volume of the polar ice sheets. Here we present numerical predictions of gravitationally consistent patterns of sea-level change following variations in either the Antarctic or Greenland ice sheets or the melting of a suite of small mountain glaciers. These predictions are characterized by geometrically distinct patterns that reconcile spatial variations in previously published sea-level records. Under the-albeit coarse-assumption of a globally uniform thermal expansion of the oceans, our approach suggests melting of the Greenland ice complex over the last century equivalent to similar to0.6 mm yr(-1) of sea-level rise.	Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Univ Durham, Dept Geol Sci, Sci Labs, Durham DH1 3LE, England	University of Toronto; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Durham University	Mitrovica, JX (corresponding author), Univ Toronto, Dept Phys, 60 St George St, Toronto, ON M5S 1A7, Canada.		Davis, James/D-8766-2013	Davis, James/0000-0003-3057-477X				BENTLEY CR, 1991, P INT C ROL POL REG, P481; Daly RA, 1925, AM J SCI, V10, P281; Davis JL, 1996, NATURE, V379, P331, DOI 10.1038/379331a0; Douglas BC, 1997, SURV GEOPHYS, V18, P279, DOI 10.1023/A:1006544227856; DOUGLAS BC, 1991, J GEOPHYS RES-OCEANS, V96, P6981, DOI 10.1029/91JC00064; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; FARRELL WE, 1976, GEOPHYS J ROY ASTR S, V46, P647, DOI 10.1111/j.1365-246X.1976.tb01252.x; JACOBS SS, 1992, J GLACIOL, V38, P375, DOI 10.3189/S0022143000002252; James TS, 1997, J GEOPHYS RES-SOL EA, V102, P605, DOI 10.1029/96JB02855; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Lambeck K, 1998, GEOPHYS J INT, V135, P375, DOI 10.1046/j.1365-246X.1998.00643.x; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; MEIER MF, 1984, SCIENCE, V226, P1418, DOI 10.1126/science.226.4681.1418; Milne GA, 1999, GEOPHYS J INT, V139, P464, DOI 10.1046/j.1365-246x.1999.00971.x; MITROVICA JX, 1991, J GEOPHYS RES-SOL EA, V96, P20053, DOI 10.1029/91JB01284; PELTIER WR, 1989, SCIENCE, V244, P806, DOI 10.1126/science.244.4906.806; PELTIER WR, 1991, J GEOPHYS RES-SOLID, V96, P6779, DOI 10.1029/90JB02067; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; PLAG HP, IN PRESS P 2 INT S E; SHENNAN I, 1992, GEOPHYS J INT, V109, P96, DOI 10.1111/j.1365-246X.1992.tb00081.x; Spencer N. E., 1993, DATA HOLDINGS PERMAN; TRUPIN A, 1990, GEOPHYS J INT, V100, P441, DOI 10.1111/j.1365-246X.1990.tb00697.x; TRUPIN AS, 1992, GEOPHYS J INT, V108, P1, DOI 10.1111/j.1365-246X.1992.tb00835.x; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; WARRICK RA, 1990, SCI CLIMATE CHARGE C, P361; WARRICK RA, 1993, CLIMATE SEA LEVEL CH; Woodward R S, 1888, US GEOL SURV B, V48, P87; Woodworth PL, 1999, GEOPHYS J INT, V136, P651, DOI 10.1046/j.1365-246x.1999.00751.x; WOODWORTH PL, 1992, SEA LEVEL CHANGES DE	29	362	373	2	86	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1026	1029		10.1038/35059054	http://dx.doi.org/10.1038/35059054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234008				2022-12-28	WOS:000167148800041
J	Murphy, TV; Gargiullo, PM; Massoudi, MS; Nelson, DB; Jumaan, AO; Okoro, CA; Zanardi, LR; Setia, S; Fair, E; LeBaron, CW; Schwartz, B; Wharton, M; Livingood, JR				Murphy, TV; Gargiullo, PM; Massoudi, MS; Nelson, DB; Jumaan, AO; Okoro, CA; Zanardi, LR; Setia, S; Fair, E; LeBaron, CW; Schwartz, B; Wharton, M; Livingood, JR		Rotavirus Intussception Investigat	Intussusception among infants given an oral rotavirus vaccine.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTION; DIARRHEA	Background: Intussusception is a form of intestinal obstruction in which a segment of the bowel prolapses into a more distal segment. Our investigation began on May 27, 1999, after nine cases of infants who had intussusception after receiving the tetravalent rhesus-human reassortant rotavirus vaccine (RRV-TV) were reported to the Vaccine Adverse Event Reporting System. Methods: In 19 states, we assessed the potential association between RRV-TV and intussusception among infants at least 1 but less than 12 months old. Infants hospitalized between November 1, 1998, and June 30, 1999, were identified by systematic reviews of medical and radiologic records. Each infant with intussusception was matched according to age with four healthy control infants who had been born at the same hospital as the infant with intussusception. Information on vaccinations was verified by the provider. Results: Data were analyzed for 429 infants with intussusception and 1763 matched controls in a case-control analysis as well as for 432 infants with intussusception in a case-series analysis. Seventy-four of the 429 infants with intussusception (17.2 percent) and 226 of the 1763 controls (12.8 percent) had received RRV-TV (P=0.02). An increased risk of intussusception 3 to 14 days after the first dose of RRV-TV was found in the case-control analysis (adjusted odds ratio, 21.7; 95 percent confidence interval, 9.6 to 48.9). In the case-series analysis, the incidence-rate ratio was 29.4 (95 percent confidence interval, 16.1 to 53.6) for days 3 through 14 after a first dose. There was also an increase in the risk of intussusception after the second dose of the vaccine, but it was smaller than the increase in risk after the first dose. Assuming full implementation of a national program of vaccination with RRV-TV, we estimated that 1 case of intussusception attributable to the vaccine would occur for every 4670 to 9474 infants vaccinated. Conclusions: The strong association between vaccination with RRV-TV and intussusception among otherwise healthy infants supports the existence of a causal relation. Rotavirus vaccines with an improved safety profile are urgently needed. (N Engl J Med 2001;344:564-72.) Copyright (C) 2001 Massachusetts Medical Society.	Ctr Dis Control & Prevent, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Data Management Div, Natl Immunizat Program, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Murphy, TV (corresponding author), Ctr Dis Control & Prevent, Epidemiol & Surveillance Div, Natl Immunizat Program, 1600 Clifton Rd NE,Mail Stop E-61, Atlanta, GA 30333 USA.							Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; Chen RT, 2000, B WORLD HEALTH ORGAN, V78, P186; Ciarlet M, 2000, ARCH VIROL, V145, P371, DOI 10.1007/s007050050029; Clemens J, 1999, EPIDEMIOL REV, V21, P24, DOI 10.1093/oxfordjournals.epirev.a017986; DUNN SJ, 1994, VIROLOGY, V203, P178, DOI 10.1006/viro.1994.1471; Ein SH, 1997, PEDIATR SURG INT, V12, P374; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; Farrington CP, 1998, AM J EPIDEMIOL, V147, P93; FRIEDMAN MG, 1993, CLIN EXP IMMUNOL, V92, P194, DOI 10.1111/j.1365-2249.1993.tb03379.x; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; Halsey NA, 1998, PEDIATRICS, V102, P1483, DOI 10.1542/peds.102.6.1483; Hemano I, 1967, Gastroenterology, V53, P71; Joensuu J, 1998, PEDIATR INFECT DIS J, V17, P334, DOI 10.1097/00006454-199804000-00013; KAPIKIAN AZ, 1986, J INFECT DIS, V153, P815, DOI 10.1093/infdis/153.5.815; KONNO T, 1978, J MED VIROL, V2, P265, DOI 10.1002/jmv.1890020310; Lin Z, 1998, J PEDIATR GASTR NUTR, V27, P301, DOI 10.1097/00005176-199809000-00006; Lundgren O, 2000, SCIENCE, V287, P491, DOI 10.1126/science.287.5452.491; Melton L, 2000, LANCET, V356, P318, DOI 10.1016/S0140-6736(05)73604-7; MULCAHY DL, 1982, J MED VIROL, V9, P51, DOI 10.1002/jmv.1890090108; Nazarian LF, 1996, PEDIATRICS, V97, P424; NICOLAS JC, 1982, J MED VIROL, V9, P267, DOI 10.1002/jmv.1890090404; Offit PA, 1996, J INFECT DIS, V174, pS59, DOI 10.1093/infdis/174.Supplement_1.S59; Parashar UD, 2000, PEDIATRICS, V106, P1413, DOI 10.1542/peds.106.6.1413; Perrin WS, 1921, BRIT J SURG, V9, P46, DOI 10.1002/bjs.1800093308; Rennels MB, 1996, J INFECT DIS, V174, pS107, DOI 10.1093/infdis/174.Supplement_1.S107; Rennels MB, 1998, PEDIATR INFECT DIS J, V17, P924, DOI 10.1097/00006454-199810000-00018; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P7; Stevens RJ, 1999, NATURE, V399, P62, DOI 10.1038/19973; STRINGER MD, 1992, BRIT J SURG, V79, P867, DOI 10.1002/bjs.1800790906; Ward RL, 1998, PEDIATR INFECT DIS J, V17, P386, DOI 10.1097/00006454-199805000-00008; [No title captured]; [No title captured]; [No title captured]	34	707	733	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2001	344	8					564	572		10.1056/NEJM200102223440804	http://dx.doi.org/10.1056/NEJM200102223440804			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403LU	11207352	Bronze			2022-12-28	WOS:000167044600004
J	White, RJ; Averner, M				White, RJ; Averner, M			Humans in space	NATURE			English	Article							SPACEFLIGHT; MICROGRAVITY; ORIENTATION	Many successful space missions over the past 40 years have highlighted the advantages and necessity of humans in the exploration of space. But as space travel becomes ever more feasible in the twenty-first century, the health and safety of future space explorers will be paramount. In particular, understanding the risks posed by exposure to radiation and extended weightlessness will be crucial if humans are to travel far from Earth.	Natl Space Biomed Res Inst, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Baylor College of Medicine; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	White, RJ (corresponding author), Natl Space Biomed Res Inst, 1 Baylor Plaza,NA-425, Houston, TX 77030 USA.							Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Baldwin KM, 1996, MED SCI SPORT EXER, V28, P983, DOI 10.1097/00005768-199608000-00008; Boyd C. A. R., 1993, LOGIC LIFE CHALLENGE; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; CONNORS MM, 1985, LIVING ALOFT; Czeisler CA, 2000, PRINCIPLES PRACTICE, P353; DAUNTON NG, 1996, HDB PHYSL 4, P765; EDGERTON VR, 1995, J APPL PHYSIOL, V78, P1733, DOI 10.1152/jappl.1995.78.5.1733; EDGERTON VR, 1996, HDB PHYSL 4, P721; Ellis S R, 2000, Ergon Des, V8, P4, DOI 10.1177/106480460000800102; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Fritsch-Yelle JM, 1998, AM J CARDIOL, V81, P1391, DOI 10.1016/S0002-9149(98)00179-9; GMUNDER FK, 1996, HDB PHYSL 4, P799; Grigoriev A I, 1998, Aviakosm Ekolog Med, V32, P21; Gundel A, 1997, J SLEEP RES, V6, P1, DOI 10.1046/j.1365-2869.1997.00028.x; Hoffman SJ., 1997, AM ASTRONAUT SOC SCI, V98, P121; KADHIM MA, 1992, NATURE, V355, P738, DOI 10.1038/355738a0; Kanas N, 1998, AVIAT SPACE ENVIR MD, V69, P1211; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; Levine BD, 1997, CIRCULATION, V96, P517; MOREYHOLTON ER, 1996, HDB PHYSL, P691; *NAT RES COUNC, 1994, SPAC STUD BOARD; *NAT RES COUNC, 1996, SPAC STUD BOARD; NELSON GA, 1996, HDB PHYSL 4, P785; Nicogossian A.E., 1994, SPACE PHYSL MED; OMAN CM, 1986, EXP BRAIN RES, V64, P316; Palinkas LA, 2000, AVIAT SPACE ENVIR MD, V71, P619; Reschke M.F., 1994, SPACE PHYSL MED, P261; Reyes C., 1999, FASEB Journal, V13, pA1048; SCHIMMERLING W, 1992, RADIAT ENVIRON BIOPH, V31, P197, DOI 10.1007/BF01214827; Smith SM, 1999, AM J PHYSIOL-REG I, V277, pR1; TAYLOR GR, 1993, J LEUKOCYTE BIOL, V54, P179, DOI 10.1002/jlb.54.3.179; Vazquez ME, 1998, ADV SPACE RES-SERIES, V22, P171, DOI 10.1016/S0273-1177(98)80009-4; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; WAUTENPAUGH DE, 1996, HDB PHYSL 4, P631; YOUNG LR, 1984, SCIENCE, V225, P205, DOI 10.1126/science.6610215	36	201	224	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1115	1118		10.1038/35059243	http://dx.doi.org/10.1038/35059243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234026				2022-12-28	WOS:000167148800060
J	Birney, E; Bateman, A; Clamp, ME; Hubbard, TJ				Birney, E; Bateman, A; Clamp, ME; Hubbard, TJ			Mining the draft human genome	NATURE			English	Article								Now that the draft human genome sequence is available, everyone wants to be able to use it. However, we have perhaps become complacent about our ability to turn new genomes into lists of genes. The higher volume of data associated with a larger genome is accompanied by a much greater increase in complexity. We need to appreciate both the scale of the challenge of vertebrate genome analysis and the limitations of current gene prediction methods and understanding.	European Bioinformat Inst, Cambridge CB10 1SA, England; Sanger Ctr, Cambridge CB10 1SA, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Birney, E (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	birney@ebi.ac.uk	Bateman, Alex/E-6518-2011; Hubbard, Tim J.P./AAT-4571-2020; Bateman, Alex/H-2861-2019; Hubbard, Tim J/C-2567-2008	Hubbard, Tim J.P./0000-0002-1767-9318; Bateman, Alex/0000-0002-6982-4660; Hubbard, Tim J/0000-0002-1767-9318; Birney, Ewan/0000-0001-8314-8497				[Anonymous], 1997, NATURE, V387, pS; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BURGE, UNPUB NATURE GENET; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Fahrer AM, 2001, NATURE, V409, P836, DOI 10.1038/35057020; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Murray AW, 2001, NATURE, V409, P844, DOI 10.1038/35057033; Nestler EJ, 2001, NATURE, V409, P834, DOI 10.1038/35057015; Pollard TD, 2001, NATURE, V409, P842, DOI 10.1038/35057029; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; Roest Crollius H, 2000, GENOME RES, V10, P939, DOI 10.1101/gr.10.7.939; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; 2000, NATURE, V406, P929	16	41	42	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					827	828		10.1038/35057004	http://dx.doi.org/10.1038/35057004			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236999	Bronze, Green Accepted			2022-12-28	WOS:000166938800046
J	Nestler, EJ; Landsman, D				Nestler, EJ; Landsman, D			Learning about addiction from the genome	NATURE			English	Article							MU-OPIOID RECEPTOR; PROTEINS; NEUROSCIENCE; SENSITIVITY; PROGRESS; GENES	Drug addiction can be defined as the compulsive seeking and taking of a drug despite adverse consequences. Although addiction involves many psychological and social factors, it also represents a biological process: the effects of repeated drug exposure on a vulnerable brain. The sequencing of the human and other mammalian genomes will help us to understand the biology of addiction by enabling us to identify both genes that contribute to individual risk for addiction and those through which drugs cause addiction. We illustrate this potential impact by searching a draft sequence of the human genome for genes related to desensitization of receptors that mediate the actions of drugs of abuse on the nervous system.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, Computat Biol Branch, Bethesda, MD 20892 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Landsman, David/GZK-5496-2022; Landsman, David/C-5923-2009	Landsman, David/0000-0002-9819-6675	NATIONAL LIBRARY OF MEDICINE [Z01LM000071, ZIALM000071] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Crabbe JC, 1999, TRENDS NEUROSCI, V22, P173, DOI 10.1016/S0166-2236(99)01393-4; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; Kandel ER, 1997, J CELL PHYSIOL, V173, P124, DOI 10.1002/(SICI)1097-4652(199711)173:2<124::AID-JCP6>3.3.CO;2-5; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Nestler EJ, 2000, NAT GENET, V26, P277, DOI 10.1038/81570; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Potenza MN, 1999, J PHARMACOL EXP THER, V291, P482; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	15	62	65	2	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					834	835		10.1038/35057015	http://dx.doi.org/10.1038/35057015			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237002	Bronze			2022-12-28	WOS:000166938800049
J	Riethman, HC; Xiang, Z; Paul, S; Morse, E; Hu, XL; Flint, J; Chi, HC; Grady, DL; Moyzis, RK				Riethman, HC; Xiang, Z; Paul, S; Morse, E; Hu, XL; Flint, J; Chi, HC; Grady, DL; Moyzis, RK			Integration of telomere sequences with the draft human genome sequence	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-SEQUENCE; COMPLETE SET; GENE FAMILY; CHROMOSOME; POLYMORPHISM; CLONING	Telomeres are the ends of linear eukaryotic chromosomes. To ensure that no large stretches of uncharacterized DNA remain between the ends of the human working draft sequence and the ends of each chromosome, we would need to connect the sequences of the telomeres to the working draft sequence. But telomeres have an unusual DNA sequence composition and organization that makes them particularly difficult to isolate and analyse. Here we use specialized linear yeast artificial chromosome clones, each carrying a large telomere-terminal fragment of human DNA, to integrate most human telomeres with the working draft sequence. Subtelomeric sequence structure appears to vary widely, mainly as a result of large differences in subtelomeric repeat sequence abundance and organization at individual telomeres. Many subtelomeric regions appear to be gene-rich, matching both known and unknown expressed genes. This indicates that human subtelomeric regions are not simply buffers of nonfunctional 'junk DNA' next to the molecular telomere, but are instead functional parts of the expressed genome.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; John Radcliffe Hosp, Inst Mol Med, Oxford, England; Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92697 USA	The Wistar Institute; University of Oxford; University of California System; University of California Irvine	Riethman, HC (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	Riethman@wistar.upenn.edu		Flint, Jonathan/0000-0002-9427-4429				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Blasco Maria A., 1999, Genes and Development, V13, P2353, DOI 10.1101/gad.13.18.2353; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; CARLSON M, 1985, MOL CELL BIOL, V5, P2894, DOI 10.1128/MCB.5.11.2894; Ciccodicola A, 2000, HUM MOL GENET, V9, P395, DOI 10.1093/hmg/9.3.395; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; DOGGETT NA, 1995, NATURE, V377, P335; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Gianfrancesco F, 1998, HUM MOL GENET, V7, P407, DOI 10.1093/hmg/7.3.407; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; LOUIS EJ, 1995, GENETICS, V139, P125; MACINA RA, 1995, GENOME RES, V5, P225, DOI 10.1101/gr.5.3.225; McCulloch R, 1997, MOL CELL BIOL, V17, P833, DOI 10.1128/MCB.17.2.833; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; Riethman H, 1997, GENOME ANAL, V1, P83; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; Rosenberg M, 1997, GENOME RES, V7, P917, DOI 10.1101/gr.7.9.917; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R	26	66	69	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					948	951		10.1038/35057180	http://dx.doi.org/10.1038/35057180			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237019	Bronze			2022-12-28	WOS:000166938800066
J	Rowe, MA; Kielpinski, D; Meyer, V; Sackett, CA; Itano, WM; Monroe, C; Wineland, DJ				Rowe, MA; Kielpinski, D; Meyer, V; Sackett, CA; Itano, WM; Monroe, C; Wineland, DJ			Experimental violation of a Bell's inequality with efficient detection	NATURE			English	Article							HIDDEN-VARIABLE THEORIES; LOOPHOLE-FREE TEST; ATOMS; PAIRS; PROPOSAL	Local realism is the idea that objects have definite properties whether or not they are measured, and that measurements of these properties are not affected by events taking place sufficiently far away(1). Einstein, Podolsky and Rosen(2) used these reasonable assumptions to conclude that quantum mechanics is incomplete. Starting in 1965, Bell and others constructed mathematical inequalities whereby experimental tests could distinguish between quantum mechanics and local realistic theories(1,3-5). Many experiments(1,6-15) have since been done that are consistent with quantum mechanics and inconsistent with local realism. But these conclusions remain the subject of considerable interest and debate, and experiments are still being refined to overcome 'loopholes' that might allow a local realistic interpretation. Here we have measured correlations in the classical properties of massive entangled particles (Be-9(+) ions): these correlations violate a form of Bell's inequality. Our measured value of the appropriate Bell's 'signal' is 2.25 +/- 0.03, whereas a value of 2 is the maximum allowed by local realistic theories of nature. In contrast to previous measurements with massive particles, this violation of Bell's inequality was obtained by use of a complete set of measurements. Moreover, the high detection efficiency of our apparatus eliminates the so-called 'detection' loophole.	Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA; Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	National Institute of Standards & Technology (NIST) - USA; University of Michigan System; University of Michigan	Wineland, DJ (corresponding author), Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA.		Sackett, Charles/AAD-1452-2019; Itano, Wayne/AAV-8781-2020; Monroe, Christopher R/G-8105-2011	Sackett, Charles/0000-0001-6741-0571; Kielpinski, David/0000-0002-2816-6892				ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Aspect A, 1999, NATURE, V398, P189, DOI 10.1038/18296; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Beige A, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052102; Bell J., 1971, F QUANTUM MECHANICS, P171; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Brif C, 2000, EUROPHYS LETT, V49, P1, DOI 10.1209/epl/i2000-00111-0; CLAUSER JF, 1978, REP PROGR PHYS, V41, P1883; EICHMANN U, 1993, PHYS REV LETT, V70, P2359, DOI 10.1103/PhysRevLett.70.2359; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; FEYNMAN RP, 1957, J APPL PHYS, V28, P49, DOI 10.1063/1.1722572; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Freyberger M, 1996, PHYS REV A, V53, P1232, DOI 10.1103/PhysRevA.53.1232; FRY ES, 1995, PHYS REV A, V52, P4381, DOI 10.1103/PhysRevA.52.4381; FRY ES, 1976, PHYS REV LETT, V37, P465, DOI 10.1103/PhysRevLett.37.465; Gisin N, 1999, PHYS LETT A, V264, P103, DOI 10.1016/S0375-9601(99)00807-5; Hagley E, 1997, PHYS REV LETT, V79, P1, DOI 10.1103/PhysRevLett.79.1; HUELGA SF, 1995, PHYS REV A, V51, P5008, DOI 10.1103/PhysRevA.51.5008; KWIAT PG, 1994, PHYS REV A, V49, P3209, DOI 10.1103/PhysRevA.49.3209; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; LAMEHIRACHTI M, 1976, PHYS REV D, V14, P2543, DOI 10.1103/PhysRevD.14.2543; LO TK, 1981, PHYS REV A, V23, P3003, DOI 10.1103/PhysRevA.23.3003; OU ZY, 1988, PHYS REV LETT, V61, P50, DOI 10.1103/PhysRevLett.61.50; RICHTER T, 1983, OPT ACTA, V30, P1769, DOI 10.1080/713821122; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; SHIH YH, 1988, PHYS REV LETT, V61, P2921, DOI 10.1103/PhysRevLett.61.2921; TAPSTER PR, 1994, PHYS REV LETT, V73, P1923, DOI 10.1103/PhysRevLett.73.1923; Tittel W, 1998, PHYS REV LETT, V81, P3563, DOI 10.1103/PhysRevLett.81.3563; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039	30	703	709	4	75	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					791	794		10.1038/35057215	http://dx.doi.org/10.1038/35057215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236986	Green Published			2022-12-28	WOS:000166938800032
J	Saghatelian, A; Yokobayashi, Y; Soltani, K; Ghadiri, MR				Saghatelian, A; Yokobayashi, Y; Soltani, K; Ghadiri, MR			A chiroselective peptide replicator	NATURE			English	Article							BIOMOLECULAR CHIRALITY; SELF-REPLICATION; OPTICAL-ACTIVITY; AMINO-ACIDS; AMPLIFICATION; TEMPLATE; ORIGIN; HOMOCHIRALITY; LIGATION	The origin of homochirality in living systems is often attributed to the generation of enantiomeric differences in a pool of chiral prebiotic molecules(1,2), but none of the possible physiochemical processes considered(1-7) can produce the significant imbalance required if homochiral biopolymers are to result from simple coupling of suitable precursor molecules. This implies a central role either for additional processes that can selectively amplify an initially minute enantiomeric difference in the starting material(1,8-12), or for a nonenzymatic process by which biopolymers undergo chiroselective molecular replication(13-16). Given that molecular self-replication and the capacity for selection are necessary conditions for the emergence of life, chiroselective replication of biopolymers seems a particularly attractive process for explaining homochirality in nature(13-16). Here we report that a 32-residue peptide replicator, designed according to our earlier principles(17-20), is capable of efficiently amplifying homochiral products from a racemic mixture of peptide fragments through a chiroselective autocatalytic cycle. The chiroselective amplification process discriminates between structures possessing even single stereochemical mutations within otherwise homochiral sequences. Moreover, the system exhibits a dynamic stereochemical 'editing' function; in contrast to the previously observed error correction(20), it makes use of heterochiral sequences that arise through uncatalysed background reactions to catalyse the production of the homochiral product. These results support the idea that self-replicating polypeptides could have played a key role in the origin of homochirality on Earth.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Ghadiri, MR (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.		Yokobayashi, Yohei/B-5898-2009	Yokobayashi, Yohei/0000-0002-2417-1934				BADA JL, 1995, NATURE, V374, P594, DOI 10.1038/374594a0; Bolli M, 1997, CHEM BIOL, V4, P309, DOI 10.1016/S1074-5521(97)90074-0; BONNER WA, 1991, ORIGINS LIFE EVOL B, V21, P59, DOI 10.1007/BF01809580; BONNER WA, 1981, ORIGINS LIFE EVOL B, V11, P119, DOI 10.1007/BF00928003; CALVIN M, 1969, CHEM EVOLUTION; Case MA, 1998, CHIRALITY, V10, P35, DOI 10.1002/(SICI)1520-636X(1998)10:1/2<35::AID-CHIR7>3.3.CO;2-F; Cronin JR, 1997, SCIENCE, V275, P951, DOI 10.1126/science.275.5302.951; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; FRANK FC, 1953, BIOCHIM BIOPHYS ACTA, V11, P459, DOI 10.1016/0006-3002(53)90082-1; GIRDARD C, 1998, ANGEW CHEM INT EDIT, V37, P2923; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; KONDEPUDI DK, 1985, NATURE, V314, P438, DOI 10.1038/314438a0; KONDEPUDI DK, 1990, SCIENCE, V250, P975, DOI 10.1126/science.250.4983.975; Kozlov IA, 1999, J AM CHEM SOC, V121, P1108, DOI 10.1021/ja9836489; Krause E, 2000, J AM CHEM SOC, V122, P4865, DOI 10.1021/ja9940524; Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0; Lee DH, 1997, NATURE, V390, P591, DOI 10.1038/37569; LI T, 1987, J CHEM SOC CHEM COMM, P1817, DOI 10.1039/c39870001817; ROTHEMUND S, 1995, BIOCHEMISTRY-US, V34, P12954, DOI 10.1021/bi00040a005; ROTHEMUND S, 1996, PEPTIDE RES, V9, P78; Schmidt JG, 1997, J AM CHEM SOC, V119, P1494, DOI 10.1021/ja963563c; Severin K, 1998, ANGEW CHEM INT EDIT, V37, P126, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<126::AID-ANIE126>3.0.CO;2-4; Severin K, 1997, CHEM-EUR J, V3, P1017, DOI 10.1002/chem.19970030706; Siegel JS, 1998, CHIRALITY, V10, P24, DOI 10.1002/chir.5; SOAI K, 1995, NATURE, V378, P767, DOI 10.1038/378767a0; WEISSBUCH I, 1984, NATURE, V310, P161, DOI 10.1038/310161a0	27	211	214	3	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					797	801		10.1038/35057238	http://dx.doi.org/10.1038/35057238			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236988				2022-12-28	WOS:000166938800034
J	Delmas, PD				Delmas, PD			Osteoporosis in patients with organ transplants: a neglected problem	LANCET			English	Editorial Material							BONE LOSS; CARDIAC TRANSPLANTATION; LIVER-TRANSPLANTATION; FRACTURE; ALENDRONATE; TURNOVER; TRIAL; WOMEN; RISK		Univ Lyon 1, Hop Edouard Herriot, Dept Med, INSERM,Res Unit 403, Lyon 03, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Claude Bernard Lyon 1	Delmas, PD (corresponding author), Univ Lyon 1, Hop Edouard Herriot, Dept Med, INSERM,Res Unit 403, Lyon 03, France.							Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; CLEEMPUT JV, 1996, TRANSPLANTATION, V61, P1495; Epstein S, 1996, J BONE MINER RES, V11, P1; Giannini S, 2000, OSTEOPOROSIS INT, V11, P417, DOI 10.1007/s001980070109; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; MEYS E, 1994, AM J MED, V97, P445, DOI 10.1016/0002-9343(94)90324-7; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; Ramsey-Goldman R, 1999, J BONE MINER RES, V14, P456, DOI 10.1359/jbmr.1999.14.3.456; Reeves HL, 1998, LIVER TRANSPLANT SUR, V4, P404, DOI 10.1002/lt.500040508; Reid DM, 2000, J BONE MINER RES, V15, P1006, DOI 10.1359/jbmr.2000.15.6.1006; Rodino MA, 1998, AM J MED, V104, P459, DOI 10.1016/S0002-9343(98)00081-3; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; Shane E, 1996, J CLIN ENDOCR METAB, V81, P1740, DOI 10.1210/jc.81.5.1740; Shane E, 1997, J CLIN ENDOCR METAB, V82, P1497, DOI 10.1210/jc.82.5.1497; Thiebaud D, 1996, EUR J CLIN INVEST, V26, P549, DOI 10.1046/j.1365-2362.1996.00170.x	15	13	13	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					325	326		10.1016/S0140-6736(00)03632-1	http://dx.doi.org/10.1016/S0140-6736(00)03632-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210987				2022-12-28	WOS:000166897900003
J	Misteli, T				Misteli, T			Nuclear structure - Protein dynamics: Implications for nuclear architecture and gene expression	SCIENCE			English	Review							HISTONE H1; SPLICING FACTOR; RAPID EXCHANGE; CELL BIOLOGY; IN-VIVO; RNA; TRANSCRIPTION; MOBILITY; ORGANIZATION; CHROMATIN		NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov						Arnone MI, 1997, DEVELOPMENT, V124, P1851; Bergel M, 2000, J BIOL CHEM, V275, P11514, DOI 10.1074/jbc.275.15.11514; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; Bral CM, 1998, GENE EXPRESSION, V7, P191; BUSCH H, 1967, EXP CELL RES, V47, P329, DOI 10.1016/0014-4827(67)90235-2; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; CARON F, 1981, J MOL BIOL, V146, P513, DOI 10.1016/0022-2836(81)90045-0; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cremer T, 2000, CRIT REV EUKAR GENE, V10, P179; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; FUSHIMI K, 1991, J CELL BIOL, V112, P719, DOI 10.1083/jcb.112.4.719; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Grigoryev SA, 1998, J BIOL CHEM, V273, P3082, DOI 10.1074/jbc.273.5.3082; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; HENDZEL M, COMMUNICATION; Herrera JE, 1999, MOL CELL BIOL, V19, P3466; Herrera JE, 2000, MOL CELL BIOL, V20, P523, DOI 10.1128/MCB.20.2.523-529.2000; Hill DA, 2000, BIOCHEMISTRY-US, V39, P11649, DOI 10.1021/bi001330z; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Huang S, 1998, J CELL BIOL, V143, P35, DOI 10.1083/jcb.143.1.35; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; KADONAGA JT, 1990, J BIOL CHEM, V265, P2624; KIMURA H, COMMUNICATION; Kruhlak MJ, 2000, J CELL BIOL, V150, P41, DOI 10.1083/jcb.150.1.41; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Misteli T, 2000, J CELL SCI, V113, P1841; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; MISTELI T, UNPUB; Newlands S, 1998, GENE DEV, V12, P2748, DOI 10.1101/gad.12.17.2748; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Pederson T, 2000, NAT CELL BIOL, V2, pE73, DOI 10.1038/35010501; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Shopland LS, 2000, J CELL BIOL, V150, pF1, DOI 10.1083/jcb.150.1.F1; SHOPLAND LS, IN PRESS MOL BIOL CE; SINCLAIR GD, 1978, EXP CELL RES, V111, P1, DOI 10.1016/0014-4827(78)90230-6; Singh OP, 1999, EXP CELL RES, V251, P135, DOI 10.1006/excr.1999.4490; Snaar S, 2000, J CELL BIOL, V151, P653, DOI 10.1083/jcb.151.3.653; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WEINTRAUB H, 1988, P NATL ACAD SCI USA, V85, P5819, DOI 10.1073/pnas.85.16.5819; WU LH, 1986, J CELL BIOL, V103, P465, DOI 10.1083/jcb.103.2.465; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	59	504	523	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2001	291	5505					843	847		10.1126/science.291.5505.843	http://dx.doi.org/10.1126/science.291.5505.843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11225636				2022-12-28	WOS:000166771700035
J	Riordan, M				Riordan, M			The suspense of strangeness - Science supplies poetry with a register of words outside common usage.	NATURE			English	Editorial Material											Riordan, M (corresponding author), 6 Daniels Rd, London SE15 3LR, England.								0	1	1	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					457	457		10.1038/35054146	http://dx.doi.org/10.1038/35054146			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206522	Bronze			2022-12-28	WOS:000166570500021
J	Alerstam, T; Gudmundsson, GA; Green, M; Hedenstrom, A				Alerstam, T; Gudmundsson, GA; Green, M; Hedenstrom, A			Migration along orthodromic sun compass routes by arctic birds	SCIENCE			English	Article							ORIENTATION	Flight directions of birds migrating at high geographic and magnetic latitudes can be used to test bird orientation by celestial or geomagnetic compass systems under polar conditions. Migration patterns of arctic shorebirds, revealed by tracking radar studies during an icebreaker expedition along the Northwest Passage in 1999, support predicted sun compass trajectories but cannot be reconciled with orientation along either geographic or magnetic loxodromes (rhumb Lines). Sun compass routes are similar to orthodromes (great circle routes) at high latitudes, showing changing geographic courses as the birds traverse longitudes and their internal clock gets out of phase with Local time. These routes bring the shorebirds from high arctic Canada to the east coast of North America, from which they make transoceanic flights to South America. The observations are also consistent with a migration Link between Siberia and the Beaufort Sea region by way of sun compass routes across the Arctic Ocean.	Univ Lund, Dept Anim Ecol, SE-22362 Lund, Sweden; Iceland Inst Nat Hist, IS-125 Reykjavik, Iceland	Lund University	Alerstam, T (corresponding author), Univ Lund, Dept Anim Ecol, Ecol Bldg, SE-22362 Lund, Sweden.		Hedenström, Anders/F-5377-2010	Hedenström, Anders/0000-0002-1757-0945				ABLE KP, 1995, NATURE, V375, P230, DOI 10.1038/375230a0; ALERSTAM T, 1991, J THEOR BIOL, V152, P191, DOI 10.1016/S0022-5193(05)80452-7; Alerstam T, 1999, P ROY SOC B-BIOL SCI, V266, P2499, DOI 10.1098/rspb.1999.0952; ALERSTAM T, 2000, CRUISE REPORT TUNDRA, P122; Batschelet E., 1981, CIRCULAR STAT BIOL; Berthold P., 1991, ORIENTATION BIRDS; EMLEN J. T., 1964, IBIS, V106, P417, DOI 10.1111/j.1474-919X.1964.tb03724.x; Emlen S. T., 1975, AVIAN BIOL, VV, P129; Gudmundsson GA, 2000, J EXP BIOL, V203, P3137; Gudmundsson GA, 1998, J AVIAN BIOL, V29, P597, DOI 10.2307/3677180; Hoffman K., 1954, Zeitschrift fuer Tierpsychologie, V11, P453; KIEPENHEUER J, 1984, BEHAV ECOL SOCIOBIOL, V14, P81, DOI 10.1007/BF00291900; Kramer G., 1957, Ibis, V99, P196, DOI 10.1111/j.1474-919X.1957.tb01947.x; MCNEIL R, 1977, WILSON BULL, V89, P167; Morrison R.I.G., 1984, Behavior of Marine Animals, V6, P125; PENNEY RL, 1967, IBIS, V109, P99, DOI 10.1111/j.1474-919X.1967.tb00006.x; Quinn J. M., 2000, GEOMAG; RICHARDSON WJ, 1979, CAN J ZOOL, V57, P107, DOI 10.1139/z79-009; Sandberg R, 1998, J EXP BIOL, V201, P1859; Schmidt-Koenig K., 1958, Zeitschrift fuer Tierpsychologie, V15, P301; STODDARD PK, 1983, ANIM BEHAV, V31, P173, DOI 10.1016/S0003-3472(83)80186-9; Wehner R, 1998, J AVIAN BIOL, V29, P370, DOI 10.2307/3677156; Williams T. C., 1978, ANIMAL MIGRATION NAV, P239; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko W, 1998, J AVIAN BIOL, V29, P606, DOI 10.2307/3677181	25	84	88	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					300	303		10.1126/science.291.5502.300	http://dx.doi.org/10.1126/science.291.5502.300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209079	Green Submitted			2022-12-28	WOS:000166352900044
J	Zhou, SQ; Burger, C; Chu, B; Sawamura, M; Nagahama, N; Toganoh, M; Hackler, UE; Isobe, H; Nakamura, E				Zhou, SQ; Burger, C; Chu, B; Sawamura, M; Nagahama, N; Toganoh, M; Hackler, UE; Isobe, H; Nakamura, E			Spherical bilayer vesicles of fullerene-based surfactants in water: A laser light scattering study	SCIENCE			English	Article							CARBOXYLIC-ACID; METAL-COMPLEXES; DNA CLEAVAGE; LIGAND; C-60	The low solubility of fullerenes in aqueous solution Limits their applications in biology. By appropriate substitution, the fullerenes can be transformed into stabilized anions that are water soluble and can form targe aggregated structures. A Laser light scattering study of the association behavior of the potassium salt of pentaphenyl fullerene (Ph5C60K) in water revealed that the hydrocarbon anions Ph5C60- associate into bilayers, forming stable spherical vesicles with an average hydrodynamic radius and a radius of gyration of about 17 nanometers at a very Low critical aggregation concentration of Less than 10(-7) moles per Liter. The average aggregation number of associated particles in these large spherical Vesicles is about 1.2 x 10(4).	SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tokyo	Chu, B (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.	bchu@notes.cc.sunysb.edu	Sawamura, Masaya/G-1428-2012; Isobe, Hiroyuki/C-2069-2008; Toganoh, Motoki/I-3047-2015; NAKAMURA, EIICHI/G-5041-2014	Isobe, Hiroyuki/0000-0001-8907-0694; 				An YZ, 1996, TETRAHEDRON, V52, P5179, DOI 10.1016/0040-4020(96)00123-8; BOUTORINE AS, 1994, ANGEW CHEM INT EDIT, V33, P2462; BURCHARD W, 1980, MACROMOLECULES, V13, P580, DOI 10.1021/ma60075a020; Cassell AM, 1998, ANGEW CHEM INT EDIT, V37, P1528, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1528::AID-ANIE1528>3.0.CO;2-Q; Iikura H, 1997, J ORG CHEM, V62, P7912, DOI 10.1021/jo971025s; MATSUMOTO M, 1995, LANGMUIR, V11, P660, DOI 10.1021/la00002a051; Murakami H, 1999, CHEM LETT, P815; Nakamura E, 2000, ANGEW CHEM INT EDIT, V39, P4254, DOI 10.1002/1521-3773(20001201)39:23<4254::AID-ANIE4254>3.0.CO;2-O; Nakamura E, 1996, B CHEM SOC JPN, V69, P2143, DOI 10.1246/bcsj.69.2143; PROVENCHER SW, 1979, MAKROMOL CHEM, V180, P201; Sano M, 2000, LANGMUIR, V16, P3773, DOI 10.1021/la991550h; Sawamura M, 1996, J AM CHEM SOC, V118, P12850, DOI 10.1021/ja962681x; Sawamura M, 2000, CHEM LETT, P1098, DOI 10.1246/cl.2000.1098; Sawamura M, 1998, J AM CHEM SOC, V120, P8285, DOI 10.1021/ja981256w; Sawamura M, 2000, J ORGANOMET CHEM, V599, P32, DOI 10.1016/S0022-328X(99)00660-9; Sawamura M, 2000, CHEM LETT, P270; Takenaka S, 1999, CHEM LETT, P319; TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064; YAMAGO S, 1995, CHEM BIOL, V2, P385, DOI 10.1016/1074-5521(95)90219-8	19	369	375	1	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2001	291	5510					1944	1947		10.1126/science.291.5510.1944	http://dx.doi.org/10.1126/science.291.5510.1944			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409TK	11239150				2022-12-28	WOS:000167401600040
J	Seijo, LM; Sterman, DH				Seijo, LM; Sterman, DH			Medical progress: Interventional pulmonology.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MALIGNANT PLEURAL EFFUSIONS; DOSE-RATE BRACHYTHERAPY; NEODYMIUM-YAG LASER; CELL LUNG-CANCER; RATE INTRALUMINAL IRRADIATION; POSITIVE AIRWAY PRESSURE; ALUMINUM-GARNET LASER; BRONCHOGENIC-CARCINOMA; TALC PLEURODESIS; PHOTODYNAMIC THERAPY		Univ Penn, Med Ctr, Div Pulm Allergy & Crit Care Med, Intervent Pulmonol Program, Philadelphia, PA 19104 USA	University of Pennsylvania	Sterman, DH (corresponding author), Hosp Univ Penn, Dept Med, Div Pulm Allergy & Crit Care Med, Intervent Pulmonol Program, 833 W Gates Pavil,3400 Spruce St, Philadelphia, PA 19104 USA.			Sterman, Daniel/0000-0003-1249-0804; Seijo, Luis/0000-0001-9344-728X				Adliff M, 1997, CHEST, V112, P1701, DOI 10.1378/chest.112.6.1701; Aelony Y, 1998, CHEST, V113, P1007, DOI 10.1378/chest.113.4.1007; ANDERSON CB, 1974, CANCER-AM CANCER SOC, V33, P916, DOI 10.1002/1097-0142(197404)33:4<916::AID-CNCR2820330405>3.0.CO;2-U; Baharloo F, 1999, CHEST, V115, P1357, DOI 10.1378/chest.115.5.1357; BALCHUM OJ, 1985, CLIN CHEST MED, V6, P255; Becker HD, 1995, J BRONCHOLOGY, V2, P98; Bloom AI, 1999, CARDIOVASC INTER RAD, V22, P433, DOI 10.1007/s002709900422; Bolliger CT, 1996, THORAX, V51, P1127, DOI 10.1136/thx.51.11.1127; BOUTIN C, 1995, CLIN CHEST MED, V16, P497; Boutin C, 1981, Poumon Coeur, V37, P11; BRUTINEL WM, 1987, CHEST, V91, P159, DOI 10.1378/chest.91.2.159; BRUTINEL WM, 1988, CHEST, V94, P902, DOI 10.1378/chest.94.5.902; CARASCO CH, 1994, ANN THORAC SURG, V58, P1012; Cavaliere S, 1997, CHEST, V111, P1476; Cavaliere S, 1994, J BRONCHOL, V1, P105, DOI DOI 10.1097/00128594-199404000-00006; Colt HG, 1999, CHEST, V116, P1409, DOI 10.1378/chest.116.5.1409; Colt HG, 1997, CHEST, V112, P202, DOI 10.1378/chest.112.1.202; COLT HG, 1995, CHEST, V108, P324, DOI 10.1378/chest.108.2.324; COLT HG, 1995, CLIN CHEST MED, V16, P505; COLT HG, 1995, CLIN CHEST MED, V16, P465; Cortese DA, 1997, MAYO CLIN PROC, V72, P595; Danby CA, 1998, CHEST, V113, P739, DOI 10.1378/chest.113.3.739; Dasgupta A, 1998, CHEST, V114, P106, DOI 10.1378/chest.114.1.106; DENTON RA, 1988, CHEST, V94, P1086, DOI 10.1378/chest.94.5.1086; DESAI SJ, 1988, CHEST, V94, P939, DOI 10.1378/chest.94.5.939; DIAZJIMENEZ JP, 1994, J BRONCHOL, V1, P15; Dullye KK, 1997, ANESTHESIOLOGY, V86, P1387, DOI 10.1097/00000542-199706000-00022; DUMON JF, 1984, CHEST, V86, P163, DOI 10.1378/chest.86.2.163; DUMON JF, 1990, CHEST, V97, P328, DOI 10.1378/chest.97.2.328; DUMON JF, 1996, J BRONCHOLOGY, V3, P6, DOI 10.1097/00128594-199601000-00003; EDELL ES, 1995, CLIN CHEST MED, V16, P455; EDELL ES, 1987, MAYO CLIN PROC, V62, P8, DOI 10.1016/S0025-6196(12)61520-1; FERGUSON GT, 1993, AM REV RESPIR DIS, V147, P457, DOI 10.1164/ajrccm/147.2.457; FERRETTI G, 1995, RADIOLOGY, V196, P831, DOI 10.1148/radiology.196.3.7644651; Freitag L, 1997, THORAC CARDIOV SURG, V45, P6, DOI 10.1055/s-2007-1013675; GHARAGOZLOO FR, 1996, J BRONCHOL, V3, P209; GOMER CJ, 1979, CANCER RES, V39, P146; HANOWELL LH, 1991, CHEST, V99, P72, DOI 10.1378/chest.99.1.72; HARRIS RJ, 1995, CHEST, V107, P845, DOI 10.1378/chest.107.3.845; Hauck RW, 1997, CHEST, V112, P134, DOI 10.1378/chest.112.1.134; HELMERS RA, 1995, CLIN CHEST MED, V16, P393; Hernandez P, 1996, THORAX, V51, P354, DOI 10.1136/thx.51.4.354; Homasson JP, 1997, SEM RESP CRIT CARE M, V18, P535, DOI 10.1055/s-2007-1009369; Homasson JP, 1995, J BRONCHOLOGY, V2, P145; Inderbitzi RGC, 1996, EUR J CARDIO-THORAC, V10, P483, DOI 10.1016/S1010-7940(96)80412-X; IZBICKI R, 1975, CANCER, V36, P1511, DOI 10.1002/1097-0142(197510)36:4<1511::AID-CNCR2820360445>3.0.CO;2-7; JOKINEN K, 1977, ANN CLIN RES, V9, P52; Kalweit G, 1996, THORAC CARDIOV SURG, V44, P105, DOI 10.1055/s-2007-1011996; Kennedy AS, 2000, J HEART LUNG TRANSPL, V19, P155, DOI 10.1016/S1053-2498(99)00117-5; KHANAVKAR B, 1991, CHEST, V99, P1062, DOI 10.1378/chest.99.5.1062; LAFORET EG, 1976, NEW ENGL J MED, V294, P941, DOI 10.1056/NEJM197604222941710; LANG NP, 1991, AM J SURG, V162, P629, DOI 10.1016/0002-9610(91)90124-V; Langendijk JA, 1998, RADIOTHER ONCOL, V49, P175, DOI 10.1016/S0167-8140(98)00103-0; LOCICERO J, 1990, CHEST, V98, P97, DOI 10.1378/chest.98.1.97; MACHA HN, 1994, CHEST, V105, P1668, DOI 10.1378/chest.105.6.1668; MAIWAND MO, 1995, CLIN CHEST MED, V16, P427; MAIWAND MO, 1995, CLIN CHEST MED, V16, pR9; MARASSO A, 1993, CHEST, V103, P472, DOI 10.1378/chest.103.2.472; Mares DC, 1997, SEMIN RESP CRIT CARE, V18, P603, DOI 10.1055/s-2007-1009376; Mares DC, 1998, CHEST, V114, P731, DOI 10.1378/chest.114.3.731; Mares DC, 1998, J BRONCHOL, V5, P147; Marom EM, 1999, RADIOLOGY, V210, P277, DOI 10.1148/radiology.210.1.r99dc04277; MartinezBallarin JI, 1996, CHEST, V109, P626, DOI 10.1378/chest.109.3.626; Masaoka A, 1996, EUR J CARDIO-THORAC, V10, P87, DOI 10.1016/S1010-7940(96)80129-1; MATHUR NP, 1995, CLIN CHEST MED, V16, P487; Mathur PN, 1996, CHEST, V110, P718, DOI 10.1378/chest.110.3.718; MATHUR PN, 1995, CLIN CHEST MED, V16, P479; McCaughan JS, 1999, LASER SURG MED, V24, P194, DOI 10.1002/(SICI)1096-9101(1999)24:3<194::AID-LSM4>3.0.CO;2-#; MEHTA AC, 1995, CLIN CHEST MED, V16, P401; Mehta AC, 1999, CLIN CHEST MED, V20, P139, DOI 10.1016/S0272-5231(05)70132-5; MENDELSON DS, 1983, J COMPUT ASSIST TOMO, V7, P892, DOI 10.1097/00004728-198310000-00027; Mendiondo O A, 1983, J Ky Med Assoc, V81, P287; MILANEZ RC, 1995, CANCER, V75, P2688, DOI 10.1002/1097-0142(19950601)75:11<2688::AID-CNCR2820751108>3.0.CO;2-3; MILLER JI, 1990, ANN THORAC SURG, V50, P190, DOI 10.1016/0003-4975(90)90731-K; MIRO AM, 1989, CHEST, V96, P1430, DOI 10.1378/chest.96.6.1430; Moghissi K, 1999, EUR J CARDIO-THORAC, V15, P1, DOI 10.1016/S1010-7940(98)00295-4; Monnier P, 1996, CHEST, V110, P1161, DOI 10.1378/chest.110.5.1161; MONTGOMERY WW, 1965, ARCHIV OTOLARYNGOL, V82, P320; NAKAMURA K, 1991, AM J ROENTGENOL, V157, P1187, DOI 10.2214/ajr.157.6.1950862; NASHEF SAM, 1992, ANN THORAC SURG, V54, P937, DOI 10.1016/0003-4975(92)90653-L; Noppen M, 1997, CHEST, V112, P1136, DOI 10.1378/chest.112.4.1136; NORI D, 1993, CHEST, V104, P1006, DOI 10.1378/chest.104.4.1006; Ofiara L, 1997, CHEST, V112, P946, DOI 10.1378/chest.112.4.946; OTTO W, 1995, OTOLARYNG HEAD NECK, V113, P211, DOI 10.1016/S0194-5998(95)70108-7; Panebianco V, 1995, G Chir, V16, P437; Patz EF, 1998, CHEST, V113, p74S, DOI 10.1378/chest.113.1_Supplement.74S; PERSONNE C, 1986, J THORAC CARDIOV SUR, V91, P710; PISCH J, 1993, CHEST, V104, P721, DOI 10.1378/chest.104.3.721; Putnam JB, 1999, CANCER, V86, P1992, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M; RAMSER ER, 1995, CLIN CHEST MED, V16, P415; Rapp-Bernhardt U, 1998, BRIT J RADIOL, V71, P1271, DOI 10.1259/bjr.71.852.10319000; Rebeiz EE, 1996, OTOLARYNG CLIN N AM, V29, P987; RODEN S, 1989, PRESSE MED, V18, P897; ROUSSEAU H, 1993, RADIOLOGY, V188, P199, DOI 10.1148/radiology.188.1.8511297; Saito M, 1996, INT J RADIAT ONCOL, V34, P1029, DOI 10.1016/0360-3016(95)02390-9; SANCHEZARMENGOL A, 1993, CHEST, V104, P1482, DOI 10.1378/chest.104.5.1482; Sarodia BD, 1999, CHEST, V116, P1669, DOI 10.1378/chest.116.6.1669; SEAGREN SL, 1985, CHEST, V88, P810, DOI 10.1378/chest.88.6.810; Shaffer JP, 1998, CHEST, V114, P1378, DOI 10.1378/chest.114.5.1378; SHAH H, 1995, CHEST, V107, P1744, DOI 10.1378/chest.107.6.1744; SHAPSHAY SM, 1987, ANN OTO RHINOL LARYN, V96, P661, DOI 10.1177/000348948709600609; SHAPSHAY SM, 1989, ANN OTO RHINOL LARYN, V98, P890, DOI 10.1177/000348948909801110; SHEA JM, 1993, CHEST, V103, P1028, DOI 10.1378/chest.103.4.1028; Sheski FD, 1998, CHEST, V114, P796, DOI 10.1378/chest.114.3.796; Sheski FD, 1999, CLIN CHEST MED, V20, P123, DOI 10.1016/S0272-5231(05)70131-3; SIMPSON GT, 1982, ANN OTO RHINOL LARYN, V91, P384, DOI 10.1177/000348948209100412; Smythe WR, 1993, THORACOSCOPIC SURG, P1; SPEISER B, 1991, INT J RADIAT ONCOL, V20, P1133, DOI 10.1016/0360-3016(91)90216-Q; STANOPOULOS IT, 1993, CRIT CARE MED, V21, P386, DOI 10.1097/00003246-199303000-00016; Strachan G, 1997, NURS ETHICS, V4, P294, DOI 10.1177/096973309700400405; SUH JH, 1994, CANCER, V73, P2583, DOI 10.1002/1097-0142(19940515)73:10<2583::AID-CNCR2820731020>3.0.CO;2-H; Susanto I, 1998, CHEST, V114, P1330, DOI 10.1378/chest.114.5.1330; SUTEDJA G, 1992, INT J RADIAT ONCOL, V24, P551, DOI 10.1016/0360-3016(92)91072-U; SUTEDJA G, 1994, RESPIRATION, V61, P167; SUTEDJA T, 1992, EUR J CANCER, V28A, P1370, DOI 10.1016/0959-8049(92)90522-4; Suto Y, 1998, AM J ROENTGENOL, V171, P393, DOI 10.2214/ajr.171.2.9694459; Taber SW, 1999, SURGERY, V126, P730, DOI 10.1016/S0039-6060(99)70129-7; TOTY L, 1981, THORAX, V36, P175, DOI 10.1136/thx.36.3.175; Turler A, 1997, SUPPORT CARE CANCER, V5, P61, DOI 10.1007/BF01681963; Turner JF, 1999, CLIN CHEST MED, V20, P107, DOI 10.1016/S0272-5231(05)70130-1; van Boxem TJ, 1998, EUR RESPIR J, V11, P169, DOI 10.1183/09031936.98.11010169; VILLANUEVA AG, 1995, CLIN CHEST MED, V16, P445; Vining DJ, 1996, CHEST, V109, P549, DOI 10.1378/chest.109.2.549; Viskum K, 1981, Poumon Coeur, V37, P25; WANAMAKER JR, 1995, OTOLARYNG CLIN N AM, V28, P751; Wassermann K, 1997, J THORAC CARDIOV SUR, V114, P527, DOI 10.1016/S0022-5223(97)70040-0; WORTHINGTON MG, 1993, ANN THORAC SURG, V56, P1054, DOI 10.1016/0003-4975(95)90013-6; ZAJAC AJ, 1993, RADIOLOGY, V187, P571, DOI 10.1148/radiology.187.2.7682723; ZANNINI P, 1994, CHEST, V106, P86, DOI 10.1378/chest.106.1.86; Zimmer PW, 1997, CHEST, V112, P430, DOI 10.1378/chest.112.2.430	130	116	137	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2001	344	10					740	749		10.1056/NEJM200103083441007	http://dx.doi.org/10.1056/NEJM200103083441007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408AX	11236779				2022-12-28	WOS:000167305300007
J	Church, S; Henderson, M; Barnard, M; Hart, G				Church, S; Henderson, M; Barnard, M; Hart, G			Violence by clients towards female prostitutes in different work settings: questionnaire survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Glasgow, Ctr Drug Misuse Res, Glasgow G12 8SQ, Lanark, Scotland; Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	University of Glasgow; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Church, S (corresponding author), Univ Glasgow, Ctr Drug Misuse Res, Glasgow G12 8SQ, Lanark, Scotland.	Stephanie@msoc.mrc.gla.ac.uk	Hart, Graham J/C-1591-2008; Henderson, Marion Mackay/AAS-2759-2021; Henderson, Marion/M-2136-2019; Henderson, Marion/G-3310-2019	Henderson, Marion/0000-0001-7582-9516; Henderson, Marion/0000-0001-7582-9516; Hart, Graham/0000-0001-9676-6577				GILCHRIST G, IN PRESS ADDICT RES; Lowman J., 1995, VIOLENCE PERSONS WHO; McKeganey N., 1996, SEX WORK STREETS PRO; Phoenix J, 2000, BRIT J CRIMINOL, V40, P37, DOI 10.1093/bjc/40.1.37; WARD H, 1993, BRIT MED J, V307, P356, DOI 10.1136/bmj.307.6900.356	5	227	227	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2001	322	7285					524	525		10.1136/bmj.322.7285.524	http://dx.doi.org/10.1136/bmj.322.7285.524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230067	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-28	WOS:000167370500026
J	Marteau, TM; Senior, V; Sasieni, P				Marteau, TM; Senior, V; Sasieni, P			Women's understanding of a "normal smear test result": experimental questionnaire based study	BRITISH MEDICAL JOURNAL			English	Article								Objectives To describe women's understanding of a negative smear test result when presented using the term "normal smear result," as required by the NHS cervical screening programme, and to evaluate the impact on understanding of different ways of presenting the residual risk inherent in such a result. Design Experimental questionnaire based study. Interventions Participants were asked to imagine that they had received a normal smear result The meaning of this result was then presented using different combinations of three different expressions of residual risk of having or developing cervical cancer over the next five years: a verbal probability of absolute risk (low risk), a numerical probability of absolute risk(1 in 5000), or a numerical probability of risk relative to an unscreened woman (five times lower). Participants: 1027 women aged 20 to 64. Results When informed only that their smear result was normal, 52% (80 of 153 women) of participants correctly understood that this entailed a residual risk of cervical cancer, compared with 70% (107 of 152) given the additional sentence explaining the meaning of a normal smear result using a verbal probability of absolute risk (difference 18%; 95% confidence interval 7% to 29%). Additionally: explaining the results using a numerical probability of absolute or relative risk did not increase the proportion who correctly understood that there was a residual risk of cervical cancer. Conclusions NHS policy for reporting normal smears needs to change to make it a definite requirement that the reporting of a "normal smear result" is accompanied by a sentence stating that this means a low risk for having or developing cervical cancer in the next five years.	Kings Coll London, Psychol & Genet Res Grp, London SE1 9RT, England; Imperial Canc Res Fund, Math Stat & Epidemiol Lab, London WC1A 3PX, England	University of London; King's College London; Cancer Research UK	Marteau, TM (corresponding author), Kings Coll London, Psychol & Genet Res Grp, London SE1 9RT, England.	theresa.marteau@kcl.ac.uk		Marteau, Theresa/0000-0003-3025-1129; /0000-0001-7745-8341; Sasieni, Peter/0000-0003-1509-8744	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AUSTOKER J, 1997, IMPROVING QUALITY WR; Brun W, 1994, SUBJECTIVE PROBABILI, P295; Edwards A, 1996, BRIT MED J, V313, P1483, DOI 10.1136/bmj.313.7070.1483; EDWARDS AGK, IN PRESS J HLTH COMM; General Medical Council, 1999, SEEK PAT CONS ETH CO; Hall S, 2000, BMJ-BRIT MED J, V320, P407, DOI 10.1136/bmj.320.7232.407; Marteau TM, 2000, PRENATAL DIAG, V20, P714, DOI 10.1002/1097-0223(200009)20:9<714::AID-PD906>3.0.CO;2-4; PETTICREW M, 2000, HEALTH TECHNOL ASSES, P4	8	40	41	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					526	528		10.1136/bmj.322.7285.526	http://dx.doi.org/10.1136/bmj.322.7285.526			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230068	Green Published, Green Submitted			2022-12-28	WOS:000167370500028
J	Maynard, A; Bloor, K				Maynard, A; Bloor, K			Reforming the contract of UK consultants	BRITISH MEDICAL JOURNAL			English	Article									Univ York, Dept Hlth Studies, York Hlth Policy Grp, York YO10 5DD, N Yorkshire, England; Univ York, Dept Hlth Sci & Clin Evaluat, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Maynard, A (corresponding author), Univ York, Dept Hlth Studies, York Hlth Policy Grp, York YO10 5DD, N Yorkshire, England.			Bloor, Karen/0000-0003-4852-9854				BARWELL F, 1999, PATTERNS WORK HOSP C; Bloor K, 1998, BRIT MED J, V316, P569, DOI 10.1136/bmj.316.7131.569; BURGESS S, 1999, 99016 CTR MARK PUBL; DAVIDGE M, 1997, EXAMINING WORKLOAD S; *DEP HLTH, 1999, AGENDA CHANGE MODERN; Department of Health, 2000, SHAP FUT NHS LONG TE; Klein R, 1998, BRIT MED J, V317, P5, DOI 10.1136/bmj.317.7150.5; *PARL SEL COMM HLT, 2000, 3 REP CONS CONTR; *SECR STAT HLTH, 2000, NHS PLAN PLAN INV PL; YATES J, 1987, WHY ARE WE WAITING	10	4	4	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					541	543		10.1136/bmj.322.7285.541	http://dx.doi.org/10.1136/bmj.322.7285.541			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230073	Green Published			2022-12-28	WOS:000167370500033
J	Burnett, A; Peel, M				Burnett, A; Peel, M			Asylum seekers and refugees in Britain - What brings asylum seekers to the United Kingdom?	BRITISH MEDICAL JOURNAL			English	Article							HEALTH		Med Fdn Care Victims Torture, London NW5 3EJ, England		Burnett, A (corresponding author), Med Fdn Care Victims Torture, London NW5 3EJ, England.							Aldous J, 1999, REFUGEE HLTH LONDON; Amnesty Internation, 2000, ANN REP 2000; BURNETT A, 1999, GUID HEALTHW PROV CA; CAREYWOOD J, 1995, 141 HOM OFF; CIENFUEGOS AJ, 1983, AM J ORTHOPSYCHIAT, V53, P43, DOI 10.1111/j.1939-0025.1983.tb03348.x; Connelly J, 2000, BRIT MED J, V321, P5, DOI 10.1136/bmj.321.7252.5; *COUNC EUR, 1999, REC DEM TRENDS; Fassil Y, 2000, BRIT MED J, V321, P59, DOI 10.1136/bmj.321.7252.59; GODLEE F, 1993, BRIT MED J, V307, P1369, DOI 10.1136/bmj.307.6916.1369; Home Office, 1995, STAT B; Jones D, 1998, BRIT MED J, V317, P1444, DOI 10.1136/bmj.317.7170.1444; *JUB COAL 2000, 1999, BREAK CHAINS; LEVENSON R, 1999, HLTH REFUGEES; MILNE S, 2000, GUARDIAN        0901; PEEL M, 1999, CAUGHT MIDDLE SURVIV; PEEL M, 1999, ASYLUM SEEKERS UK CO; PILE H, 1997, ASYLUM TRAP LABOUR M; PORTA C, 1998, ZAIRE TORTURE STATE; Sinnerbrink I, 1997, J PSYCHOL, V131, P463, DOI 10.1080/00223989709603533; SIVARD R, 1989, WORLD MIL SOC EXP; SMALL C, 1997, REACHING OUT STUDY B; Summerfield D, 1996, J NERV MENT DIS, V184, P375, DOI 10.1097/00005053-199606000-00008; Summerfield D, 1996, IMPACT WAR ATROCITY; *UN, 1948, UN DECL HUM RIGHTS; *UN HIGH COMM REF, 1999, REF OTH UNHCR STAT O; UNICEF, 1986, CHILDR SIT ARM CONFL; United Nations, 1951, CONV REL STAT REF 28; United Nations Development Programme, 1999, HUM DEV REP; United Nations (UN), 1988, HUM RIGHTS COMP INT	29	43	43	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	2001	322	7284					485	488		10.1136/bmj.322.7284.485	http://dx.doi.org/10.1136/bmj.322.7284.485			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406YD	11222429	Green Published			2022-12-28	WOS:000167243000026
J	Beets-Tan, RGH; Beets, GL; Vliegen, RFA; Kessels, AGH; Van Boven, H; De Bruine, A; von Meyenfeldt, MF; Baeten, CGMI; van Engelshoven, JMA				Beets-Tan, RGH; Beets, GL; Vliegen, RFA; Kessels, AGH; Van Boven, H; De Bruine, A; von Meyenfeldt, MF; Baeten, CGMI; van Engelshoven, JMA			Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery	LANCET			English	Article							TOTAL MESORECTAL EXCISION; RECURRENT RECTOSIGMOID CARCINOMA; LOCAL RECURRENCE; COMPUTED-TOMOGRAPHY; MR; INVOLVEMENT; CT; ADENOCARCINOMA; RADIOTHERAPY; SURVIVAL	Background Incomplete surgical removal of the circumferential tumour spread is believed to be the main cause of local recurrence after resection of rectal cancer. This study assessed the accuracy of magnetic resonance imaging (MRI) with a phased-array coil for preoperative staging and prediction of the distance of the tumour from the circumferential resection margin in a total mesorectal excision. Methods 76 patients with primary rectal cancer were preoperatively assessed by MRI at 1.5 T, with a phased-array coil. Two observers independently scored, on two occasions, the tumour stage and measured the distance to the mesorectal fascia. Their findings were compared with the final histological findings. Findings The MRI tumour stage agreed with the histological stage in 63 (83%) of 76 patients (weighted kappa =0.77 [95% CI 0.66-0.89]) for observer 1, and in 51 (67%) patients (weighted kappa =0.52 [0.37-0.67]) for observer 2, The intraobserver agreement on the tumour stage was good (kappa =0.80 [0.69-0.91]) for observer 1 but moderate (kappa =0.49 [0.34-0.65]) for observer 2, The interobserver agreement was moderate (kappa =0.53 [0.38-0.69]). In 12 patients with an obvious T4 tumour. a margin of 0 mm was correctly predicted. Of 29 patients for whom the pathologist reported a distance of at least 10 mm without specifying the actual distance, a distance of at least 10 mm was predicted in 28 by observer 1 and 27 by observer 2. For the remaining 35 patients, a regression curve was constructed; from this, a histological distance of at least 1 0 mm can be predicted with high confidence when the measured distance on MRI is at least 5.0 mm. Interpretation MRI with a phased-array coil showed moderate accuracy and reproducibility for predicting the tumour stage of rectal cancers. The clinically more important circumferential resection margin can, however, be predicted with high accuracy and consistency. allowing preoperative identification of patients at risk of recurrence who will benefit from preoperative radiotherapy, more extensive surgery, or both.	Univ Hosp Maastricht, Dept Radiol, NL-6202 AZ Maastricht, Netherlands; Univ Hosp Maastricht, Dept Surg, NL-6202 AZ Maastricht, Netherlands; Univ Hosp Maastricht, Dept Clin Epidemiol, NL-6202 AZ Maastricht, Netherlands; Univ Hosp Maastricht, Dept Pathol, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Beets-Tan, RGH (corresponding author), Univ Hosp Maastricht, Dept Radiol, P Debyelaan 25, NL-6202 AZ Maastricht, Netherlands.		Beets, Geerard/G-2682-2013; Beets-Tan, Regina/AAZ-9119-2020	Beets, Geerard/0000-0002-1671-9912; 				ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; [Anonymous], 1997, AJCC CANC STAGING MA; BEETSTAN RG, 2000, ABDOM IMAGING, V25, P20; Blomqvist L, 1999, BRIT J RADIOL, V72, P18, DOI 10.1259/bjr.72.853.10341684; Brown G, 1999, RADIOLOGY, V211, P215, DOI 10.1148/radiology.211.1.r99ap35215; BUTCH RJ, 1986, AM J ROENTGENOL, V146, P1155, DOI 10.2214/ajr.146.6.1155; CAWTHORN SJ, 1990, LANCET, V335, P1055, DOI 10.1016/0140-6736(90)92631-Q; deHaasKock DFM, 1996, BRIT J SURG, V83, P781, DOI 10.1002/bjs.1800830617; DELANGE EE, 1989, RADIOLOGY, V170, P323, DOI 10.1148/radiology.170.2.2911656; Hadfield MB, 1997, BRIT J SURG, V84, P529; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Havenga K, 1999, EUR J SURG ONCOL, V25, P368, DOI 10.1053/ejso.1999.0659; HEALD RJ, 1986, LANCET, V1, P1479; Heriot AG, 1999, BRIT J SURG, V86, P17, DOI 10.1046/j.1365-2168.1999.00996.x; HODGMAN CG, 1986, DIS COLON RECTUM, V29, P446, DOI 10.1007/BF02561581; HOLDSWORTH PJ, 1988, BRIT J SURG, V75, P1019, DOI 10.1002/bjs.1800751022; HULSMANS FJJH, 1994, RADIOLOGY, V190, P715, DOI 10.1148/radiology.190.3.8115617; HUNERBEIN M, 1995, BR J CANC S25, V72, P11; Kapiteijn E, 1999, EUR J SURG, V165, P410, DOI 10.1080/110241599750006613; Lavery IC, 2000, SURG CLIN N AM, V80, P535, DOI 10.1016/S0039-6109(05)70200-0; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Minsky BD, 1999, SEMIN ONCOL, V26, P540; MOSS AA, 1989, RADIOLOGY, V170, P308, DOI 10.1148/radiology.170.2.2643134; Pahlman L, 1997, NEW ENGL J MED, V336, P1539; Pahlman L, 1997, NEW ENGL J MED, V336, P980; Pahlman L, 1998, RECENT RES CANCER, V146, P141; Pahlman L, 2000, INT J COLORECTAL DIS, V15, P1, DOI 10.1007/s003840050001; PEMA PJ, 1994, J COMPUT ASSIST TOMO, V18, P256, DOI 10.1097/00004728-199403000-00016; PHILLIPS RKS, 1984, BRIT J SURG, V71, P12, DOI 10.1002/bjs.1800710104; QUIRKE P, 1986, LANCET, V2, P996, DOI 10.1016/s0140-6736(86)92612-7; RIFKIN MD, 1989, RADIOLOGY, V170, P319, DOI 10.1148/radiology.170.2.2643135; Sagar PM, 1996, BRIT J SURG, V83, P293, DOI 10.1002/bjs.1800830305; SCHNALL MD, 1994, RADIOLOGY, V190, P709, DOI 10.1148/radiology.190.3.8115616; Wiggers T, 1999, EUR J SURG, V165, P407	34	584	629	0	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					497	504		10.1016/S0140-6736(00)04040-X	http://dx.doi.org/10.1016/S0140-6736(00)04040-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229667				2022-12-28	WOS:000167011700008
J	Radcliffe, A; Brown, G				Radcliffe, A; Brown, G			Will MRI provide maps of lines of excision for rectal cancer?	LANCET			English	Editorial Material							PROGNOSTIC FACTORS; CARCINOMA		Llandough Hosp, Cardiff & Vale NHS Trust, Dept Surg, Penarth CF64 2XX, S Glam, Wales; Llandough Hosp, Cardiff & Vale NHS Trust, Dept Radiol, Penarth CF64 2XX, S Glam, Wales		Radcliffe, A (corresponding author), Llandough Hosp, Cardiff & Vale NHS Trust, Dept Surg, Penarth CF64 2XX, S Glam, Wales.		BROWN, GINA/F-8081-2012	Brown, Gina/0000-0002-2336-622X				Brown G, 1999, RADIOLOGY, V211, P215, DOI 10.1148/radiology.211.1.r99ap35215; CAWTHORN SJ, 1990, LANCET, V335, P1055, DOI 10.1016/0140-6736(90)92631-Q; HEALD RJ, 1986, LANCET, V1, P1479; HERMANEK P, 1995, TUMORI, V81, P60; Lindsey I, 2000, BRIT J SURG, V87, P1288, DOI 10.1046/j.1365-2168.2000.01542.x; NICHOLLS RJ, 1982, BRIT J SURG, V69, P404, DOI 10.1002/bjs.1800690716; QUIRKE P, 1988, INT J COLORECTAL DIS, V3, P127, DOI 10.1007/BF01645318	7	19	19	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					495	496		10.1016/S0140-6736(00)04038-1	http://dx.doi.org/10.1016/S0140-6736(00)04038-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229665				2022-12-28	WOS:000167011700006
J	Fields, S				Fields, S			Proteomics - Proteomics in genomeland	SCIENCE			English	Article							PROTEIN-PROTEIN INTERACTIONS; YEAST GENOME; IDENTIFICATION; COMPLEX; GENES		Univ Washington, Howard Hughes Med Inst, Dept Genet, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Dept Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fields, S (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Genet, Seattle, WA 98195 USA.	fields@u.washington.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR11823] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; BLACKSTOCK W, 2000, PROTEOMICS TRENDS GU, P12; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; JENSEN ON, 2000, PROTEOMICS TRENDS GU, P36; Johnston M, 2000, NAT GENET, V24, P5, DOI 10.1038/71681; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; MacBeath G, 2000, SCIENCE, V289, P1760; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Peltier JB, 2000, PLANT CELL, V12, P319, DOI 10.1105/tpc.12.3.319; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; SCHWIKOWSKI B, IN PRESS NATURE BIOT; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WASHBURN MP, IN PRESS NATURE BIOT; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	33	193	248	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1221	+		10.1126/science.291.5507.1221	http://dx.doi.org/10.1126/science.291.5507.1221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233445				2022-12-28	WOS:000166993400023
J	Barbara, B; Lacroix, C				Barbara, B; Lacroix, C			Louis Neel (1904-2000)	SCIENCE			English	Biographical-Item									CNRS, Lab Magnetisme Louis Neel, F-38042 Grenoble 09, France	Centre National de la Recherche Scientifique (CNRS)	Barbara, B (corresponding author), CNRS, Lab Magnetisme Louis Neel, F-38042 Grenoble 09, France.		Lacroix, Claudine/N-2715-2015	Lacroix, Claudine/0000-0002-0731-725X				NEEL L, PUBLICATION LIST	1	0	0	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					1000	1000						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232560				2022-12-28	WOS:000166860100034
J	Priest, ND				Priest, ND			Toxicity of depleted uranium	LANCET			English	Editorial Material							MORTALITY; WORKERS; PLANT		Middlesex Univ, Sch Hlth Biol & Environm Sci, London N11 2NQ, England	Middlesex University	Priest, ND (corresponding author), Middlesex Univ, Sch Hlth Biol & Environm Sci, London N11 2NQ, England.							*APEI, 1995, HLTH ENV CONS DEPL U; CHECKOWAY H, 1988, AM J EPIDEMIOL, V127, P255, DOI 10.1093/oxfordjournals.aje.a114801; Ellender M, 2001, INT J RADIAT BIOL, V77, P41, DOI 10.1080/095530001453104; Fetter S., 1999, SCI GLOB SECURITY, V8, P125, DOI DOI 10.1080/08929880008426473; FRIBERG L, 1986, HDB TOXICOLOGY METAL, V2, P623; Hodge H.C., 1973, HDB EXPT PHARM, V36, P165; *INT COMM RAD PROT, 1994, ANN ICRP, V25, P57; McGeoghegan D., 2000, Journal of Radiological Protection, V20, P111, DOI 10.1088/0952-4746/20/2/301; POLEDNAK AP, 1981, J OCCUP ENVIRON MED, V23, P169; Priest N.D., 1990, TRACE METALS FLUORID, P83; Ritz B, 1999, EPIDEMIOLOGY, V10, P531, DOI 10.1097/00001648-199909000-00012	11	130	133	0	33	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					244	246		10.1016/S0140-6736(00)03605-9	http://dx.doi.org/10.1016/S0140-6736(00)03605-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214120				2022-12-28	WOS:000166693400002
J	Harlow, ML; Ress, D; Stoschek, A; Marshall, RM; McMahan, UJ				Harlow, ML; Ress, D; Stoschek, A; Marshall, RM; McMahan, UJ			The architecture of active zone material at the frog's neuromuscular junction	NATURE			English	Article							TRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; ELECTRON TOMOGRAPHY; CALCIUM-CHANNEL; RECONSTRUCTIONS; ORGANIZATION; RECEPTORS; PROTEIN; SITES; ICE	Active zone material at the nervous system's synapses is situated next to synaptic vesicles that are docked at the presynaptic plasma membrane, and calcium channels that are anchored in the membrane. Here we use electron microscope tomography to show the arrangement and associations of structural components of this compact organelle at a model synapse, the frog's neuromuscular junction. Our findings indicate that the active zone material helps to dock the vesicles and anchor the channels, and that its architecture provides both a particular spatial relationship and a structural linkage between them. The structural linkage may include proteins that mediate the calcium-triggered exocytosis of neurotransmitter by the synaptic vesicles during synaptic transmission.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA	Stanford University	McMahan, UJ (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	ujmcmahan@stanford.edu						Bewick GS, 1996, J NEUROCYTOL, V25, P367; BRAUNFELD MB, 1994, J MICROSC-OXFORD, V174, P75, DOI 10.1111/j.1365-2818.1994.tb03451.x; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Cohen MW, 2000, J NEUROSCI, V20, P4912; Colledge M, 1998, P NATL ACAD SCI USA, V95, P3341, DOI 10.1073/pnas.95.7.3341; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; DIERKSEN K, 1993, ULTRAMICROSCOPY, V49, P109, DOI 10.1016/0304-3991(93)90217-L; DIERKSEN K, 1995, BIOPHYS J, V68, P1416, DOI 10.1016/S0006-3495(95)80314-0; Gray E. G., 1966, International Review of General and Experimental Zoology, V2, P139; GRAY EG, 1963, J ANAT, V97, P101; HAZUKA CD, 1999, FR MOLEC B, V23, P81; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Heuser JE, 1977, HDB PHYSL, VI, P261; Hoenger A, 1996, J STRUCT BIOL, V117, P99, DOI 10.1006/jsbi.1996.0075; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Katz B., 1969, RELEASE NEURAL TRANS; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Luther P.K., 1992, ELECT TOMOGRAPHY 3 D, P39; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; MCEWEN BF, 1993, J CELL BIOL, V120, P301, DOI 10.1083/jcb.120.2.301; MCMAHAN UJ, 1984, J CELL BIOL, V98, P1453, DOI 10.1083/jcb.98.4.1453; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; PETERS A, 1991, FINE STRUCTURE NERVO, P198; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; Radermacher M., 1992, ELECT TOMOGRAPHY, P91, DOI DOI 10.1007/978-1-4757-2163-8_5; Ress D, 1999, J ELECTRON MICROSC, V48, P277, DOI 10.1093/oxfordjournals.jmicro.a023679; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Stanley EF, 1997, TRENDS NEUROSCI, V20, P404, DOI 10.1016/S0166-2236(97)01091-6; Stoschek A, 1997, J STRUCT BIOL, V120, P257, DOI 10.1006/jsbi.1997.3925; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; ZHOU ZH, 1994, J MOL BIOL, V242, P456, DOI 10.1006/jmbi.1994.1594; ZWICKL P, 1994, BIOCHEMISTRY-US, V31, P964	41	273	285	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2001	409	6819					479	484		10.1038/35054000	http://dx.doi.org/10.1038/35054000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206537				2022-12-28	WOS:000166570500038
J	Lin, SY; Kinet, JP				Lin, SY; Kinet, JP			Immunology - Giving inhibitory receptors a boost	SCIENCE			English	Editorial Material							FC-EPSILON-RI		Beth Israel Deaconess Med Ctr, Dept Pathol, Div Allergy & Immunol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Lin, SY (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, Div Allergy & Immunol, Boston, MA 02215 USA.							Hahn AF, 2000, CURR OPIN NEUROL, V13, P575, DOI 10.1097/00019052-200010000-00012; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Quartier P, 1999, J PEDIATR-US, V134, P589, DOI 10.1016/S0022-3476(99)70246-5; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; RAVETCH JV, COMMUNICATION; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663	8	18	21	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2001	291	5503					445	446		10.1126/science.291.5503.445	http://dx.doi.org/10.1126/science.291.5503.445			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11228143				2022-12-28	WOS:000166487500029
J	Stirling, CH; Esat, TM; Lambeck, K; McCulloch, MT; Blake, SG; Lee, DC; Halliday, AN				Stirling, CH; Esat, TM; Lambeck, K; McCulloch, MT; Blake, SG; Lee, DC; Halliday, AN			Orbital forcing of the marine isotope stage 9 interglacial	SCIENCE			English	Article							PAPUA-NEW-GUINEA; MASS-SPECTROMETRY; SEA-LEVEL; U-SERIES; HENDERSON ISLAND; PITCAIRN GROUP; TH-230 AGES; DEVILS-HOLE; CORALS; DURATION	Milankovitch orbital forcing theory has been used to assign time scares to many paleoclimate records. However, the validity of this theory remains uncertain, and independent sea-level chronologies used to test its applicability have been restricted Largely to the past similar to 135,000 years. Here, we report U-series ages for coral reefs formed on Henderson Island during sea-level high-stands occurring at similar to 630,000 and similar to 330,000 years ago. These data are consistent with the hypothesis that interglacial climates are forced by Northern Hemisphere summer solar insolation centered at 65 degreesN latitude, as predicted by Milankovitch theory.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; ETH Zentrum, Dept Earth Sci, Inst Isotope Geol & Mineral Resources, CH-8092 Zurich, Switzerland; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	University of Michigan System; University of Michigan; Swiss Federal Institutes of Technology Domain; ETH Zurich; Australian National University	Stirling, CH (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.		Lee, Der-Chuen/N-9225-2013; McCulloch, Malcolm T/C-3651-2009	McCulloch, Malcolm T/0000-0003-1538-1558; Esat, Tezer/0000-0001-5331-6568; Lee, Der-Chuen/0000-0001-8855-9594; Esat, Sevilay/0000-0002-7257-4009				Bard E, 1996, GEOPHYS RES LETT, V23, P1473, DOI 10.1029/96GL01279; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BLAKE SG, 1995, BIOL J LINN SOC, V56, P43, DOI 10.1006/bijl.1995.0053; BROOKE M, 1992, PITCAIRN ISLAND EXPE; CHEN JH, 1991, GEOL SOC AM BULL, V103, P82, DOI 10.1130/0016-7606(1991)103<0082:PCOTLI>2.3.CO;2; EDWARDS LR, 1986, EARTH PLANET SC LETT, V81, P175; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; Galewsky J, 1996, GEOLOGY, V24, P819, DOI 10.1130/0091-7613(1996)024<0819:FTACPD>2.3.CO;2; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; GRUN R, 1994, QUATERNARY SCI REV, V13, P121, DOI 10.1016/0277-3791(94)90037-X; HAMELIN B, 1991, EARTH PLANET SC LETT, V106, P169, DOI 10.1016/0012-821X(91)90070-X; HENDERSON GM, 1993, EARTH PLANET SC LETT, V115, P65, DOI 10.1016/0012-821X(93)90213-S; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Imbrie J., 1979, ICE AGES SOLVING MYS; Karner DB, 2000, SCIENCE, V288, P2143, DOI 10.1126/science.288.5474.2143; LUDWIG KR, 1992, SCIENCE, V258, P284, DOI 10.1126/science.258.5080.284; Luo XZ, 1997, INT J MASS SPECTROM, V171, P105, DOI 10.1016/S0168-1176(97)00136-5; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Milankovitch M.K., 1941, CANON INSOLATION ICE; PANDOLFI JM, 1995, BIOL J LINN SOC, V56, P63, DOI 10.1006/bijl.1995.0054; PAULAY G, 1991, HENDERSON ISLAND BIO, P304; SHEN GT, 1995, GEOCHIM COSMOCHIM AC, V59, P2009, DOI 10.1016/0016-7037(95)00123-9; STEIN M, 1993, GEOCHIM COSMOCHIM AC, V57, P2541, DOI 10.1016/0016-7037(93)90416-T; Stirling CH, 2000, GEOCHIM COSMOCHIM AC, V64, P3737, DOI 10.1016/S0016-7037(00)00457-9; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; STIRLING CH, 1995, EARTH PLANET SC LETT, V135, P115, DOI 10.1016/0012-821X(95)00152-3; SZABO BJ, 1994, SCIENCE, V266, P93, DOI 10.1126/science.266.5182.93; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255	29	100	105	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					290	293		10.1126/science.291.5502.290	http://dx.doi.org/10.1126/science.291.5502.290			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209076				2022-12-28	WOS:000166352900041
J	Wintemute, GJ; Wright, MA; Drake, CM; Beaumont, JJ				Wintemute, GJ; Wright, MA; Drake, CM; Beaumont, JJ			Subsequent criminal activity among violent misdemeanants who seek to purchase handguns - Risk factors and effectiveness of denying handgun purchase	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARREST; MODELS	Context Some states prohibit the purchase of handguns by persons convicted of selected misdemeanor crimes, but most do not, California has denied handgun purchases by violent misdemeanants since 1991; the effectiveness of these policies is unknown. Objective To determine the risk factors for new criminal activity among violent misdemeanants who seek to purchase handguns and whether denial of handgun purchase by violent misdemeanants affects their risk of arrest for new crimes, particularly gun and/or violent crimes. Design Retrospective, population-based cohort study. Setting and Subjects Persons aged 21 to 34 years who sought to purchase a handgun through a licensed dealer in California during 1989-1991 and who had at least 1 violent misdemeanor conviction in the preceding 10 years. The study cohorts consisted of 986 persons whose purchase applications were made in 1991 and were denied (denied persons) and 787 persons whose purchase applications were made in 1989-1990 and were approved (purchasers). Main Outcome Measures Incidence and relative risk of first arrest in California for new gun and/or violent crimes and for nongun, nonviolent crimes during a 3-year follow-up after actual or attempted handgun purchase. Results During the 3-year follow-up, 546 (33.0%) of 1654 subjects with follow-up information were arrested for a new crime, including 296 (31.9%) of 927 denied persons and 250 (34.4%) of 727 purchasers. After adjusting for differences in age, sex, and prior criminal history, purchasers were more likely than denied persons to be arrested for new gun and/or violent crimes (relative hazard [RH], 1.29; 95% confidence interval [CI], 1.04-1.60), but not for nongun, nonviolent crimes (RH, 0.96; 95% CI, 0.78-1.19). In both groups, risk of arrest was strongly related to age and number of convictions accrued prior to actual or attempted handgun purchase. Conclusion Our results indicate that denial of handgun purchase to violent misdemeanants is associated with a specific decrease in risk of arrest for new gun and/or violent crimes.	Univ Calif Davis, Med Ctr, Violence Prevent Res Program, Sacramento, CA 95817 USA	University of California System; University of California Davis	Wintemute, GJ (corresponding author), Univ Calif Davis, Med Ctr, Violence Prevent Res Program, 2315 Stockton Blvd, Sacramento, CA 95817 USA.		Drake, Christiana M/M-9791-2015; drake, christiana/W-7161-2019	drake, christiana/0000-0002-0096-1800				BECK A, 1993, NCJ136949 BUR JUS ST; BLUMSTEIN A, 1979, J CRIM LAW CRIM, V70, P561, DOI 10.2307/1142642; Blumstein A, 1986, CRIMINAL CAREERS CAR, V1; Cook PJ, 1995, J CRIM LAW CRIM, V86, P59, DOI 10.2307/1144000; Cook PJ, 2000, GUN VIOLENCE REAL CO; COOK PJ, 1981, ANN AM ACAD POLIT SS, V445, P80; COX DR, 1972, J R STAT SOC B, V34, P187; CURTIS LA, 1999, ESTABLISH JUSTICE IN; Farrington David P., 1987, PREDICTION CLASSIFIC, P53; *FED BUR INV, 2000, CRIM IND TRENDS JAN; Federal Bureau of Investigation, 2000, CRIM US 2000; *GEN ACC OFF, 2000, AOGGDAIMD0064; GIFFORD LS, 2000, NCJ180882 US DEP JUS; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Jacobs JB, 1995, J CRIM LAW CRIM, V86, P93, DOI 10.2307/1144001; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kelly PJ, 2000, STAT MED, V19, P13, DOI 10.1002/(SICI)1097-0258(20000115)19:1&lt;13::AID-SIM279&gt;3.0.CO;2-5; Ludwig J, 2000, JAMA-J AM MED ASSOC, V284, P585, DOI 10.1001/jama.284.5.585; *OFF JUV JUST DEL, 1999, PROM STRAT RED GUN V; *OFF TECHN ASS, 1991, OTATCT497; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; *REG JUST INF SERV, 2000, NCJ179022 US DEP JUS; RENNISON CM, 2000, NCJ182734 US DEP JUS; Roth J, 1997, IMPACT EVALUATION PU; SHERMAN LW, 1995, NCJ150855 NAT I JUST; Teret SP, 1998, NEW ENGL J MED, V339, P813, DOI 10.1056/NEJM199809173391206; TIEN JM, 1990, NCJ123050 BUR JUST S; TILLMAN R, 1987, CRIMINOLOGY, V25, P561, DOI 10.1111/j.1745-9125.1987.tb00811.x; VISHER CA, 1991, CRIMINOLOGY, V29, P329, DOI 10.1111/j.1745-9125.1991.tb01070.x; Wintemute G., 2000, GUNS GUN VIOLENCE CR, P45; Wintemute GJ, 1998, JAMA-J AM MED ASSOC, V280, P2083, DOI 10.1001/jama.280.24.2083; WINTERMUTE GJ, 2000, JAMA-J AM MED ASSOC, V284, P2718; Wright MA, 1999, AM J PUBLIC HEALTH, V89, P88, DOI 10.2105/AJPH.89.1.88	33	80	80	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2001	285	8					1019	1026		10.1001/jama.285.8.1019	http://dx.doi.org/10.1001/jama.285.8.1019			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	403ME	11209172				2022-12-28	WOS:000167046400023
J	Beckingham, IJ; Krige, JEJ				Beckingham, IJ; Krige, JEJ			ABC of diseases of liver, pancreas, and biliary system - Liver tumours	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Queens Med Ctr, Dept Surg, Nottingham NG7 2UH, England; Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; Univ Cape Town, ZA-7700 Rondebosch, South Africa	University of Nottingham; University of Cape Town; University of Cape Town	Beckingham, IJ (corresponding author), Queens Med Ctr, Dept Surg, Nottingham NG7 2UH, England.	Ian.Beckingham@nottingham.ac.uk	Krige, Jake E/G-3496-2015	Krige, Jake E/0000-0002-7057-9156				Blumgart LH, 2000, SURG LIVER BILIARY T, V1, P1639; LAUNOIS B, 1993, MODERN OPERATIVE TEC; NEELEMAN N, 1996, BRIT J SURG, V83, P885	3	9	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2001	322	7284					477	480		10.1136/bmj.322.7284.477	http://dx.doi.org/10.1136/bmj.322.7284.477			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406YD	11222426	Green Published			2022-12-28	WOS:000167243000023
J	Corridan, BJ; Leung, SNM; Jenkins, IH				Corridan, BJ; Leung, SNM; Jenkins, IH			A case of sleeping and forgetting	LANCET			English	Editorial Material							TRANSIENT EPILEPTIC AMNESIA		Ealing Hammersmith & Fulham Mental Hlth NHS Trust, Southall UB1 3EU, Middx, England; Ealing Hosp NHS Trust, Dept Neurol, Southall, Middx, England		Corridan, BJ (corresponding author), Ealing Hammersmith & Fulham Mental Hlth NHS Trust, John Connolly Wing,Lixbridge Rd, Southall UB1 3EU, Middx, England.							KAPUR N, 1993, J NEUROL NEUROSUR PS, V56, P1184, DOI 10.1136/jnnp.56.11.1184; Kapur N., 1990, TRANSIENT GLOBAL AMN, P140; Zeman A, 2000, MEMORY DISORDERS IN PSYCHIATRIC PRACTICE, P187, DOI 10.1017/CBO9780511530197.010; Zeman AZJ, 1998, J NEUROL NEUROSUR PS, V64, P435, DOI 10.1136/jnnp.64.4.435	4	4	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					524	524		10.1016/S0140-6736(00)04045-9	http://dx.doi.org/10.1016/S0140-6736(00)04045-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229672				2022-12-28	WOS:000167011700013
J	Kawai, J; Shinagawa, A; Shibata, K; Yoshino, M; Itoh, M; Ishii, Y; Arakawa, T; Hara, A; Fukunishi, Y; Konno, H; Adachi, J; Fukuda, S; Aizawa, K; Izawa, M; Nishi, K; Kiyosawa, H; Kondo, S; Yamanaka, I; Saito, T; Okazaki, Y; Gojobori, T; Bono, H; Kasukawa, T; Saito, R; Kadota, K; Matsuda, H; Ashburner, M; Batalov, S; Casavant, T; Fleischmann, W; Gaasterland, T; Gissi, C; King, B; Kochiwa, H; Kuehl, P; Lewis, S; Matsuo, Y; Nikaido, I; Pesole, G; Quackenbush, J; Schriml, LM; Staubli, F; Suzuki, R; Tomita, M; Wagner, L; Washio, T; Sakai, K; Okido, T; Furuno, M; Aono, H; Baldarelli, R; Barsh, G; Blake, J; Boffelli, D; Bojunga, N; Carninci, P; de Bonaldo, MF; Brownstein, MJ; Bult, C; Fletcher, C; Fujita, M; Gariboldi, M; Gustincich, S; Hill, D; Hofmann, M; Hume, DA; Kamiya, M; Lee, NH; Lyons, P; Marchionni, L; Mashima, J; Mazzarelli, J; Mombaerts, P; Nordone, P; Ring, B; Ringwald, M; Rodriguez, I; Sakamoto, N; Sasaki, H; Sato, K; Schonbach, C; Seya, T; Shibata, Y; Storch, KF; Suzuki, H; Toyo-oka, K; Wang, KH; Weitz, C; Whittaker, C; Wilming, L; Wynshaw-Boris, A; Yoshida, K; Hasegawa, Y; Kawaji, H; Kohtsuki, S; Hayashizaki, Y				Kawai, J; Shinagawa, A; Shibata, K; Yoshino, M; Itoh, M; Ishii, Y; Arakawa, T; Hara, A; Fukunishi, Y; Konno, H; Adachi, J; Fukuda, S; Aizawa, K; Izawa, M; Nishi, K; Kiyosawa, H; Kondo, S; Yamanaka, I; Saito, T; Okazaki, Y; Gojobori, T; Bono, H; Kasukawa, T; Saito, R; Kadota, K; Matsuda, H; Ashburner, M; Batalov, S; Casavant, T; Fleischmann, W; Gaasterland, T; Gissi, C; King, B; Kochiwa, H; Kuehl, P; Lewis, S; Matsuo, Y; Nikaido, I; Pesole, G; Quackenbush, J; Schriml, LM; Staubli, F; Suzuki, R; Tomita, M; Wagner, L; Washio, T; Sakai, K; Okido, T; Furuno, M; Aono, H; Baldarelli, R; Barsh, G; Blake, J; Boffelli, D; Bojunga, N; Carninci, P; de Bonaldo, MF; Brownstein, MJ; Bult, C; Fletcher, C; Fujita, M; Gariboldi, M; Gustincich, S; Hill, D; Hofmann, M; Hume, DA; Kamiya, M; Lee, NH; Lyons, P; Marchionni, L; Mashima, J; Mazzarelli, J; Mombaerts, P; Nordone, P; Ring, B; Ringwald, M; Rodriguez, I; Sakamoto, N; Sasaki, H; Sato, K; Schonbach, C; Seya, T; Shibata, Y; Storch, KF; Suzuki, H; Toyo-oka, K; Wang, KH; Weitz, C; Whittaker, C; Wilming, L; Wynshaw-Boris, A; Yoshida, K; Hasegawa, Y; Kawaji, H; Kohtsuki, S; Hayashizaki, Y		RIKEN Genome Exploration Res Grp	Functional annotation of a full-length mouse cDNA collection	NATURE			English	Article							PROTEIN SEQUENCES; TOOL	The RIKEN Mouse Gene Encyclopaedia Project, a systematic approach to determining the full coding potential of the mouse genome, involves collection and sequencing of full-length complementary DNAs and physical mapping of the corresponding genes to the mouse genome. We organized an international functional annotation meeting (FANTOM) to annotate the first 21,076 cDNAs to be analysed in this project. Here we describe the first RIKEN clone collection, which is one of the largest described for any organism. Analysis of these cDNAs extends known gene families and identifies new ones.	Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat, Res Grp,Tsurumi Ku, Kanagawa 2300045, Japan; JST, CREST, Tsukuba, Ibaraki 3050074, Japan; Natl Inst Genet, Ctr Informat Biol, Shizuoka 4118540, Japan; NTT Software Corp, Naka Ku, Kanagawa 2318554, Japan; Osaka Univ, Osaka 5608531, Japan; European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Univ Iowa, Coordinated Lab Computat Genom, Iowa City, IA 52242 USA; Rockefeller Univ, New York, NY 10021 USA; Univ Milan, Dipartimento Fisiol & Biochim Gen, I-20133 Milan, Italy; Jackson Lab, Bar Harbor, ME 04609 USA; Keio Univ, Fac Environm Informat, Lab Bioinformat, Kanagawa 2520816, Japan; Univ Maryland, Dept Mol & Cell Biol, Baltimore, MD 20201 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Yokohama Inst, RIKEN Genom Sci Ctr, Bioinformat Grp, Computat Proteom Team,Tsurumi Ku, Kanagawa 2300045, Japan; Tokai Univ, Grad Sch Marine Sci & Technol, Shizuoka 4248610, Japan; Inst Genom Res, Rockville, MD 20850 USA; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; LION Biosci AG, D-69120 Heidelberg, Germany; Stanford Univ, Sch Med, Beckman Ctr B271A, Stanford, CA 94305 USA; Lawrence Berkeley Lab, Berkeley, CA 94710 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; NIMH, Genet Lab, NHGRI, NIH, Bethesda, MD 20892 USA; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; Ist Tumori Milano, I-20133 Milan, Italy; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Cambridge, Addenbrookes Hosp, Wellcome Trust Ctr Mol Mechanisms Dis, Dept Med Genet, Cambridge CB2 2XY, England; LNCIB, I-34012 Trieste, Italy; Univ Penn, Ctr Bioinformat, Computat & Bioinformat Lab, Philadelphia, PA 19104 USA; Univ Buffalo, Roswell Pk Canc Inst, Amherst, NY 14226 USA; Stanford Univ, Dept Genet, Beckman Ctr B281, Stanford, CA 94305 USA; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; Natl Canc Res Inst, Chuo Ku, Tokyo 1040045, Japan; Yokohama Inst, RIKEN Genom Sci Ctr, Bioinformat Grp, Computat Genom Team,Tsurumi Ku, Kanagawa 2300045, Japan; Osaka Med Ctr Canc, Higashinari Ku, Osaka 5378511, Japan; Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, MIT CCR, Cambridge, MA 02139 USA; Sanger Ctr, Hinxton CB10 1SA, Cambs, England; Univ Tsukuba, Tsukuba, Ibaraki 3058577, Japan	RIKEN; Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Osaka University; European Molecular Biology Laboratory (EMBL); Novartis; University of Iowa; Rockefeller University; University of Milan; Jackson Laboratory; Keio University; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Berkeley; RIKEN; Tokai University; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute of Mental Health (NIMH); University of Tokyo; Fondazione IRCCS Istituto Nazionale Tumori Milan; Harvard University; Harvard Medical School; University of Queensland; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Pennsylvania; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Stanford University; RIKEN; National Cancer Center - Japan; RIKEN; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Wellcome Trust Sanger Institute; University of Tsukuba	Kawai, J (corresponding author), Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat, Res Grp,Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.		Marchionni, Luigi/S-6774-2017; Mashima, Jun/F-3706-2010; Pesole, Graziano/K-5283-2019; Wang, Kuan Hong/J-1150-2016; Carninci, Piero/K-1568-2014; , Kadota/AAP-2804-2020; Kasukawa, Takeya/N-5070-2015; Toyooka, Kazuhito/AAQ-6928-2020; Pesole, Graziano/C-1408-2009; Nikaido, Itoshi/K-2058-2014; Konno, Hideaki/A-9191-2012; Toyooka, Kazuhito/AAH-7175-2019; Brownstein, Michael/B-8609-2009; King, Benjamin/AAI-1492-2019; Kawaji, Hideya/N-5116-2015; Kawai, Jun/A-6451-2016; shibata, kazuhiro/A-9527-2008; Pesole, Graziano/E-9051-2014; Suzuki, Harukazu/N-9553-2015; Saito, Takashi/C-9684-2009; Schriml, Lynn/AFO-9472-2022; Bono, Hidemasa/AAF-3649-2020; Hume, David A/C-7695-2013; Hayashizaki, Yoshihide/N-6590-2015; Fukunishi, Yoshifumi/L-8063-2018; Itoh, Masayoshi/N-5363-2015; Schönbach, Christian/B-1998-2009; Seya, Tsukasa/A-4336-2012; Kadota, Koji/C-9168-2011; Konno, Hideaki/N-4366-2014; Gariboldi, Manuela/K-4744-2016	Marchionni, Luigi/0000-0002-7336-8071; Mashima, Jun/0000-0003-4138-1893; Wang, Kuan Hong/0000-0002-2249-5417; Carninci, Piero/0000-0001-7202-7243; , Kadota/0000-0002-3907-4336; Kasukawa, Takeya/0000-0001-5085-0802; Toyooka, Kazuhito/0000-0002-0173-0430; Pesole, Graziano/0000-0003-3663-0859; Nikaido, Itoshi/0000-0002-7261-2570; Toyooka, Kazuhito/0000-0002-0173-0430; Kawaji, Hideya/0000-0002-0575-0308; Pesole, Graziano/0000-0003-3663-0859; Suzuki, Harukazu/0000-0002-8087-0836; Saito, Takashi/0000-0001-9495-3547; Bono, Hidemasa/0000-0003-4413-0651; Fukunishi, Yoshifumi/0000-0002-7264-250X; Itoh, Masayoshi/0000-0002-1772-318X; Schönbach, Christian/0000-0002-0693-7617; Kadota, Koji/0000-0002-3907-4336; Konno, Hideaki/0000-0002-8470-4835; Gustincich, Stefano/0000-0002-2749-2514; Whittaker, Charles/0000-0002-2400-0094; Hume, David/0000-0002-2615-1478; Fukuda, Shiro/0000-0002-0065-662X; OKIDO, Toshihisa/0000-0002-1662-8949; Gariboldi, Manuela/0000-0001-8406-165X; Gissi, Carmela/0000-0002-2269-079X; Batalov, Sergey/0000-0002-0925-0554; Wilming, Laurens/0000-0002-4154-7358; Quackenbush, John/0000-0002-2702-5879; Lewis, Suzanna/0000-0002-8343-612X; Schriml, Lynn/0000-0001-8910-9851; rodriguez, ivan/0000-0002-6468-0565; Blake, Judith/0000-0001-8522-334X; Matsuda, Hideo/0000-0002-4701-3779; King, Benjamin/0000-0001-6463-1336	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002771] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; FUKUNISHI Y, IN PRESS PHYSL GENOM; Gautheret D, 1998, GENOME RES, V8, P524, DOI 10.1101/gr.8.5.524; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Itoh M, 1999, GENOME RES, V9, P463; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Matsuda H, 2000, IEICE T FUND ELECTR, VE83A, P713; Pesole G, 2000, BIOINFORMATICS, V16, P439, DOI 10.1093/bioinformatics/16.5.439; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Shibata K, 2000, GENOME RES, V10, P1757, DOI 10.1101/gr.152600; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	25	521	584	2	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					685	690		10.1038/35055500	http://dx.doi.org/10.1038/35055500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217851	Bronze			2022-12-28	WOS:000166816400034
J	Barreiro, P; Soriano, V; Gonzalez-Lahoz, J				Barreiro, P; Soriano, V; Gonzalez-Lahoz, J			Prevention of nevirapine-associated rash	LANCET			English	Letter									Hosp Carlos III, Inst Salud Carlos III, Infect Dis Serv, Madrid, Spain	Hospital Carlos III; Instituto de Salud Carlos III	Soriano, V (corresponding author), Hosp Carlos III, Inst Salud Carlos III, Infect Dis Serv, Madrid, Spain.		Schrooten, Ward/K-3783-2015; Soriano, Vicente/O-5730-2018	Soriano, Vicente/0000-0002-4624-5199				Barreiro P, 2000, AIDS, V14, P2153, DOI 10.1097/00002030-200009290-00012; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; KNOBEL H, 2000, P 40 INT C ANT AG CH; MONTANER J, 2000, P 13 WORLD AIDS C JU	4	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					392	392		10.1016/S0140-6736(05)71524-5	http://dx.doi.org/10.1016/S0140-6736(05)71524-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11211023				2022-12-28	WOS:000166897900048
J	Ohno, H				Ohno, H			Semiconductors - Toward functional spintronics	SCIENCE			English	Editorial Material									Tohoku Univ, Elect Commun Res Inst, Lab Elect Intelligent Syst, Aoba Ku, Sendai, Miyagi 9808577, Japan	Tohoku University	Ohno, H (corresponding author), Tohoku Univ, Elect Commun Res Inst, Lab Elect Intelligent Syst, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.		Ohno, Hideo/E-6453-2010	Ohno, Hideo/0000-0001-9688-8259				Ball P, 2000, NATURE, V404, P918, DOI 10.1038/35010132; BRICENO G, 1995, SCIENCE, V270, P273, DOI 10.1126/science.270.5234.273; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Matsumoto Y, 2001, SCIENCE, V291, P854, DOI 10.1126/science.1056186; Medvedkin GA, 2000, JPN J APPL PHYS 2, V39, pL949, DOI 10.1143/JJAP.39.L949; Ohno H, 1998, SCIENCE, V281, P951, DOI 10.1126/science.281.5379.951; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; Sato K, 2000, JPN J APPL PHYS 2, V39, pL555, DOI 10.1143/JJAP.39.L555	9	167	171	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					840	841		10.1126/science.1058371	http://dx.doi.org/10.1126/science.1058371			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11225634				2022-12-28	WOS:000166771700032
J	Piotrowska, K; Zernicka-Goetz, M				Piotrowska, K; Zernicka-Goetz, M			Role for sperm in spatial patterning of the early mouse embryo	NATURE			English	Article							CELL-DIVISION ORDER; POLAR TROPHECTODERM; BLASTOCYST; AXIS; CONSEQUENCES; BLASTOMERES; ALLOCATION; LINEAGE; MASS; FATE	Despite an apparent lack of determinants that specify cell fate, spatial patterning of the mouse embryo is evident early in development. The axis of the post-implantation egg cylinder can be traced back to organization of the pre-implantation blastocyst(1). This in turn reflects the organization of the cleavage-stage embryo and the animal-vegetal axis of the zygote(2,3). These findings suggest that the cleavage pattern of normal development may be involved in specifying the future embryonic axis; however, how and when this pattern becomes established is unclear. In many animal eggs, the sperm entry position provides a cue for embryonic patterning(4-6), but until now no such role has been found in mammals. Here we show that the sperm entry position predicts the plane of initial cleavage of the mouse egg and can define embryonic and abembryonic halves of the future blastocyst. In addition, the cell inheriting the sperm entry position acquires a division advantage and tends to cleave ahead of its sister. As cell identity reflects the timing of the early cleavages, these events together shape the blastocyst whose organization will become translated into axial patterning after implantation. We present a model for axial development that accommodates these findings with the regulative nature of mouse embryos.	Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England.			Zernicka-Goetz, Magdalena/0000-0002-7004-2471	Wellcome Trust [064421] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BALAKIER H, 1982, DEV BIOL, V23, P52; BOWERMAN B, 1999, CELL LINEAGE FATE DE, P97; Ciemerych MA, 2000, DEVELOPMENT, V127, P3467; COPP AJ, 1979, J EMBRYOL EXP MORPH, V51, P109; CRUZ YP, 1985, DEV BIOL, V112, P73, DOI 10.1016/0012-1606(85)90120-4; GARBUTT CL, 1987, DEVELOPMENT, V100, P325; GARBUTT CL, 1987, DEVELOPMENT, V100, P125; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 1996, HUM REPROD, V11, P1979; GERHART J, 1989, DEVELOPMENT, V107, P37; Goldstein B, 1996, DEVELOPMENT, V122, P1467; GRAHAM CF, 1979, J EMBRYOL EXP MORPH, V49, P277; GRAHAM CF, 1978, J EMBRYOL EXP MORPH, V48, P53; KELLY SJ, 1978, J EMBRYOL EXP MORPH, V48, P37; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; SURANI MAH, 1984, DEV BIOL, V102, P335, DOI 10.1016/0012-1606(84)90198-2; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Weber RJ, 1999, DEVELOPMENT, V126, P5591; Zernicka-Goetz M, 1998, DEVELOPMENT, V125, P4803	19	182	196	1	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					517	521		10.1038/35054069	http://dx.doi.org/10.1038/35054069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206548				2022-12-28	WOS:000166570500049
J	Esiri, MM; Matthews, F; Brayne, C; Ince, PG; Matthews, FE; Xuereb, JH; Broome, JC; McKenzie, J; Rossi, M; McKeith, IG; Lowe, J; Morris, JH				Esiri, MM; Matthews, F; Brayne, C; Ince, PG; Matthews, FE; Xuereb, JH; Broome, JC; McKenzie, J; Rossi, M; McKeith, IG; Lowe, J; Morris, JH		Neuropathology Grp Med Res Council	Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales	LANCET			English	Article							ALZHEIMERS-DISEASE; DIAGNOSIS; OLD; CONSORTIUM; BRAINS	Background We have undertaken a large unselected, community-based neuropathology study in an elderly (70-103 years) UK population in relation to prospectively evaluated dementia status. The study tests the assumption that dementing disorders as defined by current diagnostic protocols underlie this syndrome in the community at large. Methods Respondents in the Medical Research Council Cognitive Function and Ageing Study were approached for consent to examine the brain at necropsy. Dementia status was assigned by use of the automated geriatric examination for computer-assisted taxonomy algorithm. Neuropathological features were standardised by use of the protocol of the Consortium to Establish a Registry of Alzheimer's Disease, which assesses the severity and distribution of Alzheimer-type pathology, vascular lesions, and other potential causes of dementia. A statistical model of dementia risk related predominantly to Alzheimer-type and vascular pathology was developed by multivariate logistic regression. Findings We report on the first 209 individuals who have come to necropsy. The median age at death was 85 years for men, and 86 years for women. Cerebrovascular (78%) and Alzheimer-type (70%) pathology were common. Dementia was present in 100 (48%), of whom 64% had features indicating probable or definite Alzheimer's disease. However, 33% of the 109 non-demented people had equivalent densities of neocortical neuritic plaques. Some degree of neocortical neurofibrillary pathology was found in 61% of demented and 34% of non-demented individuals. Vascular lesions were equally common in both groups, although the proportion with multiple vascular pathology was higher in the demented group (46% vs 33%). Interpretation Alzheimer-type and Vascular pathology were the major pathological correlates of cognitive decline in this elderly sample, as expected, but most patients had mixed disease. There were no clear thresholds of these features that predicted dementia status. The findings therefore challenge conventional dementia diagnostic criteria in this setting. Additional factors must determine whether moderate burdens of cerebral Alzheimer-type pathology and vascular lesions are associated with cognitive failure.	Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; Univ Oxford, Radcliffe Infirm, Dept Neuropathol, Oxford OX2 6HE, England; MRC, Biostat Unit, Cambridge CB2 2BW, England; Univ Cambridge, Inst Publ Hlth, Cambridge CB2 1TN, England; Newcastle Univ, Inst Hlth Elderly, Dept Neuropathol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Sheffield; Radcliffe Infirmary; University of Oxford; MRC Biostatistics Unit; University of Cambridge; Newcastle University - UK	Ince, PG (corresponding author), Royal Hallamshire Hosp, E Floor,Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	p.g.ince@sheffield.ac.uk	Brayne, Carol/AAA-4285-2020; Ince, Paul G/A-5064-2009; McKeith, Ian/AAH-3382-2021; Matthews, Fiona/O-6932-2015	Brayne, Carol/0000-0001-5307-663X; Ince, Paul G/0000-0001-6677-8753; Matthews, Fiona/0000-0002-1728-2388				BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brayne C, 1999, J AM GERIATR SOC, V47, P1283, DOI 10.1111/j.1532-5415.1999.tb07426.x; Brayne C, 1998, PSYCHOL MED, V28, P319; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008; Del Ser T, 1999, BRAIN, V122, P2309, DOI 10.1093/brain/122.12.2309; Esiri MM, 1997, J NEUROL NEUROSUR PS, V63, P749, DOI 10.1136/jnnp.63.6.749; FOLSTEIN M, 1975, J PSYCHIATR RES, V313, P1419; Green MS, 2000, NEUROLOGY, V54, P105, DOI 10.1212/WNL.54.1.105; HANSEN LA, 1989, ACTA NEUROPATHOL, V78, P194, DOI 10.1007/BF00688209; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hardy J, 1998, NAT NEUROSCI, V1, P355, DOI 10.1038/1565; HOMER AC, 1988, BMJ-BRIT MED J, V297, P894, DOI 10.1136/bmj.297.6653.894; Jellinger KA, 1996, ACTA NEUROPATHOL, V91, P219, DOI 10.1007/s004010050418; Kay DWK, 1998, INT J GERIATR PSYCH, V13, P852, DOI 10.1002/(SICI)1099-1166(1998120)13:12<852::AID-GPS882>3.0.CO;2-Y; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; Letenneur L, 2000, AM J EPIDEMIOL, V151, P1064, DOI 10.1093/oxfordjournals.aje.a010149; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MILLER FD, 1984, AM J EPIDEMIOL, V120, P331; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; PERRY RH, 1990, J NEUROL SCI, V95, P119, DOI 10.1016/0022-510X(90)90236-G; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; SKOOG I, 1993, NEW ENGL J MED, V328, P153, DOI 10.1056/NEJM199301213280301; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; Xuereb JH, 2000, ANN NY ACAD SCI, V903, P490, DOI 10.1111/j.1749-6632.2000.tb06404.x	28	997	1015	2	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					169	175						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	395QX	11213093				2022-12-28	WOS:000166593700009
J	Wade, DP; Owen, JS				Wade, DP; Owen, JS			Regulation of the cholesterol efflux gene, ABCA1	LANCET			English	Editorial Material							LXR-ALPHA; ACCUMULATION; DEFICIENCY; MUTATIONS; RECEPTORS		CV Therapeut Inc, Palo Alto, CA USA; UCL Royal Free & Univ Coll Med Sch, Dept Med, London NW3 2PF, England	CV Therapeutics, Inc.; University of London; University College London; UCL Medical School	Owen, JS (corresponding author), CV Therapeut Inc, Palo Alto, CA USA.	j.owen@rfc.ucl.ac.uk	Owen, James/C-5908-2009; Owen, James S./AAP-8628-2020					Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Costet P, 2000, J BIOL CHEM, V275, P28240; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Owen JS, 1999, LANCET, V354, P1402, DOI 10.1016/S0140-6736(99)00297-4; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; WILLY PJ, 1998, HORMONES SIGNALING, V1, P307	14	20	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 20	2001	357	9251					161	163		10.1016/S0140-6736(00)03585-6	http://dx.doi.org/10.1016/S0140-6736(00)03585-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213089				2022-12-28	WOS:000166593700005
J	Leon, DA; Walt, G; Gilson, L				Leon, DA; Walt, G; Gilson, L			Recent advances - International perspectives on health inequalities and policy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MORTALITY		Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Witwatersrand, Ctr Hlth Policy, ZA-2000 Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand	Leon, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	d.leon@lshtm.ac.uk	Gilson, Lucy/R-8846-2019; Leon, David A/G-2195-2010	Gilson, Lucy/0000-0002-2775-7703; Leon, David A/0000-0001-9747-1762				ACHESON D, 1998, REPORT INDEPENDENT I; [Anonymous], 2000, DEV FREEDOM; Braveman P, 2000, B WORLD HEALTH ORGAN, V78, P232; Gakidou EE, 2000, B WORLD HEALTH ORGAN, V78, P42; Gilson L, 1998, SOC SCI MED, V47, P1891; Kuh D, 1997, LIFE COURSE APPROACH; Kunst AE, 1999, AM J PUBLIC HEALTH, V89, P47, DOI 10.2105/AJPH.89.1.47; Kunst AE, 1998, REV EPIDEMIOL SANTE, V46, P467; LANATA CE, 2000, POVERTY INEQUALITY H, P137; Leon D., 2000, POVERTY INEQUALITY H; LEON DA, 2000, POVERTY INEQUALITY H, P58; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Murray CJL, 1999, B WORLD HEALTH ORGAN, V77, P537; Ruger JP, 2001, INTERNATIONAL PUBLIC HEALTH, P617; SEN A, 2000, POVERTY INEQUALITY H, P333; Smith GD, 1996, AM J PUBLIC HEALTH, V86, P486, DOI 10.2105/AJPH.86.4.486; SMITH GD, 2000, POVERTY INEQUALITY H, P88, DOI DOI 10.1093/ACPROF:OSO/9780192631961.003.0005; Stott R, 1999, BRIT MED J, V318, P822, DOI 10.1136/bmj.318.7187.822; WHITEHEAD M, IN PRESS CHALLENGING; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization (WHO), 1999, WHO LAB MAN EX HUM S, P7; 2000, B WHO, V78, P1	24	49	52	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2001	322	7286					591	594		10.1136/bmj.322.7286.591	http://dx.doi.org/10.1136/bmj.322.7286.591			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238156	Green Published, Green Accepted			2022-12-28	WOS:000167499900027
J	Moreno, A; Piwowarczyk, L; Grodin, MA				Moreno, A; Piwowarczyk, L; Grodin, MA			Human rights violations and refugee health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TORTURE		Boston Ctr Refugee Hlth & Human Rights, Boston, MA USA		Moreno, A (corresponding author), Boston Ctr Refugee Hlth & Human Rights, Boston, MA USA.			Grodin, Michael/0000-0002-0929-8929; Piwowarczyk, Linda/0000-0002-0791-9605				Baker R., 1992, TORTURE ITS CONSEQUE, P83; BRENNER J, 1996, HLTH HUM RIGHTS, V276, P1676; Eisenman DP, 2000, WESTERN J MED, V172, P301, DOI 10.1136/ewjm.172.5.301; IACOPINO V, 2000, MANUAL EFFECTIVE INV; Krill Francoise, 1985, INT REV RED CROSS, V25, P337; Moreno A, 2000, JAMA-J AM MED ASSOC, V284, P538, DOI 10.1001/jama.284.5.538; RANDALL G, 1991, SERVING SURVIVORS TO, P55; Sonis J, 1996, JAMA-J AM MED ASSOC, V276, P1676, DOI 10.1001/jama.276.20.1676; U.S. Census Bureau, 2000, US CENS 2000; *US DEP JUST, 2000, 1998 STAT YB INS; Walker PF, 1999, MED CLIN N AM, V83, P1103	11	16	16	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1215	1215		10.1001/jama.285.9.1215	http://dx.doi.org/10.1001/jama.285.9.1215			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231757	hybrid			2022-12-28	WOS:000167194700030
J	Riha, K; McKnight, TD; Griffing, LR; Shippen, DE				Riha, K; McKnight, TD; Griffing, LR; Shippen, DE			Living with genome instability: Plant responses to telomere dysfunction	SCIENCE			English	Article							CELLS; P53; REPAIR	Loss of telomere function in metazoans results in catastrophic damage to the genome, cell cycle arrest, and apoptosis, Here we show that the mustard weed Arabidopsis thaliana can survive up to 10 generations without telomerase. The Last five generations of telomerase-deficient plants endured increasing Levels of cytogenetic damage, which was correlated with developmental anomalies in both vegetative and reproductive organs. Mutants ultimately arrested at a terminal vegetative state harboring shoot meristems that were grossly enlarged, disorganized, and in some cases, dedifferentiated into a callusoid mass. Unexpectedly, Late-generation mutants had an extended Life-span and remained metabolically active. The differences in plant and animal responses to dysfunctional telomeres may reflect the more plastic nature of plant development and genome organization.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Shippen, DE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 2128 TAMU, College Stn, TX 77843 USA.	dshippen@tamu.edu	Riha, Karel/AAM-4429-2021; Riha, Karel/P-9614-2018; McKnight, Thomas/C-1395-2010; Riha, Karel/A-7717-2008	Riha, Karel/0000-0002-6124-0118; Riha, Karel/0000-0002-6124-0118; 				Ahmad K, 1999, GENETICS, V151, P1041; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bleecker AB, 1998, CURR OPIN PLANT BIOL, V1, P73, DOI 10.1016/S1369-5266(98)80131-3; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Clark SE, 1997, TRENDS CELL BIOL, V7, P454, DOI 10.1016/S0962-8924(97)01152-5; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; Fitzgerald MS, 1999, P NATL ACAD SCI USA, V96, P14813, DOI 10.1073/pnas.96.26.14813; Fletcher JC, 2000, CURR OPIN PLANT BIOL, V3, P23, DOI 10.1016/S1369-5266(99)00033-3; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Herrera E, 1999, EMBO J, V18, P1172, DOI 10.1093/emboj/18.5.1172; Heslop-Harrison JS, 1998, METH MOL B, V82, P119; HUGHES J, 1975, STAIN TECHNOL, V50, P319, DOI 10.3109/10520297509117082; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kass-Eisler A, 2000, TRENDS BIOCHEM SCI, V25, P200, DOI 10.1016/S0968-0004(00)01557-7; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Klosterman SJ, 2000, PHYSIOL MOL PLANT P, V56, P197, DOI 10.1006/pmpp.2000.0267; Lansdorp PM, 2000, MECH AGEING DEV, V118, P23, DOI 10.1016/S0047-6374(00)00151-2; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Laux T, 1998, SEMIN CELL DEV BIOL, V9, P195, DOI 10.1006/scdb.1997.0208; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; Lundblad V, 1998, P NATL ACAD SCI USA, V95, P8415, DOI 10.1073/pnas.95.15.8415; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Oulton R, 2000, CURR OPIN ONCOL, V12, P74, DOI 10.1097/00001622-200001000-00013; RIHA K, UNPUB; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Vasil V, 1984, CELL CULTURE SOMATIC, P738; Walbot V, 1996, TRENDS PLANT SCI, V1, P27, DOI 10.1016/S1360-1385(96)80020-3	29	175	181	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1797	1800		10.1126/science.1057110	http://dx.doi.org/10.1126/science.1057110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230697				2022-12-28	WOS:000167320600062
J	Smith-Bindman, R; Hosmer, W; Feldstein, VA; Deeks, JJ; Goldberg, JD				Smith-Bindman, R; Hosmer, W; Feldstein, VA; Deeks, JJ; Goldberg, JD			Second-trimester ultrasound to detect fetuses with Down syndrome - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SONOGRAPHIC SCORING INDEX; NUCHAL SKINFOLD THICKNESS; FEMUR LENGTH RATIO; SERUM UNCONJUGATED ESTRIOL; ADVANCED MATERNAL AGE; CHOROID-PLEXUS CYSTS; LOW-RISK POPULATION; CHROMOSOMAL-ABNORMALITIES; PRENATAL-DIAGNOSIS; 2ND-TRIMESTER FETUSES	Context Second-trimester prenatal ultrasound is widely used in an attempt to detect Down syndrome in fetuses, but the accuracy of this method is unknown. Objective To determine the accuracy of second-trimester ultrasound in detecting Down syndrome in fetuses. Data Sources English-language articles published between 1980 and February 1999 identified through MEDLINE and manual searches. Study Selection Studies were included if they recorded second-trimester findings of ultrasonographic markers, chromosomal abnormalities, and clinical outcomes for a well-described sample of women. A total of 56 articles describing 1930 fetuses with Down syndrome and 130365 unaffected fetuses were included. Data Extraction Articles were independently reviewed, selected, and abstracted by 2 reviewers. Discrepancies in data abstraction were resolved by consensus with a third reviewer. Overall estimates of sensitivity, specificity, and positive and negative likelihood ratios were calculated for the following markers: choroid plexus cyst, thickened nuchal fold, echogenic intracardiac focus, echogenic bowel, renal pyelectasis, and humeral and femoral shortening. Results were stratified by whether markers were identified in isolation or in conjunction with fetal structural malformations. Data Synthesis When ultrasonographic markers were observed without associated fetal structural malformations, sensitivity for each was low (range, 1%-16%), and most fetuses with such markers had normal outcomes. A thickened nuchal fold was the most accurate marker for discriminating between unaffected and affected fetuses and was associated with an approximately 17-fold increased risk of Down syndrome. If a thickened nuchal fold is used to screen for Down syndrome, 15 893 average-risk women or 6818 high-risk women would need to be screened for each case of Down syndrome identified. For each of the other 6 markers, when observed without associated structural malformations, the marker had marginal impact on the risk of Down syndrome. Because the markers were detected in only a small number of affected fetuses, the likelihood of Down syndrome did not decrease substantially after normal examination findings (none of the negative likelihood ratios were significant), Conclusions A thickened nuchal fold in the second trimester may be useful in distinguishing unaffected fetuses from those with Down syndrome, but the overall sensitivity of this finding is too low for it to be a practical screening test for Down syndrome. When observed without associated structural malformations, the remaining ultrasonographic markers could not discriminate well between unaffected fetuses and those with Down syndrome. Using these markers as a basis for deciding to offer amniocentesis will result in more fetal losses than cases of Down syndrome detected, and will read to a decrease in the prenatal detection of fetuses with Down syndrome.	Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94115 USA; Univ Oxford, Inst Hlth Sci, ICRF NHS Ctr Stat Med, Oxford, England; Calif Pacific Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oxford; California Pacific Medical Center	Smith-Bindman, R (corresponding author), Univ Calif San Francisco, Dept Radiol, 1600 Divisadero St, San Francisco, CA 94115 USA.	Rebecca.Smith-Bindman@radiology.ucsf.edu	Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971				ADAMS MM, 1981, JAMA-J AM MED ASSOC, V246, P758, DOI 10.1001/jama.246.7.758; BAHADOSINGH RO, 1995, AM J OBSTET GYNECOL, V173, P1106, DOI 10.1016/0002-9378(95)91334-3; BahadoSingh RO, 1996, AM J OBSTET GYNECOL, V175, P1563, DOI 10.1016/S0002-9378(96)70107-2; BENACERRAF BR, 1985, AM J OBSTET GYNECOL, V151, P1078, DOI 10.1016/0002-9378(85)90385-0; BENACERRAF BR, 1989, RADIOLOGY, V173, P377, DOI 10.1148/radiology.173.2.2529580; BENACERRAF BR, 1991, OBSTET GYNECOL, V77, P223, DOI 10.1097/00006250-199102000-00012; Benacerraf BR, 1996, ULTRASOUND OBST GYN, V7, P147, DOI 10.1046/j.1469-0705.1996.07020147.x; BENACERRAF BR, 1992, J ULTRAS MED, V11, P449, DOI 10.7863/jum.1992.11.9.449; BENACERRAF BR, 1987, NEW ENGL J MED, V317, P1371, DOI 10.1056/NEJM198711263172203; BENACERRAF BR, 1994, RADIOLOGY, V193, P135, DOI 10.1148/radiology.193.1.8090881; Bernaschek G, 1996, AM J PERINAT, V13, P259, DOI 10.1055/s-2007-994339; BIAGIOTTI R, 1994, PRENATAL DIAG, V14, P429, DOI 10.1002/pd.1970140603; Borrell A, 1997, PRENATAL DIAG, V17, P23, DOI 10.1002/(SICI)1097-0223(199701)17:1<23::AID-PD24>3.3.CO;2-0; Boyd PA, 1998, LANCET, V352, P1577, DOI 10.1016/S0140-6736(98)03202-4; BROMLEY B, 1995, OBSTET GYNECOL, V86, P998, DOI 10.1016/0029-7844(95)00323-J; Bromley B, 1997, ULTRASOUND OBST GYN, V10, P321, DOI 10.1046/j.1469-0705.1997.10050321.x; BRUMFIELD CG, 1989, OBSTET GYNECOL, V73, P644; *CAL DEP HLTH SERV, 1997, CAL EXP AFP SCREEN P; CAMPBELL WA, 1994, FETAL DIAGN THER, V9, P175, DOI 10.1159/000263928; CANICK JA, 1988, BRIT J OBSTET GYNAEC, V95, P330, DOI 10.1111/j.1471-0528.1988.tb06601.x; CARLSON DE, 1992, J REPROD MED, V37, P419; CHAN L, 1989, OBSTET GYNECOL, V73, P703; Chew S., 1996, Singapore Medical Journal, V37, P595; Chitty LS, 1995, PRENATAL DIAG, V15, P1241, DOI 10.1002/pd.1970151306; CHITTY LS, 1991, BRIT MED J, V303, P1165, DOI 10.1136/bmj.303.6811.1165; CRANE JP, 1994, AM J OBSTET GYNECOL, V171, P392, DOI 10.1016/S0002-9378(94)70040-0; CRANE JP, 1991, OBSTET GYNECOL, V77, P533; CUCKLE H, 1989, BRIT J OBSTET GYNAEC, V96, P1373, DOI 10.1111/j.1471-0528.1989.tb06297.x; D'Ottavio G, 1997, ULTRASOUND OBST GYN, V10, P375, DOI 10.1046/j.1469-0705.1997.10060375.x; DALLAIRE L, 1995, PRENATAL DIAG, V15, P249, DOI 10.1002/pd.1970150308; DAVIS GK, 1990, BRIT J OBSTET GYNAEC, V97, P27, DOI 10.1111/j.1471-0528.1990.tb01712.x; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; Deren O, 1998, AM J OBSTET GYNECOL, V178, P441, DOI 10.1016/S0002-9378(98)70417-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DEVORE GR, 1995, OBSTET GYNECOL, V85, P378, DOI 10.1016/0029-7844(94)00384-P; DICKE JM, 1989, OBSTET GYNECOL, V74, P726; DONNENFELD AE, 1994, OBSTET GYNECOL, V84, P844; Drugan A, 1996, OBSTET GYNECOL, V88, P203, DOI 10.1016/0029-7844(96)00134-2; FEDRICK J, 1978, BRIT J OBSTET GYNAEC, V85, P1, DOI 10.1111/j.1471-0528.1978.tb15816.x; Filly RA, 2000, J ULTRAS MED, V19, P1; GINSBERG N, 1990, AM J OBSTET GYNECOL, V163, P1186, DOI 10.1016/0002-9378(90)90686-2; GRANDJEAN H, 1995, AM J OBSTET GYNECOL, V173, P16, DOI 10.1016/0002-9378(95)90162-0; GRANDJEAN H, 1995, OBSTET GYNECOL, V85, P103, DOI 10.1016/0029-7844(94)00327-A; Gray DL, 1996, PRENATAL DIAG, V16, P983, DOI 10.1002/(SICI)1097-0223(199611)16:11<983::AID-PD975>3.0.CO;2-C; GRAY DL, 1994, AM J OBSTET GYNECOL, V171, P1282, DOI 10.1016/0002-9378(94)90148-1; Greenough A, 1997, EUR J PEDIATR, V156, P550, DOI 10.1007/s004310050660; GRIST TM, 1990, RADIOLOGY, V174, P837, DOI 10.1148/radiology.174.3.2137635; Haddow JE, 1998, J MED SCREEN, V5, P115, DOI 10.1136/jms.5.3.115; HADDOW JE, 1992, NEW ENGL J MED, V327, P588, DOI 10.1056/NEJM199208273270902; HALLIDAY J, 1994, PRENATAL DIAG, V14, P689, DOI 10.1002/pd.1970140808; HILL LM, 1989, OBSTET GYNECOL, V74, P620; HOOK EB, 1978, AM J HUM GENET, V30, P19; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; JOHNSON MP, 1995, AM J OBSTET GYNECOL, V172, P1229, DOI 10.1016/0002-9378(95)91484-6; JOHNSON MP, 1993, AM J OBSTET GYNECOL, V169, P557, DOI 10.1016/0002-9378(93)90620-X; Kuppermann M, 1999, PRENATAL DIAG, V19, P711, DOI 10.1002/(SICI)1097-0223(199908)19:8<711::AID-PD614>3.0.CO;2-V; LAFOLLETTE L, 1989, J ULTRAS MED, V8, P657; LEVI S, 1995, ULTRASOUND OBST GYN, V5, P366, DOI 10.1046/j.1469-0705.1995.05060366.x; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; LOCKWOOD C, 1987, AM J OBSTET GYNECOL, V157, P803, DOI 10.1016/S0002-9378(87)80059-5; LOCKWOOD CJ, 1993, AM J OBSTET GYNECOL, V169, P1190, DOI 10.1016/0002-9378(93)90280-V; LUCK CA, 1992, BRIT MED J, V304, P1474, DOI 10.1136/bmj.304.6840.1474; LYNCH L, 1989, OBSTET GYNECOL, V73, P267; Lyons Jones K., 1988, SMITHS RECOGNIZABLE; Manning JE, 1998, AM J ROENTGENOL, V170, P1083, DOI 10.2214/ajr.170.4.9530064; MARQUETTE GP, 1990, AM J OBSTET GYNECOL, V163, P1604, DOI 10.1016/0002-9378(90)90636-L; Marteau TM, 1995, PRENATAL DIAG, V15, P1215, DOI 10.1002/pd.1970151304; Meagher S., 1994, Clinical and Experimental Obstetrics and Gynecology, V21, P215; *MIDTR AMN PREN DI, 1976, JAMA-J AM MED ASSOC, V236, P1471; MILNER AD, 1992, EUR J PEDIATR, V151, P458, DOI 10.1007/BF01959364; Morris J K, 1994, J Med Screen, V1, P233; NADEL AS, 1995, J ULTRAS MED, V14, P297; NICOLAIDES K, 1993, ULTRASOUND OBST GYN, V3, P56, DOI 10.1046/j.1469-0705.1993.03010056.x; NICOLAIDES KH, 1992, LANCET, V340, P704, DOI 10.1016/0140-6736(92)92240-G; NORTON ME, 1994, SEMIN PERINATOL, V18, P256; NYBERG DA, 1990, OBSTET GYNECOL, V76, P370; NYBERG DA, 1990, AM J OBSTET GYNECOL, V162, P1247, DOI 10.1016/0002-9378(90)90028-6; NYBERG DA, 1993, AM J OBSTET GYNECOL, V168, P534, DOI 10.1016/0002-9378(93)90487-4; Nyberg DA, 1998, ULTRASOUND OBST GYN, V12, P8, DOI 10.1046/j.1469-0705.1998.12010008.x; NYBERG DA, 1995, AM J OBSTET GYNECOL, V173, P1030, DOI 10.1016/0002-9378(95)91322-X; Oberfield RG, 1991, CHILD ADOLESCENT PSY; PALOMAKI GE, 1993, AM J OBSTET GYNECOL, V169, P1558, DOI 10.1016/0002-9378(93)90436-M; RODIS JF, 1991, AM J OBSTET GYNECOL, V165, P1051, DOI 10.1016/0002-9378(91)90468-7; Santalahti P, 1998, SOC SCI MED, V46, P1067, DOI 10.1016/S0277-9536(97)10038-7; SHAH YG, 1990, OBSTET GYNECOL, V75, P186; SHIRLEY IM, 1992, BRIT J RADIOL, V65, P564, DOI 10.1259/0007-1285-65-775-564; Smith-Bindman R, 1998, JAMA-J AM MED ASSOC, V280, P1510, DOI 10.1001/jama.280.17.1510; STOLL C, 1993, PRENATAL DIAG, V13, P453, DOI 10.1002/pd.1970130606; TABOR A, 1986, LANCET, V1, P1287; Verdin SM, 1998, BRIT J OBSTET GYNAEC, V105, P63, DOI 10.1111/j.1471-0528.1998.tb09352.x; VERGANO PJ, 1995, J FOOD QUALITY, V18, P265, DOI 10.1111/j.1745-4557.1995.tb00380.x; Vintzileos AM, 1997, OBSTET GYNECOL, V89, P941, DOI 10.1016/S0029-7844(97)00152-X; Vintzileos AM, 1996, OBSTET GYNECOL, V87, P953, DOI 10.1016/0029-7844(96)00058-0; VINTZILEOS AM, 1995, AM J OBSTET GYNECOL, V172, P837, DOI 10.1016/0002-9378(95)90008-X; WAITZMAN NJ, 1994, INQUIRY-J HEALTH CAR, V31, P188; Wald N J, 1997, J Med Screen, V4, P181; WALD NJ, 1988, BRIT MED J, V297, P1029; WALD NJ, 1988, BRIT J OBSTET GYNAEC, V95, P334, DOI 10.1111/j.1471-0528.1988.tb06602.x; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701; WATSON WJ, 1994, AM J OBSTET GYNECOL, V170, P583, DOI 10.1016/S0002-9378(94)70232-2; Wickstrom E, 1996, ULTRASOUND OBST GYN, V8, P236, DOI 10.1046/j.1469-0705.1996.08040236.x; Wilson RD, 1998, LANCET, V351, P242; Winter TC, 2000, RADIOLOGY, V215, P775, DOI 10.1148/radiology.215.3.r00ma36775	106	202	217	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2001	285	8					1044	1055		10.1001/jama.285.8.1044	http://dx.doi.org/10.1001/jama.285.8.1044			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403ME	11209176				2022-12-28	WOS:000167046400027
J	Plante, OJ; Palmacci, ER; Seeberger, PH				Plante, OJ; Palmacci, ER; Seeberger, PH			Automated solid-phase synthesis of oligosaccharides	SCIENCE			English	Article							CARBOHYDRATE ANTIGENS; HEPTASACCHARIDE; DONORS	Traditionally, access to structurally defined complex carbohydrates has been very Laborious, Although recent advancements in solid-phase synthesis have made the construction of complex oligosaccharides Less tedious, a high Level of technical expertise is still necessary to obtain the desired structures. We describe the automated chemical synthesis of several oligosaccharides on a solid-phase synthesizer. A branched dodecasaccharide was synthesized through the use of glycosyl phosphate building blocks and an octenediol functionalized resin. The target oligosaccharide was readily obtained after cleavage from the solid support. Access to certain complex oligosaccharides now has become feasible ina fashion much Like the construction of oligopeptides and oligonucleotides.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Seeberger, PH (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	seeberg@mit.edu			NCRR NIH HHS [RR-00995] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000995] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andrade RB, 1999, ORG LETT, V1, P1811, DOI 10.1021/ol991071+; [Anonymous], CARBOHYDRATE CHEM; Atherton E., 1990, SOLID PHASE PEPTIDE; BUNDLE DR, 1979, CAN J CHEM, V57, P662, DOI 10.1139/v79-106; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; DANISHEFSKY SJ, 1993, SCIENCE, V260, P1307, DOI 10.1126/science.8493573; DARVILL A, 1992, GLYCOBIOLOGY, V2, P181, DOI 10.1093/glycob/2.3.181; Deshpande PP, 1997, NATURE, V387, P164, DOI 10.1038/387164a0; DOUGLAS SP, 1995, J AM CHEM SOC, V117, P2116, DOI 10.1021/ja00112a035; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; FERFUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FRECHET JM, 1971, J AM CHEM SOC, V93, P492; FUGEDI P, 1987, CARBOHYD RES, V164, P297, DOI 10.1016/0008-6215(87)80137-4; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Ito Y, 1998, CURR OPIN CHEM BIOL, V2, P701, DOI 10.1016/S1367-5931(98)80106-3; KAHNE D, 1989, J AM CHEM SOC, V111, P6881, DOI 10.1021/ja00199a081; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Liang R, 1996, SCIENCE, V274, P1520, DOI 10.1126/science.274.5292.1520; LONN H, 1985, CARBOHYD RES, V139, P105, DOI 10.1016/0008-6215(85)90011-4; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Nicolaou KC, 1997, J AM CHEM SOC, V119, P449, DOI 10.1021/ja963482g; Plante OJ, 1999, ORG LETT, V1, P211, DOI 10.1021/ol9905452; Rademann J, 1997, J ORG CHEM, V62, P3650, DOI 10.1021/jo970087f; Seeberger PH, 1997, ANGEW CHEM INT EDIT, V36, P491, DOI 10.1002/anie.199704911; Seeberger PH, 2000, CHEM REV, V100, P4349, DOI 10.1021/cr9903104; SPIJKER NM, 1992, TETRAHEDRON, V48, P6297, DOI 10.1016/S0040-4020(01)88221-1; YAN B, 1998, ACCOUNTS CHEM RES, V31, P621	27	685	711	7	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1523	1527		10.1126/science.1057324	http://dx.doi.org/10.1126/science.1057324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	405HF	11222853				2022-12-28	WOS:000167153400038
J	Clifton, GL; Miller, ER; Choi, SC; Levin, HS; McCauley, S; Smith, KR; Muizelaar, JP; Wagner, FC; Marion, DW; Luerssen, TG; Chesnut, RM; Schwartz, M				Clifton, GL; Miller, ER; Choi, SC; Levin, HS; McCauley, S; Smith, KR; Muizelaar, JP; Wagner, FC; Marion, DW; Luerssen, TG; Chesnut, RM; Schwartz, M			Lack of effect of induction of hypothermia after acute brain injury.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; PRESSURE	Background: Induction of hypothermia in patients with brain injury was shown to improve outcomes in small clinical studies, but the results were not definitive. To study this issue, we conducted a multicenter trial comparing the effects of hypothermia with those of normothermia in patients with acute brain injury. Methods: The study subjects were 392 patients 16 to 65 years of age with coma after sustaining closed head injuries who were randomly assigned to be treated with hypothermia (body temperature, 33 degreesC), which was initiated within 6 hours after injury and maintained for 48 hours by means of surface cooling, or normothermia. All patients otherwise received standard treatment. The primary outcome measure was functional status six months after the injury. Results: The mean age of the patients and the type and severity of injury in the two treatment groups were similar. The mean (+/-SD) time from injury to randomization was 4.3+/-1.1 hours in the hypothermia group and 4.1+/-1.2 hours in the normothermia group, and the mean time from injury to the achievement of the target temperature of 33 degreesC in the hypothermia group was 8.4+/-3.0 hours. The outcome was poor (defined as severe disability, a vegetative state, or death) in 57 percent of the patients in both groups. Mortality was 28 percent in the hypothermia group and 27 percent in the normothermia group (P=0.79). The patients in the hypothermia group had more hospital days with complications than the patients in the normothermia group. Fewer patients in the hypothermia group had high intracranial pressure than in the normothermia group. Conclusions: Treatment with hypothermia, with the body temperature reaching 33 degreesC within eight hours after injury, is not effective in improving outcomes in patients with severe brain injury. (N Engl J Med 2001;344:556-63.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Texas, Hlth Sci Ctr, Sch Med, Dept Neurosurg,Vivian L Smith Ctr Neurol Res, Houston, TX 77030 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Biostat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; St Louis Univ, Dept Neurosurg, St Louis, MO 63103 USA; Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA; Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, Pittsburgh, PA USA; Indiana Univ, Div Neurosurg, Indianapolis, IN 46204 USA; Oregon Hlth & Sci Univ, Dept Neurosurg, Portland, OR 97201 USA; Univ Toronto, Sunnybrook Med Ctr, Dept Neurosurg, Toronto, ON M4N 3M5, Canada	University of Texas System; University of Texas Health Science Center Houston; Virginia Commonwealth University; Virginia Commonwealth University; Baylor College of Medicine; Saint Louis University; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University-Purdue University Indianapolis; Oregon Health & Science University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Clifton, GL (corresponding author), Univ Texas, Hlth Sci Ctr, Sch Med, Dept Neurosurg,Vivian L Smith Ctr Neurol Res, 6431 Fannin,Suite 7-148, Houston, TX 77030 USA.	guy.l.clifton@uth.tmc.edu	Marion, Donald/AAR-5749-2021	Chesnut, Randall/0000-0001-6377-3666	NINDS NIH HHS [R01 NS32786-06] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032786] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CLASEN RA, 1968, ARCH NEUROL-CHICAGO, V19, P472, DOI 10.1001/archneur.1968.00480050042004; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Department of Health and Human Services (DHHS), 1996, FED REGISTER, V61, P51531; DRAKE CG, 1962, CAN MED ASSOC J, V87, P887; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; JENNETT B, 1975, LANCET, V1, P480; LASKOWSKI EJ, 1960, NEUROLOGY, V10, P499, DOI 10.1212/WNL.10.5.499; LAZORTHES G, 1958, J NEUROSURG, V15, P162, DOI 10.3171/jns.1958.15.2.0162; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Myles G L, 1995, J Neurosci Nurs, V27, P35; ROSOMOFF HL, 1960, SURG GYNECOL OBSTET, V110, P27; ROSOMOFF HL, 1955, AM J PHYSIOL, V183, P19, DOI 10.1152/ajplegacy.1955.183.1.19; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; SHAPIRO HM, 1974, J NEUROSURG, V40, P90, DOI 10.3171/jns.1974.40.1.0090; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; 1995, FED REG, V60, P38353	28	911	965	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2001	344	8					556	563		10.1056/NEJM200102223440803	http://dx.doi.org/10.1056/NEJM200102223440803			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403LU	11207351	Green Published			2022-12-28	WOS:000167044600003
J	Hines, LM; Stampfer, MJ; Ma, J; Gaziano, JM; Ridker, PM; Hankinson, SE; Sacks, F; Rimm, EB; Hunter, DJ				Hines, LM; Stampfer, MJ; Ma, J; Gaziano, JM; Ridker, PM; Hankinson, SE; Sacks, F; Rimm, EB; Hunter, DJ			Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; US MALE PHYSICIANS; RISK; POLYMORPHISM; METAANALYSIS; MORTALITY; GENOTYPE; STROKE; LIPIDS; LOCI	Background: A polymorphism in the gene for alcohol dehydrogenase type 3 (ADH3) alters the rate of alcohol metabolism. We investigated the relation among the ADH3 polymorphism, the level of alcohol consumption, and the risk of myocardial infarction in a nested case-control study based on data from the prospective Physicians' Health Study. Methods: We identified 396 patients with eligible newly diagnosed cases of myocardial infarction among men in the Physicians' Health Study. Of these patients, 374 were matched with 2 randomly selected control subjects each and the remaining 22 with 1 control each (total, 770 controls). The ADH3 genotype (gamma (1)gamma (1)), gamma (1)gamma (2), or gamma (2)gamma (2)) was determined in all subjects. We examined the relations among the level of alcohol intake, the ADH3 genotype, and plasma high-density lipoprotein (HDL) levels in this study population and in a similar cohort of women. Results: As compared with homozygosity for the allele associated with a fast rate of ethanol oxidation (gamma (1)), homozygosity for the allele associated with a slow rate of ethanol oxidation (gamma (2)) was associated with a reduced risk of myocardial infarction (relative risk, 0.65; 95 percent confidence interval, 0.43 to 0.99). Moderate alcohol consumption was associated with a decreased risk of myocardial infarction in all three genotype groups (gamma (1)gamma (1)), (gamma (1)gamma (2)), and (gamma (2)gamma (2)); however, the ADH3 genotype significantly modified this association (P=0.01 for the interaction). Among men who were homozygous for the gamma (1) allele, those who consumed at least one drink per day had a relative risk of myocardial infarction of 0.62 (95 percent confidence interval, 0.34 to 1.13), as compared with the risk among men who consumed less than one drink per week. Men who consumed at least one drink per day and were homozygous for the gamma (2) allele had the greatest reduction in risk (relative risk, 0.14; 95 percent confidence interval, 0.04 to 0.45). Such men also had the highest plasma HDL levels (P for interaction = 0.05). We confirmed the interaction among the ADH3 genotype, the level of alcohol consumption, and the HDL level in an independent study of postmenopausal women (P=0.02). Conclusions: Moderate drinkers who are homozygous for the slow-oxidizing ADH3 allele have higher HDL levels and a substantially decreased risk of myocardial infarction. (N Engl J Med 2001;344:549-55.) Copyright (C) 2001 Massachusetts Medical Society.	Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Prevent Med, Boston, MA USA; Harvard Univ, Sch Med, Div Cardiol, Boston, MA USA; Dept Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Hines, LM (corresponding author), Harvard Univ, Sch Med, Dept Med, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA049449, U01CA049449, R01CA042182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER; NCI NIH HHS [CA42182, CA49449] Funding Source: Medline; NIAAA NIH HHS [AA11181] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Ajani UA, 2000, ARCH INTERN MED, V160, P1025, DOI 10.1001/archinte.160.7.1025; Bell JRC, 2000, AM J CLIN NUTR, V71, P103; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; BOSRON WF, 1988, MOL ASPECTS MED, V10, P147, DOI 10.1016/0098-2997(88)90019-2; Camargo CA, 1997, ANN INTERN MED, V126, P372, DOI 10.7326/0003-4819-126-5-199703010-00005; CAVALLISFORZA LL, 1999, GENETICS HUMAN POPUL, P57; CHAO YC, 1994, HEPATOLOGY, V19, P360, DOI 10.1002/hep.1840190214; Cleophas TJ, 1999, BIOMED PHARMACOTHER, V53, P417, DOI 10.1016/S0753-3322(99)80121-8; DAY CP, 1991, HEPATOLOGY, V14, P798, DOI 10.1002/hep.1840140509; DAY CP, 1992, HEPATOLOGY, V15, P750; Gaziano JM, 1998, NOVART FDN SYMP, V216, P86; Gaziano JM, 2000, J AM COLL CARDIOL, V35, P96, DOI 10.1016/S0735-1097(99)00531-8; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; GROBBEE DE, 1999, HLTH ISSUES RELATED, P126; GROPPI A, 1990, CLIN CHEM, V36, P1765; Haiman CA, 1999, CANCER RES, V59, P1015; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; Harty LC, 1997, JNCI-J NATL CANCER I, V89, P1698, DOI 10.1093/jnci/89.22.1698; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; Ma J, 1996, CIRCULATION, V94, P2410, DOI 10.1161/01.CIR.94.10.2410; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; MarquesVidal P, 1996, AM J EPIDEMIOL, V143, P1089, DOI 10.1093/oxfordjournals.aje.a008683; MarquesVidal P, 1996, AM J EPIDEMIOL, V144, P622; PARKINSON A, 1990, CASARETT DOULLS TOXI, P113; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sesso HD, 1999, CURR OPIN NEPHROL HY, V8, P353, DOI 10.1097/00041552-199905000-00013; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Whitfield J B, 1994, Alcohol Alcohol Suppl, V2, P59; *WORLD HLTH ORG, 1971, 5 WHO REG OFF EUR	31	223	232	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2001	344	8					549	555		10.1056/NEJM200102223440802	http://dx.doi.org/10.1056/NEJM200102223440802			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403LU	11207350	Bronze, Green Published			2022-12-28	WOS:000167044600002
J	Kwiat, PG; Barraza-Lopez, S; Stefanov, A; Gisin, N				Kwiat, PG; Barraza-Lopez, S; Stefanov, A; Gisin, N			Experimental entanglement distillation and 'hidden' non-locality	NATURE			English	Article							NOISY ENTANGLEMENT; DENSITY-MATRICES; STATES; INEQUALITIES; PURIFICATION; NONLOCALITY	Entangled states are central to quantum information processing, including quantum teleportation(1), efficient quantum computation(2) and quantum cryptography(3). In general, these applications work best with pure, maximally entangled quantum states. However, owing to dissipation and decoherence, practically available states are likely to be non-maximally entangled, partially mixed (that is, not pure), or both. To counter this problem, various schemes of entanglement distillation, state purification and concentration have been proposed(4-11). Here we demonstrate experimentally the distillation of maximally entangled states from non-maximally entangled inputs. Using partial polarizers, we perform a filtering process to maximize the entanglement of pure polarization-entangled photon pairs generated by spontaneous parametric down-conversion(12,13).(.) We have also applied our methods to initial states that are partially mixed. After filtering, the distilled states demonstrate certain non-local correlations, as evidenced by their violation of a form of Bell's inequality(14,15). Because the initial states do not have this property, they can be said to possess 'hidden' non-locality(6,16).	Univ Calif Los Alamos Natl Lab, Div Phys, Los Alamos, NM 87545 USA; Univ Geneva, Appl Phys Grp, CH-1211 Geneva 4, Switzerland	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Geneva	Kwiat, PG (corresponding author), Univ Calif Los Alamos Natl Lab, Div Phys, P-23, Los Alamos, NM 87545 USA.		Barraza-Lopez, Salvador/E-4059-2010; Stefanov, André/H-4301-2014	Stefanov, André/0000-0002-5588-7986; Barraza-Lopez, Salvador/0000-0002-4301-3317				ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; BENNET CH, 1992, PHYS REV LETT, V70, P1895; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Bennett CH, 1996, PHYS REV A, V53, P2046, DOI 10.1103/PhysRevA.53.2046; BERGLUND AJ, 2000, THESIS DARTMOUTH COL; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Bose S, 1999, PHYS REV A, V60, P194, DOI 10.1103/PhysRevA.60.194; CLARK RBM, 2000, IN PRESS PHYS REV A; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Gisin N, 1996, PHYS LETT A, V210, P151, DOI 10.1016/S0375-9601(96)80001-6; Helstrom CW, 1976, QUANTUM DETECTION ES; Horodecki M, 1997, PHYS REV LETT, V78, P574, DOI 10.1103/PhysRevLett.78.574; HORODECKI R, 1995, PHYS LETT A, V200, P340, DOI 10.1016/0375-9601(95)00214-N; Huttner B, 1996, PHYS REV A, V54, P3783, DOI 10.1103/PhysRevA.54.3783; Kwiat PG, 1999, PHYS REV A, V60, pR773, DOI 10.1103/PhysRevA.60.R773; Kwiat PG, 2000, SCIENCE, V290, P498, DOI 10.1126/science.290.5491.498; Linden N, 1998, PHYS REV LETT, V81, P3279, DOI 10.1103/PhysRevLett.81.3279; Opatrny T, 1999, PHYS REV A, V60, P167, DOI 10.1103/PhysRevA.60.167; THEW RT, 2000, IN PRESS PHYS REV A; White AG, 1999, PHYS REV LETT, V83, P3103, DOI 10.1103/PhysRevLett.83.3103; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Zukowski M, 1998, PHYS REV A, V58, P1694, DOI 10.1103/PhysRevA.58.1694	26	281	288	1	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1014	1017		10.1038/35059017	http://dx.doi.org/10.1038/35059017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234004				2022-12-28	WOS:000167148800037
J	Bellisle, F; Rolland-Cachera, MF				Bellisle, F; Rolland-Cachera, MF			How sugar-containing drinks might increase adiposity in children	LANCET			English	Editorial Material							FOOD-INTAKE; CALORIC COMPENSATION; SELF-REGULATION; ASPARTAME		INSERM, U341, F-75181 Paris, France; Conservatoire Natl Arts & Metiers, Inst Sci & Tech Nutr & Alimentat, F-75003 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Bellisle, F (corresponding author), INSERM, U341, F-75181 Paris, France.	bellisle@imaginet.fr	Marie-Françoise, Rolland-Cachera/F-3044-2017	Marie-Françoise, Rolland-Cachera/0000-0002-0245-1687; Bellisle, France/0000-0002-6952-6890				ANDERSON GH, 1989, APPETITE, V13, P93, DOI 10.1016/0195-6663(89)90107-4; Bellisle F, 1998, BRIT J NUTR, V80, pS173, DOI 10.1079/BJN19980109; BELLISLE F, IN PRESS REV NUTRICA; Beridot-Therond ME, 1998, APPETITE, V31, P67, DOI 10.1006/appe.1997.0153; BIRCH LL, 1986, APPETITE, V7, P323, DOI 10.1016/S0195-6663(86)80001-0; Birch LL, 1998, PEDIATRICS, V101, P539; BIRCH LL, 1985, LEARN MOTIV, V16, P341, DOI 10.1016/0023-9690(85)90020-7; BIRCH LL, 1989, PHYSIOL BEHAV, V45, P387, DOI 10.1016/0031-9384(89)90145-5; Centers for Disease Control and Prevention/National Center for Health Statistics, 2000, CDC GROWTH CHARTS US, P314; DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P1133, DOI 10.1016/0031-9384(93)90370-U; HILL JO, 1995, AM J CLIN NUTR, V62, p264S, DOI 10.1093/ajcn/62.1.264S; LOUISSYLVESTRE J, 1989, APPETITE, V12, P95, DOI 10.1016/0195-6663(89)90099-8; Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1; Poppitt SD, 1996, APPETITE, V26, P153, DOI 10.1006/appe.1996.0013	14	34	35	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2001	357	9255					490	491		10.1016/S0140-6736(00)04034-4	http://dx.doi.org/10.1016/S0140-6736(00)04034-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229661				2022-12-28	WOS:000167011700002
J	Hettiaratchy, S; Butler, PEM; Lee, WPA				Hettiaratchy, S; Butler, PEM; Lee, WPA			Lessons from hand transplantations	LANCET			English	Editorial Material									Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Plast Surg, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, Boston, MA USA; Royal Free Hosp, Dept Plast Surg, London NW3 2QG, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Lee, WPA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Plast Surg, Boston, MA 02114 USA.	lee.wpa@mgh.harvard.edu		Butler, Peter/0000-0001-7419-1493				Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Lee WPA, 1999, J HAND SURG-AM, V24A, P906; LEE WPA, 1991, PLAS RECONSTR SURG, V87, P400; MALT RA, 1964, JAMA-J AM MED ASSOC, V189, P716; STRICKLAND JW, 1999, INDIANA HAND CTR NEW, V3, P2; Waldmann H, 1999, NAT MED, V5, P1245, DOI 10.1038/15197	7	36	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2001	357	9255					494	495		10.1016/S0140-6736(00)04037-X	http://dx.doi.org/10.1016/S0140-6736(00)04037-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229664				2022-12-28	WOS:000167011700005
J	Tilford, CA; Kuroda-Kawaguchi, T; Skaletsky, H; Rozen, S; Brown, LG; Rosenberg, M; McPherson, JD; Wylie, K; Sekhon, M; Kucaba, TA; Waterston, RH; Page, DC				Tilford, CA; Kuroda-Kawaguchi, T; Skaletsky, H; Rozen, S; Brown, LG; Rosenberg, M; McPherson, JD; Wylie, K; Sekhon, M; Kucaba, TA; Waterston, RH; Page, DC			A physical map of the human Y chromosome	NATURE			English	Article							RADIATION HYBRID MAP; HUMAN GENOME; DELETIONS; REGION	The non-recombining region of the human Y chromosome (NRY), which comprises 95% of the chromosome, does not undergo sexual recombination and is present only in males. An understanding of its biological functions has begun to emerge from DNA studies of individuals with partial Y chromosomes, coupled with molecular characterization of genes implicated in gonadal sex reversal, Turner syndrome, graft rejection and spermatogenic failure(1,2). But mapping strategies applied successfully elsewhere in the genome have faltered in the NRY, where there is no meiotic recombination map and intrachromosomal repetitive sequences are abundant(3). Here we report a high-resolution physical map of the euchromatic, centromeric and heterochromatic regions of the NRY and its construction by unusual methods, including genomic clone subtraction(4) and dissection of sequence family variants(5). Of the map's 758 DNA markers, 136 have multiple locations in the NRY, reflecting its unusually repetitive sequence composition. The markers anchor 1,038 bacterial artificial chromosome clones, 199 of which form a tiling path for sequencing.	MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Washington Univ, Sch Med, Dept Genet, Genome Sequencing Ctr, St Louis, MO 63108 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL)	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		McPherson, John D/D-2633-2017; Sekhon, Mandeep/L-4665-2018; Rozen, Steven G./J-5939-2013	McPherson, John D/0000-0001-8049-9347; Sekhon, Mandeep/0000-0002-9993-6938; Rozen, Steven G./0000-0002-4288-0056				Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lunetta KL, 1996, AM J HUM GENET, V59, P717; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Mumm S, 1997, GENOME RES, V7, P307, DOI 10.1101/gr.7.4.307; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Schwartz A, 1998, HUM MOL GENET, V7, P1, DOI 10.1093/hmg/7.1.1; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Vogt P. H., 1997, Cytogenetics and Cell Genetics, V79, P1, DOI 10.1159/000134680; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769	16	154	164	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					943	945		10.1038/35057170	http://dx.doi.org/10.1038/35057170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237016	Bronze			2022-12-28	WOS:000166938800063
J	Wolfsberg, TG; McEntyre, J; Schuler, GD				Wolfsberg, TG; McEntyre, J; Schuler, GD			Guide to the draft human genome	NATURE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SEQUENCE; GENE; DATABASE; LOCUSLINK; PROTEINS; REFSEQ; MAP	There are a number of ways to investigate the structure, function and evolution of the human genome. These include examining the morphology of normal and abnormal chromosomes, constructing maps of genomic landmarks, following the genetic transmission of phenotypes and DNA sequence variations, and characterizing thousands of individual genes. To this list we can now add the elucidation of the genomic DNA sequence, albeit at 'working draft' accuracy. The current challenge is to weave together these disparate types of data to produce the information infrastructure needed to support the next generation of biomedical research. Here we provide an overview of the different sources of information about the human genome and how modern information technology, in particular the internet, allows us to link them together.	Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Schuler, GD (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	schuler@ncbi.nim.nih.gov	Wolfsberg, Tyra/D-8296-2017	Wolfsberg, Tyra/0000-0001-5646-9455; McEntyre, Jo/0000-0002-1611-6935				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leipe DD, 1997, NUCLEIC ACIDS RES, V25, P3693, DOI 10.1093/nar/25.18.3693; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; McKusick V.A., 1998, MENDELIAN INHERITANC; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Poindexter K, 1999, GENE, V237, P61, DOI 10.1016/S0378-1119(99)00302-9; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sagane K, 1998, BIOCHEM J, V334, P93, DOI 10.1042/bj3340093; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Stormo GD, 2000, GENOME RES, V10, P394, DOI 10.1101/gr.10.4.394; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Wolfsberg TG, 1997, NUCLEIC ACIDS RES, V25, P1626, DOI 10.1093/nar/25.8.1626; WOLFSBERG TG, 2001, BIOINFORMATICS PRACT; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	25	34	41	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					824	826		10.1038/35057000	http://dx.doi.org/10.1038/35057000			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236998	Bronze, Green Published			2022-12-28	WOS:000166938800045
J	Cech, TR; Leonard, JS				Cech, TR; Leonard, JS			Science and business - Conflicts of interest - Moving beyond disclosure	SCIENCE			English	Editorial Material									Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Howard Hughes Medical Institute	Cech, TR (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.							Boyd EA, 2000, JAMA-J AM MED ASSOC, V284, P2209, DOI 10.1001/jama.284.17.2209; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; DeAngelis CD, 2000, JAMA-J AM MED ASSOC, V284, P2237, DOI 10.1001/jama.284.17.2237; Korn D, 2000, JAMA-J AM MED ASSOC, V284, P2234, DOI 10.1001/jama.284.17.2234; McCrary SV, 2000, NEW ENGL J MED, V343, P1621, DOI 10.1056/NEJM200011303432207	5	24	24	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					989	989		10.1126/science.291.5506.989	http://dx.doi.org/10.1126/science.291.5506.989			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232584				2022-12-28	WOS:000166860100026
J	Segal, HP				Segal, HP			Back to the future from 1888 - One writer's vision of a technological utopia has stood the test of time.	NATURE			English	Editorial Material									Univ Maine, Orono, ME 04469 USA	University of Maine System; University of Maine Orono	Segal, HP (corresponding author), Univ Maine, 5774 Stevens Hall, Orono, ME 04469 USA.								0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					563	563		10.1038/35054631	http://dx.doi.org/10.1038/35054631			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214298				2022-12-28	WOS:000166692300022
J	Brasch, AV; Atar, S; Siegel, RJ				Brasch, AV; Atar, S; Siegel, RJ			Clinical picture: Thrombus in the left atrial appendage	LANCET			English	Article									Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Brasch, AV (corresponding author), Cedars Sinai Med Ctr, Div Cardiol, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.								0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					266	266		10.1016/S0140-6736(00)03613-8	http://dx.doi.org/10.1016/S0140-6736(00)03613-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214129				2022-12-28	WOS:000166693400011
J	Shanahan, F				Shanahan, F			Relation between colitis and colon cancer	LANCET			English	Editorial Material							DISEASE		Cork Univ Hosp, Dept Med, Cork, Ireland	University College Cork	Shanahan, F (corresponding author), Cork Univ Hosp, Dept Med, Cork, Ireland.		Shanahan, Fergus/ABF-2390-2020	Shanahan, Fergus/0000-0003-0467-0936				Cordon-Cardo C, 1999, J EXP MED, V190, P1367, DOI 10.1084/jem.190.10.1367; Eaden J, 2000, ALIMENT PHARM THERAP, V14, P145; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Hussain SP, 2000, CANCER RES, V60, P3333; Itzkowitz S H, 1995, Inflamm Bowel Dis, V1, P142, DOI 10.1002/ibd.3780010208; Rhodes JM, 1996, LANCET, V347, P40, DOI 10.1016/S0140-6736(96)91563-9; Rhodes JM, 2000, J ROY COLL PHYS LOND, V34, P191; Shanahan F, 1995, Inflamm Bowel Dis, V1, P80; Shanahan F, 2000, QJM-INT J MED, V93, P131, DOI 10.1093/qjmed/93.3.131; Walsh S, 1999, AM J PATHOL, V155, P1511, DOI 10.1016/S0002-9440(10)65466-1	10	20	20	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					246	247		10.1016/S0140-6736(00)03630-8	http://dx.doi.org/10.1016/S0140-6736(00)03630-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214121				2022-12-28	WOS:000166693400003
J	Brune, W; Menard, C; Heesemann, J; Koszinowski, UH				Brune, W; Menard, C; Heesemann, J; Koszinowski, UH			A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism	SCIENCE			English	Article							IN-VITRO; IDENTIFICATION; CONSTRUCTION; MUTAGENESIS; INFECTION; APOPTOSIS; PROTEINS; CLONING; GENOME; GENES	Human cytomegalovirus infects vascular tissues and has been associated with atherogenesis and coronary restenosis. Although established Laboratory strains of human cytomegalovirus have lost the ability to grow on vascular endothelial cells, Laboratory strains of murine cytomegalovirus retain this ability. With the use of a forward-genetic procedure involving random transposon mutagenesis and rapid phenotypic screening, we identified a murine cytomegalovirus gene governing endothelial cell tropism, This gene, M45, shares sequence homology to ribonucleotide reductase genes. Endothelial cells infected with M45-mutant viruses rapidly undergo apoptosis, suggesting that a viral strategy to evade destruction by cellular apoptosis is indispensable for viral growth in endothelial cells.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Munich, Genzentrum, D-80336 Munich, Germany; Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany	Princeton University; University of Munich; University of Munich	Brune, W (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	wbrune@princeton.edu	Brune, Wolfram/H-5058-2019	Brune, Wolfram/0000-0002-6078-5255				Borst EM, 1999, J VIROL, V73, P8320, DOI 10.1128/JVI.73.10.8320-8329.1999; Brune W, 2000, TRENDS GENET, V16, P254, DOI 10.1016/S0168-9525(00)02015-1; Brune W, 1999, NAT BIOTECHNOL, V17, P360, DOI 10.1038/7914; CHABAUD S, 2000, 25 INT HERP WORKSH P; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; Epstein SE, 1996, LANCET, V348, pS13, DOI 10.1016/S0140-6736(96)98005-8; GALLINA A, COMMUNICATION; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; MacCormac LP, 1999, J MED VIROL, V57, P298, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;298::AID-JMV14&gt;3.0.CO;2-P; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Mocarski E, 1996, FIELDS VIROLOGY, P2447; PERCIVALLE E, 1993, J CLIN INVEST, V92, P663, DOI 10.1172/JCI116635; Plachter B, 1996, ADV VIRUS RES, V46, P195, DOI 10.1016/S0065-3527(08)60073-1; PLENDL J, 1995, VIRCHOWS ARCH, V426, P619; Presti RM, 1998, J EXP MED, V188, P577, DOI 10.1084/jem.188.3.577; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Sinzger C, 1999, J GEN VIROL, V80, P2867, DOI 10.1099/0022-1317-80-11-2867; Smith GA, 1999, J VIROL, V73, P6405, DOI 10.1128/JVI.73.8.6405-6414.1999; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Sun YM, 1999, J GEN VIROL, V80, P2713, DOI 10.1099/0022-1317-80-10-2713; Tanaka K, 1999, CIRCULATION, V99, P1656, DOI 10.1161/01.CIR.99.13.1656; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995; Ziegler H, 2000, EMBO J, V19, P870, DOI 10.1093/emboj/19.5.870	25	178	182	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					303	305		10.1126/science.291.5502.303	http://dx.doi.org/10.1126/science.291.5502.303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209080				2022-12-28	WOS:000166352900045
J	Dales, L; Hammer, SJ; Smith, NJ				Dales, L; Hammer, SJ; Smith, NJ			Time trends in autism and in MMR immunization coverage in California	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Considerable concern has been generated in the lay and medical communities by a theory that increased measles-mumps-rubella (MMR) immunization among young children may be the cause of an apparent marked increase in autism occurrence. Objective To determine if a correlation exists in secular trends of MMR immunization coverage among young children and autism occurrence. Design, Setting, and Participants Retrospective analyses of MMR immunization coverage rates among children born in 1980-1994 who were enrolled in California kindergartens (survey samples of 600-1900 children each year) and whose school immunization records were reviewed to retrospectively determine the age at which they first received MMR immunization; and of autism caseloads among children born in these years who were diagnosed with autism and were enrolled in the California Department of Developmental Services regional service center system. Main Outcome Measures Measles-mumps-rubella immunization coverage rates as of ages 17 months and 24 months and numbers of Department of Developmental Services system enrollees diagnosed with autism, grouped by year of birth. Results Essentially no correlation was observed between the secular trend of early childhood MMR immunization rates in California and the secular trend in numbers of children with autism enrolled in California's regional service center system. For the 1980-1994 birth cohorts, a marked, sustained increase in autism case numbers was noted, from 44 cases per 100000 live births in the 1980 cohort to 208 cases per 100000 live births in the 1994 cohort (a 373% relative increase), but changes in early childhood MMR immunization coverage over the same time period were much smaller and of shorter duration. Immunization coverage by the age of 24 months increased from 72% to 82%, a relative increase of only 14%, over the same time period. Conclusions These data do not suggest an association between MMR immunization among young children and an increase in autism occurrence.	Calif Dept Hlth Serv, Immunizat Branch, Berkeley, CA 94704 USA	California Department of Health Care Services	Dales, L (corresponding author), Calif Dept Hlth Serv, Immunizat Branch, 2151 Berkeley Way,Room 712, Berkeley, CA 94704 USA.							*CA DEP DEV SERV, 1999, CHAN POP PERS AUT PE; Fombonne E, 2001, PEDIATRICS, V107, P411, DOI 10.1542/peds.107.2.411; FRIEDMAN GD, 1987, PRIMER EPIDEMIOLOGY, P170; GILLBERG C, 1998, AUTISM, V2, P423; MANNING A, 2001, VACCINE AUTISM LINK; RIMLAND B, 2001, LOS ANGELES TIM 0429; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 1999, LANCET, V354, P949, DOI 10.1016/S0140-6736(05)75696-8	9	192	196	0	52	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1183	1185		10.1001/jama.285.9.1183	http://dx.doi.org/10.1001/jama.285.9.1183			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231748	Bronze			2022-12-28	WOS:000167194700022
J	Irie, M; Kobatake, S; Horichi, M				Irie, M; Kobatake, S; Horichi, M			Reversible surface morphology changes of a photochromic diarylethene single crystal by photoirradiation	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; SOLID-STATE; PHASE; PHOTODIMERIZATION; 1,2-BIS(2,5-DIMETHYL-3-THIENYL)PERFLUOROCYCLOPENTENE	The surface morphology of a diarylethene single crystal [1,2-bis(2,4-dimethyl-5-phenyl-3-thienyl)perfluorocyclopentene determined by atomic force microscopy changed reversibly upon photoirradiation, The crystal underwent a thermally irreversible but photochemically reversible color change (colorless to blue) upon alternate irradiation with ultraviolet (wavelength lambda = 366 nm) and visible (lambda > 500 nm) Light that drove reversible photocyclization reactions, Upon irradiation with 366-nm Light, new steps appeared on the (100) single-crystalline surface that disappeared upon irradiation with visible Light (lambda > 500 nm). The step height, about 1 nm, corresponds to one molecular Layer. Irradiation with 366-nm light formed valleys on the (010) surface that also disappeared by bleaching upon irradiation with visible Light (lambda > 500 nm). The surface morphological changes can be explained by the molecular structural changes of diarylethenes regularly packed in the single crystal. These crystals could potentially be used as photodriven nanometer-scale actuators.	Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Higashi Ku, Fukuoka 8128581, Japan; Japan Sci & Technol Corp, CREST, Higashi Ku, Fukuoka 8128581, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Irie, M (corresponding author), Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.		Kobatake, Seiya/P-4989-2015	Kobatake, Seiya/0000-0002-1526-4629				DURR H, 1990, PHOTOCHROMISM MOL SY; Harada J, 1999, J AM CHEM SOC, V121, P5809, DOI 10.1021/ja9842969; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; IRIE M, 1995, CHEM LETT, P899, DOI 10.1246/cl.1995.899; Irie M, 2000, J AM CHEM SOC, V122, P4871, DOI 10.1021/ja993181h; Irie M, 1995, J ORG CHEM, V60, P8305, DOI 10.1021/jo00130a035; Irie M, 1998, B CHEM SOC JPN, V71, P985, DOI 10.1246/bcsj.71.985; Irie M., 1994, PHOTOREACTIVE MAT UL; Jiang L, 1999, ADV MATER, V11, P649, DOI 10.1002/(SICI)1521-4095(199906)11:8<649::AID-ADMA649>3.0.CO;2-V; KAUPP G, 1992, ANGEW CHEM INT EDIT, V31, P595, DOI 10.1002/anie.199205951; KAUPP G, 1992, ANGEW CHEM INT EDIT, V31, P592, DOI 10.1002/anie.199205921; KAUPP G, 1994, J PHOTOCH PHOTOBIO A, V80, P399, DOI 10.1016/1010-6030(93)01019-X; KAUPP G, 1995, ADV PHOTOCHEM, V19, P119; Kawata S, 2000, CHEM REV, V100, P1777, DOI 10.1021/cr980073p; KAWATO T, 1985, J PHOTOCHEM, V28, P103, DOI 10.1016/0047-2670(85)87020-9; Kobatake S, 1999, J AM CHEM SOC, V121, P2380, DOI 10.1021/ja983717j; Kobatake S, 2000, J AM CHEM SOC, V122, P12135, DOI 10.1021/ja001996g; Kobatake S, 1999, J AM CHEM SOC, V121, P8450, DOI 10.1021/ja991013j; Kodani T, 2000, J AM CHEM SOC, V122, P9631, DOI 10.1021/ja001350o; Livingston R., 1971, PHOTOCHROMISM, P13; PSALTIS D, 1995, SCI AM, V273, P52; RAMAMURTHY V, 1987, CHEM REV, V87, P433, DOI 10.1021/cr00078a009; SCHEFFER JR, 1990, PHOTOCHEMISTRY ORG C, P185; TOMLINSON WJ, 1972, APPL OPTICS, V11, P533, DOI 10.1364/AO.11.000533; Yamada T, 2000, B CHEM SOC JPN, V73, P2179, DOI 10.1246/bcsj.73.2179; Yamada T, 2000, J AM CHEM SOC, V122, P1589, DOI 10.1021/ja993289x	26	493	504	4	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1769	1772		10.1126/science.291.5509.1769	http://dx.doi.org/10.1126/science.291.5509.1769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230689				2022-12-28	WOS:000167320600054
J	Murray, AW				Murray, AW			Cell cycle - Centrioles at the checkpoint	SCIENCE			English	Editorial Material							SELF-ORGANIZATION; M-PHASE; MICROTUBULES; CENTROSOMES; SPINDLE; OOCYTES; EGGS		Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA	Harvard University	Murray, AW (corresponding author), Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA.							Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; KARSENTI E, 1984, J CELL BIOL, V98, P1730, DOI 10.1083/jcb.98.5.1730; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; MANIOTIS A, 1991, CELL, V67, P495, DOI 10.1016/0092-8674(91)90524-3; MCNIVEN MA, 1984, CELL, V37, P753, DOI 10.1016/0092-8674(84)90411-2; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Rodionov VI, 1997, NATURE, V386, P170, DOI 10.1038/386170a0; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Wang YC, 2000, CURR BIOL, V10, P1379, DOI 10.1016/S0960-9822(00)00779-X; Wiens GR, 1998, CELL, V93, P313, DOI 10.1016/S0092-8674(00)81157-5	21	14	14	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1499	+		10.1126/science.291.5508.1499	http://dx.doi.org/10.1126/science.291.5508.1499			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11234079				2022-12-28	WOS:000167153400030
J	Piel, M; Nordberg, J; Euteneuer, U; Bornens, M				Piel, M; Nordberg, J; Euteneuer, U; Bornens, M			Centrosome-dependent exit of cytokinesis in animal cells	SCIENCE			English	Article							CHECKPOINTS; MITOSIS; BLOCKS; PHASE	As an organelle coupling nuclear and cytoplasmic divisions, the centrosome is essential to mitotic fidelity, and its inheritance could be critical to understanding cell transformation. Investigating the behavior of the centrosome in Living mitotic cells, we documented a transient and remarkable postanaphase repositioning of this organelle, which apparently controls the release of central microtubules from the midbody and the completion of cell division. We also observed that the absence of the centrosome Leads to defects in cytokinesis. Together with recent results in yeasts, our data point to a conserved centrosome-dependent pathway that integrates spatial controls into the decision of completing cell division, which requires the repositioning of the centrosome organelle.	Inst Curie, Sect Rech, CNRS, UMR 144, F-75248 Paris 05, France; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Massachusetts System; University of Massachusetts Worcester; University of Munich	Bornens, M (corresponding author), Inst Curie, Sect Rech, CNRS, UMR 144, 26 Rue Ulm, F-75248 Paris 05, France.							Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; BYERS B, 1968, PROTOPLASMA, V66, P413, DOI 10.1007/BF01255868; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; DEBEC A, 1989, BIOL CELL, V67, P307, DOI 10.1016/0248-4900(89)90068-3; DEBEC A, 1978, NATURE, V274, P255, DOI 10.1038/274255a0; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hoyt MA, 2000, CELL, V102, P267, DOI 10.1016/S0092-8674(00)00031-3; MANIOTIS A, 1991, CELL, V67, P495, DOI 10.1016/0092-8674(91)90524-3; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; MULLINS JM, 1973, TISSUE CELL, V5, P47, DOI 10.1016/S0040-8166(73)80005-9; MURRAY AW, 1992, NATURE, V359, P599, DOI 10.1038/359599a0; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; PAINTRAND M, 1992, J STRUCT BIOL, V108, P107, DOI 10.1016/1047-8477(92)90011-X; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Straight AF, 2000, CURR BIOL, V10, pR760, DOI 10.1016/S0960-9822(00)00746-6; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; Whitehead CM, 1998, J CELL SCI, V111, P2551; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Zang JH, 1997, MOL BIOL CELL, V8, P2617, DOI 10.1091/mbc.8.12.2617	27	315	319	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1550	1553		10.1126/science.1057330	http://dx.doi.org/10.1126/science.1057330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222861				2022-12-28	WOS:000167153400046
J	Sikes, HD; Smalley, JF; Dudek, SP; Cook, AR; Newton, MD; Chidsey, CED; Feldberg, SW				Sikes, HD; Smalley, JF; Dudek, SP; Cook, AR; Newton, MD; Chidsey, CED; Feldberg, SW			Rapid electron tunneling through oligophenylenevinylene bridges	SCIENCE			English	Article							MONOLAYERS; FERROCENE; SOLVENTS; KINETICS; DIODES; MATRIX; GOLD	We measured rate constants of thermal, interfacial electron transfer through oligophenylenevinylene bridges between a gold electrode and a tethered redox species in contact with an aqueous electrolyte using the indirect laser-induced temperature jump technique. Analysis of the distance dependence indicates that, unlike other bridges studied to date, the rate constants are not limited by electronic coupling for bridges up to 28 angstroms long. The energy Levels of the bridges relative to those of the redox species rule out hopping through the bridge. We conclude that, out to 28 angstroms, the transfer is Limited by structural reorganization and that electron tunneling occurs in less than 20 picoseconds, suggesting that oligophenylenevinylene bridges could be useful for wiring molecular electronic elements.	Brookhaven Natl Lab, Upton, NY 11973 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Stanford University	Smalley, JF (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.		Cook, Andrew/AAP-7649-2020	Cook, Andrew/0000-0001-6633-3447; /0000-0002-7096-138X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 T32 GM08412] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1992, CHEM REV, V92; BARTHEL J, 1990, CHEM PHYS LETT, V165, P369, DOI 10.1016/0009-2614(90)87204-5; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Cave RJ, 1996, CHEM PHYS LETT, V249, P15, DOI 10.1016/0009-2614(95)01310-5; Chen J, 1999, SCIENCE, V286, P1550, DOI 10.1126/science.286.5444.1550; Creager S, 1999, J AM CHEM SOC, V121, P1059, DOI 10.1021/ja983204c; Davis WB, 1998, NATURE, V396, P60, DOI 10.1038/23912; DUDEK S, UNPUB; MCCONNELL H, 1961, J CHEM PHYS, V35, P508, DOI 10.1063/1.1731961; Meggers E, 1998, J AM CHEM SOC, V120, P12950, DOI 10.1021/ja983092p; MILLER JR, 1981, J CHEM PHYS, V74, P6746, DOI 10.1063/1.441078; NEWTON MD, 1991, CHEM REV, V91, P767, DOI 10.1021/cr00005a007; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; ROWE GK, 1991, LANGMUIR, V7, P2307, DOI 10.1021/la00058a055; Sachs SB, 1997, J AM CHEM SOC, V119, P10563, DOI 10.1021/ja972244y; SMALLEY JF, 1988, J ELECTROANAL CHEM, V248, P255, DOI 10.1016/0022-0728(88)85090-3; SMALLEY JF, 1995, J PHYS CHEM-US, V99, P13141, DOI 10.1021/j100035a016; Smalley JF, 2000, ELECTROCHEM COMMUN, V2, P832, DOI 10.1016/S1388-2481(00)00132-6; SMALLEY JF, 1993, J ELECTROANAL CHEM, V356, P181, DOI 10.1016/0022-0728(93)80520-R; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611; ZERNER MC, 1980, J AM CHEM SOC, V102, P589, DOI 10.1021/ja00522a025; ZUSMAN LD, 1980, CHEM PHYS, V49, P295, DOI 10.1016/0301-0104(80)85267-0	23	320	324	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1519	1523		10.1126/science.1055745	http://dx.doi.org/10.1126/science.1055745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222852				2022-12-28	WOS:000167153400037
J	Peltonen, L; McKusick, VA				Peltonen, L; McKusick, VA			Genomics and medicine - Dissecting human disease in the postgenomic era	SCIENCE			English	Article							SIMPLE MENDELIAN DISORDERS; GENE-EXPRESSION; COMPLEX; PREDICTION; LOCUS		Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Johns Hopkins Med Inst, Dept Med Genet, Baltimore, MD 21205 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Johns Hopkins Medicine	Peltonen, L (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	lpeltonen@mednet.ucla.edu						Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brand MD, 1997, J EXP BIOL, V200, P193; Chang YPC, 1997, BRIT J HAEMATOL, V96, P806, DOI 10.1046/j.1365-2141.1997.d01-2094.x; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Karim FD, 1996, GENETICS, V143, P315; Krauss S, 1996, J THEOR BIOL, V182, P381, DOI 10.1006/jtbi.1996.0177; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McKusick V.A., 1998, MENDELIAN INHERITANC; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Patel M, 2001, AM J HUM GENET, V68, P275, DOI 10.1086/316932; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramirez F, 1999, ANN MED, V31, P202, DOI 10.3109/07853899909115979; Rogers J, 2000, GENOMICS, V67, P237, DOI 10.1006/geno.2000.6245; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473	27	251	288	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1224	+		10.1126/science.291.5507.1224	http://dx.doi.org/10.1126/science.291.5507.1224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233446				2022-12-28	WOS:000166993400024
J	Bordenstein, SR; O'Hara, FP; Werren, JH				Bordenstein, SR; O'Hara, FP; Werren, JH			Wolbachia-induced incompatibility precedes other hybrid incompatibilities in Nasonia	NATURE			English	Article							REPRODUCTIVE ISOLATION; CYTOPLASMIC INCOMPATIBILITY; GENETICS; CHROMOSOME; SPECIATION	Wolbachia are cytoplasmically inherited bacteria that cause a number of reproductive alterations in insects, including cytoplasmic incompatibility(1,2), an incompatibility between sperm and egg that results in loss of sperm chromosomes following fertilization. Wolbachia are estimated to infect 15-20% of all insect species(3), and also are common in arachnids, isopods and nematodes(3,4). Therefore, Wolbachia-induced cytoplasmic incompatibility could be an important factor promoting rapid speciation in invertebrates(5), although this contention is controversial(6,7). Here we show that high levels of bidirectional cytoplasmic incompatibility between two closely related species of insects (the parasitic wasps Nasonia giraulti and Nasonia longicornis) preceded the evolution of other postmating reproductive barriers. The presence of Wolbachia severely reduces the frequency of hybrid offspring in interspecies crosses. However, antibiotic curing of the insects results in production of hybrids. Furthermore, F-1 and F-2 hybrids are completely viable and fertile, indicating the absence of F-1 and F-2 hybrid breakdown. Partial interspecific sexual isolation occurs, yet it is asymmetric and incomplete. Our results indicate that Wolbachia-induced reproductive isolation occurred in the early stages of speciation in this system, before the evolution of other postmating isolating mechanisms (for example, hybrid inviability and hybrid sterility).	Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Bordenstein, SR (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.		郑, 丽丽/HGE-2239-2022	Werren, John/0000-0001-9353-2070				Bordenstein SR, 1998, GENETICS, V148, P1833; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; CAMPBELL BC, 1993, INSECT MOL BIOL, V22, P255; DARLING DC, 1990, ANN ENTOMOL SOC AM, V83, P352, DOI 10.1093/aesa/83.3.352; Gadau J, 1999, GENETICS, V153, P1731; Hoffmann AA, 1997, INFLUENTIAL PASSENGE; Hurst GDD, 1998, HEREDITY, V80, P2, DOI 10.1046/j.1365-2540.1998.00337.x; Margulis L., 1991, SYMBIOSISOURCE EVO; Mood A., 1973, INTRO THEORY STAT; Noor MAF, 1997, EVOLUTION, V51, P809, DOI [10.2307/2411156, 10.1111/j.1558-5646.1997.tb03663.x]; Orr HA, 1997, ANNU REV ECOL SYST, V28, P195, DOI 10.1146/annurev.ecolsys.28.1.195; PALOPOLI MF, 1994, GENETICS, V138, P329; PerrotMinnot MJ, 1996, GENETICS, V143, P961; REED KM, 1995, MOL REPROD DEV, V40, P408, DOI 10.1002/mrd.1080400404; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; True JR, 1996, GENETICS, V142, P819; WADE MJ, 1995, HEREDITY, V75, P453, DOI 10.1038/hdy.1995.161; Werren J. H., 1998, ENDLESS FORMS SPECIE; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; WERREN JH, 1997, ANNU REV ENTOMOL, V423, P5887; WU CI, 1994, ANNU REV GENET, V28, P283, DOI 10.1146/annurev.ge.28.120194.001435; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	26	301	310	6	83	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					707	710		10.1038/35055543	http://dx.doi.org/10.1038/35055543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217858				2022-12-28	WOS:000166816400041
J	Finn, CA; Sisson, TW; Deszcz-Pan, M				Finn, CA; Sisson, TW; Deszcz-Pan, M			Aerogeophysical measurements of collapse-prone hydrothermally altered zones at Mount Rainier volcano	NATURE			English	Article							WASHINGTON; ROCKS	Hydrothermally altered rocks can weaken volcanoes, increasing the potential for catastrophic sector collapses that can lead to destructive debris flows(1). Evaluating the hazards associated with such alteration is difficult because alteration has been mapped on few active volcanoes(1-4) and the distribution and severity of subsurface alteration is largely unknown on any active volcano. At Mount Rainier volcano (Washington, USA), collapses of hydrothermally altered edifice flanks have generated numerous extensive debris flows(5,6) and future collapses could threaten areas that are now densely populated(7). Preliminary geological mapping and remote-sensing data indicated that exposed alteration is contained in a dyke-controlled belt trending east-west that passes through the volcano's summit(3-5,8). But here we present helicopter-borne electromagnetic and magnetic data, combined with detailed geological mapping, to show that appreciable thicknesses of mostly buried hydrothermally altered rock lie mainly in the upper west flank of Mount Rainier. We identify this as the likely source for future large debris flows. But as negligible amounts of highly altered rock lie in the volcano's core, this might impede collapse retrogression and so limit the volumes and inundation areas of future debris flows. Our results demonstrate that high-resolution geophysical and geological observations can yield unprecedented views of the three-dimensional distribution of altered rock.	US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA; US Geol Survey, Menlo Park, CA 94025 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Finn, CA (corresponding author), US Geol Survey, Denver Fed Ctr, MS964,POB 25046, Denver, CO 80225 USA.			Finn, Carol/0000-0002-6178-0405				Crandell D.R, 1971, 677 USGS, P75, DOI DOI 10.3133/PP677; CRANDELL DR, 1956, AM J SCI, V254, P349, DOI 10.2475/ajs.254.6.349; Crowley JK, 1997, GEOLOGY, V25, P559, DOI 10.1130/0091-7613(1997)025<0559:MHAROM>2.3.CO;2; Deszcz-Pan M., 1998, EXPLOR GEOPHYS, V29, P142, DOI [10.1071/EG998142, DOI 10.1071/EG998142]; FINN C, 1987, J GEOPHYS RES-SOLID, V92, P10194, DOI 10.1029/JB092iB10p10194; FISKE RS, 1964, US GEOLOGICAL SURV I, V432; FISKE RS, 1963, 444 US GEOL SURV, P93; FRANK D, 1995, J VOLCANOL GEOTH RES, V65, P51, DOI 10.1016/0377-0273(94)00081-Q; LOPEZ DL, 1993, SCIENCE, V260, P1794, DOI 10.1126/science.260.5115.1794; Moran SC, 2000, B VOLCANOL, V61, P425, DOI 10.1007/PL00008909; REID ME, 1999, EOS, V80, pF1151; RYSTROM VL, 2000, 00027 US GEOL SURV; SCOTT KM, 1995, US GEOL SURV PROF PA, V1547, P1; SISSON TW, 1999, EOS, V80, pF1151; Vallance JW, 1997, GEOL SOC AM BULL, V109, P143, DOI 10.1130/0016-7606(1997)109<0143:TOMFMR>2.3.CO;2; WILLIAMS DL, 1987, J GEOPHYS RES-SOLID, V92, P4867, DOI 10.1029/JB092iB06p04867; WOODWARD DJ, 1993, NEW ZEAL J GEOL GEOP, V36, P447, DOI 10.1080/00288306.1993.9514590; ZIMBELMAN DR, 1996, HYDROTHERMAL ALTERAT	18	78	78	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					600	603		10.1038/35054533	http://dx.doi.org/10.1038/35054533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214315				2022-12-28	WOS:000166692300039
J	Grill, SW; Gonczy, P; Stelzer, EHK; Hyman, AA				Grill, SW; Gonczy, P; Stelzer, EHK; Hyman, AA			Polarity controls forces governing asymmetric spindle positioning in the Caenorhabditis elegans embryo	NATURE			English	Article							KINESIN-RELATED PROTEIN; CELL-DIVISION; CYTOPLASMIC LOCALIZATION; CLEAVAGE SPINDLE; LASER MICROBEAM; IDENTIFICATION; EMBRYOGENESIS; ORIENTATION; SEPARATION; MECHANISMS	Cell divisions that create daughter cells of different sizes are crucial for the generation of cell diversity during animal development(1). In such asymmetric divisions, the mitotic spindle must be asymmetrically positioned at the end of anaphase(2,3). The mechanisms by which cell polarity translates to asymmetric spindle positioning remain unclear. Here we examine the nature of the forces governing asymmetric spindle positioning in the single-cell-stage Caenorhabditis elegans embryo. To reveal the forces that act on each spindle pole, we removed the central spindle in living embryos either physically with an ultraviolet laser microbeam, or genetically by RNA-mediated interference of a kinesin(4). We show that pulling forces external to the spindle act on the two spindle poles. A stronger net force acts on the posterior pole, thereby explaining the overall posterior displacement seen in wild-type embryos. We also show that the net force acting on each spindle pole is under control of the par genes that are required for cell polarity along the anterior-posterior embryonic axis. Finally, we discuss simple mathematical models that describe the main features of spindle pole behaviour. Our work suggests a mechanism for generating asymmetry in spindle positioning by varying the net pulling force that acts on each spindle pole, thus allowing for the generation of daughter cells with different sizes.	Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Hyman, AA (corresponding author), Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany.	hyman@embl-heidelberg.de	Hyman, Anthony A/B-3917-2017; Grill, Stephan/D-9427-2012; Stelzer, Ernst H K/A-7648-2011; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Stelzer, Ernst H K/0000-0003-1545-0736; Gonczy, Pierre/0000-0002-6305-6883				AIST JR, 1993, J CELL SCI, V104, P1207; AIST JR, 1981, J CELL BIOL, V91, P446, DOI 10.1083/jcb.91.2.446; ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; CHENG NN, 1995, GENETICS, V139, P549; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Gonczy P, 1996, TRENDS CELL BIOL, V6, P382, DOI 10.1016/0962-8924(96)10035-0; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; HILL DP, 1988, DEV BIOL, V125, P75, DOI 10.1016/0012-1606(88)90060-7; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; KEMPHUES KJ, 1997, C ELEGANS, V0002, P00335; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; LESLIE RJ, 1983, J CELL BIOL, V96, P548, DOI 10.1083/jcb.96.2.548; MORTON DG, 1992, GENETICS, V130, P771; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Rose LS, 1998, DEVELOPMENT, V125, P1337; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; WATERS JC, 1993, J CELL BIOL, V122, P361, DOI 10.1083/jcb.122.2.361; Wein H, 1996, J CELL BIOL, V133, P595, DOI 10.1083/jcb.133.3.595; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95	30	385	394	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					630	633		10.1038/35054572	http://dx.doi.org/10.1038/35054572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214323				2022-12-28	WOS:000166692300047
J	Oshima, H; Rochat, A; Kedzia, C; Kobayashi, K; Barrandon, Y				Oshima, H; Rochat, A; Kedzia, C; Kobayashi, K; Barrandon, Y			Morphogenesis and renewal of hair follicles from adult multipotent stem cells	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; ROOT SHEATH-CELLS; DERMAL PAPILLA; VIBRISSAL FOLLICLES; SONIC-HEDGEHOG; NUDE LOCUS; MOUSE; EXPRESSION; KERATINOCYTE; CYCLE	The upper region of the outer root sheath of vibrissal follicles of adult mice contains multipotent stem cells that respond to morphogenetic signals to generate multiple hair follicles, sebaceous glands, and epidermis, i.e., all the lineages of the hairy skin. At the time when hair production ceases and when the lower region of the follicle undergoes major structural changes, the lower region contains a significant number of clonogenic keratinocytes, and can then respond to morphogenetic signals. This demonstrates that multipotent stem cells migrate to the root of the follicle to produce whisker growth. Moreover, our results indicate that the clonogenic keratinocytes are closely related, if not identical, to the multipotent stem cells, and that the regulation of whisker growth necessitates a precise control of stem cell trafficking.	Ecole Normale Super, Dept Biol, F-75230 Paris 05, France; Chiba Univ, Fac Sci, Inage Ku, Chiba 263, Japan	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Chiba University	Barrandon, Y (corresponding author), Ecole Normale Super, Dept Biol, 46 Rue Ulm, F-75230 Paris 05, France.	barrand@wotan.ens.fr						BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; CACHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717, DOI 10.1073/pnas.91.16.7717; CHASE HB, 1951, PHYSIOL ZOOL, V24, P1; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DHOUAILLY D, 1984, DERMATOLOGICA, V169, P228; DORFL J, 1982, J ANAT, V135, P147; DUCROS DL, 1993, J INVEST DERMATOL, V101, pS106, DOI 10.1111/1523-1747.ep12363020; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Gambardella L, 2000, MECH DEVELOP, V96, P215, DOI 10.1016/S0925-4773(00)00398-1; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GREEN MR, 1984, J INVEST DERMATOL, V83, P118, DOI 10.1111/1523-1747.ep12263298; GUO LF, 1993, EMBO J, V12, P973, DOI 10.1002/j.1460-2075.1993.tb05738.x; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HARDY MH, 1968, J EMBRYOL EXP MORPH, V19, P157; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; IBRAHIM L, 1982, J EMBRYOL EXP MORPH, V72, P209; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kamimura J, 1997, J INVEST DERMATOL, V109, P534, DOI 10.1111/1523-1747.ep12336704; Kishimoto J, 2000, GENE DEV, V14, P1181; KOBAYASHI K, 1993, P NATL ACAD SCI USA, V90, P7391, DOI 10.1073/pnas.90.15.7391; KOPAN R, 1993, J CELL BIOL, V121, P631, DOI 10.1083/jcb.121.3.631; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; LAVKER RM, 1991, ANN NY ACAD SCI, V642, P214; LAVKER RM, 1993, J INVEST DERMATOL, V101, pS16, DOI 10.1111/1523-1747.ep12362556; LENOIR MC, 1988, DEV BIOL, V130, P610, DOI 10.1016/0012-1606(88)90356-9; LIMAT A, 1991, EXP CELL RES, V194, P218, DOI 10.1016/0014-4827(91)90357-Z; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Matsuzaki T, 1996, DIFFERENTIATION, V60, P287, DOI 10.1046/j.1432-0436.1996.6050287.x; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MONTAGNA W, 1962, STRUCTURE FUNCTION S, P174; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; OLIVER RF, 1966, J EMBRYOL EXP MORPH, V15, P331; Oro AE, 1998, CELL, V95, P575, DOI 10.1016/S0092-8674(00)81624-4; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; PHILPOTT MP, 1994, J INVEST DERMATOL, V102, P186, DOI 10.1111/1523-1747.ep12371760; REYNOLDS AJ, 1993, J INVEST DERMATOL, V101, P634, DOI 10.1111/1523-1747.ep12366095; REYNOLDS AJ, 1991, J CELL SCI, V99, P373; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; SALAUN J, 1986, EUR J IMMUNOL, V16, P523, DOI 10.1002/eji.1830160511; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187; Slack JMW, 2000, SCIENCE, V287, P1431, DOI 10.1126/science.287.5457.1431; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; STRAILE WE, 1961, J EXP ZOOL, V148, P205, DOI 10.1002/jez.1401480304; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; van der Kooy D, 2000, SCIENCE, V287, P1439, DOI 10.1126/science.287.5457.1439; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vincent SB, 1913, J COMP NEUROL, V23, P1, DOI 10.1002/cne.900230101; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; YOUNG RD, 1976, J EMBRYOL EXP MORPH, V36, P597; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	65	764	847	4	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					233	245		10.1016/S0092-8674(01)00208-2	http://dx.doi.org/10.1016/S0092-8674(01)00208-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207364	Bronze			2022-12-28	WOS:000166879700007
J	Freedman, DJ; Riesenhuber, M; Poggio, T; Miller, EK				Freedman, DJ; Riesenhuber, M; Poggio, T; Miller, EK			Categorical representation of visual stimuli in the primate prefrontal cortex	SCIENCE			English	Article							RHESUS-MONKEYS; TEMPORAL CORTEX; MACAQUE; CATEGORIZATION; IMAGES; MEMORY; NEURONS	The ability to group stimuli into meaningful categories is a fundamental cognitive process. To explore its neural basis. we trained monkeys to categorize computer-generated stimuli as "cats" and "dogs." A morphing system was used to systematically vary stimulus shape and precisely define the category boundary. Neural activity in the Lateral prefrontal cortex reflected the category of visual stimuli, even when a monkey was retrained with the stimuli assigned to new categories.	MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Ctr Biol & Computat Learning, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Miller, EK (corresponding author), MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA.		Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958; Riesenhuber, Maximilian/0000-0002-5744-0408				Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Barsalou L. W., 1992, COGNITIVE PSYCHOL OV; Beymer D, 1996, SCIENCE, V272, P1905, DOI 10.1126/science.272.5270.1905; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; GAFFAN D, 1995, EXP BRAIN RES, V105, P175; Gross C. G., 1973, HDB SENSORY PHYSIOLO, P451; Gutnikov SA, 1997, EUR J NEUROSCI, V9, P1524, DOI 10.1111/j.1460-9568.1997.tb01507.x; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Lakoff George, 1987, WOMEN FIRE, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Miller EK, 1996, J NEUROSCI, V16, P5154; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Orlov T, 2000, NATURE, V404, P77, DOI 10.1038/35003571; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Rainer G, 1999, J NEUROSCI, V19, P5493; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; ROBERTS WA, 1988, J EXP PSYCHOL ANIM B, V14, P247, DOI 10.1037/0097-7403.14.3.247; Shelton CR, 2000, INT J COMPUT VISION, V38, P75, DOI 10.1023/A:1008170818506; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542	30	730	744	1	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					312	316		10.1126/science.291.5502.312	http://dx.doi.org/10.1126/science.291.5502.312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209083				2022-12-28	WOS:000166352900048
J	Tosatti, E; Prestipino, S; Kostlmeier, S; Dal Corso, A; Di Tolla, FD				Tosatti, E; Prestipino, S; Kostlmeier, S; Dal Corso, A; Di Tolla, FD			String tension and stability of magic tip-suspended nanowires	SCIENCE			English	Article							GOLD; CONDUCTANCE	Multishell helical gold nanowires were recently imaged by electron microscopy. We show theoretically that the contact with the gold tips at either end of the wire plays a crucial role and that local minima in the string tension rather than the total wire free energy determine the nanowire stability. Density functional electronic structure calculations of the simplest and thinnest coaxial gold and silver wires of variable radius and chirality were carried out. We found a string tension minimum for a single-tube gold nanowire that is chiral and consists of seven strands, in striking agreement with observation. In contrast, no such minimum was found for silver, where the s-d competition Leading to surface reconstruction is lacking.	SISSA, I-34014 Trieste, Italy; Ist Nazl Fis Mat, Unita SISSA, I-34014 Trieste, Italy; Abdus Salaam Int Ctr Theoret Phys, I-34014 Trieste, Italy	International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); International School for Advanced Studies (SISSA); University of Padua; Abdus Salam International Centre for Theoretical Physics (ICTP)	Tosatti, E (corresponding author), SISSA, I-34014 Trieste, Italy.	tosatti@sissa.it	Gemming, Sibylle/C-6898-2009; Prestipino, Santi/N-8623-2014; Dal Corso, Andrea/A-5745-2008	Prestipino, Santi/0000-0002-6266-7025; Dal Corso, Andrea/0000-0003-1186-5133; Gemming, Sibylle/0000-0003-0455-1945				Barnett RN, 1997, NATURE, V387, P788, DOI 10.1038/42904; Bilalbegovic G, 2000, SOLID STATE COMMUN, V115, P73, DOI 10.1016/S0038-1098(00)00149-6; BOGOMOLOV VN, 1990, KRISTALLOGRAFIYA+, V35, P197; DalCorso A, 1997, PHYS REV B, V56, P11369, DOI 10.1103/PhysRevB.56.R11369; FRANK FC, 1952, PROC R SOC LON SER-A, V215, P43, DOI 10.1098/rspa.1952.0194; Gulseren O, 1998, PHYS REV LETT, V80, P3775, DOI 10.1103/PhysRevLett.80.3775; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Kondo Y, 2000, SCIENCE, V289, P606, DOI 10.1126/science.289.5479.606; Kondo Y, 1997, PHYS REV LETT, V79, P3455, DOI 10.1103/PhysRevLett.79.3455; KRESSE G, 1994, J PHYS-CONDENS MAT, V6, P8245, DOI 10.1088/0953-8984/6/40/015; Miyamoto Y, 1999, PHYS REV B, V60, P13885, DOI 10.1103/PhysRevB.60.13885; Ohnishi H, 1998, NATURE, V395, P780, DOI 10.1038/27399; Rodrigues V, 2000, PHYS REV LETT, V85, P4124, DOI 10.1103/PhysRevLett.85.4124; Schaaff TG, 2000, J PHYS CHEM B, V104, P2630, DOI 10.1021/jp993691y; Sorensen MR, 1998, PHYS REV B, V57, P3283, DOI 10.1103/PhysRevB.57.3283; TAKEUCHI N, 1989, PHYS REV B, V40, P1565, DOI 10.1103/PhysRevB.40.1565; TOMAGNINI O, 1993, SURF SCI, V287, P1041, DOI 10.1016/0039-6028(93)91123-7; TOMAGNINI O, UNPUB; Torres JA, 1999, SURF SCI, V426, pL441, DOI 10.1016/S0039-6028(99)00333-7; Tosatti E., 1991, Modern Physics Letters B, V5, P413, DOI 10.1142/S0217984991000496; Tosatti E, 2000, SCIENCE, V289, P561, DOI 10.1126/science.289.5479.561; VOTER AF, 1987, LAUR933901 LOS AL NA; Yanson AI, 2000, PHYS REV LETT, V84, P5832, DOI 10.1103/PhysRevLett.84.5832	23	269	276	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					288	290		10.1126/science.291.5502.288	http://dx.doi.org/10.1126/science.291.5502.288			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209075				2022-12-28	WOS:000166352900040
J	Fitzmaurice, DA; Mant, J; Murray, ET; Hobbs, FDR				Fitzmaurice, DA; Mant, J; Murray, ET; Hobbs, FDR			Anticoagulation to prevent stroke in atrial fibrillation - It's still not clear whether results in secondary care translate to primary care	BRITISH MEDICAL JOURNAL			English	Letter														hobbs, richard/0000-0001-7976-7172; BIANCHETTI, ANGELO/0000-0002-2914-0627				Connolly ST, 2000, BRIT MED J, V320, P1219, DOI 10.1136/bmj.320.7244.1219; COPLAND M, 2000, BRIT J HAEMATOL, V8, P56; Kalra L, 2000, BMJ-BRIT MED J, V320, P1236, DOI 10.1136/bmj.320.7244.1236	3	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 4	2000	321	7269					1156	1156		10.1136/bmj.321.7269.1156	http://dx.doi.org/10.1136/bmj.321.7269.1156			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372DT	11203222	Green Published			2022-12-28	WOS:000165219600041
J	MacFadyen, L; Hastings, G; MacKintosh, AM				MacFadyen, L; Hastings, G; MacKintosh, AM			Cross sectional study of young people's awareness of and involvement with tobacco marketing	BRITISH MEDICAL JOURNAL			English	Article							CIGARETTE ADVERTISEMENTS; ALCOHOL ADVERTISEMENTS; SALES PROMOTION; SMOKING; ADOLESCENTS; SUSCEPTIBILITY; EXPOSURE; INDUSTRY; LIKING	Objectives To examine young people's awareness of and involvement with tobacco marketing and to determine the association, if any,between this and their smoking behaviour. Design Cross sectional, quantitative survey, part interview and part self completion, administered in respondents' homes. Setting North east England. Participants Stratified random sample of 629 young people aged 15 and 16 years who had "opted in" to research through a postal consent procedure. Results There was a high level of awareness of and involvement in tobacco marketing among the 15-16 year olds sampled in the study: around 95% were aware of advertising and all were aware of some method of paint of sale marketing. Awareness of and involvement with tobacco marketing were both significantly associated with being a smoker: for example, 30% (55/185) of smokers had received free Sifts through coupons in cigarette packs, compared with 11% (21/199) of non-smokers (P < 0.001). When other factors known to be linked with teenage smoking were held constant, awareness of coupon schemes, brand sc-etching, and tobacco marketing in general were all independently associated with current smoking status. Conclusions Teenagers are aware of, and are participating in, many forms of tobacco marketing, and both awareness and participation are associated with current smoking status. This suggests that the current voluntary regulations designed to protect young people from smoking are not working, and that statutory regulations are required.	Univ Strathclyde, Ctr Tobacco Control Res, Glasgow G4 0RQ, Lanark, Scotland	University of Strathclyde	MacFadyen, L (corresponding author), Univ Strathclyde, Ctr Tobacco Control Res, Glasgow G4 0RQ, Lanark, Scotland.		G, G/A-3459-2012					AITKEN PP, 1990, BRIT J ADDICT, V85, P399; AITKEN PP, 1991, BRIT J ADDICT, V86, P383; AITKEN PP, 1987, BRIT J ADDICT, V82, P615; Altman DG, 1996, AM J PUBLIC HEALTH, V86, P1590, DOI 10.2105/AJPH.86.11.1590; Arnett JJ, 1998, TOB CONTROL, V7, P129, DOI 10.1136/tc.7.2.129; Charlton A, 1997, LANCET, V350, P1474, DOI 10.1016/S0140-6736(97)26046-0; COVELL K, 1994, CAN J BEHAV SCI, V26, P404, DOI 10.1037/0008-400X.26.3.404; DIFRANZA JR, 1991, JAMA-J AM MED ASSOC, V266, P3149, DOI 10.1001/jama.266.22.3149; *EC OP RES DIV DEP, 1992, EFF TOB ADV TOB SPON; EVANS N, 1995, J NATL CANCER I, V87, P1538, DOI 10.1093/jnci/87.20.1538; Feighery E, 1998, TOB CONTROL, V7, P123, DOI 10.1136/tc.7.2.123; Gilpin EA, 1997, PREV MED, V26, P14, DOI 10.1006/pmed.1996.9980; HIGGINS V, 1998, YOUNG TEENAGERS SMOK; *HOUS COMM HLTH CO, 2000, 2 REP TOB IND HLTH R, V1; Ledwith F., 1984, HLTH ED J, V43, P85, DOI DOI 10.1177/001789698404300402; PECHMANN C, 1994, J CONSUM RES, V21, P236, DOI 10.1086/209395; PIEPE AP, 1986, HLTH ED J, V45, P145; Pierce JP, 1998, JAMA-J AM MED ASSOC, V279, P511, DOI 10.1001/jama.279.7.511; PIERCE JP, 1991, JAMA-J AM MED ASSOC, V266, P3145; Potts H., 1986, HLTH ED RES, V1, P195, DOI DOI 10.1093/HER/1.3.195; Redmond WH, 1999, PREV MED, V28, P243, DOI 10.1006/pmed.1998.0410; UNGER JB, 1995, PREV MED, V24, P461, DOI 10.1006/pmed.1995.1074	22	74	75	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					513	517		10.1136/bmj.322.7285.513	http://dx.doi.org/10.1136/bmj.322.7285.513			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	409EA	11230063	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-28	WOS:000167370500022
J	Harding, S; Balarajan, R				Harding, S; Balarajan, R			Mortality of third generation Irish people living in England and Wales: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article							2ND-GENERATION		Univ London London Sch Hyg & Trop Med, Ctr Publ Hlth Monitoring, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Harding, S (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.							ASPINALL PJ, 1999, HLTH STATUS HLTH SER; Harding S, 1998, BRIT J CANCER, V78, P958, DOI 10.1038/bjc.1998.608; Harding S, 1996, BRIT MED J, V312, P1389, DOI 10.1136/bmj.312.7043.1389; Hattersley L, 1995, LONGITUDINAL STUDY 1; HICKMAN MJ, 1997, DISCRIMINATION IRISH	5	37	37	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	2001	322	7284					466	467		10.1136/bmj.322.7284.466	http://dx.doi.org/10.1136/bmj.322.7284.466			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406YD	11222422	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000167243000020
J	Tudhope, AW; Chilcott, CP; McCulloch, MT; Cook, ER; Chappell, J; Ellam, RM; Lea, DW; Lough, JM; Shimmield, GB				Tudhope, AW; Chilcott, CP; McCulloch, MT; Cook, ER; Chappell, J; Ellam, RM; Lea, DW; Lough, JM; Shimmield, GB			Variability in the El Nino - Southern oscillation through a glacial-interglacial cycle	SCIENCE			English	Article							SEA-SURFACE TEMPERATURES; OXYGEN-ISOTOPE RECORDS; PAPUA-NEW-GUINEA; HUON-PENINSULA; PENULTIMATE DEGLACIATION; TROPICAL PACIFIC; CORAL-SKELETONS; CLIMATE-CHANGE; NORTH PACIFIC; LEVEL CHANGES	The El Nino-Southern Oscillation (ENSO) is the most potent source of interannual climate variability. Uncertainty surrounding the impact of greenhouse warming on ENSO strength and frequency has stimulated efforts to develop a better understanding of the sensitivity of ENSO to climate change, Here we use annually banded corals from Papua New Guinea to show that ENSO has existed for the past 130,000 years, operating even during "glacial" times of substantially reduced regional and global temperature and changed solar forcing. However, we also find that during the 20th century ENSO has been strong compared with ENSO of previous cool (glacial) and warm (interglacial) times. The observed pattern of change in amplitude may be due to the combined effects of ENSO dampening during cool glacial conditions and ENSO forcing by precessional orbital variations.	Univ Edinburgh, Dept Geol & Geophys, Edinburgh EH9 3JW, Midlothian, Scotland; Australian Inst Marine Sci, Townsville, Qld 4810, Australia; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Lamont Doherty Earth Observ, Tree Ring Lab, Palisades, NY 10964 USA; Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Dunstaffnage Marine Lab, Oban PA34 4AD, Argyll, Scotland	University of Edinburgh; Australian Institute of Marine Science; Australian National University; Columbia University; Scottish Universities Research & Reactor Center; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Tudhope, AW (corresponding author), Univ Edinburgh, Dept Geol & Geophys, Edinburgh EH9 3JW, Midlothian, Scotland.		McCulloch, Malcolm T/C-3651-2009; Ellam, Rob M/B-7878-2009; Lough, Janice M/L-1682-2013	McCulloch, Malcolm T/0000-0003-1538-1558; Ellam, Rob M/0000-0001-8159-4864; Lough, Janice M/0000-0002-3789-1009				AHARON P, 1986, PALAEOGEOGR PALAEOCL, V56, P337, DOI 10.1016/0031-0182(86)90101-X; Andreasen DJ, 1997, PALEOCEANOGRAPHY, V12, P395, DOI 10.1029/97PA00822; BARMATTHEWS M, 1993, GEOCHIM COSMOCHIM AC, V57, P257, DOI 10.1016/0016-7037(93)90429-Z; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; BJERKNES J, 1969, MON WEATHER REV, V97, P163, DOI 10.1175/1520-0493(1969)097<0163:ATFTEP>2.3.CO;2; Broecker WS, 1989, PALEOCEANOGRAPHY, V4, P207, DOI 10.1029/PA004i002p00207; Cane MA, 1998, SCIENCE, V282, P59, DOI 10.1126/science.282.5386.59; CHAPPELL J, 1974, GEOL SOC AM BULL, V85, P553, DOI 10.1130/0016-7606(1974)85<553:GOCTHP>2.0.CO;2; CHAPPELL J, 1991, NATURE, V349, P147, DOI 10.1038/349147a0; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; CLIMAP (Climate: Long Range Investigation Mapping and Prediction) Project Members, 1981, GEOL SOC AM MAP CHAR, V36; Collins M, 2000, J CLIMATE, V13, P1299, DOI 10.1175/1520-0442(2000)013<1299:TENOSO>2.0.CO;2; CONOVER WJ, 1999, PRACTICAL NONPARAMET, P300; EPSTEIN S, 1953, GEOL SOC AM BULL, V64, P1315, DOI 10.1130/0016-7606(1953)64[1315:RCITS]2.0.CO;2; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; Evans MN, 1998, NATURE, V394, P732, DOI 10.1038/29424; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; GRAHAM NE, 1994, CLIM DYNAM, V10, P135, DOI 10.1007/BF00210626; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Hughen KA, 1999, GEOPHYS RES LETT, V26, P3129, DOI 10.1029/1999GL006062; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Knutson TR, 1997, J CLIMATE, V10, P138, DOI 10.1175/1520-0442(1997)010<0138:SEIAGC>2.0.CO;2; Latif M, 1998, J GEOPHYS RES-OCEANS, V103, P14375, DOI 10.1029/97JC03413; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Leder JJ, 1996, GEOCHIM COSMOCHIM AC, V60, P2857, DOI 10.1016/0016-7037(96)00118-4; Lee KE, 1999, NATURE, V397, P512, DOI 10.1038/17357; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; MARTIN PA, 1999, GEOCHEM GEOPHYS GEOS; McCulloch MT, 1999, SCIENCE, V283, P202, DOI 10.1126/science.283.5399.202; Mitsuguchi T, 1996, SCIENCE, V274, P961, DOI 10.1126/science.274.5289.961; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; Otto-Bliesner BL, 1999, GEOPHYS RES LETT, V26, P87, DOI 10.1029/1998GL900236; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; PHILANDER SG, 1990, EL NINO LA NINA SO O; RASMUSSON EM, 1982, MON WEATHER REV, V110, P354, DOI 10.1175/1520-0493(1982)110<0354:VITSST>2.0.CO;2; RAYNER NA, 74 HADL CTR CLIM PRE; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Rind D, 1998, J GEOPHYS RES-ATMOS, V103, P5943, DOI 10.1029/97JD03649; Rittenour TM, 2000, SCIENCE, V288, P1039, DOI 10.1126/science.288.5468.1039; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; ROPELEWSKI C. F., 1987, MON WEA REV, V115, P2352; Sandweiss DH, 1996, SCIENCE, V273, P1531, DOI 10.1126/science.273.5281.1531; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; SHEN GT, 1995, GEOCHIM COSMOCHIM AC, V59, P2009, DOI 10.1016/0016-7037(95)00123-9; SHULMEISTER J, 1995, HOLOCENE, V5, P10, DOI 10.1177/095968369500500102; Stoll HM, 1998, GEOCHIM COSMOCHIM AC, V62, P1107, DOI 10.1016/S0016-7037(98)00042-8; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; Tudhope AW, 1995, EARTH PLANET SC LETT, V136, P575, DOI 10.1016/0012-821X(95)00156-7; TUDHOPE AW, UNPUB; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	57	644	676	1	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1511	1517		10.1126/science.1057969	http://dx.doi.org/10.1126/science.1057969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222850				2022-12-28	WOS:000167153400035
J	Wadhwa, M				Wadhwa, M			Redox state of Mars' upper mantle and crust from Eu anomalies in shergottite pyroxenes	SCIENCE			English	Article							RARE-EARTH ELEMENTS; OXIDATION-STATE; METEORITES; PETROGENESIS; CRYSTALLIZATION; CONSTRAINTS; PETROLOGY; PLANET	The oxidation state of basaltic martian meteorites is determined from the partitioning of europium (Eu) in their pyroxenes. The estimated redox conditions far these samples correlate with their initial neodymium and strontium isotopic compositions. This is interpreted to imply varying degrees of interaction between the basaltic parent melts, derived from a source in the martian mantle, and a crustal component. Thus, the mantle source of these martian basalts may have a redox state close to that of the iron-wustite buffer, whereas the martian crust may be more oxidized (with a redox state higher than or equal to that of the quartz-fayalite-magnetite buffer). A difference in redox state of more than 3 log units between mantle and crustal reservoirs on Mars could result from oxidation of the crust by a process such as aqueous alteration, together with a subsequent lack of recycling of this oxidized crust through the reduced upper mantle.	Field Museum, Dept Geol, Chicago, IL 60605 USA	Field Museum of Natural History (Chicago)	Wadhwa, M (corresponding author), Field Museum, Dept Geol, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	mwadhwa@fieldmuseum.org						ANDERSON DL, 1972, J GEOPHYS RES, V77, P789, DOI 10.1029/JB077i005p00789; Barrat JA, 2001, METEORIT PLANET SCI, V36, P23, DOI 10.1111/j.1945-5100.2001.tb01807.x; Borg LE, 1997, GEOCHIM COSMOCHIM AC, V61, P4915, DOI 10.1016/S0016-7037(97)00276-7; BORG LE, 2000, LUNAR PLANET SCI, V31; CHRISTIE DM, 1986, EARTH PLANET SC LETT, V79, P397, DOI 10.1016/0012-821X(86)90195-0; DREIBUS G, 1987, ICARUS, V71, P225, DOI 10.1016/0019-1035(87)90148-5; DREIBUS G, 1985, METEORITICS, V20, P367; Dreibus G., 1996, METEORIT PLANET SCI, V31, pA39; GHOSAL S, 1998, CONTRIB MINERAL PETR, V119, P197; GOETTEL KA, 1983, CARNEGIE I WASHINGTO, V82, P363; HAGGERTY SE, 1983, NATURE, V303, P295, DOI 10.1038/303295a0; Hale VPS, 1999, GEOCHIM COSMOCHIM AC, V63, P1459, DOI 10.1016/S0016-7037(99)00095-2; Herd CDK, 2000, METEORIT PLANET SCI, V35, pA70; JONES JH, 1986, GEOCHIM COSMOCHIM AC, V50, P969, DOI 10.1016/0016-7037(86)90377-7; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; Longhi J., 1992, MARS, V1, P184, DOI [10.2307/j.ctt207g59v.10, DOI 10.2307/J.CTT207G59V.10]; LUNDBERG LL, 1988, GEOCHIM COSMOCHIM AC, V52, P2147, DOI 10.1016/0016-7037(88)90194-9; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MCGRETCHIN TR, 1978, ICARUS, V34, P512; MCKAY G, 1994, GEOCHIM COSMOCHIM AC, V58, P2911, DOI 10.1016/0016-7037(94)90124-4; MCKAY GA, 1989, GEOCHIM COSMOCHIM AC, V50, P927; MCKAY GA, COMMUNICATION; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; McSween HY, 1996, GEOCHIM COSMOCHIM AC, V60, P4563, DOI 10.1016/S0016-7037(96)00265-7; MCSWEEN HY, 1983, GEOCHIM COSMOCHIM AC, V47, P1501, DOI 10.1016/0016-7037(83)90309-5; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; MERRILL RB, 1981, BASALTIC VOLCANISM T, P633; MEYER C, 1998, NASA JOHNSON SPACE C, P88; MORGAN JW, 1979, GEOCHIM COSMOCHIM AC, V43, P1601, DOI 10.1016/0016-7037(79)90180-7; NYQUIST LE, 1979, GEOCHIM COSMOCHIM AC, V43, P1057, DOI 10.1016/0016-7037(79)90094-2; NYQUIST LE, 1995, LUNAR PLANET SCI, V26, P1065; NYQUIST LE, 2001, LUNAR PLANET SCI, V32; Rubin AE, 2000, GEOLOGY, V28, P1011, DOI 10.1130/0091-7613(2000)28<1011:LATMDB>2.0.CO;2; SAXENA SK, 1989, GEOCHIM COSMOCHIM AC, V53, P89, DOI 10.1016/0016-7037(89)90275-5; SHIH CY, 1982, GEOCHIM COSMOCHIM AC, V46, P2323, DOI 10.1016/0016-7037(82)90205-8; SMITH JV, 1979, METEORITICS, V14, P121, DOI 10.1111/j.1945-5100.1979.tb00486.x; STOLPER E, 1977, GEOCHIM COSMOCHIM AC, V41, P587, DOI 10.1016/0016-7037(77)90300-3; STOLPER E, 1979, GEOCHIM COSMOCHIM AC, V43, P1475, DOI 10.1016/0016-7037(79)90142-X; WADHWA M, 1994, GEOCHIM COSMOCHIM AC, V58, P4213, DOI 10.1016/0016-7037(94)90274-7; Wadhwa M, 1998, METEORIT PLANET SCI, V33, P321, DOI 10.1111/j.1945-5100.1998.tb01636.x; Wadhwa M, 2001, METEORIT PLANET SCI, V36, P195, DOI 10.1111/j.1945-5100.2001.tb01864.x; WOOD BJ, 1990, SCIENCE, V248, P337, DOI 10.1126/science.248.4953.337; [No title captured]; [No title captured]; [No title captured]	45	214	215	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2001	291	5508					1527	1530		10.1126/science.1057594	http://dx.doi.org/10.1126/science.1057594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11222854				2022-12-28	WOS:000167153400039
J	La Porta, A; Voth, GA; Crawford, AM; Alexander, J; Bodenschatz, E				La Porta, A; Voth, GA; Crawford, AM; Alexander, J; Bodenschatz, E			Fluid particle accelerations in fully developed turbulence	NATURE			English	Article							PRESSURE; STATISTICS; MODELS	The motion of fluid particles as they are pushed along erratic trajectories by fluctuating pressure gradients is fundamental to transport and mixing in turbulence. It is essential in cloud formation and atmospheric transport(1,2), processes in stirred chemical reactors and combustion systems(3), and in the industrial production of nanoparticles(4). The concept of particle trajectories has been used successfully to describe mixing and transport in turbulence(3,5), but issues of fundamental importance remain unresolved. One such issue is the Heisenberg-Yaglom prediction of fluid particle accelerations(6,7), based on the 1941 scaling theory of Kolmogorov(8,9). Here we report acceleration measurements using a detector adapted from high-energy physics to track particles in a laboratory water flow at Reynolds numbers up to 63,000. We find that, within experimental errors, Kolmogorov scaling of the acceleration variance is attained at high Reynolds numbers. Our data indicate that the acceleration is an extremely intermittent variable-particles are observed with accelerations of up to 1,500 times the acceleration of gravity (equivalent to 40 times the root mean square acceleration). We find that the acceleration data reflect the anisotropy of the large-scale flow at all Reynolds numbers studied.	Cornell Univ, Atom & Solid State Phys Lab, Nucl Studies Lab, Ithaca, NY 14853 USA	Cornell University	Bodenschatz, E (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Nucl Studies Lab, Ithaca, NY 14853 USA.	eb22@cornell.edu	Crawford, Alice M/P-6996-2015	Crawford, Alice M/0000-0001-6570-6870; Bodenschatz, Eberhard/0000-0002-2901-0144				BATCHELOR GK, 1951, P CAMB PHILOS SOC, V47, P359, DOI 10.1017/S0305004100026712; BIDLINGMAYER WL, 1995, J AM MOSQUITO CONTR, V11, P295; BORGAS MS, 1993, PHILOS T ROY SOC A, V342, P379, DOI 10.1098/rsta.1993.0026; Gotoh T, 1999, J FLUID MECH, V396, P257, DOI 10.1017/S0022112099005972; GOTOH T, UNPUB PHYS REV LETT; HEISENBERG W, 1948, Z PHYS, V124, P628, DOI 10.1007/BF01668899; Kolmogoroff A, 1941, CR ACAD SCI URSS, V30, P301, DOI 10.1098/rspa.1991.0075; Kolmogoroff AN, 1941, CR ACAD SCI URSS, V31, P538; Kurien S, 2000, PHYS REV E, V62, P2206, DOI 10.1103/PhysRevE.62.2206; La Porta A, 2000, PHYS FLUIDS, V12, P1485, DOI 10.1063/1.870397; OBUKHOV AM, 1951, PRIKL MAT MEKH, V15; Ott S, 2000, J FLUID MECH, V422, P207, DOI 10.1017/S0022112000001658; POPE SB, 1994, ANNU REV FLUID MECH, V26, P23, DOI 10.1146/annurev.fl.26.010194.000323; Pratsinis SE, 1996, POWDER TECHNOL, V88, P267, DOI 10.1016/S0032-5910(96)03130-0; Reynolds AM, 1999, Q J ROY METEOR SOC, V125, P1735, DOI 10.1002/qj.49712555713; Sawford BL, 2000, PHYS FLUIDS, V12, P2033, DOI 10.1063/1.870449; Shen X, 2000, PHYS FLUIDS, V12, P2976, DOI 10.1063/1.1313552; Shraiman BI, 2000, NATURE, V405, P639, DOI 10.1038/35015000; Skubic P, 1998, NUCL INSTRUM METH A, V418, P40, DOI 10.1016/S0168-9002(98)00715-3; SREENIVASAN KR, 1995, PHYS FLUIDS, V7, P2778, DOI 10.1063/1.868656; Vaillancourt PA, 2000, B AM METEOROL SOC, V81, P285, DOI 10.1175/1520-0477(2000)081<0285:ROPIAC>2.3.CO;2; Vedula P, 1999, PHYS FLUIDS, V11, P1208, DOI 10.1063/1.869893; Virant M, 1997, MEAS SCI TECHNOL, V8, P1539, DOI 10.1088/0957-0233/8/12/017; Voth GA, 1998, PHYS FLUIDS, V10, P2268, DOI 10.1063/1.869748; WEIL JC, 1992, J APPL METEOROL, V31, P1121, DOI 10.1175/1520-0450(1992)031<1121:EAQMRA>2.0.CO;2; YAGLOM AM, 1949, DOKL AKAD NAUK SSSR+, V69, P743	26	444	447	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1017	1019		10.1038/35059027	http://dx.doi.org/10.1038/35059027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234005	Green Submitted			2022-12-28	WOS:000167148800038
J	Pack, CC; Born, RT				Pack, CC; Born, RT			Temporal dynamics of a neural solution to the aperture problem in visual area MT of macaque brain	NATURE			English	Article							PURSUIT EYE-MOVEMENTS; MOTION; DIRECTION; SELECTIVITY; NEURONS; MONKEYS; ORIENTATION; SPEED	A critical step in the interpretation of the visual world is the integration of the various local motion signals generated by moving objects. This process is complicated by the fact that local velocity measurements can differ depending on contour orientation and spatial position. Specifically, any local motion detector can measure only the component of motion perpendicular to a contour that extends beyond its field of view(1,2). This "aperture problem''(3) is particularly relevant to direction-selective neurons early in the visual pathways, where small receptive fields permit only a limited view of a moving object. Here we show that neurons in the middle temporal visual area (known as MT or V5) of the macaque brain reveal a dynamic solution to the aperture problem. MT neurons initially respond primarily to the component of motion perpendicular to a contour's orientation, but over a period of approximately 60 ms the responses gradually shift to encode the true stimulus direction, regardless of orientation. We also report a behavioural correlate of these neural responses: the initial velocity of pursuit eye movements deviates in a direction perpendicular to local contour orientation, suggesting that the earliest neural responses influence the oculomotor response.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Pack, CC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Born, Richard/M-6454-2019	Born, Richard/0000-0003-4360-427X				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALBRIGHT TD, 1987, EXP BRAIN RES, V65, P582; Beutter BR, 1998, VISION RES, V38, P1273, DOI 10.1016/S0042-6989(97)00276-9; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; Chey J, 1997, J OPT SOC AM A, V14, P2570, DOI 10.1364/JOSAA.14.002570; Duncan RO, 2000, J NEUROSCI, V20, P5885, DOI 10.1523/JNEUROSCI.20-15-05885.2000; Groh JM, 1997, J NEUROSCI, V17, P4312; Hildreth E., 1984, MEASUREMENT VISUAL M; KRAUZLIS RJ, 1994, J NEUROPHYSIOL, V72, P150, DOI 10.1152/jn.1994.72.1.150; Liden L, 1999, VISION RES, V39, P3301, DOI 10.1016/S0042-6989(99)00055-3; Lisberger SG, 1999, J NEUROSCI, V19, P2224; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Masson GS, 2000, VISUAL NEUROSCI, V17, P753, DOI 10.1017/S0952523800175091; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Movshon JA, 1996, J NEUROSCI, V16, P7733; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Pack C., 1999, Society for Neuroscience Abstracts, V25, P673; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WATANABE T, 1995, VISION RES, V35, P2853, DOI 10.1016/0042-6989(95)00064-7; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317; YO C, 1992, VISION RES, V32, P135, DOI 10.1016/0042-6989(92)90121-X	27	269	270	0	29	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1040	1042		10.1038/35059085	http://dx.doi.org/10.1038/35059085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234012				2022-12-28	WOS:000167148800045
J	Shoemaker, DD; Schadt, EE; Armour, CD; He, YD; Garrett-Engele, P; McDonagh, PD; Loerch, PM; Leonardson, A; Lum, PY; Cavet, G; Wu, LF; Altschuler, SJ; Edwards, S; King, J; Tsang, JS; Schimmack, G; Schelter, JM; Koch, J; Ziman, M; Marton, MJ; Li, B; Cundiff, P; Ward, T; Castle, J; Krolewski, M; Meyer, MR; Mao, M; Burchard, J; Kidd, MJ; Dai, H; Phillips, JW; Linsley, PS; Stoughton, R; Scherer, S; Boguski, MS				Shoemaker, DD; Schadt, EE; Armour, CD; He, YD; Garrett-Engele, P; McDonagh, PD; Loerch, PM; Leonardson, A; Lum, PY; Cavet, G; Wu, LF; Altschuler, SJ; Edwards, S; King, J; Tsang, JS; Schimmack, G; Schelter, JM; Koch, J; Ziman, M; Marton, MJ; Li, B; Cundiff, P; Ward, T; Castle, J; Krolewski, M; Meyer, MR; Mao, M; Burchard, J; Kidd, MJ; Dai, H; Phillips, JW; Linsley, PS; Stoughton, R; Scherer, S; Boguski, MS			Experimental annotation of the human genome using microarray technology	NATURE			English	Article							SEQUENCE; IDENTIFICATION; PREDICTION; GENES	The most important product of the sequencing of a genome is a complete, accurate catalogue of genes and their products, primarily messenger RNA transcripts and their cognate proteins. Such a catalogue cannot be constructed by computational annotation alone; it requires experimental validation on a genome scale. Using 'exon' and 'tiling' arrays fabricated by ink-jet oligonucleotide synthesis, we devised an experimental approach to validate and refine computational gene predictions and define full-length transcripts on the basis of co-regulated expression of their exons. These methods can provide more accurate gene numbers and allow the detection of mRNA splice variants and identification of the tissue- and disease-specific conditions under which genes are expressed. We apply our technique to chromosome 22q under 69 experimental condition pairs, and to the entire human genome under two experimental conditions. We discuss implications for more comprehensive, consistent and reliable genome annotation, more efficient, full-length complementary DNA cloning strategies and application to complex diseases.	Rosetta Inpharmat Inc, Kirkland, WA 98034 USA		Boguski, MS (corresponding author), Rosetta Inpharmat Inc, 12040 115th Ave NE, Kirkland, WA 98034 USA.	msb@rii.com	Edwards, Stephen W/G-4482-2011	Edwards, Stephen/0000-0002-7985-111X; Meyer, Martin/0000-0002-7848-6149				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Blanchard AP, 1996, BIOSENS BIOELECTRON, V11, P687, DOI 10.1016/0956-5663(96)83302-1; Boguski MS, 1999, SCIENCE, V286, P453, DOI 10.1126/science.286.5439.453; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Claverie JM, 1997, HUM MOL GENET, V6, P1735, DOI 10.1093/hmg/6.10.1735; de Souza SJ, 2000, P NATL ACAD SCI USA, V97, P12690, DOI 10.1073/pnas.97.23.12690; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Hubbard T, 2000, NATURE, V403, P825, DOI 10.1038/35002770; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Marshall E, 2000, SCIENCE, V290, P242; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Penn SG, 2000, NAT GENET, V26, P315, DOI 10.1038/81613; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Wheelan SJ, 1998, GENOME RES, V8, P168, DOI 10.1101/gr.8.3.168	28	324	376	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					922	+		10.1038/35057141	http://dx.doi.org/10.1038/35057141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237012	Bronze			2022-12-28	WOS:000166938800059
J	Carroll, SB				Carroll, SB			The big picture	NATURE			English	Editorial Material									Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.							Erwin DH, 2000, EVOL DEV, V2, P78, DOI 10.1046/j.1525-142x.2000.00045.x; Lerner LS, 2000, NATURE, V407, P287, DOI 10.1038/35030204; Leroi AM, 2000, EVOL DEV, V2, P67, DOI 10.1046/j.1525-142x.2000.00044.x	3	15	15	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					669	669		10.1038/35055637	http://dx.doi.org/10.1038/35055637			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217840				2022-12-28	WOS:000166816400023
J	Lopez-Garcia, P; Rodriguez-Valera, F; Pedros-Alio, C; Moreira, D				Lopez-Garcia, P; Rodriguez-Valera, F; Pedros-Alio, C; Moreira, D			Unexpected diversity of small eukaryotes in deep-sea Antarctic plankton	NATURE			English	Article							EVOLUTION; PHYLOGENY; SEQUENCES; ARCHAEA	Phylogenetic information from ribosomal RNA genes directly amplified from the environment changed our view of the biosphere, revealing an extraordinary diversity of previously undetected prokaryotic lineages. Using ribosomal RNA genes from marine picoplankton, several new groups of bacteria and archaea have been identified, some of which are abundant2-4. Little is known, however, about the diversity of the smallest planktonic eukaryotes, and available information in general concerns the phytoplankton of the euphotic region. Here we recover eukaryotes in the size fraction 0.2-5 mum from the aphotic zone (250-3,000 m deep) in the Antarctic polar front. The most diverse and relatively abundant were two new groups of alveolate sequences, related to dinoflagellates that are found at all studied depths. These may be important components of the microbial community in the deep ocean. Their phylogenetic position suggests a radiation early in the evolution of alveolates.	Univ Miguel Hernandez, Div Microbiol, San Juan De Alicante 03550, Spain; CSIC, Inst Ciences Mar, E-08039 Barcelona, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Moreira, D (corresponding author), Univ Miguel Hernandez, Div Microbiol, San Juan De Alicante 03550, Spain.		Lopez-Garcia, Purificacion/B-6775-2012; Rodriguez-Valera, Francisco/M-2782-2013; Moreira, David/F-7445-2012; Pedrós-Alió, Carlos/H-1222-2011	Lopez-Garcia, Purificacion/0000-0002-0927-0651; Rodriguez-Valera, Francisco/0000-0002-9809-2059; Moreira, David/0000-0002-2064-5354; Pedrós-Alió, Carlos/0000-0003-1009-4277				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; FENCHEL T, 1998, BACTERIAL BIOGEOCHEM; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; GIOVANNONI SJ, 1992, NATURE, V356, P148; Guillou L, 1999, APPL ENVIRON MICROB, V65, P4528; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; LARSEN J, 1990, J NAT HIST, V24, P801, DOI 10.1080/00222939000770571; LENAERS G, 1991, J MOL EVOL, V32, P53, DOI 10.1007/BF02099929; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; MCRAE RA, 1996, CAN J BOT, V74, P1987; Moldowan JM, 1998, SCIENCE, V281, P1168, DOI 10.1126/science.281.5380.1168; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pawlowski J, 1997, MOL BIOL EVOL, V14, P498, DOI 10.1093/oxfordjournals.molbev.a025786; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Raghukumar S, 1999, MAR ECOL PROG SER, V190, P133, DOI 10.3354/meps190133; Stiller JW, 1999, MOL BIOL EVOL, V16, P1270, DOI 10.1093/oxfordjournals.molbev.a026217; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; Takami H, 1997, FEMS MICROBIOL LETT, V152, P279, DOI 10.1016/S0378-1097(97)00211-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	27	689	735	4	124	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					603	607		10.1038/35054537	http://dx.doi.org/10.1038/35054537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214316				2022-12-28	WOS:000166692300040
J	Brugarolas, J; Haynes, BF; Nevins, JR				Brugarolas, J; Haynes, BF; Nevins, JR			Towards a genomic-based diagnosis	LANCET			English	Editorial Material							GENE-EXPRESSION; PATTERNS; CANCER; ARRAYS		Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA	Duke University; Duke University	Brugarolas, J (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.							Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; DeRisi J, 1996, NAT GENET, V14, P457; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Masters JRW, 2000, NATURE, V404, P921, DOI 10.1038/35010139; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Roses AD, 2000, LANCET, V355, P1358, DOI 10.1016/S0140-6736(00)02126-7; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343	15	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					249	250		10.1016/S0140-6736(00)03608-4	http://dx.doi.org/10.1016/S0140-6736(00)03608-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214124				2022-12-28	WOS:000166693400006
J	Weisse, ME				Weisse, ME			The fourth disease, 1900-2000	LANCET			English	Review								Measles and scarlet fever were differentiated from one another in the 17th century. Rubella was accepted as the third distinct paediatric exanthem In 1881. hill Filatow in 1885 and Clement Dukes in 1894 described two distinct forms of rubella, and in 1900 Dukes proposed that one of these forms of rubella was a separate entity which he called the fourth disease. For the past five decades, fourth disease has been considered a non-entity, perhaps a mild form of scarlet fever, but certainly not a distinct disease. In 1979 Keith Powell resurrected the idea of the fourth disease and argued that it was caused by exotoxin-producing Staphylococcus aureus. We present additional arguments for the existence of fourth disease, as well as information to link the disease to S aureus.	W Virginia Univ, Hlth Sci Ctr, Sch Med, Dept Pediat, Morgantown, WV 26506 USA	West Virginia University	Weisse, ME (corresponding author), W Virginia Univ, Hlth Sci Ctr, Sch Med, Dept Pediat, POB 9214, Morgantown, WV 26506 USA.	mweisse@hsc.wvu.edu	Weisse, Martin/AAW-7050-2021					Aranow H, 1942, J AMER MED ASSOC, V119, P1491, DOI 10.1001/jama.1942.02830350023006; BASS JW, 1982, POSTGRAD MED, V72, P58, DOI 10.1080/00325481.1982.11716247; CHEINISSE L, 1905, SEMAINE MED, V25, P205; DUKES C, 2000, LANCET, V356, P89; DUKES C, 1894, LANCET, V1, P791; FILATOW N, 1886, ARCH KINDERHEILKD, V7, P241; HOLT LE, 1897, DIS INFANCY CHILDHOO, P92; KEATING JM, 1989, CYCLOPAEDIA DIS CHIL, P44; KOPLIK H, 1906, DIS INFANCY CHILDHOO, P847; LEO H, 1897, JB KINDERHEILKD, V30, P70; MACCORMAC W, 1881, T INT MED C 7 SESS L, V4; MARGILETH AM, 1975, SOUTH MED J, V68, P447, DOI 10.1097/00007611-197504000-00015; MELISH ME, 1971, J PEDIATR-US, V78, P958, DOI 10.1016/S0022-3476(71)80425-0; MORENS DM, 1991, AM J EPIDEMIOL, V134, P628, DOI 10.1093/oxfordjournals.aje.a116135; PFAUNDLER M, 1908, DIS CHILDREN, P468; POWELL KR, 1979, AM J DIS CHILD, V133, P88, DOI 10.1001/archpedi.1979.02130010094020; RUTTER A, 2000, LANCET, V356, P289; SHREIBER W, 1987, INFECTIO, P207; Stevens FA, 1927, J AMER MED ASSOC, V88, P1957, DOI 10.1001/jama.1927.02680510015006; VONRITTERSHAIN GR, 1978, CENTRALZEITUNG KINDE, V2, P3; WINTERNITZ R, 1898, ARCH DERM SYPH-WIEN, V44, P397; ZAHORSKY J, 1910, PEDIATRICS, V22, P60	22	12	14	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	2001	357	9252					299	301		10.1016/S0140-6736(00)03623-0	http://dx.doi.org/10.1016/S0140-6736(00)03623-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214144				2022-12-28	WOS:000166693400036
J	Muniz, M; Morsomme, P; Riezman, H				Muniz, M; Morsomme, P; Riezman, H			Protein sorting upon exit from the endoplasmic reticulum	CELL			English	Article							COPII-COATED VESICLES; GPI-ANCHORED PROTEINS; GOLGI-COMPLEX; SACCHAROMYCES-CEREVISIAE; TRANSPORT VESICLES; PLASMA-MEMBRANE; SECRETORY PATHWAY; IN-VITRO; BETA-COP; YEAST	It is currently thought that all secretory proteins travel together to the Golgi apparatus where they are sorted to different destinations. However, the specific requirements for transport of GPI-anchored proteins from the endoplasmic reticulum to the Golgi apparatus in yeast could be explained if protein sorting occurs earlier in the pathway. Using an in vitro assay that reconstitutes a single round of budding from the endoplasmic reticulum, we found that GPI-anchored proteins and other secretory proteins exit the endoplasmic reticulum in distinct vesicles. Therefore, GPI-anchored proteins are sorted from other proteins, in particular other plasma membrane proteins, at an early stage of the secretory pathway. These results have wide implications for the mechanism of protein exit from the endoplasmic reticulum.	Univ Basel, Bioctr, CH-4056 Basel, Switzerland	University of Basel	Riezman, H (corresponding author), Univ Basel, Bioctr, Klingelbergstr 70, CH-4056 Basel, Switzerland.		IBIS, EUCARIONTES/H-7494-2016; Morsomme, Pierre/AAD-9600-2019; muñiz, manuel/Q-2890-2019; Nakano, Akihiko/A-6420-2016	muñiz, manuel/0000-0001-8011-6991; Nakano, Akihiko/0000-0003-3635-548X; Morsomme, Pierre/0000-0001-7780-7230; Riezman, Howard/0000-0003-4680-9422				Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Doering TL, 1996, EMBO J, V15, P182, DOI 10.1002/j.1460-2075.1996.tb00346.x; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; FULLER SD, 1985, EMBO J, V4, P297, DOI 10.1002/j.1460-2075.1985.tb03629.x; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Hicke L, 1997, MOL BIOL CELL, V8, P13, DOI 10.1091/mbc.8.1.13; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nishikawa A, 1997, J BIOL CHEM, V272, P19408, DOI 10.1074/jbc.272.31.19408; NUOFFER C, 1991, MOL CELL BIOL, V11, P27, DOI 10.1128/MCB.11.1.27; ORCI L, 1987, CELL, V51, P1039, DOI 10.1016/0092-8674(87)90590-3; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; RINDLER MJ, 1984, J CELL BIOL, V98, P1304, DOI 10.1083/jcb.98.4.1304; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; RUOHOLA H, 1988, J CELL BIOL, V107, P1465, DOI 10.1083/jcb.107.4.1465; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Sipos G, 1997, EMBO J, V16, P3494, DOI 10.1093/emboj/16.12.3494; Sutterlin C, 1997, J CELL SCI, V110, P2703; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	43	207	210	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					313	320		10.1016/S0092-8674(01)00215-X	http://dx.doi.org/10.1016/S0092-8674(01)00215-X			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207371	Bronze			2022-12-28	WOS:000166879700014
J	Ostareck, DH; Ostareck-Lederer, A; Shatsky, IN; Hentze, MW				Ostareck, DH; Ostareck-Lederer, A; Shatsky, IN; Hentze, MW			Lipoxygenase mRNA silencing in erythroid differentiation: The 3 ' UTR regulatory complex controls 60S ribosomal subunit joining	CELL			English	Article							CAP-INDEPENDENT TRANSLATION; MESSENGER-RNA; INITIATION-FACTORS; BINDING-PROTEIN; CYTOPLASMIC POLYADENYLATION; PREVENTS; YEAST; RECRUITMENT; SEQUENCE; FERRITIN	15-lipoxygenase (LOX) expression is translationally silenced in early erythroid precursor cells by a specific mRNA-protein complex formed between the differentiation control element in the 3' untranslated region (UTR) and hnRNPs K and E1. The 3'UTR regulatory complex prevents translation initiation by an unknown mechanism. We demonstrate that the 40S ribosomal subunit can be recruited and scan to the translation initiation codon even when the silencing complex is bound to the 3'UTR. However, the joining of the 60S ribosomal subunit at the AUG codon to form a translation competent 80S ribosome is inhibited, unless initiation is mediated by the IGR-IRES of the cricket paralysis virus. These findings identify the critical step at which LOX mRNA translation is controlled and reveal that 60S subunit joining can be specifically regulated.	European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia	European Molecular Biology Laboratory (EMBL); Lomonosov Moscow State University	Hentze, MW (corresponding author), European Mol Biol Lab, Gene Express Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl-heidelberg.de	Shatsky, Ivan N/A-5331-2012; Hentze, Matthias W/V-3980-2017	Hentze, Matthias W/0000-0002-4023-7876; Ostareck-Lederer, Antje/0000-0003-0733-7071; Ostareck, Dirk/0000-0001-9406-7190				Allen E, 1999, VIROLOGY, V253, P139, DOI 10.1006/viro.1998.9507; ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; CHAKRABARTI A, 1991, J BIOL CHEM, V266, P14039; Cuesta R, 2000, GENE DEV, V14, P1460; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; Das S, 2000, MOL CELL BIOL, V20, P3942, DOI 10.1128/MCB.20.11.3942-3950.2000; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; EHRENFELD E, 1996, TRANSLATIONAL CONTRO, P549; Gavis ER, 1996, DEVELOPMENT, V122, P2791; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Goodwin EB, 1997, DEVELOPMENT, V124, P749; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; HERSHEY JWB, 1966, J MOL BIOL, V18, P68, DOI 10.1016/S0022-2836(66)80077-3; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HOHNE M, 1988, BIOMED BIOCHIM ACTA, V47, P75; HUNT T, 1989, TRENDS BIOCHEM SCI, V14, P393, DOI 10.1016/0968-0004(89)90280-6; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; JACKSON RJ, 1996, TRANSLATIONAL CONTRO, P71; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; Jan E, 1997, EMBO J, V16, P6301, DOI 10.1093/emboj/16.20.6301; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Mathews M. B., 1996, TRANSLATIONAL CONTRO, P1; Merrick WC., 1996, TRANSLATION CONTROL, P31; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; RAPOPORT SM, 1986, BIOCHIM BIOPHYS ACTA, V864, P471, DOI 10.1016/0304-4157(86)90006-7; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; Schneider RJ, 1995, CURR TOP MICROBIOL, V203, P117; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1997, CRIT REV EUKAR GENE, V7, P73, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.50; STRIPECKE R, 1992, NUCLEIC ACIDS RES, V20, P5555, DOI 10.1093/nar/20.21.5555; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Thompson SR, 2000, MOL CELL BIOL, V20, P2129, DOI 10.1128/MCB.20.6.2129-2137.2000; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Wickens M, 2000, TRANSLATIONAL CONTRO; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wormington M, 1996, EMBO J, V15, P900, DOI 10.1002/j.1460-2075.1996.tb00424.x; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	53	211	219	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					281	290		10.1016/S0092-8674(01)00212-4	http://dx.doi.org/10.1016/S0092-8674(01)00212-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207368	hybrid			2022-12-28	WOS:000166879700011
J	von Hippel, PH; Delagouette, E				von Hippel, PH; Delagouette, E			A general model for nucleic acid helicases and their "coupling" within macromolecular machines	CELL			English	Review							TERMINATION FACTOR-RHO; SINGLE-STRANDED-DNA; BACTERIOPHAGE-T4 GENE-41 PROTEIN; ESCHERICHIA-COLI; T4 DNA; KINESIN MOLECULES; BINDING-PROTEIN; ATP HYDROLYSIS; 32 PROTEIN; TRANSCRIPTION		Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	von Hippel, PH (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.			von Hippel, Peter H./0000-0003-2512-8097	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015792, R37GM015792, R01GM029158] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-29158, GM-15792] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; ALBERTS BM, 1970, NATURE, V227, P1313, DOI 10.1038/2271313a0; BARRANTE JR, 1977, PHYSICAL CHEM LIFE S, P192; BARRY J, 1994, J BIOL CHEM, V269, P33049; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; CHEN YZ, 1992, J BIOMOL STRUCT DYN, V10, P415, DOI 10.1080/07391102.1992.10508656; DAUNE M, 1999, MOL BIOPHYSICS STR 1, P38; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; Dong F, 1996, P NATL ACAD SCI USA, V93, P14456, DOI 10.1073/pnas.93.25.14456; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P121, DOI 10.1021/bi00116a018; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; GREVE J, 1978, BIOCHEMISTRY-US, V17, P893, DOI 10.1021/bi00598a023; Gueron M, 1995, METHOD ENZYMOL, V261, P383; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; JENSEN DE, 1976, J BIOL CHEM, V251, P7215; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; LIU CC, 1981, J BIOL CHEM, V256, P2813; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; LONBERG N, 1981, J MOL BIOL, V145, P123, DOI 10.1016/0022-2836(81)90337-5; MATSON SW, 1989, P NATL ACAD SCI USA, V86, P4430, DOI 10.1073/pnas.86.12.4430; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MCGHEE JD, 1977, BIOCHEMISTRY-US, V16, P3267, DOI 10.1021/bi00634a001; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rosenfeld SS, 1996, J BIOL CHEM, V271, P9473, DOI 10.1074/jbc.271.16.9473; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Tackett AJ, 2001, BIOCHEMISTRY-US, V40, P543, DOI 10.1021/bi002122+; TAKAHASHI S, 1979, CAN J BIOCHEM CELL B, V57, P855, DOI 10.1139/o79-105; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; von Hippel PH, 2000, SCIENCE, V287, P2435, DOI 10.1126/science.287.5462.2435; VONHIPPEL PH, 1982, J MOL BIOL, V162, P795, DOI 10.1016/0022-2836(82)90548-4; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; Walstrom KM, 1998, J MOL BIOL, V279, P713, DOI 10.1006/jmbi.1998.1814; WANG Y, 1993, J BIOL CHEM, V268, P13947; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; Wu M, 1999, J MOL BIOL, V286, P1107, DOI 10.1006/jmbi.1999.2541; Young EC, 1998, BIOCHEMISTRY-US, V37, P3467, DOI 10.1021/bi972172n; YOUNG MC, 1994, J MOL BIOL, V235, P1447, DOI 10.1006/jmbi.1994.1100; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297; Zhu AQ, 1998, BIOCHEMISTRY-US, V37, P11215, DOI 10.1021/bi972912s	58	156	168	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2001	104	2					177	190		10.1016/S0092-8674(01)00203-3	http://dx.doi.org/10.1016/S0092-8674(01)00203-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207360	Bronze			2022-12-28	WOS:000166879700002
J	Sampson, SD; Carrano, MT; Forster, CA				Sampson, SD; Carrano, MT; Forster, CA			A bizarre predatory dinosaur from the Late Cretaceous of Madagascar	NATURE			English	Article							EVOLUTION	Here we report the discovery of a small-bodied (similar to1.8 m) predatory dinosaur from the Late Cretaceous (Maastrichtian) of Madagascar. Masiakasaurus knopfleri, gen. et sp. nov., represented by several skull elements and much of the postcranial skeleton, is unique in being the only known theropod with a highly procumbent and distinctly heterodont lower dentition. Such a derived dental morphology is otherwise unknown among dinosaurs. Numerous skeletal characteristics indicate that Masiakasaurus is a member of Abelisauroidea, an enigmatic clade of Gondwanan theropods. Previously, small-bodied abelisauroids were known only from Argentina(1-3). The occurrence of Masiakasaurus on Madagascar suggests that small-bodied abelisauroids, like their larger-bodied counterparts, were more cosmopolitan, radiating throughout much of Gondwana and paralleling the diversification of small coelurosaur theropods in Laurasia.	Univ Utah, Utah Museum Nat Hist, Salt Lake City, UT 84112 USA; Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sampson, SD (corresponding author), Univ Utah, Utah Museum Nat Hist, 1390 E Presidents Circle, Salt Lake City, UT 84112 USA.		Carrano, Matthew/C-7601-2011	Carrano, Matthew/0000-0003-2129-1612				Bonaparte J.F., 1991, Historical Biology, V5, P1; BONAPARTE JF, 1991, PALEONTOLOGIA, V4, P16; BONAPARTE JF, 1996, GEOLOGIE PALAONTOLOG, V30, P73; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; Carrano M. T., 1999, Journal of Vertebrate Paleontology, V19, p36A; Forster CA, 1999, J AFR EARTH SCI, V28, P169, DOI 10.1016/S0899-5362(99)00023-8; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gauthier J.A., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; KRAUSE DW, 1999, GSA TODAY, V9, P1; Novas FE, 1997, ENCY DINOSAURS; Rauhut Oliver W. M., 1998, Journal of Vertebrate Paleontology, V18, p71A; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; von HUENE FRIEDRICH, 1933, MEM GEOL SURV INDIA PALAEONT INDICA, V21, P1	19	102	107	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					504	506		10.1038/35054046	http://dx.doi.org/10.1038/35054046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206544				2022-12-28	WOS:000166570500045
J	Nishimura, H; Okazaki, T; Tanaka, Y; Nakatani, K; Hara, M; Matsumori, A; Sasayama, S; Mizoguchi, A; Hiai, H; Minato, N; Honjo, T				Nishimura, H; Okazaki, T; Tanaka, Y; Nakatani, K; Hara, M; Matsumori, A; Sasayama, S; Mizoguchi, A; Hiai, H; Minato, N; Honjo, T			Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice	SCIENCE			English	Article							ANTIBODIES; DISEASES	Dilated cardiomyopathy is a severe pathology of the heart with poorly understood etiology. Disruption of the gene encoding the negative immunoregulatory receptor PD-1 in BALB/c mice, but not in BALB/c RAG-2(-/-) mice, caused dilated cardiomyopathy with severely impaired contraction and sudden death by congestive heart failure. Affected hearts showed diffuse deposition of immunoglobulin G (IgG) on the surface of cardiomyocytes. ALL of the affected PD-1(-/-) mice exhibited high-titer circulating IgG autoantibodies reactive to a 33-kilodalton protein expressed specifically on the surface of cardiomyocytes. These results indicate that PD-1 may be an important factor contributing to the prevention of autoimmune diseases.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Osaka City Univ, Sch Med, Dept Anat 2, Osaka 5458585, Japan; Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Osaka Metropolitan University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.		Honjo, Tasuku/N-4470-2016	Okazaki, Taku/0000-0003-4790-1925; Tanaka, Yoshimasa/0000-0002-5024-0614				CAFORIO ALP, 1994, LANCET, V344, P773, DOI 10.1016/S0140-6736(94)92339-6; Chen J, 1999, J CLIN INVEST, V103, P1483, DOI 10.1172/JCI7297; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; HOSENPUD JD, 2000, CONGESTIVE HEART FAI, P281; KLEIN R, 1984, CLIN EXP IMMUNOL, V58, P283; Matsumori A, 1997, JPN CIRC J, V61, P275, DOI 10.1253/jcj.61.275; MIZOGUCHI A, 1994, BIOCHEM BIOPH RES CO, V202, P1235, DOI 10.1006/bbrc.1994.2063; Nishimura H, 1998, INT IMMUNOL, V10, P1563, DOI 10.1093/intimm/10.10.1563; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; NISHIMURA H, UNPUB; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; SABN DJ, 1978, CIRCULATION, V58, P1072; Sambrook J., 2002, MOL CLONING LAB MANU; SCHULZE K, 1989, CIRC RES, V64, P179, DOI 10.1161/01.RES.64.2.179; Sedarat F, 2000, AM J PHYSIOL-HEART C, V279, pH202, DOI 10.1152/ajpheart.2000.279.1.H202	16	1286	1476	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					319	322		10.1126/science.291.5502.319	http://dx.doi.org/10.1126/science.291.5502.319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209085				2022-12-28	WOS:000166352900050
J	Lam, DSC; Chan, WM				Lam, DSC; Chan, WM			Choroidal ischemia in preeclampsia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Lam, DSC (corresponding author), Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.		Lam, Dennis/AAL-1211-2020						0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2001	344	10					739	739		10.1056/NEJM200103083441006	http://dx.doi.org/10.1056/NEJM200103083441006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408AX	11236778				2022-12-28	WOS:000167305300006
J	Hanley, B; Truesdale, A; King, A; Elbourne, D; Chalmers, I				Hanley, B; Truesdale, A; King, A; Elbourne, D; Chalmers, I			Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							PATIENT	Objective To assess the extent to which consumers are involved in the work of clinical trial coordinating centres in the United Kingdom and the nature of consumers' involvement in randomised trials coordinated by these centres. Design National surveys using structured questionnaires with some open ended sections. Setting 103 clinical trial coordinating cent-es in the United Kingdom identified through a database assembled in 1997 by the NHS clinical trials adviser. Participants Named contacts at 62 coordinating centres and investigators in 60 trials that were identified as involving consumers. Main outcome measures Number of coordinating centres and number of trials in which consumers were involved and the nature of consumers' involvement Results Of the 62 eligible centres, 23 reported that consumers had already been involved in their work, and most respondents were positive about this involvement 17 centres planned to involve consumers. 15 centres had no plans to involve consumers, but only four of these considered such involvement irrelevant. Responses from investigators about the 48 individual trials were mostly positive, with respondents commenting that input from consumers had helped refine research questions, improve the quality of patient information, and make the trial more relevant to the needs of patients. Conclusions Consumer involvement in the design and conduct of controlled trials seems to be growing and seems to be welcomed by most researchers, Such involvement seems likely to improve the relevance to consumers of the questions addressed and the results obtained in controlled trials.	UK Cochrane Ctr, NHS Res & Dev Programme, Oxford OX2 7LG, England; Univ London London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England; Help Hlth Trust, Consumers NHS Res Support Unit, Winchester SO22 5DH, Hants, England	Cochrane Centre; University of London; London School of Hygiene & Tropical Medicine	Truesdale, A (corresponding author), Univ London London Sch Hyg & Trop Med, Med Stat Unit, Keppel St, London WC1E 7HT, England.							*ASS BRIT PHARM IN, 1992, GOOD CLIN RES PRACT; CARRHILL R, 1999, DATABASE EXAMPLES CO; CHALMERS I, 1995, BRIT MED J, V310, P1315, DOI 10.1136/bmj.310.6990.1315; Chalmers I, 2000, LANCET, V356, P774, DOI 10.1016/S0140-6736(05)73681-3; Edwards SJL, 1998, BRIT MED J, V317, P1209, DOI 10.1136/bmj.317.7167.1209; Epstein S., 1996, IMPURE SCI; Goodare H, 1999, BRIT MED J, V319, P724, DOI 10.1136/bmj.319.7212.724; GRANTPEARCE C, 1998, MISMATCHES PRIORITIE; HANLEY B, 1999, INVOLVEMENT WORKS; Jadad AR, 1998, RANDOMISED CONTROLLE; MARLIN A, 1996, BREAST CANC RES AUST; *MED RES COUNC, 1998, GUID GOOD PRACT CLIN; *NHS EX, 1998, RES WHATS IT CONS; Oliver S, 1997, NONRANDOM REFLECTION, P272; Tallon D, 2000, LANCET, V355, P2037, DOI 10.1016/S0140-6736(00)02351-5; THORNTON H, 1998, NATL CTR CLIN A 0508, P11; THORNTON H, 1997, DUCTAL CARCINOMA IN, P433	17	127	127	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					519	523		10.1136/bmj.322.7285.519	http://dx.doi.org/10.1136/bmj.322.7285.519			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230065	Green Accepted, Bronze, Green Published, Green Submitted			2022-12-28	WOS:000167370500024
J	Cziczo, DJ; Thomson, DS; Murphy, DM				Cziczo, DJ; Thomson, DS; Murphy, DM			Ablation, flux, and atmospheric implications of meteors inferred from stratospheric aerosol	SCIENCE			English	Article							ACCRETION RATE; ABUNDANCES; COLLECTION; PARTICLES; ELEMENTS; OZONE; DUST; IRON	Single-particle analyses of stratospheric aerosol show that about half of the particles contain 0.5 to 1.0 weight percent meteoritic iron by mass, requiring a total extraterrestrial influx of 8 to 38 gigagrams per year. The sodium/iron ratio in these stratospheric particles is higher and the magnesium/iron and calcium/iron ratios are Lower than in chondritic meteorites, implying that the fraction of material that is ablated must lie at the Low end of previous estimates and that the extraterrestrial component that resides in the mesosphere and stratosphere is not of chondritic composition.	NOAA, Aeron Lab, Boulder, CO 80305 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Murphy, DM (corresponding author), NOAA, Aeron Lab, Boulder, CO 80305 USA.	murphyd@al.noaa.gov	Murphy, Daniel/J-4357-2012	Murphy, Daniel/0000-0002-8091-7235				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; [Anonymous], 1999, 44 WORLD MET ORG; Biermann UM, 1996, GEOPHYS RES LETT, V23, P1693, DOI 10.1029/96GL01577; BIGG EK, 1970, TELLUS, V22, P550, DOI 10.1111/j.2153-3490.1970.tb00522.x; BROWNLEE DE, 1981, SEA, V8, pCH18; DAVIS AM, 1994, P 24 LUN PLAN SCI C, P37; GADSEN M, 1961, J ATMOS TERR PHYS, V30, P151; HASHIMOTO A, 1983, GEOCHEM J, V17, P111, DOI 10.2343/geochemj.17.111; Helmer M, 1998, J GEOPHYS RES-ATMOS, V103, P10913, DOI 10.1029/97JD03075; HERRMANN U, 1978, SPACE RES, V18, P249; HOFMANN DJ, 1988, J GEOPHYS RES-ATMOS, V93, P665, DOI 10.1029/JD093iD01p00665; HUGHES DW, 1975, SPACE RES, V15, P531; HUNTEN DM, 1980, J ATMOS SCI, V37, P1342, DOI 10.1175/1520-0469(1980)037<1342:SADPOM>2.0.CO;2; JUNGE CE, 1961, J METEOROL, V18, P81, DOI 10.1175/1520-0469(1961)018<0081:SA>2.0.CO;2; KYTE FT, 1986, SCIENCE, V232, P1225, DOI 10.1126/science.232.4755.1225; Linke W., 1965, SOLUBILITIES INORGAN, V4th ed.; LOVE SG, 1991, ICARUS, V89, P26, DOI 10.1016/0019-1035(91)90085-8; LOVE SG, 1993, SCIENCE, V262, P550, DOI 10.1126/science.262.5133.550; MAURETTE M, 1991, NATURE, V351, P44, DOI 10.1038/351044a0; McNeil WJ, 1998, J GEOPHYS RES-ATMOS, V103, P10899, DOI 10.1029/98JD00282; MOSSOP SC, 1963, NATURE, V199, P325, DOI 10.1038/199325a0; Murphy DM, 1998, SCIENCE, V282, P1664, DOI 10.1126/science.282.5394.1664; MURPHY DM, IN PESS ACCRETION EX; PRATHER MJ, 1988, GEOPHYS RES LETT, V15, P1, DOI 10.1029/GL015i001p00001; Rietmeijer FJM, 2000, METEORIT PLANET SCI, V35, pA136; SHERIDAN PJ, 1994, GEOPHYS RES LETT, V21, P2587, DOI 10.1029/94GL01387; SOLOMON S, 1985, J ATMOS SCI, V42, P1072, DOI 10.1175/1520-0469(1985)042<1072:PATOCM>2.0.CO;2; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; Taylor S, 1998, NATURE, V392, P899, DOI 10.1038/31894; Taylor S, 2000, METEORIT PLANET SCI, V35, P651, DOI 10.1111/j.1945-5100.2000.tb01450.x; Thomson DS, 2000, AEROSOL SCI TECH, V33, P153, DOI 10.1080/027868200410903; TURCO RP, 1981, J GEOPHYS RES-OCEANS, V86, P1113, DOI 10.1029/JC086iC02p01113; von Zahn U, 1999, METEORIT PLANET SCI, V34, P1017, DOI 10.1111/j.1945-5100.1999.tb01421.x	33	112	114	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2001	291	5509					1772	1775		10.1126/science.1057737	http://dx.doi.org/10.1126/science.1057737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230690				2022-12-28	WOS:000167320600055
J	Wilmore, DW; Kehlet, H				Wilmore, DW; Kehlet, H			Recent advances - Management of patients in fast track surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANESTHESIA; MORTALITY		Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Surg, Labs Surg Metab & Nutr, Boston, MA 02215 USA; Hvidovre Univ Hosp, Dept Surg Gastroenterol, DK-2650 Hvidovre, Denmark	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Copenhagen	Wilmore, DW (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Surg, Labs Surg Metab & Nutr, Boston, MA 02215 USA.	dwilmore@partners.org						Basse L, 2000, ANN SURG, V232, P51, DOI 10.1097/00000658-200007000-00008; Bran D F, 1995, AORN J, V62, P810, DOI 10.1016/S0001-2092(06)63534-5; CHEATHAM ML, 1995, ANN SURG, V221, P469, DOI 10.1097/00000658-199505000-00004; COLLIER PE, 1995, AM J SURG, V170, P140, DOI 10.1016/S0002-9610(99)80273-6; Coveney E, 1998, ANN SURG, V227, P496, DOI 10.1097/00000658-199804000-00008; Daltroy LH, 1998, ARTHRIT CARE RES, V11, P469, DOI 10.1002/art.1790110607; Egbert L, 1964, NEW ENGL J MED, V207, P824; Holte K, 2000, BRIT J SURG, V87, P1480, DOI 10.1046/j.1365-2168.2000.01595.x; Kehlet H, 1997, PHYSIOLOGY, STRESS, AND MALNUTRITION, P95; Kehlet H, 1999, WORLD J SURG, V23, P801, DOI 10.1007/s002689900583; Kehlet H, 1999, SURG CLIN N AM, V79, P431, DOI 10.1016/S0039-6109(05)70390-X; Kehlet H, 1997, BRIT J ANAESTH, V78, P606, DOI 10.1093/bja/78.5.606; KEHLET H, 1998, NEURAL BLOCKADE CLIN, P129; Kirsh EJ, 2000, UROLOGY, V56, P101, DOI 10.1016/S0090-4295(00)00594-X; McQuay H, 1997, BMJ-BRIT MED J, V314, P1531, DOI 10.1136/bmj.314.7093.1531; Mezei G, 1999, ANN SURG, V230, P721, DOI 10.1097/00000658-199911000-00016; Mjaland O, 1997, BRIT J SURG, V84, P958, DOI 10.1002/bjs.1800840714; Nierman E, 1999, RHEUM DIS CLIN N AM, V25, P585, DOI 10.1016/S0889-857X(05)70088-0; Podore PC, 1999, J VASC SURG, V29, P787, DOI 10.1016/S0741-5214(99)70204-1; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Power I, 1999, SURG CLIN N AM, V79, P275, DOI 10.1016/S0039-6109(05)70383-2; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Sessler DI, 1997, NEW ENGL J MED, V336, P1730, DOI 10.1056/NEJM199706123362407; Shea JA, 1998, ANN SURG, V227, P343, DOI 10.1097/00000658-199803000-00005; Spath-Schwalbe E, 1998, J CLIN ENDOCR METAB, V83, P1573, DOI 10.1210/jc.83.5.1573; STRUNIN L, 1999, EFFECTIVE MANAGEMENT, P1; Tonnesen H, 1999, BMJ-BRIT MED J, V318, P1311, DOI 10.1136/bmj.318.7194.1311; Tovar EA, 1998, ANN THORAC SURG, V65, P803, DOI 10.1016/S0003-4975(97)01381-7; Trondsen E, 2000, BRIT J SURG, V87, P1708, DOI 10.1046/j.1365-2168.2000.01578.x; WARNER MA, 1993, JAMA-J AM MED ASSOC, V270, P1337; Watcha MF, 2000, ANESTHESIOLOGY, V92, P931, DOI 10.1097/00000542-200004000-00007; White PF, 2000, ANESTH ANALG, V90, P1234, DOI 10.1097/00000539-200005000-00047	32	521	735	4	80	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2001	322	7284					473	476		10.1136/bmj.322.7284.473	http://dx.doi.org/10.1136/bmj.322.7284.473			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406YD	11222424	Green Published			2022-12-28	WOS:000167243000022
J	Harvey, PH; Godfray, CJ				Harvey, PH; Godfray, CJ			Evolution - A horn for an eye	SCIENCE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ London Imperial Coll Sci Technol & Med, Nat Envrionm Res Council Ctr Populat Biol, Ascot SL5 7PY, Berks, England	University of Oxford; Imperial College London	Harvey, PH (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.							ANDERSON JM, 1974, OECOLOGIA, V14, P111, DOI 10.1007/BF00344902; Darwin C, 1890, DESCENT MAN SELECTIO; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; Matthews E.G., 1972, Australian J Zool, VNo. 9, P1; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685	5	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2001	291	5508					1505	1506		10.1126/science.291.5508.1505	http://dx.doi.org/10.1126/science.291.5508.1505			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405HF	11234082				2022-12-28	WOS:000167153400033
J	Dennery, PA; Seidman, DS; Stevenson, DK				Dennery, PA; Seidman, DS; Stevenson, DK			Drug therapy: Neonatal hyperbilirubinemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BIRTH-WEIGHT INFANTS; NEAR-TERM NEWBORNS; BILIRUBIN PRODUCTION; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; SERUM BILIRUBIN; CARBON-MONOXIDE; FULL-TERM; TRANSCUTANEOUS BILIRUBINOMETRY; EARLY DISCHARGE; GREEN LIGHT		Stanford Univ, Sch Med, Dept Neonatol, Stanford, CA 94305 USA; Bikur Cholim Hosp, Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel	Stanford University; Hebrew University of Jerusalem	Dennery, PA (corresponding author), Stanford Univ, Med Ctr, Dept Pediat, Stanford, CA 94305 USA.	dennery@leland.stanford.edu	Dennery, Phyllis/GQG-9113-2022	Dennery, Phyllis/0000-0001-5745-1855	NCRR NIH HHS [RR00070] Funding Source: Medline; NICHD NIH HHS [HD14426] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD014426] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Agrawal V K, 1998, Indian Pediatr, V35, P513; AHLFORS CE, 1994, PEDIATRICS, V93, P488; Akaba K, 1998, BIOCHEM MOL BIOL INT, V46, P21; *AM AC PED, 1997, GUID PER CAR, P183; AMATO MM, 1994, BIOL NEONATE, V66, P288; Bancroft JD, 1998, J PEDIATR-US, V132, P656, DOI 10.1016/S0022-3476(98)70356-7; BERGMAN DA, 1994, PEDIATRICS, V94, P558; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Bhutani VK, 1999, PEDIATRICS, V103, P6, DOI 10.1542/peds.103.1.6; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; BRATLID D, 1990, CLIN PERINATOL, V17, P449, DOI 10.1016/S0095-5108(18)30578-5; BRAVEMAN P, 1995, PEDIATRICS, V96, P716; BRITTON JR, 1994, PEDIATRICS, V94, P291; BRODERSEN R, 1990, ACTA PAEDIATR SCAND, V79, P12, DOI 10.1111/j.1651-2227.1990.tb11323.x; BROUILLARD RP, 1974, JAMA-J AM MED ASSOC, V230, P1304, DOI 10.1001/jama.230.9.1304; BROWN A K, 1962, Adv Pediatr, V12, P121; Chuniaud L, 1996, CLIN CHIM ACTA, V256, P103, DOI 10.1016/S0009-8981(96)06407-8; Conlee JW, 1997, ACTA NEUROPATHOL, V93, P450, DOI 10.1007/s004010050639; CONNOLLY AM, 1990, CLIN PERINATOL, V17, P371, DOI 10.1016/S0095-5108(18)30573-6; CREMER RJ, 1958, LANCET, V1, P1094; Dai J, 1997, CLIN BIOCHEM, V30, P1, DOI 10.1016/S0009-9120(96)00131-2; DAVIS DR, 1987, DEV PHARMACOL THERAP, V10, P12, DOI 10.1159/000457723; DIAMOND LK, 1951, NEW ENGL J MED, V244, P40, DOI 10.1056/NEJM195101112440201; ENNEVER JF, 1990, CLIN PERINATOL, V17, P467, DOI 10.1016/S0095-5108(18)30579-7; ENNEVER JF, 1987, J CLIN INVEST, V79, P1674, DOI 10.1172/JCI113006; FISCHER AF, 1988, J PEDIATR GASTR NUTR, V7, P27, DOI 10.1097/00005176-198801000-00007; Gale R, 1990, J Perinatol, V10, P239; Gartner U, 1997, GASTROENTEROLOGY, V113, P1707, DOI 10.1053/gast.1997.v113.pm9352876; GOPINATHAN V, 1994, FEBS LETT, V349, P197, DOI 10.1016/0014-5793(94)00666-0; Green RM, 1997, GASTROENTEROLOGY, V112, P649, DOI 10.1053/gast.1997.v112.agast970649; Gupta AK, 1998, AM J OTOLARYNG, V19, P232, DOI 10.1016/S0196-0709(98)90123-5; HALAMEK LP, 1997, NEONATAL PERINATAL M, V2, P1345; HANSEN TWR, 1995, PEDIATRICS, V95, P798; Hansen TWR, 1997, ACTA PAEDIATR, V86, P843; Hansen TWR, 1998, BIOL NEONATE, V73, P106, DOI 10.1159/000013966; Hoffman DJ, 1996, PEDIATR RES, V40, P804, DOI 10.1203/00006450-199612000-00005; Holt L. E., 1897, DIS INFANCY CHILDHOO; HOLTROP PC, 1992, AM J DIS CHILD, V146, P235, DOI 10.1001/archpedi.1992.02160140101029; HSIA DYY, 1952, NEW ENGL J MED, V247, P668, DOI 10.1056/NEJM195210302471802; Jackson JC, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e7; JARDINE DS, 1989, PEDIATRICS, V83, P153; JOHNSON JD, 1986, AM J DIS CHILD, V140, P889, DOI 10.1001/archpedi.1986.02140230059032; JOHNSON JD, 1984, AM J DIS CHILD, V138, P1047, DOI 10.1001/archpedi.1984.02140490047011; Johnson L, 1999, PEDIATRICS, V104, P736; Johnson LH, 1999, PEDIATR RES, V45, p203A; JOHNSTON WH, 1967, PEDIATRICS, V39, P88; KANG JH, 1995, AM J PERINAT, V12, P178, DOI 10.1055/s-2007-994446; Kaplan M, 1996, J PEDIATR-US, V128, P695, DOI 10.1016/S0022-3476(96)80138-7; Kaplan M, 1997, P NATL ACAD SCI USA, V94, P12128, DOI 10.1073/pnas.94.22.12128; KAPPAS A, 1995, PEDIATRICS, V95, P468; KAPPAS A, 1986, J CLIN INVEST, V77, P335, DOI 10.1172/JCI112309; Knudsen A, 1996, ARCH DIS CHILD-FETAL, V75, pF53, DOI 10.1136/fn.75.1.F53; Kotal P, 1996, GASTROENTEROLOGY, V111, P217, DOI 10.1053/gast.1996.v111.pm8698202; LAUER BA, 1982, PEDIATRICS, V70, P43; LAVIN A, 1985, SCIENCE, V230, P543, DOI 10.1126/science.4048947; LEVINE RL, 1985, PEDIATR RES, V19, P1040, DOI 10.1203/00006450-198510000-00019; LIVADITIS A, 1974, ACTA PAEDIATR SCAND, V63, P277, DOI 10.1111/j.1651-2227.1974.tb04796.x; LUCEY J, 1968, PEDIATRICS, V41, P1047; MACDONALD MG, 1995, PEDIATRICS, V96, P734; Maisels MJ, 1996, PEDIATRICS, V98, P283; Maisels MJ, 1997, PEDIATRICS, V99, P599, DOI 10.1542/peds.99.4.599; Maisels MJ, 1998, CLIN PERINATOL, V25, P295, DOI 10.1016/S0095-5108(18)30116-7; Maisels MJ, 1999, PEDIATRICS, V103, P493, DOI 10.1542/peds.103.2.493; Maisels MJ, 1998, PEDIATRICS, V101, P995, DOI 10.1542/peds.101.6.995; MAISELS MJ, 1995, PEDIATRICS, V96, P730; MARTICHKRISS V, 1995, AM J NEURORADIOL, V16, P819; Martin-Calama J, 1997, J Hum Lact, V13, P209, DOI 10.1177/089033449701300309; Martinez JC, 1999, PEDIATRICS, V103, P1, DOI 10.1542/peds.103.1.1; MULLON CJ, 1952, PEDIATR RES, V27, P117; MULLON CJP, 1989, PEDIATR RES, V26, P452, DOI 10.1203/00006450-198911000-00018; Myara A, 1997, BIOL NEONATE, V71, P75; NEWMAN TB, 1993, PEDIATRICS, V92, P651; NEWMAN TB, 1990, CLIN PERINATOL, V17, P331, DOI 10.1016/S0095-5108(18)30571-2; NEWMAN TB, 1992, PEDIATRICS, V89, P809; Newman TB, 1999, PEDIATRICS, V104, P1198; ODELL GB, 1983, PEDIATR RES, V17, P810, DOI 10.1203/00006450-198310000-00009; ODELL GB, 1962, PEDIATRICS, V30, P613; PENN AA, 1994, PEDIATRICS, V93, P1003; ROGER C, 1995, DEV BRAIN RES, V87, P194, DOI 10.1016/0165-3806(95)00076-P; SCHEIDT PC, 1977, J PEDIATR-US, V91, P292, DOI 10.1016/S0022-3476(77)80835-4; SCHMORL G, 1904, VERH DTSCH PATHOL GE, V6, P109; SCOTT J, 1990, J PHOTOCH PHOTOBIO B, V7, P149, DOI 10.1016/1011-1344(90)85152-M; SEIDMAN DS, 1991, PEDIATRICS, V88, P828; SEIDMAN DS, 1995, PEDIATRICS, V96, P727; SELLINGER M, 1990, AM J PHYSIOL, V258, pF986, DOI 10.1152/ajprenal.1990.258.4.F986; SILVERMAN WA, 1956, PEDIATRICS, V18, P614; SLUSHER TM, 1995, J PEDIATR-US, V126, P102, DOI 10.1016/S0022-3476(95)70510-4; Stanley TV, 1997, J PAEDIATR CHILD H, V33, P451; STERN L, 1970, AM J DIS CHILD, V120, P26, DOI 10.1001/archpedi.1970.02100060060007; STEVENSON DK, 1994, CLIN CHEM, V40, P1934; STEVENSON DK, 1979, J PEDIATR-US, V94, P956, DOI 10.1016/S0022-3476(79)80232-2; STEVENSON DK, 1989, AM J DIS CHILD, V143, P353, DOI 10.1001/archpedi.1989.02150150111027; TAN KL, 1989, J PEDIATR-US, V114, P132, DOI 10.1016/S0022-3476(89)80620-1; TAN KL, 1987, AUST PAEDIATR J, V23, P185; Tan KL, 1998, ARCH PEDIAT ADOL MED, V152, P1187; TAN KL, 1984, J PEDIATR-US, V104, P284, DOI 10.1016/S0022-3476(84)81014-8; TAN KL, 1991, CLIN PERINATOL, V18, P423, DOI 10.1016/S0095-5108(18)30506-2; VALAES T, 1980, PEDIATR RES, V14, P947, DOI 10.1203/00006450-198008000-00011; Valaes T, 1996, ACTA PAEDIATR, V85, P273, DOI 10.1111/j.1651-2227.1996.tb14013.x; VALAES T, 1994, PEDIATRICS, V93, P1; VANDEBOR M, 1992, PEDIATRICS, V89, P359; VANDEBOR M, 1989, PEDIATRICS, V83, P915; VECCHI C, 1983, PEDIATR RES, V17, P461, DOI 10.1203/00006450-198306000-00006; VOHR BR, 1990, J PEDIATR-US, V117, P288, DOI 10.1016/S0022-3476(05)80549-9; VOLPE JJ, 1995, NEUROLOGY NEWBORN, P490; Vreman Hendrik J., 1998, Pediatric Research, V43, p202A; VREMAN HJ, 1994, CLIN CHEM, V40, P1927; Vreman HJ, 1996, CLIN CHEM, V42, P50; Vreman HJ, 1998, PEDIATR RES, V44, P804, DOI 10.1203/00006450-199811000-00027; VREMAN HJ, 2000, CARBON MONOXIDE TOXI, P22; WATCHKO JF, 1983, PEDIATRICS, V71, P660; Watchko JF, 1998, PEDIATR RES, V44, P763, DOI 10.1203/00006450-199811000-00020; WENNBERG RP, 1993, PEDIATR RES, V34, P6, DOI 10.1203/00006450-199307000-00002; Yetman RJ, 1998, J PEDIATR-US, V133, P705, DOI 10.1016/S0022-3476(98)70117-9; 1958, PEDIATRICS, V95, P458	115	374	392	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2001	344	8					581	590		10.1056/NEJM200102223440807	http://dx.doi.org/10.1056/NEJM200102223440807			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403LU	11207355				2022-12-28	WOS:000167044600007
J	Huntley, JS				Huntley, JS			In search of A Fortunate Man	LANCET			English	Article							MEDICINE		Royal Infirm, Dept Orthopaed, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Huntley, JS (corresponding author), Royal Infirm, Dept Orthopaed, Edinburgh EH3 9YW, Midlothian, Scotland.							Balint M., 1964, DOCTOR HIS PATIENT I; BERGER J, 1968, FORTUNATE MAN; Berger J., 1975, 7 MAN; Berger J., 1989, ANOTHER WAY TELLING; Berger John, 1972, WAYS SEEING; Bolton G, 1999, LANCET, V354, P243, DOI 10.1016/S0140-6736(98)06443-5; Burns-Cox C, 1999, LANCET, V354, P344, DOI 10.1016/S0140-6736(05)75258-2; Camus A., 1942, ESSAIS; Horton R, 1997, LANCET, V349, P872, DOI 10.1016/S0140-6736(97)02336-2; Hull D, 1999, ESSENTIAL PAEDIAT; Jones AH, 1996, LANCET, V348, P1360, DOI 10.1016/S0140-6736(96)09219-7; McLellan MF, 1996, LANCET, V348, P109, DOI 10.1016/S0140-6736(96)03521-0; McLellan MF, 1996, LANCET, V348, P1014, DOI 10.1016/S0140-6736(96)07316-3; NORRELL J, 1993, J ROY SOC MED, V86, P435; ROCK I, 1990, SCI AM, V263, P48; WROE N, 1999, GUARDIAN REV    0213, P8	16	4	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					546	549		10.1016/S0140-6736(00)04047-2	http://dx.doi.org/10.1016/S0140-6736(00)04047-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229685				2022-12-28	WOS:000167011700028
J	Ludwig, DS; Peterson, KE; Gortmaker, SL				Ludwig, DS; Peterson, KE; Gortmaker, SL			Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis	LANCET			English	Article							BODY-MASS INDEX; CHILDREN; REPRODUCIBILITY; ADOLESCENTS; VALIDITY; HEALTH; QUESTIONNAIRE; COMPENSATION; INTERVENTION; OVERWEIGHT	Background The rising prevalence of obesity in children has been linked in part to the consumption of sugar-sweetened drinks. Our aim was to examine this relation. Methods We enrolled 548 ethnically diverse schoolchildren (age 11.7 years, SD 0.8) from public schools in four Massachusetts communities, and studied them prospectively for 19 months from October, 1995, to May. 1997. We examined the association between baseline and change in consumption of sugar-sweetened drinks (the independent variables), and difference in measures of obesity, with linear and logistic regression analyses adjusted for potentially confounding variables and clustering of results within schools. Findings For each additional serving of sugar-sweetened drink consumed, both body mass index (BMI) (mean 0.24 kg/m(2); 95% CI 0.10-0.39; p=0.03) and frequency of obesity (odds ratio 1.60; 95% CI 1.14-2.24; p=0.02) increased after adjustment for anthropometric, demographic, dietary. and lifestyle variables. Baseline consumption of sugar-sweetened drinks was also independently associated with change in BMI (mean 0.18 kg/m(2) for each daily serving; 95% CI 0.09-0.27; p=0.02). Interpretation Consumption of sugar-sweetened drinks is associated with obesity in children.	Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth & Social Behav, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, Boston, MA 02115 USA.	david.ludwig@tch.harvard.edu	Fahimifar, Sepideh/M-5303-2019; Atta, Hussein/B-9059-2009	Atta, Hussein/0000-0003-1118-8347; Ludwig, David/0000-0003-3307-8544	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002440] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-30780] Funding Source: Medline; NIDDK NIH HHS [1K08 DK02440] Funding Source: Medline; PHS HHS [U48/CCU115807] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Allshouse JJ., 1999, FOOD CONSUMPTION PRI; Bellizzi MC, 1999, AM J CLIN NUTR, V70, p173S; BORRUD L, 1997, COMMUN NUTR I, V27, P4; BOWMAN SA, 1999, FAM EC NUTR REV, V12, P31; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Cook T.C., 1979, QUASIEXPERIMENTATION; Daniels SR, 1997, PEDIATRICS, V99, P804, DOI 10.1542/peds.99.6.804; DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P1133, DOI 10.1016/0031-9384(93)90370-U; Field AE, 1999, PUBLIC HEALTH NUTR, V2, P293, DOI 10.1017/S1368980099000397; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3; Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6; HILL JO, 1995, AM J CLIN NUTR, V62, p264S, DOI 10.1093/ajcn/62.1.264S; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Koplan JP, 1999, JAMA-J AM MED ASSOC, V282, P1579, DOI 10.1001/jama.282.16.1579; Lawton CL, 1998, BRIT J NUTR, V80, P149, DOI 10.1017/S0007114598001056; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1; Morton J. F., 1998, FAM EC NUTR REV, V11, P44; MUST A, 1991, AM J CLIN NUTR, V53, P839, DOI 10.1093/ajcn/53.4.839; PETERSON KE, 1996, VALIDATION YRBSS QUE; Rockett HRH, 1997, PREV MED, V26, P808, DOI 10.1006/pmed.1997.0200; ROSNER B, 1988, AM J EPIDEMIOL, V127, P377, DOI 10.1093/oxfordjournals.aje.a114811; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; TROWBRIDGE F, 1993, PUBLIC HEALTH REP, V108, P37; *US BUR CENS, 1998, 1996 STAT ABSTR US; WESTAT I, 1988, NATL HLTH NUTR EXAMI, V3; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	31	1541	1586	2	278	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2001	357	9255					505	508		10.1016/S0140-6736(00)04041-1	http://dx.doi.org/10.1016/S0140-6736(00)04041-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229668				2022-12-28	WOS:000167011700009
J	Li, WH; Gu, ZL; Wang, HD; Nekrutenko, A				Li, WH; Gu, ZL; Wang, HD; Nekrutenko, A			Evolutionary analyses of the human genome	NATURE			English	Article							SEQUENCES	The completion of the human genome will greatly accelerate the development of a new branch of science - evolutionary genomics. We can now directly address important questions about the evolutionary history of human genes and their regulatory sequences. Computational analyses of the human genome will reveal the number of genes and repetitive elements, the extent of gene duplication and compositional heterogeneity in the human genome, and the extent of domain shuffling and domain sharing among proteins. Here we present some first glimpses of these features.	Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Li, WH (corresponding author), Univ Chicago, 1101 E 57th St, Chicago, IL 60637 USA.	whli@uchicago.edu		Li, Wen-Hsiung/0000-0003-1086-1456; Nekrutenko, Anton/0000-0002-5987-8032				Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3	5	301	317	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2001	409	6822					847	849		10.1038/35057039	http://dx.doi.org/10.1038/35057039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237007	Bronze			2022-12-28	WOS:000166938800054
J	Madsen, O; Scally, M; Douady, CJ; Kao, DJ; DeBry, RW; Adkins, R; Amrine, HM; Stanhope, MJ; de Jong, WW; Springer, MS				Madsen, O; Scally, M; Douady, CJ; Kao, DJ; DeBry, RW; Adkins, R; Amrine, HM; Stanhope, MJ; de Jong, WW; Springer, MS			Parallel adaptive radiations in two major clades of placental mammals	NATURE			English	Article							MOLECULAR SEQUENCES; EUTHERIAN MAMMALS; DIVERGENCE; TREE; PHYLOGENY; EVOLUTION; ORIGINS	Higher level relationships among placental mammals, as well as the historical biogeography and morphological diversification of this group, remain unclear(1-3). Here we analyse independent molecular data sets, having aligned lengths of DNA of 5,708 and 2,947 base pairs, respectively, for all orders of placental mammals. Phylogenetic analyses resolve placental orders into four groups: Xenarthra, Afrotheria, Laurasiatheria, and Euarchonta plus Glires. The first three groups are consistently monophyletic with different methods of analysis. Euarchonta plus Glires is monophyletic or paraphyletic depending on the phylogenetic method. A unique nine-base-pair deletion in exon 11 of the BRCA1 gene provides additional support for the monophyly of Afrotheria, which includes proboscideans, sirenians, hyracoids, tubulidentates, macroscelideans, chrysochlorids and tenrecids. Laurasiatheria contains cetartiodactyls, perissodactyls, carnivores, pangolins, bats and eulipotyphlan insectivores. Parallel adaptive radiations have occurred within Laurasiatheria and Afrotheria. In each group, there are aquatic, ungulate and insectivore-like forms.	Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Queens Univ Belfast, Belfast BT9 7BL, Antrim, North Ireland; Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Univ Calif Riverside, Grad Grp Genet, Riverside, CA 92521 USA; SmithKline Beecham Pharmaceut, Collegeville, PA 19426 USA; Inst Biodivers & Ecosyst Dynam, NL-1090 GT Amsterdam, Netherlands	University of California System; University of California Riverside; Radboud University Nijmegen; Queens University Belfast; University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Riverside; GlaxoSmithKline; University of Amsterdam	Springer, MS (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.		Douady, Christophe J/N-1357-2014; Madsen, Ole/E-3730-2012; DeBry, Ronald/K-3444-2015; Douady, Christophe/N-3069-2019	Douady, Christophe J/0000-0002-4503-8040; Madsen, Ole/0000-0001-8082-7881; Douady, Christophe/0000-0002-4503-8040				Asher RJ, 1999, CLADISTICS, V15, P231, DOI 10.1111/j.1096-0031.1999.tb00266.x; de Jong WW, 1998, TRENDS ECOL EVOL, V13, P270, DOI 10.1016/S0169-5347(98)01335-4; Easteal S, 1999, BIOESSAYS, V21, P1052, DOI 10.1002/(SICI)1521-1878(199912)22:1<1052::AID-BIES9>3.0.CO;2-6; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Krajewski C, 1997, MOL PHYLOGENET EVOL, V8, P236, DOI 10.1006/mpev.1997.0421; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Luckett W. P., 1993, Journal of Mammalian Evolution, V1, P127, DOI 10.1007/BF01041591; Matthew W.D., 1909, MEM AM MUS NAT HIST, V9, P291; McKenna MC, 1997, CLASSIFICATION MAMMA; Mouchaty SK, 2000, MOL BIOL EVOL, V17, P60, DOI 10.1093/oxfordjournals.molbev.a026238; NOVACEK MJ, 1986, B AM MUS NAT HIST, V183, P1; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Penny D, 1999, SYST BIOL, V48, P76, DOI 10.1080/106351599260454; RAINGER R, 1991, AGENDA ANTIQUITY HF; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P303; RASMUSSEN DT, 1989, EVOLUTION PERISSODAC, P57; Rich TH, 1997, SCIENCE, V278, P1438, DOI 10.1126/science.278.5342.1438; Shoshani J, 1998, MOL PHYLOGENET EVOL, V9, P572, DOI 10.1006/mpev.1998.0520; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Springer MS, 1997, P NATL ACAD SCI USA, V94, P13754, DOI 10.1073/pnas.94.25.13754; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Swofford David L., 1996, P407; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Waddell PJ, 1999, SYST BIOL, V48, P31, DOI 10.1080/106351599260427	28	517	540	1	128	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					610	614		10.1038/35054544	http://dx.doi.org/10.1038/35054544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214318				2022-12-28	WOS:000166692300042
J	Munte, TF; Kohlmetz, C; Nager, W; Altenmuller, E				Munte, TF; Kohlmetz, C; Nager, W; Altenmuller, E			Neuroperception - Superior auditory spatial tuning in conductors	NATURE			English	Article							ATTENTION		Univ Magdeburg, Dept Neuropsychol, D-39016 Magdeburg, Germany; Hannover Acad Music & Theatre, Inst Music Physiol & Performing Arts, D-30175 Hannover, Germany; Hannover Med Sch, Dept Neurol, D-30623 Hannover, Germany	Otto von Guericke University; Hannover Medical School	Munte, TF (corresponding author), Univ Magdeburg, Dept Neuropsychol, POB 4120, D-39016 Magdeburg, Germany.		Münte, Thomas/C-2077-2014; Altenmuller, Eckart/AAB-9948-2021					Bregman A.S., 1990, AUDITORY SCENE ANAL; Feng AS, 2000, ANNU REV PSYCHOL, V51, P699, DOI 10.1146/annurev.psych.51.1.699; Grady CL, 1997, NEUROREPORT, V8, P2511, DOI 10.1097/00001756-199707280-00019; MONDOR TA, 1995, J EXP PSYCHOL HUMAN, V21, P387, DOI 10.1037/0096-1523.21.2.387; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Schuller Gunther, 1997, COMPLEAT CONDUCTOR; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722	8	84	84	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					580	580		10.1038/35054668	http://dx.doi.org/10.1038/35054668			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214309				2022-12-28	WOS:000166692300033
J	Carr, PD; Gustin, SE; Church, AP; Murphy, JM; Ford, SC; Mann, DA; Woltring, DM; Walker, I; Ollis, DL; Young, IG				Carr, PD; Gustin, SE; Church, AP; Murphy, JM; Ford, SC; Mann, DA; Woltring, DM; Walker, I; Ollis, DL; Young, IG			Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration	CELL			English	Article							COLONY-STIMULATING FACTOR; HIGH-AFFINITY BINDING; CRYSTAL-STRUCTURE; HUMAN INTERLEUKIN-5; ALPHA-CHAIN; ERYTHROPOIETIN RECEPTOR; CYTOKINE RECEPTORS; GROWTH-HORMONE; PROTEIN AIC2A; IDENTIFICATION	The receptor systems for the hemopoietic cytokines GM-CSF, IL-3, and IL-5 consist of ligand-specific alpha receptor subunits that play an essential role in the activation of the shared betac subunit, the major signaling entity. Here, we report the structure of the complete betac extracellular domain. It has a structure unlike any class I cytokine receptor described thus far, forming a stable interlocking dimer in the absence of ligand in which the G strand of domain 1 hydrogen bonds into the corresponding beta sheet of domain 3 of the dimer-related molecule. The G strand of domain 3 similarly partners with the dimer-related domain 1. The structure provides new insights into receptor activation by the respective ru receptor:ligand complexes.	Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Canberra, ACT 2601, Australia; Australian Natl Univ, Res Sch Chem, Acton, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Young, IG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Canberra, ACT 2601, Australia.	ian.young@anu.edu.au	Ollis, David/I-5967-2014; Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949				Aritomi M, 1999, NATURE, V401, P713, DOI 10.1038/44394; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRY SC, 1994, J BIOL CHEM, V269, P8488; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1996, X PLOR VERSION 3 85; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Dickason RR, 1996, NATURE, V379, P652, DOI 10.1038/379652a0; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GORMAN DM, 1990, P NATL ACAD SCI USA, V87, P5459, DOI 10.1073/pnas.87.14.5459; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Haman A, 1999, J BIOL CHEM, V274, P34155, DOI 10.1074/jbc.274.48.34155; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HERCUS TR, 1994, P NATL ACAD SCI USA, V91, P5838, DOI 10.1073/pnas.91.13.5838; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Ihle JN, 1997, STEM CELLS, V15, P105, DOI 10.1002/stem.5530150814; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kishore R, 1997, J BIOL CHEM, V272, P17078, DOI 10.1074/jbc.272.27.17078; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; LOCK P, 1994, P NATL ACAD SCI USA, V91, P252, DOI 10.1073/pnas.91.1.252; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; Mulhern TD, 2000, J MOL BIOL, V297, P989, DOI 10.1006/jmbi.2000.3610; Muto A, 1996, J EXP MED, V183, P1911, DOI 10.1084/jem.183.4.1911; Niu LH, 2000, BLOOD, V95, P3357, DOI 10.1182/blood.V95.11.3357.011k43_3357_3362; OGOROCHI T, 1992, BLOOD, V79, P895; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Rossjohn J, 2000, BLOOD, V95, P2491; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; SATO N, 1994, CURR OPIN CELL BIOL, V6, P174, DOI 10.1016/0955-0674(94)90133-3; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Stomski FC, 1998, J BIOL CHEM, V273, P1192, DOI 10.1074/jbc.273.2.1192; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; TAVERNIER J, 1995, P NATL ACAD SCI USA, V92, P5194, DOI 10.1073/pnas.92.11.5194; Verschelde JL, 1998, FEBS LETT, V424, P121, DOI 10.1016/S0014-5793(98)00146-X; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WANG HM, 1992, J BIOL CHEM, V267, P979; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Zhang J, 1999, ANAL BIOCHEM, V268, P134, DOI 10.1006/abio.1998.3058	52	81	88	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					291	300		10.1016/S0092-8674(01)00213-6	http://dx.doi.org/10.1016/S0092-8674(01)00213-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207369	Bronze			2022-12-28	WOS:000166879700012
J	Ma, DK; Zerangue, N; Lin, YF; Collins, A; Yu, M; Jan, YN; Jan, LY				Ma, DK; Zerangue, N; Lin, YF; Collins, A; Yu, M; Jan, YN; Jan, LY			Role of ER export signals in controlling surface potassium channel numbers	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN; GOLGI	Little is known about the identity of endoplasmic reticulum (ER) export signals and how they are used to regulate the number of proteins on the cell surface. Here, we describe two ER export signals that profoundly altered the steady-state distribution of potassium channels and were required for channel localization to the plasma membrane. When transferred to other potassium channels or a G protein-coupled receptor, these ER export signals increased the number of functional proteins on the cell surface. Thus, ER export of membrane proteins is not necessarily limited by folding or assembly, but may be under the control of specific export signals.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Oregon State University	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Jan, Lily/0000-0003-3938-8498; /0000-0002-6129-2938; Jan, Yuh Nung/0000-0003-1367-6299; Lin, Yu-Fung/0000-0003-1471-949X				BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7; Hille B., 1992, IONIC CHANNELS EXCIT; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Kennedy ME, 1999, J BIOL CHEM, V274, P2571, DOI 10.1074/jbc.274.4.2571; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MIZUNO M, 1993, P NATL ACAD SCI USA, V90, P5732, DOI 10.1073/pnas.90.12.5732; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; ROTHMAN JE, 1987, CELL, V50, P521, DOI 10.1016/0092-8674(87)90024-9; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	15	309	344	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 12	2001	291	5502					316	319		10.1126/science.291.5502.316	http://dx.doi.org/10.1126/science.291.5502.316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209084				2022-12-28	WOS:000166352900049
J	Cullington, HE				Cullington, HE			Light eye colour linked to deafness after meningitis	BRITISH MEDICAL JOURNAL			English	Article									Univ Southampton, Inst Sound & Vibrat Res, Hearing & Balance Ctr, Southampton SO17 1BJ, Hants, England	University of Southampton	Cullington, HE (corresponding author), Univ Southampton, Inst Sound & Vibrat Res, Hearing & Balance Ctr, Southampton SO17 1BJ, Hants, England.		Cullington, Helen/B-5540-2016	Cullington, Helen/0000-0002-5093-2020				BARRENAS ML, 1990, SCAND AUDIOL, V19, P97, DOI 10.3109/01050399009070759; HENNEBERGER PK, 1983, AM J EPIDEMIOL, V117, P484, DOI 10.1093/oxfordjournals.aje.a113566; TODD NW, 1995, J LARYNGOL OTOL, V109, P926, DOI 10.1017/S002221510013169X	3	10	10	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					587	587						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238154				2022-12-28	WOS:000167499900024
J	Burnett, A; Peel, M				Burnett, A; Peel, M			Asylum seekers and refugees in Britain - Health needs of asylum seekers and refugees	BRITISH MEDICAL JOURNAL			English	Article							IMMIGRANTS; CARE		Med Fdn Care Victims Torture, London NW5 3EJ, England		Burnett, A (corresponding author), Med Fdn Care Victims Torture, London NW5 3EJ, England.							Acheson D., 1998, INDEPENDENT INQUIRY; BARISO EU, 1997, HORN AFRICA HLTH RES; BRACKEN PJ, 1995, SOC SCI MED, V40, P1073, DOI 10.1016/0277-9536(94)00181-R; *BRENT HARR HLTH A, 1995, BRENT HARR REF SURV; Burnett A, 1999, GUIDELINES HEALTHWOR; CIENFUEGOS AJ, 1983, AM J ORTHOPSYCHIAT, V53, P43, DOI 10.1111/j.1939-0025.1983.tb03348.x; Connelly J, 2000, BRIT MED J, V321, P5, DOI 10.1136/bmj.321.7252.5; DICK B, 1984, T ROY SOC TROP MED H, V78, P734, DOI 10.1016/0035-9203(84)90004-X; *E OLDF UN, 1997, GUID PROV COUNS TRAI; EPSTEIN H, 1996, SUNDAY TIMES    0218; Fassil Y, 2000, BRIT MED J, V321, P59, DOI 10.1136/bmj.321.7252.59; Ferron S., 2000, HYGIENE PROMOTION PR; GAMMELL H, 1993, REFUGES POLITICAL AS; GARCIASAMANIEGO J, 1994, AM J GASTROENTEROL, V89, P1918; Gorst-Unsworth C, 1998, BRIT J PSYCHIAT, V172, P90, DOI 10.1192/bjp.172.1.90; *HLTH ED AUTH EXP, 1998, PROM HLTH REF; Kansu F, 1997, ASSESSING HLTH NEEDS, P44; KARMI G, 1992, BRIT MED J, V305, P205, DOI 10.1136/bmj.305.6847.205; MCAFEE B, 1998, REPORT BOSNIAN MENTA; Melzak S, 1999, WORKING CHILDREN ADO; ORMEROD LP, 1990, RESP MED, V84, P269, DOI 10.1016/S0954-6111(08)80051-0; PATEL N, 1999, THIS MADNESS ARTICAL; *PRAX, 1998, HOST INN SCHEM MEET; Richman N., 1998, MIDST WHIRLWIND MANU; SHACKMAN J, 1996, MENTAL HLTH MATTERS; Sinnerbrink I, 1996, MED J AUSTRALIA, V165, P634, DOI 10.5694/j.1326-5377.1996.tb138671.x; Summerfield D., 1995, TRAUMA; SUMMERFIELD D, 1996, IMPACT WAR ATRACITY; SUMMERFIELD D, 1995, DEV PRACTICE, V5, P352; Victorian Foundation for Survivors of Torture, 1998, REF HLTH GEN PRACT; Walker PF, 1999, MED CLIN N AM, V83, P1103; WALLACE T, 1990, REFUGEE WOMEN THEIR; WATTERS C, 1998, CURRENT ISSUES ASYLU; WOOD JC, 1995, HOME OFFICE RES STUD, V141	34	218	219	2	20	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					544	547		10.1136/bmj.322.7285.544	http://dx.doi.org/10.1136/bmj.322.7285.544			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230074	Green Published			2022-12-28	WOS:000167370500035
J	Hutchon, DJR				Hutchon, DJR			Publishing raw data and real time statistical analysis on e-journals	BRITISH MEDICAL JOURNAL			English	Article									Mem Hosp, Durham DL3 6HX, England		Hutchon, DJR (corresponding author), Mem Hosp, Durham DL3 6HX, England.								0	26	26	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					530	530		10.1136/bmj.322.7285.530	http://dx.doi.org/10.1136/bmj.322.7285.530			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230070	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000167370500030
J	Turpie, AGG; Gallus, AS; Hoek, JA				Turpie, AGG; Gallus, AS; Hoek, JA		Pentasaccharide Investigators	A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOSIS; STANDARD HEPARIN; GENERATION; INHIBITION	Background: Venous thromboembolism is a frequent complication of total hip replacement. The pentasaccharide Org31540/SR90107A, a highly selective, indirect inhibitor of activated factor X, is the first of a new class of synthetic antithrombotic agents. To determine the optimal dose for phase 3 studies, we conducted a dose-ranging study in which Org31540/SR90107A was compared with a low-molecular-weight heparin, enoxaparin, in patients undergoing total hip replacement. Methods: In a double-blind study, patients were randomly assigned to postoperative administration of one of five daily doses of Org31540/SR90107A, given once daily, or to 30 mg of enoxaparin, given every 12 hours. Treatment was continued for 10 days or until bilateral venography was performed after a minimum of 5 days. Results: Of 933 patients treated, 593 were eligible for the efficacy analysis. With Org31540/SR90107A a dose effect was observed (P = 0.002), with rates of venous thromboembolism of 11.8 percent, 6.7 percent, 1.7 percent, 4.4 percent, and 0 percent for the groups assigned to 0.75 mg, 1.5 mg, 3.0 mg, 6.0 mg, and 8.0 mg of the drug, respectively, as compared with a rate of 9.4 percent in the enoxaparin group. The reduction in the risk of venous thromboembolism was 82 percent for the 3.0-mg Org31540/SR90107A group (P = 0.01) and 29 percent for the 1.5-mg group (P = 0.51). Enrollment in the 6.0-mg and 8.0-mg Org31540/SR90107A groups was discontinued because of bleeding complications. Major bleeding occurred 3.5 percent less frequently in the 0.75-mg group (P = 0.01) and 3.0 percent less frequently in the 1.5-mg group (P = 0.05) than in the enoxaparin group (in which the rate was similar to that in the 3.0-mg group). Conclusions: Org31540/SR90107A, a synthetic pentasaccharide, has the potential to improve significantly the risk-benefit ratio for the prevention of venous thromboembolism, as compared with low-molecular-weight heparin. (N Engl J Med 2001;344:619-25.) Copyright (C) 2001 Massachusetts Medical Society.	McMaster Univ, Hamilton, ON, Canada; Flinders Med Ctr, Adelaide, SA, Australia; Sanofi Synthelabo Res, Malvern, PA USA	McMaster University; Flinders Medical Centre; Sanofi-Aventis	Turpie, AGG (corresponding author), Hamilton Hlth Sci, Gen Div, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	turpica@mcmaster.ca	Hoek, Janet/A-5186-2010	Hoek, Janet/0000-0003-4362-1539; Gallus, Alexander/0000-0001-7347-9989				World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Clagett GP, 1998, CHEST, V114, p531S, DOI 10.1378/chest.114.5_Supplement.531S; Eriksson BI, 1997, NEW ENGL J MED, V337, P1329, DOI 10.1056/NEJM199711063371901; Ginsberg JS, 1996, NEW ENGL J MED, V335, P1816, DOI 10.1056/NEJM199612123352407; Herbert JM, 1996, CIRC RES, V79, P590, DOI 10.1161/01.RES.79.3.590; Kearon C, 1998, ANN INTERN MED, V129, P425, DOI 10.7326/0003-4819-128-8-199804150-00011; Lormeau JC, 1995, THROMB HAEMOSTASIS, V74, P1474; LORMEAU JC, 1993, THROMB HAEMOSTASIS, V69, P152; *MED EC, 2000, PHYS DESK REF, P2560; NURMOHAMED MT, 1992, LANCET, V340, P152, DOI 10.1016/0140-6736(92)93223-A; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Patel H I, 1992, J Biopharm Stat, V2, P1, DOI 10.1080/10543409208835027; PATEL HI, 1994, J BIOPHARM STAT, V4, P127; PETITOU M, 1991, NATURE, V350, P30; Planes A, 1999, THROMB HAEMOSTASIS, V81, P22; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Turpie AGG, 1998, ORTHOPEDICS, V21, P1275; VANBOECKEL CAA, 1993, ANGEW CHEM INT EDIT, V32, P1671, DOI 10.1002/anie.199316713; Walenga JM, 1997, THROMB RES, V86, P1, DOI 10.1016/S0049-3848(97)00042-X; WALENGA JM, 1988, THROMB RES, V51, P23, DOI 10.1016/0049-3848(88)90279-4; WALENGA JM, 1991, THROMB HAEMORRHAGIC, P53; WESSLER S, 1974, THROMB DIATH HAEMOST, V32, P71, DOI 10.1055/s-0038-1647674; WESSLER S, 1975, THROMB DIATH HAEMOST, V33, P81, DOI 10.1055/s-0038-1647815; 1994, GOOD CLIN PRACT J S, V1	24	305	315	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2001	344	9					619	625		10.1056/NEJM200103013440901	http://dx.doi.org/10.1056/NEJM200103013440901			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405TR	11228275				2022-12-28	WOS:000167177100001
J	Auer, S; Frenkel, D				Auer, S; Frenkel, D			Prediction of absolute crystal-nucleation rate in hard-sphere colloids	NATURE			English	Article							MONTE-CARLO; CRYSTALLIZATION; BCC; ENTROPY; LIQUIDS	Crystal nucleation is a much-studied phenomenon, yet the rate at which it occurs remains difficult to predict. Small crystal nuclei form spontaneously in supersaturated solutions, but unless their size exceeds a critical value-the so-called critical nucleus-they will re-dissolve rather than grow. It is this rate-limiting step that has proved difficult to probe experimentally. The crystal nucleation rate depends on P-crit, the (very small) probability that a critical nucleus forms spontaneously, and on a kinetic factor (kappa) that measures the rate at which critical nuclei subsequently grow. Given the absence of a priori knowledge of either quantity, classical nucleation theory(1) is commonly used to analyse crystal nucleation experiments, with the unconstrained parameters adjusted to fit the observations. This approach yields no 'first principles' prediction of absolute nucleation rates. Here we approach the problem from a different angle, simulating the nucleation process in a suspension of hard colloidal spheres, to obtain quantitative numerical predictions of the crystal nucleation rate. We find large discrepancies between the computed nucleation rates and those deduced from experiments(2-4): the best experimental estimates of P-crit seem to be too large by several orders of magnitude.	FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands	AMOLF	Frenkel, D (corresponding author), FOM, Inst Atom & Mol Phys, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.		Auer, Stefan/F-8395-2011; Frenkel, Daan/G-2580-2014	Frenkel, Daan/0000-0002-6362-2021				ALEXANDER S, 1978, PHYS REV LETT, V41, P702, DOI 10.1103/PhysRevLett.41.702; Bolhuis PG, 1997, NATURE, V388, P235, DOI 10.1038/40779; CHENG Z, 1998, THESIS PRINCETON U; CICHOCKI B, 1990, PHYSICA A, V166, P473, DOI 10.1016/0378-4371(90)90068-4; Davidchack RL, 2000, PHYS REV LETT, V85, P4751, DOI 10.1103/PhysRevLett.85.4751; GEYER CJ, 1995, J AM STAT ASSOC, V90, P909, DOI 10.1080/01621459.1995.10476590; Groh B, 1999, PHYS REV E, V59, P5613, DOI 10.1103/PhysRevE.59.5613; HALL KR, 1972, J CHEM PHYS, V57, P2252, DOI 10.1063/1.1678576; Harland JL, 1997, PHYS REV E, V55, P3054, DOI 10.1103/PhysRevE.55.3054; HOOVER WG, 1968, J CHEM PHYS, V49, P3609, DOI 10.1063/1.1670641; KELTON KF, 1991, SOLID STATE PHYS, V45, P75; KLEIN W, 1986, PHYS REV LETT, V57, P2845, DOI 10.1103/PhysRevLett.57.2845; Mau SC, 1999, PHYS REV E, V59, P4396, DOI 10.1103/PhysRevE.59.4396; MEDINANOYOLA M, 1988, PHYS REV LETT, V60, P2705, DOI 10.1103/PhysRevLett.60.2705; Ostwald W., 1897, Z PHYS CHEM, V22, P289, DOI [DOI 10.1515/ZPCH-1897-2233, 10.1515/zpch-1897-2233]; Pronk S, 1999, J CHEM PHYS, V110, P4589, DOI 10.1063/1.478339; PUSEY PN, 1989, PHYS REV LETT, V63, P2753, DOI 10.1103/PhysRevLett.63.2753; SCHATZEL K, 1993, PHYS REV E, V48, P3766, DOI 10.1103/PhysRevE.48.3766; TENWOLDE PR, 1995, PHYS REV LETT, V75, P2714, DOI 10.1103/PhysRevLett.75.2714; TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0; Van Duijneveldt J. S., 1995, SCI TECHNOLOGY CRYST, P279; VANDUIJNEVELDT JS, 1992, J CHEM PHYS, V96, P4655, DOI 10.1063/1.462802; Zhu JX, 1997, NATURE, V387, P883, DOI 10.1038/43141	23	768	773	10	339	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1020	1023		10.1038/35059035	http://dx.doi.org/10.1038/35059035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234006	Green Published			2022-12-28	WOS:000167148800039
J	Cole, ST; Eiglmeier, K; Parkhill, J; James, KD; Thomson, NR; Wheeler, PR; Honore, N; Garnier, T; Churcher, C; Harris, D; Mungall, K; Basham, D; Brown, D; Chillingworth, T; Connor, R; Davies, RM; Devlin, K; Duthoy, S; Feltwell, T; Fraser, A; Hamlin, N; Holroyd, S; Hornsby, T; Jagels, K; Lacroix, C; Maclean, J; Moule, S; Murphy, L; Oliver, K; Quail, MA; Rajandream, MA; Rutherford, KM; Rutter, S; Seeger, K; Simon, S; Simmonds, M; Skelton, J; Squares, R; Squares, S; Stevens, K; Taylor, K; Whitehead, S; Woodward, JR; Barrell, BG				Cole, ST; Eiglmeier, K; Parkhill, J; James, KD; Thomson, NR; Wheeler, PR; Honore, N; Garnier, T; Churcher, C; Harris, D; Mungall, K; Basham, D; Brown, D; Chillingworth, T; Connor, R; Davies, RM; Devlin, K; Duthoy, S; Feltwell, T; Fraser, A; Hamlin, N; Holroyd, S; Hornsby, T; Jagels, K; Lacroix, C; Maclean, J; Moule, S; Murphy, L; Oliver, K; Quail, MA; Rajandream, MA; Rutherford, KM; Rutter, S; Seeger, K; Simon, S; Simmonds, M; Skelton, J; Squares, R; Squares, S; Stevens, K; Taylor, K; Whitehead, S; Woodward, JR; Barrell, BG			Massive gene decay in the leprosy bacillus	NATURE			English	Article							MYCOBACTERIUM-LEPRAE; GENOME SEQUENCE; TUBERCULOSIS; IDENTIFICATION; CLUSTER; DOMAIN	Leprosy, a chronic human neurological disease, results from infection with the obligate intracellular pathogen Mycobacterium leprae, a close relative of the tubercle bacillus. Mycobacterium leprae has the longest doubling time of all known bacteria and has thwarted every effort at culture in the laboratory. Comparing the 3.27-megabase (Mb) genome sequence of an armadillo-derived Indian isolate of the leprosy bacillus with that of Mycobacterium tuberculosis (4.41 Mb) provides clear explanations for these properties and reveals an extreme case of reductive evolution. Less than half of the genome contains functional genes but pseudogenes, with intact counterparts in M. tuberculosis, abound. Genome downsizing and the current mosaic arrangement appear to have resulted from extensive recombination events between dispersed repetitive sequences. Gene deletion and decay have eliminated many important metabolic activities including siderophore production, part of the oxidative and most of the microaerophilic and anaerobic respiratory chains, and numerous catabolic systems and their regulatory circuits.	Inst Pasteur, Unite Genet Mol Bacterienne, F-75724 Paris 15, France; Sanger Ctr, Hinxton CB10 1SA, England; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Wellcome Trust Sanger Institute; Veterinary Laboratories Agency	Cole, ST (corresponding author), Inst Pasteur, Unite Genet Mol Bacterienne, 28 Rue Docteur Roux, F-75724 Paris 15, France.		Wheeler, Paul/C-6709-2011; Quail, michael/ABE-6131-2020; Parkhill, Julian/G-4703-2011; Rutherford, Kim/Y-7995-2018; Thomson, Nicholas/P-5988-2014	Parkhill, Julian/0000-0002-7069-5958; Rutherford, Kim/0000-0001-6277-726X; Thomson, Nicholas/0000-0002-4432-8505; Murphy, Lee/0000-0001-6467-7449				ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Brosch R, 2000, RES MICROBIOL, V151, P135, DOI 10.1016/S0923-2508(00)00117-0; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cole ST, 1999, FEBS LETT, V452, P7, DOI 10.1016/S0014-5793(99)00536-0; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; DRAPER P, 1982, ANN INST PASTEUR MIC, VB133, P39; EIGLMEIER K, 1993, MOL MICROBIOL, V7, P197, DOI 10.1111/j.1365-2958.1993.tb01111.x; Eiglmeier K, 1997, FEMS MICROBIOL LETT, V149, P273, DOI 10.1111/j.1574-6968.1997.tb10340.x; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; FRANZBLAU SG, 1989, ANTIMICROB AGENTS CH, V33, P2115, DOI 10.1128/AAC.33.12.2115; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gordon SV, 1999, MICROBIOL-SGM, V145, P881, DOI 10.1099/13500872-145-4-881; HALL RM, 1983, INT J LEPROSY, V51, P490; Hansen GHA., 1874, NORSK MAG LAEGEVIDEN, V4, P1; Jungblut PR, 1999, MOL MICROBIOL, V33, P1103, DOI 10.1046/j.1365-2958.1999.01549.x; KIRCHHEIMER W F, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P693; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; Marques MAM, 1998, INFECT IMMUN, V66, P2625, DOI 10.1128/IAI.66.6.2625-2631.1998; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MELANCONKAPLAN J, 1988, P NATL ACAD SCI USA, V85, P1917, DOI 10.1073/pnas.85.6.1917; Mizrahi V, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P159; NORDEEN SK, 1993, TROPICAL DIS RES PRO, P47; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Peterson JA, 1998, STRUCTURE, V6, P1079, DOI 10.1016/S0969-2126(98)00109-9; Philipp WJ, 1998, ELECTROPHORESIS, V19, P573, DOI 10.1002/elps.1150190418; POULET S, 1995, ARCH MICROBIOL, V163, P79, DOI 10.1007/BF00381780; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; RATLEDGE CR, 1982, BIOL MYCOBACTERIA, P53; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sheppard CC, 1985, LEPROSY, P269; Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857; Smith DR, 1997, GENOME RES, V7, P802, DOI 10.1101/gr.7.8.802; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Wheeler Paul R., 1994, P353; WHEELER PR, 1984, J GEN MICROBIOL, V130, P381; *WHO, 1998, WHO WEEKLY EPIDEMIOL, V73, P40; Wolf YI, 1999, GENOME RES, V9, P689; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; ZUBENTRUP KH, 1999, J BACTERIOL, V181, P7161	50	1281	2012	0	106	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1007	1011		10.1038/35059006	http://dx.doi.org/10.1038/35059006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234002				2022-12-28	WOS:000167148800035
J	Inoue, T; Higuchi, M; Hashimoto, Y; Seki, M; Kobayashi, M; Kato, T; Tabata, S; Shinozaki, K; Kakimoto, T				Inoue, T; Higuchi, M; Hashimoto, Y; Seki, M; Kobayashi, M; Kato, T; Tabata, S; Shinozaki, K; Kakimoto, T			Identification of CRE1 as a cytokinin receptor from Arabidopsis	NATURE			English	Article							SIGNAL-TRANSDUCTION; RESPONSE REGULATORS; HISTIDINE KINASE; THALIANA; ETHYLENE; MUTANTS; GENE; SIMILARITY; OSMOSENSOR; VECTORS	Cytokinins are a class of plant hormones that are central to the regulation of cell division and differentiation in plants(1,2). It has been proposed that they are detected by a two-component system, because overexpression of the histidine kinase gene CKI1 induces typical cytokinin responses(3) and genes for a set of response regulators of two-component systems can be induced by cytokinins(4,5). Two-component systems use a histidine kinase as an environmental sensor and rely on a phosphorelay for signal transduction. They are common in microorganisms, and are also emerging as important signal detection routes in plants(6-9). Here we report the identification of a cytokinin receptor. We identified Arabidopsis cre1 (cytokinin response 1) mutants, which exhibited reduced responses to cytokinins. The mutated gene CRE1 encodes a histidine kinase. CRE1 expression conferred a cytokinin-dependent growth phenotype on a yeast mutant that lacked the endogenous histidine kinase SLN1 (ref. 10), providing direct evidence that CRE1 is a cytokinin receptor. We also provide evidence that cytokinins can activate CRE1 to initiate phosphorelay signalling.	Osaka Univ, Grad Sch Sci, Dept Biol, Osaka 5600043, Japan; RIKEN, Tsukuba Inst, Plant Mol Biol Lab, Tsukuba, Ibaraki 3050074, Japan; Kazusa DNA Res Inst, Chiba 2920812, Japan	Osaka University; RIKEN; Kazusa DNA Research Institute	Kakimoto, T (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol, Osaka 5600043, Japan.		Seki, Motoaki/I-2854-2012; Shinozaki, Kazuo/G-4202-2013; Ding, Cheng-Qiang/B-6287-2011	Seki, Motoaki/0000-0001-8288-0467; Shinozaki, Kazuo/0000-0002-6317-9867; 				AKAMA K, 1992, PLANT CELL REP, V12, P7, DOI 10.1007/BF00232413; BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; D'Agostino IB, 1999, TRENDS BIOCHEM SCI, V24, P452, DOI 10.1016/S0968-0004(99)01465-6; HAYASHI H, 1992, SCIENCE, V258, P1350, DOI 10.1126/science.1455228; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Kubo M, 2000, PLANT J, V23, P385, DOI 10.1046/j.1365-313x.2000.00796.x; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; MCKINNEY EC, 1995, PLANT J, V8, P613, DOI 10.1046/j.1365-313X.1995.8040613.x; Miyata S, 1998, FEBS LETT, V437, P11, DOI 10.1016/S0014-5793(98)01188-0; Mizuno T, 1998, J BIOCHEM, V123, P555; Mok MC., 1994, CYTOKININS CHEM ACTI, P155, DOI DOI 10.1201/9781351071284; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Sakakibara H, 1998, PLANT J, V14, P337, DOI 10.1046/j.1365-313X.1998.00134.x; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; SCHMITZ RY, 1972, PLANT PHYSIOL, V50, P702, DOI 10.1104/pp.50.6.702; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Suzuki T, 1998, PLANT CELL PHYSIOL, V39, P1258, DOI 10.1093/oxfordjournals.pcp.a029329; UEGUCHI C, IN PRESS PLANT CELL; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743	27	659	711	1	136	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1060	1063		10.1038/35059117	http://dx.doi.org/10.1038/35059117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234017				2022-12-28	WOS:000167148800050
J	Mazzarello, P				Mazzarello, P			Lombroso and Tolstoy - An anthropologist's unwitting gift to literature.	NATURE			English	Article									Univ Pavia, Volta Coll, I-27100 Pavia, Italy; CNR, IGBE, I-27100 Pavia, Italy	University of Pavia; Consiglio Nazionale delle Ricerche (CNR)	Mazzarello, P (corresponding author), Univ Pavia, Volta Coll, Via Abbiategrasso 207, I-27100 Pavia, Italy.			MAZZARELLO, PAOLO ANGELO/0000-0003-4130-5727				LOMBROSO C, 1894, UOMO GENIO; LOMBROSO C, 1984, TOLSTOJ NELLE MEMORI, P185	2	5	5	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					983	983		10.1038/35059175	http://dx.doi.org/10.1038/35059175			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234045	Bronze			2022-12-28	WOS:000167148800022
J	Murray, AW; Marks, D				Murray, AW; Marks, D			Can sequencing shed light on cell cycling?	NATURE			English	Article							DEPENDENT KINASES; ACTIVATION; CHECKPOINT; YEAST	Every organism must have cells that can replicate indefinitely. Can the draft human genome sequence tell us how the cell cycle works and how it evolved? We studied two protein families-the cyclins and their partners the cyclin-dependent kinases (Cdks)-and a conserved regulatory circuit, the spindle checkpoint. Disappointingly, we discovered a few novel cyclins and no new Cdks or components of the spindle checkpoint, and could shed little light on the organization of the cell cycle.	Harvard Univ, Ctr Genom Res, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, BCMP & Cell Biol, Boston, MA 02115 USA; Harvard Univ, Ctr Cellular & Mol Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University	Murray, AW (corresponding author), Harvard Univ, Ctr Genom Res, Cambridge, MA 02138 USA.	amurray@mcb.harvard.edu						Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee KM, 1999, CURR BIOL, V9, P441, DOI 10.1016/S0960-9822(99)80194-8; Moffat J, 2000, Prog Cell Cycle Res, V4, P97; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MULLER SJ, 1993, J BIOL CHEM, V268, P1310; PLFLEGER CM, 2000, GENE DEV, V14, P655	10	65	72	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					844	846		10.1038/35057033	http://dx.doi.org/10.1038/35057033			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237006	Bronze			2022-12-28	WOS:000166938800053
J	Ma, LQ; Komar, KM; Tu, C; Zhang, WH; Cai, Y; Kennelley, ED				Ma, LQ; Komar, KM; Tu, C; Zhang, WH; Cai, Y; Kennelley, ED			A fern that hyperaccumulates arsenic - A hardy, versatile, fast-growing plant helps to remove arsenic from contaminated soils.	NATURE			English	Article									Univ Florida, Dept Soil & Water Sci, Gainesville, FL 32611 USA; Univ Georgia, Cooperat Extens Serv, Dawson, GA 31742 USA; Florida Int Univ, Dept Chem, Miami, FL 33199 USA; Florida Int Univ, SE Environm Res Ctr, Miami, FL 33199 USA	State University System of Florida; University of Florida; University System of Georgia; University of Georgia; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Ma, LQ (corresponding author), Univ Florida, Dept Soil & Water Sci, Gainesville, FL 32611 USA.		Cai, Yong/K-9868-2015; Ma, Lena Q/E-5854-2010; Tu, Cong/H-9750-2013	Cai, Yong/0000-0002-2811-4638; Ma, Lena Q/0000-0002-8463-9957; 				Brooks R. R., 1998, PLANTS HYPERACCUMULA; Jones DL., 1987, ENCY FERNS; KABATAPENDIAS A, 1991, TRACE ELEMENTS SOILS, P203; Koch I, 2000, ENVIRON SCI TECHNOL, V34, P22, DOI 10.1021/es9906756; Nriagu JO, 1994, ARSENIC ENV	5	1269	1443	23	467	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2001	409	6820					579	579		10.1038/35054664	http://dx.doi.org/10.1038/35054664			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214308				2022-12-28	WOS:000166692300032
J	She, QX; Peng, X; Zillig, W; Garrett, RA				She, QX; Peng, X; Zillig, W; Garrett, RA			Genome evolution - Gene capture in archaeal chromosomes	NATURE			English	Article							FAMILY		Univ Copenhagen, Inst Mol Biol, Microbial Genome Grp, DK-1307 Copenhagen K, Denmark; Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Copenhagen; Max Planck Society	She, QX (corresponding author), Univ Copenhagen, Inst Mol Biol, Microbial Genome Grp, Solvgade 83H, DK-1307 Copenhagen K, Denmark.		She, Qunxin/E-4311-2012; Peng, Xu/M-8980-2014; Garrett, Roger A/M-2450-2014	She, Qunxin/0000-0002-4448-6669; Peng, Xu/0000-0003-3926-7514; Garrett, Roger A/0000-0001-8452-9099				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Kawarabayasi Y, 1999, DNA Res, V6, P83, DOI 10.1093/dnares/6.2.83; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Kletzin A, 1999, GENETICS, V152, P1307; Makino S, 1999, P JPN ACAD B-PHYS, V75, P166, DOI 10.2183/pjab.75.166; MUSKHELISHVILI G, 1993, MOL GEN GENET, V237, P334, DOI 10.1007/BF00279436; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; Peng X, 2000, J MOL BIOL, V303, P449, DOI 10.1006/jmbi.2000.4160; REITER WD, 1990, MOL GEN GENET, V221, P65, DOI 10.1007/BF00280369; Rowe-Magnus DA, 1999, CURR OPIN MICROBIOL, V2, P483, DOI 10.1016/S1369-5274(99)00004-1; She QX, 2000, DNA SEQUENCE, V11, P183, DOI 10.3109/10425170009033231	12	47	50	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					478	478		10.1038/35054138	http://dx.doi.org/10.1038/35054138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206536				2022-12-28	WOS:000166570500037
J	Kyne, L; Warny, M; Qamar, A; Kelly, CP				Kyne, L; Warny, M; Qamar, A; Kelly, CP			Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea	LANCET			English	Article							RISK-FACTORS; DISEASE; PURIFICATION; SEVERITY; ILLNESS; COLITIS	Background We have reported that symptom-free carriers of Clostridium difficile have a systemic anamnestic immune response to toxin A. The aim of this study was to determine whether an acquired immune response to toxin A, during an episode of C difficile diarrhoea, influences risk of recurrence. Methods We prospectively studied 63 patients with nosocomial C difficile diarrhoea. Serial serum IgA, IgG, and IgM concentrations against C difficile toxin A, toxin B, or non-toxin antigens were measured by ELISA. Individuals were followed for 60 days. Findings 19 patients died (30%). Of the 44 who survived, 22 had recurrent C difficile diarrhoea. Patients with a single episode of C difficile diarrhoea (n=22) had higher concentrations of serum IgM against toxin A on day 3 of their first episode of diarrhoea than those with recurrent diarrhoea (n=22, p=0.004). On day 12, serum IgG values against toxin A were higher in patients who had a single episode of diarrhoea (n=7) than in those who subsequently had recurrent diarrhoea (n=9, p=0.009). The odds ratio for recurrence associated with a low concentration of serum IgG against toxin A. measured 12 days after onset of C difficile diarrhoea, was 48.0 (95% CI 3.5-663). Interpretation A serum antibody response to toxin A, during an initial episode of C difficile diarrhoea, is associated with protection against recurrence.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Gerontol Div, Boston, MA 02215 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kyne, L (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Gerontol Div, Boston, MA 02215 USA.	lkyne@caregroup.harvard.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008812, R03AG016956, P60AG008812] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-01032] Funding Source: Medline; NIA NIH HHS [AG08812, AG16956] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARONSSON B, 1985, INFECTION, V13, P97, DOI 10.1007/BF01642866; BACON AE, 1994, DIAGN MICR INFEC DIS, V18, P205, DOI 10.1016/0732-8893(94)90021-3; BENTLEY DW, 1990, INFECT CONT HOSP EP, V11, P434; CHARLSON ME, 1986, J CHRON DIS, V39, P439, DOI 10.1016/0021-9681(86)90111-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Do AN, 1998, CLIN INFECT DIS, V26, P954, DOI 10.1086/513952; Fekety R, 1997, AM J GASTROENTEROL, V92, P739; Fekety R, 1997, CLIN INFECT DIS, V24, P324, DOI 10.1093/clinids/24.3.324; HORN SD, 1983, MED CARE, V21, P14, DOI 10.1097/00005650-198301000-00002; JOHNSON S, 1992, J INFECT DIS, V166, P1287, DOI 10.1093/infdis/166.6.1287; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kelly CP, 1996, EUR J GASTROEN HEPAT, V8, P1048, DOI 10.1097/00042737-199611000-00004; KELLY CP, 1992, GASTROENTEROLOGY, V102, P35, DOI 10.1016/0016-5085(92)91781-X; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 1998, BIODRUGS, V10, P173, DOI 10.2165/00063030-199810030-00001; LEUNG DYM, 1991, J PEDIATR-US, V118, P633, DOI 10.1016/S0022-3476(05)83393-1; McFarland LV, 1999, INFECT CONT HOSP EP, V20, P43, DOI 10.1086/501553; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Nair S, 1998, AM J GASTROENTEROL, V93, P1873; OLSON MM, 1994, INFECT CONT HOSP EP, V15, P371; Pothoulakis C, 1996, EUR J GASTROEN HEPAT, V8, P1041, DOI 10.1097/00042737-199611000-00003; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; SULLIVAN NM, 1982, INFECT IMMUN, V35, P1032, DOI 10.1128/IAI.35.3.1032-1040.1982; VONEICHELSTREIBER C, 1987, MICROB PATHOGENESIS, V2, P307, DOI 10.1016/0882-4010(87)90073-8; WARNY M, 1994, INFECT IMMUN, V62, P384, DOI 10.1128/IAI.62.2.384-389.1994; Wilcox MH, 1998, J ANTIMICROB CHEMOTH, V41, P41, DOI 10.1093/jac/41.suppl_3.41; Wilcox MH, 1998, J HOSP INFECT, V39, P181, DOI 10.1016/S0195-6701(98)90256-0	28	600	638	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2001	357	9251					189	193		10.1016/S0140-6736(00)03592-3	http://dx.doi.org/10.1016/S0140-6736(00)03592-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213096				2022-12-28	WOS:000166593700012
J	Wilcox, M; Minton, J				Wilcox, M; Minton, J			Role of antibody response in outcome of antibiotic-associated diarrhoea	LANCET			English	Editorial Material							CLOSTRIDIUM-DIFFICILE INFECTION; TOXIN-A; SYMPTOMS		Univ Leeds, Dept Microbiol & Infect Dis, Leeds LS2 9JT, W Yorkshire, England; Leeds Teaching Hosp Trust, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Wilcox, M (corresponding author), Univ Leeds, Dept Microbiol & Infect Dis, Leeds LS2 9JT, W Yorkshire, England.							*COMM DIS SURV CTR, 1999, COMMUN DIS REP CDR W, V10, P135; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 1999, AGE AGEING, V28, P107, DOI 10.1093/ageing/28.2.107; Salcedo J, 1997, GUT, V41, P366, DOI 10.1136/gut.41.3.366; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Starr JM, 1997, LANCET, V349, P426, DOI 10.1016/S0140-6736(97)80053-0; Stubbe H, 2000, J IMMUNOL, V164, P1952, DOI 10.4049/jimmunol.164.4.1952; VISCIDI R, 1983, J INFECT DIS, V148, P93, DOI 10.1093/infdis/148.1.93; WARNY M, 1994, INFECT IMMUN, V62, P384, DOI 10.1128/IAI.62.2.384-389.1994; Wilcox MH, 1998, J HOSP INFECT, V38, P93, DOI 10.1016/S0195-6701(98)90062-7; Wilcox MH, 1996, J HOSP INFECT, V34, P23, DOI 10.1016/S0195-6701(96)90122-X	11	20	26	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2001	357	9251					158	159		10.1016/S0140-6736(00)03582-0	http://dx.doi.org/10.1016/S0140-6736(00)03582-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213086				2022-12-28	WOS:000166593700002
J	Mallouk, TE				Mallouk, TE			Nanomaterials - Stretching the mold	SCIENCE			English	Editorial Material									Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mallouk, TE (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.		Mallouk, Thomas E/K-7391-2012	Mallouk, Thomas E/0000-0003-4599-4208				ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924; BOWDEN NB, 2000, ACC CHEM RES    1221; Gracias DH, 2000, SCIENCE, V289, P1170, DOI 10.1126/science.289.5482.1170; HO CC, 1993, COLLOID POLYM SCI, V271, P469, DOI 10.1007/BF00657391; HO KM, 1990, PHYS REV LETT, V65, P3152, DOI 10.1103/PhysRevLett.65.3152; JABLONOVITCH E, 1994, J MOD OPTIC, V41, P173; Jiang P, 2001, SCIENCE, V291, P453, DOI 10.1126/science.291.5503.453; KITAIGORODSKY AI, 1978, CHEM SOC REV, V7, P133, DOI 10.1039/cs9780700133; MA Z, 2000, J CHEM SOC CHEM COMM, P2365; Mann S, 2000, J CHEM SOC DALTON, P3753, DOI 10.1039/b004066p; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; Snoeks E, 2000, ADV MATER, V12, P1511, DOI 10.1002/1521-4095(200010)12:20<1511::AID-ADMA1511>3.0.CO;2-6	13	17	18	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2001	291	5503					443	444		10.1126/science.1058265	http://dx.doi.org/10.1126/science.1058265			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11228141				2022-12-28	WOS:000166487500027
J	Wolpoff, MH; Hawks, J; Frayer, DW; Hunley, K				Wolpoff, MH; Hawks, J; Frayer, DW; Hunley, K			Modern human ancestry at the peripheries: A test of the replacement theory	SCIENCE			English	Article								The replacement theory of modern human origins stipulates that populations outside of Africa were replaced by a new African species of modern humans. Here we test the replacement theory in two peripheral areas far from Africa by examining the ancestry of early modern Australians and Central Europeans. Analysis of pairwise differences was used to determine if dual ancestry in Local archaic populations and earlier modern populations from the Levant and/or Africa could be rejected. The data imply that both have a dual ancestry. The diversity of recent humans cannot result exclusively from a single Late Pleistocene dispersal.	Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA	University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of Kansas	Wolpoff, MH (corresponding author), Univ Michigan, Dept Anthropol, 500 S State, Ann Arbor, MI 49109 USA.	wolpoff@umich.edu	Hawks, John/H-5737-2015	Hawks, John/0000-0003-3187-3755; Hunley, Keith/0000-0003-0987-8277				Brauer G., 1992, CONTINUITY REPLACEME, P83; Brauer G., 1998, ORIGINS MODERN HUMAN, P106; BROWN P, 1989, COOBOOL CREEK TERRA, V13; CADDIE D, 1987, ARCHAEOMETRY FURTHER, P156; Duarte C, 1999, P NATL ACAD SCI USA, V96, P7604, DOI 10.1073/pnas.96.13.7604; FRAYER DW, 1986, BRNO ANTHROPOS, V23, P243; FRAYER DW, 1993, PREHIST EUR, V2, P9; Hawks J, 2000, J HUM EVOL, V39, P1, DOI 10.1006/jhev.1999.0384; Hublin JJ, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P295; JELINEK J., 1983, ANTHROPOLOGIE BRNO, V21, P57; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lahr MM, 1996, J HUM EVOL, V31, P157, DOI 10.1006/jhev.1996.0056; MANN AE, 1991, AM J PHYS ANTHROPOL, V86, P175, DOI 10.1002/ajpa.1330860207; Relethford JH, 1999, EVOL ANTHROPOL, V8, P7, DOI 10.1002/(SICI)1520-6505(1999)8:1<7::AID-EVAN4>3.0.CO;2-O; Rightmire G. P., 1990, EVOLUTION HOMO ERECT; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Simpson JJ, 1998, QUATERNARY SCI REV, V17, P1009, DOI 10.1016/S0277-3791(97)00088-7; SMITH FH, 1982, CURR ANTHROPOL, V23, P667, DOI 10.1086/202920; SMITH FH, 1997, HIST PHYS ANTHR ENCY, P659; SOLOW B, 1966, ACTA ODONT SCAND S46, V24, P1; Stringer C, 1998, J HUM EVOL, V34, P327, DOI 10.1006/jhev.1997.0204; STRINGER C, 1992, NATURE, V356, P201, DOI 10.1038/356201a0; STRINGER CB, 1994, INTERD CONT, P149; Svoboda J, 2000, J HUM EVOL, V38, P523, DOI 10.1006/jhev.1999.0361; Swed FS, 1943, ANN MATH STAT, V14, P66, DOI 10.1214/aoms/1177731494; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; Szilvassy JV, 1987, ANN VIENNA NAT HIST, V89, P313; SZOMBATHY J, 1925, EISZEIT, V2, P73; TATTERSALL I, 1995, LAST NEANDERTHAL RIS; Templeton AR., 1997, CONCEPTUAL ISSUES MO, P329; Willermet C. M., 1997, CONCEPTUAL ISSUES MO; Wolpoff M. H., 1997, RACE HUMAN EVOLUTION; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K	33	149	176	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					293	297		10.1126/science.291.5502.293	http://dx.doi.org/10.1126/science.291.5502.293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209077				2022-12-28	WOS:000166352900042
J	Jasienska, G; Thune, I				Jasienska, G; Thune, I			Lifestyle, hormones, and risk of breast cancer	BRITISH MEDICAL JOURNAL			English	Article									Jagiellonian Univ, Inst Publ Hlth, PL-31531 Krakow, Poland; Univ Tromso, Fac Med, Norwegian Canc Soc, Inst Community Med, N-90037 Tromso, Norway	Jagiellonian University; Collegium Medicum Jagiellonian University; UiT The Arctic University of Tromso	Jasienska, G (corresponding author), Jagiellonian Univ, Inst Publ Hlth, Grzegorzecka 20, PL-31531 Krakow, Poland.		Jasienska, Grazyna/E-4901-2011	Jasienska, Grazyna/0000-0001-8716-6342				Friedenreich CM, 1998, CANCER-AM CANCER SOC, V83, P600, DOI 10.1002/(SICI)1097-0142(19980801)83:3+<600::AID-CNCR2>3.3.CO;2-0; Jasienska G, 2000, EUR J CANCER PREV, V9, P231, DOI 10.1097/00008469-200008000-00003; Vitzthum V J, 2000, High Alt Med Biol, V1, P39, DOI 10.1089/152702900320676	3	49	51	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					586	587		10.1136/bmj.322.7286.586	http://dx.doi.org/10.1136/bmj.322.7286.586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238153	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000167499900023
J	Marenco, JP; Wang, PJ; Link, MS; Homoud, MK; Estes, NAM				Marenco, JP; Wang, PJ; Link, MS; Homoud, MK; Estes, NAM			Improving survival from sudden cardiac arrest - The role of the automated external defibrillator	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PUBLIC-ACCESS DEFIBRILLATION; BIPHASIC WAVE-FORMS; EMERGENCY MEDICAL TECHNICIANS; HEALTH-CARE PROFESSIONALS; ASSOCIATION TASK-FORCE; BASIC LIFE-SUPPORT; IN-HOSPITAL CHAIN; VENTRICULAR-FIBRILLATION; RAPID DEFIBRILLATION; PREHOSPITAL DEFIBRILLATION	Context Sudden cardiac death is a major public health problem in the United States, and improving survival after out-of-hospital cardiac arrest has been the subject of intense study. Early defibrillation has been shown to be critical to improving survival. Use of automated external defibrillators (AEDs) has become an important component of emergency medical systems, and recent advances in AED technology have allowed expansion of AED use to nontraditional first responders and the lay public. Objectives To examine advancements in AED technology, review the impact of AEDs on time to defibrillation and survival, and explore the future role of AEDs in the effort to improve survival following sudden cardiac arrest. Data Sources MEDLINE was searched for articles from 1966 through December 2000 (Medical Subject Headings: electric countershock, heart arrest, resuscitation, emergency medical services; keywords: automatic external defibrillator, automated external defibrillator, public access defibrillation). Reference lists of relevant articles, news releases, and product information from manufacturers were also reviewed. Study Selection Initial MEDLINE search produced 4816 articles, from which 101 articles were selected for referencing based on having been published in a peer-reviewed journal and on relevance to the subject of the manuscript as determined by all 5 authors. Data Extraction All studies were critically reviewed for relevance, accuracy, and quality of data and study design by all authors. Data Synthesis Recent advances in AED technology and design have resulted in marked simplification of AED operation, improvements in accuracy and effectiveness, and reductions in cost. Use of AEDs by first responders and laypersons has reduced time to defibrillation and improved survival from sudden cardiac arrest in several communities. Initial studies of the cost-effectiveness of AED use in comparison with other commonly used treatments are favorable. Conclusion The AED represents an efficient method of delivering defibrillation to persons experiencing out-of-hospital cardiac arrest and its use by both traditional and nontraditional first responders appears to be safe and effective. The rapidly expanding role of AEDs in traditional emergency medical systems is supported by the literature, and initial studies of public access to defibrillation offer hope that further improvements in survival after sudden cardiac death can be achieved.	Tufts Univ New England Med Ctr, New England Cardiac Arrhythmia Ctr, Div Cardiol, Dept Med, Boston, MA 02111 USA	Tufts Medical Center	Estes, NAM (corresponding author), Tufts Univ New England Med Ctr, New England Cardiac Arrhythmia Ctr, Div Cardiol, Dept Med, 750 Washington St, Boston, MA 02111 USA.	nestes@lifespan.org						AKHTAR M, 1992, CIRCULATION, V85, P1; American Heart Association in collaboration with International Liaison Committee On Resuscitation, 2000, CIRCULATION, V102, P160; Asplin BR, 1999, JAMA-J AM MED ASSOC, V282, P1033, DOI 10.1001/jama.282.11.1033-a; AUBLE TE, 1995, ANN EMERG MED, V25, P642, DOI 10.1016/S0196-0644(95)70178-8; BACHMAN JW, 1986, JAMA-J AM MED ASSOC, V256, P477, DOI 10.1001/jama.256.4.477; BARDY GH, 1995, CIRCULATION, V91, P1768, DOI 10.1161/01.CIR.91.6.1768; Bardy GH, 1996, CIRCULATION, V94, P2507, DOI 10.1161/01.CIR.94.10.2507; BARDY GH, 1997, CIRCULATION S, V96, P560; Becker L, 1998, CIRCULATION, V97, P2106, DOI 10.1161/01.CIR.97.21.2106; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; BRISON RJ, 1992, CAN MED ASSOC J, V147, P191; CARLSON MD, 1988, AM J CARDIOL, V61, P787, DOI 10.1016/0002-9149(88)91067-3; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; CUMMINS RO, 1987, JAMA-J AM MED ASSOC, V257, P1605, DOI 10.1001/jama.257.12.1605; CUMMINS RO, 1984, LANCET, V2, P318; Cummins RO, 1998, CIRCULATION, V97, P1654, DOI 10.1161/01.CIR.97.16.1654; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; DALZELL GWN, 1991, BRIT HEART J, V65, P311; DALZELL GWN, 1989, AM J CARDIOL, V64, P741, DOI 10.1016/0002-9149(89)90757-1; Davis E A, 1998, Prehosp Emerg Care, V2, P101, DOI 10.1080/10903129808958851; Destro A, 1996, RESUSCITATION, V31, P39, DOI 10.1016/0300-9572(95)00914-0; DIACK AW, 1979, MED INSTRUM, V13, P78; DICKEY W, 1992, BRIT HEART J, V67, P334; EISENBERG M, 1981, JAMA-J AM MED ASSOC, V246, P50, DOI 10.1001/jama.246.1.50; EISENBERG MS, 1986, SCI AM, V254, P37, DOI 10.1038/scientificamerican0586-37; EISENBERG MS, 1989, AM J CARDIOL, V63, P443, DOI 10.1016/0002-9149(89)90316-0; EISENBERG MS, 1984, JAMA-J AM MED ASSOC, V251, P1723, DOI 10.1001/jama.251.13.1723; EISENBERG MS, 1980, NEW ENGL J MED, V302, P1379, DOI 10.1056/NEJM198006193022502; GILLUM RF, 1989, CIRCULATION, V79, P756, DOI 10.1161/01.CIR.79.4.756; Gliner Bradford E., 1998, Biomedical Instrumentation and Technology, V32, P631; GRAY AJ, 1987, BRIT MED J, V294, P1133, DOI 10.1136/bmj.294.6580.1133; GREENE HL, 1995, AM J CARDIOL, V75, P1135, DOI 10.1016/S0002-9149(99)80745-0; Gundry JW, 1999, CIRCULATION, V100, P1703, DOI 10.1161/01.CIR.100.16.1703; HASKELL WL, 1978, CIRCULATION, V57, P920, DOI 10.1161/01.CIR.57.5.920; Hossack KF, 1982, J CARDIAC REHABIL, V2, P402; HOYT R, 1981, CIRCULATION, V64, P818, DOI 10.1161/01.CIR.64.4.818; IDEKER RE, 1997, 2 AM HEART ASS PUBL; JAKOBSSON J, 1987, EUR HEART J, V8, P1189, DOI 10.1093/oxfordjournals.eurheartj.a062191; Jermyn B D, 2000, Prehosp Emerg Care, V4, P43, DOI 10.1080/10903120090941632; Jones FD, 1999, J CLIN ANESTH, V11, P336, DOI 10.1016/S0952-8180(99)00042-2; KAYE W, 1995, ANN EMERG MED, V25, P163, DOI 10.1016/S0196-0644(95)70318-7; KAYE W, 1995, RESUSCITATION, V30, P151, DOI 10.1016/0300-9572(95)00881-S; Kaye W, 1996, RESUSCITATION, V31, P181, DOI 10.1016/0300-9572(95)00941-8; KELLERMANN AL, 1993, JAMA-J AM MED ASSOC, V270, P1708, DOI 10.1001/jama.270.14.1708; Kerber RE, 1997, CIRCULATION, V95, P1677; KERBER RE, 1988, CIRCULATION, V77, P1038, DOI 10.1161/01.CIR.77.5.1038; KERBER RE, 1993, ANN EMERG MED, V22, P296, DOI 10.1016/S0196-0644(05)80459-7; KERBER RE, 1994, CIRCULATION, V89, P2369, DOI 10.1161/01.CIR.89.5.2369; KOUWENHOVEN WB, 1969, ANN INTERN MED, V71, P449, DOI 10.7326/0003-4819-71-3-449; LAZZAM C, 1991, CAN J CARDIOL, V7, P113; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; Mancini M E, 1998, Am J Crit Care, V7, P314; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; MCDANIEL CM, 1988, PACING CLIN ELECTROP, V11, P155; Mosesso VN, 1998, ANN EMERG MED, V32, P200, DOI 10.1016/S0196-0644(98)70137-4; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; *NAT CTR HLTH STAT, 1997, MONTHLY VITAL STAT R, V45, pS2; Nichol G, 1999, ANN EMERG MED, V34, P517, DOI 10.1016/S0196-0644(99)80054-7; Nichol G, 1998, CIRCULATION, V97, P1309, DOI 10.1161/01.CIR.97.13.1309; Nichol G, 1998, CIRCULATION, V97, P1315, DOI 10.1161/01.CIR.97.13.1315; OLSON DW, 1989, ANN EMERG MED, V18, P806, DOI 10.1016/S0196-0644(89)80200-8; ORourke MF, 1997, CIRCULATION, V96, P2849, DOI 10.1161/01.CIR.96.9.2849; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; PELESKA B, 1966, CIRC RES, V18, P10, DOI 10.1161/01.RES.18.1.10; Poole JE, 1997, J CARDIOVASC ELECTR, V8, P1373, DOI 10.1111/j.1540-8167.1997.tb01034.x; Robertson RM, 2000, NEW ENGL J MED, V343, P1259, DOI 10.1056/NEJM200010263431709; SHUSTER M, 1993, ANN EMERG MED, V22, P721, DOI 10.1016/S0196-0644(05)81856-6; SIEBELS J, 1994, AM HEART J, V127, P1139, DOI 10.1016/0002-8703(94)90101-5; Smith SC, 1998, CIRCULATION, V97, P1321, DOI 10.1161/01.CIR.97.13.1321; SoRelle R, 1999, CIRCULATION, V99, P2606, DOI 10.1161/01.CIR.99.20.2606; Spearpoint KG, 2000, RESUSCITATION, V44, P165, DOI 10.1016/S0300-9572(00)00158-1; Stiell IG, 1999, JAMA-J AM MED ASSOC, V281, P1175, DOI 10.1001/jama.281.13.1175; STULTS KR, 1986, CIRCULATION, V73, P701, DOI 10.1161/01.CIR.73.4.701; STULTS KR, 1984, NEW ENGL J MED, V310, P219, DOI 10.1056/NEJM198401263100403; STULTS KR, 1987, ANN EMERG MED, V16, P872, DOI 10.1016/S0196-0644(87)80525-5; SWARTZ JF, 1993, CIRCULATION, V88, P2646, DOI 10.1161/01.CIR.88.6.2646; Sweeney TA, 1998, ANN EMERG MED, V31, P234, DOI 10.1016/S0196-0644(98)70313-0; Tang WC, 1999, J AM COLL CARDIOL, V34, P815, DOI 10.1016/S0735-1097(99)00270-3; Tang WC, 2000, CRIT CARE MED, V28, pN222, DOI 10.1097/00003246-200011001-00014; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; VANCAMP SP, 1986, JAMA-J AM MED ASSOC, V256, P1160, DOI 10.1001/jama.256.9.1160; VUKOV LF, 1988, ANN EMERG MED, V17, P318, DOI 10.1016/S0196-0644(88)80771-6; Walcott GP, 1998, CIRCULATION, V98, P2210, DOI 10.1161/01.CIR.98.20.2210; WATTS DD, 1995, ANN EMERG MED, V26, P635, DOI 10.1016/S0196-0644(95)70017-X; WEAVER WD, 1986, AM J CARDIOL, V57, P1017, DOI 10.1016/0002-9149(86)90667-3; WEAVER WD, 1984, CIRCULATION, V69, P943, DOI 10.1161/01.CIR.69.5.943; WEAVER WD, 1988, NEW ENGL J MED, V319, P661, DOI 10.1056/NEJM198809153191101; WEAVER WD, 1986, J AM COLL CARDIOL, V7, P752, DOI 10.1016/S0735-1097(86)80332-1; WEISFELDT ML, 1995, CIRCULATION, V92, P2763, DOI 10.1161/01.CIR.92.9.2763; WHITE RD, 1994, ANN EMERG MED, V23, P1009, DOI 10.1016/S0196-0644(94)70095-8; White RD, 1996, ANN EMERG MED, V28, P480, DOI 10.1016/S0196-0644(96)70109-9; Whittaker RJ, 1996, GLOBAL ECOL BIOGEOGR, V5, P1; WILSON CM, 1989, J ELECTROCARDIOL, V22, P241, DOI 10.1016/0022-0736(89)90035-6; Yamanouchi Y, 1999, CIRCULATION, V100, P826, DOI 10.1161/01.CIR.100.8.826; Yamanouchi Y, 1998, CIRCULATION, V98, P2487, DOI 10.1161/01.CIR.98.22.2487; Zimmermann P G, 1997, J Emerg Nurs, V23, P340, DOI 10.1016/S0099-1767(97)90224-5; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	98	184	187	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1193	1200		10.1001/jama.285.9.1193	http://dx.doi.org/10.1001/jama.285.9.1193			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231750	Bronze			2022-12-28	WOS:000167194700024
J	Morrow, JI				Morrow, JI			Data protection and patients' consent - Informed consent should be sought before data are used by registries	BRITISH MEDICAL JOURNAL			English	Letter									Royal Victoria Hosp, Dept Neurol, Belfast BT12 6BA, Antrim, North Ireland		Morrow, JI (corresponding author), Royal Victoria Hosp, Dept Neurol, Belfast BT12 6BA, Antrim, North Ireland.			Ellis, Simon/0000-0002-9131-6427				Brown P, 2000, BRIT MED J, V321, P849, DOI 10.1136/bmj.321.7265.849	1	3	3	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	2001	322	7285					549	550		10.1136/bmj.322.7285.549	http://dx.doi.org/10.1136/bmj.322.7285.549			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230085	Green Published			2022-12-28	WOS:000167370500043
J	Pretre, R; Turina, MI				Pretre, R; Turina, MI			Choice of revascularization strategy for patients with coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY-OF-LIFE; BALLOON ANGIOPLASTY; BYPASS-SURGERY; RANDOMIZED-TRIAL; CARDIOPULMONARY BYPASS; MULTIVESSEL DISEASE; FOLLOW-UP; THERAPY; INTERVENTION; IMPLANTATION		Univ Zurich Hosp, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Pretre, R (corresponding author), Univ Zurich Hosp, 100 Ramistr, CH-8091 Zurich, Switzerland.	rene.pretre@chi.usz.ch						Alderman EL, 1996, NEW ENGL J MED, V335, P217; [Anonymous], 1995, Lancet, V346, P1179; Arom KV, 2000, ANN THORAC SURG, V69, P704, DOI 10.1016/S0003-4975(99)01510-6; BOURASSA MG, 1984, AM J CARDIOL, V53, pC102, DOI 10.1016/0002-9149(84)90759-8; Calafiore AM, 1999, ANN THORAC SURG, V67, P450, DOI 10.1016/S0003-4975(98)01194-1; Carrie D, 1997, CIRCULATION, V96, P1; Cartier R, 2000, J THORAC CARDIOV SUR, V119, P221, DOI 10.1016/S0022-5223(00)70176-0; Erbel R, 1998, NEW ENGL J MED, V339, P1672, DOI 10.1056/NEJM199812033392304; GOY JJ, 1994, LANCET, V343, P1449, DOI 10.1016/S0140-6736(94)92579-8; HAMM CW, 1994, NEW ENGL J MED, V331, P1037, DOI 10.1056/NEJM199410203311601; Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3; Hlatky MA, 1997, CIRCULATION, V96, P11; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; HUEB WA, 1995, J AM COLL CARDIOL, V26, P1600, DOI 10.1016/0735-1097(95)00384-3; HUNT SM, 1981, SOC SCI MED-MED SOC, V15, P221, DOI 10.1016/0271-7123(81)90005-5; Jones RH, 1996, J THORAC CARDIOV SUR, V111, P1013, DOI 10.1016/S0022-5223(96)70378-1; King SB, 1997, AM J CARDIOL, V79, P1453, DOI 10.1016/S0002-9149(97)00170-7; KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602; LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101; Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; NEWMAN MF, 1994, CIRCULATION, V90, P243; Pedersen TR, 1999, AM HEART J, V138, pS177, DOI 10.1016/S0002-8703(99)70340-6; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; POCOCK SJ, 1995, LANCET, V346, P1184, DOI 10.1016/S0140-6736(95)92897-9; Pocock SJ, 1996, CIRCULATION, V94, P135, DOI 10.1161/01.CIR.94.2.135; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060, DOI 10.1016/0735-1097(93)90416-X; Rodriguez A, 1998, J AM COLL CARDIOL, V32, P1351, DOI 10.1016/S0735-1097(98)00388-X; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; TOWNES BD, 1989, J THORAC CARDIOV SUR, V98, P774; Windecker S, 2000, HEART, V83, P481, DOI 10.1136/heart.83.4.481; Wittwer T, 2000, HEART, V83, P58, DOI 10.1136/heart.83.1.58; Wolman RL, 1999, STROKE, V30, P514, DOI 10.1161/01.STR.30.3.514	36	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2001	285	8					992	994		10.1001/jama.285.8.992	http://dx.doi.org/10.1001/jama.285.8.992			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403ME	11209153				2022-12-28	WOS:000167046400001
J	Little, P; Everitt, H; Williamson, I; Warner, G; Moore, M; Gould, C; Ferrier, K; Payne, S				Little, P; Everitt, H; Williamson, I; Warner, G; Moore, M; Gould, C; Ferrier, K; Payne, S			Preferences of patients for patient centred approach to consultation in primary care: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; PATIENTS SATISFACTION; DOCTORS PERCEPTIONS; DECISION; COMMUNICATION; QUESTIONNAIRE; EXPECTATIONS	Objective To identify patient's preferences for patient centred consultation in general practice. Design Questionnaire study. Setting Consecutive patients in the waiting room of three doctors' surgeries. Main outcome measures Key domains of patient centredness from the patient perspective. Predictors of preferences for patient centredness, a prescription, and examination. Results 865 patients participated: 824 (95%) returned the pre-consultation questionnaire and were similar in demographic characteristic to national samples. Factor analysis identified three domains of patient preferences: communication (agreed with by 88-99%), partnership (77-87%), and health promotion (85-89%). Fewer wanted an examination (63%), and only a quarter wanted a prescription. As desire for a prescription was modestly associated with desire for good communication (odds ratio 1.20; 95% confidence interval 0.85 to 1.69), partnership (1.46; 1.01 to 2.09), and health promotion (1.61; 1.12 to 2.31) this study may have underestimated preferences for patient centredness compared with populations with stronger preferences for a prescription. Patients who strongly wanted good communication were more likely to feel unwell (very, moderately, and slightly unwell; odds ratios 1, 0.56, 0.39 respectively, z trend P < 0.001), be high attenders (1.70; 1.18 to 2.44), and have no paid work(1.84; 1.21 to 2.79). Strongly wanting partnership was also related to feeling unwell, worrying about the problem, high attendance, and no paid work; and health promotion to high attendance and worry. Conclusion Patients in primary care strongly want a patient centred approach, with communication, partnership, and health promotion. Doctors should be sensitive to. patients who have a strong preference for patient centredness-those vulnerable either psychosocially or because they are feeling particularly unwell.	Univ Southampton, Aldermoor Hlth Ctr, Community Clin Sci Div, Primary Med Care Grp, Southampton SO16 5ST, Hants, England; Nightingale Surg, Romsey SO51 7QM, Hants, England; Three Swans Surg, Salisbury SP1 1DX, Wilts, England; Univ Southampton, Sch Hlth Profess & Reahbil Sci, Hlth Res Unit, Southampton SO16 5ST, Hants, England	University of Southampton; University of Southampton	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Community Clin Sci Div, Primary Med Care Grp, Southampton SO16 5ST, Hants, England.	psl3@soton.ac.uk	Moore, Michael/C-3447-2011	Moore, Michael/0000-0002-5127-4509; Little, Paul/0000-0003-3664-1873; Everitt, Hazel/0000-0001-7362-8403; Payne, Sheila/0000-0001-6982-9181				BAKER R, 1990, BRIT J GEN PRACT, V40, P487; Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Britten N, 1997, BRIT MED J, V315, P1506, DOI 10.1136/bmj.315.7121.1506; Britten N, 2000, BMJ-BRIT MED J, V320, P484, DOI 10.1136/bmj.320.7233.484; BROWN JB, 1995, WORKING PAPER SERIES, V952; Charles C, 1998, SOCIOL HEALTH ILL, V20, P71, DOI 10.1111/1467-9566.00081; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Coulter A, 1999, BRIT MED J, V319, P719, DOI 10.1136/bmj.319.7212.719; Dowsett SM, 2000, PSYCHO-ONCOL, V9, P147, DOI 10.1002/(SICI)1099-1611(200003/04)9:2<147::AID-PON443>3.0.CO;2-X; Grol R, 1999, FAM PRACT, V16, P4, DOI 10.1093/fampra/16.1.4; Guadagnoli E, 1998, SOC SCI MED, V47, P329, DOI 10.1016/S0277-9536(98)00059-8; HENBEST RJ, 1992, FAM PRACT, V9, P311, DOI 10.1093/fampra/9.3.311; HENBEST RJ, 1990, FAM PRACT, V7, P28, DOI 10.1093/fampra/7.1.28; HJORTDAHL P, 1992, BRIT MED J, V304, P1287, DOI 10.1136/bmj.304.6837.1287; Jung HP, 1997, BRIT J GEN PRACT, V47, P805; Kinnersley P, 1999, BRIT J GEN PRACT, V49, P711; LAW SAT, 1995, BRIT J GEN PRACT, V45, P520; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Meryn S, 1998, BRIT MED J, V316, P1922, DOI 10.1136/bmj.316.7149.1922; Neal R, 1996, BRIT J GEN PRACT, V46, P131; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; SAVAGE R, 1990, BRIT MED J, V301, P968, DOI 10.1136/bmj.301.6758.968; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; STREINE DL, 1995, HLTH MEASUREMENT SCA; WILLIAMS S, 1995, FAM PRACT, V12, P193, DOI 10.1093/fampra/12.2.193; Winefield HR, 1995, FAM PRACT, V12, P402, DOI 10.1093/fampra/12.4.402	26	371	382	2	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2001	322	7284					468	472		10.1136/bmj.322.7284.468	http://dx.doi.org/10.1136/bmj.322.7284.468			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406YD	11222423	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000167243000021
J	Hellwig, B; Haussler, S; Schelter, B; Lauk, M; Guschlbauer, B; Timmer, J; Lucking, CH				Hellwig, B; Haussler, S; Schelter, B; Lauk, M; Guschlbauer, B; Timmer, J; Lucking, CH			Tremor-correlated cortical activity in essential tremor	LANCET			English	Article							CROSS-SPECTRAL ANALYSIS; PHYSIOLOGICAL TREMOR; CENTRAL MECHANISMS; MUSCLE-ACTIVITY; TIME-SERIES; ELECTROMYOGRAM; COHERENCE	Background In patients with parkinsonian resting tremor, tremor-correlated activity in the contralateral sensorimotor cortex has been studied by both magnetoencephalography (MEG) and electroencephalography (EEG). In essential tremor, MEG failed to detect cortical involvement. The objective of this study was to investigate whether EEG recording can reveal tremor-correlated cortical activity in patients with essential tremor or enhanced physiological tremor. (MEG) tremor. Methods Seven patients with essential tremor and three patients with enhanced physiological tremor participated in the study. Unilateral postural tremor was activated by wrist extension on the right or on the left side. Electromyography (EMG) signals arising from the wrist extensor and flexor muscles, and a high-resolution EEG were recorded simultaneously. Coherences between the time series of the rectified tremor EMG and the EEG were estimated. Findings In five of nine arms with essential tremor, we found highly significant coherences at the tremor frequency between the tremor EMG and the EEG. Isocoherence maps illustrating the topography of significant coherences over the scalp showed that the maximum coherences were located over the contralateral sensorimotor cortex. In the patients with enhanced physiological tremor, we were unable to detect consistent significant corticomuscular coherences at the tremor frequency. Interpretation Using simultaneous EEG-EMG recordings, we showed that significant corticomuscular coherences at the tremor frequency can be found in essential tremor. This finding contrasts with a recent study based on MEG recordings. The results suggest that the sensorimotor cortex is involved in the generation of essential tremor. in a similar way to that previously shown in parkinsonian resting tremor.	Univ Freiburg, Neurol Klin, Neurozentrum, D-79106 Freiburg, Germany; Zentrum Datenanal & Modellbildung, Freiburg, Germany	University of Freiburg	Lucking, CH (corresponding author), Univ Freiburg, Neurol Klin, Neurozentrum, Hugstetter Str 55, D-79106 Freiburg, Germany.							ALBERTS WW, 1969, NATURE, V221, P670, DOI 10.1038/221670a0; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Brockwell P.J., 1986, TIME SERIES THEORY M; Bucher SF, 1997, ANN NEUROL, V41, P32, DOI 10.1002/ana.410410108; ELBIE RJ, 2000, LANCET, V355, P1113; ELBLE RJ, 1986, NEUROLOGY, V36, P225, DOI 10.1212/WNL.36.2.225; Elble RJ, 1996, J CLIN NEUROPHYSIOL, V13, P133, DOI 10.1097/00004691-199603000-00004; FINDLEY LJ, 1987, NEUROLOGY, V37, P1194, DOI 10.1212/WNL.37.7.1194; HALLETT M, 1993, J NEUROL SCI, V114, P45, DOI 10.1016/0022-510X(93)90047-3; Halliday DM, 2000, LANCET, V355, P1149, DOI 10.1016/S0140-6736(00)02064-X; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; Hellwig B, 2000, CLIN NEUROPHYSIOL, V111, P806, DOI 10.1016/S1388-2457(00)00248-0; HJORTH B, 1991, J CLIN NEUROPHYSIOL, V8, P391, DOI 10.1097/00004691-199110000-00004; Hua SE, 1998, J NEUROL NEUROSUR PS, V64, P273, DOI 10.1136/jnnp.64.2.273; JENKINS IH, 1993, ANN NEUROL, V34, P82, DOI 10.1002/ana.410340115; Koster B, 1998, NEUROSCI LETT, V241, P135, DOI 10.1016/S0304-3940(98)00015-9; LAMARRE Y, 1984, MOVEMENT DISORDERS T, P183; LLINAS R, 1973, EXP BRAIN RES, V18, P69; LUCKING CH, 1999, PARKINSONS DIS NEURO, V80, P335; Mima T, 2000, CLIN NEUROPHYSIOL, V111, P326, DOI 10.1016/S1388-2457(99)00229-1; Mima T, 1999, CLIN NEUROPHYSIOL, V110, P1892, DOI 10.1016/S1388-2457(99)00238-2; Mima T, 1999, J CLIN NEUROPHYSIOL, V16, P501, DOI 10.1097/00004691-199911000-00002; Priestley M., 1989, SPECTRAL ANAL TIME S; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Timmer J, 1998, INT J BIFURCAT CHAOS, V8, P1505, DOI 10.1142/S0218127498001157; Timmer J, 1998, BIOL CYBERN, V78, P349, DOI 10.1007/s004220050439; Timmer J, 1998, BIOL CYBERN, V78, P359, DOI 10.1007/s004220050440; Timmer J, 1996, ELECTROMYOGR MOTOR C, V101, P461, DOI 10.1016/0924-980X(96)94658-5; Volkmann J, 1996, NEUROLOGY, V46, P1359, DOI 10.1212/WNL.46.5.1359	29	129	135	4	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					519	523		10.1016/S0140-6736(00)04044-7	http://dx.doi.org/10.1016/S0140-6736(00)04044-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229671				2022-12-28	WOS:000167011700012
J	MacKie, RM; Stewart, B; Brown, SM				MacKie, RM; Stewart, B; Brown, SM			Intralesional injection of herpes simplex virus 1716 in metastatic melanoma	LANCET			English	Article							TYPE-1	We have previously shown that avirulent but replication-competent herpes simplex virus (HSV) 1716 causes cell death in human melanoma cell lines in vitro and selectively replicates in melanoma tissue in nude mice. We now present a pilot study of intratumoral Injection of HSV1716 Into subcutaneous nodules of metastatic melanoma in five patients with stage 4 melanoma. Two patients each received one Injection, two received two Injections, and one received four injections of 10(3) plaque-forming units HSV1716. In one patient, Rattening of previously palpable tumour nodules was seen 21 days after two direct injections of HSV1716, and in injected nodules from all three patients who received two or more injections there was microscopic evidence of tumour necrosis. Immunohistochemical staining of injected nodules revealed evidence of virus replication confined to tumour cells. These findings suggest that HSV1716 is non-toxic and could be of therapeutic benefit in patients with metastatic melanoma.	Univ Glasgow, Dept Dermatol, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, So Gen Hosp, Inst Neurol Sci, Neurovirol Res Labs, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	MacKie, RM (corresponding author), Univ Glasgow, Dept Dermatol, Glasgow G12 8QQ, Lanark, Scotland.							BROWN SM, 1994, J GEN VIROL, V75, P2367, DOI 10.1099/0022-1317-75-9-2367; KESARI S, 1995, LAB INVEST, V73, P636; MACLEAN AR, 1991, J GEN VIROL, V72, P631, DOI 10.1099/0022-1317-72-3-631; Rampling R, 2000, GENE THER, V7, P859, DOI 10.1038/sj.gt.3301184; Randazzo BP, 1997, J INVEST DERMATOL, V108, P933, DOI 10.1111/1523-1747.ep12295238	5	129	144	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					525	526		10.1016/S0140-6736(00)04048-4	http://dx.doi.org/10.1016/S0140-6736(00)04048-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229673				2022-12-28	WOS:000167011700014
J	Berry, A; Morassin, B; Kamar, N; Magnaval, JF				Berry, A; Morassin, B; Kamar, N; Magnaval, JF			Clinical picture: Human babesiosis	LANCET			English	Article									CHU Rangueil, Serv Parasitol, F-31403 Toulouse, France; CHU Purpan, Serv Malad Infect & Trop, F-31059 Toulouse, France	CHU de Toulouse; CHU de Toulouse	Berry, A (corresponding author), CHU Rangueil, Serv Parasitol, F-31403 Toulouse, France.		Magnaval, Jean-Francois/AAA-7549-2022; Berry, Antoine/J-9352-2014; Kamar, Nassim/L-6462-2014	Kamar, Nassim/0000-0003-1930-8964; Berry, Antoine/0000-0002-6626-7766					0	8	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					341	341		10.1016/S0140-6736(00)03640-0	http://dx.doi.org/10.1016/S0140-6736(00)03640-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210995				2022-12-28	WOS:000166897900011
J	Moon-van der Staay, SY; De Wachter, R; Vaulot, D				Moon-van der Staay, SY; De Wachter, R; Vaulot, D			Oceanic 18S rDNA sequences from picoplankton reveal unsuspected eukaryotic diversity	NATURE			English	Article							CENTRAL NORTH PACIFIC; SP-NOV; ALGAL CLASS; PROCHLOROCOCCUS; ACANTHAREA; EVOLUTION; ALIGNMENT; POSITION; DATABASE; GEN.	Picoplankton-cells with a diameter of less than 3 mum-are the dominant contributors to both primary production and biomass in open oceanic regions(1,2). However, compared with the prokaryotes(3), the eukaryotic component of picoplankton is still poorly known. Recent discoveries of new eukaryotic algal taxa based on picoplankton cultures(4,5) suggest the existence of many undiscovered taxa. Conventional approaches based on phenotypic criteria have limitations in depicting picoplankton composition due to their tiny size and lack of distinctive taxonomic characters(6). Here we analyse, using an approach that has been very successful for prokaryotes(7) but has so far seldom been applied to eukaryotes(8), 35 full sequences of the small-subunit (18S) ribosomal RNA gene derived from a picoplanktonic assemblage collected at a depth of 75 min the equatorial Pacific Ocean, and show that there is a high diversity of picoeukaryotes. Most of the sequences were previously unknown but could still be assigned to important marine phyla including prasinophytes, haptophytes, dinoflagellates, stramenopiles, choanoflagellates and acantharians. We also found a novel lineage, closely related to dinoflagellates and not previously described.	Biol Stn, CNRS, UPR 9042, F-29682 Roscoff, France; Univ Paris 06, F-29682 Roscoff, France; Univ Instelling Antwerp, Dept Biochem, B-2610 Antwerp, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Antwerp	Vaulot, D (corresponding author), Biol Stn, CNRS, UPR 9042, BP 74, F-29682 Roscoff, France.	vaulot@sb-roscoff.fr	Vaulot, Daniel/T-6649-2019	Vaulot, Daniel/0000-0002-0717-5685				Amann R, 1998, CURR OPIN MICROBIOL, V1, P352, DOI 10.1016/S1369-5274(98)80041-6; ANDERSEN RA, 1993, J PHYCOL, V29, P701, DOI 10.1111/j.0022-3646.1993.00701.x; Bernstein RE, 1998, DEEP-SEA RES PT I, V45, P491, DOI 10.1016/S0967-0637(97)00095-2; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; DERIJK P, 1993, COMPUT APPL BIOSCI, V9, P735; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P720, DOI 10.1128/jb.170.2.720-726.1988; Guillou L, 1999, J PHYCOL, V35, P368, DOI 10.1046/j.1529-8817.1999.3520368.x; Guillou L, 1999, PROTIST, V150, P383, DOI 10.1016/S1434-4610(99)70040-4; Gunderson JH, 1999, J EUKARYOT MICROBIOL, V46, P194, DOI 10.1111/j.1550-7408.1999.tb04603.x; HOLLANDE A, 1974, Protistologica, V10, P567; Leipe DD, 1996, EUR J PROTISTOL, V32, P449, DOI 10.1016/S0932-4739(96)80004-6; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; MAIDAK BL, 1994, NUCLEIC ACIDS RES, V22, P3485, DOI 10.1093/nar/22.17.3485; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; Melkonian Michael, 1996, Progress in Botany, V57, P281; Moon-van der Staay SY, 2000, LIMNOL OCEANOGR, V45, P98, DOI 10.4319/lo.2000.45.1.0098; Noren F, 1999, EUR J PROTISTOL, V35, P233, DOI 10.1016/S0932-4739(99)80001-7; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Potter D, 1997, BIODIVERS CONSERV, V6, P99, DOI 10.1023/A:1018379716868; Rappe MS, 1998, APPL ENVIRON MICROB, V64, P294; Sarjeant WAS., 1993, CLASSIFICATION LIVIN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van de Peer Y, 1997, J MOL EVOL, V45, P619, DOI 10.1007/PL00006266; Van de Peer Y, 2000, NUCLEIC ACIDS RES, V28, P175, DOI 10.1093/nar/28.1.175; VandePeer Y, 1997, NUCLEIC ACIDS RES, V25, P111, DOI 10.1093/nar/25.1.111; Venrick EL, 1999, J PLANKTON RES, V21, P1029, DOI 10.1093/plankt/21.6.1029; Zettler LA, 1997, P NATL ACAD SCI USA, V94, P11411, DOI 10.1073/pnas.94.21.11411; Zettler LAA, 2000, EUR J PROTISTOL, V36, P34, DOI 10.1016/S0932-4739(00)80020-6	30	712	748	4	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					607	610		10.1038/35054541	http://dx.doi.org/10.1038/35054541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214317				2022-12-28	WOS:000166692300041
J	Jennings, PJ; Swiss, S				Jennings, PJ; Swiss, S			Supporting local efforts to document human-rights violations in armed conflict	LANCET			English	Editorial Material									Univ Wyoming, Dept Psychol, Laramie, WY 82071 USA; Womens Rights Int, Laramie, WY 82073 USA	University of Wyoming	Jennings, PJ (corresponding author), Univ Wyoming, Dept Psychol, Laramie, WY 82071 USA.							Ball P., 2000, MAKING CASE INVESTIG; Swiss S, 1998, JAMA-J AM MED ASSOC, V279, P625, DOI 10.1001/jama.279.8.625	2	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					302	303		10.1016/S0140-6736(00)03625-4	http://dx.doi.org/10.1016/S0140-6736(00)03625-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214146				2022-12-28	WOS:000166693400037
J	Shanks, L; Ford, N; Schull, M; de Jong, K				Shanks, L; Ford, N; Schull, M; de Jong, K			Responding to rape	LANCET			English	Editorial Material									Med Sans Frontieres, Toronto, ON, Canada		Shanks, L (corresponding author), Med Sans Frontieres, 720 Spanida Ave, Toronto, ON, Canada.		Schull, Michael J/A-7955-2013	Schull, Michael J/0000-0002-1318-6364					0	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 27	2001	357	9252					304	304		10.1016/S0140-6736(00)03626-6	http://dx.doi.org/10.1016/S0140-6736(00)03626-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397JW	11214147				2022-12-28	WOS:000166693400039
J	Deslys, JP; Comoy, E; Hawkins, S; Simon, S; Schimmel, H; Wells, G; Grassi, J; Moynagh, J				Deslys, JP; Comoy, E; Hawkins, S; Simon, S; Schimmel, H; Wells, G; Grassi, J; Moynagh, J			Public health - Screening slaughtered cattle for BSE	NATURE			English	Article									CEA, Serv Neurovirol, DRM DSV, F-92265 Fontenay Aux Roses, France; Biorad Life Sci Labs, Hercules, CA 94547 USA; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England; CEA, Serv Pharmacol & Immunol, DRM DSV, Saclay, France; Commiss European Communities, Joint Res Ctr, Inst Reference Mat & Measurements, B-2440 Geel, Belgium; Commiss European Communities, Directorate Gen Hlth & Consumer Protect, B-1049 Brussels, Belgium	CEA; UDICE-French Research Universities; Universite Paris Saclay; Veterinary Laboratories Agency; CEA; European Commission Joint Research Centre; EC JRC Institute for Reference Materials & Measurements (IRMM)	Deslys, JP (corresponding author), CEA, Serv Neurovirol, DRM DSV, BP6, F-92265 Fontenay Aux Roses, France.	jpdeslys@cea.fr	Simon, Stephanie/E-4289-2012; Hawkins, Stephen/F-1136-2011	Simon, Stephanie/0000-0002-6071-8255; 				*EUR COMM, 2000, OR EXP HUM BSE AG IN; *EUR COMM, EV TESTS DIAGN TRANS; Grassi J, 2000, ARCH VIROL, P197; Moynagh J, 1999, NATURE, V400, P105, DOI 10.1038/21981; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103	5	65	68	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2001	409	6819					476	478		10.1038/35054134	http://dx.doi.org/10.1038/35054134			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206535				2022-12-28	WOS:000166570500036
J	Lu, BW; Roegiers, F; Jan, LY; Jan, YN				Lu, BW; Roegiers, F; Jan, LY; Jan, YN			Adherens junctions inhibit asymmetric division in the Drosophila epithelium	NATURE			English	Article							GENETIC INTERFERENCE; CELL DIVISIONS; PROTEIN; BAZOOKA; LOCALIZATION; ORIENTATION; NEUROBLASTS; SELECTION; PROSPERO; PATHWAY	Asymmetric division is a fundamental mechanism for generating cellular diversity. In the central nervous system of Drosophila, neural progenitor cells called neuroblasts undergo asymmetric division along the apical-basal cellular axis(1,2). Neuroblasts originate from neuroepithelial cells, which are polarized along the apical-basal axis and divide symmetrically along the planar axis. The asymmetry of neuroblasts might arise from neuroblast-specific expression of the proteins required for asymmetric division. Alternatively, both neuroblasts and neuroepithelial cells could be capable of dividing asymmetrically, but in neuroepithelial cells other polarity cues might prevent asymmetric division. Here we show that by disrupting adherens junctions we can convert the symmetric epithelial division into asymmetric division. We further confirm that the adenomatous polyposis coli (APC) tumour suppressor protein is recruited to adherens junctions(3), and demonstrate that both APC and microtubule-associated EB1 homologues(3-5) are required for the symmetric epithelial division along the planar axis. Our results indicate that neuroepithelial cells have all the necessary components to execute asymmetric division, but that this pathway is normally overridden by the planar polarity cue provided by adherens junctions.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Lu, Bingwei/0000-0002-5807-7014				Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Jan YN, 2000, CELL, V100, P599, DOI 10.1016/S0092-8674(00)80695-9; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SU LK, 1995, CANCER RES, V55, P2972; Tepass U, 1997, BIOESSAYS, V19, P673, DOI 10.1002/bies.950190807; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064	30	206	212	1	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					522	525		10.1038/35054077	http://dx.doi.org/10.1038/35054077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206549				2022-12-28	WOS:000166570500050
J	Yogodzinski, GM; Lees, JM; Churikova, TG; Dorendorf, F; Woerner, G; Volynets, ON				Yogodzinski, GM; Lees, JM; Churikova, TG; Dorendorf, F; Woerner, G; Volynets, ON			Geochemical evidence for the melting of subducting oceanic lithosphere at plate edges	NATURE			English	Article							MAGNESIAN ANDESITES; PRIMITIVE MAGMAS; VOLCANIC-ROCKS; ARC; CALIFORNIA; KAMCHATKA; MANTLE; ISLAND; MODEL; SOUTHWEST	Most island-arc magmatism appears to result from the lowering of the melting point of peridotite within the wedge of mantle above subducting slabs owing to the introduction of fluids from the dehydration of subducting oceanic crust(1). Volcanic rocks interpreted to contain a component of melt (not just a fluid) from the subducting slab itself are uncommon, but possible examples have been recognized in the Aleutian islands, Baja California, Patagonia and elsewhere(2-4). The geochemically distinctive rocks from these areas, termed 'adakites', are often associated with subducting plates that are young and warm, and therefore thought to be more prone to melting(5). But the subducting lithosphere in some adakite locations (such as the Aleutian islands) appears to be too old and hence too cold to melt(6,7). This implies either that our interpretation of adakite geochemistry is incorrect, or that our understanding of the tectonic context of adakites is incomplete. Here we present geochemical data from the Kamchatka peninsula and the Aleutian islands that reaffirms the slab-melt interpretation of adakites(2), but in the tectonic context of the exposure to mantle flow around the edge of a torn subducting plate. We conclude that adakites are likely to form whenever the edge of a subducting plate is warmed or ablated by mantle flow. The use of adakites as tracers for such plate geometry may improve our understanding of magma genesis and thermal structure in a variety of subduction-zone environments.	Dickinson Coll, Dept Geol, Carlisle, PA 17013 USA; Univ N Carolina, Dept Geol Sci, Chapel Hill, NC 27516 USA; Inst Volcan Geol & Geochem, Petropavlovsk Kamchatski 683006, Russia; Inst Geochem, D-37077 Gottingen, Germany	Dickinson College; University of North Carolina; University of North Carolina Chapel Hill; Institute of Volcanology & Seismology, Far Eastern Branch, RAS	Yogodzinski, GM (corresponding author), Dickinson Coll, Dept Geol, Carlisle, PA 17013 USA.		; Churikova, Tatiana/P-6740-2015	Lees, Jonathan/0000-0002-0218-7038; Churikova, Tatiana/0000-0002-9929-9764				ABRATIS M, IN PRESS GEOLOGY; Bacon CR, 1997, CAN MINERAL, V35, P397; BAKER MB, 1994, CONTRIB MINERAL PETR, V118, P111, DOI 10.1007/BF01052863; Borg LE, 1997, CAN MINERAL, V35, P425; Conrey RM, 1997, CAN MINERAL, V35, P367; CREAGER KC, 1991, J GEOPHYS RES-SOLID, V96, P2293, DOI 10.1029/90JB01918; DAVAILLE A, IN PRESS GEOPHYS RES; DAVIES JH, 1992, J GEOPHYS RES-SOL EA, V97, P2037, DOI 10.1029/91JB02571; DEFANT MJ, 1990, NATURE, V347, P662, DOI 10.1038/347662a0; ENGDAHL ER, 1998, SEISMOL RES LETT, V69, P153; Furlong K. P., 1988, ANN GEOPHYS, V16, P45; Gorbatov A, 1997, J GEOPHYS RES-SOL EA, V102, P17883, DOI 10.1029/96JB03491; HEARN BC, 1981, RES GEYSERS CLEAR LA, P25; Hochstaedter AG, 1996, J GEOPHYS RES-SOL EA, V101, P697, DOI 10.1029/95JB02404; JOHNSON CM, 1984, EARTH PLANET SC LETT, V71, P241, DOI 10.1016/0012-821X(84)90090-6; Johnston ST, 1997, EARTH PLANET SC LETT, V146, P465, DOI 10.1016/S0012-821X(96)00242-7; KAY RW, 1978, J VOLCANOL GEOTH RES, V4, P117, DOI 10.1016/0377-0273(78)90032-X; Kepezhinskas P, 1997, GEOCHIM COSMOCHIM AC, V61, P577, DOI 10.1016/S0016-7037(96)00349-3; KERSTING AB, 1994, J PETROL, V35, P1; LONSDALE P, 1988, GEOL SOC AM BULL, V100, P733, DOI 10.1130/0016-7606(1988)100<0733:PHOTKP>2.3.CO;2; MORRIS PA, 1995, GEOLOGY, V23, P395, DOI 10.1130/0091-7613(1995)023<0395:SMAAEO>2.3.CO;2; Ozerov AY, 1997, PETROLOGY, V5, P550; PEACOCK SM, 1994, EARTH PLANET SC LETT, V121, P227, DOI 10.1016/0012-821X(94)90042-6; Peacock SM, 1999, SCIENCE, V286, P937, DOI 10.1126/science.286.5441.937; PERFIT MR, 1980, CHEM GEOL, V30, P227, DOI 10.1016/0009-2541(80)90107-2; Reay A, 1997, NEW ZEAL J GEOL GEOP, V40, P121, DOI 10.1080/00288306.1997.9514746; ROGERS G, 1985, NATURE, V315, P389, DOI 10.1038/315389a0; SCHOLL DW, 1976, GEOL SOC AM BULL, V87, P547, DOI 10.1130/0016-7606(1976)87<547:EARIAI>2.0.CO;2; Stern C., 1984, ANDEAN MAGMATISM CHE, P31; Yogodzinski GM, 1998, EARTH PLANET SC LETT, V158, P53, DOI 10.1016/S0012-821X(98)00041-7; YOGODZINSKI GM, 1995, GEOL SOC AM BULL, V107, P505, DOI 10.1130/0016-7606(1995)107<0505:MAITWA>2.3.CO;2; YOGODZINSKI GM, 1994, J PETROL, V35, P163, DOI 10.1093/petrology/35.1.163	32	431	498	4	107	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 25	2001	409	6819					500	504		10.1038/35054039	http://dx.doi.org/10.1038/35054039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	395FW	11206543				2022-12-28	WOS:000166570500044
J	Ball, P				Ball, P			Life's lessons in design	NATURE			English	Article							MICROTUBULES; RECOGNITION; MOTION; FLIGHT	So long as it avoids a Panglossian view of nature, the science of biomimetics has the potential to enrich many areas of technology. But accurate mimicry will require greater understanding of natural mechanisms at the molecular scale. As this continues to unfold, emulation may increasingly give way to assimilation of biological machinery.										ALTSHULLER G, 1999, SUDDENLY INVENTOR AP; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; Bromberg R, 1998, J CRYST GROWTH, V193, P656, DOI 10.1016/S0022-0248(98)00517-X; Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269; Convey P. V., 2000, J AM CHEM SOC, V122, P11557; Dennis JR, 1999, NANOTECHNOLOGY, V10, P232, DOI 10.1088/0957-4484/10/3/302; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; FEYNMAN RP, 1960, ENG SCI FEB; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; FUNG DC, 1995, NATURE, V375, P809, DOI 10.1038/375809a0; GORDON JE, 1980, PHILOS T R SOC A, V294, P545, DOI 10.1098/rsta.1980.0063; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; JERONIMIDIS G, 1998, P WORKSH BION BIOM; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; Krausse E., 1995, REZEPTION EVOLUTIONS; Krieger MJB, 2000, NATURE, V406, P992, DOI 10.1038/35023164; Kube C. Ronald, 1993, Adaptive Behavior, V2, P189, DOI 10.1177/105971239300200204; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; MANN D, 1999, TRIZ J           NOV; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Steinberg-Yfrach G, 1998, NATURE, V392, P479, DOI 10.1038/33116; SteinbergYfrach G, 1997, NATURE, V385, P239, DOI 10.1038/385239a0; Thompson D. W., 1917, GROWTH FORM; TROLIERMCKINSTR.S, 1993, MRS B            APR, P27; VINCENT JFV, 2000, TRIZ J           AUG; VOGEL S, 1999, CATS PAWS CATAPAULST; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043	32	123	130	0	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2001	409	6818					413	416		10.1038/35053198	http://dx.doi.org/10.1038/35053198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201757				2022-12-28	WOS:000166434300065
J	Mackay, JL				Mackay, JL			Why have sex?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	5	5	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2001	322	7286					623	623		10.1136/bmj.322.7286.623	http://dx.doi.org/10.1136/bmj.322.7286.623			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238171	Green Published			2022-12-28	WOS:000167499900069
J	Bernard, GR; Vincent, JL; Laterre, P; LaRosa, SP; Dhainaut, JF; Lopez-Rodriguez, A; Steingrub, JS; Garber, GE; Helterbrand, JD; Ely, EW; Fisher, CJ				Bernard, GR; Vincent, JL; Laterre, P; LaRosa, SP; Dhainaut, JF; Lopez-Rodriguez, A; Steingrub, JS; Garber, GE; Helterbrand, JD; Ely, EW; Fisher, CJ		Recombinant Human Activated Protei	Efficacy and safety of recombinant human activated protein C for severe sepsis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; CRITICALLY ILL PATIENTS; SEPTIC SHOCK; ORGAN FAILURE; FACTOR-V; FIBRINOLYSIS; CLASSIFICATION; THROMBOMODULIN; INFLAMMATION; INACTIVATION	Background: Drotrecogin alfa (activated), or recombinant human activated protein C, has antithrombotic, antiinflammatory, and profibrinolytic properties. In a previous study, drotrecogin alfa activated produced dose-dependent reductions in the levels of markers of coagulation and inflammation in patients with severe sepsis. In this phase 3 trial, we assessed whether treatment with drotrecogin alfa activated reduced the rate of death from any cause among patients with severe sepsis. Methods: We conducted a randomized, double-blind, placebo-controlled, multicenter trial. Patients with systemic inflammation and organ failure due to acute infection were enrolled and assigned to receive an intravenous infusion of either placebo or drotrecogin alfa activated (24 microg per kilogram of body weight per hour) for a total duration of 96 hours. The prospectively defined primary end point was death from any cause and was assessed 28 days after the start of the infusion. Patients were monitored for adverse events; changes in vital signs, laboratory variables, and the results of microbiologic cultures; and the development of neutralizing antibodies against activated protein C. Results: A total of 1690 randomized patients were treated (840 in the placebo group and 850 in the drotrecogin alfa activated group). The mortality rate was 30.8 percent in the placebo group and 24.7 percent in the drotrecogin alfa activated group. On the basis of the prospectively defined primary analysis, treatment with drotrecogin alfa activated was associated with a reduction in the relative risk of death of 19.4 percent (95 percent confidence interval, 6.6 to 30.5) and an absolute reduction in the risk of death of 6.1 percent (P = 0.005). The incidence of serious bleeding was higher in the drotrecogin alfa activated group than in the placebo group (3.5 percent vs. 2.0 percent, P = 0.06). Conclusions: Treatment with drotrecogin alfa activated significantly reduces mortality in patients with severe sepsis and may be associated with an increased risk of bleeding. (N Engl J Med 2001;344:699-709.) Copyright (C) 2001 Massachusetts Medical Society.	Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium; Clin Univ St Luc, Dept Crit Care & Emergency Med, B-1200 Brussels, Belgium; Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; Univ Paris 05, CHU Cochin Port Royal, Dept Intens Care, Paris, France; Hosp Infanta Cristina, Serv Med Intens, Unidad Cuidados Intens, Badajoz, Spain; Baystate Med Ctr, Crit Care Div, Springfield, MA USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ Ottawa, Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada	Vanderbilt University; Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Eli Lilly; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Baystate Medical Center; Tufts University; University of Ottawa; Ottawa Hospital Research Institute	Bernard, GR (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, T-1208 Med Ctr N, Nashville, TN 37232 USA.		Ruiz-Rodriguez, Juan Carlos/H-7703-2012; Joyce, Christopher/B-7437-2013; Ely, E. Wesley/Z-2018-2019	Ruiz-Rodriguez, Juan Carlos/0000-0001-7392-8617; Ely, E. Wesley/0000-0003-3957-2172; Vincent, Jean-Louis/0000-0001-6011-6951; Breen, Dorothy/0000-0001-5010-4017				Angus DC, 2000, JAMA-J AM MED ASSOC, V283, P1723, DOI 10.1001/jama.283.13.1723; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Bajzar L, 1996, BLOOD, V88, P2093, DOI 10.1182/blood.V88.6.2093.bloodjournal8862093; BEVILACQUA MP, 1986, P NATL ACAD SCI USA, V83, P4533, DOI 10.1073/pnas.83.12.4533; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Boldt J, 2000, CRIT CARE MED, V28, P445, DOI 10.1097/00003246-200002000-00026; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; CONKLING PR, 1988, BLOOD, V72, P128; ESMON CT, 1992, ARTERIOSCLER THROMB, V12, P135, DOI 10.1161/01.ATV.12.2.135; ESMON CT, 1991, THROMB HAEMOSTASIS, V66, P160; Esmon CT, 1998, IMMUNOLOGIST, V6, P84; FOURRIER F, 1992, CHEST, V101, P816, DOI 10.1378/chest.101.3.816; FULCHER CA, 1984, BLOOD, V63, P486; GREY ST, 1994, J IMMUNOL, V153, P3664; GRINNELL BW, 1994, GLYCOBIOLOGY, V4, P221, DOI 10.1093/glycob/4.2.221; Hartman DL, 1998, INTENS CARE MED, V24, pS77; Hirose K, 2000, ANN SURG, V232, P272, DOI 10.1097/00000658-200008000-00018; Iba T, 1998, J AM COLL SURGEONS, V187, P321, DOI 10.1016/S1072-7515(98)00177-X; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Linde-Zwirble WT, 1999, CRIT CARE MED, V27, pA33, DOI 10.1097/00003246-199901001-00023; LORENTE JA, 1993, CHEST, V103, P1536, DOI 10.1378/chest.103.5.1536; Nesheim M, 1997, THROMB HAEMOSTASIS, V78, P386; POWARS D, 1993, CLIN INFECT DIS, V17, P254, DOI 10.1093/clinids/17.2.254; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Stouthard JML, 1996, THROMB HAEMOSTASIS, V76, P738; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Vervloet MG, 1998, SEMIN THROMB HEMOST, V24, P33, DOI 10.1055/s-2007-995821; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; Yan S. Betty, 1994, Perspectives in Drug Discovery and Design, V1, P503, DOI 10.1007/BF02171862; YAN SCB, 1990, BIO-TECHNOL, V8, P655, DOI 10.1038/nbt0790-655; 1990, JAMA, V263, P937	34	4090	4370	4	165	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2001	344	10					699	709		10.1056/NEJM200103083441001	http://dx.doi.org/10.1056/NEJM200103083441001			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408AX	11236773				2022-12-28	WOS:000167305300001
J	Jacobs, HO; Whitesides, GM				Jacobs, HO; Whitesides, GM			Submicrometer patterning of charge in thin-film electrets	SCIENCE			English	Article							SCANNING CAPACITANCE MICROSCOPY; ATOMIC-FORCE MICROSCOPE; STORAGE; SILICON; POLYMER; CONTRAST; SPM	Thin-film electrets have been patterned with trapped charge with submicrometer resolution using a flexible, electrically conductive electrode. A poly(dimethylsiloxane) stamp, patterned in bas-relief and supporting an 80-nanometer-thick gold film, is brought into contact with an 80-nanometer-thick film of poly(methylmethacrylate) supported on n-doped silicon. A voltage pulse between the gold film and the silicon transfers charge at the contact areas between the gold and the polymer electret. Areas as large as 1 square centimeter were patterned with trapped charges at a resolution better than 150 nanometers in Less than 20 seconds, This process provides a new method for patterning; it suggests possible methods for high-density, charge-based data storage and for high-resolution charge-based printing.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Jacobs, HO (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.		Han, Kyuhee/B-6201-2009					BARRETT RC, 1991, J APPL PHYS, V70, P2725, DOI 10.1063/1.349388; BauerGogonea S, 1996, IEEE T DIELECT EL IN, V3, P677, DOI 10.1109/94.544187; Born A, 1999, APPL PHYS A-MATER, V68, P131, DOI 10.1007/s003390050867; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; DREYER M, 1995, APPL PHYS A-MATER, V61, P357; Fang J, 1999, APPL PHYS LETT, V75, P3506, DOI 10.1063/1.125370; Jackson J., 1975, CLASSICAL ELECTRODYN; Jacobs HO, 1998, J APPL PHYS, V84, P1168, DOI 10.1063/1.368181; Jacobs HO, 1999, SURF INTERFACE ANAL, V27, P361, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<361::AID-SIA482>3.0.CO;2-8; Jacobs HO, 1997, ULTRAMICROSCOPY, V69, P39, DOI 10.1016/S0304-3991(97)00027-2; Legrand B, 1999, APPL PHYS LETT, V74, P4049, DOI 10.1063/1.123257; LIDE DR, 1980, HDB CHEM PHYSICS, V80, P13; Mamin HJ, 1995, IBM J RES DEV, V39, P681, DOI 10.1147/rd.396.0681; Mazur K, 1997, J PHYS D APPL PHYS, V30, P1383, DOI 10.1088/0022-3727/30/9/014; Nalwa H.S., 1995, FERROELECTRIC POLYM; PAI DM, 1993, REV MOD PHYS, V65, P163, DOI 10.1103/RevModPhys.65.163; Pauley MA, 1996, J CHEM PHYS, V104, P6834, DOI 10.1063/1.471350; Sessler G.M., 1987, ELECTRETS, V33, DOI [10.1007/3-540-17335-8, DOI 10.1007/3-540-17335-8]; Topinka MA, 2000, SCIENCE, V289, P2323, DOI 10.1126/science.289.5488.2323; Wilder K, 1998, APPL PHYS LETT, V73, P2527, DOI 10.1063/1.122504; Wright WMD, 1998, NANOTECHNOLOGY, V9, P133, DOI 10.1088/0957-4484/9/2/016; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G	22	303	338	2	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1763	1766		10.1126/science.1057061	http://dx.doi.org/10.1126/science.1057061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230687	Green Submitted			2022-12-28	WOS:000167320600052
J	Li, P; Chan, HC; He, B; So, SC; Chung, YW; Shang, Q; Zhang, YD; Zhang, YL				Li, P; Chan, HC; He, B; So, SC; Chung, YW; Shang, Q; Zhang, YD; Zhang, YL			An antimicrobial peptide gene found in the male reproductive system of rats	SCIENCE			English	Article							INNATE HOST-DEFENSE; CHLAMYDIA-TRACHOMATIS; ANION SECRETION; MESSENGER-RNA; EPIDIDYMIS; ANTIBIOTICS; EPITHELIA; BETA-DEFENSIN-1; EXPRESSION; CHANNEL	Little is known about the innate defense mechanisms of the male reproductive tract. We cloned a 385-base pair complementary DNA and its genomic DNA named Bin1b that is exclusively expressed in the caput region of the rat epididymis and that is responsible for sperm maturation, storage, and protection. Bin1b exhibits structural characteristics and antimicrobial activity similar to that of cationic antimicrobial peptides, beta -defensins. Bin1b is maximally expressed when the rats are sexually mature and can be up-regulated by inflammation. Bin1b appears to be a natural epididymis-specific antimicrobial peptide that plays a role in reproductive tract host defense and male fertility.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; Chinese Univ Hong Kong, Fac Med, Dept Physiol, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong	Zhang, YL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.		Chan, Hsiao Chang/E-1507-2016; 郑, 丽丽/HGE-2239-2022					APTE AN, 1995, REVERSER TRANSCRIPTA, P232; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Bevins CL, 1999, GUT, V45, P911, DOI 10.1136/gut.45.6.911; BLANCHARD TJ, 1994, BRIT J CLIN PRACT, V48, P201; CHAN HC, 1995, BIOL REPROD, V52, P192, DOI 10.1095/biolreprod52.1.192; Cooper TG, 1999, HUM REPROD UPDATE, V5, P141, DOI 10.1093/humupd/5.2.141; CUTHBERT AW, 1986, J PHYSIOL-LONDON, V378, P335, DOI 10.1113/jphysiol.1986.sp016222; DCRUZ OJ, 1995, J ANDROL, V16, P432; Diamond G, 1996, P NATL ACAD SCI USA, V93, P5156, DOI 10.1073/pnas.93.10.5156; Diamond G, 1998, CLIN IMMUNOL IMMUNOP, V88, P221, DOI 10.1006/clin.1998.4587; FLICKINGER CJ, 1990, BIOL REPROD, V43, P34, DOI 10.1095/biolreprod43.1.34; Frohlich O, 2000, J ANDROL, V21, P421; Ganz T, 1997, SEMIN HEMATOL, V34, P343; Grandjean V, 1997, BIOL REPROD, V57, P1115, DOI 10.1095/biolreprod57.5.1115; Hamil KG, 2000, ENDOCRINOLOGY, V141, P1245, DOI 10.1210/en.141.3.1245; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; JANTOS C, 1992, INFECT IMMUN, V60, P2324, DOI 10.1128/IAI.60.6.2324-2328.1992; Lencer WI, 1997, P NATL ACAD SCI USA, V94, P8585, DOI 10.1073/pnas.94.16.8585; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MOU LJ, 1994, BIOCHEM BIOPH RES CO, V199, P564, DOI 10.1006/bbrc.1994.1265; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; PerezSanchez F, 1996, MOL REPROD DEV, V45, P364, DOI 10.1002/(SICI)1098-2795(199611)45:3<364::AID-MRD14>3.0.CO;2-Z; Sawicki W, 1999, LANCET, V353, P464, DOI 10.1016/S0140-6736(98)04648-0; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; So SC, 1998, BBA-BIOMEMBRANES, V1415, P261, DOI 10.1016/S0005-2736(98)00201-6; TAMAMURA H, 1994, BIOCHEM BIOPH RES CO, V205, P1729, DOI 10.1006/bbrc.1994.2868; TSUKAMOTO T, 1991, International Journal of Developmental Biology, V35, P25; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Yasin B, 1996, INFECT IMMUN, V64, P709, DOI 10.1128/IAI.64.3.709-713.1996	29	196	229	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1783	1785		10.1126/science.1056545	http://dx.doi.org/10.1126/science.1056545			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230693				2022-12-28	WOS:000167320600058
J	Hemingway, H; Crook, AM; Feder, G; Banerjee, S; Dawson, JR; Magee, P; Philpott, S; Sanders, J; Wood, A; Timmis, AD				Hemingway, H; Crook, AM; Feder, G; Banerjee, S; Dawson, JR; Magee, P; Philpott, S; Sanders, J; Wood, A; Timmis, AD			Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BYPASS GRAFT-SURGERY; NEW-YORK-STATE; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; CARDIAC PROCEDURES; ANGIOGRAPHY; ORGANIZATION; ANGIOPLASTY; NETHERLANDS; GUIDELINES	Background: Ratings by an expert panel of the appropriateness of treatments may offer better guidance for clinical practice than the variable decisions of individual clinicians, yet there have been no prospective studies of clinical outcomes. We compared the clinical outcomes of patients treated medically after angiography with those of patients who underwent revascularization, within groups defined by ratings of the degree of appropriateness of revascularization in varying clinical circumstances. Methods: This was a prospective study of consecutive patients undergoing coronary angiography at three London hospitals. Before patients were recruited, a nine-member expert panel rated the appropriateness of percutaneous transluminal coronary angioplasty (PTCA) and coronary-artery bypass grafting (CABG) on a nine-point scale (with 1 denoting highly inappropriate and 9 denoting highly appropriate) for specific clinical indications. These ratings were then applied to a population of patients with coronary artery disease. However, the patients were treated without regard to the ratings. A total of 2552 patients were followed for a median of 30 months after angiography. Results: Of 908 patients with indications for which PTCA was rated appropriate (score, 7 to 9), 34 percent were treated medically; these patients were more likely to have angina at follow-up than those who underwent PTCA (odds ratio, 1.97; 95 percent confidence interval, 1.29 to 3.00). Of 1353 patients with indications for which CABG was considered appropriate, 26 percent were treated medically; they were more likely than those who underwent CABG to die or have a nonfatal myocardial infarction - the composite primary outcome (hazard ratio, 4.08; 95 percent confidence interval, 2.82 to 5.93) - and to have angina (odds ratio, 3.03; 95 percent confidence interval, 2.08 to 4.42). Furthermore, there was a graded relation between rating and outcome over the entire scale of appropriateness (P for linear trend = 0.002). Conclusions: On the basis of the ratings of the expert panel, we identified substantial underuse of coronary revascularization among patients who were considered appropriate candidates for these procedures. Underuse was associated with adverse clinical outcomes. (N Engl J Med 2001;344:645-54.) Copyright (C) 2001 Massachusetts Medical Society.	Kensington & Chelsea & Westminster Hlth Author, Dept Res & Dev, London W2 6LX, England; UCL, Sch Med, Dept Epidemiol & Publ Hlth, London W1N 8AA, England; St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London, England; Barts & London Natl Hlth Serv Trust, Cardiac Directorate, London, England	University of London; University College London; UCL Medical School; University of London; Queen Mary University London; Barts Health NHS Trust; University of London; Queen Mary University London	Hemingway, H (corresponding author), Kensington & Chelsea & Westminster Hlth Author, Dept Res & Dev, 50 Eastbourne Terr, London W2 6LX, England.	harry.hemingway@ha.kcw-ha.nthames.nhs.uk	Hemingway, Harry/C-1219-2009; Greiver, Michelle/N-8764-2015	Hemingway, Harry/0000-0003-2279-0624; Greiver, Michelle/0000-0001-8957-0285; Feder, Gene/0000-0002-7890-3926; Sanders, Julie/0000-0002-7335-2803				[Anonymous], 1992, ICD 10; [Anonymous], CORONARY ANGIOGRAPHY; Ayanian JZ, 1998, NEW ENGL J MED, V338, P1896, DOI 10.1056/NEJM199806253382608; Banerjee S, 2000, AM J CARDIOL, V85, P309, DOI 10.1016/S0002-9149(99)00738-9; BELL MR, 1995, J AM COLL CARDIOL, V25, P1650, DOI 10.1016/0735-1097(95)00044-5; BENGTSON A, 1994, JAMA-J AM MED ASSOC, V271, P1260, DOI 10.1001/jama.271.16.1260; Bernstein SJ, 1999, HEART, V81, P470, DOI 10.1136/hrt.81.5.470; BROOK RH, 1988, LANCET, V1, P750; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Carlisle DM, 1999, AM J MED, V106, P391, DOI 10.1016/S0002-9343(99)00051-0; Eagle KA, 1999, J AM COLL CARDIOL, V34, P1262, DOI 10.1016/S0735-1097(99)00389-7; GRAY D, 1990, LANCET, V335, P1317, DOI 10.1016/0140-6736(90)91196-H; Hemingway H, 2000, LANCET, V355, P985, DOI 10.1016/S0140-6736(00)90018-7; Hemingway H, 1999, J PUBLIC HEALTH MED, V21, P421, DOI 10.1093/pubmed/21.4.421; HILBORNE LH, 1993, JAMA-J AM MED ASSOC, V269, P761, DOI 10.1001/jama.269.6.761; Hux JE, 1996, LANCET, V348, P1202, DOI 10.1016/S0140-6736(96)04091-3; KOSECOFF J, 1987, MED CARE, V25, P196, DOI 10.1097/00005650-198703000-00003; Kravitz RL, 1997, JOINT COMM J QUAL IM, V23, P268, DOI 10.1016/S1070-3241(16)30317-0; KRAVITZ RL, 1995, JAMA-J AM MED ASSOC, V274, P632, DOI 10.1001/jama.274.8.632; Laouri M, 1997, J AM COLL CARDIOL, V29, P891, DOI 10.1016/S0735-1097(96)00434-2; LEAPE LL, 1993, JAMA-J AM MED ASSOC, V269, P753, DOI 10.1001/jama.269.6.753; Leape LL, 1999, ANN INTERN MED, V130, P183, DOI 10.7326/0003-4819-130-3-199902020-00003; MCGLYNN EA, 1994, JAMA-J AM MED ASSOC, V272, P934, DOI 10.1001/jama.272.12.934; Meijler AP, 1997, HEART, V77, P219, DOI 10.1136/hrt.77.3.219; PARSONNET V, 1989, CIRCULATION, V79, P3; Peters RJG, 2000, HEART, V83, P3, DOI 10.1136/heart.83.1.3; Rigter H, 1997, HEART, V77, P211, DOI 10.1136/hrt.77.3.211; RINGQVIST I, 1983, J CLIN INVEST, V71, P1854, DOI 10.1172/JCI110941; ROOS LL, 1994, CAN J CARDIOL, V10, P49; *SAS I, 1990, SAS US GUID VERS 6; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; WINSLOW CM, 1988, JAMA-J AM MED ASSOC, V260, P505, DOI 10.1001/jama.260.4.505	34	202	207	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2001	344	9					645	654		10.1056/NEJM200103013440906	http://dx.doi.org/10.1056/NEJM200103013440906			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405TR	11228280	Green Published			2022-12-28	WOS:000167177100006
J	Cohen, J; Stewart, I				Cohen, J; Stewart, I			Where are the dolphins?	NATURE			English	Editorial Material							LIFE	Interest in extraterrestrial life has tended to focus on a search for extrasolar planets similar to the Earth. But what of forms of intelligent life that are very different from those found on Earth? Some features of life will not be peculiar to our planet, and alien life will resemble ours in such universals. But if intelligent, non-humanoid aliens exist, where might they be? Would they wish to visit Earth and would we know if they did?.	Univ Warwick, Inst Math, Coventry CV4 7AL, W Midlands, England	University of Warwick	Cohen, J (corresponding author), Univ Warwick, Inst Math, Coventry CV4 7AL, W Midlands, England.							Adams Douglas, 1979, HITCHHIKERS GUIDE GA; Anderson RT, 1998, SCIENCE, V281, P976, DOI 10.1126/science.281.5379.976; [Anonymous], [No title captured]; ARTSUTANOV YN, 1960, PRAVDA          0731; Atkins JF, 2000, NATURE, V407, P463, DOI 10.1038/35035189; Auyang S.Y., 1998, FDN COMPLEX SYSTEM T, DOI DOI 10.1017/CBO9780511626135; BENFORD G, 1988, GREAT SKY RIVER; BENFORD G, 1998, FDN FEAR; Brin D, 1987, UPLIFT WAR; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; Chapman CR, 1999, SCIENCE, V283, P338, DOI 10.1126/science.283.5400.338; Chyba CF, 2000, NATURE, V403, P381, DOI 10.1038/35000281; Clarke A. C., 2013, PROFILES FUTURE; Cohen J, 1994, COLLAPSE CHAOS; COHEN J, 2000, WHEELERS; COLLAR AR, 1969, JBIS-J BRIT INTERPLA, V22, P442; Crawford I, 2000, SCI AM, V283, P38, DOI 10.1038/scientificamerican0700-38; FOGG MJ, 1987, ICARUS, V69, P370, DOI 10.1016/0019-1035(87)90112-6; FRIEDMANN EI, 1982, SCIENCE, V215, P1045, DOI 10.1126/science.215.4536.1045; Gee H., 1999, SEARCH DEEP TIME; GOLD T, 1992, P NATL ACAD SCI USA, V89, P6045, DOI 10.1073/pnas.89.13.6045; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; ISAACS JD, 1966, SCIENCE, V151, P682, DOI 10.1126/science.151.3711.682; Kauffman S. A., 1993, ORIGINS ORDER; Keller Evelyn Fox, 2000, CENTURY GENE; LACHMANN M, 2000, 9907054 SANT FE I; Marcy GW, 1998, ANNU REV ASTRON ASTR, V36, P57, DOI 10.1146/annurev.astro.36.1.57; Neumann J.V.A.W., 1966, THEORY SELF REPRODUC; Pepperberg IM., 1999, ALEX STUDIES COGNITI; Pratchett T., 1999, SCI DISCWORLD; Russell Michael J., 1998, P77; SCHROPE M, 2000, NEW SCI         0219, P12; *SETI I, 1999, PERSP; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Stetter KO, 1998, WILEY S ECO, P1; STEWART I, 1997, FIGMENTS REALITY; TOUGH A, 1999, JBIS-J BRIT INTERPLA, V52, P286; Ward P., 2000, RARE EARTH WHY COMPL; WHITE RH, 1984, NATURE, V310, P430, DOI 10.1038/310430a0; ZUCKERMAN B, 1995, EXTRATERRESTRIALS WH	40	6	6	5	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1119	1122		10.1038/35059248	http://dx.doi.org/10.1038/35059248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234027				2022-12-28	WOS:000167148800061
J	Nadeau, JH; Balling, R; Barsh, G; Beier, D; Brown, SDM; Bucan, M; Camper, S; Carlson, G; Copeland, N; Eppig, J; Fletcher, C; Frankel, WN; Ganten, D; Goldowitz, D; Goodnow, C; Guenet, JL; Hicks, G; de Angelis, MH; Jackson, I; Jacob, HJ; Jenkins, N; Johnson, D; Justice, M; Kay, S; Kingsley, D; Lehrach, H; Magnuson, T; Meisler, M; Poustka, AM; Rinchik, EM; Rossant, J; Russell, LB; Schimenti, J; Shiroishi, T; Skarnes, WC; Soriano, P; Stanford, W; Takahashi, JS; Wurst, W; Zimmer, A				Nadeau, JH; Balling, R; Barsh, G; Beier, D; Brown, SDM; Bucan, M; Camper, S; Carlson, G; Copeland, N; Eppig, J; Fletcher, C; Frankel, WN; Ganten, D; Goldowitz, D; Goodnow, C; Guenet, JL; Hicks, G; de Angelis, MH; Jackson, I; Jacob, HJ; Jenkins, N; Johnson, D; Justice, M; Kay, S; Kingsley, D; Lehrach, H; Magnuson, T; Meisler, M; Poustka, AM; Rinchik, EM; Rossant, J; Russell, LB; Schimenti, J; Shiroishi, T; Skarnes, WC; Soriano, P; Stanford, W; Takahashi, JS; Wurst, W; Zimmer, A		Int Mouse Mutagenesis Consortium	Sequence interpretation - Functional annotation of mouse genome sequences	SCIENCE			English	Article							MUTANT MICE; MUTAGENESIS; CHROMOSOME; WIDE		Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA	Case Western Reserve University	Nadeau, JH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, BRB 624,10900 Euclid Ave, Cleveland, OH 44106 USA.	jhn4@po.cwru.edu	Takahashi, Joseph S./Y-2781-2019; Balling, Rudi/E-9680-2010; Goodnow, Christopher C/V-8108-2018; Soriano, Philippe M/E-5797-2015; de Angelis, Martin Hrabe/F-5531-2012; Zimmer, Andreas/B-8357-2009; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Balling, Rudi/0000-0003-2902-5650; Goodnow, Christopher C/0000-0001-5296-6155; Soriano, Philippe M/0000-0002-0427-926X; de Angelis, Martin Hrabe/0000-0002-7898-2353; Takahashi, Joseph S/0000-0003-0384-8878; Goldowitz, Daniel/0000-0003-4756-4017; Stanford, William/0000-0002-5813-8016; Wurst, Wolfgang/0000-0003-4422-7410; Camper, Sally/0000-0001-8556-3379; Hicks, Geoffrey/0000-0003-4688-2312				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Justice MJ, 2000, NAT REV GENET, V1, P109, DOI 10.1038/35038549; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Metzger D, 1999, CURR OPIN BIOTECH, V10, P470, DOI 10.1016/S0958-1669(99)00012-9; NADEAU J, IN PRESS NATURE REV; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; Su H, 2000, NAT GENET, V24, P92, DOI 10.1038/71756; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Zheng BH, 1999, NAT GENET, V22, P375, DOI 10.1038/11949; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000	14	114	117	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1251	+		10.1126/science.1058244	http://dx.doi.org/10.1126/science.1058244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233449				2022-12-28	WOS:000166993400028
J	Roos, DS				Roos, DS			Computational biology - Bioinformatics - Trying to swim in a sea of data	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; SEQUENCE		Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Genom Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Roos, DS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.			Roos, David Siker/0000-0001-6725-4089				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bell E, 2000, SCIENCE, V290, P1696; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Brazma A, 2000, NATURE, V403, P699, DOI 10.1038/35001676; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gottlieb M, 2000, NATURE, V406, P121, DOI 10.1038/35018270; Hyman RW, 2001, SCIENCE, V291, P827; Jasny BR, 2001, SCIENCE, V291, P1153, DOI 10.1126/science.291.5506.1153; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kissinger JC, 2001, NUCLEIC ACIDS RES, V29, P66; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Macilwain C, 2000, NATURE, V405, P601, DOI 10.1038/35015216; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rowen L, 2000, SCIENCE, V289, P1881, DOI 10.1126/science.289.5486.1881; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; 2000, NATURE, V405, P719	20	59	74	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1260	+		10.1126/science.291.5507.1260	http://dx.doi.org/10.1126/science.291.5507.1260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11233452				2022-12-28	WOS:000166993400031
J	Montgomery, KT; Lee, E; Miller, A; Lau, S; Shim, C; Decker, J; Chiu, D; Emerling, S; Sekhon, M; Kim, R; Lenz, J; Han, JH; Ioshikhes, I; Renault, B; Marondel, I; Yoon, SJK; Song, K; Murty, VVVS; Scherer, S; Yonescu, R; Kirsch, IR; Ried, T; McPherson, J; Gibbs, R; Kucherlapati, R				Montgomery, KT; Lee, E; Miller, A; Lau, S; Shim, C; Decker, J; Chiu, D; Emerling, S; Sekhon, M; Kim, R; Lenz, J; Han, JH; Ioshikhes, I; Renault, B; Marondel, I; Yoon, SJK; Song, K; Murty, VVVS; Scherer, S; Yonescu, R; Kirsch, IR; Ried, T; McPherson, J; Gibbs, R; Kucherlapati, R			A high-resolution map of human chromosome 12	NATURE			English	Article							PHYSICAL MAP; HUMAN GENOME; SEQUENCE	Our sequence-tagged site-content map of chromosome 12 is now integrated with the whole-genome fingerprinting effort(1,2). It provides accurate and nearly complete bacterial clone coverage of chromosome 12. We propose that this integrated mapping protocol serves as a model for constructing physical maps for entire genomes.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Catholic Univ, Coll Med, Res Inst Med Sci, Seoul 137404, South Korea; Univ Ulsan, Coll Med, Seoul 138736, South Korea; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; NCI, Dept Genet, Med Branch, NIH, Bethesda, MD 20892 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA	Yeshiva University; Albert Einstein College of Medicine; Catholic University of Korea; University of Ulsan; Columbia University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL)	Kucherlapati, R (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Sekhon, Mandeep/L-4665-2018; McPherson, John D/D-2633-2017; Kucherlapati, Raju/ABC-8807-2021	Sekhon, Mandeep/0000-0002-9993-6938; McPherson, John D/0000-0001-8049-9347; 				Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Kirsch IR, 2000, NAT GENET, V24, P339, DOI 10.1038/74149; KRAUTER K, 1995, NATURE, V377, P321; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; MONTGOMERY KT, 1993, GENOMICS, V17, P682, DOI 10.1006/geno.1993.1390; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Renault B, 1997, GENOMICS, V45, P271, DOI 10.1006/geno.1997.4888; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422	14	18	18	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					945	946		10.1038/35057174	http://dx.doi.org/10.1038/35057174			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237017	Green Published, Bronze			2022-12-28	WOS:000166938800064
J	Gittleman, JL; Gompper, ME				Gittleman, JL; Gompper, ME			Ecology and evolution - The risk of extinction - What you don't know will hurt you	SCIENCE			English	Editorial Material									Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Columbia Univ, Ctr Environm Res & Conservat, New York, NY 10027 USA	University of Virginia; Columbia University	Gittleman, JL (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.							Alroy John, 1999, P105; Berger J, 1999, P ROY SOC B-BIOL SCI, V266, P2261, DOI 10.1098/rspb.1999.0917; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; BOITANI L, IN PRESS CARNIVORE C; BREITENMOSER U, IN PRESS CARNIVORE C; CEBALLOS G, 1995, CONSERV BIOL, V9, P559, DOI 10.1046/j.1523-1739.1995.09030559.x; Craighead J.J., 1995, GRIZZLY BEARS YELLOW; CRAWLEY MJ, 1992, NATURAL ENEMIES; Diamond J.M., 1984, P191; *IUCN, 1996, 1996 IUCN RED LIST T; IUCN, 1998, IUCN GUID REINTR; MACE GM, 2000, PRIORITIES CONSERVAT, P27; MARTINPS, 1999, EXTINCTIONS NEAR TIM, P17; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; PRINS HHT, 1989, BEHAVIOUR, V108, P262, DOI 10.1163/156853989X00330; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; van Heezik Y, 1999, ANIM CONSERV, V2, P155, DOI 10.1111/j.1469-1795.1999.tb00061.x	17	35	38	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					997	999		10.1126/science.291.5506.997	http://dx.doi.org/10.1126/science.291.5506.997			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11232588				2022-12-28	WOS:000166860100032
J	Okawa, Y; Aono, M				Okawa, Y; Aono, M			Materials science - Nanoscale control of chain polymerization	NATURE			English	Article							MULTILAYERS		RIKEN, Surface & Interface Lab, Wako, Saitama 3510198, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; Osaka Univ, Dept Precis Sci & Technol, Suita, Osaka 5650871, Japan	RIKEN; Japan Science & Technology Agency (JST); Osaka University	Okawa, Y (corresponding author), RIKEN, Surface & Interface Lab, Wako, Saitama 3510198, Japan.		Okawa, Yuji/H-2786-2011	Okawa, Yuji/0000-0002-3641-8498				ALBRECHT TR, 1989, APPL PHYS LETT, V55, P1727, DOI 10.1063/1.102201; DAY DR, 1981, J APPL POLYM SCI, V26, P1605, DOI 10.1002/app.1981.070260516; DONOVAN KJ, 1992, THIN SOLID FILMS, V210, P271, DOI 10.1016/0040-6090(92)90231-Y; TIEKE B, 1979, J POLYM SCI POL CHEM, V17, P1631, DOI 10.1002/pol.1979.170170607; WEGNER G, 1972, MAKROMOLEKUL CHEM, V154, P35; WEGNER G, 1969, Z NATURFORSCH PT B, VB 24, P824	6	377	384	3	105	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2001	409	6821					683	684		10.1038/35055625	http://dx.doi.org/10.1038/35055625			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217849				2022-12-28	WOS:000166816400032
J	Rowland, M; Drumm, B				Rowland, M; Drumm, B			Helicobacter pylori and sudden-infant-death syndrome	LANCET			English	Editorial Material									Univ Coll Dublin, Conway Inst, Dept Paediat, Dublin 12, Ireland; Our Ladys Hosp Sick Children, Childrens Res Ctr, Dublin 12, Ireland	University College Dublin; Our Ladys Children Hospital Crumlin	Rowland, M (corresponding author), Univ Coll Dublin, Conway Inst, Dept Paediat, Dublin 12, Ireland.		Drumm, Brendan/AAL-2361-2020	Drumm, Brendan/0000-0002-9322-5086				BOSELEY S, 2000, GUARDIAN        1031; Elitsur Y, 2000, HELICOBACTER, V5, P227, DOI 10.1046/j.1523-5378.2000.00035.x; GOTTRAND F, 1992, LANCET, V340, P495, DOI 10.1016/0140-6736(92)91824-R; HALL C, 2000, DAILY TELEGRAPH 1024; Kattwinkel J, 2000, PEDIATRICS, V105, P650, DOI 10.1542/peds.105.3.650; Kerr JR, 2000, ARCH DIS CHILD, V83, P429, DOI 10.1136/adc.83.5.429; ORENSTEIN SR, 1983, J PEDIATR-US, V103, P534, DOI 10.1016/S0022-3476(83)80578-2; Pattison CP, 1997, MED HYPOTHESES, V49, P365, DOI 10.1016/S0306-9877(97)90080-3; RAYMOND J, 1995, EUR J CLIN MICROBIOL, V14, P727, DOI 10.1007/BF01690886; Rowland M, 2000, LANCET, V355, P332, DOI 10.1016/S0140-6736(99)00427-4	10	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2001	357	9253					327	327		10.1016/S0140-6736(00)03634-5	http://dx.doi.org/10.1016/S0140-6736(00)03634-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11210989				2022-12-28	WOS:000166897900005
J	Segre, PN; Liu, F; Umbanhowar, P; Weitz, DA				Segre, PN; Liu, F; Umbanhowar, P; Weitz, DA			An effective gravitational temperature for sedimentation	NATURE			English	Article							VELOCITY FLUCTUATIONS; DIFFUSION	The slow sedimentation of suspensions of solid particles in a fluid results in complex phenomena that are poorly understood. For a low volume fraction (phi) of particles, long-range hydrodynamic interactions result in surprising spatial correlations(1) in the velocity fluctuations; these are reminiscent of turbulence, even though the Reynolds number is very low(2-4). At higher values of phi, the behaviour of sedimentation remains unclear; the upward backflow of fluid becomes increasingly important, while collisions and crowding further complicate inter-particle interactions(5-8). Concepts from equilibrium statistical mechanics could in principle be used to describe the fluctuations and thereby provide a unified picture of sedimentation, but one essential ingredient-an effective temperature that provides a mechanism for thermalization-is missing. Here we show that the gravitational energy of fluctuations in particle number can act as an effective temperature. Moreover, we demonstrate that the high-phi behaviour is in fact identical to that at low phi, provided that the suspension viscosity and sedimentation velocity are scaled appropriately, and that the effects of particle packing are included.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Univ Penn, Dept Phys, Philadelphia, PA 19104 USA; Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	Harvard University; University of Pennsylvania; Northwestern University	Weitz, DA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	weitz@deas.harvard.edu						ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; Bender J, 1996, J RHEOL, V40, P899, DOI 10.1122/1.550767; Brenner MP, 1999, PHYS FLUIDS, V11, P754, DOI 10.1063/1.869948; CAFLISCH RE, 1985, PHYS FLUIDS, V28, P759, DOI 10.1063/1.865095; Cowan ML, 2000, PHYS REV LETT, V85, P453, DOI 10.1103/PhysRevLett.85.453; DEKRUIF CG, 1985, J CHEM PHYS, V83, P4717, DOI 10.1063/1.448997; Hinch E.J., 1988, DISORDER MIXING, P153; KOCH DL, 1991, J FLUID MECH, V224, P275, DOI 10.1017/S0022112091001763; Levine A, 1998, PHYS REV LETT, V81, P5944, DOI 10.1103/PhysRevLett.81.5944; NICOLAI H, 1995, PHYS FLUIDS, V7, P3, DOI 10.1063/1.868727; NICOLAI H, 1995, PHYS FLUIDS, V7, P12, DOI 10.1063/1.868733; Richardson J.F., 1954, T I CHEM ENG-LOND, V32, P35, DOI DOI 10.1016/S0263-8762(97)80006-8; Segre PN, 1997, PHYS REV LETT, V79, P2574, DOI 10.1103/PhysRevLett.79.2574; Tong P, 1998, PHYS REV E, V58, pR6931, DOI 10.1103/PhysRevE.58.R6931; XUE JZ, 1992, PHYS REV LETT, V69, P1715, DOI 10.1103/PhysRevLett.69.1715	16	137	138	3	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2001	409	6820					594	597		10.1038/35054518	http://dx.doi.org/10.1038/35054518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	397JJ	11214313				2022-12-28	WOS:000166692300037
J	Ridanpaa, M; van Eenennaam, H; Pelin, K; Chadwick, R; Johnson, C; Yuan, B; vanVenrooij, W; Pruijn, G; Salmela, R; Rockas, S; Makitie, O; Kaitila, I; de la Chapelle, A				Ridanpaa, M; van Eenennaam, H; Pelin, K; Chadwick, R; Johnson, C; Yuan, B; vanVenrooij, W; Pruijn, G; Salmela, R; Rockas, S; Makitie, O; Kaitila, I; de la Chapelle, A			Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia	CELL			English	Article							RIBONUCLEOPROTEIN ENDORIBONUCLEASE; PROTEIN SUBUNIT; RIBONUCLEASE-P; POLYMERASE-III; NUCLEAR GENE; CONTAINS; TRANSCRIPTION; POPULATIONS; FINLAND; REGION	The recessively inherited developmental disorder, cartilage-hair hypoplasia (CHH) is highly pleiotropic with manifestations including short stature, defective cellular immunity, and predisposition to several cancers. The endoribonuclease RNase MRP consists of an RNA molecule bound to several proteins. It has at least two functions, namely, cleavage of RNA in mitochondrial DNA synthesis and nucleolar cleaving of pre-rRNA. We describe numerous mutations in the untranslated RMRP gene that cosegragate with the CHH phenotype. Insertion mutations immediately upstream of the coding sequence silence transcription while mutations in the transcribed region do not. The association of protein subunits with RNA appears unaltered. We conclude that mutations in RMRP cause CHH by disrupting a function of RNase MRP RNA that affects multiple organ systems.	Helsinki Univ Hosp, Dept Clin Genet, Helsinki 00290, Finland; Folkhalsan Inst Genet, Helsinki 00280, Finland; Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; Univ Nijmegen, Dept Biochem, Nijmegen, Netherlands; Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; Helsinki Univ Hosp, Hosp Children & Adolescents, Helsinki 00290, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Radboud University Nijmegen; University System of Ohio; Ohio State University; University of Helsinki; Helsinki University Central Hospital	de la Chapelle, A (corresponding author), Helsinki Univ Hosp, Dept Clin Genet, Helsinki 00290, Finland.	delachapelle-1@medctr.osu.edu	Pruijn, Ger/D-6664-2012	Makitie, Outi/0000-0002-4547-001X	NCI NIH HHS [CA67941, CA16058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016058, U01CA067941, R01CA067941] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ben-Yosef T, 1999, GENOMICS, V62, P316, DOI 10.1006/geno.1999.6019; BROWN JW, 1990, CELL, V62, P407, DOI 10.1016/0092-8674(90)90003-W; Cai T, 1999, MOL CELL BIOL, V19, P7857; CHANG DD, 1989, CELL, V56, P131, DOI 10.1016/0092-8674(89)90991-4; CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; CHU S, 1994, P NATL ACAD SCI USA, V91, P659, DOI 10.1073/pnas.91.2.659; CLAYTON DA, 1994, P NATL ACAD SCI USA, V91, P4615, DOI 10.1073/pnas.91.11.4615; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Eder PS, 1997, P NATL ACAD SCI USA, V94, P1101, DOI 10.1073/pnas.94.4.1101; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HSIEH CL, 1990, GENOMICS, V6, P540, DOI 10.1016/0888-7543(90)90483-B; Kurz JC, 2000, CURR OPIN CHEM BIOL, V4, P553, DOI 10.1016/S1367-5931(00)00131-9; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LUX SE, 1970, NEW ENGL J MED, V282, P231, DOI 10.1056/NEJM197001292820501; Lygerou Z, 1996, EMBO J, V15, P5936, DOI 10.1002/j.1460-2075.1996.tb00980.x; Makitie O, 1999, J PEDIATR-US, V134, P315, DOI 10.1016/S0022-3476(99)70456-7; MAKITIE O, 1993, EUR J PEDIATR, V152, P211, DOI 10.1007/BF01956147; MAKITIE O, 1992, THESIS U HELSINKI, P1; McKusick VA, 2000, NAT GENET, V24, P203, DOI 10.1038/73389; MCKUSICK VA, 1965, B JOHNS HOPKINS HOSP, V116, P285; MURPHY S, 1987, CELL, V51, P81, DOI 10.1016/0092-8674(87)90012-2; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; PIERCE GF, 1982, J IMMUNOL, V129, P570; Pluk H, 1999, RNA, V5, P512, DOI 10.1017/S1355838299982079; Sbisa E, 1996, J MOL EVOL, V43, P46, DOI 10.1007/BF02352299; SCHMITT ME, 1993, FASEB J, V7, P208, DOI 10.1096/fasebj.7.1.7678563; SCHMITT ME, 1992, GENE DEV, V6, P1975, DOI 10.1101/gad.6.10.1975; SULISALO T, 1994, AM J HUM GENET, V55, P937; SULISALO T, 1995, HUM GENET, V95, P157, DOI 10.1007/BF00209394; SULISALO T, 1993, NAT GENET, V3, P338, DOI 10.1038/ng0493-338; Sulisalo T, 1997, EUR J HUM GENET, V5, P35, DOI 10.1159/000484729; SULISALO T, 1994, GENOMICS, V20, P347, DOI 10.1006/geno.1994.1187; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; TOPPER JN, 1990, NUCLEIC ACIDS RES, V18, P793, DOI 10.1093/nar/18.4.793; Vakkilainen T, 1999, GENOMICS, V59, P319, DOI 10.1006/geno.1999.5883; van Eenennaam H, 1999, NUCLEIC ACIDS RES, V27, P2465, DOI 10.1093/nar/27.12.2465; van Eenennaam H, 2000, IUBMB LIFE, V49, P265; VERHEIJEN R, 1994, J IMMUNOL METHODS, V169, P173, DOI 10.1016/0022-1759(94)90261-5; VIROLAINEN M, 1978, PEDIATR RES, V12, P961, DOI 10.1203/00006450-197810000-00002; YUAN Y, 1991, BIOCHIM BIOPHYS ACTA, V1089, P33, DOI 10.1016/0167-4781(91)90081-V	43	325	332	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2001	104	2					195	203		10.1016/S0092-8674(01)00205-7	http://dx.doi.org/10.1016/S0092-8674(01)00205-7			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400PB	11207361	Bronze			2022-12-28	WOS:000166879700004
J	Chua, F				Chua, F			Clinical picture: Paravertebral abscess	LANCET			English	Article									UCL Royal Free & Univ Coll Hosp, Rayne Inst, Ctr Resp Res, London WC1E 6JJ, England	University of London; King's College London; University College London	Chua, F (corresponding author), UCL Royal Free & Univ Coll Hosp, Rayne Inst, Ctr Resp Res, London WC1E 6JJ, England.			Chua, Felix/0000-0001-7845-0173					0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 20	2001	357	9251					168	168		10.1016/S0140-6736(00)03588-1	http://dx.doi.org/10.1016/S0140-6736(00)03588-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213092	Bronze			2022-12-28	WOS:000166593700008
J	Jain, H; Greenblatt, JM; Albornoz, AM				Jain, H; Greenblatt, JM; Albornoz, AM			Emphysematous pyelonephritis: a rare cause of pneumaturia	LANCET			English	Editorial Material									Mercy Catholic Med Ctr, Dept Med, Darby, PA 19023 USA		Jain, H (corresponding author), 18 N Oak Ave,C-5, Clifton Heights, PA 19018 USA.							BOHLMAN ME, 1991, SOUTH MED J, V84, P1438, DOI 10.1097/00007611-199112000-00007; Eloubeidi MAS, 1999, NEW ENGL J MED, V341, P737, DOI 10.1056/NEJM199909023411005; Huang JJ, 2000, ARCH INTERN MED, V160, P797, DOI 10.1001/archinte.160.6.797; Stein JP, 1996, UROLOGY, V47, P129, DOI 10.1016/S0090-4295(99)80399-9; SYNHAIVSKY A, 1985, AM J MED, V78, P617, DOI 10.1016/0002-9343(85)90404-8	5	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 20	2001	357	9251					194	194		10.1016/S0140-6736(00)03593-5	http://dx.doi.org/10.1016/S0140-6736(00)03593-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	395QX	11213097				2022-12-28	WOS:000166593700013
J	Angel, R				Angel, R			Future optical and infrared telescopes	NATURE			English	Article								New telescopes, new detectors and new regions of the electromagnetic spectrum have often revealed totally unsuspected aspects of the Universe. How can we maximize the chances of such serendipity in the future?	Univ Arizona, Dept Astron, Tucson, AZ 85721 USA; Univ Arizona, Steward Observ, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Angel, R (corresponding author), Univ Arizona, Dept Astron, Tucson, AZ 85721 USA.							ANGEL JRP, 1986, NATURE, V322, P341, DOI 10.1038/322341a0; ANGEL JRP, 2000, P SOC PHOTO-OPT INS, V4013, P699; Angel R, 2000, SCIENCE, V288, P455, DOI 10.1126/science.288.5465.455; Burge JH, 2000, P SOC PHOTO-OPT INS, V4013, P640, DOI 10.1117/12.393999; Harwit M., 1981, COSMIC DISCOVERY SEA; TYSON JA, GRAVITATIONAL LENSIN; Tyson T, 1997, AIP CONF PROC, V408, P204, DOI 10.1063/1.53791	7	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2001	409	6818					427	430		10.1038/35053217	http://dx.doi.org/10.1038/35053217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	392VY	11201760				2022-12-28	WOS:000166434300069
J	Chan, AWS; Chong, KY; Martinovich, C; Simerly, C; Schatten, G				Chan, AWS; Chong, KY; Martinovich, C; Simerly, C; Schatten, G			Transgenic monkeys produced by retroviral gene transfer into mature oocytes	SCIENCE			English	Article							MOUSE MODEL; NUCLEAR TRANSFER; RHESUS-MONKEY; DISEASE; FETAL; INJECTION	Transgenic rhesus monkeys carrying the green fluorescent protein (GFP) gene were produced by injecting pseudotyped replication-defective retroviral vector into the perivitelline space of 224 mature rhesus oocytes, Later fertilized by intracytoplasmic sperm injection. Of the three males born from 20 embryo transfers, one was transgenic when accessible tissues were assayed for transgene DNA and messenger RNA. ALL tissues that were studied from a fraternal set of twins, miscarried at 73 days, carried the transgene, as confirmed by Southern analyses, and the GFP transgene reporter was detected by both direct and indirect fluorescence imaging.	Oregon Reg Primate Res Ctr, Ctr Womens Hlth, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Dept Cell Dev Biol, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Dept Obstet Gynecol, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University	Schatten, G (corresponding author), Oregon Reg Primate Res Ctr, Ctr Womens Hlth, 505 NW 185th Ave, Beaverton, OR 97006 USA.	schatten@ohsu.edu	simerly, Calvin/AAC-9564-2021; Schatten, Gerald/B-3253-2009	Schatten, Gerald/0000-0001-5206-7782				Barouch DH, 2000, P NATL ACAD SCI USA, V97, P4192, DOI 10.1073/pnas.050417697; Blouin MJ, 2000, NAT MED, V6, P177, DOI 10.1038/72279; Chan AWS, 2000, SCIENCE, V287, P317, DOI 10.1126/science.287.5451.317; Chan AWS, 1998, P NATL ACAD SCI USA, V95, P14028, DOI 10.1073/pnas.95.24.14028; Chan AWS, 2000, MOL HUM REPROD, V6, P26, DOI 10.1093/molehr/6.1.26; Chien KR, 1996, J CLIN INVEST, V98, pS19; Chinnasamy N, 2000, HUM GENE THER, V11, P1901, DOI 10.1089/10430340050129512; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Eckert RL, 2000, INT J ONCOL, V16, P853; Erickson RP, 1996, BIOESSAYS, V18, P993, DOI 10.1002/bies.950181209; Hewitson L, 1998, HUM REPROD, V13, P3449, DOI 10.1093/humrep/13.12.3449; Hewitson L, 1999, NAT MED, V5, P431, DOI 10.1038/7430; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kuroda MJ, 2000, J VIROL, V74, P8751, DOI 10.1128/JVI.74.18.8751-8756.2000; Lee HC, 2000, NATURE, V408, P483, DOI 10.1038/35044106; Muller U, 1999, MECH DEVELOP, V82, P3, DOI 10.1016/S0925-4773(99)00021-0; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Nathanson N, 1999, AIDS, V13, pS113; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Schott B, 1997, NUCLEIC ACIDS RES, V25, P2940, DOI 10.1093/nar/25.14.2940; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Thomson JA, 1998, CURR TOP DEV BIOL, V38, P133; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weinstein EJ, 2000, MOL MED, V6, P4, DOI 10.1007/BF03401930; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wolf DP, 1999, BIOL REPROD, V60, P199, DOI 10.1095/biolreprod60.2.199; Wu GJ, 1996, BIOL REPROD, V55, P260, DOI 10.1095/biolreprod55.2.260; YEE JK, 1994, METHOD CELL BIOL, V43, P99	33	225	253	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2001	291	5502					309	312		10.1126/science.291.5502.309	http://dx.doi.org/10.1126/science.291.5502.309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391JM	11209082				2022-12-28	WOS:000166352900047
J	Eriksson, U; Seifert, B; Schaffner, A				Eriksson, U; Seifert, B; Schaffner, A			Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEAN BODY-MASS; NEUTROPENIC PATIENTS; FUNGAL-INFECTIONS; UNKNOWN ORIGIN; TOXICITY; PHARMACOKINETICS; CLEARANCE; FEVER	Objective To test the hypothesis that amphotericin B deoxycholate is less toxic when given by continuous infusion than by conventional rapid infusion. Design Randomised, controlled, non-blinded, single centre study. Setting University hospital providing tertiary clinical care. Patients 80 mostly neutropenic patients with refractory fever and suspected or proved invasive fungal infections. Intervention Patients were randomised to receive 0.97 mg/kg amphotericin B by continuous infusion over 24 hours or 0.95 mg/kg by rapid infusion over four hours. Main outcome measures Patients were evaluated for side effects related to infusion, nephrotoxicity, and mortality up to three months after treatment Analysis was on an intention to treat basis. Results Patients in the continuous infusion group had fewer side effects and significantly reduced nephrotoxicity compared with those in the rapid infusion group, Overall mortality was higher during treatment and after three months' follow up in the rapid infusion than in the continuous infusion group. Conclusion Continuous infusions of amphotericin B reduce nephrotoxicity and side effects related to infusion without increasing mortality.	Univ Zurich, Univ Hosp, CH-8091 Zurich, Switzerland; Univ Zurich, Dept Biostat, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich	Eriksson, U (corresponding author), Univ Basel Hosp, CH-4031 Basel, Switzerland.	klinerr@usz.unizh.ch		Eriksson, Urs/0000-0003-1217-9696; Seifert, Burkhardt/0000-0002-5829-2478				ADLERMOORE J, 1994, BONE MARROW TRANSPL, V14, pS3; ARNING M, 1989, KLIN WOCHENSCHR, V67, P1020, DOI 10.1007/BF01727003; BERNARDO JF, 1995, NEPHRON, V70, P235, DOI 10.1159/000188590; CAMPBELL MJ, 1988, BRIT MED J, V296, P1454, DOI 10.1136/bmj.296.6634.1454; CHABOT GG, 1989, J PHARM SCI, V78, P307, DOI 10.1002/jps.2600780409; CLEARY JD, 1992, ANTIMICROB AGENTS CH, V36, P977, DOI 10.1128/AAC.36.5.977; CRUZ JM, 1992, AM J MED, V93, P123, DOI 10.1016/0002-9343(92)90040-I; DANESHMEND TK, 1983, CLIN PHARMACOKINET, V8, P17, DOI 10.2165/00003088-198308010-00002; ELLIS ME, 1992, ANTIMICROB AGENTS CH, V36, P172, DOI 10.1128/AAC.36.1.172; FEELY J, 1981, LANCET, V1, P1422; GOODWIN SD, 1995, CLIN INFECT DIS, V20, P755, DOI 10.1093/clinids/20.4.755; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; HALLYNCK T, 1981, CLIN PHARMACOL THER, V30, P414, DOI 10.1038/clpt.1981.181; HALLYNCK TH, 1981, BRIT J CLIN PHARMACO, V11, P523, DOI 10.1111/j.1365-2125.1981.tb01163.x; Hiemenz JW, 1996, CLIN INFECT DIS, V22, pS133, DOI 10.1093/clinids/22.Supplement_2.S133; MILLS W, 1994, BRIT J HAEMATOL, V86, P754, DOI 10.1111/j.1365-2141.1994.tb04825.x; OLDFIELD EC, 1990, ANTIMICROB AGENTS CH, V34, P1402, DOI 10.1128/AAC.34.7.1402; Prentice HG, 1997, BRIT J HAEMATOL, V98, P711, DOI 10.1046/j.1365-2141.1997.2473063.x; Rogers PD, 1998, J INFECT DIS, V178, P1726, DOI 10.1086/314495; Schoffski P, 1998, BRIT MED J, V317, P379, DOI 10.1136/bmj.317.7155.379; Walsh TJ, 1999, NEW ENGL J MED, V340, P764, DOI 10.1056/NEJM199903113401004	21	157	159	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2001	322	7286					579	582		10.1136/bmj.322.7286.579	http://dx.doi.org/10.1136/bmj.322.7286.579			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411KU	11238151	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000167499900021
J	O'Brien, E; Waeber, B; Parati, G; Staessen, J; Myers, MG				O'Brien, E; Waeber, B; Parati, G; Staessen, J; Myers, MG		European Soc Hypertension Working	Blood pressure measuring devices: recommendations of the European Society of Hypertension	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MONITORING DEVICE; PORTABLE MONITOR; HOME MEASUREMENT; ACCURACY; VALIDATION; ADVANCEMENT; ASSOCIATION; PERFORMANCE; SPHYGMOMANOMETERS; INACCURACY		Beaumont Hosp, Blood Pressure Unit, Dublin 9, Ireland; CHU Vaudois, Div Hypertens, Dept Med Interne, CH-1011 Lausanne, Switzerland; Univ Milano Biocca, Ist Sci Osped San Luca, IRCCS, Ist Auxol Italiano, I-20149 Milan, Italy; Katholieke Univ Leuven, UZ Gasthuisberg, B-3000 Louvain, Belgium; Sunnybrook & Womens Coll, Hlth Sci Ctr, Div Cardiol, Toronto, ON M4N 3M5, Canada	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); IRCCS Istituto Auxologico Italiano; University of Milano-Bicocca; KU Leuven; University Hospital Leuven; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	O'Brien, E (corresponding author), Beaumont Hosp, Blood Pressure Unit, Dublin 9, Ireland.	eobrien@iol.ie	Staessen, Jan A/A-1065-2011; Parati, Gianfranco/K-7151-2016	Staessen, Jan A/0000-0002-3026-1637; Parati, Gianfranco/0000-0001-9402-7439				Alpert, 1996, Blood Press Monit, V1, P69; Anwar, 1997, Blood Press Monit, V2, P105; Anwar, 1998, Blood Press Monit, V3, P261; Artigao M, 1998, J HYPERTENS, V16, pS276; *ASS ADV MED INSTR, 1987, AM NAT STAND EL AUT, P25; Association for the Advancement of Medical Instrumentation, 1993, ANSI AAMI SP, P40; Barna I, 1998, Blood Press Monit, V3, P363; Baumgart, 1998, Blood Press Monit, V3, P303; Belsha, 1996, Blood Press Monit, V1, P127; BOBRIE G, 1999, J HYPERTENS       S3, V17, pS22; Bortolotto L A, 1999, Blood Press Monit, V4, P21, DOI 10.1097/00126097-199904010-00004; Brown WCB, 1997, J HUM HYPERTENS, V11, P75, DOI 10.1038/sj.jhh.1000405; BURKE MJ, 1982, BRIT MED J, V285, P469, DOI 10.1136/bmj.285.6340.469; Cordoba R, 1997, Aten Primaria, V20, P247; de Gaudemaris R, 1999, ARCH MAL COEUR VAISS, V92, P1133; Dieterle T, 1998, Blood Press Monit, V3, P339; Eckert, 1997, Blood Press Monit, V2, P189; FOSTER C, 1994, J HUM HYPERTENS, V8, P661; Franx A, 1997, HYPERTENS PREGNANCY, V16, P187, DOI 10.3109/10641959709031636; Germano G, 1998, AM J HYPERTENS, V11, P1486, DOI 10.1016/S0895-7061(98)00147-2; Gizdulich P, 1996, J HYPERTENS, V14, P243, DOI 10.1097/00004872-199602000-00014; GOSSE P, 1997, J HYPERTENS        S, V15, pS18; IMAI Y, 1992, AM J HYPERTENS, V5, P719, DOI 10.1093/ajh/5.10.719; Iqbal, 1996, Blood Press Monit, V1, P367; Kuwajima I, 1998, AM J HYPERTENS, V11, P1328, DOI 10.1016/S0895-7061(98)00155-1; Livi R, 1996, AM J HYPERTENS, V9, P1228, DOI 10.1016/S0895-7061(96)00320-2; LONES CR, 2000, J HUM HYPERTENS, V14, P843; MANNING G, 1994, J AMB MON, V7, P255; Mee F, 1998, Blood Press Monit, V3, P353; MEE F, 1994, J HUM HYPERTENS, V8, P295; MEE F, 1999, BLOOD PRESS MONIT, V4, P35; Modesti, 1996, Blood Press Monit, V1, P63; Mufunda J., 1996, Central African Journal of Medicine, V42, P230; Myers MG, 1999, AM J HYPERTENS, V12, P1149, DOI 10.1016/S0895-7061(99)00199-5; MYERS MG, 1998, CAN J CARDIOL SF, V14, pF148; NARA AR, 1996, MED ELECT, V27, P63; Natarajan P, 1999, AM J OBSTET GYNECOL, V181, P1203, DOI 10.1016/S0002-9378(99)70109-2; Ng K G, 1995, Intensive Care World, V12, P89; Ng Kim-Gau, 1994, Journal of Clinical Engineering, V19, P452; O'Brien, 1996, Blood Press Monit, V1, P55; O'Brien, 1998, Blood Press Monit, V3, P205; O'Brien, 1997, Blood Press Monit, V2, P31; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Brien E, 2000, BLOOD PRESS MONIT, V5, P43, DOI 10.1097/00126097-200002000-00010; O'Brien E, 2000, BLOOD PRESS MONIT, V5, P93; O'Brien E, 1991, J HYPERTENS       S5, V9, pS25; O'Brien E, 1993, J HYPERTENS S2, V11, pS43; O'Shea J. C., 1994, American Journal of Hypertension, V7, p118A; O'Sullivan JJ, 1998, J MED ENG TECHNOL, V22, P101, DOI 10.3109/03091909809062474; OBRIEN E, 1995, HYPERTENSION, V26, P835, DOI 10.1161/01.HYP.26.5.835; OBRIEN E, 1990, LANCET, V336, P1465, DOI 10.1016/0140-6736(90)93177-Q; OBRIEN E, 1991, J HYPERTENS, V9, P571; OBRIEN E, 1994, J HYPERTENS, V12, P1089; OBRIEN E, 1991, J HUM HYPERTENS, V5, P223; OBRIEN E, 1993, J HYPERTENS, V11, pS282; OBRIEN E, 1990, J HYPERTENS, V8, P621, DOI 10.1097/00004872-199007000-00005; OBRIEN E, 1993, J HYPERTENS, V11, P761, DOI 10.1097/00004872-199307000-00012; OBRIEN E, 1990, J HYPERTENS, V8, P607, DOI 10.1097/00004872-199007000-00004; OBRIEN E, 1991, J HYPERTENS, V9, P567, DOI 10.1097/00004872-199106000-00013; OBRIEN E, 1993, J HYPERTENS S2, V11, pS1; OBRIEN E, 1993, J HYPERTENS S2, V11, pS9; OBRIEN E, 1991, J HYPERTENS       S5, V9, pS9; OBRIEN E, 1998, BLOOD PRESS MONIT, V3, P133; Omboni S, 1997, J APPL PHYSIOL, V82, P698, DOI 10.1152/jappl.1997.82.2.698; Omboni S, 1998, HYPERTENSION, V32, P52, DOI 10.1161/01.HYP.32.1.52; Palatini, 1998, Blood Press Monit, V3, P255; Palatini P., 1991, J AMBUL MONITOR, V4, P281; Peixoto A J, 1999, Blood Press Monit, V4, P217; Penny JA, 1996, HYPERTENS PREGNANCY, V15, P313, DOI 10.3109/10641959609009592; Pickering T, 1996, AM J HYPERTENS, V9, P1, DOI 10.1016/0895-7061(95)00341-X; RITHALIA SVS, 1994, J MED ENG TECHNOL, V18, P179, DOI 10.3109/03091909409030249; Rogers P, 1999, CLIN EXP PHARMACOL P, V26, P477, DOI 10.1046/j.1440-1681.1999.03059.x; Shennan A, 1996, BRIT J OBSTET GYNAEC, V103, P171, DOI 10.1111/j.1471-0528.1996.tb09671.x; SHENNAN AH, 1993, BRIT J OBSTET GYNAEC, V100, P904, DOI 10.1111/j.1471-0528.1993.tb15104.x; SHENNAN AH, 1998, J HUM HYPERTENS, V12, P794; TAYLOR R, 1993, J HYPERTENS, V11, P1275; WALMA EP, 1995, J HUM HYPERTENS, V9, P169; WHITE WB, 1991, AM J HYPERTENS, V4, P890, DOI 10.1093/ajh/4.11.890; WHITE WB, 1994, AM J HYPERTENS, V7, P509, DOI 10.1093/ajh/7.6.509; Zorn, 1997, Blood Press Monit, V2, P185	80	654	667	2	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2001	322	7285					531	536		10.1136/bmj.322.7285.531	http://dx.doi.org/10.1136/bmj.322.7285.531			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	409EA	11230071	Green Published, Green Accepted			2022-12-28	WOS:000167370500031
J	Lake, B; Aeppli, G; Clausen, KN; McMorrow, DF; Lefmann, K; Hussey, NE; Mangkorntong, N; Nohara, M; Takagi, H; Mason, TE; Schroder, A				Lake, B; Aeppli, G; Clausen, KN; McMorrow, DF; Lefmann, K; Hussey, NE; Mangkorntong, N; Nohara, M; Takagi, H; Mason, TE; Schroder, A			Spins in the vortices of a high-temperature superconductor	SCIENCE			English	Article							DENSITY-OF-STATES; MAGNETIC FLUCTUATIONS; VORTEX; LINES; GAP; LA2-XSRXCUO4; SCATTERING; TRANSITION; LATTICE; FIELDS	Neutron scattering is used to characterize the magnetism of the vortices for the optimally doped high-temperature superconductor La2-xSrxCuO4 (x = 0.163) in an applied magnetic field. As temperature is reduced, Low-frequency spin fluctuations first disappear with the loss of vortex mobility, but then reappear. We find that the vortex state can be regarded as an inhomogeneous mixture of a superconducting spin fluid and a material containing a nearly ordered antiferromagnet. These experiments show that as for many other properties of cuprate superconductors, the important underlying microscopic forces are magnetic.	NEC Res, Princeton, NJ 08540 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Riso Natl Lab, Dept Condensed Matter Phys & Chem, DK-4000 Roskilde, Denmark; Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Univ Loughborough, Dept Phys, Loughborough LE11 3TU, Leics, England; Univ Karlsruhe, Inst Phys, D-76128 Karlsruhe, Germany	United States Department of Energy (DOE); Oak Ridge National Laboratory; Technical University of Denmark; University of Tokyo; Loughborough University; Helmholtz Association; Karlsruhe Institute of Technology	Aeppli, G (corresponding author), NEC Res, 4 Independence Way, Princeton, NJ 08540 USA.		Lake, Bella/A-6264-2011; Takagi, Hidenori/B-2935-2010; McMorrow, Desmond/C-2655-2008; TAKAGI, HIDENORI/Q-1041-2019; Hussey, Nigel E/F-9699-2015; NOHARA, Minoru/B-1476-2011; Mason, Thomas/M-5809-2014; Lefmann, Kim/M-9228-2014; McMorrow, Desmond Francis/M-9036-2019	Lake, Bella/0000-0003-0034-0964; McMorrow, Desmond/0000-0002-4947-7788; TAKAGI, HIDENORI/0000-0001-5700-3761; NOHARA, Minoru/0000-0003-1931-9903; Mason, Thomas/0000-0003-1880-3971; Lefmann, Kim/0000-0003-4282-756X; McMorrow, Desmond Francis/0000-0002-4947-7788				Aeppli G, 1997, SCIENCE, V278, P1432, DOI 10.1126/science.278.5342.1432; Ando Y, 1999, PHYS REV B, V60, P12475, DOI 10.1103/PhysRevB.60.12475; Arovas DP, 1997, PHYS REV LETT, V79, P2871, DOI 10.1103/PhysRevLett.79.2871; BARDEEN J, 1965, PHYS REV, V140, P1197, DOI 10.1103/PhysRev.140.A1197; Bending SJ, 1999, ADV PHYS, V48, P449, DOI 10.1080/000187399243437; Blumberg G, 1997, PHYS REV LETT, V78, P2461, DOI 10.1103/PhysRevLett.78.2461; CAROLI C, 1964, PHYS LETT, V9, P307, DOI 10.1016/0031-9163(64)90375-0; CHEONG SW, 1991, PHYS REV LETT, V67, P1791, DOI 10.1103/PhysRevLett.67.1791; Clausen KN, 1997, PHYSICA B, V241, P50, DOI 10.1016/S0921-4526(97)00510-3; Cohen LF, 1997, REP PROG PHYS, V60, P1581, DOI 10.1088/0034-4885/60/12/003; FORGAN EM, 1991, PHYSICA C, V185, P247, DOI 10.1016/0921-4534(91)91980-I; GAMMEL PL, 1988, PHYS REV LETT, V61, P1666, DOI 10.1103/PhysRevLett.61.1666; HESS HF, 1990, PHYS REV LETT, V64, P2711, DOI 10.1103/PhysRevLett.64.2711; Kimura H, 1999, PHYS REV B, V59, P6517, DOI 10.1103/PhysRevB.59.6517; KITTEL C, 1986, INTRO SOLID STATE PH, P319; Lake B, 1999, NATURE, V400, P43, DOI 10.1038/21840; Lefmann K, 2000, PHYSICA B, V283, P343, DOI 10.1016/S0921-4526(00)00335-5; MANOUSAKIS E, 1991, REV MOD PHYS, V63, P1, DOI 10.1103/RevModPhys.63.1; Nohara M, 1999, J PHYS SOC JPN, V68, P1078, DOI 10.1143/JPSJ.68.1078; PAN SC, UNPUB; Pannetier B, 1996, PHYSICA B, V222, P253, DOI 10.1016/0921-4526(96)00202-5; Renner C, 1998, PHYS REV LETT, V80, P3606, DOI 10.1103/PhysRevLett.80.3606; Sasagawa T, 2000, PHYS REV B, V61, P1610, DOI 10.1103/PhysRevB.61.1610; SATO H, 1974, INT J MAGN, V6, P183; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; VOLOVIK GE, 1993, JETP LETT+, V58, P469; YAMADA K, 1995, PHYS REV LETT, V75, P1626, DOI 10.1103/PhysRevLett.75.1626; Yamada K, 1998, PHYS REV B, V57, P6165, DOI 10.1103/PhysRevB.57.6165; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391	29	309	312	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2001	291	5509					1759	1762		10.1126/science.1056986	http://dx.doi.org/10.1126/science.1056986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HK	11230686	Green Submitted			2022-12-28	WOS:000167320600051
J	Marik, PE				Marik, PE			Primary care: Aspiration pneumonitis and aspiration pneumonia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VENTILATOR-ASSOCIATED PNEUMONIA; COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-DISTRESS SYNDROME; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PROTECTED SPECIMEN BRUSH; CRITICALLY ILL PATIENTS; INDUCED LUNG INJURY; ACID-ASPIRATION; PULMONARY ASPIRATION; UNIT PATIENTS		Mercy Hosp Pittsburgh, Sect Crit Care Med, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Marik, PE (corresponding author), Mercy Hosp Pittsburgh, Sect Crit Care Med, 1400 Locust St, Pittsburgh, PA 15219 USA.		Marik, Paul E/U-9733-2019					Adnet F, 1996, LANCET, V348, P123, DOI 10.1016/S0140-6736(05)64630-2; Agency for Health Care Policy & Research, 1999, DIAGN TREATM SWALL D; ALDRICH T, 1980, SOUTHERN MED J, V73, P456, DOI 10.1097/00007611-198004000-00017; BAETEN C, 1992, SCAND J GASTROENTERO, V27, P95, DOI 10.3109/00365529209096035; Balan KK, 1998, AM J GASTROENTEROL, V93, P946, DOI 10.1111/j.1572-0241.1998.00284.x; BARTLETT JG, 1974, AM J MED, V56, P202, DOI 10.1016/0002-9343(74)90598-1; BARTLETT JG, 1975, JAMA-J AM MED ASSOC, V234, P935, DOI 10.1001/jama.234.9.935; BECKSAGUE C, 1994, INFECT CONT HOSP EP, V15, P494; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; BONE RC, 1987, CHEST, V92, P1032, DOI 10.1378/chest.92.6.1032; BONE RC, 1988, CHEST, V94, P448, DOI 10.1016/S0012-3692(16)33495-X; Bonten MJM, 1996, AM J RESP CRIT CARE, V154, P394, DOI 10.1164/ajrccm.154.2.8756812; BONTEN MJM, 1994, CRIT CARE MED, V22, P939, DOI 10.1097/00003246-199406000-00010; BONTEN MJM, 1995, AM J RESP CRIT CARE, V152, P1825, DOI 10.1164/ajrccm.152.6.8520743; Cassiere HA, 1998, TXB PULMONARY DIS, V1, P645; CESAR L, 1975, ARCH INTERN MED, V135, P711; COLE MJ, 1987, J CLIN GASTROENTEROL, V9, P90, DOI 10.1097/00004836-198702000-00023; Croghan John E., 1994, Dysphagia, V9, P141, DOI 10.1007/BF00341256; Daniels SK, 1998, ARCH PHYS MED REHAB, V79, P14, DOI 10.1016/S0003-9993(98)90200-3; DELARMINAT V, 1995, CRIT CARE MED, V23, P486, DOI 10.1097/00003246-199503000-00012; DIVE A, 1995, CRIT CARE MED, V23, P1356, DOI 10.1097/00003246-199508000-00008; DONOWITZ GR, 1995, MANDELL DOUGLAS BENN, V1, P619; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; EVASHWICK C, 1982, AM J PUBLIC HEALTH, V72, P1129, DOI 10.2105/AJPH.72.10.1129; EXARHOS ND, 1965, DIS CHEST, V47, P167, DOI 10.1378/chest.47.2.167; FOLKESSON HG, 1995, J CLIN INVEST, V96, P107, DOI 10.1172/JCI118009; FOX KA, 1995, AM J SURG, V170, P564, DOI 10.1016/S0002-9610(99)80016-6; GARVEY BM, 1989, CRIT CARE MED, V17, P211, DOI 10.1097/00003246-198903000-00002; GIBBS CP, 1994, ANESTHESIA, V2, P1437; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; GOLDMAN G, 1990, ANN SURG, V212, P513, DOI 10.1097/00000658-199010000-00013; GOLDMAN G, 1992, SURGERY, V111, P55; Grant MD, 1998, JAMA-J AM MED ASSOC, V279, P1973, DOI 10.1001/jama.279.24.1973; Graves EJ, 1997, VITAL HLTH STAT, V13; HAUSMANN W, 1955, J OBSTET GYNAECOL, V62, P509; HOLAS MA, 1994, ARCH NEUROL-CHICAGO, V51, P1051, DOI 10.1001/archneur.1994.00540220099020; HORNER J, 1988, NEUROLOGY, V38, P317, DOI 10.1212/WNL.38.2.317; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; Irwin RS, 1999, IRWIN RIPPES INTENSI, V1, P685; JAMES CF, 1984, ANESTH ANALG, V63, P665; JONES BJM, 1986, GUT, V27, P47, DOI 10.1136/gut.27.Suppl_1.47; KENNEDY TP, 1989, ANESTH ANALG, V69, P87; KIDD D, 1993, Q J MED, V86, P825; KIKUCHI R, 1994, AM J RESP CRIT CARE, V150, P251, DOI 10.1164/ajrccm.150.1.8025758; KNIGHT PR, 1992, ANESTHESIOLOGY, V77, P772, DOI 10.1097/00000542-199210000-00023; KNIGHT PR, 1993, ANESTH ANALG, V77, P754; KOLLEF MH, 1995, ANN INTERN MED, V122, P743, DOI 10.7326/0003-4819-122-10-199505150-00002; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; KOLLEF MH, 1995, NEW ENGL J MED, V332, P27, DOI 10.1056/NEJM199501053320106; Langmore S E, 1988, Dysphagia, V2, P216, DOI 10.1007/BF02414429; LANGMORE SE, 1991, ANN OTO RHINOL LARYN, V100, P678; Leder SB, 1998, DYSPHAGIA, V13, P208, DOI 10.1007/PL00009573; LEE M, 1980, MT SINAI J MED, V47, P341; Limeback H, 1998, Ann Periodontol, V3, P262, DOI 10.1902/annals.1998.3.1.262; LORBER B, 1974, ANN INTERN MED, V81, P329, DOI 10.7326/0003-4819-81-3-329; LOWREY LD, 1982, J SURG RES, V32, P168, DOI 10.1016/0022-4804(82)90086-5; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Marik PE, 1999, CHEST, V115, P178, DOI 10.1378/chest.115.1.178; MARIK PE, 1995, CHEST, V108, P203, DOI 10.1378/chest.108.1.203; MARRIE TJ, 1986, J AM GERIATR SOC, V34, P697, DOI 10.1111/j.1532-5415.1986.tb04300.x; MARRIE TJ, 1989, REV INFECT DIS, V11, P586; MENDELSON CL, 1946, AM J OBSTET GYNECOL, V52, P191; MIER L, 1993, INTENS CARE MED, V19, P279, DOI 10.1007/BF01690548; MOINE P, 1994, CHEST, V105, P1487, DOI 10.1378/chest.105.5.1487; MONTECALVO MA, 1992, CRIT CARE MED, V20, P1377, DOI 10.1097/00003246-199210000-00004; MOSER KM, 1982, AM REV RESPIR DIS, V125, P436; Nader-Djalal N, 1998, ANESTH ANALG, V87, P127, DOI 10.1097/00000539-199807000-00028; Nagase T, 1996, AM J RESP CRIT CARE, V154, P504, DOI 10.1164/ajrccm.154.2.8756829; OLSSON GL, 1986, ACTA ANAESTH SCAND, V30, P84, DOI 10.1111/j.1399-6576.1986.tb02373.x; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; PARK RHR, 1992, BRIT MED J, V304, P1406, DOI 10.1136/bmj.304.6839.1406; POTTS RG, 1993, CHEST, V103, P117, DOI 10.1378/chest.103.1.117; ROY TM, 1989, CHEST, V96, P852, DOI 10.1378/chest.96.4.852; Schmidt John, 1994, Dysphagia, V9, P7; SCHWARTZ DJ, 1980, AM REV RESPIR DIS, V121, P119; Smithard DG, 1997, DYSPHAGIA, V12, P188, DOI 10.1007/PL00009535; Spain DA, 1995, J TRAUMA, V39, P1100, DOI 10.1097/00005373-199512000-00015; Spilker CA, 1996, CHEST, V110, P243, DOI 10.1378/chest.110.1.243; SPLAINGARD ML, 1988, ARCH PHYS MED REHAB, V69, P637; STRONG RM, 1992, JPEN-PARENTER ENTER, V16, P59, DOI 10.1177/014860719201600159; SUKUMARAN M, 1980, MT SINAI J MED, V47, P335; TEABEAUT JR, 1952, AM J PATHOL, V28, P51; TERPENNING M, 1993, CLIN INFECT DIS, V16, pS314, DOI 10.1093/clinids/16.Supplement_4.S314; Tolep K, 1996, CHEST, V109, P167, DOI 10.1378/chest.109.1.167; TORRES A, 1991, AM REV RESPIR DIS, V144, P312, DOI 10.1164/ajrccm/144.2.312; TUOMANEN EI, 1995, NEW ENGL J MED, V332, P1280, DOI 10.1056/NEJM199505113321907; WARNER MA, 1993, ANESTHESIOLOGY, V78, P56, DOI 10.1097/00000542-199301000-00010; Weiser MR, 1997, J APPL PHYSIOL, V83, P1090, DOI 10.1152/jappl.1997.83.4.1090; WOLFE JE, 1977, AM J MED, V63, P719, DOI 10.1016/0002-9343(77)90157-7; WYNNE JW, 1981, ARCH SURG-CHICAGO, V116, P46; Yoneyama T, 1999, LANCET, V354, P515, DOI 10.1016/S0140-6736(05)75550-1	91	859	919	3	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2001	344	9					665	671		10.1056/NEJM200103013440908	http://dx.doi.org/10.1056/NEJM200103013440908			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405TR	11228282				2022-12-28	WOS:000167177100008
J	Rayfield, EJ; Norman, DB; Horner, CC; Horner, JR; Smith, PM; Thomason, JJ; Upchurch, P				Rayfield, EJ; Norman, DB; Horner, CC; Horner, JR; Smith, PM; Thomason, JJ; Upchurch, P			Cranial design and function in a large theropod dinosaur	NATURE			English	Article							ORTHOPEDIC BIOMECHANICS; TYRANNOSAURUS REX; FORCES; EVOLUTION; TISSUE	Finite element analysis (FEA)(1) is used by industrial designers and biomechanicists to estimate the performance of engineered structures or human skeletal and soft tissues subjected to varying regimes of stress and strain(2-4). FEA is rarely applied to problems of biomechanical design in animals, despite its potential to inform structure-function analysis. Non-invasive techniques such as computed tomography scans can be used to generate accurate three-dimensional images of structures, such as skulls, which can form the basis of an accurate finite element model. Here we have applied this technique to the long skull of the large carnivorous theropod dinosaur Allosaurus fragilis(5). We have generated the most geometrically complete and complex FEA model of the skull of any extinct or extant organism and used this to test its mechanical properties and examine, in a quantitative way, long-held hypotheses concerning overall shape and function(6-8). The combination of a weak muscle-driven bite force, a very 'light' and 'open' skull architecture and unusually high cranial strength, suggests a very specific feeding behaviour for this animal. These results demonstrate simply the inherent potential of FEA for testing mechanical behaviour in fossils in ways that, until now, have been impossible.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Cambridge; Montana State University System; Montana State University Bozeman; University of Guelph	Rayfield, EJ (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.		Rayfield, Emily/F-5038-2010; Upchurch, Paul/C-1654-2008; Rohlf, F J/A-8710-2008	Rayfield, Emily/0000-0002-2618-750X; 				[Anonymous], 1971, FINITE ELEMENT METHO; Auffenberg W., 1981, BEHAV ECOLOGY KOMODO; BUCKLANDWRIGHT JC, 1978, J MORPHOL, V155, P35, DOI 10.1002/jmor.1051550104; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Crompton A.W., 1986, P263; Diamond Jared M., 1998, P21; DODSON P, 1980, PALEOBIOLOGY, V6, P208, DOI 10.1017/S009483730000676X; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Farlow J.O., 1991, Modern Geology, V16, P161; FARLOW JO, 1976, AM MIDL NAT, V95, P186, DOI 10.2307/2424244; HUISKES R, 1993, J BIOMECH ENG-T ASME, V115, P520, DOI 10.1115/1.2895534; HUISKES R, 1983, J BIOMECH, V16, P385, DOI 10.1016/0021-9290(83)90072-6; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Molnar R.E., 1990, P210; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Paul G.S., 1988, PREDATORY DINOSAURS, P464; Perez-Moreno BP, 1999, J GEOL SOC LONDON, V156, P449, DOI 10.1144/gsjgs.156.3.0449; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; REILLY DT, 1975, J BIOMECH, V8, P393, DOI 10.1016/0021-9290(75)90075-5; ROSS CTF, 1990, FINITE ELEMENT METHO, P519; SINCLAIR AG, 1987, J ZOOL, V213, P107, DOI 10.1111/j.1469-7998.1987.tb03681.x; Sues H.-D., 1990, P498; THOMASON JJ, 1986, J MORPHOL, V189, P199, DOI 10.1002/jmor.1051890210; THOMASON JJ, 1990, CAN J ZOOL, V68, P318, DOI 10.1139/z90-047; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; WATERS NE, 1980, MECH PROPERTIES BIOL, P99; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027	28	190	201	4	80	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1033	1037		10.1038/35059070	http://dx.doi.org/10.1038/35059070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234010				2022-12-28	WOS:000167148800043
J	Sinnarajah, S; Dessauer, CW; Srikumar, D; Chen, J; Yuen, J; Yilma, S; Dennis, JC; Morrison, EE; Vodyanoy, V; Kehrl, JH				Sinnarajah, S; Dessauer, CW; Srikumar, D; Chen, J; Yuen, J; Yilma, S; Dennis, JC; Morrison, EE; Vodyanoy, V; Kehrl, JH			RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III	NATURE			English	Article							RECEPTOR-CELLS; ODORANT DETECTION; IDENTIFICATION; STIMULATION; INHIBITION; MECHANISM; PROTEINS; ROLES; CAMP	The heterotrimeric G-protein G(s) couples cell-surface receptors to the activation of adenylyl cyclases and cyclic AMP production (reviewed in refs 1, 2). RGS proteins, which act as GTPase-activating proteins (GAPs) for the G-protein alpha -subunits alpha (i) and alpha (q), lack such activity for alpha (s) (refs 3-6). But several RGS proteins inhibit cAMP production by G(s)-linked receptors(7,8). Here we report that RGS2 reduces cAMP production by odorant-stimulated olfactory epithelium membranes, in which the alpha (s) family member alpha (olf) links odorant receptors to adenylyl cyclase activation(9,10). Unexpectedly, RGS2 reduces odorant-elicited cAMP production, not by acting on alpha (olf) but by inhibiting the activity of adenylyl cyclase type III, the predominant adenylyl cyclase isoform in olfactory neurons. Furthermore, whole-cell voltage clamp recordings of odorant-stimulated olfactory neurons indicate that endogenous RGS2 negatively regulates odorant-evoked intracellular signalling. These results reveal a mechanism for controlling the activities of adenylyl cyclases, which probably contributes to the ability of olfactory neurons to discriminate odours.	NIAID, Cell Mol Biol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; Univ Texas, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA; Auburn Univ, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; Auburn University System; Auburn University	Kehrl, JH (corresponding author), NIAID, Cell Mol Biol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Kehrl, John/AAE-6292-2019; Dessauer, Carmen/N-6933-2018	Kehrl, John/0000-0002-6526-159X; Dessauer, Carmen/0000-0003-1210-4280	NIGMS NIH HHS [R01 GM060419, R01 GM060419-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Beadling C, 1999, J IMMUNOL, V162, P2677; Chatterjee TK, 1997, J BIOL CHEM, V272, P15481, DOI 10.1074/jbc.272.24.15481; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FIRESTEIN S, 1989, CHEM SENSES, V1, P449; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Natochin M, 1998, BIOCHEMISTRY-US, V37, P13776, DOI 10.1021/bi981155a; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; REED RR, 1992, NEURON, V8, P205, DOI 10.1016/0896-6273(92)90287-N; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Sinnarajah S, 1998, FEBS LETT, V426, P377, DOI 10.1016/S0014-5793(98)00368-8; SKLAR PB, 1986, J BIOL CHEM, V261, P5538; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1, P555; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Tseng CC, 1998, ENDOCRINOLOGY, V139, P4470, DOI 10.1210/en.139.11.4470; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9	25	204	210	1	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1051	1055		10.1038/35059104	http://dx.doi.org/10.1038/35059104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234015				2022-12-28	WOS:000167148800048
J	Tio, M; Udolph, G; Yang, XH; Chia, W				Tio, M; Udolph, G; Yang, XH; Chia, W			cdc2 links the Drosophila cell cycle and asymmetric division machineries	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; GANGLION MOTHER CELLS; LOCALIZATION; PROSPERO; PROTEIN; MITOSIS; NUMB; NEUROBLASTS; SEGREGATION; MIRANDA	Asymmetric cell divisions can be mediated by the preferential segregation of cell-fate determinants into one of two sibling daughters. In Drosophila neural progenitors, Inscuteable(1-3), Partner of Inscuteable(4,5) and Bazooka(6,7) localize as an apical cortical complex at interphase, which directs the apical-basal orientation of the mitotic spindle as well as the basal/cortical localization of the cell-fate determinants Numb(8,9) and/or Prospero(10,11) during mitosis. Although localization of these proteins shows dependence on the cell cycle, the involvement of cell-cycle components in asymmetric divisions has not been demonstrated. Here we show that neural progenitor asymmetric divisions require the cell-cycle regulator cdc2. By attenuating Drosophila cdc2 function without blocking mitosis, normally asymmetric progenitor divisions become defective, failing to correctly localize asymmetric components during mitosis and/or to resolve distinct sibling fates, cdc2 is not necessary for initiating apical complex formation during interphase; however, maintaining the asymmetric localization of the apical components during mitosis requires Cdc2/B-type cyclin complexes. Our findings link cdc2 with asymmetric divisions, and explain why the asymmetric localization of molecules like Inscuteable show cell-cycle dependence.	Inst Mol & Cell Biol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Chia, W (corresponding author), Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.							BRAND AH, 1993, DEVELOPMENT, V118, P401; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; CLEGG NJ, 1993, GENOME, V36, P676, DOI 10.1139/g93-091; DOE CQ, 1992, DEVELOPMENT, V116, P855; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Lear BC, 1999, MECH DEVELOP, V88, P207, DOI 10.1016/S0925-4773(99)00190-2; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; LUNDELL MJ, 1994, BIOTECHNIQUES, V16, P434; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; SIGRIST S, 1995, MECH DEVELOP, V53, P247, DOI 10.1016/0925-4773(95)00441-3; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STERN B, 1993, DEVELOPMENT, V117, P219; Tio M, 1999, J CELL SCI, V112, P1541; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	30	87	90	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 22	2001	409	6823					1063	1067		10.1038/35059124	http://dx.doi.org/10.1038/35059124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234018				2022-12-28	WOS:000167148800051
J	Zahidi, E; Oudghiri-Hassani, H; McBreen, PH				Zahidi, E; Oudghiri-Hassani, H; McBreen, PH			Formation of thermally stable alkylidene layers on a catalytically active surface	NATURE			English	Article							OXIDATIVE ADDITION; SILICON SURFACES; OXO-ALKYLIDENE; CARBIDE; WCL2(PMEPH2)4; MONOLAYERS; CONVERSION	Materials containing organic-inorganic interfaces usually display a combination of molecular and solid-state properties, which are of interest for applications ranging from chemical sensing(1) to microelectronics(2) and catalysis(3). Thiols-organic compounds carrying a SH group-are widely used to anchor organic layers to gold surfaces(6), because gold is catalytically sufficiently active to replace relatively weak S-H bonds with Au-S bonds, yet too inert to attack C-C and C-H bonds in the organic layer. But although several methods(4-6) of functionalizing the surfaces of semiconductors, oxides and metals are known, it remains difficult to attach a wide range of more complex organic species. Organic layers could, in principle, be formed on the surfaces of metals that are capable of inserting into strong bonds, but such surfaces catalyse the decomposition of organic layers at temperatures above 400 to 600 K, through progressive C-H and C-C bond breaking(7). Here we report that cycloketones adsorbed on molybdenum carbide, a material known to catalyse a variety of hydrocarbon conversion reactions(8-11), transform into surface-bound alkylidenes stable to above 900 K. We expect that this chemistry can be used to create a wide range of exceptionally stable organic layers on molybdenum carbide.	Univ Laval, Dept Chim, Quebec City, PQ G1K 7P4, Canada; Univ Laval, CERPIC, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	McBreen, PH (corresponding author), Univ Laval, Dept Chim, Quebec City, PQ G1K 7P4, Canada.	peter.mcbreen@chm.ulaval.ca	Zahidi, El Mamoune/AAM-7817-2021	Oudghiri-Hassani, Hicham/0000-0001-5386-8864				BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; BRYAN JC, 1987, J AM CHEM SOC, V109, P7213, DOI 10.1021/ja00257a064; BRYAN JC, 1990, J AM CHEM SOC, V112, P2298, DOI 10.1021/ja00162a034; Buriak JM, 1999, CHEM COMMUN, P1051, DOI 10.1039/a900108e; CATALIOTTI R, 1975, SPECTROCHIM ACTA A, V31, P1879, DOI 10.1016/0584-8539(75)80242-X; Chen JG, 1998, J MOL CATAL A-CHEM, V131, P285, DOI 10.1016/S1381-1169(97)00271-9; Cheon J, 1997, J AM CHEM SOC, V119, P6814, DOI 10.1021/ja9708124; Crooks RM, 1998, ACCOUNTS CHEM RES, V31, P219, DOI 10.1021/ar970246h; Furstner A, 2000, ANGEW CHEM INT EDIT, V39, P3012; Jeon NL, 1999, APPL PHYS LETT, V75, P4201, DOI 10.1063/1.125582; KAPOOR R, 1998, ACS SYM SER, pCH18; Lofberg A, 2000, J CATAL, V189, P170, DOI 10.1006/jcat.1999.2692; Mayr A, 1999, J AM CHEM SOC, V121, P1760, DOI 10.1021/ja982324h; NUGENT WA, 1988, METAL LIGAND MULTIPL, pCH4; Oyama S. T., 1996, CHEM TRANSITION META; Park SC, 2000, SURF SCI, V450, P117, DOI 10.1016/S0039-6028(00)00052-2; Silverstein R. M., 1991, SPECTROMETRIC IDENTI; Solymosi F, 1998, APPL CATAL A-GEN, V166, P225, DOI 10.1016/S0926-860X(97)00260-3; SOMORJAI GA, 1994, INTRO SURFACE CHEM C, P420; SPESSARD GO, 1997, ORGANOMETALLIC CHEM, P348; Tanaka K, 1999, J MOL CATAL A-CHEM, V141, P39, DOI 10.1016/S1381-1169(98)00248-9; Wang KF, 1997, CHINESE J CHEM ENG, V5, P347; Watson KJ, 1999, J AM CHEM SOC, V121, P462, DOI 10.1021/ja983173l; Weck M, 1999, J AM CHEM SOC, V121, P4088, DOI 10.1021/ja983297y; Wolkow RA, 1999, ANNU REV PHYS CHEM, V50, P413, DOI 10.1146/annurev.physchem.50.1.413; Yan C, 2000, LANGMUIR, V16, P6208, DOI 10.1021/la000128a; York APE, 1997, CHEM COMMUN, P39, DOI 10.1039/a605693h; Zhang Y, 1999, SCIENCE, V285, P1719, DOI 10.1126/science.285.5434.1719	28	38	41	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2001	409	6823					1023	1026		10.1038/35059047	http://dx.doi.org/10.1038/35059047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405FT	11234007				2022-12-28	WOS:000167148800040
J	Reid, IR; Hague, W; Emberson, J; Baker, J; Tonkin, A; Hunt, D; MacMahon, S; Sharpe, N				Reid, IR; Hague, W; Emberson, J; Baker, J; Tonkin, A; Hunt, D; MacMahon, S; Sharpe, N		LIPID Study Grp	Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial	LANCET			English	Article							NITROGEN-CONTAINING BISPHOSPHONATES; NORMAL POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; BONE-DENSITY; PREVENTION; ALENDRONATE; DISEASE; RISK	Background Statins inhibit the same biochemical pathway as aminobisphosphonates, therefore these cholesterol-lowering agents may have a beneficial effect on osteoporosis. This possibility has been supported by the finding that some statins also stimulate bone formation, and by observational studies suggesting that patients using statins have higher bone densities and lower fracture rates than controls. To assess whether statins have clinically significant effects on bone, we studied the frequency of fractures in a large randomised controlled trial of these agents. Methods 9014 patients (17% women, median age 62 years) with ischaemic heart disease were randomly assigned pravastatin 40 mg daily or placebo and followed up for a mean of 6.0 years. Fractures were ascertained from adverse-event reports. Findings 101 patients in the placebo group were admitted to hospital for fracture compared with 107 in the pravastatin group (hazard ratio 1.05 [95% CI 0.80-1.37]). When patients with fractures not necessitating hospital admission were added, the total number of patients having a fracture was 183 in the placebo group and 175 in the pravastatin group (0.94 [0.77-1.16]). Separate analyses for women alone and for individuals aged 65 years and over gave similar results. Interpretation These findings offer no support for the hypothesis that statins have a significant effect on fracture risk. However, this study was not of an osteoporotic population, and fracture rate, although clinically important, is an insensitive index of effects on bone. Statins should not be used to prevent osteoporosis until there is evidence for their efficacy based on randomised controlled trials.	Univ Auckland, Dept Med, Auckland, New Zealand; Univ Sydney, Clin Trials Ctr, Natl Hlth & Med Res Council, Sydney, NSW 2006, Australia; Therapeut Goods Adm, Drug Safety & Evaluat Branch, Canberra, ACT, Australia; Natl Heart Fdn Australia, Melbourne, Vic, Australia; Royal Melbourne Hosp, Dept Cardiol, Melbourne, Vic, Australia; Univ Sydney, Inst Int Hlth, Sydney, NSW 2006, Australia	University of Auckland; University of Sydney; Royal Melbourne Hospital; University of Sydney	Reid, IR (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland, New Zealand.			Emberson, Jonathan/0000-0001-7792-9422; MacMahon, Stephen/0000-0003-2064-7699				Bauer DC, 1999, J BONE MINER RES, V14, pS179; Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; Chung YS, 2000, J CLIN ENDOCR METAB, V85, P1137, DOI 10.1210/jcem.85.3.6476; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Edwards CJ, 2000, LANCET, V355, P2218, DOI 10.1016/S0140-6736(00)02408-9; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Komulainen MH, 1998, MATURITAS, V31, P45, DOI 10.1016/S0378-5122(98)00085-1; LaCroix AZ, 2000, J BONE MINER RES, V15, pS155; LINDSAY R, 1980, LANCET, V2, P1151; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; REID IR, 1993, AM J PHYSIOL, V265, pE655, DOI 10.1152/ajpendo.1993.265.4.E655; REID IR, 1992, J CLIN ENDOCR METAB, V75, P45, DOI 10.1210/jc.75.1.45; Sanders KM, 1999, OSTEOPOROSIS INT, V10, P240, DOI 10.1007/s001980050222; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Tsuchihashi K, 1999, INTERNAL MED, V38, P691, DOI 10.2169/internalmedicine.38.691; van Beek E, 1999, BIOCHEM BIOPH RES CO, V264, P108, DOI 10.1006/bbrc.1999.1499; van Staa TP, 2000, J BONE MINER RES, V15, pS155; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211	25	200	213	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2001	357	9255					509	512		10.1016/S0140-6736(00)04042-3	http://dx.doi.org/10.1016/S0140-6736(00)04042-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402WT	11229669				2022-12-28	WOS:000167011700010
J	Yu, A; Zhao, CF; Fan, Y; Jang, WH; Mungall, AJ; Deloukas, P; Olsen, A; Doggett, NA; Ghebranious, N; Broman, KW; Weber, JL				Yu, A; Zhao, CF; Fan, Y; Jang, WH; Mungall, AJ; Deloukas, P; Olsen, A; Doggett, NA; Ghebranious, N; Broman, KW; Weber, JL			Comparison of human genetic and sequence-based physical maps	NATURE			English	Article							HIGH-RESOLUTION ANALYSIS; HUMAN-CHROMOSOME 22; HUMAN GENOME; MEIOTIC RECOMBINATION; DNA-SEQUENCE; INTEGRATION; CROSSOVER; REPEATS; REGION	Recombination is the exchange of information between two homologous chromosomes during meiosis. The rate of recombination per nucleotide, which profoundly affects the evolution of chromosomal segments, is calculated by comparing genetic and physical maps. Human physical maps have been constructed using cytogenetics(1), overlapping DNA clones(2) and radiation hybrids(3); but the ultimate and by far the most accurate physical map is the actual nucleotide sequence. The completion of the draft human genomic sequence(4) provides us with the best opportunity yet to compare the genetic and physical maps. Here we describe our estimates of female, male and sex-average recombination rates for about 60% of the genome. Recombination rates varied greatly along each chromosome, from 0 to at least 9 centiMorgans per megabase (cM Mb(-1)). Among several sequence and marker parameters tested, only relative marker position along the metacentric chromosomes in males correlated strongly with recombination rate. We identified several chromosomal regions up to 6 Mb in length with particularly low (deserts) or high (jungles) recombination rates. Linkage disequilibrium was much more common and extended for greater distances in the deserts than in the jungles.	Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Sanger Ctr, Cambridge CB10 1SA, England; Joint Genome Inst, Walnut Creek, CA 94598 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; Wellcome Trust Sanger Institute; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Los Alamos National Laboratory; Johns Hopkins University	Weber, JL (corresponding author), Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA.	weberj@cmg.mfldclin.edu	Mungall, Andrew J./U-7067-2018; Deloukas, Panos/B-2922-2013	Mungall, Andrew J./0000-0002-0905-2742; Deloukas, Panos/0000-0001-9251-070X; Broman, Karl/0000-0002-4914-6671				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Carrington M, 1999, IMMUNOL REV, V167, P245, DOI 10.1111/j.1600-065X.1999.tb01397.x; CHEN TL, 1989, CHROMOSOMA, V98, P309, DOI 10.1007/BF00292382; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; EISENREICH SJ, 1980, CONTAMINANTS SEDIMEN, V1, P67; Fain PR, 1996, HUM MOL GENET, V5, P1631, DOI 10.1093/hmg/5.10.1631; Faris JD, 2000, GENETICS, V154, P823; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Huttley GA, 1999, GENETICS, V152, P1711; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; KLIMAN RM, 1993, MOL BIOL EVOL, V10, P1239; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Mohrenweiser HW, 1998, GENOMICS, V47, P153, DOI 10.1006/geno.1997.5097; Nachman MW, 2000, GENETICS, V155, P1855; Nachman MW, 1998, GENETICS, V150, P1133; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; Nicolas A, 1998, P NATL ACAD SCI USA, V95, P87, DOI 10.1073/pnas.95.1.87; Payseur BA, 2000, GENETICS, V156, P1285; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Wahls WP, 1998, CURR TOP DEV BIOL, V37, P37; Yu J, 1996, AM J HUM GENET, V59, P1186; Zhao C, 1999, AM J HUM GENET, V65, pA102	30	221	227	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					951	953		10.1038/35057185	http://dx.doi.org/10.1038/35057185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11237020	Bronze			2022-12-28	WOS:000166938800067
J	Franzese, G; Malescio, G; Skibinsky, A; Buldyrev, SV; Stanley, HE				Franzese, G; Malescio, G; Skibinsky, A; Buldyrev, SV; Stanley, HE			Generic mechanism for generating a liquid-liquid phase transition	NATURE			English	Article							CRITICAL-POINT; TRANSFORMATION; BEHAVIOR; DENSITY	Recent experimental results(1) indicate that phosphorus-a single component system-can have a high-density liquid (HDL) and a low-density liquid (LDL) phase. A first-order transition between two liquids of different densities(2) is consistent with experimental data for a variety of materials(3,4), including single-component systems such as water(5-8), silica(9) and carbon(10). Molecular dynamics simulations of very specific models for supercooled water(2,11), liquid carbon(12) and supercooled silica(13) predict a LDL-HDL critical point, but a coherent and general interpretation of the LDL-HDL transition is lacking. Here we show that the presence of a LDL and a HDL can be directly related to an interaction potential with an attractive part and two characteristic short-range repulsive distances. This kind of interaction is common to other single-component materials in the liquid state (in particular, liquid metals(2,14-21)), and such potentials are often used to describe systems that exhibit a density anomaly(2). However, our results show that the LDL and HDL phases can occur in systems with no density anomaly. Our results therefore present an experimental challenge to uncover a liquid-liquid transition in systems like liquid metals, regardless of the presence of a density anomaly.	Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; Boston Univ, Dept Phys, Boston, MA 02215 USA; Univ Messina, Dipartimento Fis, I-98166 Messina, Italy; Ist Nazl Fis Mat, I-98166 Messina, Italy	Boston University; Boston University; University of Messina; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR)	Franzese, G (corresponding author), Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA.	franzese@argento.bu.edu	Buldyrev, Sergey V/I-3933-2015; Franzese, Giancarlo/A-9655-2009	Franzese, Giancarlo/0000-0003-3006-2766; Buldyrev, Sergey/0000-0002-3008-1070				Behrens SH, 2000, LANGMUIR, V16, P2566, DOI 10.1021/la991154z; Bellissent-Funel MC, 1998, NUOVO CIMENTO D, V20, P2107; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brazhkin V. V., 1998, REV HIGH PRESSURE SC, V7, P1129; Brazhkin VV, 1997, HIGH PRESSURE RES, V15, P267, DOI 10.1080/08957959708240477; Caccamo C, 1996, PHYS REP, V274, P1, DOI 10.1016/0370-1573(96)00011-7; CUMMINGS PT, 1981, MOL PHYS, V43, P1267, DOI 10.1080/00268978100102051; DEBENEDETTI P, 1998, METASTABLE LIQUIDS C; DEBENEDETTI PG, 1991, J PHYS CHEM-US, V95, P4540, DOI 10.1021/j100164a066; Glosli JN, 1999, PHYS REV LETT, V82, P4659, DOI 10.1103/PhysRevLett.82.4659; HAGEN MHJ, 1993, NATURE, V365, P425, DOI 10.1038/365425a0; Jagla EA, 1999, J CHEM PHYS, V111, P8980, DOI 10.1063/1.480241; Katayama Y, 2000, NATURE, V403, P170, DOI 10.1038/35003143; KINCAID JM, 1978, PHYS LETT A, V65, P131, DOI 10.1016/0375-9601(78)90594-7; Lacks DJ, 2000, PHYS REV LETT, V84, P4629, DOI 10.1103/PhysRevLett.84.4629; LEVESQUE D, 1977, PHYS LETT A, V60, P473, DOI 10.1016/0375-9601(77)90059-7; Mishima O, 2000, PHYS REV LETT, V85, P334, DOI 10.1103/PhysRevLett.85.334; MON KK, 1979, PHYS REV B, V19, P5103, DOI 10.1103/PhysRevB.19.5103; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; Sadr-Lahijany MR, 1998, PHYS REV LETT, V81, P4895, DOI 10.1103/PhysRevLett.81.4895; Saika-Voivod I, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.011202; SILBERT M, 1976, PHYS LETT A, V58, P469, DOI 10.1016/0375-9601(76)90487-4; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; STELL G, 1972, J CHEM PHYS, V56, P4274, DOI 10.1063/1.1677857; STILLINGER FH, 1993, PHYS REV E, V47, P2484, DOI 10.1103/PhysRevE.47.2484; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; VANTHIEL M, 1993, PHYS REV B, V48, P3591, DOI 10.1103/PhysRevB.48.3591; Velasco E, 2000, PHYS REV LETT, V85, P122, DOI 10.1103/PhysRevLett.85.122; VORONEL A, 1983, PHYS REV LETT, V50, P247, DOI 10.1103/PhysRevLett.50.247; WILDING MC, IN PRESS J CRYST NON	30	346	348	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2001	409	6821					692	695		10.1038/35055514	http://dx.doi.org/10.1038/35055514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	399MF	11217853	Green Submitted			2022-12-28	WOS:000166816400036
J	zur Hausen, H				zur Hausen, H			Proliferation-inducing viruses in non-permissive systems as possible causes of human cancers	LANCET			English	Article							IOWA FARMERS; LUNG-CANCER; MORTALITY; PAPILLOMAVIRUSES; IDENTIFICATION; HERPESVIRUS; BUTCHERS; WORKERS; TUMORS; PLANTS	Animal viruses, some of which are probably unable to replicate in human cells, could be transmitted to people where they may be linked to tumours currently not attributed to viruses. Several human virus types have oncogenic potential in animals. A potential risk for acquiring such infections by handling and preparation of animal products was analysed against the background of available epidemiological reports. Human tumours should be systematically assessed for proliferation-inducing viruses in non-permissive systems.	Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	zur Hausen, H (corresponding author), Deutsch Krebsforschungszentrum, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	zurhausen@dkfz-heidelberg.de						Astori G, 1998, J INVEST DERMATOL, V110, P752, DOI 10.1046/j.1523-1747.1998.00191.x; Bingham SA, 1999, P NUTR SOC, V58, P243, DOI 10.1017/S0029665199000336; Blair A, 1982, Basic Life Sci, V21, P93; BREGMAN CL, 1987, VET PATHOL, V24, P477, DOI 10.1177/030098588702400602; BURMEISTER LF, 1981, JNCI-J NATL CANCER I, V66, P461; Carbone M, 1997, ONCOGENE, V15, P1877, DOI 10.1038/sj.onc.1201375; Cerhan JR, 1998, CANCER CAUSE CONTROL, V9, P311, DOI 10.1023/A:1008877204830; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; COGGON D, 1989, BRIT J IND MED, V46, P188; de Villiers E M, 1994, Curr Top Microbiol Immunol, V186, P1; DORKEN H, 1975, ARCH GESCHWULSTFORSC, V45, P283; Ehlers B, 1999, J GEN VIROL, V80, P971, DOI 10.1099/0022-1317-80-4-971; EPSTEIN MA, 1973, INT J CANCER, V12, P309, DOI 10.1002/ijc.2910120202; Haocai L, 1983, Ecol Dis, V2, P249; Johnson ES, 1997, INT J EPIDEMIOL, V26, P1142, DOI 10.1093/ije/26.6.1142; JOHNSON ES, 1995, AM J IND MED, V27, P389, DOI 10.1002/ajim.4700270308; Khuder SA, 1998, AM J IND MED, V34, P252, DOI 10.1002/(SICI)1097-0274(199809)34:3&lt;252::AID-AJIM7&gt;3.0.CO;2-X; KRISTENSEN TS, 1993, SCAND J WORK ENV HEA, V19, P137, DOI 10.5271/sjweh.1489; LEHMANNGRUBE F, 1979, MED MICROBIOL IMMUN, V167, P205, DOI 10.1007/BF02121187; LONDON WT, 1978, SCIENCE, V201, P1246, DOI 10.1126/science.211583; MEISCHKE HRC, 1979, J GEN VIROL, V43, P473, DOI 10.1099/0022-1317-43-3-473; Mercer A, 1997, ARCH VIROL, P25; MILLER RW, 1975, J NATL CANCER I, V54, P535, DOI 10.1093/jnci/54.3.535; Nakamura Y, 2000, J VIROL, V74, P4601, DOI 10.1128/JVI.74.10.4601-4611.2000; Nasir L, 1997, RES VET SCI, V63, P289, DOI 10.1016/S0034-5288(97)90036-9; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Okamoto H, 1999, VIROLOGY, V259, P428, DOI 10.1006/viro.1999.9770; ORTH G, 1981, J INVEST DERMATOL, V76, P97, DOI 10.1111/1523-1747.ep12525394; PERSSON B, 1989, BRIT J IND MED, V46, P516; Pukkala E, 1997, CANCER CAUSE CONTROL, V8, P25, DOI 10.1023/A:1018474919807; RAGLAND WL, 1968, AM J VET RES, V29, P1363; Rovnak J, 1998, J VIROL, V72, P4237, DOI 10.1128/JVI.72.5.4237-4242.1998; RUBIO CA, 1989, CANCER, V64, P2511, DOI 10.1002/1097-0142(19891215)64:12&lt;2511::AID-CNCR2820641218&gt;3.0.CO;2-U; Sandstrom PA, 2000, LANCET, V355, P551, DOI 10.1016/S0140-6736(99)05292-7; SHOPE T, 1973, P NATL ACAD SCI USA, V70, P2487, DOI 10.1073/pnas.70.9.2487; STUDDERT MJ, 1994, AUST VET J, V71, P351, DOI [10.1111/j.1751-0813.1994.tb00921.x, 10.1111/j.1751-0813.1994.tb00922.x]; TISCHER I, 1995, ARCH VIROL, V140, P1799, DOI 10.1007/BF01384343; Weiss RA, 1999, SCIENCE, V285, P1221, DOI 10.1126/science.285.5431.1221; WOGNUM AW, 1984, VIROLOGY, V134, P254, DOI 10.1016/0042-6822(84)90293-9	39	25	27	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2001	357	9253					381	384		10.1016/S0140-6736(00)03652-7	http://dx.doi.org/10.1016/S0140-6736(00)03652-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	400XL	11211014				2022-12-28	WOS:000166897900037
J	Carter, AP; Clemons, WM; Brodersen, DE; Morgan-Warren, RJ; Hartsch, T; Wimberly, BT; Ramakrishnan, V				Carter, AP; Clemons, WM; Brodersen, DE; Morgan-Warren, RJ; Hartsch, T; Wimberly, BT; Ramakrishnan, V			Crystal structure of an initiation factor bound to the 30S ribosomal subunit	SCIENCE			English	Article							ESCHERICHIA-COLI; TRANSLATIONAL INITIATION; FACTOR IF1; TRANSFER-RNA; PROTEIN-BIOSYNTHESIS; FACTORS IF-1; BINDING; MECHANISM; DISSOCIATION; DOMAINS	Initiation of translation at the correct position on messenger RNA is essential for accurate protein synthesis. In prokaryotes, this process requires three initiation factors: IF1, IF2, and IF3, Here we report the crystal structure of a complex of IF1 and the 30S ribosomal subunit, Binding of IF1 occludes the ribosomal A site and flips out the functionally important bases A1492 and A1493 from helix 44 of 16S RNA, burying them in pockets in IF1. The binding of IF1 causes long-range changes in the conformation of H44 and Leads to movement of the domains of 30S with respect to each other. The structure explains how localized changes at the ribosomal A site lead to global alterations in the conformation of the 30S subunit.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Gottingen, Inst Genet & Mikrobiol, Gottingen Genom Lab, D-37077 Gottingen, Germany	MRC Laboratory Molecular Biology; University of Gottingen	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk	Brodersen, Ditlev E./AAQ-5241-2020; Clemons, William M/D-1026-2009	Clemons, William M/0000-0002-0021-889X; Brodersen, Ditlev/0000-0002-5413-4667; Ramakrishnan, V/0000-0002-4699-2194; Carter, Andrew/0000-0001-7292-5430	NIGMS NIH HHS [GM 44973] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNE R, 1973, EUR J BIOCHEM, V32, P372, DOI 10.1111/j.1432-1033.1973.tb02619.x; BOILEAU G, 1983, BIOCHEMISTRY-US, V22, P3162, DOI 10.1021/bi00282a020; Brock S, 1998, MOL MICROBIOL, V29, P409, DOI 10.1046/j.1365-2958.1998.00893.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; CANONACO MA, 1986, FEBS LETT, V207, P198, DOI 10.1016/0014-5793(86)81488-0; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CUMMINGS HS, 1994, J BACTERIOL, V176, P198, DOI 10.1128/JB.176.1.198-205.1994; Dahlquist KD, 2000, J MOL BIOL, V299, P1, DOI 10.1006/jmbi.2000.3672; DOTTAVIOMARTIN D, 1979, FEBS LETT, V97, P105, DOI 10.1016/0014-5793(79)80062-9; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; GERCHMAN SE, 1994, PROTEIN EXPRES PURIF, V5, P242, DOI 10.1006/prep.1994.1037; GODEFROYCOLBURN T, 1975, J MOL BIOL, V94, P461, DOI 10.1016/0022-2836(75)90215-6; GRIBSKOV M, 1992, GENE, V119, P107, DOI 10.1016/0378-1119(92)90073-X; Gualerzi CO, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P477; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; GUALERZI CO, 1989, PROTEIN ENG, V3, P133, DOI 10.1093/protein/3.2.133; HARTZ D, 1990, GENE DEV, V4, P1790, DOI 10.1101/gad.4.10.1790; KYCIA JH, 1995, BIOCHEMISTRY-US, V34, P6183, DOI 10.1021/bi00018a022; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; McCutcheon JP, 1999, P NATL ACAD SCI USA, V96, P4301, DOI 10.1073/pnas.96.8.4301; Meinnel T, 1999, J MOL BIOL, V290, P825, DOI 10.1006/jmbi.1999.2881; Merryman C, 1999, J MOL BIOL, V285, P97, DOI 10.1006/jmbi.1998.2242; MOAZED D, 1995, J MOL BIOL, V248, P207, DOI 10.1016/S0022-2836(95)80042-5; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Moreno JMP, 1999, FEBS LETT, V455, P130, DOI 10.1016/S0014-5793(99)00858-3; NOLL M, 1972, NATURE-NEW BIOL, V238, P225, DOI 10.1038/newbio238225a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PON CL, 1984, FEBS LETT, V175, P203, DOI 10.1016/0014-5793(84)80737-1; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; STRINGER EA, 1977, J BIOL CHEM, V252, P1739; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; VanLoock MS, 2000, J MOL BIOL, V304, P507, DOI 10.1006/jmbi.2000.4213; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1997, STRUCTURE, V5, P1187, DOI 10.1016/S0969-2126(97)00269-4; WINTERMEYER W, 1983, BIOCHEMISTRY-US, V22, P690, DOI 10.1021/bi00272a025; Wu XQ, 1997, J BIOL CHEM, V272, P1891, DOI 10.1074/jbc.272.3.1891	40	293	328	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2001	291	5503					498	501		10.1126/science.1057766	http://dx.doi.org/10.1126/science.1057766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11228145				2022-12-28	WOS:000166487500046
J	Schwetz, BA				Schwetz, BA			Proposal for public disclosure about clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1146	1146		10.1001/jama.285.9.1146	http://dx.doi.org/10.1001/jama.285.9.1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231734				2022-12-28	WOS:000167194700008
J	Schwetz, BA				Schwetz, BA			New suppository for ulcerative proctitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2001	285	9					1146	1146		10.1001/jama.285.9.1146	http://dx.doi.org/10.1001/jama.285.9.1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406BH	11231734				2022-12-28	WOS:000167194700007
J	Bobrow, M; Thomas, S				Bobrow, M; Thomas, S			Patents in a genetic age - The present patent system risks becoming a barrier to medical progress.	NATURE			English	Editorial Material									Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XQ, England; Nuffield Council Bioeth, London WC1 3JS, England	Addenbrooke's Hospital; University of Cambridge	Bobrow, M (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Wellcome MRC Bldg, Cambridge CB2 2XQ, England.							Barton JH, 2000, SCIENCE, V287, P1933, DOI 10.1126/science.287.5460.1933; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Meyers TC, 2000, NAT STRUCT BIOL, V7, P950, DOI 10.1038/80723; 5835382	4	21	22	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2001	409	6822					763	764		10.1038/35057480	http://dx.doi.org/10.1038/35057480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	401QC	11236975				2022-12-28	WOS:000166938800013
